data_2fin_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fin _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.0 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.809 0.338 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -76.0 -29.29 58.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 m -49.26 129.8 18.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.511 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -58.6 -21.89 54.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.536 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.2 p -77.44 -20.12 55.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 m -82.95 -50.47 8.54 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.989 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -165.42 173.43 11.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.972 0.415 . . . . 0.0 111.095 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.86 159.28 3.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.4 p -85.06 173.76 10.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.917 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -119.25 5.36 11.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.319 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.29 92.87 7.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.75 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 17.9 mp0 -27.6 -63.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.506 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -77.16 53.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 22' ' ' HIS . 19.9 tttp -163.08 137.13 6.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 63.0 m80 -157.42 123.22 4.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.81 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 128' ' ' PRO . 2.0 t60 -64.67 109.26 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 111.219 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 72.9 mmm -84.43 137.44 33.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.381 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.57 156.56 22.51 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.5 tp -110.7 151.25 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -157.27 106.56 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 110.253 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.86 148.97 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.313 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mt -117.45 145.77 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.69 108.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.992 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -106.3 96.07 6.21 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -91.18 134.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.466 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 m -113.92 121.68 44.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.692 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -77.5 151.04 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.721 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.462 ' CD ' ' N ' ' A' ' 36' ' ' ASP . 13.5 tm0? -80.07 148.96 30.83 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 15.4 t70 -72.76 65.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.721 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -172.09 -23.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 0.0 110.114 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.2 m -75.14 121.78 85.97 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.214 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -39.62 159.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.87 1.713 . . . . 0.0 112.318 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -73.57 147.14 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.353 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 86' ' ' GLY . 0.6 OUTLIER -174.08 101.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -112.27 25.42 11.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -86.12 54.62 3.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.83 176.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.007 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.9 m 55.6 34.99 24.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 46' ' ' GLN . 29.8 tp60 -59.72 -43.06 94.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.054 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.426 ' HG ' ' N ' ' A' ' 48' ' ' VAL . 4.0 t 178.71 165.52 0.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.055 0.455 . . . . 0.0 110.754 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.426 ' N ' ' HG ' ' A' ' 47' ' ' SER . 5.1 p -150.2 134.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.538 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.4 m -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -82.98 141.62 31.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.588 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -143.39 154.37 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.92 110.73 4.06 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.79 115.59 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.298 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.52 -0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.094 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 CA--C 1.54 0.797 0 N-CA-C 113.111 0.389 . . . . 0.0 113.111 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -131.32 150.66 52.06 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.619 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.9 m -121.05 128.22 52.44 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -127.37 153.88 45.67 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.0 0.429 . . . . 0.0 110.496 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 64.4 m-85 -128.85 137.45 51.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.964 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.5 p -105.03 66.18 0.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.062 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.68 98.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.842 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.73 145.09 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.63 161.97 11.5 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.404 ' O ' ' ND2' ' A' ' 41' ' ' ASN . . . 61.3 25.62 65.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.187 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.06 65.3 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.595 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.2 163.0 30.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.934 0.397 . . . . 0.0 110.084 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -129.95 112.46 13.53 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.445 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 mpt? -101.09 106.95 18.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.958 0.408 . . . . 0.0 110.662 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -88.84 128.63 35.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.74 -162.95 1.0 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.624 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.1 70.45 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 5.0 p90 -89.0 156.16 19.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -141.46 125.64 17.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm 61.93 35.08 16.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.531 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 m -121.84 146.02 44.88 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -39.1 148.03 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.928 1.752 . . . . 0.0 112.159 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -64.46 145.05 56.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.5 mt -108.47 116.64 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -119.28 0.8 11.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -115.38 118.26 32.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.503 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.33 120.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.8 m -144.91 159.25 43.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.857 0.36 . . . . 0.0 110.738 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -148.76 168.33 23.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.82 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.71 159.34 24.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.511 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.18 127.7 36.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.545 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -142.25 107.6 5.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.482 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.23 -134.38 19.61 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -96.43 23.38 6.83 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.778 0.323 . . . . 0.0 110.383 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -130.54 159.34 37.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.434 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.03 138.86 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.471 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -108.34 171.38 7.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 111.647 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.5 120.44 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.55 ' NH2' ' HG ' ' A' ' 235' ' ' SER . 7.3 tpp85 -113.97 114.9 26.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.826 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.8 mp -115.84 127.42 55.03 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.4 p -164.7 175.96 9.26 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.664 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.433 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 73.6 p -92.79 166.36 12.47 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.6 m -92.55 145.5 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 0.0 110.879 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.2 p -89.26 150.09 44.15 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.32 162.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.776 1.65 . . . . 0.0 112.21 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.13 69.99 0.84 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.136 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.11 -46.13 0.43 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.21 -8.09 2.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.081 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -117.57 -176.86 3.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.63 170.13 12.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -163.21 61.89 1.1 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.946 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.501 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 97.1 Cg_exo -42.87 125.16 3.84 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.84 2.36 . . . . 0.0 113.484 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.31 149.92 21.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -149.57 163.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 p -79.61 177.42 8.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -71.25 -34.74 71.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.42 -43.88 80.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.95 -30.57 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.41 -56.52 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.162 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -32.58 39.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.163 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.1 66.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.512 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.1 mtt -63.69 -56.72 13.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.626 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 50.5 mt -46.35 -22.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -86.19 -42.06 14.14 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.72 -27.16 25.45 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.53 119.38 3.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -138.72 125.0 20.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.338 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 145' ' ' SER . 93.4 t -94.49 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.479 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.467 ' N ' ' CG1' ' A' ' 144' ' ' VAL . 12.4 p -140.22 144.54 36.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.386 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.1 mt -140.83 143.1 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.984 0.421 . . . . 0.0 110.595 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -158.29 77.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.027 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.62 152.0 6.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -134.7 -149.11 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.344 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.4 t -132.67 108.97 9.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.216 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 m -97.25 173.08 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.5 10.79 0.97 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.927 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -64.22 104.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.759 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.24 1.93 30.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -52.34 150.15 4.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.565 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.03 171.59 1.69 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.162 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 80.5 p -97.83 149.62 22.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.922 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -121.5 93.35 3.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.735 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.35 178.1 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.807 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' A' ' 162' ' ' HIS . 42.9 tttp -135.64 125.9 26.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.831 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.3 m -57.95 -2.33 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.24 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.608 ' HD1' ' N ' ' A' ' 163' ' ' PRO . 1.3 t-80 -75.08 116.36 53.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.376 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.608 ' N ' ' HD1' ' A' ' 162' ' ' HIS . 64.6 Cg_exo -40.49 160.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.81 1.674 . . . . 0.0 111.97 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.31 129.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 mt -79.03 121.26 24.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.56 160.68 22.76 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.303 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -92.04 8.08 39.36 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 58.75 -0.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.494 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 167' ' ' SER . 9.4 tp -90.73 141.82 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -88.58 -176.53 5.32 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -123.73 24.2 8.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.026 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -58.26 -166.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -101.8 122.94 44.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.07 -168.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.254 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.7 m -49.78 148.54 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 54.5 p90 -98.34 133.38 42.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.07 132.34 23.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.39 97.85 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.568 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.5 mt -107.86 -51.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -56.23 115.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.946 0.403 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.78 -123.86 0.7 Allowed Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.1 t -75.2 148.7 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.763 0.316 . . . . 0.0 110.759 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.3 p -141.81 87.23 2.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.556 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 8.8 tp -98.87 135.58 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.9 129.96 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.711 0.291 . . . . 0.0 111.526 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -81.79 90.02 6.35 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -46.25 -27.22 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.279 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -44.93 -16.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.76 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 187' ' ' THR . 57.0 m -143.71 24.55 1.69 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 p -163.98 104.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.512 0.672 . . . . 0.0 110.313 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -72.21 -56.52 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.493 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -125.71 141.1 52.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.236 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.1 tt -145.34 106.74 4.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.66 151.86 19.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.05 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -140.77 138.03 33.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 110.242 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.452 ' HG ' ' C ' ' A' ' 195' ' ' PHE . 1.8 m -143.85 135.92 26.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.347 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.2 160.06 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -171.79 113.87 0.34 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.985 0.421 . . . . 0.0 110.842 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.3 128.96 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.791 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.76 167.71 40.36 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.224 -0.512 . . . . 0.0 111.938 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -53.46 123.34 11.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.433 ' SD ' ' OG ' ' A' ' 118' ' ' SER . 77.9 mtm -82.74 4.67 24.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 34.8 t -106.88 -46.76 3.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.69 117.56 2.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 6.0 mp0 -43.98 156.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.701 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 208' ' ' GLU . 17.9 t -141.11 17.8 2.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.646 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 208' ' ' GLU . 73.7 p 56.28 -74.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.0 mm-40 -49.25 -54.41 16.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.57 0.224 . . . . 0.0 111.597 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 209' ' ' LEU . 8.4 mp -74.57 4.38 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -104.0 124.21 48.61 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.8 m -146.56 -179.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.22 167.55 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.485 0.66 . . . . 0.0 111.834 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 213' ' ' ASP . 0.6 OUTLIER -157.3 172.9 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.956 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 157.3 143.4 3.65 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.496 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -121.15 179.28 4.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.98 104.16 5.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.406 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -97.72 118.71 34.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.877 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.1 t -138.34 100.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.38 52.45 13.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.923 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.99 48.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.646 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.9 t -85.63 106.03 16.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 111.479 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.5 143.96 32.03 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.2 m -164.63 130.85 2.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.647 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -82.25 140.91 33.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.351 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -177.71 110.8 0.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.63 127.39 32.85 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 47.1 p -150.21 161.07 43.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.09 95.52 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.607 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -87.21 26.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.286 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.6 m -67.13 -29.57 69.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.6 t -116.57 5.89 13.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.664 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.28 -28.43 0.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 35.9 pt -156.39 152.01 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.33 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.11 98.92 4.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.55 ' HG ' ' NH2' ' A' ' 115' ' ' ARG . 23.3 t -64.08 -9.58 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.298 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 64.3 p -82.79 -12.37 57.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -102.74 7.44 39.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.576 0.227 . . . . 0.0 111.386 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -81.32 132.04 35.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.097 0.475 . . . . 0.0 110.786 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -123.15 135.55 54.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.388 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.74 127.3 31.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.104 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 34.0 m -88.58 -3.72 58.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.695 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.432 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 11.7 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.434 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 1.8 t -97.11 154.06 17.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.691 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.65 146.59 48.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -116.84 -23.46 8.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.335 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -151.54 154.9 37.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.108 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -114.95 154.82 28.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.91 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -76.38 139.75 41.1 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 -20.94 40.54 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.149 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -105.54 127.88 53.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -84.51 114.34 21.87 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.45 115.15 42.84 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.903 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.67 153.44 0.15 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.045 1.83 . . . . 0.0 112.606 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 25' ' ' VAL . 84.5 mtp180 -45.7 -49.89 14.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.67 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.416 ' N ' HD21 ' B' ' 23' ' ' ASN . 2.3 m120 -38.89 -34.69 0.16 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.9 OUTLIER -106.08 38.18 2.09 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.934 0.397 . . . . 0.0 109.983 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' B' ' 22' ' ' ARG . 48.8 t -152.95 97.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.571 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.7 -13.86 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.88 179.48 9.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.189 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.492 ' O ' ' CD2' ' B' ' 29' ' ' TYR . 13.4 p90 -165.56 169.92 14.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.187 0.518 . . . . 0.0 111.796 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' B' ' 28' ' ' TYR . 94.5 m-85 -159.0 153.62 24.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.601 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' B' ' 31' ' ' THR . 41.6 mt-10 -97.71 147.31 24.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.854 0.359 . . . . 0.0 111.11 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.475 ' HG1' ' H ' ' B' ' 39' ' ' ALA . 41.9 p -53.11 -110.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.146 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.7 m -150.81 -145.72 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.666 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.5 ' C ' ' H ' ' B' ' 35' ' ' CYS . 65.9 p -141.38 -22.9 0.74 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.424 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.23 -5.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.1 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.5 ' H ' ' C ' ' B' ' 33' ' ' SER . 8.6 p -117.5 120.83 39.3 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 34.4 t -72.66 36.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.245 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.473 ' H ' ' C ' ' B' ' 35' ' ' CYS . 11.9 pt20 -167.51 60.86 0.53 Allowed Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.16 -161.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.665 2.243 . . . . 0.0 112.83 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . 0.475 ' H ' ' HG1' ' B' ' 31' ' ' THR . . . 173.48 176.92 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 134.98 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.67 130.32 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.018 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -111.26 146.51 36.87 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.48 169.06 10.63 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -136.12 -142.92 0.18 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.249 0.547 . . . . 0.0 111.092 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.499 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.53 -40.46 2.22 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.848 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.47 47.88 2.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.39 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' B' ' 48' ' ' ALA . 59.6 p -151.48 -79.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.422 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' B' ' 47' ' ' SER . . . 155.58 -90.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.76 147.67 35.95 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.954 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.63 123.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.021 0.438 . . . . 0.0 110.111 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.76 162.26 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.242 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.5 125.71 7.32 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.762 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.14 123.06 82.99 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 0.37 8.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.235 1.29 . . . . 0.0 111.357 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 62.2 p -68.22 -14.7 63.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -100.08 124.02 44.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -50.86 -38.38 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.989 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -56.4 -33.69 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.744 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.89 -36.35 57.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.123 0.487 . . . . 0.0 109.887 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.72 -37.94 73.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.482 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -71.01 -35.69 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.176 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.05 -37.65 88.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.71 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 60.9 t -70.67 -45.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.93 -38.97 80.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.986 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.1 -41.72 90.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.932 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.25 -19.81 63.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.51 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.33 66.2 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.9 mt -76.4 -77.49 0.14 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.896 0.379 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.529 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.824 0.345 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -76.58 -23.91 53.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.685 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -51.08 139.59 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.6 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 p -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.702 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -77.59 -28.7 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.71 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.9 p -78.55 -50.79 10.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.999 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -161.92 172.6 15.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.705 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.41 150.59 47.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.346 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 18' ' ' GLU . 12.4 t -63.48 170.45 3.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 0.0 110.742 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' N ' ' HG1' ' A' ' 16' ' ' THR . 23.8 mp0 -113.06 4.88 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.593 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.663 ' H ' ' HG1' ' A' ' 16' ' ' THR . 60.8 mm-40 -61.98 -164.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.964 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -127.01 -62.85 1.09 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.0 110.72 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -82.15 34.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.535 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.93 142.5 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -144.43 159.75 42.22 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.0 OUTLIER -88.02 81.56 7.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.852 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.605 ' N ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -69.33 123.67 21.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.65 179.31 17.03 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 tt -136.0 154.92 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.747 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 53.8 t0 -145.67 137.65 25.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.435 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 91.9 t -137.95 107.87 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.538 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.498 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.3 mp -94.28 142.62 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.577 ' H ' HH21 ' A' ' 115' ' ' ARG . 9.1 tt -155.62 117.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.54 0.686 . . . . 0.0 111.482 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -104.52 127.65 52.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.663 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -125.31 117.1 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.043 0.449 . . . . 0.0 111.89 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 m -96.79 132.98 41.96 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -94.54 164.0 13.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.926 0.394 . . . . 0.0 109.971 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.76 157.1 37.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.019 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -83.02 -34.67 26.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.993 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.2 m -45.04 110.77 1.14 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.03 159.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.725 1.616 . . . . 0.0 111.998 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -70.04 137.92 51.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.796 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -157.68 102.87 1.89 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 44' ' ' ILE . 14.5 t70 -101.6 -12.93 18.08 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.762 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -58.4 81.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.977 0.418 . . . . 0.0 110.548 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.5 tp -86.56 156.25 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 12.4 t 57.08 61.8 2.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.539 0.685 . . . . 0.0 110.048 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 155' ' ' LYS . 7.9 tt0 -80.26 -30.07 38.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 46' ' ' GLN . 38.0 m -171.54 166.76 6.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.488 ' CG2' ' SG ' ' A' ' 241' ' ' CYS . 6.7 t -148.7 105.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -106.71 112.16 25.02 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.869 0.366 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -89.09 138.61 31.26 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.284 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.1 mt -140.39 151.25 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.9 p -149.59 138.65 21.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.224 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -45.26 169.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.961 179.913 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 N--CA 1.463 -0.323 0 N-CA-C 110.791 -0.504 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -130.82 145.69 52.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.936 0.398 . . . . 0.0 111.251 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.9 t -121.86 130.95 53.77 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -124.91 114.98 19.88 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.952 0.406 . . . . 0.0 111.252 -177.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.86 124.15 37.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.289 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -96.36 71.58 2.76 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.05 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.42 111.97 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.997 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.82 169.49 18.1 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.339 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.31 20.36 43.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.851 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.88 10.0 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.75 155.53 46.49 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -121.38 106.9 11.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 mtt -101.57 106.66 17.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.942 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -95.6 127.67 41.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.539 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.75 -169.93 1.73 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.29 72.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -76.21 135.78 39.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 110.972 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.2 m -140.04 122.61 16.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.0 32.66 22.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.3 m -121.42 149.56 52.57 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.644 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -38.7 152.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.98 1.787 . . . . 0.0 112.093 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 99' ' ' GLN . 19.4 mp0 -79.57 109.25 13.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.041 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 127.37 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.848 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -123.13 2.78 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.467 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.0 p -130.86 131.24 44.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.25 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.2 tt -144.98 130.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.6 p -150.29 152.84 35.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.182 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -142.28 175.49 9.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 110.689 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 t -168.54 164.36 12.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.948 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.17 131.38 42.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 20.9 p-10 -144.43 107.74 4.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.028 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.41 -122.72 18.7 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.744 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -102.93 20.82 16.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.621 0.248 . . . . 0.0 110.649 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.4 p -128.63 151.84 49.03 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.076 0.465 . . . . 0.0 111.024 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.42 135.88 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.61 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.73 165.42 11.08 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 111.458 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.632 ' H ' ' NH2' ' A' ' 115' ' ' ARG . . . -163.46 120.56 1.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.632 ' NH2' ' H ' ' A' ' 114' ' ' ALA . 13.1 mmp_? -115.34 111.66 21.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.422 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.24 118.91 37.22 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.484 ' HG ' ' HG ' ' A' ' 167' ' ' SER . 33.4 p -156.75 177.08 11.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.328 0.585 . . . . 0.0 111.763 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 p -93.38 164.96 13.01 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.534 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.457 ' O ' ' CE ' ' A' ' 202' ' ' MET . 8.2 p -97.78 130.49 46.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 111.326 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 p -72.91 153.29 91.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.797 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.17 151.53 58.68 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.934 1.756 . . . . 0.0 111.5 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.35 50.12 8.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.23 -0.509 . . . . 0.0 111.845 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -134.75 -22.76 1.63 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.778 0.323 . . . . 0.0 110.281 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.73 14.97 11.53 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -135.04 164.48 27.54 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.24 148.01 45.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.509 . . . . 0.0 111.757 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.0 m -155.43 62.66 3.37 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.705 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.4 142.26 2.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.877 2.385 . . . . 0.0 113.361 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.56 150.22 22.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.231 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 tp -131.01 164.61 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.649 0.261 . . . . 0.0 110.62 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.8 m -81.66 154.92 25.86 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 121.182 0.515 . . . . 0.0 111.322 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -50.73 -38.43 47.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.724 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -56.53 -42.34 78.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.14 -56.84 16.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 tp -51.65 -35.44 42.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.909 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.19 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.737 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.403 ' C ' ' N ' ' A' ' 140' ' ' LYS . 48.5 mtt -69.07 -62.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.526 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.5 mt -44.96 -20.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.728 0.299 . . . . 0.0 111.218 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 138' ' ' MET . 19.7 tptm -87.47 -33.65 18.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.396 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -94.36 -26.03 16.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 34.0 t -49.61 118.62 2.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -137.72 118.93 14.53 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.2 t -115.16 126.89 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.5 p -100.96 165.14 11.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.9 mp -142.96 150.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.11 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -160.77 86.89 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.705 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.8 tt -83.32 151.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 111.904 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.48 ' CG ' ' H ' ' A' ' 150' ' ' CYS . 57.2 ttt180 -149.01 176.07 10.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.075 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.48 ' H ' ' CG ' ' A' ' 149' ' ' ARG . 11.8 m -90.99 143.35 26.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 65.3 p -129.91 124.77 33.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.311 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.22 -10.09 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.498 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 153' ' ' GLU . 1.5 mp0 -51.34 101.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -89.21 17.22 6.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.949 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.491 ' N ' ' OE1' ' A' ' 46' ' ' GLN . 63.6 mmtt -58.47 162.18 3.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.496 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 168.87 8.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.73 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.6 p -97.38 148.89 22.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 85.2 m-20 -117.21 91.11 3.48 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.65 177.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.141 0.496 . . . . 0.0 111.232 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -105.88 -171.39 1.89 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -127.32 -6.01 5.95 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.429 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 37.1 m80 -108.88 129.05 24.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.895 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -39.18 157.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.176 1.917 . . . . 0.0 112.807 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.21 143.91 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.173 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.39 116.33 22.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.891 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.02 172.68 49.85 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.624 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 169' ' ' ILE . 11.4 m -105.18 8.88 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.8 m-20 59.24 -3.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.501 ' H ' ' C ' ' A' ' 167' ' ' SER . 56.4 mt -86.96 154.3 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 172' ' ' LYS . 53.9 p -118.33 135.52 54.26 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.512 ' NE2' ' OG ' ' A' ' 196' ' ' SER . 0.1 OUTLIER -73.55 39.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.583 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 170' ' ' SER . 26.0 mmtp -67.12 179.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.15 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -90.97 122.02 33.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.43 -160.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.8 t -50.81 140.83 14.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.138 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -104.95 139.86 39.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 11.3 tm-20 -161.22 146.21 13.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.481 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.437 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 41.8 t0 -66.94 104.17 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.859 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.4 mt -114.19 -23.86 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.9 pt -90.91 137.95 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 110.876 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.38 -134.47 7.05 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.438 ' HG ' ' N ' ' A' ' 183' ' ' THR . 35.7 t -71.59 154.78 41.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.314 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.438 ' N ' ' HG ' ' A' ' 182' ' ' SER . 84.8 m -149.74 94.54 2.19 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 1.7 mp -97.39 138.11 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.61 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 1.5 m -140.92 123.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.032 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.46 ' OD2' ' SG ' ' A' ' 150' ' ' CYS . 34.6 p-10 -79.39 110.23 14.49 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.2 m -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -34.97 -46.17 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.09 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 26.5 p -143.09 40.29 1.49 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.299 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.4 t -149.4 96.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -80.12 -58.93 2.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.137 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 36.3 t-20 -127.28 137.65 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.118 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.432 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 7.7 tt -138.61 106.67 5.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.934 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -93.48 140.25 29.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -137.77 133.43 34.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.993 0.425 . . . . 0.0 111.259 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 171' ' ' HIS . 1.2 t -144.02 144.25 31.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.934 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 198' ' ' ARG . 2.7 p -139.43 166.62 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.937 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.491 ' N ' ' CG2' ' A' ' 197' ' ' VAL . 21.3 ttt180 -169.35 111.27 0.48 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.783 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 25.6 mt -102.37 122.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -163.24 -161.28 12.3 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -78.86 137.71 37.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.496 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 22.6 mtp -92.09 -6.37 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.258 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.45 -57.8 2.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.544 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -155.22 136.03 13.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -42.72 158.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.198 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 9.6 t -147.15 6.56 0.88 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.504 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.2 m 58.44 -75.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.0 mt-10 -47.84 -48.85 30.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.867 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.23 0.42 45.58 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 207' ' ' SER . 10.0 mp0 -95.72 118.03 31.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.96 163.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.077 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -164.28 168.01 19.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.573 0.701 . . . . 0.0 112.188 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.7 t70 -141.53 171.33 14.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.861 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 173.13 148.13 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.145 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -139.62 174.22 10.74 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -139.17 104.14 4.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.964 0.411 . . . . 0.0 110.592 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.57 116.8 30.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.477 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.65 118.88 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.391 0.615 . . . . 0.0 110.959 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 15.5 t70 48.25 43.04 18.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.769 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.32 -3.9 85.09 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.469 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.1 t -100.4 116.7 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.027 0.413 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.403 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -102.77 150.55 23.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.792 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 70.9 m -166.24 128.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.455 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -77.61 141.5 39.44 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.86 101.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.267 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.28 98.02 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.3 p -129.28 160.09 34.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.405 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -63.32 95.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -89.95 35.92 0.85 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.608 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.6 p -71.51 -45.22 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 233' ' ' ILE . 44.4 t -94.34 -1.9 53.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 53.5 tp -42.15 -20.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.757 0.313 . . . . 0.0 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 231' ' ' SER . 2.2 pp -149.16 174.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.329 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.93 93.87 5.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.004 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 82.3 p -66.18 -6.2 12.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 60.0 p -91.78 -17.21 25.7 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -105.05 4.71 31.85 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.18 161.15 29.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.159 0.504 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -144.6 129.73 18.58 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.962 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.66 155.75 9.46 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 48' ' ' VAL . 28.3 t -119.2 -3.85 10.55 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.62 179.725 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.4 m -119.1 128.37 54.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 p -71.21 135.2 47.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.218 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -110.34 -15.48 13.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.569 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 75.7 m -122.98 147.24 46.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.316 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.487 ' CE2' ' OD1' ' B' ' 53' ' ' ASP . 16.8 m-85 -118.89 153.6 34.3 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.244 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -78.97 134.88 36.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.905 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.66 27.94 4.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.788 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.02 126.64 21.89 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.943 0.401 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -57.51 164.01 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.91 89.95 33.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -41.91 142.87 1.32 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.737 1.625 . . . . 0.0 111.987 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -42.9 -48.51 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.45 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -37.72 -34.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -107.54 42.4 1.34 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.675 0.274 . . . . 0.0 111.227 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -144.44 86.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.038 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.54 -28.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 26.7 t0 -157.83 -179.77 8.46 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.648 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.505 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.4 p90 -163.06 169.06 20.07 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.233 0.539 . . . . 0.0 112.071 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 55.7 t80 -159.06 164.45 35.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.132 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.6 pt-20 -114.38 152.21 31.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.72 0.295 . . . . 0.0 110.588 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.426 ' O ' ' O ' ' B' ' 30' ' ' GLU . 36.3 p -55.69 -116.1 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.078 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -149.43 -156.07 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.473 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.501 ' C ' ' H ' ' B' ' 35' ' ' CYS . 75.2 m -126.09 -24.62 3.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.343 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.4 mm? -53.09 -9.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.227 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' B' ' 33' ' ' SER . 4.1 p -120.13 123.65 43.85 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -74.57 42.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -166.31 56.86 0.42 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.97 -161.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 122.795 2.33 . . . . 0.0 113.013 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 167.83 177.39 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.67 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.77 134.07 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.137 0.494 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.94 141.83 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.474 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -119.33 150.32 40.34 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.683 0.277 . . . . 0.0 110.649 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -115.63 112.13 21.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 109.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 4.7 p -75.62 -138.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.027 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.485 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -131.02 -32.22 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.062 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.39 40.5 3.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.043 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 27.4 t -142.94 -83.35 0.17 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 121.378 -0.129 . . . . 0.0 110.704 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 154.58 -90.73 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.704 0.627 . . . . 0.0 109.612 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' O ' ' B' ' 48' ' ' ALA . 15.4 mm100 -141.11 135.98 31.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 t -148.57 124.0 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.424 0.631 . . . . 0.0 110.26 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.3 t -72.35 155.57 40.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.468 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 135.24 17.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.271 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . 0.487 ' OD1' ' CE2' ' B' ' 15' ' ' TYR . 60.9 m-20 -63.86 128.16 92.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.237 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.25 0.6 9.23 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.423 1.415 . . . . 0.0 110.889 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 71.0 m -70.57 -12.55 61.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.198 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -96.46 129.21 43.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.205 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 31.9 t -48.75 -51.97 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.041 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -56.5 -32.46 65.07 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.001 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.98 -35.89 76.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.819 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -73.95 -37.84 64.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.628 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.4 -36.91 79.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.859 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.7 -36.68 84.66 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.64 -42.83 86.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' OE2' ' B' ' 67' ' ' GLU . 57.4 t80 -62.67 -34.17 76.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.472 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -70.05 -48.35 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.9 -19.62 66.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -71.77 -32.69 67.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.1 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' B' ' 69' ' ' ASN . 7.5 tt -83.66 -79.51 0.2 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.539 ' N ' ' CD2' ' B' ' 68' ' ' LEU . 49.3 t30 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.51 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.884 0.373 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 m -76.87 -19.49 57.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 13' ' ' SER . 15.9 p -50.08 141.24 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.615 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.8 p -68.96 -5.77 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -101.86 -18.31 15.79 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.563 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.703 ' H ' ' HG ' ' A' ' 10' ' ' SER . 57.9 m -86.75 -48.85 7.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -156.71 177.1 11.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.012 0.434 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.71 141.78 39.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.613 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.488 ' OG1' ' NE2' ' A' ' 23' ' ' HIS . 2.4 m -61.39 166.67 3.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.884 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.4 9.71 12.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.017 0.437 . . . . 0.0 109.903 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' LYS . 49.9 mt-10 -86.02 91.5 8.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -33.98 -41.73 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.812 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -80.6 25.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.532 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.4 mmtp -138.43 136.52 36.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.847 0.356 . . . . 0.0 110.08 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.578 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 27.9 m170 -130.92 135.33 47.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.488 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 11.6 m-70 -80.62 102.8 10.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -66.41 175.56 2.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.268 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.39 126.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 tt -109.91 150.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.876 0.37 . . . . 0.0 110.454 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -132.86 141.82 48.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.66 97.47 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.8 0.334 . . . . 0.0 111.246 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mm -91.69 136.43 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.15 126.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.33 0.586 . . . . 0.0 111.501 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -115.82 126.87 54.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.76 133.21 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.744 0.307 . . . . 0.0 111.383 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -105.79 130.72 53.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -80.42 155.09 27.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.232 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.414 ' N ' ' HG1' ' A' ' 38' ' ' THR . 12.9 tp60 -66.88 179.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -77.85 -31.34 51.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.707 0.289 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.38 -34.01 31.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.218 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.414 ' HG1' ' N ' ' A' ' 35' ' ' GLN . 15.4 p -40.98 104.96 0.36 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.134 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.5 164.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.9 1.733 . . . . 0.0 111.941 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 p -68.21 145.87 53.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.489 ' C ' HD21 ' A' ' 41' ' ' ASN . 0.3 OUTLIER -171.64 97.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -103.02 0.09 31.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.653 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.1 87.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.402 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 pt -85.07 150.79 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 39.2 t 57.18 64.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.644 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.501 HE22 ' C ' ' A' ' 156' ' ' ASP . 37.8 mm-40 -77.29 -26.89 52.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 t 174.29 164.63 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.72 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -144.21 139.04 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.73 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.2 m -136.54 102.71 5.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.811 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -82.3 126.24 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.338 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.07 152.83 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.8 137.94 16.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.537 ' CG ' ' H ' ' A' ' 54' ' ' SER . 1.4 tm-20 -52.95 -176.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.537 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 31.1 t . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 78' ' ' THR . 44.2 Cg_endo . . . . . 0 CA--C 1.534 0.521 0 N-CA-C 111.388 -0.274 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 77' ' ' PRO . 9.6 t -139.43 144.82 38.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.731 0.3 . . . . 0.0 110.897 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.484 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 1.6 p -105.35 130.92 53.35 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -123.79 111.63 16.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.74 0.305 . . . . 0.0 110.91 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.2 120.38 40.36 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -91.16 77.82 5.93 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.632 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.32 106.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 tt -98.08 146.96 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.116 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.63 173.37 20.68 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.08 18.37 26.9 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.341 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.15 3.53 88.4 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.095 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.9 mt -129.88 158.07 40.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.913 0.387 . . . . 0.0 110.337 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -126.02 113.09 16.66 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.53 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.451 ' C ' HD21 ' A' ' 91' ' ' ASN . 16.7 mtt -101.91 111.39 23.63 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.766 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.663 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.7 OUTLIER -99.84 124.52 45.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.755 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.17 -167.09 1.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.03 71.91 0.05 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.912 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.484 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -77.68 148.29 35.06 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.227 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.9 m -136.02 114.28 11.55 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.6 tttt 64.27 40.18 6.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.97 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.6 m -124.59 149.72 62.82 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -37.79 147.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.068 1.845 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -74.85 109.91 8.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 133.51 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.086 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 -13.59 6.77 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.544 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t -105.6 121.81 44.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.922 0.391 . . . . 0.0 110.835 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 mt -135.37 121.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.572 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 10.9 t -137.63 178.22 7.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 111.017 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.491 ' N ' ' OG ' ' A' ' 104' ' ' SER . 55.3 tt0 -161.68 154.44 20.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.428 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.31 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.68 133.46 43.58 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -148.68 115.15 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.251 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.83 -104.5 1.55 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.209 -0.519 . . . . 0.0 111.941 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -129.35 24.84 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 110.349 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.68 159.22 40.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.38 138.25 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.69 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.676 HD21 ' H ' ' A' ' 114' ' ' ALA . 1.7 t-20 -116.88 147.06 42.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.537 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.676 ' H ' HD21 ' A' ' 113' ' ' ASN . . . -143.19 129.76 20.19 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.873 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -115.26 115.41 26.62 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.121 0.486 . . . . 0.0 111.459 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.536 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -115.88 120.5 39.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.459 ' HG ' ' H ' ' A' ' 118' ' ' SER . 7.9 t -159.09 -178.83 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.206 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.459 ' H ' ' HG ' ' A' ' 117' ' ' SER . 74.2 p -91.82 159.66 15.69 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.45 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.88 147.16 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.045 0.45 . . . . 0.0 111.528 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 p -87.39 152.1 51.9 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.729 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.32 162.89 18.83 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.943 1.762 . . . . 0.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.79 -1.51 58.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.99 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -81.05 -56.08 4.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.547 0.213 . . . . 0.0 110.55 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.17 -9.02 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.638 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -113.85 175.67 5.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -77.14 152.01 35.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 111.265 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.5 m -154.38 63.2 4.02 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.65 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.54 151.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.061 2.507 . . . . 0.0 113.273 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.08 150.2 41.56 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.113 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.7 tp -144.82 164.57 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.554 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 48.6 p -68.91 171.62 7.76 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.239 0.543 . . . . 0.0 111.436 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.578 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 5.0 m170 -68.07 -33.79 75.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.171 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.51 -57.19 12.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.845 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -62.95 -42.98 99.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.607 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -57.02 11.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.952 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.14 -34.52 66.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.933 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.14 -30.44 65.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.3 mtt -74.33 -61.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.634 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.0 pt -47.24 -21.8 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.663 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -82.54 -30.61 29.61 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.27 -28.09 13.16 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 48.6 t -49.54 119.21 3.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 0.0 111.313 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -137.0 118.03 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.99 125.34 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.8 t -100.79 158.21 16.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.129 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.7 mm -140.76 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.912 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -152.32 88.83 1.39 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 mt -85.93 148.41 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.013 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -148.41 178.41 8.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.481 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.0 t -91.75 125.14 36.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.548 ' HG ' ' N ' ' A' ' 152' ' ' GLU . 9.5 t -109.54 162.23 14.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.548 ' N ' ' HG ' ' A' ' 151' ' ' SER . 27.0 mp0 -139.7 19.12 2.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.62 0.247 . . . . 0.0 110.939 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -75.86 103.28 5.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.273 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.98 8.7 11.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 4.0 mptp? -52.81 173.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.501 ' C ' HE22 ' A' ' 46' ' ' GLN . 28.0 m-20 -81.66 171.42 14.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -95.12 143.62 26.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.462 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 77.8 m-20 -114.78 92.72 4.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.755 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 160' ' ' LYS . 96.6 mt -123.47 163.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 162' ' ' HIS . 21.7 pttm -125.12 138.43 54.17 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.62 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 54.2 m -65.09 6.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.653 ' N ' ' HD1' ' A' ' 162' ' ' HIS . 0.2 OUTLIER -76.18 117.62 65.44 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.434 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.87 158.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.661 1.574 . . . . 0.0 111.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.75 128.77 38.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.0 112.15 17.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.69 171.07 40.97 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.526 -0.369 . . . . 0.0 112.509 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 169' ' ' ILE . 5.8 t -103.8 8.9 37.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.007 0.432 . . . . 0.0 109.91 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 60.48 -5.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.95 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.2 pp -80.38 164.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.759 -0.377 . . . . 0.0 109.991 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 172' ' ' LYS . 6.1 t -126.82 130.64 50.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -72.45 37.86 0.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.813 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 170' ' ' SER . 49.4 pttt -66.64 -173.4 0.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.004 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.04 119.83 35.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.0 110.715 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.492 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 0.2 OUTLIER -142.08 -166.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.4 m -50.89 145.32 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.853 0.359 . . . . 0.0 110.551 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -98.25 131.37 44.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.57 114.66 8.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.901 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.8 OUTLIER -61.77 99.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.52 6.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 82.6 mt -100.6 113.61 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.97 -137.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.994 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.507 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 6.1 t -72.81 158.45 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.5 p -143.59 90.02 2.12 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.91 128.03 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.099 0.476 . . . . 0.0 109.76 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.38 123.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.157 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -82.65 109.52 16.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.11 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 28.1 m -45.93 -27.06 0.81 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.506 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -34.58 -38.37 0.07 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.199 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 79.7 m -142.15 31.32 1.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 28.4 m -155.9 103.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.127 0.489 . . . . 0.0 110.65 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.49 -56.2 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.641 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 217' ' ' TYR . 7.4 t-20 -115.07 171.46 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 192' ' ' ASN . 0.3 OUTLIER 179.45 105.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.49 . . . . 0.0 109.804 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.62 142.07 36.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.347 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -127.99 142.74 51.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.595 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 5.9 p -143.51 136.68 27.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.1 t -131.42 158.38 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.446 ' CD ' ' O ' ' A' ' 170' ' ' SER . 14.1 ttt85 -166.3 106.6 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.251 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 tp -109.42 124.46 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -167.96 -151.97 7.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.86 118.57 30.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.41 ' H ' ' HG3' ' A' ' 202' ' ' MET . 0.0 OUTLIER -84.61 4.83 30.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.445 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 1.3 m -99.63 -50.73 3.97 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -161.36 127.81 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.708 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -43.64 145.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.1 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 208' ' ' GLU . 3.2 t -131.6 5.99 4.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.488 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.491 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.4 t 58.31 -76.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.662 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' SER . 50.5 mt-10 -48.81 -50.19 35.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.774 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 209' ' ' LEU . 8.0 mp -80.63 0.84 32.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.243 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 210' ' ' GLU . 13.6 mp0 -101.67 124.85 48.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.837 0.351 . . . . 0.0 110.801 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.96 -178.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.492 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 16.8 ptmt -165.54 167.79 17.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.531 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -159.59 169.61 23.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.982 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 146.69 140.25 3.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.24 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -119.69 -168.94 1.68 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.64 ' HZ3' ' HG1' ' A' ' 227' ' ' THR . 77.3 mttt -144.98 110.0 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.523 ' O ' ' ND2' ' A' ' 192' ' ' ASN . 97.7 m-85 -103.41 122.07 44.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.103 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.8 117.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.191 0.52 . . . . 0.0 110.583 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 1.1 m-20 51.87 42.33 30.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.486 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.27 -0.71 87.22 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.4 -0.429 . . . . 0.0 113.145 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.0 m -97.49 117.03 30.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.935 0.368 . . . . 0.0 110.158 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.409 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -89.58 159.14 17.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.483 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 65.8 m -168.13 110.43 0.59 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.24 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -78.51 141.75 37.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.62 123.14 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.573 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.07 103.96 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.326 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.64 ' HG1' ' HZ3' ' A' ' 216' ' ' LYS . 61.2 p -129.83 151.76 50.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 228' ' ' ASP . 0.8 OUTLIER -51.16 95.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -90.69 27.32 1.79 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.2 m -74.0 -32.49 63.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.97 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 233' ' ' ILE . 13.9 m -103.12 -3.91 25.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.204 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -40.79 -27.84 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 0.0 110.749 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.522 ' N ' ' CD1' ' A' ' 233' ' ' ILE . 0.0 OUTLIER -144.01 -177.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.585 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 236' ' ' THR . 12.3 m-20 -118.51 91.93 3.69 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.1 m -62.22 1.51 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.291 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 234' ' ' ASP . 44.6 p -90.24 -22.9 21.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.36 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.87 6.66 39.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.607 0.241 . . . . 0.0 111.049 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.82 138.26 32.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.947 0.403 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 104' ' ' SER . 46.5 mttm -126.43 142.55 51.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.07 167.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 242' ' ' VAL . 40.7 t -132.39 -11.51 3.18 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 241' ' ' CYS . 13.4 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.295 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.516 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 94.1 m -137.27 128.07 27.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.099 0.476 . . . . 0.0 111.34 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 t -39.71 135.82 1.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.638 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.516 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 12.4 m-85 -117.17 -25.85 6.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.317 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -151.94 150.77 30.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -107.81 157.59 18.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -78.79 135.8 37.19 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.08 24.82 2.0 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.69 0.281 . . . . 0.0 110.388 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.75 127.88 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 110.74 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.545 ' NZ ' ' CG ' ' B' ' 58' ' ' TRP . 31.2 ttmt -79.0 122.19 25.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.612 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.54 111.0 45.09 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.79 148.45 0.48 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.857 1.705 . . . . 0.0 112.478 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 -47.27 -47.45 25.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.545 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -37.36 -34.73 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.539 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 2.4 m-85 -106.78 44.32 1.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.495 0.188 . . . . 0.0 110.926 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -149.22 95.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.78 -25.9 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 34.5 t70 -168.67 170.82 9.18 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.408 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.404 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 20.4 m-85 -124.2 163.58 21.28 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.95 0.881 . . . . 0.0 112.369 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -154.99 134.87 12.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.514 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' B' ' 31' ' ' THR . 18.4 pt-20 -99.43 148.96 23.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.257 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 30' ' ' GLU . 46.9 p -55.03 -112.39 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 7.0 m -150.28 -141.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.701 0.286 . . . . 0.0 110.597 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.492 ' C ' ' H ' ' B' ' 35' ' ' CYS . 26.1 t -143.04 -24.42 0.61 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -58.12 -6.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.492 ' H ' ' C ' ' B' ' 33' ' ' SER . 22.0 m -114.91 118.58 33.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.549 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -73.12 38.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -165.74 58.99 0.57 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -170.48 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.721 2.281 . . . . 0.0 113.25 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.24 176.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 49.4 t -109.49 129.81 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.59 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.6 128.84 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.064 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.425 ' C ' ' NE2' ' B' ' 43' ' ' GLN . 30.5 p90 -107.93 145.88 33.18 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.211 0.529 . . . . 0.0 111.225 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' B' ' 43' ' ' GLN . 1.7 mp0 -93.34 170.17 9.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.646 ' HG1' ' N ' ' B' ' 45' ' ' ALA . 9.8 p -140.1 -143.22 0.15 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.202 0.525 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.646 ' N ' ' HG1' ' B' ' 44' ' ' THR . . . -125.79 -38.57 2.2 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.854 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.65 2.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.88 -0.145 . . . . 0.0 111.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 23.3 t -153.54 -82.24 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.458 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 156.05 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.418 0.449 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -140.96 147.76 39.29 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.7 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.1 t -151.62 117.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.876 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.507 ' H ' ' CB ' ' A' ' 182' ' ' SER . 22.9 t -52.13 157.99 1.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.19 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.47 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.45 127.91 8.55 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -68.57 123.81 88.58 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.04 0.36 8.48 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.279 1.319 . . . . 0.0 111.271 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -66.57 -13.82 61.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.097 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -100.07 123.46 44.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -50.8 -38.35 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.965 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.545 ' CG ' ' NZ ' ' B' ' 19' ' ' LYS . 82.5 m95 -56.72 -33.23 66.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.224 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.22 -35.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.111 0.482 . . . . 0.0 110.195 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -73.35 -39.9 64.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.845 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -69.5 -38.66 77.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -63.11 -39.95 96.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.954 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.01 -42.58 79.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.938 0.399 . . . . 0.0 110.117 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -63.74 -21.72 66.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.99 -36.38 36.08 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.96 -19.42 37.19 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.361 -0.536 . . . . 0.0 109.667 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.57 -35.47 77.42 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.01 -70.25 0.42 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.919 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.575 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.799 0.333 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.3 m -75.39 -34.48 61.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.583 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.4 p -50.21 125.71 13.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.519 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -55.66 -20.31 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.769 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.7 m -75.59 -27.6 58.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 t -82.62 -39.73 21.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 p -166.07 172.99 10.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 0.0 110.698 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.75 155.92 39.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 p -71.94 171.92 10.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -121.19 5.44 10.29 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.333 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 20' ' ' ASN . 43.2 mm-40 -80.88 91.88 6.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 2.9 pm0 -32.42 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.982 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' GLU . 23.0 p-10 -95.49 38.65 1.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.565 0.221 . . . . 0.0 111.308 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -154.1 139.31 17.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.533 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -135.54 158.97 43.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.213 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CE1' ' CE ' ' A' ' 202' ' ' MET . 0.9 OUTLIER -96.53 76.88 2.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 24' ' ' MET . 3.8 mpp? -57.04 117.31 3.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.503 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.98 149.72 17.35 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.888 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -111.57 135.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 63.2 t0 -140.46 137.82 34.2 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 11.5 t -138.66 142.78 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.046 0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.01 132.61 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.248 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.43 135.31 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.178 0.513 . . . . 0.0 110.831 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -121.12 94.67 4.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.552 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.95 112.52 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.038 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.68 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 5.9 p -86.42 127.81 34.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.518 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' CB ' ' NZ ' ' A' ' 34' ' ' LYS . 5.0 mtpm? -80.37 151.76 29.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.73 164.21 25.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.71 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.01 -35.49 80.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.272 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.439 ' N ' ' CD ' ' A' ' 37' ' ' GLN . 4.4 mp0 -75.34 -35.17 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.023 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.6 m -44.14 106.9 0.55 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.245 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 92.6 Cg_exo -43.79 161.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.817 1.678 . . . . 0.0 112.021 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.3 p -70.06 148.7 48.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 5.4 p30 -173.49 102.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -103.1 -4.29 24.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.465 ' C ' HE22 ' A' ' 46' ' ' GLN . 11.0 ptpt -64.93 89.39 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.409 0.623 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 45' ' ' CYS . 6.1 mm -96.3 164.1 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.807 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 90.1 m 58.82 49.38 10.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.605 ' N ' HE21 ' A' ' 46' ' ' GLN . 0.0 OUTLIER -65.87 -44.36 85.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.861 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.3 t -167.7 176.8 6.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 0.0 111.461 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.88 103.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.717 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.9 p -103.92 96.82 6.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.527 0.204 . . . . 0.0 111.178 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.27 142.27 32.23 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.427 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 mt -144.51 151.2 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.938 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 m -151.47 144.98 24.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' CD ' ' CE1' ' B' ' 24' ' ' PHE . 29.5 mt-10 -52.15 179.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 CA--C 1.53 0.322 0 CA-C-O 120.748 0.228 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.407 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 38.7 p -123.75 126.9 47.32 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.452 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 m -102.87 126.23 49.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -126.46 119.6 27.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -112.54 121.17 44.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.62 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -90.58 78.43 6.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.296 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 tp -71.72 114.41 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.068 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.14 144.63 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.87 166.64 16.83 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.43 21.82 49.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.661 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.64 14.96 79.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.129 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.18 157.24 45.85 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.102 0.477 . . . . 0.0 110.676 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -124.53 105.92 9.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.266 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -101.25 123.23 45.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 111.06 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -106.64 128.41 54.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 25.5 m-85 -100.11 -169.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.257 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.01 67.84 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.422 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.486 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.51 145.84 36.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.256 0.528 . . . . 0.0 110.182 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.9 m -132.2 102.6 5.85 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.529 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt 70.85 45.31 0.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.337 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.5 m -124.23 149.64 61.41 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.53 142.72 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.878 1.719 . . . . 0.0 112.228 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -55.06 143.86 25.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 tp -98.01 135.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.451 ' HZ3' ' H ' ' A' ' 126' ' ' ASP . 87.6 mttt -145.5 -7.66 0.59 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.921 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -111.02 111.1 21.97 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.09 114.08 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 239' ' ' LYS . 29.5 t -142.33 161.11 38.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.304 0.573 . . . . 0.0 112.067 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -155.42 173.22 16.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.72 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 t -170.65 165.24 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.039 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.42 136.61 46.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.928 0.394 . . . . 0.0 110.292 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.448 ' CG ' ' HZ2' ' A' ' 237' ' ' LYS . 2.5 m-20 -143.94 110.97 5.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.023 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.15 -91.0 0.36 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -142.86 21.33 1.97 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.5 m -114.69 138.42 50.72 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.787 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.33 120.58 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.841 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -104.42 164.63 11.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.829 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -168.43 125.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.073 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -113.82 114.36 26.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.41 118.79 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 t -161.55 173.12 15.24 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.507 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 167' ' ' SER . 94.0 p -89.4 170.5 10.48 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.824 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.84 133.16 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.003 0.43 . . . . 0.0 111.259 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.15 164.06 39.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.87 144.29 43.03 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.162 1.908 . . . . 0.0 111.406 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.03 9.13 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -126.4 -51.82 1.5 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.97 0.47 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.642 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -108.39 -178.54 3.63 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 2.2 m-20 -63.96 -179.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.895 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.0 m -171.29 59.76 0.3 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.416 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.11 146.11 0.4 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.465 2.11 . . . . 0.0 112.654 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.43 127.07 20.31 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 mm -132.8 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 110.109 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.595 ' HG1' ' N ' ' A' ' 132' ' ' HIS . 0.8 OUTLIER -69.17 166.04 19.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.931 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.595 ' N ' ' HG1' ' A' ' 131' ' ' THR . 16.8 p80 -59.15 -33.96 71.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.556 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.503 ' H ' ' HG1' ' A' ' 131' ' ' THR . 37.1 tt0 -51.51 -51.96 50.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 138' ' ' MET . 8.5 tp10 -66.52 -47.79 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.755 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.77 8.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.412 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.9 mt -51.3 -42.29 61.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.71 -21.07 59.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.593 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.3 ttt -79.05 -64.19 1.24 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.94 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.467 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -54.55 -20.9 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.919 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.467 ' N ' ' CD1' ' A' ' 139' ' ' ILE . 56.0 tttp -74.3 -33.42 63.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.5 ' OD2' ' NE ' ' B' ' 18' ' ' ARG . 12.3 t70 -102.72 -21.33 14.11 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.5 t -51.64 119.83 4.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.65 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -138.65 125.55 21.12 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.24 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 t -120.23 125.89 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -101.75 164.67 11.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.102 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.37 146.92 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.896 0.379 . . . . 0.0 110.139 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 90.29 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.7 146.33 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 111.758 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -130.57 170.44 14.26 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.788 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.6 t -91.5 105.3 17.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.659 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.6 p -85.83 169.32 13.45 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.796 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.51 14.18 1.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -67.54 111.22 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.269 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.71 1.83 28.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -46.29 158.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.891 0.377 . . . . 0.0 111.226 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -75.75 170.65 15.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.587 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.8 m -87.23 135.52 33.28 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.046 0.451 . . . . 0.0 110.781 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -113.32 89.55 3.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.75 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 pt -119.85 171.22 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -159.42 0.68 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.2 t -129.77 -4.32 4.65 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.707 0.289 . . . . 0.0 110.46 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -84.55 124.57 73.18 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -39.36 155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.884 1.723 . . . . 0.0 112.335 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.8 p -74.93 133.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.05 134.23 36.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.324 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.31 179.71 27.07 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.668 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.527 ' C ' ' H ' ' A' ' 169' ' ' ILE . 17.3 m -113.56 8.36 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.8 t30 62.73 -11.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.374 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.527 ' H ' ' C ' ' A' ' 167' ' ' SER . 14.1 pt -93.33 139.89 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.225 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.406 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 40.4 t -100.94 150.52 22.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.264 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -79.05 47.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -71.1 169.57 14.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.757 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -83.8 119.24 24.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 175' ' ' SER . 13.8 p -151.49 163.34 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.089 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 174' ' ' VAL . 53.3 p -14.73 132.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.036 0.835 . . . . 0.0 113.197 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 45.1 p90 -90.6 134.38 34.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.423 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.54 134.57 20.33 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.9 OUTLIER -69.86 101.09 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.52 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.1 mm -114.09 -14.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.65 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.8 mt -91.23 127.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.816 0.341 . . . . 0.0 111.031 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.66 -134.06 6.6 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 69.9 p -69.25 150.77 47.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.94 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.534 ' OG1' ' CE1' ' B' ' 13' ' ' PHE . 0.8 OUTLIER -142.43 95.06 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.239 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 18.4 mt -99.32 134.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.062 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.32 114.05 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.11 106.96 3.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.0 m -48.08 -27.48 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -39.4 -37.66 0.48 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.622 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.7 m -137.95 37.45 2.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.732 0.301 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.4 t -150.74 103.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.547 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -85.39 -61.0 1.87 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.68 ' H ' ' HG1' ' A' ' 33' ' ' THR . 0.4 OUTLIER -130.04 140.79 50.81 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.714 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.5 tt -139.91 114.73 9.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.888 0.375 . . . . 0.0 110.817 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -94.47 152.67 18.39 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -147.55 131.69 17.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.149 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.2 m -144.26 138.08 27.73 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.434 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 198' ' ' ARG . 2.8 p -138.09 163.91 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.475 ' N ' ' CG2' ' A' ' 197' ' ' VAL . 55.1 ttt-85 -164.96 111.22 0.96 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.837 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.8 mm -94.1 126.7 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.18 173.25 46.14 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.402 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -72.24 131.85 43.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.691 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 23' ' ' HIS . 28.8 mtm -86.49 4.59 39.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.724 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 85.5 m -97.74 -61.32 1.41 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -152.64 122.83 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.484 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.84 148.52 0.37 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.589 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 4.7 t -133.91 13.41 3.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.793 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.1 m 58.81 -76.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.735 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 35.1 tt0 -49.59 -54.33 18.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.609 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -73.69 4.92 4.44 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.115 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 175' ' ' SER . 9.0 mm-40 -104.14 125.5 50.5 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.759 0.314 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.5 168.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 45.7 tttm -157.18 159.97 38.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.312 0.577 . . . . 0.0 111.224 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 9.7 t70 -153.59 170.35 21.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.034 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.14 166.22 25.85 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.758 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -148.89 169.73 19.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 7.7 mtpm? -131.84 103.42 6.32 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -100.02 116.4 31.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.61 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.69 118.87 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.256 0.55 . . . . 0.0 110.752 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 50.54 43.26 27.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.516 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.32 80.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.09 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -98.29 117.97 33.89 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.673 -0.31 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.85 15.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.0 t -169.97 123.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.528 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -78.39 139.02 38.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.53 108.2 0.27 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.481 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -72.06 104.89 3.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.0 t -132.16 152.98 50.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.139 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 95.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.84 34.02 0.66 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.986 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.4 t -73.02 -35.0 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.912 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 233' ' ' ILE . 68.9 p -105.12 -0.36 26.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.978 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.01 -24.58 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.085 0.469 . . . . 0.0 110.526 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 231' ' ' SER . 0.4 OUTLIER -165.11 137.79 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.0 108.18 7.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.055 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 66.2 m -76.23 6.36 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.61 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -20.37 25.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.448 ' HZ2' ' CG ' ' A' ' 108' ' ' ASP . 51.9 pttt -103.33 4.98 37.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.595 0.236 . . . . 0.0 111.339 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.66 147.81 29.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.042 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.412 ' O ' ' OG ' ' A' ' 104' ' ' SER . 56.6 mttm -132.9 142.83 49.12 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.4 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.46 134.82 49.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 242' ' ' VAL . 34.7 m -91.37 1.66 56.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.767 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.648 -0.692 . . . . 0.0 111.482 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.451 0 CA-C-O 121.021 0.439 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -105.85 127.18 52.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -65.73 142.06 58.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.334 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.534 ' CE1' ' OG1' ' A' ' 183' ' ' THR . 11.1 p90 -116.19 -11.54 11.31 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 29.5 m -131.8 144.68 51.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.248 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -114.94 158.67 21.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.04 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -83.22 144.92 29.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.871 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.74 -47.59 11.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.903 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.5 ' NE ' ' OD2' ' A' ' 141' ' ' ASP . 5.3 tpt85 -70.9 126.2 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -83.74 118.95 24.24 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' B' ' 20' ' ' LEU . 6.1 mp -75.48 145.53 79.42 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.693 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.7 152.07 37.15 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.382 2.055 . . . . 0.0 112.558 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' B' ' 24' ' ' PHE . 11.4 ptp180 -45.64 -43.84 12.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.38 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -68.09 24.82 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' B' ' 22' ' ' ARG . 12.2 t80 -150.88 32.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.371 0.605 . . . . 0.0 109.555 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -151.04 92.44 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.149 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.16 -25.28 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -156.42 -179.74 8.46 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.068 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 9.2 p90 -163.35 167.7 21.42 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.981 0.419 . . . . 0.0 111.256 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 57.4 m-85 -158.12 156.15 30.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' B' ' 31' ' ' THR . 69.7 mt-10 -98.53 145.58 26.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.812 0.339 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.425 ' O ' ' O ' ' B' ' 30' ' ' GLU . 63.2 p -52.35 -107.44 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -146.93 -128.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.453 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.513 ' C ' ' H ' ' B' ' 35' ' ' CYS . 18.2 t -158.95 -40.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.693 0.282 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -59.08 -2.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.573 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.513 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.8 m -80.25 -34.48 37.1 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.224 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m 75.05 23.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.402 0.62 . . . . 0.0 110.087 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.523 ' N ' ' CD ' ' B' ' 38' ' ' PRO . 3.2 pt20 -173.56 49.61 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.533 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 29.7 Cg_endo -58.63 -158.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.191 2.594 . . . . 0.0 112.974 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 168.36 176.95 0.03 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.25 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.33 131.31 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.8 t -110.45 133.87 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.658 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' B' ' 42' ' ' PHE . 29.9 p90 -113.16 146.02 39.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.075 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.37 169.74 10.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 5.1 p -138.84 -142.73 0.16 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.187 0.517 . . . . 0.0 110.68 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.472 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.33 -36.33 1.71 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.177 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.97 46.43 2.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.287 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 23.6 m -153.72 -80.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.54 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.688 0.618 . . . . 0.0 109.475 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -161.34 143.71 12.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -148.9 136.19 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 0.0 109.781 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.65 162.22 13.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.631 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 124.79 7.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.318 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -62.33 122.58 74.05 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 1.28 7.07 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.225 1.284 . . . . 0.0 111.161 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -67.82 -18.22 64.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.108 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -95.31 125.88 40.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -51.56 -39.75 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.976 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -56.39 -34.92 67.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.078 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.92 -35.22 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.93 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.03 -35.69 66.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -72.14 -35.89 69.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -65.09 -36.48 84.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.689 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.02 -44.47 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.04 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -62.11 -28.7 69.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -74.65 -40.87 61.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.959 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.12 -21.69 63.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.26 -29.37 62.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.17 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt -79.11 -84.5 0.08 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.374 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.562 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.2 p -75.02 -22.15 58.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.117 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 t -48.22 133.13 15.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -60.07 -29.39 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.438 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 t -76.2 -27.42 56.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.8 t -72.04 -51.1 23.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.8 t -169.66 178.82 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.143 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -61.45 160.8 10.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.66 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 2.9 p -81.58 166.67 20.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.192 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.41 4.37 12.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.436 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 56.5 mt-10 -62.52 -152.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.749 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.16 -72.15 0.7 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.562 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -83.09 59.33 4.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.277 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -130.38 135.8 48.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.134 0.492 . . . . 0.0 111.242 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.93 123.35 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.438 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.66 ' CE1' ' H ' ' A' ' 16' ' ' THR . 67.5 m80 -75.27 76.18 2.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 tpt -46.54 170.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.358 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 158.19 132.94 1.48 Allowed Glycine 0 CA--C 1.512 -0.149 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 tt -110.68 129.26 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.079 0.466 . . . . 0.0 110.921 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 -105.04 135.61 46.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.83 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.46 128.86 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.8 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 pt -124.42 162.86 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 tt -164.01 135.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.147 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -123.47 94.64 4.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.615 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.48 115.18 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.479 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -90.06 127.47 36.08 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -82.21 154.71 25.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.643 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -68.85 -170.55 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.8 -31.11 18.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.938 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -79.01 -39.72 33.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.237 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 p -40.7 106.48 0.42 Allowed Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -43.68 170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.963 1.776 . . . . 0.0 112.277 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p -75.49 134.88 40.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.923 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -158.1 95.31 1.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.106 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.77 -7.31 25.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -63.74 92.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 110.407 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.55 154.75 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 34.9 t 53.7 65.46 1.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.122 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 153' ' ' GLU . 23.0 mt-30 -79.2 -24.62 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 46' ' ' GLN . 3.4 m 178.09 164.82 0.71 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.417 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.65 132.14 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.404 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 p -134.17 104.4 6.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.177 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -83.29 136.79 34.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.282 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.1 mm -132.7 162.67 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.484 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 93.0 m -154.18 151.25 28.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' B' ' 24' ' ' PHE . 91.4 mt-10 -52.71 175.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.6 p . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 109.818 179.837 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 CA--C 1.528 0.202 0 N-CA-C 111.365 -0.283 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -122.45 114.87 21.31 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.806 0.336 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 p -96.35 129.96 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.56 141.7 50.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -136.31 134.44 37.95 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.428 1.109 . . . . 0.0 110.845 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' NE ' ' A' ' 89' ' ' ARG . 33.1 t -96.12 73.87 2.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.064 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 pt -71.13 98.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 tp -86.88 146.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.603 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.91 166.79 17.1 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.302 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.71 23.39 44.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.208 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 7.98 74.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -127.99 153.82 46.31 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.439 ' NE ' ' OG ' ' A' ' 82' ' ' SER . 63.3 ttt180 -122.65 113.91 19.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.36 152.08 21.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 110.147 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -149.06 126.95 11.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.413 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -116.81 -169.99 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.947 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.05 81.53 0.16 Allowed Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.293 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.548 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 1.8 m-30 -73.35 115.01 12.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.6 m -124.69 111.79 16.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.686 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.1 tptp 64.84 31.3 11.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.02 150.32 44.88 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -38.64 160.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.956 1.771 . . . . 0.0 112.123 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -81.67 107.07 14.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.533 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.57 144.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.923 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -147.14 -21.92 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 p -98.18 122.02 40.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.361 . . . . 0.0 110.317 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 tp -139.89 133.53 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.536 ' HG ' ' N ' ' A' ' 239' ' ' LYS . 11.2 t -150.11 165.41 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.248 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -148.86 161.5 41.72 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.085 0.469 . . . . 0.0 110.789 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.14 156.64 22.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.228 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.5 137.95 44.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.219 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -151.06 108.04 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.337 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.35 -103.53 2.17 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.168 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 110' ' ' ASN . 17.5 p-10 -130.67 23.29 5.04 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.668 0.271 . . . . 0.0 110.552 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.1 155.63 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.645 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.7 t -127.31 129.73 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.064 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.639 ' ND2' ' H ' ' A' ' 114' ' ' ALA . 2.9 t-20 -107.54 154.99 20.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.525 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.639 ' H ' ' ND2' ' A' ' 113' ' ' ASN . . . -154.83 121.73 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.541 HH21 ' CD2' ' A' ' 238' ' ' LEU . 19.5 tpp85 -105.07 113.0 26.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.811 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.1 114.21 22.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.416 ' HG ' ' HG ' ' A' ' 167' ' ' SER . 22.9 t -158.85 171.73 19.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.164 0.507 . . . . 0.0 112.029 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -87.83 163.83 16.22 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.1 141.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.141 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 p -83.22 152.6 65.12 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.616 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.52 152.35 33.81 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 121.921 1.747 . . . . 0.0 111.584 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.1 50.22 13.52 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.71 -53.96 0.88 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.59 0.233 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 160.87 -11.35 0.14 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.232 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -129.94 151.12 50.84 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 117.278 0.539 . . . . 0.0 110.114 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.0 146.51 42.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.787 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.0 p -139.76 62.36 22.31 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.957 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.17 129.63 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.227 2.618 . . . . 0.0 113.427 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.48 165.08 13.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.2 pt -145.05 165.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -82.67 154.84 24.67 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.738 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -51.35 -37.07 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.55 -51.82 68.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 110.436 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.05 -43.66 91.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.133 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.49 -56.55 19.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 110.319 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tp -51.65 -35.84 43.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.903 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.09 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.5 mmt -71.3 -62.43 1.4 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.7 pt -46.9 -21.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.462 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -91.02 -28.72 17.8 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.622 0.248 . . . . 0.0 110.894 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.495 ' CG ' ' HE ' ' B' ' 18' ' ' ARG . 15.1 t0 -92.19 -44.12 8.95 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.4 t -43.43 120.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.937 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -141.5 132.93 26.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.699 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.41 132.08 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.033 0.444 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.7 p -103.14 171.02 7.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.362 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.9 mm -139.4 154.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -163.58 88.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.272 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.97 147.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.083 0.468 . . . . 0.0 111.292 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -137.04 171.68 14.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.804 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 m -100.31 116.21 31.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.197 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.1 m -104.85 -176.84 3.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.929 0.395 . . . . 0.0 110.256 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -149.47 0.69 0.5 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.888 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -55.37 99.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.56 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.64 9.72 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.952 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -45.43 156.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.92 170.24 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.1 m -90.46 135.87 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.634 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.472 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 9.8 t70 -115.56 89.13 3.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.768 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -124.29 168.18 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -113.18 155.14 25.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.559 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 69.0 m -83.43 -3.92 58.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.903 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.546 ' NE2' ' CB ' ' A' ' 240' ' ' ALA . 0.5 OUTLIER -77.49 147.48 75.43 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.972 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.94 160.45 33.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.561 1.507 . . . . 0.0 110.988 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.63 134.92 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 6.6 mp -82.51 117.89 22.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.11 171.27 40.42 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.759 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 169' ' ' ILE . 2.0 p -101.12 7.29 43.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 60.97 -3.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.477 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.2 tt -98.24 139.2 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.323 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 172' ' ' LYS . 67.5 p -98.34 145.62 26.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.59 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -75.59 40.88 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.499 ' NZ ' ' CB ' ' A' ' 172' ' ' LYS . 5.6 ttpm? -65.11 171.87 3.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 172' ' ' LYS . 36.7 pttt -87.27 128.24 35.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.307 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.562 ' CG2' ' H ' ' A' ' 175' ' ' SER . 14.9 p -157.13 177.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.773 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.562 ' H ' ' CG2' ' A' ' 174' ' ' VAL . 71.4 m -27.54 141.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.506 0.503 . . . . 0.0 112.018 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -100.24 134.09 43.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.07 138.85 33.88 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.006 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.75 86.78 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.772 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 37.8 mt -100.77 -36.89 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.303 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.58 124.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.231 0.538 . . . . 0.0 110.601 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.77 -125.41 2.81 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 12.0 m -79.76 153.05 29.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.164 0.507 . . . . 0.0 111.086 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 22.4 p -141.09 95.04 2.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.457 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 1.8 mp -98.44 117.09 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.403 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 6.0 m -131.74 117.64 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.287 0.565 . . . . 0.0 111.602 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -78.66 111.89 15.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.823 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.6 m -46.34 -32.3 3.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.232 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -34.97 -34.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.201 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 189' ' ' CYS . 32.1 p -152.1 56.93 0.84 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.305 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.77 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.487 . . . . 0.0 110.009 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.78 -57.39 4.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.631 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 37.9 t-20 -127.16 137.92 53.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 2.2 tt -134.13 128.14 33.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.926 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -113.57 135.81 53.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -137.01 134.59 36.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.019 0.437 . . . . 0.0 111.071 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.6 t -142.79 141.44 31.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.778 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 44.4 t -134.69 159.16 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.069 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.403 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 44.2 ttt180 -174.19 116.59 0.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.903 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.4 tt -119.02 136.08 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -171.65 -150.13 6.97 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.568 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 43.3 t0 -88.49 119.15 28.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.622 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -78.38 3.57 15.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.08 -178.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 23.9 t -111.15 -51.3 2.87 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.742 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.439 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 67.6 mttm -146.94 109.93 4.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -44.52 147.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.372 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 3.2 m -148.75 96.14 2.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 206' ' ' SER . 69.1 m -23.45 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.339 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 36.3 mt-10 -58.65 -73.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.845 0.355 . . . . 0.0 111.629 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.3 9.6 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -96.5 126.1 41.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.834 0.349 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.69 178.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.5 164.86 19.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.105 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -158.92 168.63 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.178 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 165.34 171.03 31.07 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.8 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 12.7 m-85 -151.9 172.7 15.81 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -136.83 103.75 5.28 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.28 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -101.84 122.33 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.69 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 220' ' ' GLY . 7.3 p -140.48 115.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.298 0.571 . . . . 0.0 111.556 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.39 -8.87 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.768 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 137.99 -2.12 2.92 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 12.3 m -101.3 117.08 34.26 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.638 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.38 150.01 23.46 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.3 m -164.98 127.63 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.519 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -78.04 139.28 39.1 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.83 109.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.655 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.81 97.31 4.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 59.3 m -126.75 157.23 39.69 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.04 95.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -90.61 30.66 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -73.25 -30.12 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.285 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.0 t -111.4 1.34 16.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -44.31 -28.79 0.57 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.99 0.424 . . . . 0.0 110.478 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.42 143.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.179 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 236' ' ' THR . 6.1 p30 -75.75 97.04 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.042 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.0 m -59.29 -4.14 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 238' ' ' LEU . 41.1 p -78.96 -53.5 6.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.9 13.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.541 ' CD2' HH21 ' A' ' 115' ' ' ARG . 8.3 mp -77.05 140.23 40.26 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 110.444 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.536 ' N ' ' HG ' ' A' ' 104' ' ' SER . 18.7 mtpp -131.64 131.59 43.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.616 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.546 ' CB ' ' NE2' ' A' ' 162' ' ' HIS . . . -54.87 155.73 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 46.9 t -123.98 -8.37 7.75 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.638 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 241' ' ' CYS . 2.0 p . . . . . 0 C--O 1.218 -0.564 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.379 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.685 0.279 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.512 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 18.8 m -129.85 120.92 25.73 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 33.7 t -38.37 129.17 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.658 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 29.0 m-85 -109.63 -32.46 7.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.19 157.79 36.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.032 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.81 161.15 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.9 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -83.52 136.44 34.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.02 7.78 17.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.065 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.495 ' HE ' ' CG ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -134.0 127.48 32.41 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.812 0.339 . . . . 0.0 111.006 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -83.43 127.37 33.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.602 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.39 112.69 54.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.34 152.76 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.787 1.658 . . . . 0.0 111.942 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.639 HH21 HD22 ' B' ' 69' ' ' ASN . 8.5 tpt180 -45.14 -47.19 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.299 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -37.57 -33.59 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CE2' ' OE1' ' A' ' 53' ' ' GLU . 3.1 m-85 -109.5 43.19 1.34 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.795 0.331 . . . . 0.0 110.585 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -153.12 92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.707 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.28 -24.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -157.69 -179.03 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.168 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -157.78 170.69 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.223 0.535 . . . . 0.0 112.04 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 57.6 t80 -158.39 151.47 22.72 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.444 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 49.4 mt-10 -99.33 148.69 23.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.488 ' HG1' ' H ' ' B' ' 39' ' ' ALA . 72.4 p -54.31 -109.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -152.58 -141.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.698 0.285 . . . . 0.0 110.526 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.437 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.9 t -146.53 -23.29 0.43 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.405 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.63 -10.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.437 ' H ' ' C ' ' B' ' 33' ' ' SER . 83.1 m -112.8 122.04 46.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.575 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -72.75 37.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.84 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.2 pt20 -168.51 60.17 0.44 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.6 -164.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.713 2.275 . . . . 0.0 113.059 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . 0.488 ' H ' ' HG1' ' B' ' 31' ' ' THR . . . 178.9 176.64 0.54 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.499 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.51 131.75 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.938 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.62 132.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.036 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -112.72 151.44 30.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -92.66 169.39 10.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -137.11 -145.09 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 110.703 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.99 -39.48 1.39 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.99 46.82 2.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.301 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 9.8 m -155.33 -83.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.375 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.35 -90.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -138.86 148.62 43.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 t -151.84 113.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.289 0.566 . . . . 0.0 110.446 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.555 ' N ' ' OG ' ' A' ' 182' ' ' SER . 54.0 t -50.53 161.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.439 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -153.58 139.97 18.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.187 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -74.64 115.36 43.12 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.29 -0.64 8.41 Favored 'Trans proline' 0 C--N 1.356 0.933 0 CA-C-N 120.145 1.087 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -74.72 -10.08 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.888 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 37.4 mt-10 -98.97 125.55 44.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.21 0.529 . . . . 0.0 110.317 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.8 m -46.89 -50.58 18.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 63.9 p-90 -55.99 -25.29 43.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.077 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.99 -36.67 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.971 0.415 . . . . 0.0 110.139 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 56' ' ' GLU . 2.5 mp0 -68.3 -44.27 75.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.908 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.14 -35.31 80.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.294 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -63.1 -46.78 85.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 80.3 t -65.16 -47.64 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.725 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.5 -33.85 68.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -73.12 -34.49 66.16 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.982 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.7 -21.65 61.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.424 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -78.56 -77.27 0.17 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.639 HD22 HH21 ' B' ' 22' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.53 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.5 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 p -79.68 -27.85 40.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.55 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.9 m -49.91 130.23 21.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -56.61 -25.89 54.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -73.67 -28.42 61.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.355 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -76.15 -55.6 5.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -158.91 162.79 36.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.75 149.62 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.4 p -73.27 171.26 13.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.4 15.93 16.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.215 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -90.21 90.87 8.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -44.43 -23.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.164 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -80.99 18.92 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' C ' ' CG ' ' A' ' 22' ' ' HIS . 9.9 ptmm? -170.11 165.63 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.679 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.4 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 81.6 m-70 -152.94 -178.38 6.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.793 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.453 ' O ' ' SD ' ' A' ' 202' ' ' MET . 21.2 t60 -101.51 93.43 5.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.81 120.98 20.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.669 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -125.37 160.15 19.92 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.55 134.02 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -124.68 124.29 41.86 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.041 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 t -137.61 142.07 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.6 pt -146.29 138.46 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.722 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -138.08 134.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -118.38 94.01 4.33 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.13 135.7 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.483 0.658 . . . . 0.0 112.084 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.432 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 15.8 p -113.0 130.67 56.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.697 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -89.34 164.45 14.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.851 0.358 . . . . 0.0 110.741 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.428 ' C ' ' H ' ' A' ' 37' ' ' GLN . 92.3 mt-30 -77.81 151.31 34.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.712 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.06 -3.76 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.68 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 35' ' ' GLN . 62.6 mt-30 -91.7 -41.45 10.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.004 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.6 p -48.26 146.08 4.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.832 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.21 162.36 28.57 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.023 1.816 . . . . 0.0 111.306 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.2 p -54.63 146.07 17.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.183 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.488 ' N ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -167.02 90.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 110.836 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.31 -5.77 32.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.05 0.452 . . . . 0.0 110.036 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -61.05 83.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.658 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tp -96.4 159.96 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.775 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.1 m 60.87 40.19 16.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 110.443 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 155' ' ' LYS . 3.7 tp60 -55.44 -55.05 36.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.921 0.391 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.1 t -178.87 150.97 0.51 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -115.31 142.72 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.232 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.5 m -127.7 102.11 6.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.92 129.01 34.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.678 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -138.94 149.54 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -153.37 145.94 24.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' SER . 1.5 mp0 -54.63 -176.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 6.2 t . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.478 0.618 0 CA-C-O 120.732 0.222 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 p -123.63 137.53 54.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.56 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -93.1 126.72 38.34 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -122.59 101.6 7.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 0.0 111.275 -178.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 9.9 m -143.45 68.38 1.29 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.409 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.0 tp -73.65 107.09 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.225 0.536 . . . . 0.0 110.203 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.2 mt -89.14 148.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.56 169.86 20.39 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.264 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.82 23.58 51.16 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.41 8.73 71.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.925 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -130.07 156.75 44.01 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.911 0.386 . . . . 0.0 110.403 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.7 ttm105 -115.95 117.84 31.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 68.4 mmm -102.22 108.35 19.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -100.98 120.44 40.19 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.122 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -100.9 -169.7 1.74 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.853 0.359 . . . . 0.0 110.89 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -178.92 70.65 0.07 OUTLIER Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.031 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -76.68 137.38 39.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.711 0.291 . . . . 0.0 110.776 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.9 m -138.83 118.46 13.04 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 60.09 32.34 20.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.133 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -119.81 149.72 49.09 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -38.61 145.55 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.851 . . . . 0.0 111.986 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -71.12 137.06 48.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 0.0 110.889 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.89 145.65 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -143.04 -9.56 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.636 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -124.08 123.25 39.92 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.16 106.99 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -140.16 145.83 38.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -142.35 -173.23 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 t -170.03 164.6 9.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.1 114.69 16.06 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -128.81 110.97 12.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.174 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.79 -127.48 22.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.857 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -100.98 21.42 13.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.66 0.267 . . . . 0.0 110.544 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -129.66 159.02 37.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 t -131.47 136.3 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.911 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -91.99 174.47 7.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -164.79 121.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.504 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -121.97 102.43 8.16 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.415 ' O ' ' OG ' ' A' ' 117' ' ' SER . 2.6 mm? -115.58 111.86 21.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 116' ' ' LEU . 12.1 m -166.34 168.01 15.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.168 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -90.2 176.09 6.89 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.9 p -116.9 155.13 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.094 0.473 . . . . 0.0 111.565 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.4 t -91.22 146.31 33.26 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.748 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.477 ' C ' ' NE2' ' A' ' 123' ' ' GLN . 33.9 Cg_exo -34.81 155.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 122.669 2.246 . . . . 0.0 112.778 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.569 ' N ' HE22 ' A' ' 123' ' ' GLN . . . 72.29 70.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.569 HE22 ' N ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -154.75 -40.67 0.09 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.662 0.268 . . . . 0.0 110.876 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.432 ' H ' ' CD ' ' A' ' 123' ' ' GLN . . . 124.89 7.16 6.17 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.41 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 31.4 mmtp -125.33 170.34 11.43 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 23.0 p-10 -73.61 156.12 38.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.83 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 p -155.7 66.18 4.5 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.894 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -48.24 134.31 25.0 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 122.893 2.395 . . . . 0.0 113.256 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.97 156.73 18.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.317 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.6 pt -150.46 166.54 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.178 0.513 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.5 p -72.69 164.66 26.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.347 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -60.74 -34.32 74.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.259 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 4.3 mp0 -56.62 -57.17 13.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.142 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.467 ' O ' ' SD ' ' A' ' 138' ' ' MET . 39.6 mt-10 -57.3 -46.14 83.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.26 -55.4 18.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.05 -36.12 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.63 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.37 -30.23 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -76.35 -61.89 1.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.0 pp -47.21 -21.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.186 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -83.79 -55.05 4.47 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.565 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -76.67 -37.8 55.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.9 t -39.31 120.42 1.04 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.59 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.34 124.85 16.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.0 t -117.99 126.97 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.101 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.0 t -102.63 166.24 10.62 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.2 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.64 144.5 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.99 0.424 . . . . 0.0 110.719 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.38 88.67 1.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.848 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 15.9 tt -77.47 151.27 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -145.25 -177.44 5.55 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.884 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.5 m -91.3 135.08 34.06 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.829 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.9 p -127.87 130.56 48.76 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -117.38 40.21 3.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.44 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.465 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -81.5 100.9 9.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.159 0.504 . . . . 0.0 110.704 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -72.13 -2.59 19.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.525 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.487 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.8 mmtm -51.53 161.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.855 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -77.09 177.51 7.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.8 p -96.59 142.02 29.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.55 92.04 3.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.55 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.84 177.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -132.92 134.52 44.65 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.3 p -70.18 4.17 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.399 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -83.2 121.6 77.08 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -39.89 161.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.785 1.657 . . . . 0.0 112.076 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.47 134.26 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 8.1 mp -84.38 121.29 27.33 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.49 168.3 25.23 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.482 -0.327 . . . . 0.0 112.675 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.5 p -95.83 6.92 47.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.76 0.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.029 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 167' ' ' SER . 10.2 tp -100.84 138.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.494 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 97.0 p -99.09 142.31 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.567 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -75.79 43.12 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.268 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -66.56 -174.52 0.3 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -88.24 123.73 33.15 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.465 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.93 -175.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.779 0.323 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 66.4 m -44.98 144.34 1.24 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.119 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 48.4 p90 -96.29 126.9 41.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.817 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -141.49 130.99 23.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.42 97.13 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.071 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.2 mm -107.65 -38.32 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.88 124.01 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.55 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.53 -130.67 2.09 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.476 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 24.8 t -75.29 155.87 36.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.663 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 26.4 m -142.94 93.8 2.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.522 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 1.8 mp -98.75 116.18 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.59 132.59 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.012 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.76 94.69 6.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 189' ' ' CYS . 17.8 p -47.38 -26.68 1.37 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.878 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -43.49 -16.23 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.509 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 187' ' ' THR . 13.0 m -148.43 12.59 0.93 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.63 91.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.678 0.751 . . . . 0.0 110.563 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.95 -53.88 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.391 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.432 ' H ' ' HG1' ' A' ' 33' ' ' THR . 12.0 m-20 -131.99 148.44 52.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.601 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 tt -148.13 110.56 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.044 0.449 . . . . 0.0 111.425 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -93.41 135.76 34.34 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -130.02 135.69 48.56 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.968 0.413 . . . . 0.0 111.106 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.2 t -144.31 141.06 29.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.488 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 198' ' ' ARG . 4.1 p -137.73 163.48 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 170' ' ' SER . 60.4 ttt180 -171.7 115.94 0.38 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.361 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 tt -114.95 126.05 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -168.54 -149.24 6.07 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.228 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.51 140.31 33.4 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.913 0.387 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -103.98 -2.58 25.86 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.914 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 70.7 m -107.33 -56.54 2.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.679 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -146.42 126.4 13.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.483 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.72 144.96 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 208' ' ' GLU . 20.7 m -127.06 9.09 6.77 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.25 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.4 m 58.29 -76.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.716 0.293 . . . . 0.0 111.476 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' SER . 71.6 mm-40 -49.35 -50.19 40.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.64 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.1 mt -75.1 -1.36 22.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.368 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.22 130.05 44.49 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.865 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.8 m -142.68 -179.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.473 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 48.6 tttm -171.04 161.94 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.369 0.604 . . . . 0.0 111.611 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 15.4 t70 -158.95 169.52 24.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.711 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.64 138.35 2.43 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.935 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -118.39 168.65 10.44 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -132.63 103.06 5.94 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -97.63 113.38 25.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.109 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.61 116.16 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.3 0.572 . . . . 0.0 110.726 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 1.2 m-20 52.82 28.28 6.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.861 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.4 66.15 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.994 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.5 t -98.61 116.22 30.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.31 158.66 15.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.8 m -168.28 117.69 0.75 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.992 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -85.05 96.64 9.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.089 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -129.33 133.93 7.74 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.56 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.34 97.69 10.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 86.0 m -123.96 156.21 36.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -57.68 95.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.2 30.0 0.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.4 m -70.38 -49.28 50.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.2 t -90.01 2.21 55.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 tp -39.2 -33.14 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.875 0.369 . . . . 0.0 111.15 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.54 144.43 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.894 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 234' ' ' ASP . 1.5 p30 -74.97 102.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.044 0.45 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 92.6 p -68.94 -4.14 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.478 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 69.9 p -83.21 -15.68 49.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -102.01 11.41 38.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.585 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.58 153.89 34.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -142.33 121.16 12.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.14 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 123.24 16.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.728 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 15.0 m -88.15 4.72 44.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.436 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 11.1 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.375 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 120.779 0.323 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.51 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 63.5 m -138.39 128.35 25.44 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.026 0.441 . . . . 0.0 110.528 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 80.1 m -45.37 141.37 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.808 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.51 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 24.9 m-85 -114.1 -26.24 8.17 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.785 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.6 m -155.42 157.22 36.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.88 162.56 15.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.377 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -85.28 139.52 31.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.651 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.46 -26.19 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.338 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.75 125.9 41.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 0.0 111.522 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -77.95 122.68 25.84 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -87.14 112.71 49.64 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.725 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.45 148.4 1.3 Allowed 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 121.909 1.74 . . . . 0.0 112.289 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -44.99 -41.83 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.353 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.56 -32.39 0.55 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 7.0 m-85 -108.53 41.67 1.53 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.66 0.267 . . . . 0.0 110.473 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -151.4 92.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.68 -25.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 35.1 t70 -155.11 -179.19 7.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.743 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.5 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 9.1 p90 -161.86 173.93 13.85 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.338 0.589 . . . . 0.0 111.848 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.493 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 45.2 t80 -156.64 179.75 8.97 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.265 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.493 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 13.1 pt-20 -128.76 152.23 48.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.267 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.587 ' HG1' ' H ' ' B' ' 39' ' ' ALA . 35.7 p -57.2 -113.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -151.66 -142.56 0.12 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.514 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.468 ' C ' ' H ' ' B' ' 35' ' ' CYS . 13.2 t -143.32 -16.78 0.65 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.91 -3.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.018 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' B' ' 33' ' ' SER . 2.9 p -123.3 122.9 39.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -74.49 44.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -173.31 57.85 0.22 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.61 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.964 2.443 . . . . 0.0 113.137 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . 0.587 ' H ' ' HG1' ' B' ' 31' ' ' THR . . . 174.62 176.96 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.029 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.93 133.98 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.187 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 140.86 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.768 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -115.09 150.87 35.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -93.1 170.26 9.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.0 p -137.95 -145.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.18 0.514 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.469 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.94 -38.32 2.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.37 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.17 46.07 2.43 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.065 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 32.3 t -154.05 -83.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.61 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 159.21 -87.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -144.65 148.19 33.98 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.835 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 38.5 t -150.79 121.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.394 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.476 ' H ' ' CB ' ' A' ' 182' ' ' SER . 99.6 m -57.75 161.59 3.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.86 132.37 12.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.83 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -68.74 116.11 37.54 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.74 0.38 7.12 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 120.935 1.09 . . . . 0.0 111.112 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 13.0 m -71.59 -6.06 38.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.962 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -105.77 128.04 53.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -48.38 -49.25 35.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -56.12 -30.43 62.1 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.736 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.04 -36.92 70.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.996 0.427 . . . . 0.0 110.092 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.1 -36.63 66.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.72 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.24 -35.53 78.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.338 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.54 -37.94 89.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.91 -45.76 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -59.64 -38.44 81.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.0 110.771 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -64.94 -24.88 67.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.785 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -71.63 -30.89 66.26 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.258 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.26 -81.78 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.272 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.54 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.766 0.317 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.1 p -74.81 -14.93 60.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.585 ' HG ' ' H ' ' A' ' 12' ' ' SER . 47.9 t -50.88 126.14 15.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.658 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.6 p -59.28 -10.61 3.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.378 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.585 ' H ' ' HG ' ' A' ' 10' ' ' SER . 79.1 p -92.51 -25.36 18.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.559 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p -81.08 -45.58 16.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 m -167.8 173.06 8.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.38 146.57 50.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.943 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.29 173.22 10.52 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -114.0 21.28 15.0 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.432 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -87.71 86.49 7.19 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 18' ' ' GLU . 49.3 mt-10 -17.71 -61.06 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.55 52.12 0.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.8 149.15 27.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -168.1 120.9 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.242 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CE1' ' OG ' ' A' ' 127' ' ' SER . 7.0 t-80 -67.79 78.73 0.2 Allowed 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.758 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -54.28 138.19 39.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.041 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.56 162.68 27.31 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 pt -109.15 169.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.077 0.439 . . . . 0.0 110.959 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -154.12 105.62 2.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.295 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 t -99.08 128.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.751 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 mm -123.59 123.11 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.52 133.64 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.32 92.8 3.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.22 135.44 25.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.117 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 m -103.75 124.72 49.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.638 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' CG ' ' OG1' ' A' ' 38' ' ' THR . 18.9 ttpp -76.14 151.62 36.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.805 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.494 ' C ' ' H ' ' A' ' 37' ' ' GLN . 49.7 tt0 -74.24 148.28 41.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.168 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -74.12 36.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.85 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 35' ' ' GLN . 14.7 tt0 -136.56 -46.98 0.61 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.377 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 34' ' ' LYS . 1.4 p -53.25 151.66 9.32 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.22 157.47 59.4 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.21 1.94 . . . . 0.0 111.875 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -65.06 141.67 58.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -158.82 97.41 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.468 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 13.5 t70 -91.56 -18.6 23.84 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -51.43 87.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 9.9 tp -96.19 150.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.376 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 17.1 t 58.81 67.05 0.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.87 -42.39 33.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.7 p -173.65 163.42 4.28 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.777 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.39 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -123.4 115.15 21.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -82.78 135.59 34.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.728 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.59 150.21 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -152.75 121.86 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.18 114.24 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.92 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.396 178.871 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 N--CA 1.479 0.657 0 CA-C-O 120.905 0.294 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -140.37 138.24 34.67 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.345 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.505 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 10.8 p -101.35 138.22 38.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.643 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 10.4 m-85 -119.03 160.84 21.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.327 0.584 . . . . 0.0 110.976 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -142.43 118.93 10.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.444 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 t -97.66 65.55 1.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.364 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -71.43 109.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.705 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.2 148.1 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.978 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.48 23.08 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.94 26.94 43.04 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.001 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.28 72.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.435 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -132.75 158.71 41.7 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.889 0.376 . . . . 0.0 110.453 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.67 109.07 13.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.802 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 mtt -103.41 107.11 17.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -90.37 107.18 18.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 56.4 t80 -92.42 163.23 13.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.763 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.09 143.16 8.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.505 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 4.6 p90 -147.28 157.86 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.948 0.404 . . . . 0.0 110.328 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 t -142.16 127.46 18.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.96 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' SD ' ' A' ' 138' ' ' MET . 30.1 mtpt 56.89 33.11 22.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.473 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.5 141.3 40.5 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -32.71 135.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.777 2.318 . . . . 0.0 113.195 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.505 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -70.06 147.73 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.563 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -91.77 137.31 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.957 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -124.68 3.74 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.123 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 t -137.7 135.04 36.07 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.128 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.95 98.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.302 0.572 . . . . 0.0 109.681 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.3 p -113.35 158.75 20.2 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.932 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -151.06 169.37 21.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 p -166.51 163.07 17.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.61 134.23 42.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -151.89 113.85 4.45 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.3 -122.41 8.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.812 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.71 22.91 15.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.664 0.269 . . . . 0.0 110.633 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.63 ' HG1' ' N ' ' A' ' 112' ' ' VAL . 1.4 t -133.52 159.24 41.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 110.518 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.63 ' N ' ' HG1' ' A' ' 111' ' ' THR . 1.5 m -137.62 136.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -104.25 167.43 9.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.15 0.5 . . . . 0.0 111.299 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.017 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -116.55 122.9 46.01 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.503 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.89 117.13 28.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.9 p -161.41 152.09 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.127 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.5 t -71.03 170.25 13.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.13 147.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 111.256 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 m -69.79 150.84 96.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.149 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.406 ' CD ' ' SD ' ' A' ' 202' ' ' MET . 35.5 Cg_endo -62.57 142.61 90.59 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.743 1.629 . . . . 0.0 111.252 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.67 53.64 2.38 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -143.67 -33.65 0.42 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.968 -0.137 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.18 20.38 0.51 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.142 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.607 ' HZ2' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -144.78 177.69 8.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.91 0.355 . . . . 0.0 110.72 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.503 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 14.3 m-20 -90.36 135.79 33.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.217 0.532 . . . . 0.0 112.189 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.607 ' CB ' ' HZ2' ' A' ' 125' ' ' LYS . 1.1 m -133.58 67.24 75.27 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.548 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -42.09 129.88 4.44 Favored 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.066 2.511 . . . . 0.0 113.404 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.82 26.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.559 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 mm -141.5 153.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.518 ' HG1' ' N ' ' A' ' 132' ' ' HIS . 0.9 OUTLIER -84.44 166.99 16.85 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 111.003 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.518 ' N ' ' HG1' ' A' ' 131' ' ' THR . 27.0 m170 -60.23 -35.68 76.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.201 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.55 -52.39 46.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.475 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -65.59 -41.94 92.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.968 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.06 -56.85 16.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.539 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.3 tp -49.72 -32.78 14.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.087 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.2 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.975 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 96' ' ' LYS . 23.7 mmt -64.8 -49.47 70.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -46.92 -22.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 111.071 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -87.52 -47.94 8.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.89 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -34.27 55.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -40.27 110.27 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.007 0.432 . . . . 0.0 111.493 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 42.9 tp10 -141.16 114.14 8.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.997 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 m -108.01 130.8 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.538 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -108.6 164.18 12.58 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.904 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.4 tp -154.76 149.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.945 0.402 . . . . 0.0 110.533 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -148.9 95.02 2.34 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.015 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.7 mm -80.5 136.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.64 175.71 9.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.8 t -91.96 130.16 37.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.9 p -120.26 148.36 43.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -131.3 34.66 3.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.499 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.72 101.4 10.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -71.96 -3.98 25.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.685 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -48.71 149.44 1.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.839 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.27 176.46 1.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.924 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.2 m -98.51 142.06 30.58 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.467 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 26.8 t70 -119.03 92.61 3.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.665 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -121.48 161.59 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -108.31 139.26 43.28 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.133 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.6 p -73.53 4.51 4.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -80.5 127.27 76.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.316 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -39.06 162.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.921 1.747 . . . . 0.0 112.297 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.37 133.51 29.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.961 0.41 . . . . 0.0 110.521 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.86 123.69 33.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.99 173.16 16.39 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.593 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ILE . 16.1 t -99.95 3.87 44.61 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 50.2 t30 67.07 -10.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.4 mt -73.43 143.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.166 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 172' ' ' LYS . 95.5 p -102.44 141.54 35.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -77.22 33.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.079 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 170' ' ' SER . 76.9 tttt -62.05 172.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -88.13 132.76 34.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.713 0.292 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.58 -162.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.319 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 m -47.59 149.89 1.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.678 0.275 . . . . 0.0 110.569 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 53.5 p90 -107.48 135.4 49.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.952 0.406 . . . . 0.0 111.379 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.494 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 4.0 tm-20 -146.03 141.67 27.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.014 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.494 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 6.3 p-10 -76.68 96.86 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.618 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.4 tt -112.72 -29.84 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.192 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 13.6 mt -76.01 111.36 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.85 -117.68 0.47 Allowed Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.703 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.489 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 12.4 t -77.7 141.89 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.1 m -139.22 85.83 2.09 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 9.9 tp -104.17 120.03 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 110.131 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.0 m -136.69 131.66 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.883 0.373 . . . . 0.0 111.379 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.34 108.3 18.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.955 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.7 p -48.55 -27.88 3.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.346 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.05 -26.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.002 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 68.3 m -142.49 27.99 1.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.796 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -165.18 99.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.498 0.666 . . . . 0.0 109.855 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -72.29 -55.91 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.41 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -133.19 142.65 48.71 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.282 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.12 138.08 31.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 111.029 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 4.1 mp0 -105.19 156.81 17.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 133.57 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 0.0 110.869 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.05 18.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.3 t -136.6 112.77 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.439 HH12 ' H ' ' A' ' 211' ' ' VAL . 12.9 ttt85 -108.43 163.27 13.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -160.96 109.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -162.52 -150.85 6.14 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.754 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 1.1 m-20 -89.37 140.63 29.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.535 ' SD ' ' SG ' ' A' ' 203' ' ' CYS . 0.0 OUTLIER -97.64 1.52 48.79 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.3 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.535 ' SG ' ' SD ' ' A' ' 202' ' ' MET . 24.1 m -115.37 -58.11 2.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -134.39 108.91 8.43 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.145 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 9.4 mp0 -58.39 121.9 11.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 209' ' ' LEU . 25.3 m -116.43 110.26 18.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.572 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 63.1 p -33.55 -46.86 0.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.617 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.88 -40.93 94.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.57 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 209' ' ' LEU . 2.3 mm? -88.05 0.59 55.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -86.64 137.44 32.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.21 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.439 ' H ' HH12 ' A' ' 198' ' ' ARG . 0.2 OUTLIER -170.09 152.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -161.68 153.75 19.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.313 0.578 . . . . 0.0 111.89 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 16.9 t70 -134.37 172.75 12.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.489 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 164.11 144.53 4.07 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.207 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -131.17 -178.26 4.76 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -149.67 105.82 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.201 0.524 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' B' ' 13' ' ' PHE . 5.3 t80 -96.44 128.38 43.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.573 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 220' ' ' GLY . 18.4 m -139.27 107.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.95 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 8.7 t70 64.58 -12.68 0.11 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.39 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 144.06 -0.36 1.14 Allowed Glycine 0 N--CA 1.461 0.366 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.687 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.4 m -105.2 121.39 43.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.37 160.24 14.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.7 t -173.83 120.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.438 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -74.42 135.93 42.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.24 103.66 0.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.413 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.91 95.75 2.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 51.4 m -123.42 150.81 43.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -55.33 95.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -88.75 36.18 0.8 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.6 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -75.36 -41.7 55.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.792 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 92.1 p -96.05 1.47 52.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.5 tp -42.26 -34.44 0.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.912 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.0 mt -148.37 145.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.013 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -75.18 94.6 2.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.988 0.423 . . . . 0.0 109.936 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -13.76 2.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.826 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.46 -7.81 58.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -103.9 9.12 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.563 0.221 . . . . 0.0 110.964 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 238' ' ' LEU . 7.3 mp -84.86 142.14 29.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -129.11 132.8 47.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.007 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.67 141.23 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 48.5 t -108.08 -4.47 17.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.628 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.443 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 10.4 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.129 -1.415 . . . . 0.0 111.503 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 71.1 m -140.64 143.45 35.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.757 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -69.08 148.0 50.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.667 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 3.3 m-85 -122.71 -19.01 6.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.499 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 149.5 35.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.142 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -114.23 149.08 36.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -71.78 133.05 45.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.385 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.509 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -78.17 -42.79 30.54 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.877 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 12.4 mmm-85 -81.79 127.91 33.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.081 0.467 . . . . 0.0 111.493 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -68.18 152.97 44.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.624 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 19.6 mt -108.5 94.62 14.16 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.13 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -40.65 152.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.758 1.639 . . . . 0.0 112.343 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' B' ' 22' ' ' ARG . 8.1 tpt85 -45.49 -51.26 11.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.935 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -40.51 -39.22 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -105.77 46.05 0.94 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -155.67 92.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.33 -19.25 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.2 t70 -157.99 -179.55 8.23 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.492 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.499 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.4 p90 -165.48 163.37 19.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 111.287 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -148.06 179.83 7.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.437 ' N ' ' CD2' ' B' ' 29' ' ' TYR . 49.9 mt-10 -123.7 149.06 45.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.041 0.448 . . . . 0.0 111.168 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.472 ' HG1' ' H ' ' B' ' 39' ' ' ALA . 41.3 p -55.58 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.997 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -148.29 -156.15 0.69 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.675 0.274 . . . . 0.0 110.536 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 47.4 t -129.82 -25.69 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.508 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 28.7 mt -58.24 -11.28 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.031 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' B' ' 37' ' ' GLN . 26.9 m -106.72 121.03 43.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.959 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -73.54 34.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.0 pt20 -168.67 63.08 0.54 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.63 -161.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.629 2.22 . . . . 0.0 113.16 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . 0.472 ' H ' ' HG1' ' B' ' 31' ' ' THR . . . 173.35 176.94 0.11 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 82.9 t -108.95 133.6 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.539 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 m -106.29 139.32 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.67 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -115.32 148.18 39.55 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.03 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 44' ' ' THR . 5.3 tt0 -100.18 168.05 10.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 1.7 p -143.84 -142.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.227 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.529 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -119.55 -39.93 2.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.063 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.73 46.65 2.36 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 81.1 p -147.42 -84.58 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.581 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 154.01 -84.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.441 ' NE2' ' C ' ' B' ' 48' ' ' ALA . 21.8 mp0 -139.66 145.22 38.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.718 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.8 117.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.489 ' H ' ' CB ' ' A' ' 182' ' ' SER . 0.1 OUTLIER -73.48 148.82 42.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.377 0.608 . . . . 0.0 112.025 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.75 134.25 28.24 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.53 126.25 89.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.79 -0.73 9.8 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.332 1.354 . . . . 0.0 111.258 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 51.9 m -69.76 -17.39 63.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.99 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.0 125.74 35.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.093 0.473 . . . . 0.0 110.176 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -48.6 -49.04 38.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -56.26 -26.43 51.59 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.677 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -72.91 -35.67 49.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.002 0.429 . . . . 0.0 110.112 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -70.42 -35.51 73.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.693 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -72.14 -35.25 69.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -64.73 -35.37 80.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.12 -45.63 61.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.81 -30.5 71.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.26 -39.35 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.718 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.91 -23.31 59.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.304 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -34.14 65.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -75.04 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.402 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.628 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.862 0.363 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.5 -21.98 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.602 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.484 ' HG ' ' HG ' ' A' ' 12' ' ' SER . 38.0 p -49.95 127.89 17.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.531 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 6.3 t -54.28 -23.96 17.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.484 ' HG ' ' HG ' ' A' ' 10' ' ' SER . 98.8 p -76.17 -31.54 58.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.448 ' H ' ' HG ' ' A' ' 10' ' ' SER . 59.3 m -74.44 -47.46 33.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.977 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.3 p -167.21 165.79 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.764 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.1 146.72 54.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.432 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 174.69 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 110.834 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -116.99 17.28 14.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.53 97.07 6.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.261 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 6.8 mp0 -32.99 -60.22 0.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.07 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -80.1 52.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.324 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 13.1 tttp -164.24 139.33 5.86 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.107 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 50.4 m80 -155.7 122.61 5.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.644 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -57.76 115.53 2.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.752 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -88.94 124.42 34.22 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.056 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.468 ' CA ' ' HG ' ' A' ' 118' ' ' SER . . . -128.22 141.02 12.21 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.78 150.83 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.797 0.332 . . . . 0.0 110.253 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 21.2 t0 -139.46 142.82 37.37 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.484 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 27.6 t -137.62 107.52 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.844 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.567 ' CG1' ' HE ' ' A' ' 115' ' ' ARG . 4.1 mp -102.07 128.06 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tt -135.85 130.46 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.429 0.633 . . . . 0.0 111.75 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -116.34 125.11 51.65 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.44 131.53 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.088 0.47 . . . . 0.0 111.406 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.2 m -105.81 132.55 51.79 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -86.58 163.45 17.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.318 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.476 ' C ' ' H ' ' A' ' 37' ' ' GLN . 6.7 tt0 -75.81 137.48 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.675 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -50.52 -10.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.476 ' H ' ' C ' ' A' ' 35' ' ' GLN . 1.2 mp0 -87.83 -41.73 13.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.963 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -46.36 148.29 1.67 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.796 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.57 167.26 25.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.06 1.84 . . . . 0.0 111.519 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.0 p -69.79 135.55 49.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.304 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -158.32 98.21 1.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.404 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 7.0 m-20 -97.55 -13.61 21.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.164 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.1 mmtm -54.93 85.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.963 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.1 tp -89.46 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.281 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 21.2 t 57.93 64.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.234 0.54 . . . . 0.0 110.402 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.4 ' NE2' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -72.86 -33.5 66.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.546 ' HG ' ' H ' ' A' ' 48' ' ' VAL . 12.4 t -173.09 -172.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.579 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.546 ' H ' ' HG ' ' A' ' 47' ' ' SER . 3.5 p -167.7 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.38 0.61 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 m -82.54 155.24 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.723 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -152.22 124.34 8.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 110.682 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.8 168.97 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.26 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' GLU . 10.1 t -153.36 154.29 34.22 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.458 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 2.6 pm0 -38.74 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.667 0.27 . . . . 0.0 110.675 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.262 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 CA--C 1.527 0.131 0 N-CA-C 114.13 0.781 . . . . 0.0 114.13 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.1 p -118.66 117.44 28.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.056 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -86.54 129.84 34.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' B' ' 47' ' ' SER . 49.2 t80 -113.52 143.3 44.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.695 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -138.01 118.61 13.95 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.743 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 t -101.02 67.0 1.17 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.909 0.385 . . . . 0.0 110.61 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.23 111.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.727 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -98.84 145.89 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.45 161.44 11.77 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.68 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.88 26.85 48.96 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.323 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.51 3.03 61.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.923 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -115.94 149.4 38.81 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.04 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.584 ' CZ ' HD22 ' A' ' 91' ' ' ASN . 44.7 ttt-85 -111.91 115.05 28.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.9 mpt? -101.07 145.48 28.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.175 0.512 . . . . 0.0 110.847 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.584 HD22 ' CZ ' ' A' ' 89' ' ' ARG . 72.0 m-80 -138.4 129.76 27.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.051 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -112.05 -167.04 1.13 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.788 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.11 67.5 0.07 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.028 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.24 132.53 39.95 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -135.89 115.58 12.92 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? 70.22 30.91 3.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.865 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.92 149.16 50.33 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.6 148.04 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.898 1.732 . . . . 0.0 111.97 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.16 138.69 54.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.384 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.1 pp -92.74 159.43 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -156.8 -22.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.303 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.1 p -101.1 121.73 42.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 130.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.9 p -152.52 160.62 43.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -148.19 170.54 17.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -165.29 161.89 19.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.61 124.91 30.93 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.63 107.72 6.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.138 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.78 -127.73 19.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -97.98 19.52 13.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.581 0.229 . . . . 0.0 110.867 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.3 p -127.21 155.5 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.887 0.375 . . . . 0.0 110.754 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.27 133.19 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.437 ' CG ' ' N ' ' A' ' 114' ' ' ALA . 10.1 t30 -99.05 165.18 11.86 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.752 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 113' ' ' ASN . . . -164.41 118.72 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.498 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.567 ' HE ' ' CG1' ' A' ' 29' ' ' ILE . 12.2 mmt85 -112.13 130.58 55.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.809 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tt -137.97 116.23 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.7 p -160.31 170.46 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 111.603 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.468 ' HG ' ' CA ' ' A' ' 25' ' ' GLY . 80.4 p -84.61 163.73 19.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.906 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.3 149.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.795 0.331 . . . . 0.0 110.808 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 121' ' ' PRO . 37.3 p -98.14 149.78 36.07 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 120' ' ' SER . 72.7 Cg_exo -40.08 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.54 2.16 . . . . 0.0 113.046 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.65 3.06 61.98 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.492 ' CG ' ' H ' ' A' ' 124' ' ' GLY . 2.3 pt20 -81.84 -115.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 0.0 110.421 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.492 ' H ' ' CG ' ' A' ' 123' ' ' GLN . . . -161.16 20.84 0.21 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.488 ' H ' ' CD ' ' A' ' 123' ' ' GLN . 7.2 tptm -144.83 -179.26 6.48 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.99 152.0 26.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.372 0.606 . . . . 0.0 112.04 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 11' ' ' SER . 14.2 p -146.9 70.0 12.12 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.386 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.74 134.02 2.41 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.228 2.619 . . . . 0.0 114.135 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.3 161.49 16.35 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.154 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.56 154.72 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.262 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 132' ' ' HIS . 62.2 m -82.54 162.31 22.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.427 0.632 . . . . 0.0 111.695 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.429 ' N ' ' CG2' ' A' ' 131' ' ' THR . 38.3 t60 -50.88 -40.67 57.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.168 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.07 -57.42 11.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.143 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.7 OUTLIER -56.48 -44.38 80.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.038 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.51 -56.58 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 109.896 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.1 mt -53.81 -35.08 61.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.781 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.11 -28.6 61.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.423 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 mmt -74.78 -61.82 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.036 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -53.61 -20.41 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.189 -178.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' N ' ' CD1' ' A' ' 139' ' ' ILE . 34.9 ttpt -77.64 -55.16 5.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.634 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.1 -31.76 56.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.6 t -43.89 118.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.996 0.426 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 144' ' ' VAL . 1.6 tm-20 -141.23 126.44 18.51 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.46 ' N ' ' OE2' ' A' ' 143' ' ' GLU . 7.2 p -122.07 128.5 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.83 0.348 . . . . 0.0 110.59 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.2 p -101.39 167.67 10.02 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.55 146.74 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -166.99 94.95 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 pt -92.68 127.31 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.29 0.567 . . . . 0.0 112.273 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -103.0 -179.33 3.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.946 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 8.0 m -93.35 129.29 39.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.451 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 p -103.45 -179.07 3.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.788 0.328 . . . . 0.0 110.29 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -155.49 -2.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 153' ' ' GLU . 6.1 mp0 -62.1 100.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.793 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.04 11.91 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -56.51 149.75 16.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.576 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.2 m-20 -55.74 172.8 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.3 t -98.8 145.65 26.74 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.637 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p-10 -119.99 93.43 4.06 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.693 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.583 ' H ' ' CD1' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -119.03 176.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -130.08 135.28 48.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.7 m -70.16 2.81 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -80.74 117.98 70.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -40.35 155.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.698 1.598 . . . . 0.0 112.05 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -81.64 138.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.935 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 2.3 mm? -83.84 114.69 21.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.05 171.56 46.61 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.492 -0.385 . . . . 0.0 112.197 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 169' ' ' ILE . 9.3 t -101.95 7.32 41.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.8 t30 64.15 -8.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.508 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.1 pp -80.35 161.27 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.218 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.483 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 13.0 t -123.57 137.46 54.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.468 ' ND1' ' N ' ' A' ' 171' ' ' HIS . 1.0 OUTLIER -74.19 38.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.106 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 170' ' ' SER . 58.8 mttp -67.62 -170.79 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.217 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -102.76 127.5 49.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.998 0.428 . . . . 0.0 110.509 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.462 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 12.1 m -151.64 -168.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.896 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -43.97 144.08 0.98 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.344 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -111.78 141.97 44.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -162.29 151.6 15.69 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.534 177.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.98 104.5 2.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.161 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.3 mt -107.09 -42.76 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.0 tt -72.59 138.08 22.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.087 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -101.13 -118.52 4.34 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.9 t -72.84 143.91 47.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.1 m -137.78 84.17 2.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.93 103.95 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.1 m -124.16 143.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.551 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.37 110.3 21.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.499 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 189' ' ' CYS . 7.0 m -50.75 -28.47 9.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.484 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -36.4 -28.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.077 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 187' ' ' THR . 30.2 p -149.34 24.23 0.91 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 24.9 t -143.25 81.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -69.19 -57.47 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.266 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 14.0 t-20 -111.7 162.08 15.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.403 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.452 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 6.9 tt -169.22 106.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 110.419 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.89 130.87 46.96 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -125.24 133.44 52.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.809 0.338 . . . . 0.0 110.514 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.8 p -143.92 139.0 28.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.951 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.7 t -135.03 160.34 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.483 ' NH1' ' O ' ' A' ' 170' ' ' SER . 57.0 ttt180 -170.67 111.54 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.124 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.3 tt -110.45 128.52 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.669 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.96 -155.24 8.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.878 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -91.39 119.98 31.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.464 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -82.01 2.37 31.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 92.2 m -100.77 -55.85 2.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 109.861 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.498 ' CB ' ' NZ ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -150.58 122.25 8.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.677 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -42.94 141.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.147 0.499 . . . . 0.0 111.754 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 208' ' ' GLU . 12.7 t -140.83 89.3 2.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.272 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.1 m -37.11 -27.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.25 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 206' ' ' SER . 85.0 mt-10 -73.06 -52.33 14.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.01 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 39.3 mt -91.5 7.81 39.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.305 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -97.21 119.03 34.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.2 m -145.29 168.21 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.462 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -154.22 167.71 28.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 112.557 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -151.12 163.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.295 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 171.29 160.21 19.28 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.156 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -148.02 172.64 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -139.6 104.74 5.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -103.31 122.96 45.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.703 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.7 m -143.59 120.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.252 0.548 . . . . 0.0 110.918 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.5 37.99 10.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.101 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.12 -4.86 83.14 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.726 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -100.08 116.18 31.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.23 0.515 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.28 154.6 19.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.356 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 42.2 t -169.7 127.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.329 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -77.53 140.55 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -169.25 111.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.452 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.24 100.91 8.56 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 69.7 p -131.63 166.26 21.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.631 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.14 96.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.781 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.92 18.2 4.34 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.589 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -62.7 -38.18 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 84.0 p -98.01 -2.28 40.72 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.297 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.68 -36.34 0.95 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.992 0.425 . . . . 0.0 110.541 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 8.6 mt -148.26 142.81 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 236' ' ' THR . 0.9 OUTLIER -75.99 101.5 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.213 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.431 ' CB ' HH12 ' A' ' 115' ' ' ARG . 84.9 p -65.58 4.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.481 ' H ' ' C ' ' A' ' 234' ' ' ASP . 46.9 p -91.19 -18.38 24.54 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.456 ' CB ' ' NZ ' ' A' ' 237' ' ' LYS . 9.1 mtmp? -104.64 8.44 35.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.94 161.8 26.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -145.21 134.6 23.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.69 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.39 134.04 55.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.151 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 41.0 t -100.92 -7.03 23.81 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.275 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.414 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 117.641 -1.171 . . . . 0.0 111.751 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.534 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 98.0 m -142.53 142.24 32.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.22 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 14' ' ' SER . 2.7 t -73.43 147.07 44.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 110.685 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.534 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -114.68 -20.86 10.49 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 12' ' ' CYS . 7.9 m -146.23 148.82 32.89 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.049 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.493 ' CD2' ' OD2' ' B' ' 53' ' ' ASP . 9.5 m-85 -107.92 164.5 12.21 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -86.94 138.15 31.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.784 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.39 23.51 3.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.925 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.25 125.46 18.71 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.721 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -80.53 119.19 22.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.755 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 2.6 mm? -80.57 113.56 40.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.343 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -46.66 149.34 3.04 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.38 1.387 . . . . 0.0 111.786 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -43.87 -47.3 8.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.315 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -38.3 -32.25 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.0 44.33 1.23 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.775 0.322 . . . . 0.0 110.735 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -149.8 86.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.796 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -89.11 -28.23 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -153.26 -179.41 7.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.998 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -164.11 164.1 22.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.527 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.509 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 57.1 t80 -148.12 -179.98 7.32 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.509 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 44.3 mt-10 -123.0 149.62 44.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 110.789 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.409 ' O ' ' O ' ' B' ' 30' ' ' GLU . 40.8 p -55.67 -111.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.815 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.9 t -152.01 -153.84 0.5 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.781 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.447 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.4 m -132.98 -25.51 1.81 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.399 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -59.36 -7.08 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.451 ' C ' ' H ' ' B' ' 37' ' ' GLN . 25.2 m -112.54 120.92 43.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 m -74.08 36.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.305 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.4 pt20 -169.91 61.68 0.41 Allowed Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.14 -162.06 0.12 Allowed 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.793 2.329 . . . . 0.0 113.319 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.96 176.93 0.13 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.972 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -107.77 135.79 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.136 0.493 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.01 137.83 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.605 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.07 146.08 42.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.369 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -92.79 169.97 10.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.2 p -138.59 -143.34 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 110.742 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -128.69 -38.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.278 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.27 41.66 3.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.76 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 11.6 t -147.06 -84.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.568 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 156.08 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.321 0.388 . . . . 0.0 110.044 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -144.0 145.94 32.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.344 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 24.1 t -153.2 125.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' B' ' 14' ' ' SER . 13.8 p -77.55 148.84 35.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.169 0.509 . . . . 0.0 111.395 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.89 142.37 42.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . 0.493 ' OD2' ' CD2' ' B' ' 15' ' ' TYR . 9.2 m-20 -64.15 122.78 79.64 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.07 0.46 8.37 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.062 1.175 . . . . 0.0 110.863 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 44.5 t -77.27 -5.25 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.702 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 57' ' ' SER . 1.1 tp10 -105.4 125.18 50.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.526 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 19.2 m -44.83 -43.86 9.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -56.4 -34.36 66.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.2 t -69.94 -38.87 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.334 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.04 -52.49 59.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.796 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.85 -35.64 75.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.06 -35.91 81.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.19 -45.55 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.832 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -63.13 -32.31 73.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -71.48 -41.82 68.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.29 -19.45 63.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.265 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -34.08 67.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.98 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.51 -77.62 0.15 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.813 0.339 . . . . 0.0 110.361 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 53.0 p30 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.537 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.729 0.299 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.6 m -65.37 -27.87 68.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.985 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.2 m -49.5 132.2 20.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -56.93 -25.36 57.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.581 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m -74.74 -29.45 61.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.609 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -74.35 -56.36 4.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.273 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -159.25 173.17 16.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 110.791 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.4 m -62.9 161.3 13.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.828 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 p -74.32 163.58 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.86 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 30.1 mp0 -112.15 7.47 19.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.529 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -67.32 -149.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.211 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -135.38 -68.87 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.461 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 41.8 t30 -79.02 52.07 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.424 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' O ' ' ND1' ' A' ' 22' ' ' HIS . 10.5 tptm -148.86 137.5 21.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.819 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 21' ' ' LYS . 22.9 m-70 -143.24 158.05 43.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 76.76 2.05 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.415 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 46.6 tpp -65.71 128.33 35.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 0.0 111.441 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -135.67 149.04 19.89 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.79 148.21 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -135.15 139.12 44.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.501 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.15 101.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.984 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.0 131.9 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.39 140.1 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.506 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.97 0.414 . . . . 0.0 110.056 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.48 135.06 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.746 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -102.15 120.1 39.89 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.636 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -74.58 152.87 39.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.853 0.358 . . . . 0.0 110.858 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 37' ' ' GLN . 33.7 mm-40 -70.63 158.82 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.284 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.33 28.62 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.737 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 35' ' ' GLN . 22.8 tt0 -141.05 -19.44 0.8 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -67.72 115.68 29.98 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.168 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 61.5 Cg_exo -40.0 157.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.0 p -73.42 136.13 44.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 20.0 m-80 -156.58 101.77 2.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.169 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.65 7.56 46.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.668 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -67.47 88.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.401 ' O ' ' OG ' ' A' ' 157' ' ' SER . 20.1 pt -85.12 141.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.02 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 22.1 t 55.43 67.82 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 46' ' ' GLN . 10.2 tm0? -78.73 -25.99 44.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 t 177.48 159.34 0.42 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.589 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.25 125.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -119.76 123.34 43.5 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.643 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 19.1 mp0 -102.69 129.43 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mm -134.71 159.61 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.2 m -152.63 108.41 3.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.927 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 78' ' ' THR . 4.3 pt-20 -52.3 120.97 6.09 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 22.6 t . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 CA--C 1.53 0.307 0 N-CA-C 111.185 -0.352 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.574 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 16.1 p -130.3 139.59 50.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.858 0.361 . . . . 0.0 110.869 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 m -98.83 132.15 44.4 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -113.72 143.24 44.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 110.429 -178.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 86.3 m-85 -129.57 124.87 34.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.652 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 82' ' ' SER . 25.2 p -103.91 62.66 0.76 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.662 0.267 . . . . 0.0 110.859 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.1 tt -71.22 102.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -102.14 148.05 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.956 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.51 144.52 5.18 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.31 9.22 57.05 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.28 2.52 57.88 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.758 -0.258 . . . . 0.0 113.098 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 173.95 13.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.307 0.554 . . . . 0.0 111.367 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -129.09 117.18 20.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.738 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.5 mtt -101.99 122.0 43.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.297 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.476 ' ND2' ' HH ' ' A' ' 80' ' ' TYR . 7.2 m120 -109.93 122.57 47.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.493 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.8 178.03 4.68 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.617 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.01 74.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.037 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -76.9 143.26 39.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.045 0.423 . . . . 0.0 110.441 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -127.75 105.53 8.52 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.474 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.8 tttt 67.08 40.14 2.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.759 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.8 m -119.02 148.86 45.67 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.28 129.95 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.882 1.721 . . . . 0.0 111.937 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.64 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.9 mp0 -50.39 144.99 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.9 mt -96.39 142.56 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.78 -11.54 1.15 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.016 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -113.17 116.48 29.88 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 pt -128.58 120.02 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.0 p -135.82 172.22 13.32 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.928 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 64.0 tt0 -161.57 152.83 18.53 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 t -155.47 152.23 28.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.033 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.23 121.83 28.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -133.41 108.61 8.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.006 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.68 -119.06 6.35 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -112.58 26.35 10.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.806 0.336 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 p -130.34 157.36 42.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.511 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.64 136.68 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.601 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.1 OUTLIER -124.48 158.22 33.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.967 0.413 . . . . 0.0 110.728 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.49 135.82 13.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -114.0 123.66 50.26 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.02 118.83 34.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 t -167.05 161.22 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.902 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.634 ' HG ' ' H ' ' A' ' 119' ' ' VAL . 12.9 t -82.69 174.59 10.86 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.634 ' H ' ' HG ' ' A' ' 118' ' ' SER . 34.2 m -110.06 144.43 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.013 0.435 . . . . 0.0 110.982 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.452 ' HG ' ' ND2' ' A' ' 168' ' ' ASN . 16.4 p -79.73 151.02 73.58 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.047 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.77 163.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.921 1.747 . . . . 0.0 112.185 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.55 61.78 7.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.209 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -139.31 -52.27 0.54 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.07 -12.78 0.37 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.696 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -126.92 172.46 10.42 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -74.56 150.7 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.644 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.0 m -143.41 63.05 12.09 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.292 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.52 131.54 2.52 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.116 2.544 . . . . 0.0 113.339 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.8 152.46 23.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.38 176.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.699 0.285 . . . . 0.0 110.735 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.2 p -81.19 172.33 13.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.183 0.516 . . . . 0.0 111.692 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.461 ' CG ' ' OD1' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -61.26 -37.35 82.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -63.65 -57.07 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.44 -57.24 8.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.039 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -53.54 -31.57 47.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.219 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.48 73.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.68 -52.34 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.54 -22.84 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.453 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -87.28 -54.51 4.27 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -79.89 -36.02 37.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 t -44.26 116.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.721 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 49.9 mt-10 -145.02 156.61 44.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.12 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.9 136.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.965 0.412 . . . . 0.0 110.374 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.0 p -102.37 163.91 11.97 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.71 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.56 137.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.88 0.372 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -143.95 92.89 2.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.7 mm -79.23 139.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.648 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.452 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 58.3 ttt180 -134.17 165.36 25.27 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 7.1 t -90.67 118.09 29.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.318 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 152' ' ' GLU . 31.2 t -100.3 -176.05 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.706 0.289 . . . . 0.0 110.262 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.429 ' N ' ' OG ' ' A' ' 151' ' ' SER . 16.0 tp10 -162.45 17.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.043 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.12 103.38 7.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.485 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.16 8.7 3.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -56.01 138.38 49.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.112 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.09 174.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.975 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 44' ' ' ILE . 10.8 t -94.66 143.9 26.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.498 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.464 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 m-20 -117.6 91.44 3.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.955 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.5 pt -124.51 170.3 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.689 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -160.88 0.78 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.034 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.7 t -130.53 -3.48 4.26 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -83.45 130.6 55.65 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -39.29 158.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.876 1.717 . . . . 0.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.6 p -80.25 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.257 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 18.0 mt -82.07 125.04 30.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.591 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.89 163.96 17.29 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.562 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 t -94.72 5.61 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.801 0.334 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.452 ' ND2' ' HG ' ' A' ' 120' ' ' SER . 1.2 m-20 60.31 9.5 1.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.988 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.01 154.65 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 172' ' ' LYS . 80.1 p -117.49 129.17 55.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.21 35.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 170' ' ' SER . 19.3 tttp -59.21 -164.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.481 ' CB ' ' HZ1' ' A' ' 173' ' ' LYS . 7.8 ttpm? -99.31 119.9 38.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.7 t -148.02 171.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.3 p -31.48 149.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.495 0.497 . . . . 0.0 111.529 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -106.58 141.69 37.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.191 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 3.8 tm-20 -150.85 137.42 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.619 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.433 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.1 t70 -65.92 96.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.1 mt -107.26 -52.99 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.388 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.5 tp -63.45 124.95 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.048 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.61 -117.38 2.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.574 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 41.5 m -74.18 139.25 44.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.793 -0.203 . . . . 0.0 111.16 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.552 ' OG1' ' CE1' ' B' ' 13' ' ' PHE . 15.7 p -138.3 91.58 2.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.21 0.529 . . . . 0.0 110.77 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.1 mm -99.13 115.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.051 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.27 138.48 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.155 0.502 . . . . 0.0 111.497 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.84 92.81 7.61 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.519 ' HG1' ' N ' ' A' ' 188' ' ' LYS . 1.3 p -47.27 -44.15 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.061 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.519 ' N ' ' HG1' ' A' ' 187' ' ' THR . 3.0 ttmp? -37.55 -27.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.038 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 187' ' ' THR . 81.6 m -146.17 31.43 1.02 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.4 t -149.75 100.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.711 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -77.02 -60.64 2.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.843 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -117.91 177.94 4.59 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.567 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.1 tt -174.07 108.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -93.44 137.65 32.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.553 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -117.37 130.77 56.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.713 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.0 m -144.3 119.73 10.3 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 45.3 t -131.06 157.87 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.326 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.433 ' CZ ' ' O ' ' A' ' 170' ' ' SER . 45.5 ttt180 -158.31 156.13 30.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.56 112.71 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.21 167.89 40.91 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.078 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -49.28 141.14 8.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.7 mtm -95.66 3.81 53.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.2 t -118.57 -47.92 2.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.719 0.295 . . . . 0.0 110.867 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.79 108.84 4.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 110.164 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -48.28 156.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.6 p -156.54 112.27 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.982 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 t -33.16 -59.3 0.36 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.582 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -52.19 -53.34 44.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.0 61.87 4.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -163.8 105.59 0.94 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.717 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.15 174.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.969 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -171.38 147.3 2.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.567 . . . . 0.0 111.584 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.3 t70 -121.73 171.2 9.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.39 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . -179.83 158.57 22.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.888 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . 0.429 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 46.7 m-85 -150.31 165.45 32.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -134.03 104.92 6.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -101.93 117.58 35.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.79 104.04 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.061 0.458 . . . . 0.0 110.703 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.6 t0 55.23 52.17 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.255 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.63 -9.52 50.24 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.908 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.8 p -89.6 109.11 20.09 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.63 -0.335 . . . . 0.0 110.944 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -103.08 147.65 26.71 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 73.1 m -166.79 129.53 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -82.2 141.14 33.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -171.07 108.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.272 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.1 97.28 2.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.242 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.6 p -126.06 154.18 43.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.91 95.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.55 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.2 35.6 0.81 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.353 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.6 m -74.65 -41.62 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.714 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -93.61 5.04 52.93 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.149 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -38.52 -37.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.135 0.493 . . . . 0.0 110.767 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 7.7 tp -159.66 148.88 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.728 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.65 100.57 4.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.3 t -68.23 -0.82 5.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.2 p -82.58 -21.15 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -105.2 10.06 33.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.241 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.7 mt -92.84 129.27 38.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -113.67 143.85 43.91 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.068 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.75 171.32 0.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 40.1 t -126.21 -6.13 6.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.71 179.695 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.837 0.351 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 87.8 m -149.29 116.23 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . 0.402 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 0.1 OUTLIER -62.94 137.53 58.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.96 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.552 ' CE1' ' OG1' ' A' ' 183' ' ' THR . 25.4 p90 -114.94 -20.62 10.46 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.985 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -122.43 143.58 49.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.483 ' CD2' ' OD1' ' B' ' 53' ' ' ASP . 16.4 m-85 -121.73 152.48 39.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 111.808 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -80.29 141.27 35.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.503 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -89.15 -28.02 20.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -87.54 126.03 34.68 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.724 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -85.85 114.61 22.91 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' B' ' 20' ' ' LEU . 9.3 mp -75.33 115.08 41.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -41.93 151.04 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.134 1.889 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 25' ' ' VAL . 39.7 ttm180 -45.87 -50.0 14.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.386 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -28.99 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -109.6 50.26 0.8 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.941 0.4 . . . . 0.0 110.241 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 22' ' ' ARG . 66.1 t -150.22 88.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -95.42 -21.14 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.35 179.21 8.52 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.499 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -166.98 163.38 15.99 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.287 0.565 . . . . 0.0 112.037 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -152.16 167.25 29.14 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.165 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' B' ' 31' ' ' THR . 50.9 mt-10 -114.08 152.18 31.44 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.422 ' O ' ' O ' ' B' ' 30' ' ' GLU . 73.0 p -55.92 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.091 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -147.84 -149.29 0.29 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.676 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.473 ' C ' ' H ' ' B' ' 35' ' ' CYS . 91.1 p -135.51 -24.38 1.37 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.276 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.24 -3.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.46 . . . . 0.0 109.788 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.473 ' H ' ' C ' ' B' ' 33' ' ' SER . 58.0 m -114.99 117.31 30.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.503 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -73.65 37.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.964 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.466 ' H ' ' C ' ' B' ' 35' ' ' CYS . 10.2 pt20 -169.22 64.3 0.54 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.95 -162.86 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.422 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.32 176.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.971 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.14 144.06 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.224 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.44 130.47 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.505 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -112.14 144.21 41.9 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -111.51 115.19 28.79 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.066 0.46 . . . . 0.0 111.047 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.4 p -79.52 -140.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.48 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.85 -27.91 2.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.87 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.97 46.44 2.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.435 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 48.0 t -157.26 -84.95 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.944 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 154.76 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.715 0.635 . . . . 0.0 109.777 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -131.17 140.68 49.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.726 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.0 t -150.19 112.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 110.827 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.574 ' N ' ' OG ' ' A' ' 182' ' ' SER . 2.6 t -73.33 152.16 41.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.605 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.13 135.79 22.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.893 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . 0.483 ' OD1' ' CD2' ' B' ' 15' ' ' TYR . 69.3 m-20 -61.74 125.9 85.81 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.99 2.64 5.24 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.433 1.422 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 30.2 m -73.39 -3.49 27.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.292 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.404 ' O ' ' OE1' ' B' ' 60' ' ' GLN . 39.0 mt-10 -109.53 125.13 52.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.93 0.395 . . . . 0.0 110.363 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -50.12 -36.19 28.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.113 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -56.14 -36.18 67.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.936 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 t -70.72 -36.88 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.001 0.429 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . 0.404 ' OE1' ' O ' ' B' ' 56' ' ' GLU . 2.2 mp0 -70.07 -36.79 75.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.99 -37.56 69.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.225 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.31 -41.03 94.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.628 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.47 -44.21 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.919 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -60.13 -28.9 68.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.746 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -75.33 -43.7 49.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.946 0.403 . . . . 0.0 110.728 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.74 -22.75 63.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.457 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.57 -36.53 68.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -75.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.581 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.776 0.322 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -72.37 -20.77 61.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.592 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.9 t -50.42 131.98 24.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.565 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.5 p -57.77 -29.59 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -76.83 -23.54 52.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.721 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -79.08 -48.05 15.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -165.35 171.27 13.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.093 0.473 . . . . 0.0 111.05 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.66 148.75 48.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.553 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.7 p -70.93 176.18 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.548 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.6 5.71 6.81 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 19' ' ' GLU . 43.1 mt-10 -83.03 92.9 7.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.411 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' GLU . 37.1 tt0 -23.54 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.171 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -76.22 50.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.358 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -158.49 135.71 9.99 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -145.53 166.43 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.82 0.343 . . . . 0.0 111.003 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -95.03 107.05 19.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.64 107.21 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.297 0.57 . . . . 0.0 110.581 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.86 148.32 18.71 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.98 151.86 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' CD1' ' A' ' 29' ' ' ILE . 59.0 t0 -147.25 130.83 16.81 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -138.67 99.8 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.846 0.355 . . . . 0.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.438 ' CD1' ' OD1' ' A' ' 27' ' ' ASP . 1.7 mp -95.23 139.54 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 pt -148.71 135.13 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.471 0.653 . . . . 0.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -115.98 123.19 47.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.589 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.63 110.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.784 0.326 . . . . 0.0 111.162 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -87.58 122.24 31.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.758 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.442 ' NZ ' ' C ' ' A' ' 110' ' ' ASN . 25.1 mtmm -80.55 154.31 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.758 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.642 ' NE2' ' H ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.06 154.06 39.38 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' H ' ' CD ' ' A' ' 35' ' ' GLN . 15.2 t70 -62.1 -19.47 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.4 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.642 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 70.6 mt-30 -82.75 -36.71 25.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.193 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.8 p -48.04 147.21 3.71 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.742 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.09 168.47 24.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.113 1.876 . . . . 0.0 111.575 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -75.36 128.46 35.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.63 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.475 ' ND2' ' OE1' ' A' ' 154' ' ' GLU . 29.7 m120 -158.24 101.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.73 -0.27 21.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.643 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -72.69 71.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.06 170.36 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 110.383 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 32.6 t 50.35 57.86 6.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.48 0.657 . . . . 0.0 110.443 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.98 -21.2 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 t 173.14 154.12 0.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.905 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.16 135.06 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.524 ' HG1' ' H ' ' A' ' 82' ' ' SER . 17.5 p -114.29 153.93 28.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -136.22 109.73 7.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.531 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 mt -122.01 154.02 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 t -153.59 151.32 29.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 37.8 tt0 -52.96 171.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 p . . . . . 0 C--N 1.32 -0.706 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.307 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.481 0.784 0 N-CA-C 113.105 0.387 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 94' ' ' PHE . 1.4 t -140.67 149.56 42.4 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.032 0.444 . . . . 0.0 111.498 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 m -101.37 129.85 47.45 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 63.8 t80 -118.39 101.8 8.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -108.96 117.56 34.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.915 0.388 . . . . 0.0 110.277 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.524 ' H ' ' HG1' ' A' ' 49' ' ' THR . 13.8 t -95.95 85.32 4.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.327 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.59 118.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.069 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 tt -106.62 146.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.796 0.331 . . . . 0.0 110.109 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 157.57 7.77 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.31 7.95 82.02 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.99 60.29 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.829 -0.224 . . . . 0.0 112.582 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.56 174.47 15.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 111.045 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -115.81 123.88 49.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.719 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.2 mpp? -102.71 97.94 8.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.415 ' ND2' ' OH ' ' A' ' 80' ' ' TYR . 84.3 m-20 -86.88 133.89 33.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.456 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 78.6 m-85 -116.27 -164.91 1.0 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.76 71.94 0.03 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.07 140.54 40.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.166 0.508 . . . . 0.0 110.641 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -131.97 108.27 9.25 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? 69.04 36.5 2.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 31.9 m -122.38 149.65 55.53 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -34.91 153.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.408 2.072 . . . . 0.0 112.573 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -76.21 106.43 7.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -62.48 146.05 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.21 -12.05 0.42 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.861 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -106.09 113.79 27.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.2 mt -124.03 108.2 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -139.48 153.92 47.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.77 0.319 . . . . 0.0 111.815 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 17.0 mp0 -145.11 169.69 17.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.6 p -157.83 153.95 27.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.87 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.27 118.2 20.97 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.853 0.358 . . . . 0.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.4 107.63 8.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.99 -138.7 25.96 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.442 ' C ' ' NZ ' ' A' ' 34' ' ' LYS . 24.5 p30 -91.99 26.29 2.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 110.494 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.0 m -129.63 156.47 44.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.772 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.07 138.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.316 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.47 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -119.57 168.08 11.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.115 0.483 . . . . 0.0 111.194 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.25 127.33 9.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.105 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.477 ' NH1' ' OG ' ' A' ' 235' ' ' SER . 76.9 ttt180 -113.52 110.79 20.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.656 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -115.19 124.9 52.62 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 p -168.07 161.75 12.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.938 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -77.93 171.0 15.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.623 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.83 145.56 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.043 0.449 . . . . 0.0 111.338 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.15 163.38 53.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.43 150.23 84.37 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 122.209 1.939 . . . . 0.0 111.664 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.37 9.67 85.59 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.329 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -82.96 -60.51 2.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.35 -16.73 0.29 Allowed Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -110.42 179.0 4.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.48 158.74 35.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.108 0.48 . . . . 0.0 111.242 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.4 p -155.04 61.03 2.86 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -40.36 135.55 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.936 2.424 . . . . 0.0 113.286 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -114.99 145.87 41.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.272 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.8 tp -140.71 168.35 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -73.14 178.58 4.32 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 111.475 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -71.23 -34.3 70.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.54 -57.61 11.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.64 -31.89 73.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.993 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.89 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.505 ' O ' ' NZ ' ' A' ' 140' ' ' LYS . 35.3 tp -74.23 -32.82 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.595 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.18 -52.02 18.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.55 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -64.12 -54.53 32.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.587 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.585 ' N ' ' SD ' ' A' ' 138' ' ' MET . 20.7 tt -45.87 -22.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 136' ' ' LEU . 26.4 mtmm -92.96 -26.35 17.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.283 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.47 -30.84 14.83 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.0 t -47.3 117.02 1.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -138.74 121.57 16.52 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.349 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.26 125.77 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.621 ' HG ' ' N ' ' A' ' 146' ' ' ILE . 10.4 t -100.78 159.2 15.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.906 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.621 ' N ' ' HG ' ' A' ' 145' ' ' SER . 3.2 mt -148.78 156.86 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.938 0.399 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -166.1 85.76 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.59 144.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.495 . . . . 0.0 111.793 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -135.8 175.41 9.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.812 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.7 t -91.46 134.88 34.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.45 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 p -111.39 166.16 11.35 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.771 0.319 . . . . 0.0 110.169 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.89 6.99 2.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.93 99.45 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.096 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.475 ' OE1' ' ND2' ' A' ' 41' ' ' ASN . 9.8 mm-40 -83.23 18.88 1.6 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -63.71 148.84 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.613 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 157' ' ' SER . 38.4 t70 -52.16 171.79 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.194 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.443 ' H ' ' CG ' ' A' ' 156' ' ' ASP . 35.2 p -100.02 149.82 23.07 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.086 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.2 m-20 -116.73 88.83 2.98 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.3 pt -103.25 177.13 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.388 0.613 . . . . 0.0 111.528 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.758 ' HZ2' ' H ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -108.36 -173.29 2.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.06 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.8 m -124.56 -9.26 7.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.401 ' O ' ' NZ ' ' A' ' 160' ' ' LYS . 14.6 m-70 -100.14 127.56 33.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.787 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -39.42 159.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.03 1.82 . . . . 0.0 112.705 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.09 140.38 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 20.2 mt -85.2 125.29 32.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.366 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 159.85 20.32 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.469 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.3 m -93.8 12.0 27.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.4 t30 58.08 9.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.719 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.22 148.58 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 20.5 m -112.6 140.06 47.68 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.412 ' NE2' ' OD2' ' A' ' 27' ' ' ASP . 22.0 m80 -74.95 43.95 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.535 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -71.53 162.68 29.06 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -77.39 128.02 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.7 m -149.29 -166.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.0 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.1 p -48.08 145.06 3.3 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.423 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -112.47 144.38 42.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.906 0.384 . . . . 0.0 111.239 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -158.74 152.1 22.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.483 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -68.61 106.33 2.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.274 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -116.93 -59.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.724 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.1 mt -61.26 122.05 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.14 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.4 -119.81 2.11 Favored Glycine 0 C--O 1.225 -0.412 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.955 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.538 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 52.2 p -72.07 141.86 49.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.508 ' OG1' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -145.02 83.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.68 97.04 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.991 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 18.1 m -112.18 131.65 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.953 0.406 . . . . 0.0 111.59 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -79.44 114.99 18.8 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.112 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.9 p -52.25 -28.04 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -39.21 -30.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.514 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 65.1 m -143.95 26.43 1.53 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.732 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 44.0 t -149.22 89.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 110.483 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -67.71 -56.44 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.648 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -133.65 146.32 50.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.14 120.81 11.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 12.7 mp0 -105.92 130.78 53.8 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . 0.512 ' N ' ' CD1' ' A' ' 195' ' ' PHE . 0.2 OUTLIER -107.23 138.63 43.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.912 0.387 . . . . 0.0 110.528 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.2 t -144.35 120.64 10.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.62 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 198' ' ' ARG . 6.7 p -131.93 159.64 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.416 ' N ' ' CG2' ' A' ' 197' ' ' VAL . 11.4 ttt85 -171.25 112.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.241 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 8.5 tt -113.3 129.84 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.819 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -168.83 -148.97 5.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.862 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -95.95 119.83 35.15 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 167' ' ' SER . 21.8 mmt -82.85 3.86 27.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.29 -54.31 2.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.689 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -153.76 120.73 5.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.726 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -49.2 129.22 17.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.148 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.4 t -124.8 113.33 17.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.797 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.9 p -35.58 -39.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.859 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -79.21 -45.58 19.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 61.21 3.98 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.07 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.34 128.17 7.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.185 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 212' ' ' LYS . 3.8 t -142.9 164.35 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.03 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.477 ' N ' ' CG1' ' A' ' 211' ' ' VAL . 0.9 OUTLIER -161.13 127.34 3.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.03 171.51 11.79 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.448 ' C ' ' CD1' ' A' ' 215' ' ' PHE . . . 155.76 160.49 10.01 Favored Glycine 0 CA--C 1.511 -0.166 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 215' ' ' PHE . 14.5 m-85 -141.57 -176.8 4.88 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -134.73 105.99 6.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.203 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.66 113.55 25.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.401 ' O ' ' OD1' ' A' ' 219' ' ' ASP . 31.8 m -135.98 120.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 0.0 110.523 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 218' ' ' VAL . 4.5 p-10 46.09 51.32 11.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.979 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.24 2.96 68.53 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.668 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.7 t -104.41 119.89 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.066 0.433 . . . . 0.0 110.678 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.07 155.87 18.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.121 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 79.3 p -170.87 129.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -80.14 141.9 35.29 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -170.86 101.6 0.17 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.17 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.39 96.55 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.714 0.292 . . . . 0.0 110.387 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 77.2 p -126.04 160.43 30.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.64 99.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -91.66 21.96 4.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 87.5 m -63.24 -35.4 80.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.746 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.1 p -97.95 -4.75 35.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.1 tp -43.45 -31.8 0.76 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.852 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.3 tt -143.53 144.35 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.203 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 236' ' ' THR . 31.5 m-20 -83.15 91.4 7.23 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 115' ' ' ARG . 14.2 t -56.78 -0.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.202 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 234' ' ' ASP . 58.4 m -88.36 -20.24 25.59 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -101.6 11.42 38.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.747 0.308 . . . . 0.0 111.465 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -84.78 133.23 34.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.694 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -127.09 132.3 50.67 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.361 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.758 ' H ' ' HZ2' ' A' ' 160' ' ' LYS . . . -55.67 165.48 0.85 Allowed 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.156 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 38.1 t -126.23 -2.9 6.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.971 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 121.125 0.488 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 33.3 m -116.29 135.49 53.84 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.603 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 t -41.31 138.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.779 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.508 ' CD2' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -125.17 -26.79 3.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.305 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.6 m -138.66 143.02 39.03 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.506 ' N ' ' CD1' ' B' ' 15' ' ' TYR . 1.1 m-85 -107.18 149.12 28.04 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.2 t -74.94 133.72 41.69 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.463 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.06 -45.44 20.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.589 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -79.33 126.13 30.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.87 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.61 150.22 48.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.118 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 20.8 mt -105.01 100.06 22.51 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.513 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -42.23 146.44 0.68 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.69 1.594 . . . . 0.0 111.968 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -46.12 -48.21 17.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.643 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -49.37 -22.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 111.291 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.407 ' CE1' ' OE1' ' A' ' 53' ' ' GLU . 9.6 t80 -109.42 33.57 4.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.201 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 66.3 t -153.47 93.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.686 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 32.0 m -88.42 -23.72 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.5 t70 -156.76 -179.52 8.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.163 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.492 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 7.9 p90 -158.51 170.61 21.81 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.084 0.469 . . . . 0.0 111.36 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.45 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -154.02 179.28 9.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.12 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.45 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 85.9 mt-10 -124.14 147.37 48.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.873 0.368 . . . . 0.0 110.364 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -55.82 -109.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.5 m -153.86 -147.96 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.669 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.507 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.1 t -136.47 -32.43 0.84 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.308 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 4.3 mp -51.79 -10.99 0.13 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.507 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.6 p -111.04 118.63 36.57 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 79.4 p -72.58 37.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.723 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.4 pt20 -171.27 61.83 0.35 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.66 -167.66 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.669 2.246 . . . . 0.0 113.386 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.45 176.02 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.639 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.25 131.85 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.683 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.08 132.94 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.597 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -103.74 147.7 26.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.167 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -94.05 169.57 10.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.2 p -142.0 -145.82 0.18 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.719 0.691 . . . . 0.0 111.499 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.468 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -127.62 -40.12 1.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.33 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.75 43.09 3.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.361 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 8.5 t -149.04 -83.78 0.1 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.435 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -87.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.004 0.43 . . . . 0.0 109.878 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -139.53 147.37 41.13 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.65 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -150.39 119.09 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 111.098 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.538 ' H ' ' CB ' ' A' ' 182' ' ' SER . 7.2 t -59.8 157.51 12.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.664 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.485 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.1 134.79 13.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.811 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -73.01 121.28 84.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.32 1.4 6.15 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.223 1.282 . . . . 0.0 111.863 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 27.7 t -76.05 -4.05 39.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.957 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' B' ' 57' ' ' SER . 0.8 OUTLIER -106.87 124.87 50.24 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.511 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 22.1 p -44.32 -47.34 9.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.4 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 85.9 m95 -55.11 -27.79 47.75 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.22 -43.98 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 109.646 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -62.05 -41.67 98.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.97 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -70.66 -34.86 72.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -66.45 -37.57 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 73.3 t -71.11 -47.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.95 -31.72 70.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -72.56 -37.44 68.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.58 -22.09 61.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.558 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -73.17 -32.2 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.235 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.63 -78.07 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.8 t30 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.549 -180.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.913 0.387 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 m -79.14 -25.48 42.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.625 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 p -47.93 128.52 13.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 127' ' ' SER . 3.2 t -61.28 -19.94 62.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.1 p -77.4 -30.9 53.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.379 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.523 ' HG ' ' N ' ' A' ' 14' ' ' SER . 66.0 p -77.24 -46.68 22.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.523 ' N ' ' HG ' ' A' ' 13' ' ' SER . 33.6 m -163.15 158.88 22.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.912 0.387 . . . . 0.0 110.669 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.11 154.34 10.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.5 p -68.62 165.5 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.514 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 34.9 mp0 -115.42 7.94 15.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.258 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.24 -163.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 15.3 mp0 -114.56 -73.01 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.023 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -87.61 60.26 5.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.145 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 21.7 tttm -157.78 141.46 15.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.258 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -149.42 179.13 8.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.387 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.508 ' CD2' ' OG ' ' A' ' 127' ' ' SER . 32.1 t60 -108.93 90.23 3.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 53.9 tpp -71.92 126.72 30.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.903 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.44 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -136.07 167.13 24.48 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.5 pt -111.32 150.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.23 121.04 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.8 146.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.184 0.516 . . . . 0.0 111.254 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.1 mt -137.27 140.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tt -130.77 122.26 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.138 0.494 . . . . 0.0 111.429 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -107.69 111.28 23.41 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.7 t -112.32 122.1 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.952 0.406 . . . . 0.0 111.643 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.0 m -97.25 114.62 26.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -68.3 151.8 46.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.82 179.35 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -80.63 -28.43 36.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.737 0.303 . . . . 0.0 110.71 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -85.31 -34.75 21.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.2 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.3 m -40.3 104.1 0.32 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.87 161.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.931 1.754 . . . . 0.0 112.039 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.8 p -67.99 140.14 56.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.639 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.401 ' C ' HD21 ' A' ' 41' ' ' ASN . 0.4 OUTLIER -165.3 96.21 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.42 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -99.32 10.62 41.07 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.35 82.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.125 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.6 pt -81.26 142.74 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.634 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.489 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 33.9 t 56.21 67.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.5 tp60 -78.47 -31.45 47.88 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.4 p -178.32 167.47 1.9 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.504 ' CG1' ' SG ' ' A' ' 241' ' ' CYS . 4.0 m -145.95 130.04 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.918 0.39 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 82' ' ' SER . 41.6 p -102.99 172.89 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.933 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -159.93 116.02 2.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.73 158.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -150.87 110.64 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.497 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 7.4 pt-20 -57.17 84.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 123.566 1.65 . . . . 0.0 109.601 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' THR . 9.9 p . . . . . 0 C--N 1.305 -1.349 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.571 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 CA--C 1.533 0.468 0 N-CA-C 111.707 -0.151 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.501 ' N ' ' OE2' ' A' ' 53' ' ' GLU . 32.8 m -119.14 131.28 55.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.793 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.9 p -87.72 126.17 34.83 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 59.8 t80 -136.72 107.8 6.75 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CD2' ' CE1' ' A' ' 92' ' ' PHE . 4.8 p90 -106.8 -179.03 3.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.496 ' N ' ' OG1' ' A' ' 49' ' ' THR . 15.8 m -152.53 75.42 1.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 pt -72.4 119.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.51 0.671 . . . . 0.0 110.753 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.1 mt -101.26 145.13 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.518 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.46 166.1 16.32 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.37 22.36 50.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.09 14.18 76.32 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.36 156.57 48.27 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.938 0.399 . . . . 0.0 110.502 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -122.57 114.87 21.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.314 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 36.5 mtt -101.3 123.06 44.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.78 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -115.48 119.97 37.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.256 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.655 ' CE1' ' CD2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -108.15 169.36 8.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.77 77.63 0.19 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.337 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.45 145.35 29.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.642 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -141.63 122.21 14.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 66.45 34.26 6.3 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.378 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.55 143.72 49.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -34.39 144.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.387 2.058 . . . . 0.0 112.74 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -68.59 154.87 41.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.338 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.65 144.62 9.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.221 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.437 ' NZ ' ' OD2' ' A' ' 126' ' ' ASP . 4.0 tppt? -143.27 -15.96 0.66 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.717 0.294 . . . . 0.0 110.331 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -113.16 118.06 33.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.278 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 tp -135.05 128.68 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 p -142.79 179.41 7.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 60.0 tt0 -164.22 154.58 14.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.2 t -157.63 153.03 26.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.414 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.24 123.65 30.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -135.3 107.9 7.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.966 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.31 -124.69 7.35 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -106.61 27.78 8.5 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.732 0.301 . . . . 0.0 110.511 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -133.72 159.83 39.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 110.731 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.35 134.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.476 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.86 155.08 27.47 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.06 128.44 8.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -108.24 122.99 48.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.033 0.444 . . . . 0.0 111.154 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -112.98 114.6 27.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.41 ' HG ' ' N ' ' A' ' 118' ' ' SER . 20.4 t -157.58 170.0 23.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.593 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.41 ' N ' ' HG ' ' A' ' 117' ' ' SER . 31.3 p -94.52 166.17 12.18 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.438 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.98 150.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.374 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 p -99.43 150.42 36.74 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.867 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -38.84 163.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.121 1.88 . . . . 0.0 112.543 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 50.23 73.54 0.36 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.215 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -152.89 -27.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.088 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.88 12.62 13.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.193 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -134.95 155.42 50.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.437 ' OD2' ' NZ ' ' A' ' 101' ' ' LYS . 4.6 p30 -56.31 151.33 13.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.527 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.508 ' OG ' ' CD2' ' A' ' 23' ' ' HIS . 2.2 t -153.19 67.13 6.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.53 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.22 130.0 27.19 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.887 2.391 . . . . 0.0 113.331 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.443 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -96.2 158.07 15.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.694 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.8 pt -145.34 160.87 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.82 0.343 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.8 p -75.78 178.53 6.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.047 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -69.27 -35.95 76.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.503 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.31 -57.85 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.989 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.995 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.29 -56.96 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.769 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.0 tp -54.46 -32.61 58.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.127 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.51 -52.46 18.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.646 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mtt -57.16 -52.72 64.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.145 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.2 mm -45.98 -21.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.296 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -91.43 -41.55 10.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.79 -31.06 56.73 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 m -41.47 111.15 0.2 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.48 116.96 11.35 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.055 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.57 127.35 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.055 0.455 . . . . 0.0 110.659 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 m -101.06 162.9 12.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.4 tp -145.47 136.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.992 0.425 . . . . 0.0 110.646 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -146.99 90.42 1.9 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.882 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.9 tt -83.73 140.33 16.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.72 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 35.8 ttm180 -133.39 170.45 15.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 5.8 t -90.48 126.64 35.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.187 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.7 p -120.38 133.45 55.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -100.57 21.23 13.64 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.622 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -50.29 158.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -144.54 -0.74 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.197 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 26.8 mtmm -63.89 171.58 2.74 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.632 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.23 173.89 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.5 t -92.54 144.28 25.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.6 t70 -120.18 89.86 3.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.999 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 pt -120.53 172.25 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.428 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.592 ' NZ ' ' NE2' ' A' ' 162' ' ' HIS . 31.0 tttm -124.32 136.4 54.08 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.005 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.8 m -64.26 0.43 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.592 ' NE2' ' NZ ' ' A' ' 160' ' ' LYS . 1.8 m-70 -79.3 119.14 76.03 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.11 157.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.811 1.674 . . . . 0.0 112.281 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.45 134.7 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.47 120.02 21.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.18 162.42 22.77 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.491 ' HG ' ' H ' ' A' ' 169' ' ' ILE . 10.3 p -98.08 5.37 48.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.091 0.472 . . . . 0.0 109.766 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 58.5 t30 60.31 -0.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.815 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.491 ' H ' ' HG ' ' A' ' 167' ' ' SER . 0.2 OUTLIER -88.98 133.62 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.7 t -79.12 -176.49 5.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.271 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.525 ' CD2' HH21 ' A' ' 198' ' ' ARG . 0.0 OUTLIER -124.52 22.23 8.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -59.63 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -93.5 123.97 37.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.613 ' CG2' ' H ' ' A' ' 175' ' ' SER . 14.4 p -146.97 -176.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.931 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.613 ' H ' ' CG2' ' A' ' 174' ' ' VAL . 58.6 m -38.65 143.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.744 0.307 . . . . 0.0 111.228 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -104.35 140.64 37.61 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.056 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -151.09 144.81 25.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.58 89.18 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.1 -42.74 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.964 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.8 tp -64.03 124.84 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.22 -128.73 3.79 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.448 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.74 ' HG ' ' H ' ' B' ' 51' ' ' CYS . 10.1 t -73.26 148.54 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 69.0 m -129.58 133.85 47.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.8 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 7.6 mm -138.42 128.16 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 2.3 m -144.56 124.49 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.0 97.82 11.42 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 26.1 p -45.27 -27.84 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.386 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -44.56 -20.96 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.961 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 97.0 m -147.33 16.75 1.17 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.7 m -148.27 108.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.485 0.66 . . . . 0.0 111.119 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -79.42 -56.19 4.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.586 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -109.69 170.1 8.29 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.545 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -169.74 105.84 0.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -108.36 130.81 55.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -114.81 140.48 48.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.594 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.46 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 14.4 t -143.95 124.2 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.484 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.46 150.19 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.525 HH21 ' CD2' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -166.41 108.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.674 -179.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.0 mt -104.51 148.64 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.233 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.29 34.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.575 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -88.07 121.22 30.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.905 0.384 . . . . 0.0 110.303 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -79.48 1.15 26.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.731 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.62 -47.36 5.12 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.121 0.486 . . . . 0.0 109.9 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -168.09 127.21 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.65 148.05 0.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.848 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 47.9 p -136.69 12.81 3.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.924 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.6 m 58.39 -75.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.4 mt-10 -46.24 -54.38 8.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.681 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.4 mt -76.99 -0.83 25.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.785 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.88 134.83 37.09 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.669 0.271 . . . . 0.0 110.491 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m -154.62 -179.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.295 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.59 ' HZ1' ' CB ' ' A' ' 226' ' ' ALA . 13.9 pttp -170.67 167.5 7.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.431 0.634 . . . . 0.0 112.136 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.2 t70 -155.26 168.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.7 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 172.1 168.13 33.14 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 10.4 m-85 -153.4 167.3 29.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 2.7 ttmp? -133.42 104.0 6.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.035 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -100.57 118.13 36.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.866 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.38 111.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.614 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.4 t70 53.12 47.47 24.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.692 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.28 -5.61 71.72 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.356 -0.45 . . . . 0.0 113.408 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.7 t -96.95 116.66 29.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.099 0.45 . . . . 0.0 110.716 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.402 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -104.63 153.51 21.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.079 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 60.4 m -167.83 129.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.276 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -83.01 142.62 31.21 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.66 116.74 0.61 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.587 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.59 ' CB ' ' HZ1' ' A' ' 212' ' ' LYS . . . -73.86 111.45 9.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 28.5 m -140.99 153.07 45.4 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.924 0.392 . . . . 0.0 110.581 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 95.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.617 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -87.27 30.03 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.3 t -71.34 -39.1 71.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 55.6 m -96.94 2.67 51.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.9 tp -44.38 -40.64 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.788 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 27.5 mm -141.18 146.33 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.777 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 236' ' ' THR . 34.4 m-20 -78.18 92.86 4.49 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 m -56.6 -6.5 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 234' ' ' ASP . 26.0 m -86.68 -17.05 34.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.411 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -99.04 7.43 45.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.503 0.192 . . . . 0.0 111.347 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.67 144.77 35.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.407 . . . . 0.0 110.809 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -133.49 133.49 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.536 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.71 156.73 4.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 48' ' ' VAL . 53.7 t -126.5 -10.28 6.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.457 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.857 -1.068 . . . . 0.0 110.434 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 121.184 0.516 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.499 ' O ' ' CE2' ' B' ' 13' ' ' PHE . 85.6 m -106.4 161.42 14.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.67 135.48 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.346 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' B' ' 11' ' ' CYS . 6.8 m-85 -114.01 -26.91 7.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -149.66 153.76 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.261 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -111.52 155.07 23.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.74 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -77.49 137.17 38.5 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -27.17 41.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.62 0.248 . . . . 0.0 110.99 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -92.5 127.09 37.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.385 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -77.43 116.24 17.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.825 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.01 139.87 97.75 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.505 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.49 147.67 32.46 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.859 1.706 . . . . 0.0 111.367 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' B' ' 24' ' ' PHE . 41.5 ttp180 -44.68 -49.53 10.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.73 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' B' ' 23' ' ' ASN . 46.0 t-20 -69.67 29.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' B' ' 22' ' ' ARG . 57.8 t80 -155.45 33.33 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 86.4 t -155.97 97.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.751 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.42 -7.19 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 25.3 t0 -166.67 -178.74 4.49 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.096 -0.641 . . . . 0.0 111.259 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.498 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.7 p90 -158.24 163.52 37.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.097 0.475 . . . . 0.0 111.303 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -155.39 141.6 18.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.893 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' B' ' 31' ' ' THR . 88.8 mt-10 -90.0 142.5 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.91 0.386 . . . . 0.0 111.287 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 67.4 p -51.45 -108.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -154.47 -167.37 2.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.477 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.8 t -117.32 -30.4 5.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.502 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.536 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 4.4 mp -49.59 -13.14 0.08 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.477 ' H ' ' C ' ' B' ' 33' ' ' SER . 27.8 m -111.06 127.12 55.45 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.049 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -76.44 35.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -163.98 59.27 0.74 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.4 -164.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 122.59 2.194 . . . . 0.0 112.862 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.14 176.69 0.25 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.089 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.43 127.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.99 134.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -105.3 151.52 24.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.65 ' NE2' ' H ' ' B' ' 44' ' ' THR . 41.5 tp60 -93.67 164.56 13.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.687 ' HG1' ' H ' ' B' ' 48' ' ' ALA . 56.5 p -136.57 -168.42 2.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.289 0.566 . . . . 0.0 111.528 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.78 -41.82 4.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.713 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.91 47.11 2.02 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.374 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 3.0 m -158.47 -79.61 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.227 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.687 ' H ' ' HG1' ' B' ' 44' ' ' THR . . . 155.8 -90.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.397 0.436 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -136.86 151.45 49.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -150.08 124.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.74 ' H ' ' HG ' ' A' ' 182' ' ' SER . 10.2 t -64.18 159.5 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.298 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.496 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.0 130.59 10.68 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.238 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -67.76 116.88 42.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.33 0.57 5.87 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 120.938 1.092 . . . . 0.0 111.71 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 53.4 m -73.89 -16.07 61.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.983 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -91.61 127.25 36.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.168 0.509 . . . . 0.0 110.666 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 52.9 m -47.22 -49.8 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -56.15 -25.05 44.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.14 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 62.2 t -73.77 -37.38 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.181 0.515 . . . . 0.0 110.302 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.14 -37.56 78.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.504 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -72.07 -35.36 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.242 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.99 -36.1 82.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.477 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.06 -44.87 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.978 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -63.49 -27.59 69.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.018 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.41 -39.17 62.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.812 0.339 . . . . 0.0 110.934 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.43 -29.76 62.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.347 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OH ' ' B' ' 28' ' ' TYR . 32.1 mm-40 -69.7 -32.94 71.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.85 -74.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.336 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.553 179.891 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.729 0.3 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -75.44 -24.59 57.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.748 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 12' ' ' SER . 15.3 t -50.57 134.47 24.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -57.62 -29.39 64.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.45 ' H ' ' HG ' ' A' ' 10' ' ' SER . 85.4 p -74.35 -25.94 59.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.656 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.23 -57.08 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.974 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -159.01 175.94 12.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.922 0.392 . . . . 0.0 110.907 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -61.92 159.92 13.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.887 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.494 ' OG1' ' NE2' ' A' ' 23' ' ' HIS . 2.2 m -75.2 165.89 24.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 1.4 pm0 -114.75 3.16 14.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.777 0.323 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.64 -165.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.35 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -116.05 -75.92 0.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.901 0.382 . . . . 0.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.494 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 64.8 t30 -77.81 53.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.627 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -154.63 132.13 11.27 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.577 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 34.3 m170 -140.9 165.49 27.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.201 0.524 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.494 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 32.3 m-70 -97.75 76.19 2.46 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.965 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.2 ttm -68.88 133.69 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.29 25.03 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.0 tp -111.17 142.37 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -149.89 106.31 3.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.556 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.29 134.53 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.68 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.5 pt -113.99 163.33 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.92 132.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.437 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -120.68 133.08 55.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.538 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.4 116.71 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.872 0.368 . . . . 0.0 111.326 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -81.76 112.41 18.89 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.59 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -68.22 150.14 48.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.888 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -58.89 168.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -91.3 5.02 50.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.843 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -120.48 -33.38 3.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.846 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.4 t -54.17 119.28 19.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.463 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -39.25 157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.976 1.784 . . . . 0.0 112.544 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 p -75.49 143.91 42.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.46 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -157.33 107.1 2.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.424 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' ILE . 2.7 p30 -101.16 -2.56 31.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.064 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 154' ' ' GLU . 4.8 mmmm -63.51 83.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.3 tp -90.53 150.62 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.078 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.451 ' SG ' ' CG ' ' A' ' 105' ' ' GLU . 1.7 m 56.17 62.09 2.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.139 0.495 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -78.19 -40.02 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 t -172.51 163.32 5.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.04 0.448 . . . . 0.0 111.181 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.06 140.36 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.489 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -129.54 105.29 7.98 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.847 0.356 . . . . 0.0 110.857 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.08 128.87 34.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.494 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 mm -132.36 154.7 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.456 ' HG1' ' N ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -152.62 142.57 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' N ' ' HG1' ' A' ' 52' ' ' THR . 4.6 tp10 -51.11 176.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.366 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.531 0.349 0 N-CA-C 111.363 -0.284 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -123.76 141.46 52.01 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 p -107.59 127.0 53.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.755 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -112.25 148.02 35.01 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.201 0.524 . . . . 0.0 110.285 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -139.89 116.85 11.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.9 p -103.45 69.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.821 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.0 tt -74.37 102.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.185 0.517 . . . . 0.0 110.534 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 pt -88.08 147.84 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.181 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.5 170.06 19.91 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.7 37.8 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.77 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.09 86.47 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.618 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.08 159.2 40.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.057 0.456 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -117.4 108.98 16.22 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.312 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 45.7 mtt -101.23 112.13 24.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.45 124.1 48.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 84.7 m-85 -100.97 -176.03 3.05 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.1 71.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.249 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -75.92 138.54 41.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.385 . . . . 0.0 110.367 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.7 m -144.42 119.89 10.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.248 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? 66.87 26.74 9.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.214 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 m -120.72 149.83 51.33 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -40.06 154.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.815 1.677 . . . . 0.0 111.942 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.06 137.9 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.508 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -95.54 138.5 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -137.4 -10.6 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.738 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.9 t -112.21 122.77 48.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 tt -141.57 129.6 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.844 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.1 p -158.01 171.39 20.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.451 ' CG ' ' SG ' ' A' ' 45' ' ' CYS . 7.7 pt-20 -168.07 -172.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.6 t -171.56 165.96 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.445 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -127.01 116.68 21.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.172 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -127.93 107.9 10.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.029 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.81 -127.78 16.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -102.6 23.73 11.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.737 0.304 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 p -131.33 158.69 40.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.521 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.45 136.04 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.687 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -112.26 163.04 14.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.41 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -160.9 129.41 4.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.661 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -116.85 113.31 22.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.52 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.29 123.62 50.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -164.06 175.02 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.157 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.3 m -95.28 171.77 8.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.145 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.4 149.03 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.136 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 t -93.23 144.56 28.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -37.62 144.68 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.05 1.833 . . . . 0.0 112.516 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 57.11 6.16 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.187 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -138.75 -5.13 1.54 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.48 -8.35 64.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.81 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -115.56 168.82 9.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.98 147.06 39.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.288 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.5 m -148.73 65.56 8.42 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.689 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.27 148.03 1.32 Allowed 'Trans proline' 0 N--CA 1.474 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.903 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -117.87 146.68 43.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.311 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.42 171.11 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.844 0.354 . . . . 0.0 110.087 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -81.73 162.61 22.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.429 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.577 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 36.4 m170 -58.0 -36.45 72.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -54.38 -47.63 72.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.479 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -72.94 -33.21 65.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.97 9.39 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -56.14 -32.86 64.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.17 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.777 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 tpp -71.18 -63.17 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.102 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.3 -21.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.455 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -79.39 -55.11 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 41.4 t0 -79.14 -30.26 43.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.9 t -45.74 117.78 1.59 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.503 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.18 124.29 16.4 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.04 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 p -116.67 131.24 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.87 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.4 m -103.09 157.59 16.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.201 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.0 mm -140.43 145.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' OD2' ' NE2' ' B' ' 49' ' ' GLN . 2.0 m-20 -152.88 92.86 1.69 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.877 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.4 mt -89.26 142.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.301 0.572 . . . . 0.0 111.075 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -138.53 177.25 8.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.639 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.3 m -91.58 132.23 36.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.739 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -103.79 -173.98 2.44 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.47 11.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.861 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -79.92 103.59 9.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.495 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 11.1 pt-20 -77.52 7.75 5.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -49.73 145.66 5.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.93 0.395 . . . . 0.0 110.365 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.21 173.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.99 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.1 t -94.97 142.1 27.88 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -120.04 91.6 3.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.589 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.4 pt -121.06 168.69 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 162' ' ' HIS . 40.5 tptt -119.5 139.6 51.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.0 p -72.29 5.55 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.426 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.54 ' HD1' ' N ' ' A' ' 163' ' ' PRO . 3.3 t-80 -80.5 121.06 81.0 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.4 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.54 ' N ' ' HD1' ' A' ' 162' ' ' HIS . 66.9 Cg_exo -40.1 154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.826 1.684 . . . . 0.0 112.064 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.2 t -80.05 133.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.422 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.71 123.35 30.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.25 162.4 19.03 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.363 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.4 t -91.15 9.42 31.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 109.94 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.6 5.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.825 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.423 ' H ' ' C ' ' A' ' 167' ' ' SER . 9.9 tp -101.93 141.31 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.5 m -100.77 149.04 24.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.748 0.309 . . . . 0.0 110.35 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.448 ' NE2' ' N ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -83.13 39.55 0.65 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.019 0.438 . . . . 0.0 110.547 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.664 ' N ' HH12 ' A' ' 198' ' ' ARG . 74.7 tttt -65.16 173.5 2.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.295 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -84.18 123.81 30.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.427 HG21 ' H ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -149.11 -170.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.427 ' H ' HG21 ' A' ' 174' ' ' VAL . 25.3 p -44.71 146.87 0.69 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.571 0.224 . . . . 0.0 110.752 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -112.64 145.52 40.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.986 0.422 . . . . 0.0 111.437 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 1.6 tm-20 -157.88 145.73 18.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.447 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 9.9 t0 -70.34 100.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.403 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.4 mm -109.37 -50.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -61.67 125.35 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' B' ' 14' ' ' SER . . . -91.44 -123.11 2.87 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.191 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.2 t -73.3 140.58 46.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.628 0.251 . . . . 0.0 111.16 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.528 ' OG1' ' CE2' ' B' ' 13' ' ' PHE . 18.0 p -139.08 87.83 2.23 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.0 tt -102.65 129.1 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.418 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.6 137.67 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.556 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 109.41 19.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.22 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 189' ' ' CYS . 12.7 p -51.55 -27.48 11.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.573 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -38.36 -28.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.291 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 187' ' ' THR . 27.5 p -148.42 29.39 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.323 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.1 88.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.092 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -68.16 -58.33 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.167 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -123.07 179.38 4.69 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.403 ' C ' ' CD2' ' A' ' 193' ' ' LEU . 5.7 tt -173.22 106.65 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 25.2 mp0 -97.24 128.83 44.46 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -128.08 134.69 49.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.093 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.0 m -143.42 144.08 31.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.448 ' N ' ' NE2' ' A' ' 171' ' ' HIS . 18.1 m -140.6 167.39 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.124 0.488 . . . . 0.0 111.34 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.664 HH12 ' N ' ' A' ' 172' ' ' LYS . 21.8 ttm180 -164.09 156.32 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.154 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.6 mt -148.5 120.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.54 174.37 46.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.277 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -56.26 129.34 39.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.923 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 57.0 mtm -86.23 8.14 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.6 t -112.88 -48.2 3.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.239 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -159.19 115.02 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 7.9 mp0 -47.63 158.71 0.18 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 208' ' ' GLU . 69.9 m -143.38 23.02 1.84 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.01 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 t 57.68 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.822 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.5 mm-40 -48.68 -48.39 40.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.729 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -77.54 -0.65 27.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.445 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.79 155.36 19.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.971 0.415 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.8 p -175.55 158.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.409 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.428 ' HZ1' ' CB ' ' A' ' 226' ' ' ALA . 1.2 pptp? -168.56 136.83 2.16 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.401 0.62 . . . . 0.0 111.767 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 9.3 t70 -124.95 172.6 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 172.4 164.58 28.13 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.946 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -148.97 170.22 18.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -135.69 104.34 5.74 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.315 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -101.44 119.83 39.37 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.85 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.48 123.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.126 0.488 . . . . 0.0 110.442 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.62 37.88 27.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.31 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.32 89.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.91 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.4 p -103.19 120.9 41.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.843 0.321 . . . . 0.0 110.576 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.74 165.15 12.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.019 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.6 t -174.97 120.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.564 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -78.44 136.71 37.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.95 116.22 0.66 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.702 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.428 ' CB ' ' HZ1' ' A' ' 212' ' ' LYS . . . -81.61 96.56 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.3 m -129.55 151.41 50.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.989 0.423 . . . . 0.0 110.767 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.406 ' OD1' ' OG1' ' A' ' 230' ' ' THR . 14.3 t70 -57.32 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.553 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -93.26 31.0 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.406 ' OG1' ' OD1' ' A' ' 228' ' ' ASP . 50.6 p -73.71 -34.81 64.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.768 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -99.89 -2.55 34.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.896 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -43.42 -29.27 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.21 143.38 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.628 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.76 101.13 4.95 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -63.9 -5.68 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.147 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -47.28 12.67 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -71.4 9.43 0.8 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 238' ' ' LEU . 7.5 mp -72.98 152.28 41.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.493 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -137.15 135.16 37.11 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.561 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.19 144.71 23.42 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.49 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . 0.452 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 0.1 OUTLIER -104.34 -17.88 14.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.452 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 1.5 m . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.606 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 121.146 0.498 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -144.6 118.0 9.07 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.426 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 85.5 m -63.93 131.32 47.33 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE2' ' OG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -93.44 -26.78 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.018 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 181' ' ' GLY . 28.0 p -122.9 155.05 37.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.375 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.86 158.94 25.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.392 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -82.92 139.22 33.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.184 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.06 19.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.612 0.244 . . . . 0.0 111.32 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -80.2 127.83 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.785 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -81.92 128.68 34.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.38 52.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.808 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -42.04 153.08 0.13 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.208 1.938 . . . . 0.0 112.878 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' B' ' 25' ' ' VAL . 13.3 tpt180 -46.07 -50.46 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.353 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -35.95 -35.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 3.3 m-85 -105.58 43.23 1.14 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.102 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 22' ' ' ARG . 49.9 t -151.61 92.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.937 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -97.72 -22.95 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.265 -0.272 . . . . 0.0 110.823 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.455 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 6.3 p90 -166.06 168.91 15.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.253 0.549 . . . . 0.0 111.871 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 89.0 m-85 -157.34 178.26 10.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.243 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' B' ' 31' ' ' THR . 11.3 pt-20 -127.64 149.62 50.11 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.804 0.335 . . . . 0.0 110.501 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.414 ' O ' ' O ' ' B' ' 30' ' ' GLU . 77.8 p -53.93 -111.4 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -154.98 -148.68 0.24 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.425 ' C ' ' H ' ' B' ' 35' ' ' CYS . 10.5 m -135.82 -24.02 1.34 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.103 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.3 mm? -53.67 -13.56 0.7 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.794 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.443 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.3 p -115.94 122.16 44.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.58 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.3 m -73.31 38.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.402 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.5 pt20 -164.29 61.1 0.87 Allowed Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.14 -161.82 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.887 2.391 . . . . 0.0 113.294 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 170.76 176.53 0.06 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.217 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -111.59 136.74 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.73 143.2 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.618 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -115.69 149.9 37.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -92.97 169.26 10.57 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.3 p -138.17 -144.85 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.196 0.522 . . . . 0.0 110.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.501 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -126.27 -39.0 2.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.81 46.48 2.32 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.143 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 52.1 m -152.83 -83.17 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.428 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.586 0.554 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 49' ' ' GLN . 3.4 pp0? -145.31 147.87 32.8 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.12 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 t -150.26 115.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 71.7 m -68.05 144.72 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.785 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.69 139.3 41.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.998 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.69 126.33 92.49 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.54 -0.52 9.41 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.368 1.379 . . . . 0.0 111.554 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -65.18 -14.54 60.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.06 127.74 47.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.513 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 42.2 t -50.42 -46.89 56.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -55.99 -28.12 55.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.374 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.92 -36.16 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.112 0.482 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.72 -39.23 64.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.569 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -67.89 -35.7 78.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.47 -42.55 87.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.619 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.74 -46.01 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.841 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.66 -31.49 66.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.32 -35.67 63.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.585 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.336 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.52 -35.19 70.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' B' ' 68' ' ' LEU . 7.3 mp -79.79 -83.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.225 0.536 . . . . 0.0 109.64 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.643 -179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.812 0.339 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.7 t -79.44 -18.15 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.5 t -50.5 134.36 23.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.652 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -58.25 -27.41 63.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 95.8 p -73.76 -23.9 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.63 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -80.0 -53.43 6.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 p -168.07 169.38 11.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.866 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.1 m -55.3 155.8 4.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.537 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -76.46 173.19 11.8 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -112.84 5.59 17.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -62.44 -167.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.246 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 17.2 mp0 -119.21 -65.48 1.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.874 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.0 54.29 3.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.392 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' C ' ' ND1' ' A' ' 22' ' ' HIS . 3.6 tppt? -151.17 140.06 20.93 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.42 ' ND1' ' C ' ' A' ' 21' ' ' LYS . 53.5 m80 -145.67 158.59 43.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.888 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -95.65 76.41 3.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 29.9 ttp -64.74 133.0 51.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.47 . . . . 0.0 111.181 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.74 160.89 26.21 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.258 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -114.68 158.49 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.98 0.419 . . . . 0.0 110.586 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -151.35 137.48 18.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.69 109.26 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.325 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.2 mt -97.5 134.2 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.29 134.41 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.174 0.511 . . . . 0.0 112.003 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -121.05 127.49 51.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.79 112.89 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.449 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 35.9 p -84.71 121.3 27.47 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -75.32 151.82 38.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.782 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 37' ' ' GLN . 51.8 tt0 -67.85 144.5 55.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.215 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 47.7 p30 -76.26 43.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.599 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 35' ' ' GLN . 45.0 tt0 -152.3 -28.33 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.377 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.8 m -71.16 125.45 91.94 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -38.47 156.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.026 1.817 . . . . 0.0 112.542 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -76.27 140.08 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.42 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -157.17 107.29 2.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.366 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.84 8.82 37.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.258 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 12.0 mptt -69.0 82.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -77.5 -177.92 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.9 m 32.82 40.29 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -55.56 -34.44 64.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.289 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 t -178.12 168.99 1.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.1 t -149.14 112.27 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.942 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.2 m -111.39 116.46 30.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.323 . . . . 0.0 110.87 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -95.38 135.42 37.01 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.184 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.76 151.44 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -150.76 149.11 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 54' ' ' SER . 18.5 tp10 -51.7 171.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.082 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.524 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 58.1 m . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.981 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 N--CA 1.473 0.278 0 N-CA-C 111.025 -0.413 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.9 m -125.93 131.03 52.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.3 m -107.16 123.95 49.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -121.64 112.98 19.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.947 0.403 . . . . 0.0 111.112 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -93.83 127.41 39.55 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 t -103.07 69.38 1.02 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.24 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.5 tt -74.54 122.25 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 110.566 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.44 147.46 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.94 169.53 20.94 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.209 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.47 22.34 23.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.239 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.8 4.06 69.91 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.187 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.48 149.15 41.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' NH2' ' OG ' ' A' ' 151' ' ' SER . 45.6 ttm-85 -115.83 105.15 12.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 92' ' ' PHE . 18.8 ttt -101.71 135.63 42.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.116 0.484 . . . . 0.0 110.882 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -127.44 120.44 28.4 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.043 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 90' ' ' MET . 67.1 m-85 -90.42 -168.4 2.09 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.74 67.7 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.08 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -90.28 162.08 15.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.163 0.506 . . . . 0.0 111.448 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 t -150.91 131.82 14.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.942 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 62.95 33.65 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.529 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 98' ' ' PRO . 33.5 m -124.04 145.6 48.59 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 97' ' ' CYS . 78.2 Cg_exo -38.55 162.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.012 1.808 . . . . 0.0 112.423 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -71.33 142.54 50.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -97.1 118.09 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.33 -21.67 4.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 117' ' ' SER . 5.7 p -100.45 111.16 23.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.771 0.319 . . . . 0.0 110.862 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.23 121.83 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.556 ' HG ' ' N ' ' A' ' 105' ' ' GLU . 28.3 t -142.45 177.56 8.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.064 0.459 . . . . 0.0 111.171 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.556 ' N ' ' HG ' ' A' ' 104' ' ' SER . 34.9 tt0 -165.83 161.68 17.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.42 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.4 t -163.9 158.67 20.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.588 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.06 132.75 46.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.331 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -144.73 111.66 5.86 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.155 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.73 -110.87 3.31 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -122.21 23.88 9.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 p -128.74 156.16 43.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.64 132.99 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.573 ' ND2' ' H ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -117.96 155.76 29.68 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.885 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.52 133.07 12.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -118.0 125.76 51.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 111.333 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.7 121.48 40.97 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 102' ' ' SER . 1.8 m -164.94 156.67 15.3 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.58 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.8 p -74.19 173.85 9.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.39 134.37 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 110.999 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -59.55 155.15 40.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.0 157.6 28.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.254 1.969 . . . . 0.0 111.486 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.419 ' N ' ' OE1' ' A' ' 123' ' ' GLN . . . 73.68 59.73 3.97 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.738 HE21 ' H ' ' A' ' 125' ' ' LYS . 4.3 pm0 -141.24 -37.35 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.739 0.304 . . . . 0.0 110.348 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.03 5.97 2.93 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.265 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.738 ' H ' HE21 ' A' ' 123' ' ' GLN . 51.7 mttp -129.45 -173.48 3.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.782 0.325 . . . . 0.0 110.463 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 156.17 21.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.49 . . . . 0.0 111.456 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.4 t -159.19 63.42 2.31 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.439 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.78 142.31 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.112 2.541 . . . . 0.0 113.447 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.26 28.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.46 162.56 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 110.24 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.7 p -78.69 164.6 24.46 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -60.51 -34.71 74.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -63.15 -55.1 28.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.31 -44.71 92.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.335 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.29 -56.58 20.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.123 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 tp -49.37 -35.63 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.46 -49.24 43.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.557 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 140' ' ' LYS . 44.2 mtt -60.09 -60.42 3.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.7 mt -44.64 -21.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.13 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' MET . 31.5 ttmt -87.5 -33.81 18.85 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.595 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -94.92 -23.33 17.47 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.98 122.9 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.889 0.376 . . . . 0.0 110.758 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -139.1 123.26 18.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.218 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.31 128.21 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.06 0.457 . . . . 0.0 111.114 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.6 m -109.33 167.24 10.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.548 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.8 pt -151.2 149.17 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -147.9 88.47 1.68 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 tt -83.35 145.24 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.506 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.417 ' HG3' ' H ' ' A' ' 150' ' ' CYS . 5.0 tpt180 -145.59 -177.2 5.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.417 ' H ' ' HG3' ' A' ' 149' ' ' ARG . 7.1 m -90.61 134.44 34.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.698 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' NH2' ' A' ' 89' ' ' ARG . 5.6 t -117.3 119.58 35.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.075 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -93.62 14.81 17.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.161 0.505 . . . . 0.0 109.82 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.2 OUTLIER -50.68 150.62 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.155 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.55 -10.08 3.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.466 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.78 158.06 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.93 175.49 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -90.48 143.33 26.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -114.07 92.23 3.9 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 pt -119.03 165.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.147 0.499 . . . . 0.0 111.323 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -119.54 134.63 55.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 m -76.52 54.59 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.538 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.424 ' HD1' ' N ' ' A' ' 163' ' ' PRO . 6.0 t-80 -130.77 123.74 20.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.424 ' N ' ' HD1' ' A' ' 162' ' ' HIS . 48.6 Cg_exo -38.14 147.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.916 1.744 . . . . 0.0 112.344 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.3 m -73.4 130.46 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.422 ' CD1' ' HZ1' ' A' ' 125' ' ' LYS . 34.8 mt -79.32 115.46 18.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.315 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.97 159.55 22.85 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.117 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.457 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 0.1 OUTLIER -95.2 11.14 33.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 110.295 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 168' ' ' ASN . 10.9 t30 58.72 21.19 8.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.343 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.63 -176.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.601 ' H ' ' HE ' ' A' ' 198' ' ' ARG . 51.1 m -147.94 113.82 5.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.619 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -68.6 28.22 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.284 -178.254 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 170' ' ' SER . 16.9 mmmt -67.6 175.27 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.125 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.42 ' CB ' ' NZ ' ' A' ' 173' ' ' LYS . 0.2 OUTLIER -90.86 124.7 35.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.12 -165.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.041 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.4 p -50.55 145.77 6.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.807 0.337 . . . . 0.0 110.53 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -95.69 132.52 40.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -141.45 127.07 18.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.209 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -68.45 95.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.65 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.9 mt -107.35 -40.61 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.475 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 tp -66.84 114.42 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.468 . . . . 0.0 110.502 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.22 -122.91 0.7 Allowed Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.4 m -77.21 150.8 35.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 93.07 2.1 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.093 0.473 . . . . 0.0 110.263 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.3 tt -98.86 133.26 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.914 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.2 m -146.76 131.29 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.99 0.424 . . . . 0.0 111.86 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 34.0 p-10 -85.93 103.34 14.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.754 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.7 m -46.99 -27.12 1.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.845 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -41.92 -26.38 0.09 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.966 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 9.8 m -142.78 36.23 1.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.4 p -169.43 105.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.4 0.619 . . . . 0.0 110.756 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -74.56 -54.43 7.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.729 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.449 ' H ' ' HG1' ' A' ' 33' ' ' THR . 2.6 m-20 -118.31 173.83 6.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.137 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.7 tt -173.56 106.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.228 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 19.2 mp0 -93.24 149.74 21.0 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -140.83 134.32 29.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.253 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.429 ' HG ' ' CD2' ' A' ' 232' ' ' LEU . 69.4 m -143.19 129.54 19.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.8 t -122.61 153.47 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . 0.601 ' HE ' ' H ' ' A' ' 170' ' ' SER . 14.4 ttt85 -154.55 144.42 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.871 0.367 . . . . 0.0 110.155 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.94 119.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.652 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -169.57 -156.59 11.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.063 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 58.3 t0 -79.21 123.78 27.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.865 0.364 . . . . 0.0 110.434 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.457 ' SD ' ' OG ' ' A' ' 167' ' ' SER . 24.2 mmt -81.14 -3.24 51.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.4 -50.05 3.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.466 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.486 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 20.2 tptp -157.38 112.35 2.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 198' ' ' ARG . 2.0 mm-40 -43.65 156.17 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' GLU . 2.5 p -156.86 67.08 0.54 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 208' ' ' GLU . 41.1 p 30.84 -88.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 206' ' ' SER . 17.8 mm-40 -40.52 -50.93 2.95 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.453 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 209' ' ' LEU . 1.9 mm? -81.68 54.27 2.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.527 ' CG ' HH22 ' A' ' 198' ' ' ARG . 1.3 tp10 -156.22 120.25 4.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.083 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.74 179.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.96 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -171.01 146.67 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.143 0.496 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 10.2 t70 -144.17 169.43 17.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.017 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 159.58 154.07 7.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.613 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.7 177.52 7.72 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -132.48 103.68 6.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -98.31 113.81 25.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.596 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.25 111.81 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.957 0.408 . . . . 0.0 110.691 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.13 43.39 30.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.98 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.16 74.77 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.455 -0.402 . . . . 0.0 112.561 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.8 p -89.84 112.9 24.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.67 149.45 23.3 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.714 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.6 m -166.29 124.29 1.44 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.623 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -77.99 138.99 39.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.424 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.75 108.22 0.27 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.52 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.11 104.23 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.6 p -129.53 159.22 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.468 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.13 95.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.29 12.65 4.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.0 m -45.29 -51.45 10.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.706 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 233' ' ' ILE . 20.4 m -97.18 6.37 48.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.429 ' CD2' ' HG ' ' A' ' 196' ' ' SER . 43.8 tp -42.64 -24.44 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.936 0.398 . . . . 0.0 110.84 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 231' ' ' SER . 0.4 OUTLIER -163.93 142.91 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -74.87 100.52 4.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -64.28 -6.35 6.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.916 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.04 -10.35 50.53 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.531 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -100.94 0.21 37.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.477 0.18 . . . . 0.0 111.145 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.02 142.06 35.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.152 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 104' ' ' SER . 63.8 mttp -130.44 136.83 49.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.837 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.84 138.03 57.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.733 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 74.6 m -100.17 -8.73 23.28 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.088 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.516 -179.324 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.548 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 76.2 m -119.29 155.8 31.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.21 134.51 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.677 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.548 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 23.5 m-85 -111.89 -27.52 8.42 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -152.05 155.07 37.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.991 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.5 OUTLIER -110.42 160.53 16.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.894 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -84.0 139.08 32.77 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.48 5.53 38.56 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.453 -178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.73 126.56 47.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.822 0.344 . . . . 0.0 111.247 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -77.89 133.42 38.12 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.687 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 3.8 mm? -93.7 111.11 51.22 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.908 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.05 149.51 1.25 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.164 1.909 . . . . 0.0 112.599 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.552 ' C ' ' H ' ' B' ' 24' ' ' PHE . 7.5 ptp85 -45.46 -43.07 11.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.677 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -70.2 26.31 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.552 ' H ' ' C ' ' B' ' 22' ' ' ARG . 14.9 t80 -146.22 27.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -152.27 100.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.013 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 20.4 m -84.15 -27.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.647 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -165.61 -178.34 4.83 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.755 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 8.6 p90 -154.08 173.48 15.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 74.2 m-85 -160.91 141.12 11.14 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.802 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' B' ' 30' ' ' GLU . 2.1 mp0 -84.83 146.24 27.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 111.636 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 32.0 p -52.51 -108.57 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.948 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -150.57 -149.45 0.3 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.496 ' C ' ' H ' ' B' ' 35' ' ' CYS . 67.9 m -142.2 -24.6 0.67 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.279 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -54.77 -10.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.732 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' B' ' 33' ' ' SER . 4.1 p -118.71 123.03 43.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.505 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 45.2 p -72.61 35.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.347 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' B' ' 35' ' ' CYS . 26.0 mt-30 -155.04 56.16 1.35 Allowed Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -64.98 -167.86 0.1 Allowed 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 122.712 2.275 . . . . 0.0 112.827 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.21 176.57 0.11 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.787 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.1 t -107.82 131.85 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.95 129.81 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.657 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -110.82 146.16 36.91 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.972 0.415 . . . . 0.0 111.147 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -93.85 169.79 10.03 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 15.8 p -140.08 -143.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 111.089 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.36 -36.95 2.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.297 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.03 46.86 2.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.557 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 18.4 m -156.09 -80.48 0.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.532 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 154.72 -90.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.679 0.612 . . . . 0.0 109.759 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -143.68 144.18 31.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.439 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -149.31 120.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.636 . . . . 0.0 110.73 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 6.9 t -54.61 159.06 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.776 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.463 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.13 131.29 11.09 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.62 120.5 71.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 0.1 8.66 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.114 1.21 . . . . 0.0 111.242 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 90.0 p -67.99 -18.55 64.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.169 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -93.02 124.38 36.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.006 0.431 . . . . 0.0 110.29 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -50.87 -40.69 56.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.909 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.449 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 88.9 m95 -56.43 -33.48 65.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.047 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.89 -35.79 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.185 0.516 . . . . 0.0 109.706 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -68.7 -48.05 64.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.606 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -64.9 -35.79 82.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -62.02 -37.76 86.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.25 -44.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.85 -32.81 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.86 -38.29 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.42 -22.22 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.23 -31.06 63.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.416 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.44 -84.51 0.09 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.572 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.596 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.808 0.337 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -75.7 -33.47 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.6 m -49.47 131.06 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.498 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 127' ' ' SER . 4.9 t -59.84 -20.52 57.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.662 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 m -75.86 -21.39 57.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.283 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -87.37 -41.39 13.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.112 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -167.94 179.71 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.994 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.19 157.37 37.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.448 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -78.93 175.58 10.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.993 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -125.26 7.56 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.859 0.361 . . . . 0.0 110.302 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' GLU . 42.4 mm-40 -83.68 89.81 7.19 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.573 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' GLU . 42.2 mt-10 -23.51 -63.6 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.059 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.0 OUTLIER -76.68 49.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.594 0.235 . . . . 0.0 111.014 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -155.85 125.56 6.41 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 132' ' ' HIS . 27.5 m-70 -125.61 152.44 45.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' SD ' ' A' ' 202' ' ' MET . 11.6 t-160 -93.7 82.57 4.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.47 ' O ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -47.05 174.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.617 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.99 133.79 1.61 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.3 tt -111.17 146.1 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.381 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.99 140.04 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.66 139.82 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.152 0.501 . . . . 0.0 111.837 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.0 mt -114.58 149.19 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.189 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.46 107.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 232' ' ' LEU . 32.3 ttmt -110.69 95.05 5.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.38 133.72 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.933 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 m -107.97 124.85 50.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.024 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -76.61 149.48 36.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 37' ' ' GLN . 3.9 pt20 -73.14 159.12 34.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.38 40.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.798 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 35' ' ' GLN . 56.5 mt-30 -145.3 -28.51 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.2 m -68.32 115.72 32.29 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.414 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -40.29 158.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.79 1.66 . . . . 0.0 112.229 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.497 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 67.0 p -69.03 136.39 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 40' ' ' THR . 25.9 m120 -153.94 102.35 2.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.114 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -102.75 11.05 38.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 1.8 mptp? -70.36 88.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 pt -90.96 157.73 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.347 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m 57.18 39.44 28.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.307 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -55.51 -50.67 69.34 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.976 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.4 p -173.26 156.56 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.85 134.8 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.7 p -133.41 106.3 7.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.178 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -81.84 146.4 29.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.181 0.515 . . . . 0.0 110.862 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -142.06 156.22 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.255 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -152.53 151.67 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 54' ' ' SER . 19.4 tp10 -56.27 174.72 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.49 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-O 120.938 0.399 . . . . 0.0 110.215 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 N--CA 1.475 0.413 0 CA-C-O 120.759 0.233 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 p -118.81 125.68 50.12 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.458 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 p -94.37 119.27 32.86 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.513 ' CE1' ' OD1' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -126.72 113.66 16.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.733 0.301 . . . . 0.0 110.569 -178.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 92' ' ' PHE . 11.9 p90 -113.01 122.22 46.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.967 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -92.07 76.88 5.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.318 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.74 110.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.402 0.62 . . . . 0.0 109.725 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.3 mt -93.21 145.84 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.437 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.28 159.11 10.28 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.211 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.65 27.54 68.37 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.046 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.23 18.25 72.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.94 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -134.61 159.02 42.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 110.544 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -122.3 110.24 15.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.1 mtt -100.17 99.59 10.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.124 0.487 . . . . 0.0 110.808 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' OD1' ' CE1' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -84.02 129.28 34.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.1 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 70.3 m-85 -112.94 -173.45 2.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.0 0.429 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.64 72.49 0.05 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.643 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.62 147.25 35.69 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 t -146.57 128.45 15.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm 59.3 29.94 19.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.515 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.2 146.47 40.73 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.47 153.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.681 1.587 . . . . 0.0 111.933 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.49 ' OE1' ' NZ ' ' A' ' 101' ' ' LYS . 3.4 pt20 -67.81 140.28 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.642 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.67 122.51 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.49 ' NZ ' ' OE1' ' A' ' 99' ' ' GLN . 47.1 mttp -126.36 -1.39 6.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.125 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 t -123.42 126.14 46.24 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.271 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.2 pt -147.89 139.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.858 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.1 p -146.46 177.06 9.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -158.64 155.36 28.06 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 p -155.45 151.63 28.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.229 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.47 110.34 11.79 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.639 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.401 ' O ' ' OG1' ' A' ' 111' ' ' THR . 11.1 p-10 -118.91 107.7 13.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.68 -126.8 18.73 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -100.79 24.06 9.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 110.24 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 108' ' ' ASP . 24.5 p -126.12 154.07 43.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.7 t -133.39 132.73 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -123.38 155.68 36.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.886 0.374 . . . . 0.0 110.768 -178.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.05 142.25 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.101 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -118.05 125.13 49.74 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -112.59 119.34 37.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 t -164.47 168.62 18.2 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.083 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.0 m -83.77 172.93 11.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.607 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -105.39 132.87 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.583 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.473 ' CB ' ' ND2' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -70.18 164.49 52.48 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.952 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.25 139.21 23.4 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.455 2.104 . . . . 0.0 112.103 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.24 -11.63 40.13 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.562 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.499 ' OE1' ' N ' ' A' ' 123' ' ' GLN . 12.2 mp0 -76.29 -50.79 13.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.82 -2.17 1.18 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.404 -0.427 . . . . 0.0 112.419 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -103.97 -176.89 3.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.89 161.44 30.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 1.9 t -156.48 68.33 4.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.809 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.16 115.24 2.23 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 122.68 2.253 . . . . 0.0 112.861 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.9 141.59 29.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.5 pt -137.88 175.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 111.128 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.9 m -83.48 161.16 21.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.788 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.579 ' NE2' ' CD2' ' A' ' 22' ' ' HIS . 21.0 m170 -58.63 -34.2 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.416 ' CD ' ' N ' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -61.34 -53.06 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.214 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -60.73 -43.95 97.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 138' ' ' MET . . . -59.95 -57.17 14.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.124 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -47.05 -39.07 12.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.988 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.82 62.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.344 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 135' ' ' ALA . 36.3 tpp -73.59 -29.67 62.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.83 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.35 -21.13 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.7 -37.37 18.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD2' ' CZ ' ' B' ' 18' ' ' ARG . 10.4 m-20 -85.43 -33.96 21.79 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.5 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.406 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 30.6 t -51.39 114.38 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.08 0.467 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 141' ' ' ASP . 0.3 OUTLIER -127.25 164.26 22.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 145' ' ' SER . 96.1 t -141.4 162.78 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.45 ' N ' ' CG1' ' A' ' 144' ' ' VAL . 88.0 p -143.37 145.66 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.637 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 mp -140.2 144.32 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.025 0.44 . . . . 0.0 110.594 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -157.89 79.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.612 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.4 mt -73.8 142.29 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.535 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -134.37 171.99 13.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.446 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.06 118.72 30.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.842 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 t -85.94 -173.51 4.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.26 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.401 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 6.9 tp10 -165.52 7.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -81.57 105.76 12.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.769 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 154' ' ' GLU . 20.1 mp0 -78.35 12.97 1.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -49.45 155.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.771 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.54 167.6 14.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.667 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.0 p -89.51 143.31 26.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.868 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -117.07 88.49 2.91 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.678 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.7 pt -110.14 177.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.119 0.485 . . . . 0.0 111.424 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 162' ' ' HIS . 73.7 tttt -137.33 125.95 23.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.781 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.4 m -59.22 -0.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.526 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.9 m80 -82.07 114.88 54.05 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.104 -0.239 . . . . 0.0 110.375 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -40.77 154.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.729 1.619 . . . . 0.0 112.184 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 49.2 t -77.28 136.56 24.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.577 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.8 mt -83.61 124.31 30.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.659 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 164.94 32.68 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.4 t -99.12 9.12 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.473 ' ND2' ' CB ' ' A' ' 120' ' ' SER . 7.1 m-20 59.11 -0.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.523 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.432 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.5 pp -82.03 173.56 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.989 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 172' ' ' LYS . 19.9 m -133.28 129.38 37.54 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -73.13 31.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.48 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 170' ' ' SER . 3.1 mmmm -64.61 -178.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -90.63 121.37 32.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.413 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.44 -167.3 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.727 0.299 . . . . 0.0 110.477 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.1 t -48.24 142.95 4.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.922 0.391 . . . . 0.0 110.88 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -95.72 129.09 43.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -141.43 141.07 33.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.033 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.1 91.6 4.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.581 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.08 -59.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 16.3 tt -50.26 122.28 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.48 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -91.66 -122.26 2.8 Favored Glycine 0 C--O 1.228 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.82 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.471 ' OG ' ' SG ' ' B' ' 51' ' ' CYS . 7.6 t -76.61 143.73 40.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.108 0.48 . . . . 0.0 112.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 62.8 m -139.89 84.97 2.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.103 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mt -103.89 103.83 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.942 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.1 m -120.83 134.27 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.8 p-10 -78.89 116.5 19.25 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.6 m -52.09 -29.24 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -36.18 -36.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.54 32.74 1.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.643 0.259 . . . . 0.0 110.486 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 92.4 t -149.71 95.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.35 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -61.92 1.81 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.498 ' ND2' ' OE1' ' A' ' 194' ' ' GLU . 22.3 t30 -122.55 137.41 54.9 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -145.27 122.51 11.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.498 ' OE1' ' ND2' ' A' ' 192' ' ' ASN . 2.7 mp0 -109.8 161.35 15.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.89 139.25 17.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.9 p -144.15 140.07 29.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.341 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.2 m -128.12 158.23 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -159.76 104.09 1.55 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.878 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 36.1 mt -106.99 118.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.67 -157.16 9.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.316 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 53.6 t0 -86.2 123.34 31.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 23' ' ' HIS . 55.2 mtp -78.12 0.26 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.326 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 5.7 t -112.4 -48.77 3.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.773 0.321 . . . . 0.0 110.628 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.44 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 3.2 tppp? -158.29 113.4 2.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.165 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -46.1 145.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 208' ' ' GLU . 7.5 t -130.23 25.25 5.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.495 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 84.1 p 52.93 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.602 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 206' ' ' SER . 33.5 tt0 -51.58 -34.24 36.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 209' ' ' LEU . 2.0 mm? -88.59 -4.18 58.63 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.787 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 206' ' ' SER . 14.5 mp0 -96.15 144.84 26.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.983 0.421 . . . . 0.0 110.793 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.0 m -153.98 175.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.592 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 227' ' ' THR . 25.1 tttt -170.23 147.01 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.478 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -140.86 168.54 19.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 174.68 145.08 5.17 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.624 -1.274 . . . . 0.0 113.052 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . 0.441 ' CZ ' ' OG ' ' B' ' 14' ' ' SER . 27.9 m-85 -129.37 164.9 22.6 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.45 103.27 5.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.427 ' O ' ' OD1' ' A' ' 192' ' ' ASN . 21.9 m-85 -97.44 116.5 29.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.817 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.76 101.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.311 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.6 t70 56.29 37.61 28.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.938 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.35 75.02 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.639 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.9 t -89.23 112.47 23.52 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.699 -0.295 . . . . 0.0 110.452 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.25 167.5 11.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.5 t -174.49 116.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.82 95.03 9.94 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -136.96 129.27 4.71 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 116.416 -0.357 . . . . 0.0 112.448 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -90.67 102.07 14.82 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.494 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.499 ' O ' ' NZ ' ' A' ' 212' ' ' LYS . 69.4 p -123.71 153.13 41.29 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.8 95.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -90.71 35.55 0.89 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.8 t -75.29 -39.62 59.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.309 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 99.3 p -102.56 3.78 37.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.339 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.488 ' O ' ' NZ ' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -48.41 -32.87 8.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.133 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.6 tt -135.06 150.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.242 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 236' ' ' THR . 4.0 p30 -87.41 92.39 9.06 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 45.8 m -60.66 -3.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.332 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 234' ' ' ASP . 30.7 p -91.01 -21.56 21.21 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -101.55 8.45 41.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.65 153.09 31.32 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.148 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -141.12 133.88 28.82 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.727 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.63 55.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.379 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 59.8 m -110.42 -1.93 16.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.528 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.853 0.358 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.539 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.6 m -134.76 146.33 49.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . 0.469 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 55.7 m -67.47 140.54 57.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.215 0.531 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 38.7 m-85 -117.33 -31.02 5.41 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.766 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 215' ' ' PHE . 2.7 m -140.88 145.29 35.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.04 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -109.28 152.22 25.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -78.43 139.56 38.73 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.599 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.1 -42.86 20.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.778 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.438 ' CZ ' ' OD2' ' A' ' 141' ' ' ASP . 0.9 OUTLIER -75.9 126.29 30.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.682 -179.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -77.12 137.85 39.16 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -92.79 110.71 47.29 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -44.62 150.09 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.041 1.827 . . . . 0.0 112.68 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.562 ' C ' ' H ' ' B' ' 24' ' ' PHE . 50.1 mtt85 -46.02 -44.03 14.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.751 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' B' ' 23' ' ' ASN . 2.0 m-20 -68.45 27.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.562 ' H ' ' C ' ' B' ' 22' ' ' ARG . 22.2 t80 -151.98 27.3 0.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -155.97 104.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.353 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.14 -10.75 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.7 t0 -161.88 -178.61 6.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.897 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.498 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 12.6 p90 -163.2 175.74 10.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.217 0.532 . . . . 0.0 111.658 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 59.9 t80 -167.18 140.81 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.837 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.3 pt-20 -89.44 147.33 24.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.781 0.324 . . . . 0.0 111.17 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.469 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 41.1 p -50.51 -107.29 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -151.7 -132.93 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.52 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.487 ' C ' ' H ' ' B' ' 35' ' ' CYS . 23.8 t -152.47 -25.28 0.17 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.684 0.278 . . . . 0.0 110.588 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 20.3 mt -57.7 -7.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.057 0.456 . . . . 0.0 109.921 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.487 ' H ' ' C ' ' B' ' 33' ' ' SER . 37.8 m -113.42 118.59 34.95 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.524 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 87.4 p -72.33 35.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.533 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.9 pt20 -167.59 61.71 0.57 Allowed Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.94 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.803 2.335 . . . . 0.0 113.134 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.57 176.37 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.834 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 72.7 t -103.4 139.15 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.038 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.44 124.26 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.794 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -100.64 148.78 24.45 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.035 0.445 . . . . 0.0 110.542 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.465 ' CG ' ' N ' ' B' ' 44' ' ' THR . 26.9 tt0 -93.15 169.22 10.57 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.465 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 17.6 p -138.11 -145.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 111.709 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.49 -40.24 1.96 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.736 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.17 47.05 2.14 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.794 -0.184 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 8.6 t -156.2 -79.23 0.08 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.504 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.59 -90.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -143.76 147.97 34.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.438 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.6 t -150.28 114.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.259 0.552 . . . . 0.0 111.021 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.471 ' SG ' ' OG ' ' A' ' 182' ' ' SER . 74.5 m -50.12 159.99 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.704 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 130.59 10.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.34 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' B' ' 53' ' ' ASP . 23.4 p-10 -66.17 125.45 90.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.33 -2.06 11.84 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.141 1.227 . . . . 0.0 111.011 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 36.2 t -69.2 -12.22 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.199 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -101.02 122.65 43.92 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.132 0.491 . . . . 0.0 110.307 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 45.2 t -48.17 -46.86 35.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.496 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 35.4 p-90 -56.27 -24.71 44.71 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.572 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -75.26 -38.08 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 109.771 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -66.6 -48.43 69.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.41 -34.98 77.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -61.8 -40.81 96.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.36 -47.71 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.06 -31.43 65.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.748 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -73.7 -35.16 65.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.91 -20.01 59.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -73.27 -35.76 66.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.77 -77.46 0.14 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.342 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 p30 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.524 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.624 0.25 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 t -72.82 -25.5 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.796 0.331 . . . . 0.0 110.755 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 13' ' ' SER . 13.3 t -51.53 144.16 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.54 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -68.07 -28.57 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -76.88 -22.68 53.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.628 ' HG ' ' N ' ' A' ' 14' ' ' SER . 90.8 p -81.11 -49.0 11.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.628 ' N ' ' HG ' ' A' ' 13' ' ' SER . 15.6 m -162.24 169.98 19.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.026 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 t -63.84 153.43 36.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.68 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.7 p -72.84 172.36 10.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.461 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.68 2.69 9.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 1.6 mp0 -77.78 98.17 5.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.439 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -31.17 -53.53 0.21 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.694 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -86.65 52.06 2.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 110.682 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 16.7 tttm -160.26 133.46 6.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 110.246 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.44 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 70.6 m-70 -154.35 124.31 6.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.523 ' CE1' ' CG ' ' A' ' 121' ' ' PRO . 11.1 p80 -76.68 97.2 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.53 149.13 40.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.61 158.38 26.56 Favored Glycine 0 CA--C 1.508 -0.388 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 tt -110.33 150.73 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -152.1 106.44 3.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 110.008 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.86 126.7 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.991 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.97 166.47 4.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 tt -161.2 110.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.796 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -98.3 132.9 43.4 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.03 120.67 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.995 0.426 . . . . 0.0 110.844 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.525 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 68.4 p -88.33 121.26 30.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CB ' ' HZ1' ' A' ' 34' ' ' LYS . 9.6 mtmp? -75.81 150.76 37.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.75 136.44 40.3 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.82 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -46.77 -19.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 1.3 mp0 -81.31 -43.89 18.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.547 0.213 . . . . 0.0 111.16 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -42.7 147.77 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.067 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.71 172.1 16.81 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.122 1.881 . . . . 0.0 111.446 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.7 p -74.02 135.23 43.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.474 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -167.09 99.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.47 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -103.64 -1.08 28.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.535 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -67.87 91.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.8 160.49 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.907 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 36.9 t 55.26 62.87 2.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.507 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.557 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.4 tp60 -77.44 -27.55 52.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.1 p -174.2 -176.19 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.888 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 p -170.36 101.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 109.956 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.8 p -103.38 126.7 50.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 1.5 pm0 -104.39 142.51 34.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.964 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.99 157.9 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -153.37 151.61 30.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 52.0 tt0 -48.0 168.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.006 0.432 . . . . 0.0 110.06 179.74 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 CA--C 1.527 0.144 0 N-CA-C 111.039 -0.408 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -124.27 121.95 36.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 111.001 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 p -97.76 125.45 42.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -121.47 110.49 16.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.248 0.547 . . . . 0.0 111.019 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -93.73 124.09 37.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.519 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' ' CZ ' ' A' ' 80' ' ' TYR . 4.9 m -94.53 72.9 3.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.051 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.3 mm -74.67 101.73 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.801 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.6 mm -94.25 145.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.021 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.55 169.71 18.17 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.502 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.1 20.48 54.1 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.22 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.28 10.84 84.41 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 mt -131.98 155.62 47.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.58 115.45 27.2 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.3 mtt -102.07 124.16 47.2 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.04 0.448 . . . . 0.0 110.939 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.512 ' C ' HD21 ' A' ' 91' ' ' ASN . 0.2 OUTLIER -114.18 133.1 55.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.729 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.38 -174.73 2.86 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.821 0.343 . . . . 0.0 110.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.52 74.13 0.1 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.077 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -76.98 135.35 38.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.7 m -143.65 121.12 11.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.449 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? 65.0 31.72 11.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.979 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.2 m -126.42 149.81 68.58 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.22 143.51 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.999 1.799 . . . . 0.0 111.978 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.434 ' CD ' ' N ' ' A' ' 99' ' ' GLN . 4.2 mp0 -73.21 110.03 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.849 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.4 pt -69.13 142.1 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -135.34 -6.89 2.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.349 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.2 m -107.36 119.54 39.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.81 0.338 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 34.8 mt -132.04 120.02 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -146.58 162.87 37.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 111.015 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -148.39 164.83 32.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -155.12 151.86 28.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.911 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.08 124.9 33.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.424 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -145.22 111.43 5.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.002 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 -127.14 8.96 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -108.29 24.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.753 0.311 . . . . 0.0 110.32 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 p -129.16 159.17 36.88 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.637 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t -139.09 137.17 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 106' ' ' SER . 50.9 p30 -120.93 153.21 37.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.465 . . . . 0.0 111.006 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.21 130.66 19.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.605 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -116.52 116.49 27.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 110.899 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.3 mt -116.25 126.72 53.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 p -166.68 167.42 15.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.508 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 167' ' ' SER . 74.0 m -84.28 172.82 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.686 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 m -96.18 147.92 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 111.024 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.466 ' OG ' ' ND2' ' A' ' 168' ' ' ASN . 1.6 t -92.71 152.2 41.63 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CG ' ' CE1' ' A' ' 23' ' ' HIS . 74.0 Cg_exo -37.89 158.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.21 64.45 3.81 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.175 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -140.99 -1.12 1.41 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 11.15 82.59 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.439 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -136.47 150.14 48.56 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.53 154.72 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.982 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -158.44 60.72 1.84 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.384 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -35.53 143.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.333 2.689 . . . . 0.0 113.715 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.45 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -109.96 146.56 35.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.568 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.01 165.81 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 110.186 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -87.44 174.48 8.49 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' OG1' ' A' ' 131' ' ' THR . 2.0 t60 -63.92 -39.33 93.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.34 -57.52 12.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.28 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -63.18 -42.26 99.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.538 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.16 -57.01 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.177 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.86 -36.68 59.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.056 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.48 -37.66 71.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 21.1 mtt -62.34 -58.43 7.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -24.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.859 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -78.29 -55.27 5.38 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.376 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.41 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 33.9 m-20 -77.82 -23.65 48.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 19.0 t -58.07 113.59 1.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.526 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.511 ' CD ' ' HE ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -143.51 148.3 35.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.269 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.95 131.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.931 0.396 . . . . 0.0 110.309 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.6 p -103.19 173.12 6.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 15.1 pt -150.78 148.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.776 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -152.19 83.37 1.26 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.879 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.58 154.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.1 ttt85 -145.36 172.17 13.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.022 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.2 t -91.02 116.16 28.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.774 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.8 p -92.94 -176.85 4.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.208 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.9 6.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.295 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.469 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 63.8 tt0 -70.24 107.01 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.95 16.25 6.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.557 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 3.9 mmmm -60.73 172.72 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.674 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -76.55 169.65 17.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.636 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 71.6 m -96.6 147.65 23.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.47 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 16.3 t70 -113.18 90.94 3.48 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 160' ' ' LYS . 63.6 mt -115.11 159.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.17 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 162' ' ' HIS . 6.7 mmtp -121.9 128.93 52.13 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.9 p -62.55 1.97 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 160' ' ' LYS . 80.1 t60 -78.72 116.91 63.36 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -40.39 150.12 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.654 1.569 . . . . 0.0 111.939 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.85 137.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.898 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.6 mt -78.01 147.43 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.753 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -119.46 156.96 15.61 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.091 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 169' ' ' ILE . 3.5 m -89.57 10.31 23.43 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.466 ' ND2' ' OG ' ' A' ' 120' ' ' SER . 10.6 m-20 56.5 1.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.502 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.52 ' H ' ' C ' ' A' ' 167' ' ' SER . 8.4 tp -94.33 144.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 26.6 p -105.65 149.91 25.92 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -83.83 46.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.373 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -73.0 -177.16 2.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -93.55 117.56 30.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.538 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.502 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 13.3 m -139.83 -171.24 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.145 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.1 t -43.31 138.15 2.41 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.77 0.319 . . . . 0.0 110.898 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.502 ' CE1' ' O ' ' A' ' 174' ' ' VAL . 2.3 m-85 -98.95 136.79 38.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.252 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 178' ' ' ASP . 5.1 tm-20 -151.84 158.11 42.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.506 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 4.5 p-10 -92.94 93.36 8.33 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.42 17.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.126 0.488 . . . . 0.0 110.016 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 pp -113.14 119.11 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.292 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.59 -142.67 2.64 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.876 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.438 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 37.5 t -69.33 158.96 34.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.434 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -144.6 95.06 2.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.114 0.483 . . . . 0.0 110.151 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.8 132.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.655 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 3.3 m -142.74 123.02 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.691 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.6 p-10 -85.08 98.06 10.21 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 189' ' ' CYS . 31.3 m -47.58 -26.88 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.592 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -39.82 -26.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 187' ' ' THR . 94.0 m -146.31 24.94 1.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.185 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 23.3 t -148.5 95.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.74 -54.9 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASN . . . . . 0.525 ' H ' ' HG1' ' A' ' 33' ' ' THR . 7.2 m-20 -125.35 -176.57 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.753 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.7 tt -172.88 109.16 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -96.12 121.3 37.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -120.73 129.88 53.82 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.038 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.9 p -144.58 134.22 23.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.88 154.91 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.53 144.77 30.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.237 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.8 mt -148.99 117.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.568 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.44 172.53 45.55 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.416 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.43 119.92 10.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 0.0 111.326 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 49.7 mtm -77.17 4.18 10.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.7 t -97.23 -61.74 1.36 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.437 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -147.49 115.02 6.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.323 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -43.64 123.23 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.633 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.0 t -117.16 105.05 11.83 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.652 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.3 m -38.21 -36.97 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.156 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.83 -48.98 62.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 209' ' ' LEU . 2.5 mm? -90.42 13.88 14.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.245 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 128.16 42.65 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 212' ' ' LYS . 74.6 t -153.31 161.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.374 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.479 ' HZ1' ' CA ' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -167.38 160.34 13.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.473 0.654 . . . . 0.0 112.444 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.6 t70 -146.5 171.39 15.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.352 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 162.89 145.4 4.34 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.902 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.23 -171.4 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -152.93 108.14 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.439 0.638 . . . . 0.0 111.439 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 217' ' ' TYR . 0.1 OUTLIER -96.85 123.66 40.61 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.601 ' C ' ' H ' ' A' ' 220' ' ' GLY . 6.2 p -141.06 118.31 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.4 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.0 t70 59.92 -13.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.308 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 140.08 0.44 1.93 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 t -104.11 117.5 34.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.58 156.24 17.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.906 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.3 t -166.17 123.26 1.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -81.28 99.09 8.44 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -120.55 134.51 10.36 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.934 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.479 ' CA ' ' HZ1' ' A' ' 212' ' ' LYS . . . -98.39 98.09 9.36 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 70.0 p -134.73 163.34 30.0 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.401 ' OD2' ' OG1' ' A' ' 230' ' ' THR . 22.4 t70 -66.16 95.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.486 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.69 28.96 0.73 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.712 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.401 ' OG1' ' OD2' ' A' ' 228' ' ' ASP . 27.6 m -64.21 -57.09 10.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.165 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 m -84.57 1.25 46.79 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.544 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.35 -29.5 0.15 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.75 0.31 . . . . 0.0 111.413 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.4 pp -152.29 145.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.304 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.79 93.08 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' SER . . . . . 0.428 ' O ' ' CD2' ' A' ' 238' ' ' LEU . 31.4 t -64.42 -2.54 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.188 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 74.3 m -93.73 -19.41 21.1 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 237' ' ' LYS . 3.3 mptp? -98.76 -2.38 38.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 235' ' ' SER . 1.1 pt? -91.04 158.2 16.82 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.363 0.983 . . . . 0.0 111.223 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -131.92 151.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.617 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.57 161.62 1.96 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.723 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 54.0 t -124.19 -13.78 7.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.017 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.588 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 121.072 0.463 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.0 m -104.57 151.8 23.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -55.48 139.94 41.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.133 0.492 . . . . 0.0 112.008 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 8.8 m-85 -112.17 -27.26 8.43 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.7 t -158.42 158.8 34.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.489 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.39 -178.2 3.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.18 0.514 . . . . 0.0 111.778 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' THR . . . . . 0.564 ' HG1' HH11 ' B' ' 18' ' ' ARG . 9.8 t -99.05 135.83 39.9 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.78 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.4 12.12 4.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.564 HH11 ' HG1' ' B' ' 16' ' ' THR . 0.0 OUTLIER -148.92 136.64 20.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.023 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -79.54 130.31 35.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -84.12 114.46 54.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.546 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.34 141.87 1.97 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.783 1.655 . . . . 0.0 112.168 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ARG . . . . . 0.544 ' C ' ' H ' ' B' ' 24' ' ' PHE . 46.0 mtt85 -44.18 -42.62 6.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.597 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -69.77 28.24 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' PHE . . . . . 0.544 ' H ' ' C ' ' B' ' 22' ' ' ARG . 23.2 t80 -153.12 29.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -155.03 99.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.902 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.48 -9.35 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.6 t70 -163.85 -178.97 6.0 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.883 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . 0.504 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.2 p90 -165.09 172.44 12.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.285 0.564 . . . . 0.0 111.652 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.441 ' CZ ' ' OD2' ' B' ' 27' ' ' ASP . 76.7 m-85 -153.87 179.63 8.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.064 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -125.5 147.38 49.26 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.843 0.354 . . . . 0.0 110.081 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.439 ' HG1' ' H ' ' B' ' 32' ' ' SER . 36.9 p -53.92 -106.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' SER . . . . . 0.439 ' H ' ' HG1' ' B' ' 31' ' ' THR . 14.5 t -157.7 -142.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.595 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.495 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.3 m -145.65 -22.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.296 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -56.83 -7.46 0.45 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' B' ' 33' ' ' SER . 3.6 p -121.29 122.51 40.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 86.1 p -74.55 42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.195 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -167.69 57.0 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -68.94 -164.2 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 175.59 176.82 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.972 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.47 135.05 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.021 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.71 134.28 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.217 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -108.34 151.74 25.58 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.707 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.13 168.84 10.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 7.5 p -135.6 -144.96 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.343 0.592 . . . . 0.0 111.132 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ALA . . . . . 0.412 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.46 -38.82 1.33 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.988 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.47 46.24 2.34 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.728 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 15.5 t -156.58 -81.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.532 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 156.16 -87.79 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.93 148.02 32.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.98 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -152.32 123.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 109.844 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.438 ' H ' ' CB ' ' A' ' 182' ' ' SER . 5.4 t -58.36 164.44 2.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.979 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.9 134.62 13.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.717 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -68.21 120.13 72.43 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.05 -0.02 8.49 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.065 1.177 . . . . 0.0 111.318 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 59.5 p -74.11 -9.1 58.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.28 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -102.28 125.65 49.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 110.422 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -47.47 -50.07 24.04 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 64.4 p-90 -56.13 -27.56 54.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.758 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.48 -38.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -67.12 -51.6 52.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.357 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.81 -35.46 70.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.517 ' HH ' HH21 ' B' ' 22' ' ' ARG . 3.0 m-85 -62.88 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -71.01 -46.38 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.92 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.17 -28.85 69.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.27 -41.07 61.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.699 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.34 -22.5 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -69.93 -33.56 72.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.2 -102.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.6 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.597 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 1' ' ' MET . 70.9 Cg_exo -51.77 -171.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.82 1.68 . . . . 0.0 112.085 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.49 175.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.625 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 m -165.61 -8.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.447 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.6 110.24 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.163 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -167.41 124.85 1.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.577 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -60.95 -143.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.539 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.0 p -158.11 -14.7 0.08 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.419 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -76.0 -29.29 58.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 m -49.26 129.8 18.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.511 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -58.6 -21.89 54.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.536 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.2 p -77.44 -20.12 55.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 m -82.95 -50.47 8.54 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.989 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -165.42 173.43 11.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.972 0.415 . . . . 0.0 111.095 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.86 159.28 3.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.4 p -85.06 173.76 10.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.917 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -119.25 5.36 11.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.319 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.29 92.87 7.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.75 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 17.9 mp0 -27.6 -63.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.506 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -77.16 53.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 22' ' ' HIS . 19.9 tttp -163.08 137.13 6.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 63.0 m80 -157.42 123.22 4.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.81 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 128' ' ' PRO . 2.0 t60 -64.67 109.26 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 111.219 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 72.9 mmm -84.43 137.44 33.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.381 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.57 156.56 22.51 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.5 tp -110.7 151.25 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -157.27 106.56 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 110.253 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.86 148.97 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.313 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mt -117.45 145.77 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.69 108.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.992 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -106.3 96.07 6.21 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -91.18 134.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.466 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.8 m -113.92 121.68 44.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.692 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -77.5 151.04 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.721 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.462 ' CD ' ' N ' ' A' ' 36' ' ' ASP . 13.5 tm0? -80.07 148.96 30.83 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 15.4 t70 -72.76 65.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.721 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -172.09 -23.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 0.0 110.114 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.2 m -75.14 121.78 85.97 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.214 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -39.62 159.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.87 1.713 . . . . 0.0 112.318 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -73.57 147.14 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.353 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 86' ' ' GLY . 0.6 OUTLIER -174.08 101.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -112.27 25.42 11.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -86.12 54.62 3.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.83 176.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.007 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.9 m 55.6 34.99 24.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 46' ' ' GLN . 29.8 tp60 -59.72 -43.06 94.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.054 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.426 ' HG ' ' N ' ' A' ' 48' ' ' VAL . 4.0 t 178.71 165.52 0.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.055 0.455 . . . . 0.0 110.754 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.426 ' N ' ' HG ' ' A' ' 47' ' ' SER . 5.1 p -150.2 134.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.538 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.4 m -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -82.98 141.62 31.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.588 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -143.39 154.37 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -150.92 110.73 4.06 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 55' ' ' GLU . 0.9 OUTLIER -64.79 115.59 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.298 -178.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.15 -46.09 0.61 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.094 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 53' ' ' GLU . 33.8 tt0 -57.34 -33.27 67.57 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.211 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.516 ' N ' ' OG1' ' A' ' 52' ' ' THR . 45.5 m 39.71 -105.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.601 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.644 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 6.7 t0 -160.31 -37.82 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.644 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 10.0 Cg_endo -80.92 -94.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.611 1.541 . . . . 0.0 110.895 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.46 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 11.7 p30 -176.13 51.67 0.08 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' CG ' ' H ' ' A' ' 61' ' ' GLU . 44.8 Cg_endo -98.05 -55.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.395 2.064 . . . . 0.0 111.304 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 63' ' ' GLU . 23.8 tp10 62.72 61.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.982 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.2 t 72.54 -25.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.653 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 61' ' ' GLU . 28.5 tt0 63.35 63.04 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.918 0.389 . . . . 0.0 110.5 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.0 t -88.39 77.41 8.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -77.68 55.94 1.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.387 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 23.8 p-10 -167.81 90.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.2 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.56 167.98 20.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.17 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 p -173.56 -47.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 110.208 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.75 -39.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.123 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 98.9 p -46.85 136.68 7.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.486 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 m -158.28 33.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.275 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 73' ' ' ASP . 6.4 pt-20 -59.38 -34.31 72.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.497 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 75' ' ' ASP . 80.9 m-20 -34.35 -98.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.1 t 57.33 -80.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.763 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' ASP . 12.9 m-20 -75.77 149.82 83.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.345 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' PRO . 58.6 Cg_endo -68.5 147.89 71.78 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 121.964 1.776 . . . . 0.0 111.467 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' PRO . 31.3 Cg_exo -55.84 -147.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.852 1.702 . . . . 0.0 113.111 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.4 p -131.32 150.66 52.06 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.619 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.9 m -121.05 128.22 52.44 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -127.37 153.88 45.67 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.0 0.429 . . . . 0.0 110.496 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 64.4 m-85 -128.85 137.45 51.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.964 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.5 p -105.03 66.18 0.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.062 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.68 98.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.842 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.73 145.09 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.63 161.97 11.5 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.404 ' O ' ' ND2' ' A' ' 41' ' ' ASN . . . 61.3 25.62 65.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.187 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.06 65.3 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.595 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.2 163.0 30.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.934 0.397 . . . . 0.0 110.084 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -129.95 112.46 13.53 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.445 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 mpt? -101.09 106.95 18.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.958 0.408 . . . . 0.0 110.662 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -88.84 128.63 35.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.74 -162.95 1.0 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.624 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.1 70.45 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 5.0 p90 -89.0 156.16 19.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -141.46 125.64 17.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm 61.93 35.08 16.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.531 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 m -121.84 146.02 44.88 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -39.1 148.03 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.928 1.752 . . . . 0.0 112.159 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -64.46 145.05 56.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.5 mt -108.47 116.64 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -119.28 0.8 11.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -115.38 118.26 32.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.503 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.33 120.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.8 m -144.91 159.25 43.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.857 0.36 . . . . 0.0 110.738 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -148.76 168.33 23.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.82 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.71 159.34 24.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.511 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.18 127.7 36.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.545 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -142.25 107.6 5.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.482 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.23 -134.38 19.61 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -96.43 23.38 6.83 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.778 0.323 . . . . 0.0 110.383 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -130.54 159.34 37.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.434 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.03 138.86 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.471 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -108.34 171.38 7.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 111.647 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.5 120.44 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.55 ' NH2' ' HG ' ' A' ' 235' ' ' SER . 7.3 tpp85 -113.97 114.9 26.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.826 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 10.8 mp -115.84 127.42 55.03 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.4 p -164.7 175.96 9.26 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.664 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.433 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 73.6 p -92.79 166.36 12.47 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.6 m -92.55 145.5 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 0.0 110.879 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.2 p -89.26 150.09 44.15 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.32 162.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.776 1.65 . . . . 0.0 112.21 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.13 69.99 0.84 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.136 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.11 -46.13 0.43 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.21 -8.09 2.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.081 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -117.57 -176.86 3.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.63 170.13 12.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -163.21 61.89 1.1 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.946 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.501 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 97.1 Cg_exo -42.87 125.16 3.84 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.84 2.36 . . . . 0.0 113.484 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.31 149.92 21.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -149.57 163.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 p -79.61 177.42 8.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -71.25 -34.74 71.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.42 -43.88 80.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.95 -30.57 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.41 -56.52 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.162 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -32.58 39.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.163 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.1 66.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.512 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.1 mtt -63.69 -56.72 13.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.626 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 50.5 mt -46.35 -22.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -86.19 -42.06 14.14 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.72 -27.16 25.45 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.53 119.38 3.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -138.72 125.0 20.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.338 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 145' ' ' SER . 93.4 t -94.49 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.479 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.467 ' N ' ' CG1' ' A' ' 144' ' ' VAL . 12.4 p -140.22 144.54 36.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.386 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.1 mt -140.83 143.1 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.984 0.421 . . . . 0.0 110.595 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -158.29 77.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.027 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.62 152.0 6.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -134.7 -149.11 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.344 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.4 t -132.67 108.97 9.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.216 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 m -97.25 173.08 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.5 10.79 0.97 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.927 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -64.22 104.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.759 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.24 1.93 30.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -52.34 150.15 4.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.565 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.03 171.59 1.69 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.162 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 80.5 p -97.83 149.62 22.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.922 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -121.5 93.35 3.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.735 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.35 178.1 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.807 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' A' ' 162' ' ' HIS . 42.9 tttp -135.64 125.9 26.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.831 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.3 m -57.95 -2.33 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.24 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.608 ' HD1' ' N ' ' A' ' 163' ' ' PRO . 1.3 t-80 -75.08 116.36 53.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.376 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.608 ' N ' ' HD1' ' A' ' 162' ' ' HIS . 64.6 Cg_exo -40.49 160.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.81 1.674 . . . . 0.0 111.97 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.31 129.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 mt -79.03 121.26 24.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.56 160.68 22.76 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.303 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -92.04 8.08 39.36 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 58.75 -0.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.494 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 167' ' ' SER . 9.4 tp -90.73 141.82 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -88.58 -176.53 5.32 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -123.73 24.2 8.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.026 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -58.26 -166.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -101.8 122.94 44.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.07 -168.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.254 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.7 m -49.78 148.54 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 54.5 p90 -98.34 133.38 42.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.07 132.34 23.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.39 97.85 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.568 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.5 mt -107.86 -51.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -56.23 115.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.946 0.403 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.78 -123.86 0.7 Allowed Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.1 t -75.2 148.7 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.763 0.316 . . . . 0.0 110.759 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.3 p -141.81 87.23 2.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.556 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 8.8 tp -98.87 135.58 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.9 129.96 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.711 0.291 . . . . 0.0 111.526 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -81.79 90.02 6.35 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -46.25 -27.22 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.279 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -44.93 -16.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.76 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 187' ' ' THR . 57.0 m -143.71 24.55 1.69 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 p -163.98 104.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.512 0.672 . . . . 0.0 110.313 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -72.21 -56.52 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.493 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -125.71 141.1 52.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.236 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.1 tt -145.34 106.74 4.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.66 151.86 19.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.05 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -140.77 138.03 33.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 110.242 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.452 ' HG ' ' C ' ' A' ' 195' ' ' PHE . 1.8 m -143.85 135.92 26.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.347 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.2 160.06 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -171.79 113.87 0.34 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.985 0.421 . . . . 0.0 110.842 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.3 128.96 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.791 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.76 167.71 40.36 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.224 -0.512 . . . . 0.0 111.938 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -53.46 123.34 11.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.433 ' SD ' ' OG ' ' A' ' 118' ' ' SER . 77.9 mtm -82.74 4.67 24.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 34.8 t -106.88 -46.76 3.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.69 117.56 2.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 6.0 mp0 -43.98 156.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.701 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 208' ' ' GLU . 17.9 t -141.11 17.8 2.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.646 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 208' ' ' GLU . 73.7 p 56.28 -74.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.0 mm-40 -49.25 -54.41 16.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.57 0.224 . . . . 0.0 111.597 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 209' ' ' LEU . 8.4 mp -74.57 4.38 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -104.0 124.21 48.61 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.8 m -146.56 -179.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.22 167.55 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.485 0.66 . . . . 0.0 111.834 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 213' ' ' ASP . 0.6 OUTLIER -157.3 172.9 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.956 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 157.3 143.4 3.65 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.496 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -121.15 179.28 4.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.98 104.16 5.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.406 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -97.72 118.71 34.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.877 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.1 t -138.34 100.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.38 52.45 13.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.923 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.99 48.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.646 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.9 t -85.63 106.03 16.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 111.479 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.5 143.96 32.03 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.2 m -164.63 130.85 2.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.647 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -82.25 140.91 33.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.351 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -177.71 110.8 0.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.63 127.39 32.85 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 47.1 p -150.21 161.07 43.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.09 95.52 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.607 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -87.21 26.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.286 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.6 m -67.13 -29.57 69.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.6 t -116.57 5.89 13.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.664 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.28 -28.43 0.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 35.9 pt -156.39 152.01 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.33 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.11 98.92 4.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.55 ' HG ' ' NH2' ' A' ' 115' ' ' ARG . 23.3 t -64.08 -9.58 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.298 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 64.3 p -82.79 -12.37 57.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -102.74 7.44 39.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.576 0.227 . . . . 0.0 111.386 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -81.32 132.04 35.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.097 0.475 . . . . 0.0 110.786 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -123.15 135.55 54.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.388 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.74 127.3 31.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.104 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 34.0 m -88.58 -3.72 58.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.695 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.432 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 11.7 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.434 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.768 0.318 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -44.07 120.91 2.68 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.705 2.27 . . . . 0.0 112.277 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.81 155.18 27.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.517 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.84 160.94 44.26 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.064 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.5 p -54.75 -91.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.727 0.299 . . . . 0.0 110.564 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -133.1 68.26 78.02 Favored Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.471 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -41.92 124.64 2.84 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.777 2.318 . . . . 0.0 111.762 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -34.33 -99.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.432 2.088 . . . . 0.0 114.684 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 163.5 165.2 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.92 57.93 1.41 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 1.8 t -97.11 154.06 17.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.691 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.65 146.59 48.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -116.84 -23.46 8.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.335 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -151.54 154.9 37.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.108 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -114.95 154.82 28.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.91 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -76.38 139.75 41.1 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 -20.94 40.54 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.149 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -105.54 127.88 53.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -84.51 114.34 21.87 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 10.9 mp -75.45 115.15 42.84 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.903 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.67 153.44 0.15 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.045 1.83 . . . . 0.0 112.606 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 25' ' ' VAL . 84.5 mtp180 -45.7 -49.89 14.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.67 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.416 ' N ' HD21 ' B' ' 23' ' ' ASN . 2.3 m120 -38.89 -34.69 0.16 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.9 OUTLIER -106.08 38.18 2.09 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.934 0.397 . . . . 0.0 109.983 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' B' ' 22' ' ' ARG . 48.8 t -152.95 97.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.571 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.7 -13.86 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.88 179.48 9.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.189 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.492 ' O ' ' CD2' ' B' ' 29' ' ' TYR . 13.4 p90 -165.56 169.92 14.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.187 0.518 . . . . 0.0 111.796 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' B' ' 28' ' ' TYR . 94.5 m-85 -159.0 153.62 24.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.601 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' B' ' 31' ' ' THR . 41.6 mt-10 -97.71 147.31 24.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.854 0.359 . . . . 0.0 111.11 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.475 ' HG1' ' H ' ' B' ' 39' ' ' ALA . 41.9 p -53.11 -110.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.146 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.7 m -150.81 -145.72 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.666 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.5 ' C ' ' H ' ' B' ' 35' ' ' CYS . 65.9 p -141.38 -22.9 0.74 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.424 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.23 -5.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.1 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.5 ' H ' ' C ' ' B' ' 33' ' ' SER . 8.6 p -117.5 120.83 39.3 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 34.4 t -72.66 36.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.245 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.473 ' H ' ' C ' ' B' ' 35' ' ' CYS . 11.9 pt20 -167.51 60.86 0.53 Allowed Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.16 -161.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.665 2.243 . . . . 0.0 112.83 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . 0.475 ' H ' ' HG1' ' B' ' 31' ' ' THR . . . 173.48 176.92 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 134.98 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.67 130.32 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.018 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -111.26 146.51 36.87 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.48 169.06 10.63 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -136.12 -142.92 0.18 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.249 0.547 . . . . 0.0 111.092 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.499 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.53 -40.46 2.22 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.848 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.47 47.88 2.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.39 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' B' ' 48' ' ' ALA . 59.6 p -151.48 -79.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.422 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' B' ' 47' ' ' SER . . . 155.58 -90.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.76 147.67 35.95 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.954 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.63 123.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.021 0.438 . . . . 0.0 110.111 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.76 162.26 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.242 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.5 125.71 7.32 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.762 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.14 123.06 82.99 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 0.37 8.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.235 1.29 . . . . 0.0 111.357 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 62.2 p -68.22 -14.7 63.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -100.08 124.02 44.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -50.86 -38.38 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.989 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -56.4 -33.69 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.744 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.89 -36.35 57.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.123 0.487 . . . . 0.0 109.887 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.72 -37.94 73.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.482 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -71.01 -35.69 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.176 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.05 -37.65 88.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.71 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 60.9 t -70.67 -45.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.93 -38.97 80.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.986 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.1 -41.72 90.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.932 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.25 -19.81 63.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.51 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.33 66.2 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.9 mt -76.4 -77.49 0.14 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.896 0.379 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.529 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.778 0.323 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -43.04 163.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.71 2.273 . . . . 0.0 112.149 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.43 -174.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.455 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -165.88 -165.3 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.504 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.3 mt 53.86 98.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.404 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 1.8 pm0 -166.74 133.51 2.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -69.17 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.412 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.4 t -168.31 -18.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.583 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -76.58 -23.91 53.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.685 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -51.08 139.59 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.6 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 p -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.702 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -77.59 -28.7 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.71 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.9 p -78.55 -50.79 10.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.999 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -161.92 172.6 15.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.705 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.41 150.59 47.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.346 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 18' ' ' GLU . 12.4 t -63.48 170.45 3.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 0.0 110.742 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' N ' ' HG1' ' A' ' 16' ' ' THR . 23.8 mp0 -113.06 4.88 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.593 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.663 ' H ' ' HG1' ' A' ' 16' ' ' THR . 60.8 mm-40 -61.98 -164.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.964 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -127.01 -62.85 1.09 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.0 110.72 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -82.15 34.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.535 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.93 142.5 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -144.43 159.75 42.22 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.0 OUTLIER -88.02 81.56 7.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.852 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.605 ' N ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -69.33 123.67 21.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.65 179.31 17.03 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 tt -136.0 154.92 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.747 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 53.8 t0 -145.67 137.65 25.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.435 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 91.9 t -137.95 107.87 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.538 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.498 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 1.3 mp -94.28 142.62 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.577 ' H ' HH21 ' A' ' 115' ' ' ARG . 9.1 tt -155.62 117.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.54 0.686 . . . . 0.0 111.482 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -104.52 127.65 52.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.663 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -125.31 117.1 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.043 0.449 . . . . 0.0 111.89 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 m -96.79 132.98 41.96 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -94.54 164.0 13.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.926 0.394 . . . . 0.0 109.971 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.76 157.1 37.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.019 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -83.02 -34.67 26.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.993 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.2 m -45.04 110.77 1.14 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.03 159.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.725 1.616 . . . . 0.0 111.998 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -70.04 137.92 51.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.796 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -157.68 102.87 1.89 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 44' ' ' ILE . 14.5 t70 -101.6 -12.93 18.08 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.762 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -58.4 81.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.977 0.418 . . . . 0.0 110.548 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.5 tp -86.56 156.25 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 12.4 t 57.08 61.8 2.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.539 0.685 . . . . 0.0 110.048 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 155' ' ' LYS . 7.9 tt0 -80.26 -30.07 38.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 46' ' ' GLN . 38.0 m -171.54 166.76 6.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' CG2' ' SG ' ' A' ' 241' ' ' CYS . 6.7 t -148.7 105.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -106.71 112.16 25.02 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.869 0.366 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -89.09 138.61 31.26 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.284 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.1 mt -140.39 151.25 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.9 p -149.59 138.65 21.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.224 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 55' ' ' GLU . 4.4 tp10 -45.26 169.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 56' ' ' SER . 9.0 m -50.04 -10.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.961 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 53' ' ' GLU . 36.5 tt0 -30.85 88.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.641 0.588 . . . . 0.0 111.739 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' SER . 73.2 m 44.17 60.55 2.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.438 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.59 166.97 6.44 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -34.88 107.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.773 2.315 . . . . 0.0 112.307 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 0.5 OUTLIER -77.45 114.71 43.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.743 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.93 -43.91 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.651 1.568 . . . . 0.0 111.91 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -53.76 142.59 23.19 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 63' ' ' GLU . 10.5 m -65.0 -46.26 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.439 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 11.3 pt-20 -83.4 -155.16 0.16 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.487 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.3 p -157.99 159.85 36.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.948 0.404 . . . . 0.0 110.665 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.537 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 2.3 pm0 -41.08 -89.78 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t0 58.98 68.56 0.8 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 110.526 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 68' ' ' SER . 52.0 t0 -62.23 -60.23 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.432 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 67' ' ' ASP . 1.2 t 80.54 44.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.7 p -149.79 -14.1 0.27 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.125 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.4 p -168.89 -53.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.268 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 t 51.93 72.72 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.808 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -154.85 -49.92 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.216 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.24 157.72 35.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.584 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.6 m -69.1 -154.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.256 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -156.68 130.31 4.67 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -33.24 95.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.979 2.453 . . . . 0.0 114.172 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -99.08 145.1 0.46 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.129 2.552 . . . . 0.0 110.791 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -130.82 145.69 52.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.936 0.398 . . . . 0.0 111.251 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.9 t -121.86 130.95 53.77 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -124.91 114.98 19.88 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.952 0.406 . . . . 0.0 111.252 -177.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.86 124.15 37.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.289 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -96.36 71.58 2.76 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.05 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.42 111.97 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.997 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.82 169.49 18.1 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.339 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.31 20.36 43.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.851 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.88 10.0 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.75 155.53 46.49 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -121.38 106.9 11.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 mtt -101.57 106.66 17.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.942 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -95.6 127.67 41.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.539 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.75 -169.93 1.73 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.29 72.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -76.21 135.78 39.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 110.972 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.2 m -140.04 122.61 16.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.0 32.66 22.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.3 m -121.42 149.56 52.57 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.644 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -38.7 152.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.98 1.787 . . . . 0.0 112.093 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 99' ' ' GLN . 19.4 mp0 -79.57 109.25 13.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.041 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 127.37 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.848 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -123.13 2.78 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.467 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.0 p -130.86 131.24 44.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.25 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.2 tt -144.98 130.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.6 p -150.29 152.84 35.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.182 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -142.28 175.49 9.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 110.689 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 t -168.54 164.36 12.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.948 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.17 131.38 42.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 20.9 p-10 -144.43 107.74 4.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.028 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.41 -122.72 18.7 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.744 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -102.93 20.82 16.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.621 0.248 . . . . 0.0 110.649 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.4 p -128.63 151.84 49.03 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.076 0.465 . . . . 0.0 111.024 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.42 135.88 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.61 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.73 165.42 11.08 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 111.458 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.632 ' H ' ' NH2' ' A' ' 115' ' ' ARG . . . -163.46 120.56 1.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.632 ' NH2' ' H ' ' A' ' 114' ' ' ALA . 13.1 mmp_? -115.34 111.66 21.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.422 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.24 118.91 37.22 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.484 ' HG ' ' HG ' ' A' ' 167' ' ' SER . 33.4 p -156.75 177.08 11.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.328 0.585 . . . . 0.0 111.763 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 p -93.38 164.96 13.01 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.534 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.457 ' O ' ' CE ' ' A' ' 202' ' ' MET . 8.2 p -97.78 130.49 46.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 111.326 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 p -72.91 153.29 91.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.797 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.17 151.53 58.68 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.934 1.756 . . . . 0.0 111.5 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.35 50.12 8.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.23 -0.509 . . . . 0.0 111.845 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -134.75 -22.76 1.63 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.778 0.323 . . . . 0.0 110.281 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.73 14.97 11.53 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -135.04 164.48 27.54 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.24 148.01 45.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.509 . . . . 0.0 111.757 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.0 m -155.43 62.66 3.37 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.705 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.4 142.26 2.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.877 2.385 . . . . 0.0 113.361 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.56 150.22 22.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.231 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 tp -131.01 164.61 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.649 0.261 . . . . 0.0 110.62 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.8 m -81.66 154.92 25.86 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 121.182 0.515 . . . . 0.0 111.322 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -50.73 -38.43 47.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.724 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -56.53 -42.34 78.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.14 -56.84 16.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 tp -51.65 -35.44 42.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.909 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.19 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.737 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.403 ' C ' ' N ' ' A' ' 140' ' ' LYS . 48.5 mtt -69.07 -62.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.526 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.5 mt -44.96 -20.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.728 0.299 . . . . 0.0 111.218 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 138' ' ' MET . 19.7 tptm -87.47 -33.65 18.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.396 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -94.36 -26.03 16.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 34.0 t -49.61 118.62 2.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -137.72 118.93 14.53 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.2 t -115.16 126.89 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.5 p -100.96 165.14 11.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.9 mp -142.96 150.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.11 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -160.77 86.89 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.705 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.8 tt -83.32 151.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 111.904 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.48 ' CG ' ' H ' ' A' ' 150' ' ' CYS . 57.2 ttt180 -149.01 176.07 10.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.075 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.48 ' H ' ' CG ' ' A' ' 149' ' ' ARG . 11.8 m -90.99 143.35 26.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 65.3 p -129.91 124.77 33.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.311 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.22 -10.09 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.498 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 153' ' ' GLU . 1.5 mp0 -51.34 101.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -89.21 17.22 6.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.949 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.491 ' N ' ' OE1' ' A' ' 46' ' ' GLN . 63.6 mmtt -58.47 162.18 3.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.496 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 168.87 8.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.73 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.6 p -97.38 148.89 22.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 85.2 m-20 -117.21 91.11 3.48 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.65 177.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.141 0.496 . . . . 0.0 111.232 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -105.88 -171.39 1.89 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -127.32 -6.01 5.95 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.429 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 37.1 m80 -108.88 129.05 24.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.895 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -39.18 157.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.176 1.917 . . . . 0.0 112.807 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.21 143.91 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.173 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.39 116.33 22.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.891 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.02 172.68 49.85 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.624 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 169' ' ' ILE . 11.4 m -105.18 8.88 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.8 m-20 59.24 -3.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.501 ' H ' ' C ' ' A' ' 167' ' ' SER . 56.4 mt -86.96 154.3 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 172' ' ' LYS . 53.9 p -118.33 135.52 54.26 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.512 ' NE2' ' OG ' ' A' ' 196' ' ' SER . 0.1 OUTLIER -73.55 39.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.583 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 170' ' ' SER . 26.0 mmtp -67.12 179.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.15 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -90.97 122.02 33.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.43 -160.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.8 t -50.81 140.83 14.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.138 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -104.95 139.86 39.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 11.3 tm-20 -161.22 146.21 13.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.481 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.437 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 41.8 t0 -66.94 104.17 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.859 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.4 mt -114.19 -23.86 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.9 pt -90.91 137.95 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 110.876 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.38 -134.47 7.05 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.438 ' HG ' ' N ' ' A' ' 183' ' ' THR . 35.7 t -71.59 154.78 41.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.314 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.438 ' N ' ' HG ' ' A' ' 182' ' ' SER . 84.8 m -149.74 94.54 2.19 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 1.7 mp -97.39 138.11 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.61 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 1.5 m -140.92 123.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.032 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.46 ' OD2' ' SG ' ' A' ' 150' ' ' CYS . 34.6 p-10 -79.39 110.23 14.49 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.2 m -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -34.97 -46.17 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.09 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 26.5 p -143.09 40.29 1.49 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.299 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.4 t -149.4 96.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -80.12 -58.93 2.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.137 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 36.3 t-20 -127.28 137.65 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.118 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.432 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 7.7 tt -138.61 106.67 5.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.934 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -93.48 140.25 29.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -137.77 133.43 34.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.993 0.425 . . . . 0.0 111.259 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 171' ' ' HIS . 1.2 t -144.02 144.25 31.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.934 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 198' ' ' ARG . 2.7 p -139.43 166.62 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.937 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.491 ' N ' ' CG2' ' A' ' 197' ' ' VAL . 21.3 ttt180 -169.35 111.27 0.48 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.783 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 25.6 mt -102.37 122.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -163.24 -161.28 12.3 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -78.86 137.71 37.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.496 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 22.6 mtp -92.09 -6.37 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.258 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.45 -57.8 2.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.544 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -155.22 136.03 13.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -42.72 158.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.198 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 9.6 t -147.15 6.56 0.88 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.504 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.2 m 58.44 -75.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.0 mt-10 -47.84 -48.85 30.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.867 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.23 0.42 45.58 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 207' ' ' SER . 10.0 mp0 -95.72 118.03 31.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.96 163.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.077 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -164.28 168.01 19.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.573 0.701 . . . . 0.0 112.188 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.7 t70 -141.53 171.33 14.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.861 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 173.13 148.13 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.145 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -139.62 174.22 10.74 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -139.17 104.14 4.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.964 0.411 . . . . 0.0 110.592 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.57 116.8 30.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.477 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 p -140.65 118.88 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.391 0.615 . . . . 0.0 110.959 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 15.5 t70 48.25 43.04 18.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.769 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.32 -3.9 85.09 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.469 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.1 t -100.4 116.7 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.027 0.413 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.403 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -102.77 150.55 23.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.792 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 70.9 m -166.24 128.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.455 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -77.61 141.5 39.44 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.86 101.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.267 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.28 98.02 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.3 p -129.28 160.09 34.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.405 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -63.32 95.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -89.95 35.92 0.85 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.608 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.6 p -71.51 -45.22 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 233' ' ' ILE . 44.4 t -94.34 -1.9 53.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 53.5 tp -42.15 -20.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.757 0.313 . . . . 0.0 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 231' ' ' SER . 2.2 pp -149.16 174.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.329 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.93 93.87 5.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.004 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 82.3 p -66.18 -6.2 12.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 60.0 p -91.78 -17.21 25.7 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -105.05 4.71 31.85 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.18 161.15 29.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.159 0.504 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -144.6 129.73 18.58 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.962 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.66 155.75 9.46 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 48' ' ' VAL . 28.3 t -119.2 -3.85 10.55 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.62 179.725 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.719 0.295 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.41 115.52 4.37 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.604 2.203 . . . . 0.0 111.628 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 5.4 tpt -65.55 145.39 56.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.403 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.43 -176.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.979 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 31.8 t -130.15 125.78 35.89 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 110.253 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 48.37 74.73 0.76 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.475 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.531 ' O ' ' O ' ' B' ' 8' ' ' PRO . 62.4 Cg_endo -86.9 161.96 8.95 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.87 2.38 . . . . 0.0 111.018 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.531 ' O ' ' O ' ' B' ' 7' ' ' PRO . 28.6 Cg_exo -38.18 -122.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.802 3.002 . . . . 0.0 114.743 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.411 ' CB ' ' O ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 157.23 68.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.45 82.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.308 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.4 m -119.1 128.37 54.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 p -71.21 135.2 47.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.218 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -110.34 -15.48 13.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.569 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 75.7 m -122.98 147.24 46.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.316 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.487 ' CE2' ' OD1' ' B' ' 53' ' ' ASP . 16.8 m-85 -118.89 153.6 34.3 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.244 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -78.97 134.88 36.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.905 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.66 27.94 4.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.788 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.02 126.64 21.89 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.943 0.401 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -57.51 164.01 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.91 89.95 33.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -41.91 142.87 1.32 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.737 1.625 . . . . 0.0 111.987 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -42.9 -48.51 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.45 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -37.72 -34.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -107.54 42.4 1.34 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.675 0.274 . . . . 0.0 111.227 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -144.44 86.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.038 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.54 -28.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 26.7 t0 -157.83 -179.77 8.46 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.648 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.505 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.4 p90 -163.06 169.06 20.07 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.233 0.539 . . . . 0.0 112.071 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 55.7 t80 -159.06 164.45 35.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.132 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.6 pt-20 -114.38 152.21 31.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.72 0.295 . . . . 0.0 110.588 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.426 ' O ' ' O ' ' B' ' 30' ' ' GLU . 36.3 p -55.69 -116.1 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.078 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -149.43 -156.07 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.473 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.501 ' C ' ' H ' ' B' ' 35' ' ' CYS . 75.2 m -126.09 -24.62 3.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.343 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.4 mm? -53.09 -9.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.227 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' B' ' 33' ' ' SER . 4.1 p -120.13 123.65 43.85 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -74.57 42.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -166.31 56.86 0.42 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.97 -161.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 122.795 2.33 . . . . 0.0 113.013 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 167.83 177.39 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.67 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.77 134.07 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.137 0.494 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.94 141.83 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.474 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -119.33 150.32 40.34 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.683 0.277 . . . . 0.0 110.649 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -115.63 112.13 21.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 109.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 4.7 p -75.62 -138.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.027 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.485 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -131.02 -32.22 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.062 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.39 40.5 3.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.043 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 27.4 t -142.94 -83.35 0.17 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 121.378 -0.129 . . . . 0.0 110.704 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 154.58 -90.73 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.704 0.627 . . . . 0.0 109.612 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' O ' ' B' ' 48' ' ' ALA . 15.4 mm100 -141.11 135.98 31.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 t -148.57 124.0 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.424 0.631 . . . . 0.0 110.26 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 2.3 t -72.35 155.57 40.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.468 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 135.24 17.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.271 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.487 ' OD1' ' CE2' ' B' ' 15' ' ' TYR . 60.9 m-20 -63.86 128.16 92.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.237 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.25 0.6 9.23 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.423 1.415 . . . . 0.0 110.889 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 71.0 m -70.57 -12.55 61.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.198 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -96.46 129.21 43.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.205 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 31.9 t -48.75 -51.97 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.041 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -56.5 -32.46 65.07 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.001 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.98 -35.89 76.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.819 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -73.95 -37.84 64.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.628 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.4 -36.91 79.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.859 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.7 -36.68 84.66 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.64 -42.83 86.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' OE2' ' B' ' 67' ' ' GLU . 57.4 t80 -62.67 -34.17 76.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.472 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -70.05 -48.35 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.9 -19.62 66.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -71.77 -32.69 67.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.1 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' B' ' 69' ' ' ASN . 7.5 tt -83.66 -79.51 0.2 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.539 ' N ' ' CD2' ' B' ' 68' ' ' LEU . 49.3 t30 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.51 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.5 mmt . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 1' ' ' MET . 78.0 Cg_exo -51.76 -173.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.982 1.788 . . . . 0.0 111.982 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.02 172.77 2.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.595 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.9 t -61.1 -38.65 87.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.541 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -172.24 159.1 4.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.532 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -149.58 -177.5 5.9 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.559 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -59.86 137.5 58.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.585 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -76.41 -7.38 54.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 m -76.87 -19.49 57.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 13' ' ' SER . 15.9 p -50.08 141.24 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.615 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.8 p -68.96 -5.77 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -101.86 -18.31 15.79 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.563 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.703 ' H ' ' HG ' ' A' ' 10' ' ' SER . 57.9 m -86.75 -48.85 7.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -156.71 177.1 11.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.012 0.434 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.71 141.78 39.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.613 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.488 ' OG1' ' NE2' ' A' ' 23' ' ' HIS . 2.4 m -61.39 166.67 3.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.884 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.4 9.71 12.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.017 0.437 . . . . 0.0 109.903 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' LYS . 49.9 mt-10 -86.02 91.5 8.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -33.98 -41.73 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.812 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -80.6 25.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.532 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.4 mmtp -138.43 136.52 36.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.847 0.356 . . . . 0.0 110.08 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.578 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 27.9 m170 -130.92 135.33 47.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.488 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 11.6 m-70 -80.62 102.8 10.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -66.41 175.56 2.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.268 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.39 126.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 tt -109.91 150.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.876 0.37 . . . . 0.0 110.454 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -132.86 141.82 48.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.66 97.47 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.8 0.334 . . . . 0.0 111.246 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mm -91.69 136.43 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.15 126.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.33 0.586 . . . . 0.0 111.501 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -115.82 126.87 54.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.76 133.21 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.744 0.307 . . . . 0.0 111.383 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -105.79 130.72 53.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -80.42 155.09 27.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.232 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.414 ' N ' ' HG1' ' A' ' 38' ' ' THR . 12.9 tp60 -66.88 179.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -77.85 -31.34 51.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.707 0.289 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.38 -34.01 31.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.218 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.414 ' HG1' ' N ' ' A' ' 35' ' ' GLN . 15.4 p -40.98 104.96 0.36 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.134 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.5 164.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.9 1.733 . . . . 0.0 111.941 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 p -68.21 145.87 53.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.489 ' C ' HD21 ' A' ' 41' ' ' ASN . 0.3 OUTLIER -171.64 97.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -103.02 0.09 31.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.653 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.1 87.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.402 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 pt -85.07 150.79 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.481 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 39.2 t 57.18 64.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.644 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.501 HE22 ' C ' ' A' ' 156' ' ' ASP . 37.8 mm-40 -77.29 -26.89 52.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 t 174.29 164.63 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.72 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -144.21 139.04 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.73 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.2 m -136.54 102.71 5.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.811 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -82.3 126.24 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.338 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 mt -126.07 152.83 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.8 137.94 16.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.537 ' CG ' ' H ' ' A' ' 54' ' ' SER . 1.4 tm-20 -52.95 -176.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.537 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 31.1 t -55.2 -24.77 28.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 56' ' ' SER . 0.8 OUTLIER 50.38 178.23 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.531 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 36.1 t -91.66 59.08 3.67 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.623 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 59' ' ' ASP . 67.7 m-20 -159.22 141.47 10.04 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.505 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -42.49 89.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.835 1.69 . . . . 0.0 112.736 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.1 p30 -179.57 59.6 0.11 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.807 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.02 74.39 5.58 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.592 2.194 . . . . 0.0 111.6 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -58.99 -48.25 82.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.38 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 63' ' ' GLU . 60.6 t -85.24 -64.27 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 13.5 tt0 88.05 168.18 0.05 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.064 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 1.5 t 165.02 -17.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 67' ' ' ASP . 4.8 tm-20 -156.92 147.0 20.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 110.57 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.455 ' N ' ' CD ' ' A' ' 65' ' ' GLU . 33.1 t70 -58.58 -70.09 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.104 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.499 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 10.7 m-20 -158.74 167.03 30.58 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.56 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.0 p -156.92 158.31 36.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.403 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 84.9 m -140.83 -45.22 0.39 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.629 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 72' ' ' GLU . 84.8 p 50.89 -161.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.456 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -75.21 29.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.735 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 70' ' ' SER . 41.9 mt-10 55.13 76.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.687 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -164.28 21.66 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 m -58.28 114.06 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.066 0.46 . . . . 0.0 110.219 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -66.37 150.57 97.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.952 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.89 155.97 48.24 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.908 1.738 . . . . 0.0 111.485 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 78' ' ' THR . 44.2 Cg_endo -79.89 -143.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.511 2.14 . . . . 0.0 111.388 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.419 ' H ' ' HB2' ' A' ' 77' ' ' PRO . 9.6 t -139.43 144.82 38.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.731 0.3 . . . . 0.0 110.897 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.484 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 1.6 p -105.35 130.92 53.35 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -123.79 111.63 16.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.74 0.305 . . . . 0.0 110.91 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.2 120.38 40.36 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -91.16 77.82 5.93 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.632 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.32 106.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 tt -98.08 146.96 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.116 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.63 173.37 20.68 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.08 18.37 26.9 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.341 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.15 3.53 88.4 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.095 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.9 mt -129.88 158.07 40.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.913 0.387 . . . . 0.0 110.337 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -126.02 113.09 16.66 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.53 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.451 ' C ' HD21 ' A' ' 91' ' ' ASN . 16.7 mtt -101.91 111.39 23.63 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.766 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.663 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.7 OUTLIER -99.84 124.52 45.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.755 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.17 -167.09 1.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.03 71.91 0.05 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.912 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.484 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -77.68 148.29 35.06 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.227 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.9 m -136.02 114.28 11.55 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.6 tttt 64.27 40.18 6.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.97 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.6 m -124.59 149.72 62.82 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -37.79 147.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.068 1.845 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -74.85 109.91 8.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 133.51 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.086 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 -13.59 6.77 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.544 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t -105.6 121.81 44.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.922 0.391 . . . . 0.0 110.835 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 mt -135.37 121.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.572 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 10.9 t -137.63 178.22 7.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 111.017 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.491 ' N ' ' OG ' ' A' ' 104' ' ' SER . 55.3 tt0 -161.68 154.44 20.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.428 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.31 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.68 133.46 43.58 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -148.68 115.15 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.251 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.83 -104.5 1.55 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.209 -0.519 . . . . 0.0 111.941 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -129.35 24.84 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 110.349 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.68 159.22 40.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.38 138.25 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.69 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.676 HD21 ' H ' ' A' ' 114' ' ' ALA . 1.7 t-20 -116.88 147.06 42.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.537 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.676 ' H ' HD21 ' A' ' 113' ' ' ASN . . . -143.19 129.76 20.19 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.873 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -115.26 115.41 26.62 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.121 0.486 . . . . 0.0 111.459 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.536 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -115.88 120.5 39.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.459 ' HG ' ' H ' ' A' ' 118' ' ' SER . 7.9 t -159.09 -178.83 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.206 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.459 ' H ' ' HG ' ' A' ' 117' ' ' SER . 74.2 p -91.82 159.66 15.69 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.45 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.88 147.16 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.045 0.45 . . . . 0.0 111.528 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 p -87.39 152.1 51.9 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.729 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.32 162.89 18.83 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.943 1.762 . . . . 0.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.79 -1.51 58.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.99 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -81.05 -56.08 4.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.547 0.213 . . . . 0.0 110.55 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.17 -9.02 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.638 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -113.85 175.67 5.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -77.14 152.01 35.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 111.265 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.5 m -154.38 63.2 4.02 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.65 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.54 151.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.061 2.507 . . . . 0.0 113.273 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.08 150.2 41.56 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.113 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.7 tp -144.82 164.57 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.554 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 48.6 p -68.91 171.62 7.76 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.239 0.543 . . . . 0.0 111.436 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.578 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 5.0 m170 -68.07 -33.79 75.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.171 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.51 -57.19 12.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.845 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -62.95 -42.98 99.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.607 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -57.02 11.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.952 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.14 -34.52 66.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.933 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.14 -30.44 65.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.3 mtt -74.33 -61.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.634 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.0 pt -47.24 -21.8 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.663 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -82.54 -30.61 29.61 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.27 -28.09 13.16 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 48.6 t -49.54 119.21 3.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 0.0 111.313 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -137.0 118.03 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.99 125.34 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.8 t -100.79 158.21 16.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.129 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.7 mm -140.76 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.912 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -152.32 88.83 1.39 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 mt -85.93 148.41 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.013 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -148.41 178.41 8.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.481 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.0 t -91.75 125.14 36.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.548 ' HG ' ' N ' ' A' ' 152' ' ' GLU . 9.5 t -109.54 162.23 14.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.548 ' N ' ' HG ' ' A' ' 151' ' ' SER . 27.0 mp0 -139.7 19.12 2.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.62 0.247 . . . . 0.0 110.939 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -75.86 103.28 5.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.273 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.98 8.7 11.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 4.0 mptp? -52.81 173.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.501 ' C ' HE22 ' A' ' 46' ' ' GLN . 28.0 m-20 -81.66 171.42 14.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -95.12 143.62 26.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.462 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 77.8 m-20 -114.78 92.72 4.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.755 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 160' ' ' LYS . 96.6 mt -123.47 163.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 162' ' ' HIS . 21.7 pttm -125.12 138.43 54.17 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.62 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 54.2 m -65.09 6.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.653 ' N ' ' HD1' ' A' ' 162' ' ' HIS . 0.2 OUTLIER -76.18 117.62 65.44 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.434 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.87 158.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.661 1.574 . . . . 0.0 111.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.75 128.77 38.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.0 112.15 17.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.69 171.07 40.97 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.526 -0.369 . . . . 0.0 112.509 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 169' ' ' ILE . 5.8 t -103.8 8.9 37.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.007 0.432 . . . . 0.0 109.91 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 60.48 -5.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.95 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.2 pp -80.38 164.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.759 -0.377 . . . . 0.0 109.991 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 172' ' ' LYS . 6.1 t -126.82 130.64 50.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -72.45 37.86 0.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.813 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 170' ' ' SER . 49.4 pttt -66.64 -173.4 0.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.004 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.04 119.83 35.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.0 110.715 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.492 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 0.2 OUTLIER -142.08 -166.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.4 m -50.89 145.32 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.853 0.359 . . . . 0.0 110.551 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -98.25 131.37 44.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.57 114.66 8.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.901 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.8 OUTLIER -61.77 99.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.52 6.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 82.6 mt -100.6 113.61 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.97 -137.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.994 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.507 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 6.1 t -72.81 158.45 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.5 p -143.59 90.02 2.12 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.91 128.03 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.099 0.476 . . . . 0.0 109.76 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.38 123.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.157 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -82.65 109.52 16.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.11 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 28.1 m -45.93 -27.06 0.81 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.506 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -34.58 -38.37 0.07 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.199 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 79.7 m -142.15 31.32 1.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 28.4 m -155.9 103.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.127 0.489 . . . . 0.0 110.65 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.49 -56.2 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.641 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 217' ' ' TYR . 7.4 t-20 -115.07 171.46 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 192' ' ' ASN . 0.3 OUTLIER 179.45 105.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.49 . . . . 0.0 109.804 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.62 142.07 36.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.347 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -127.99 142.74 51.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.595 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 5.9 p -143.51 136.68 27.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.1 t -131.42 158.38 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.446 ' CD ' ' O ' ' A' ' 170' ' ' SER . 14.1 ttt85 -166.3 106.6 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.251 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 tp -109.42 124.46 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -167.96 -151.97 7.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.86 118.57 30.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.41 ' H ' ' HG3' ' A' ' 202' ' ' MET . 0.0 OUTLIER -84.61 4.83 30.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.445 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 1.3 m -99.63 -50.73 3.97 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -161.36 127.81 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.708 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -43.64 145.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.1 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 208' ' ' GLU . 3.2 t -131.6 5.99 4.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.488 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.491 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.4 t 58.31 -76.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.662 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' SER . 50.5 mt-10 -48.81 -50.19 35.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.774 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 209' ' ' LEU . 8.0 mp -80.63 0.84 32.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.243 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.494 ' OE1' ' N ' ' A' ' 210' ' ' GLU . 13.6 mp0 -101.67 124.85 48.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.837 0.351 . . . . 0.0 110.801 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.96 -178.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.492 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 16.8 ptmt -165.54 167.79 17.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.531 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -159.59 169.61 23.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.982 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 146.69 140.25 3.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.24 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -119.69 -168.94 1.68 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.64 ' HZ3' ' HG1' ' A' ' 227' ' ' THR . 77.3 mttt -144.98 110.0 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.523 ' O ' ' ND2' ' A' ' 192' ' ' ASN . 97.7 m-85 -103.41 122.07 44.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.103 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.8 117.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.191 0.52 . . . . 0.0 110.583 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 1.1 m-20 51.87 42.33 30.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.486 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.27 -0.71 87.22 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.4 -0.429 . . . . 0.0 113.145 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.0 m -97.49 117.03 30.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.935 0.368 . . . . 0.0 110.158 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.409 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -89.58 159.14 17.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.483 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 65.8 m -168.13 110.43 0.59 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.24 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -78.51 141.75 37.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.62 123.14 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.573 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.07 103.96 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.326 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.64 ' HG1' ' HZ3' ' A' ' 216' ' ' LYS . 61.2 p -129.83 151.76 50.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 228' ' ' ASP . 0.8 OUTLIER -51.16 95.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -90.69 27.32 1.79 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.2 m -74.0 -32.49 63.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.97 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 233' ' ' ILE . 13.9 m -103.12 -3.91 25.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.204 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -40.79 -27.84 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 0.0 110.749 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.522 ' N ' ' CD1' ' A' ' 233' ' ' ILE . 0.0 OUTLIER -144.01 -177.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.585 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 236' ' ' THR . 12.3 m-20 -118.51 91.93 3.69 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.1 m -62.22 1.51 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.291 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 234' ' ' ASP . 44.6 p -90.24 -22.9 21.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.36 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.87 6.66 39.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.607 0.241 . . . . 0.0 111.049 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.82 138.26 32.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.947 0.403 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 104' ' ' SER . 46.5 mttm -126.43 142.55 51.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.07 167.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 242' ' ' VAL . 40.7 t -132.39 -11.51 3.18 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 241' ' ' CYS . 13.4 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.295 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.733 0.301 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.78 118.9 3.88 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.644 2.229 . . . . 0.0 111.868 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' MET . . . . . 0.457 ' O ' ' SD ' ' B' ' 3' ' ' MET . 0.0 OUTLIER -56.65 142.49 39.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.472 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.52 161.12 52.69 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.162 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 7' ' ' PRO . 16.3 t -70.17 169.95 12.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.513 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' B' ' 5' ' ' SER . 34.5 t70 -21.0 84.7 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 21.1 Cg_exo -65.85 -173.6 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.463 2.109 . . . . 0.0 111.751 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 74.5 Cg_exo -54.34 -132.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 123.322 2.681 . . . . 0.0 113.215 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.485 ' O ' ' N ' ' B' ' 11' ' ' CYS . 2.8 t 177.73 45.06 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.503 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.32 93.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.762 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.516 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 94.1 m -137.27 128.07 27.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.099 0.476 . . . . 0.0 111.34 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 t -39.71 135.82 1.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.638 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.516 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 12.4 m-85 -117.17 -25.85 6.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.317 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -151.94 150.77 30.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -107.81 157.59 18.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -78.79 135.8 37.19 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.08 24.82 2.0 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.69 0.281 . . . . 0.0 110.388 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.75 127.88 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 110.74 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.545 ' NZ ' ' CG ' ' B' ' 58' ' ' TRP . 31.2 ttmt -79.0 122.19 25.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.612 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.54 111.0 45.09 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.79 148.45 0.48 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.857 1.705 . . . . 0.0 112.478 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 -47.27 -47.45 25.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.545 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -37.36 -34.73 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.539 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 2.4 m-85 -106.78 44.32 1.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.495 0.188 . . . . 0.0 110.926 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -149.22 95.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.78 -25.9 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 34.5 t70 -168.67 170.82 9.18 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.408 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.404 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 20.4 m-85 -124.2 163.58 21.28 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.95 0.881 . . . . 0.0 112.369 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -154.99 134.87 12.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.514 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' B' ' 31' ' ' THR . 18.4 pt-20 -99.43 148.96 23.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.257 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 30' ' ' GLU . 46.9 p -55.03 -112.39 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 7.0 m -150.28 -141.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.701 0.286 . . . . 0.0 110.597 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.492 ' C ' ' H ' ' B' ' 35' ' ' CYS . 26.1 t -143.04 -24.42 0.61 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -58.12 -6.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.492 ' H ' ' C ' ' B' ' 33' ' ' SER . 22.0 m -114.91 118.58 33.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.549 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -73.12 38.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -165.74 58.99 0.57 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -170.48 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.721 2.281 . . . . 0.0 113.25 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.24 176.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 49.4 t -109.49 129.81 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.59 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.6 128.84 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.064 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.425 ' C ' ' NE2' ' B' ' 43' ' ' GLN . 30.5 p90 -107.93 145.88 33.18 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.211 0.529 . . . . 0.0 111.225 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' B' ' 43' ' ' GLN . 1.7 mp0 -93.34 170.17 9.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.646 ' HG1' ' N ' ' B' ' 45' ' ' ALA . 9.8 p -140.1 -143.22 0.15 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.202 0.525 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.646 ' N ' ' HG1' ' B' ' 44' ' ' THR . . . -125.79 -38.57 2.2 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.854 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.65 2.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.88 -0.145 . . . . 0.0 111.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 23.3 t -153.54 -82.24 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.458 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 156.05 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.418 0.449 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -140.96 147.76 39.29 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.7 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.1 t -151.62 117.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.876 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.507 ' H ' ' CB ' ' A' ' 182' ' ' SER . 22.9 t -52.13 157.99 1.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.19 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.47 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.45 127.91 8.55 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -68.57 123.81 88.58 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.04 0.36 8.48 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.279 1.319 . . . . 0.0 111.271 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -66.57 -13.82 61.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.097 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -100.07 123.46 44.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -50.8 -38.35 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.965 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.545 ' CG ' ' NZ ' ' B' ' 19' ' ' LYS . 82.5 m95 -56.72 -33.23 66.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.224 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.22 -35.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.111 0.482 . . . . 0.0 110.195 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -73.35 -39.9 64.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.845 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -69.5 -38.66 77.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -63.11 -39.95 96.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.954 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.01 -42.58 79.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.938 0.399 . . . . 0.0 110.117 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -63.74 -21.72 66.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.99 -36.38 36.08 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.96 -19.42 37.19 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.361 -0.536 . . . . 0.0 109.667 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.57 -35.47 77.42 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.01 -70.25 0.42 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.919 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.575 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' O ' ' A' ' 2' ' ' PRO . 40.4 mtt . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.793 0.33 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 1' ' ' MET . 76.0 Cg_exo -49.88 -172.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.474 0.356 0 C-N-CA 122.737 2.291 . . . . 0.0 112.221 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.5 -151.91 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.437 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.5 t -170.03 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.627 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 2.3 mm? -70.3 157.21 38.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -164.95 83.17 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.416 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -144.93 -160.6 1.15 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.4 t -167.39 -11.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.545 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.3 m -75.39 -34.48 61.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.583 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.4 p -50.21 125.71 13.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.519 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -55.66 -20.31 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.769 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.7 m -75.59 -27.6 58.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 t -82.62 -39.73 21.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 p -166.07 172.99 10.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 0.0 110.698 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.75 155.92 39.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 p -71.94 171.92 10.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -121.19 5.44 10.29 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.333 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 20' ' ' ASN . 43.2 mm-40 -80.88 91.88 6.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 2.9 pm0 -32.42 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.982 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' GLU . 23.0 p-10 -95.49 38.65 1.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.565 0.221 . . . . 0.0 111.308 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -154.1 139.31 17.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.533 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -135.54 158.97 43.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.213 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CE1' ' CE ' ' A' ' 202' ' ' MET . 0.9 OUTLIER -96.53 76.88 2.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 24' ' ' MET . 3.8 mpp? -57.04 117.31 3.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.503 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.98 149.72 17.35 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.888 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -111.57 135.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 63.2 t0 -140.46 137.82 34.2 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 11.5 t -138.66 142.78 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.046 0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.01 132.61 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.248 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.43 135.31 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.178 0.513 . . . . 0.0 110.831 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -121.12 94.67 4.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.552 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.95 112.52 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.038 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.68 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 5.9 p -86.42 127.81 34.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.518 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' CB ' ' NZ ' ' A' ' 34' ' ' LYS . 5.0 mtpm? -80.37 151.76 29.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.73 164.21 25.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.71 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.01 -35.49 80.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.272 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.439 ' N ' ' CD ' ' A' ' 37' ' ' GLN . 4.4 mp0 -75.34 -35.17 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.023 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.6 m -44.14 106.9 0.55 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.245 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 92.6 Cg_exo -43.79 161.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.817 1.678 . . . . 0.0 112.021 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.3 p -70.06 148.7 48.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 5.4 p30 -173.49 102.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -103.1 -4.29 24.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.465 ' C ' HE22 ' A' ' 46' ' ' GLN . 11.0 ptpt -64.93 89.39 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.409 0.623 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 45' ' ' CYS . 6.1 mm -96.3 164.1 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.807 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 44' ' ' ILE . 90.1 m 58.82 49.38 10.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.605 ' N ' HE21 ' A' ' 46' ' ' GLN . 0.0 OUTLIER -65.87 -44.36 85.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.861 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.3 t -167.7 176.8 6.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 0.0 111.461 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.88 103.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.717 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.9 p -103.92 96.82 6.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.527 0.204 . . . . 0.0 111.178 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.27 142.27 32.23 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.427 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 mt -144.51 151.2 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.938 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 m -151.47 144.98 24.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' CD ' ' CE1' ' B' ' 24' ' ' PHE . 29.5 mt-10 -52.15 179.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -65.72 -34.75 78.92 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.24 90.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.729 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 p 175.14 -96.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.173 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.786 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 28.9 t70 -169.48 -4.65 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.786 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 97.5 Cg_endo -79.4 -98.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 CA-C-N 122.02 1.757 . . . . 0.0 111.906 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 60' ' ' PRO . 4.2 m-20 -155.13 -59.14 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.433 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' C ' ' O ' ' A' ' 59' ' ' ASP . 23.1 Cg_exo -19.86 112.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 123.711 2.941 . . . . 0.0 114.009 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 30.0 mp0 -100.14 -145.03 0.34 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.531 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 63' ' ' GLU . 1.2 p -165.55 -98.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.49 ' N ' ' CG2' ' A' ' 62' ' ' VAL . 0.6 OUTLIER -125.01 82.33 2.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.1 t 60.01 -172.04 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -147.3 84.05 1.57 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.954 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -156.3 46.42 0.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.541 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -59.12 -67.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.599 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.8 m 62.87 -149.8 0.35 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.598 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t 33.63 65.87 0.26 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.903 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.625 ' HG ' ' N ' ' A' ' 71' ' ' VAL . 44.1 t -167.04 167.35 14.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.375 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.625 ' N ' ' HG ' ' A' ' 70' ' ' SER . 21.9 m -157.21 -46.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.522 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -46.59 -95.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.217 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 165.24 84.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.13 103.96 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.132 0.491 . . . . 0.0 110.581 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -166.14 67.24 1.05 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.544 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -89.02 110.6 0.52 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.199 2.6 . . . . 0.0 111.95 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -87.58 163.36 7.96 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.164 1.909 . . . . 0.0 112.39 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.407 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 38.7 p -123.75 126.9 47.32 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.452 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 m -102.87 126.23 49.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -126.46 119.6 27.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -112.54 121.17 44.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.62 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -90.58 78.43 6.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.296 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.1 tp -71.72 114.41 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.068 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.14 144.63 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.87 166.64 16.83 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.43 21.82 49.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.661 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.64 14.96 79.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.129 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.18 157.24 45.85 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.102 0.477 . . . . 0.0 110.676 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -124.53 105.92 9.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.266 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -101.25 123.23 45.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 111.06 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -106.64 128.41 54.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 25.5 m-85 -100.11 -169.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.257 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.01 67.84 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.422 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.486 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.51 145.84 36.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.256 0.528 . . . . 0.0 110.182 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.9 m -132.2 102.6 5.85 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.529 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt 70.85 45.31 0.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.337 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.5 m -124.23 149.64 61.41 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.53 142.72 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.878 1.719 . . . . 0.0 112.228 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -55.06 143.86 25.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 tp -98.01 135.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.451 ' HZ3' ' H ' ' A' ' 126' ' ' ASP . 87.6 mttt -145.5 -7.66 0.59 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.921 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -111.02 111.1 21.97 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.09 114.08 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 239' ' ' LYS . 29.5 t -142.33 161.11 38.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.304 0.573 . . . . 0.0 112.067 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -155.42 173.22 16.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.72 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 t -170.65 165.24 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.039 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.42 136.61 46.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.928 0.394 . . . . 0.0 110.292 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.448 ' CG ' ' HZ2' ' A' ' 237' ' ' LYS . 2.5 m-20 -143.94 110.97 5.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.023 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.15 -91.0 0.36 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -142.86 21.33 1.97 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.5 m -114.69 138.42 50.72 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.787 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.33 120.58 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.841 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -104.42 164.63 11.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.829 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -168.43 125.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.073 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -113.82 114.36 26.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.41 118.79 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 t -161.55 173.12 15.24 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.507 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 167' ' ' SER . 94.0 p -89.4 170.5 10.48 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.824 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.84 133.16 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.003 0.43 . . . . 0.0 111.259 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.15 164.06 39.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.87 144.29 43.03 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.162 1.908 . . . . 0.0 111.406 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.03 9.13 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -126.4 -51.82 1.5 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.97 0.47 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.642 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -108.39 -178.54 3.63 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 2.2 m-20 -63.96 -179.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.895 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.0 m -171.29 59.76 0.3 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.416 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.11 146.11 0.4 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.465 2.11 . . . . 0.0 112.654 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.43 127.07 20.31 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 mm -132.8 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 110.109 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.595 ' HG1' ' N ' ' A' ' 132' ' ' HIS . 0.8 OUTLIER -69.17 166.04 19.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.931 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.595 ' N ' ' HG1' ' A' ' 131' ' ' THR . 16.8 p80 -59.15 -33.96 71.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.556 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.503 ' H ' ' HG1' ' A' ' 131' ' ' THR . 37.1 tt0 -51.51 -51.96 50.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 138' ' ' MET . 8.5 tp10 -66.52 -47.79 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.755 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.77 8.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.412 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.9 mt -51.3 -42.29 61.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.71 -21.07 59.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.593 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.3 ttt -79.05 -64.19 1.24 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.94 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.467 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -54.55 -20.9 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.919 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.467 ' N ' ' CD1' ' A' ' 139' ' ' ILE . 56.0 tttp -74.3 -33.42 63.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.5 ' OD2' ' NE ' ' B' ' 18' ' ' ARG . 12.3 t70 -102.72 -21.33 14.11 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.5 t -51.64 119.83 4.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.65 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -138.65 125.55 21.12 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.24 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 t -120.23 125.89 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -101.75 164.67 11.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.102 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.37 146.92 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.896 0.379 . . . . 0.0 110.139 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 90.29 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.7 146.33 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 111.758 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -130.57 170.44 14.26 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.788 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.6 t -91.5 105.3 17.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.659 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.6 p -85.83 169.32 13.45 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.796 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.51 14.18 1.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -67.54 111.22 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.269 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.71 1.83 28.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -46.29 158.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.891 0.377 . . . . 0.0 111.226 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -75.75 170.65 15.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.587 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.8 m -87.23 135.52 33.28 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.046 0.451 . . . . 0.0 110.781 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -113.32 89.55 3.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.75 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 pt -119.85 171.22 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -159.42 0.68 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.2 t -129.77 -4.32 4.65 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.707 0.289 . . . . 0.0 110.46 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -84.55 124.57 73.18 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -39.36 155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.884 1.723 . . . . 0.0 112.335 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.8 p -74.93 133.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.05 134.23 36.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.324 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.31 179.71 27.07 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.668 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.527 ' C ' ' H ' ' A' ' 169' ' ' ILE . 17.3 m -113.56 8.36 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.8 t30 62.73 -11.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.374 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.527 ' H ' ' C ' ' A' ' 167' ' ' SER . 14.1 pt -93.33 139.89 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.225 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.406 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 40.4 t -100.94 150.52 22.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.264 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -79.05 47.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -71.1 169.57 14.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.757 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -83.8 119.24 24.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 175' ' ' SER . 13.8 p -151.49 163.34 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.089 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 174' ' ' VAL . 53.3 p -14.73 132.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.036 0.835 . . . . 0.0 113.197 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 45.1 p90 -90.6 134.38 34.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.423 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.54 134.57 20.33 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.9 OUTLIER -69.86 101.09 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.52 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 41.1 mm -114.09 -14.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.65 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.8 mt -91.23 127.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.816 0.341 . . . . 0.0 111.031 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.66 -134.06 6.6 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 69.9 p -69.25 150.77 47.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.94 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.534 ' OG1' ' CE1' ' B' ' 13' ' ' PHE . 0.8 OUTLIER -142.43 95.06 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.239 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 18.4 mt -99.32 134.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.062 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.32 114.05 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.11 106.96 3.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.0 m -48.08 -27.48 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -39.4 -37.66 0.48 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.622 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.7 m -137.95 37.45 2.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.732 0.301 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 45.4 t -150.74 103.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.547 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -85.39 -61.0 1.87 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.68 ' H ' ' HG1' ' A' ' 33' ' ' THR . 0.4 OUTLIER -130.04 140.79 50.81 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.714 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.5 tt -139.91 114.73 9.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.888 0.375 . . . . 0.0 110.817 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -94.47 152.67 18.39 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -147.55 131.69 17.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.149 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.2 m -144.26 138.08 27.73 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.434 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.475 ' CG2' ' N ' ' A' ' 198' ' ' ARG . 2.8 p -138.09 163.91 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.475 ' N ' ' CG2' ' A' ' 197' ' ' VAL . 55.1 ttt-85 -164.96 111.22 0.96 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.837 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.8 mm -94.1 126.7 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.18 173.25 46.14 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.402 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -72.24 131.85 43.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.691 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 23' ' ' HIS . 28.8 mtm -86.49 4.59 39.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.724 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 85.5 m -97.74 -61.32 1.41 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -152.64 122.83 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.484 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.84 148.52 0.37 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.589 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 4.7 t -133.91 13.41 3.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.793 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.1 m 58.81 -76.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.735 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 35.1 tt0 -49.59 -54.33 18.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.609 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -73.69 4.92 4.44 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.115 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 175' ' ' SER . 9.0 mm-40 -104.14 125.5 50.5 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.759 0.314 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.5 168.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 45.7 tttm -157.18 159.97 38.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.312 0.577 . . . . 0.0 111.224 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 9.7 t70 -153.59 170.35 21.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.034 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.14 166.22 25.85 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.758 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -148.89 169.73 19.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 7.7 mtpm? -131.84 103.42 6.32 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -100.02 116.4 31.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.61 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.69 118.87 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.256 0.55 . . . . 0.0 110.752 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 50.54 43.26 27.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.516 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.32 80.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.09 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -98.29 117.97 33.89 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.673 -0.31 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.85 15.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.0 t -169.97 123.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.528 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -78.39 139.02 38.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.53 108.2 0.27 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.481 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -72.06 104.89 3.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.0 t -132.16 152.98 50.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.139 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 95.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.84 34.02 0.66 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.986 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.4 t -73.02 -35.0 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.912 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 233' ' ' ILE . 68.9 p -105.12 -0.36 26.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.978 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.01 -24.58 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.085 0.469 . . . . 0.0 110.526 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 231' ' ' SER . 0.4 OUTLIER -165.11 137.79 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.0 108.18 7.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.055 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 66.2 m -76.23 6.36 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.61 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -20.37 25.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.448 ' HZ2' ' CG ' ' A' ' 108' ' ' ASP . 51.9 pttt -103.33 4.98 37.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.595 0.236 . . . . 0.0 111.339 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.66 147.81 29.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.042 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.412 ' O ' ' OG ' ' A' ' 104' ' ' SER . 56.6 mttm -132.9 142.83 49.12 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.4 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.46 134.82 49.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 242' ' ' VAL . 34.7 m -91.37 1.66 56.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.767 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.648 -0.692 . . . . 0.0 111.482 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.731 0.3 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 118.86 5.74 Favored 'Trans proline' 0 N--CA 1.474 0.331 0 C-N-CA 122.501 2.134 . . . . 0.0 111.575 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.27 159.0 30.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.528 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.67 164.69 25.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.266 -0.493 . . . . 0.0 111.999 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 p -76.54 -84.55 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.332 . . . . 0.0 110.671 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -123.36 82.35 52.68 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.421 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 52.0 Cg_exo -53.02 -168.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.538 2.159 . . . . 0.0 110.82 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' B' ' 9' ' ' THR . 64.9 Cg_endo -88.17 -111.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.997 1.798 . . . . 0.0 111.67 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.467 ' OG1' ' SG ' ' B' ' 11' ' ' CYS . 0.0 OUTLIER 158.01 72.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.34 71.62 1.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.138 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.467 ' SG ' ' OG1' ' B' ' 9' ' ' THR . 4.4 m -105.85 127.18 52.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -65.73 142.06 58.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.334 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.534 ' CE1' ' OG1' ' A' ' 183' ' ' THR . 11.1 p90 -116.19 -11.54 11.31 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 29.5 m -131.8 144.68 51.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.248 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -114.94 158.67 21.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.04 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -83.22 144.92 29.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.871 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.74 -47.59 11.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.903 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.5 ' NE ' ' OD2' ' A' ' 141' ' ' ASP . 5.3 tpt85 -70.9 126.2 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -83.74 118.95 24.24 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' B' ' 20' ' ' LEU . 6.1 mp -75.48 145.53 79.42 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.693 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.7 152.07 37.15 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.382 2.055 . . . . 0.0 112.558 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' B' ' 24' ' ' PHE . 11.4 ptp180 -45.64 -43.84 12.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.38 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -68.09 24.82 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.529 ' H ' ' C ' ' B' ' 22' ' ' ARG . 12.2 t80 -150.88 32.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.371 0.605 . . . . 0.0 109.555 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -151.04 92.44 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.149 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.16 -25.28 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -156.42 -179.74 8.46 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.068 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 9.2 p90 -163.35 167.7 21.42 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.981 0.419 . . . . 0.0 111.256 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 57.4 m-85 -158.12 156.15 30.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' B' ' 31' ' ' THR . 69.7 mt-10 -98.53 145.58 26.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.812 0.339 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.425 ' O ' ' O ' ' B' ' 30' ' ' GLU . 63.2 p -52.35 -107.44 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -146.93 -128.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.453 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.513 ' C ' ' H ' ' B' ' 35' ' ' CYS . 18.2 t -158.95 -40.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.693 0.282 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -59.08 -2.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.573 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.513 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.8 m -80.25 -34.48 37.1 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.224 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m 75.05 23.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.402 0.62 . . . . 0.0 110.087 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.523 ' N ' ' CD ' ' B' ' 38' ' ' PRO . 3.2 pt20 -173.56 49.61 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.533 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 29.7 Cg_endo -58.63 -158.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.191 2.594 . . . . 0.0 112.974 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 168.36 176.95 0.03 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.25 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.33 131.31 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.8 t -110.45 133.87 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.658 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' B' ' 42' ' ' PHE . 29.9 p90 -113.16 146.02 39.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.075 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.37 169.74 10.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 5.1 p -138.84 -142.73 0.16 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.187 0.517 . . . . 0.0 110.68 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.472 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.33 -36.33 1.71 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.177 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.97 46.43 2.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.287 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 23.6 m -153.72 -80.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.54 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.688 0.618 . . . . 0.0 109.475 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -161.34 143.71 12.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -148.9 136.19 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 0.0 109.781 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.65 162.22 13.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.631 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 124.79 7.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.318 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -62.33 122.58 74.05 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 1.28 7.07 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.225 1.284 . . . . 0.0 111.161 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -67.82 -18.22 64.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.108 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -95.31 125.88 40.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -51.56 -39.75 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.976 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -56.39 -34.92 67.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.078 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.92 -35.22 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.93 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.03 -35.69 66.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -72.14 -35.89 69.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -65.09 -36.48 84.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.689 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.02 -44.47 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.04 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -62.11 -28.7 69.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -74.65 -40.87 61.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.959 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.12 -21.69 63.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.26 -29.37 62.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.17 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt -79.11 -84.5 0.08 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.374 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.562 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 2' ' ' PRO . 46.0 mtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.765 0.317 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 1' ' ' MET . 51.8 Cg_exo -54.4 -157.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 122.803 2.335 . . . . 0.0 112.257 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.76 -42.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.257 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.1 t 56.94 -157.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.1 mt 58.44 108.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -150.06 51.91 0.91 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.501 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.486 ' CD ' ' H ' ' A' ' 7' ' ' GLN . 1.5 mp0 -61.39 -166.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.4 m -164.62 -58.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.2 p -75.02 -22.15 58.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.117 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 t -48.22 133.13 15.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -60.07 -29.39 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.438 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 t -76.2 -27.42 56.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.8 t -72.04 -51.1 23.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.8 t -169.66 178.82 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.143 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -61.45 160.8 10.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.66 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 2.9 p -81.58 166.67 20.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.192 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.41 4.37 12.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.436 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 56.5 mt-10 -62.52 -152.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.749 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.16 -72.15 0.7 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.562 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -83.09 59.33 4.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.277 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -130.38 135.8 48.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.134 0.492 . . . . 0.0 111.242 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.93 123.35 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.438 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.66 ' CE1' ' H ' ' A' ' 16' ' ' THR . 67.5 m80 -75.27 76.18 2.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 tpt -46.54 170.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.358 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 158.19 132.94 1.48 Allowed Glycine 0 CA--C 1.512 -0.149 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 tt -110.68 129.26 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.079 0.466 . . . . 0.0 110.921 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 -105.04 135.61 46.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.83 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.46 128.86 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.8 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.9 pt -124.42 162.86 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 tt -164.01 135.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.147 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -123.47 94.64 4.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.615 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.48 115.18 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.479 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -90.06 127.47 36.08 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -82.21 154.71 25.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.643 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -68.85 -170.55 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.8 -31.11 18.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.938 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -79.01 -39.72 33.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.237 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 p -40.7 106.48 0.42 Allowed Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -43.68 170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.963 1.776 . . . . 0.0 112.277 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p -75.49 134.88 40.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.923 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -158.1 95.31 1.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.106 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.77 -7.31 25.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -63.74 92.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 110.407 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.55 154.75 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 34.9 t 53.7 65.46 1.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.122 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 153' ' ' GLU . 23.0 mt-30 -79.2 -24.62 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 46' ' ' GLN . 3.4 m 178.09 164.82 0.71 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.417 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.65 132.14 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.404 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 p -134.17 104.4 6.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.177 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -83.29 136.79 34.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.282 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.1 mm -132.7 162.67 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.484 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 93.0 m -154.18 151.25 28.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' B' ' 24' ' ' PHE . 91.4 mt-10 -52.71 175.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.6 p -62.91 -21.88 66.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 109.818 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 56' ' ' SER . 65.7 mm-40 -44.95 164.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.748 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 2.0 m 159.76 -23.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.848 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.4 p30 -162.01 152.45 14.44 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.879 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -35.49 -27.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.451 2.101 . . . . 0.0 112.581 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' ASP . 73.6 m-20 -118.14 85.24 23.82 Favored Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.184 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 59' ' ' ASP . 74.1 Cg_exo -50.27 -164.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.776 2.317 . . . . 0.0 112.898 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 64' ' ' SER . 39.5 tt0 -119.93 -115.96 0.32 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.033 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p 41.19 91.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.903 0.859 . . . . 0.0 110.996 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 47.37 57.29 5.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.291 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 61' ' ' GLU . 20.1 m 55.95 -120.71 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.571 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 67' ' ' ASP . 12.1 tt0 -161.14 -137.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.34 -3.93 0.96 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 110.368 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 69' ' ' THR . 3.4 p30 -156.6 154.29 29.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.323 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.6 t 73.18 -14.86 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.546 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 67' ' ' ASP . 10.1 t -70.33 -173.01 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.525 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.412 ' N ' ' OG1' ' A' ' 69' ' ' THR . 86.3 p -167.02 153.71 8.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.564 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.8 p -129.66 -30.77 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.175 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -49.62 -61.55 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.414 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -85.45 -175.56 5.73 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.319 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.2 -130.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.919 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -158.59 71.87 3.77 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.84 112.51 1.51 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.922 2.414 . . . . 0.0 112.335 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -87.19 151.21 8.1 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.441 2.094 . . . . 0.0 111.365 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -122.45 114.87 21.31 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.806 0.336 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 p -96.35 129.96 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.56 141.7 50.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -136.31 134.44 37.95 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.428 1.109 . . . . 0.0 110.845 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' NE ' ' A' ' 89' ' ' ARG . 33.1 t -96.12 73.87 2.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.064 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 pt -71.13 98.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 tp -86.88 146.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.603 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.91 166.79 17.1 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.302 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.71 23.39 44.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.208 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 7.98 74.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -127.99 153.82 46.31 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.439 ' NE ' ' OG ' ' A' ' 82' ' ' SER . 63.3 ttt180 -122.65 113.91 19.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.36 152.08 21.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 110.147 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -149.06 126.95 11.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.413 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -116.81 -169.99 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.947 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.05 81.53 0.16 Allowed Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.293 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.548 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 1.8 m-30 -73.35 115.01 12.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.6 m -124.69 111.79 16.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.686 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.1 tptp 64.84 31.3 11.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.02 150.32 44.88 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -38.64 160.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.956 1.771 . . . . 0.0 112.123 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -81.67 107.07 14.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.533 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.57 144.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.923 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -147.14 -21.92 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 p -98.18 122.02 40.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.361 . . . . 0.0 110.317 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 tp -139.89 133.53 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.536 ' HG ' ' N ' ' A' ' 239' ' ' LYS . 11.2 t -150.11 165.41 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.248 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -148.86 161.5 41.72 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.085 0.469 . . . . 0.0 110.789 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.14 156.64 22.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.228 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.5 137.95 44.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.219 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -151.06 108.04 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.337 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.35 -103.53 2.17 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.168 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 110' ' ' ASN . 17.5 p-10 -130.67 23.29 5.04 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.668 0.271 . . . . 0.0 110.552 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.1 155.63 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.645 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.7 t -127.31 129.73 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.064 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.639 ' ND2' ' H ' ' A' ' 114' ' ' ALA . 2.9 t-20 -107.54 154.99 20.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.525 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.639 ' H ' ' ND2' ' A' ' 113' ' ' ASN . . . -154.83 121.73 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.541 HH21 ' CD2' ' A' ' 238' ' ' LEU . 19.5 tpp85 -105.07 113.0 26.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.811 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.1 114.21 22.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.416 ' HG ' ' HG ' ' A' ' 167' ' ' SER . 22.9 t -158.85 171.73 19.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.164 0.507 . . . . 0.0 112.029 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -87.83 163.83 16.22 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.1 141.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.141 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 p -83.22 152.6 65.12 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.616 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.52 152.35 33.81 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 121.921 1.747 . . . . 0.0 111.584 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.1 50.22 13.52 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.71 -53.96 0.88 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.59 0.233 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 160.87 -11.35 0.14 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.232 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -129.94 151.12 50.84 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 117.278 0.539 . . . . 0.0 110.114 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.0 146.51 42.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.787 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.0 p -139.76 62.36 22.31 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.957 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.17 129.63 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.227 2.618 . . . . 0.0 113.427 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.48 165.08 13.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.2 pt -145.05 165.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -82.67 154.84 24.67 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.738 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -51.35 -37.07 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.55 -51.82 68.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 110.436 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.05 -43.66 91.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.133 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.49 -56.55 19.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 110.319 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tp -51.65 -35.84 43.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.903 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.09 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.5 mmt -71.3 -62.43 1.4 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.7 pt -46.9 -21.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.462 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -91.02 -28.72 17.8 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.622 0.248 . . . . 0.0 110.894 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.495 ' CG ' ' HE ' ' B' ' 18' ' ' ARG . 15.1 t0 -92.19 -44.12 8.95 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.4 t -43.43 120.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.937 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -141.5 132.93 26.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.699 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.41 132.08 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.033 0.444 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.7 p -103.14 171.02 7.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.362 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.9 mm -139.4 154.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -163.58 88.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.272 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.97 147.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.083 0.468 . . . . 0.0 111.292 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -137.04 171.68 14.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.804 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 m -100.31 116.21 31.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.197 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.1 m -104.85 -176.84 3.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.929 0.395 . . . . 0.0 110.256 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -149.47 0.69 0.5 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.888 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -55.37 99.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.56 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.64 9.72 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.952 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -45.43 156.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.92 170.24 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.1 m -90.46 135.87 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.634 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.472 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 9.8 t70 -115.56 89.13 3.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.768 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -124.29 168.18 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -113.18 155.14 25.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.559 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 69.0 m -83.43 -3.92 58.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.903 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.546 ' NE2' ' CB ' ' A' ' 240' ' ' ALA . 0.5 OUTLIER -77.49 147.48 75.43 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.972 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.94 160.45 33.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.561 1.507 . . . . 0.0 110.988 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.63 134.92 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 6.6 mp -82.51 117.89 22.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.11 171.27 40.42 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.759 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 169' ' ' ILE . 2.0 p -101.12 7.29 43.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 60.97 -3.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.477 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.2 tt -98.24 139.2 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.323 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 172' ' ' LYS . 67.5 p -98.34 145.62 26.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.59 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -75.59 40.88 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.499 ' NZ ' ' CB ' ' A' ' 172' ' ' LYS . 5.6 ttpm? -65.11 171.87 3.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 172' ' ' LYS . 36.7 pttt -87.27 128.24 35.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.307 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.562 ' CG2' ' H ' ' A' ' 175' ' ' SER . 14.9 p -157.13 177.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.773 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.562 ' H ' ' CG2' ' A' ' 174' ' ' VAL . 71.4 m -27.54 141.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.506 0.503 . . . . 0.0 112.018 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -100.24 134.09 43.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.07 138.85 33.88 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.006 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.75 86.78 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.772 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 37.8 mt -100.77 -36.89 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.303 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.58 124.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.231 0.538 . . . . 0.0 110.601 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.77 -125.41 2.81 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 12.0 m -79.76 153.05 29.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.164 0.507 . . . . 0.0 111.086 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 22.4 p -141.09 95.04 2.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.457 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 1.8 mp -98.44 117.09 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.403 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 6.0 m -131.74 117.64 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.287 0.565 . . . . 0.0 111.602 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -78.66 111.89 15.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.823 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.6 m -46.34 -32.3 3.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.232 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -34.97 -34.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.201 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 189' ' ' CYS . 32.1 p -152.1 56.93 0.84 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.305 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.77 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.487 . . . . 0.0 110.009 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.78 -57.39 4.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.631 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 37.9 t-20 -127.16 137.92 53.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 2.2 tt -134.13 128.14 33.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.926 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -113.57 135.81 53.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -137.01 134.59 36.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.019 0.437 . . . . 0.0 111.071 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.6 t -142.79 141.44 31.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.778 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 44.4 t -134.69 159.16 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.069 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.403 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 44.2 ttt180 -174.19 116.59 0.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.903 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.4 tt -119.02 136.08 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -171.65 -150.13 6.97 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.568 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 43.3 t0 -88.49 119.15 28.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.622 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -78.38 3.57 15.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.08 -178.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 23.9 t -111.15 -51.3 2.87 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.742 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.439 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 67.6 mttm -146.94 109.93 4.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -44.52 147.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.372 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 3.2 m -148.75 96.14 2.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 206' ' ' SER . 69.1 m -23.45 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.339 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 36.3 mt-10 -58.65 -73.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.845 0.355 . . . . 0.0 111.629 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.3 9.6 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -96.5 126.1 41.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.834 0.349 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.69 178.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.5 164.86 19.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.105 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -158.92 168.63 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.178 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 165.34 171.03 31.07 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.8 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 12.7 m-85 -151.9 172.7 15.81 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -136.83 103.75 5.28 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.28 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -101.84 122.33 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.69 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 220' ' ' GLY . 7.3 p -140.48 115.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.298 0.571 . . . . 0.0 111.556 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.39 -8.87 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.768 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 137.99 -2.12 2.92 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 12.3 m -101.3 117.08 34.26 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.638 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.38 150.01 23.46 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.3 m -164.98 127.63 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.519 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -78.04 139.28 39.1 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.83 109.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.655 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.81 97.31 4.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 59.3 m -126.75 157.23 39.69 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.04 95.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -90.61 30.66 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -73.25 -30.12 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.285 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.0 t -111.4 1.34 16.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -44.31 -28.79 0.57 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.99 0.424 . . . . 0.0 110.478 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.42 143.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.179 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 236' ' ' THR . 6.1 p30 -75.75 97.04 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.042 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.0 m -59.29 -4.14 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 238' ' ' LEU . 41.1 p -78.96 -53.5 6.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.9 13.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.541 ' CD2' HH21 ' A' ' 115' ' ' ARG . 8.3 mp -77.05 140.23 40.26 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 110.444 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.536 ' N ' ' HG ' ' A' ' 104' ' ' SER . 18.7 mtpp -131.64 131.59 43.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.616 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.546 ' CB ' ' NE2' ' A' ' 162' ' ' HIS . . . -54.87 155.73 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 46.9 t -123.98 -8.37 7.75 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.638 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 241' ' ' CYS . 2.0 p . . . . . 0 C--O 1.218 -0.564 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.379 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.7 0.286 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.88 115.78 4.47 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.538 2.159 . . . . 0.0 111.738 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 39.8 ttm -53.03 150.4 5.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.587 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.09 179.31 1.17 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.162 -0.542 . . . . 0.0 111.916 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 17.7 t -70.88 -88.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.553 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -152.26 66.64 6.6 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.343 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' B' ' 8' ' ' PRO . 98.5 Cg_endo -80.84 113.97 2.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.66 2.24 . . . . 0.0 111.846 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' B' ' 7' ' ' PRO . 82.8 Cg_exo -46.02 176.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.767 1.645 . . . . 0.0 111.181 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 25.3 p -150.5 -170.59 3.7 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.124 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.0 113.24 16.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.88 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.512 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 18.8 m -129.85 120.92 25.73 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 33.7 t -38.37 129.17 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.658 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 29.0 m-85 -109.63 -32.46 7.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.19 157.79 36.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.032 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.81 161.15 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.9 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -83.52 136.44 34.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.02 7.78 17.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.065 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.495 ' HE ' ' CG ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -134.0 127.48 32.41 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.812 0.339 . . . . 0.0 111.006 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -83.43 127.37 33.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.602 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 9.4 mp -90.39 112.69 54.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.34 152.76 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.787 1.658 . . . . 0.0 111.942 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.639 HH21 HD22 ' B' ' 69' ' ' ASN . 8.5 tpt180 -45.14 -47.19 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.299 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -37.57 -33.59 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CE2' ' OE1' ' A' ' 53' ' ' GLU . 3.1 m-85 -109.5 43.19 1.34 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.795 0.331 . . . . 0.0 110.585 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -153.12 92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.707 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.28 -24.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -157.69 -179.03 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.168 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -157.78 170.69 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.223 0.535 . . . . 0.0 112.04 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 57.6 t80 -158.39 151.47 22.72 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.444 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 49.4 mt-10 -99.33 148.69 23.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.488 ' HG1' ' H ' ' B' ' 39' ' ' ALA . 72.4 p -54.31 -109.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -152.58 -141.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.698 0.285 . . . . 0.0 110.526 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.437 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.9 t -146.53 -23.29 0.43 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.405 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.63 -10.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.437 ' H ' ' C ' ' B' ' 33' ' ' SER . 83.1 m -112.8 122.04 46.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.575 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -72.75 37.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.84 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.2 pt20 -168.51 60.17 0.44 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.6 -164.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.713 2.275 . . . . 0.0 113.059 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . 0.488 ' H ' ' HG1' ' B' ' 31' ' ' THR . . . 178.9 176.64 0.54 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.499 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.51 131.75 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.938 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.62 132.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.036 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -112.72 151.44 30.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -92.66 169.39 10.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -137.11 -145.09 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 110.703 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.99 -39.48 1.39 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.99 46.82 2.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.301 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 9.8 m -155.33 -83.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.375 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.35 -90.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -138.86 148.62 43.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 t -151.84 113.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.289 0.566 . . . . 0.0 110.446 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.555 ' N ' ' OG ' ' A' ' 182' ' ' SER . 54.0 t -50.53 161.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.439 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -153.58 139.97 18.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.187 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -74.64 115.36 43.12 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.29 -0.64 8.41 Favored 'Trans proline' 0 C--N 1.356 0.933 0 CA-C-N 120.145 1.087 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -74.72 -10.08 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.888 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 37.4 mt-10 -98.97 125.55 44.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.21 0.529 . . . . 0.0 110.317 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.8 m -46.89 -50.58 18.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 63.9 p-90 -55.99 -25.29 43.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.077 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.99 -36.67 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.971 0.415 . . . . 0.0 110.139 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 56' ' ' GLU . 2.5 mp0 -68.3 -44.27 75.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.908 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.14 -35.31 80.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.294 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -63.1 -46.78 85.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 80.3 t -65.16 -47.64 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.725 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.5 -33.85 68.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -73.12 -34.49 66.16 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.982 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.7 -21.65 61.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.424 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -78.56 -77.27 0.17 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.639 HD22 HH21 ' B' ' 22' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.53 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.79 0.329 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.63 -49.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.688 2.259 . . . . 0.0 111.801 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.08 101.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.553 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.6 m -166.03 161.95 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.648 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.0 tp 55.74 45.85 23.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.383 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -87.68 177.73 6.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.524 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.529 ' CD ' ' H ' ' A' ' 7' ' ' GLN . 0.5 OUTLIER -84.41 -97.7 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.964 179.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.5 p -154.28 -12.23 0.13 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.323 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 p -79.68 -27.85 40.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.55 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.9 m -49.91 130.23 21.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -56.61 -25.89 54.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -73.67 -28.42 61.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.355 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -76.15 -55.6 5.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -158.91 162.79 36.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.75 149.62 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.4 p -73.27 171.26 13.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.4 15.93 16.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.215 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -90.21 90.87 8.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -44.43 -23.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.164 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -80.99 18.92 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' C ' ' CG ' ' A' ' 22' ' ' HIS . 9.9 ptmm? -170.11 165.63 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.679 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.4 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 81.6 m-70 -152.94 -178.38 6.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.793 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.453 ' O ' ' SD ' ' A' ' 202' ' ' MET . 21.2 t60 -101.51 93.43 5.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.81 120.98 20.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.669 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -125.37 160.15 19.92 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.55 134.02 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -124.68 124.29 41.86 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.041 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 t -137.61 142.07 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.6 pt -146.29 138.46 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.722 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -138.08 134.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -118.38 94.01 4.33 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.13 135.7 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.483 0.658 . . . . 0.0 112.084 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.432 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 15.8 p -113.0 130.67 56.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.697 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -89.34 164.45 14.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.851 0.358 . . . . 0.0 110.741 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.428 ' C ' ' H ' ' A' ' 37' ' ' GLN . 92.3 mt-30 -77.81 151.31 34.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.712 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.06 -3.76 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.68 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 35' ' ' GLN . 62.6 mt-30 -91.7 -41.45 10.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.004 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.6 p -48.26 146.08 4.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.832 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.21 162.36 28.57 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.023 1.816 . . . . 0.0 111.306 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.2 p -54.63 146.07 17.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.183 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.488 ' N ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -167.02 90.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 110.836 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.31 -5.77 32.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.05 0.452 . . . . 0.0 110.036 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -61.05 83.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.658 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tp -96.4 159.96 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.775 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.1 m 60.87 40.19 16.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 110.443 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 155' ' ' LYS . 3.7 tp60 -55.44 -55.05 36.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.921 0.391 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.1 t -178.87 150.97 0.51 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -115.31 142.72 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.232 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.5 m -127.7 102.11 6.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.92 129.01 34.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.678 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -138.94 149.54 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -153.37 145.94 24.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' SER . 1.5 mp0 -54.63 -176.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 6.2 t 102.22 -2.97 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 2.6 mp0 65.06 167.98 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.454 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 m -102.19 -38.03 7.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.786 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.31 -51.19 65.73 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.369 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -86.53 55.31 3.36 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.391 2.061 . . . . 0.0 112.067 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.88 106.99 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 62' ' ' VAL . 90.2 Cg_exo -43.68 97.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.025 1.817 . . . . 0.0 112.952 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 33.24 29.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 60' ' ' PRO . 13.8 t -76.4 -78.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.043 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.4 ' CG ' ' H ' ' A' ' 64' ' ' SER . 21.3 tt0 -68.06 170.87 7.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.596 ' HG ' ' H ' ' A' ' 65' ' ' GLU . 28.8 t -41.08 163.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.875 0.369 . . . . 0.0 111.34 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.596 ' H ' ' HG ' ' A' ' 64' ' ' SER . 22.3 pt-20 -60.84 -0.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.032 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 64' ' ' SER . 27.4 t0 51.99 100.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.414 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 29.0 p-10 -171.86 169.01 5.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.774 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.1 p -145.28 -59.48 0.34 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.461 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.571 ' CG2' ' H ' ' A' ' 70' ' ' SER . 4.8 t -58.48 -63.32 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.541 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.571 ' H ' ' CG2' ' A' ' 69' ' ' THR . 17.2 t 54.53 60.59 3.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.796 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 t -73.13 -76.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.447 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -172.14 28.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.697 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -110.07 -169.67 1.51 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.893 0.378 . . . . 0.0 110.961 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.7 m 37.42 73.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.157 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -48.28 150.48 2.21 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -35.72 156.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.628 2.218 . . . . 0.0 112.582 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.93 166.01 30.84 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.708 2.272 . . . . 0.0 112.211 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 p -123.63 137.53 54.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.56 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -93.1 126.72 38.34 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -122.59 101.6 7.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 0.0 111.275 -178.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 9.9 m -143.45 68.38 1.29 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.409 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.0 tp -73.65 107.09 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.225 0.536 . . . . 0.0 110.203 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.2 mt -89.14 148.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.56 169.86 20.39 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.264 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.82 23.58 51.16 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.41 8.73 71.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.925 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -130.07 156.75 44.01 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.911 0.386 . . . . 0.0 110.403 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.7 ttm105 -115.95 117.84 31.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 68.4 mmm -102.22 108.35 19.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -100.98 120.44 40.19 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.122 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -100.9 -169.7 1.74 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.853 0.359 . . . . 0.0 110.89 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -178.92 70.65 0.07 OUTLIER Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.031 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -76.68 137.38 39.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.711 0.291 . . . . 0.0 110.776 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.9 m -138.83 118.46 13.04 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 60.09 32.34 20.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.133 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -119.81 149.72 49.09 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -38.61 145.55 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.851 . . . . 0.0 111.986 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -71.12 137.06 48.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 0.0 110.889 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.89 145.65 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -143.04 -9.56 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.636 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -124.08 123.25 39.92 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.16 106.99 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -140.16 145.83 38.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -142.35 -173.23 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 t -170.03 164.6 9.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.1 114.69 16.06 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -128.81 110.97 12.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.174 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.79 -127.48 22.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.857 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -100.98 21.42 13.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.66 0.267 . . . . 0.0 110.544 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -129.66 159.02 37.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 t -131.47 136.3 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.911 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -91.99 174.47 7.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -164.79 121.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.504 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -121.97 102.43 8.16 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.415 ' O ' ' OG ' ' A' ' 117' ' ' SER . 2.6 mm? -115.58 111.86 21.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 116' ' ' LEU . 12.1 m -166.34 168.01 15.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.168 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -90.2 176.09 6.89 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.9 p -116.9 155.13 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.094 0.473 . . . . 0.0 111.565 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.4 t -91.22 146.31 33.26 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.748 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' C ' ' NE2' ' A' ' 123' ' ' GLN . 33.9 Cg_exo -34.81 155.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 122.669 2.246 . . . . 0.0 112.778 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.569 ' N ' HE22 ' A' ' 123' ' ' GLN . . . 72.29 70.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.569 HE22 ' N ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -154.75 -40.67 0.09 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.662 0.268 . . . . 0.0 110.876 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.432 ' H ' ' CD ' ' A' ' 123' ' ' GLN . . . 124.89 7.16 6.17 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.41 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 31.4 mmtp -125.33 170.34 11.43 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 23.0 p-10 -73.61 156.12 38.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.83 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 p -155.7 66.18 4.5 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.894 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -48.24 134.31 25.0 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 122.893 2.395 . . . . 0.0 113.256 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.97 156.73 18.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.317 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.6 pt -150.46 166.54 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.178 0.513 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.5 p -72.69 164.66 26.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.347 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -60.74 -34.32 74.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.259 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 4.3 mp0 -56.62 -57.17 13.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.142 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.467 ' O ' ' SD ' ' A' ' 138' ' ' MET . 39.6 mt-10 -57.3 -46.14 83.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.26 -55.4 18.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.05 -36.12 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.63 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.37 -30.23 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -76.35 -61.89 1.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.0 pp -47.21 -21.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.186 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -83.79 -55.05 4.47 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.565 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -76.67 -37.8 55.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.9 t -39.31 120.42 1.04 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.59 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.34 124.85 16.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.0 t -117.99 126.97 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.101 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.0 t -102.63 166.24 10.62 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.2 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.64 144.5 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.99 0.424 . . . . 0.0 110.719 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.38 88.67 1.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.848 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 15.9 tt -77.47 151.27 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -145.25 -177.44 5.55 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.884 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.5 m -91.3 135.08 34.06 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.829 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.9 p -127.87 130.56 48.76 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -117.38 40.21 3.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.44 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.465 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -81.5 100.9 9.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.159 0.504 . . . . 0.0 110.704 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -72.13 -2.59 19.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.525 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.487 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.8 mmtm -51.53 161.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.855 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -77.09 177.51 7.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.8 p -96.59 142.02 29.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.55 92.04 3.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.55 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.84 177.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -132.92 134.52 44.65 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.3 p -70.18 4.17 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.399 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -83.2 121.6 77.08 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -39.89 161.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.785 1.657 . . . . 0.0 112.076 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.47 134.26 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 8.1 mp -84.38 121.29 27.33 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.49 168.3 25.23 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.482 -0.327 . . . . 0.0 112.675 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.466 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.5 p -95.83 6.92 47.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.76 0.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.029 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 167' ' ' SER . 10.2 tp -100.84 138.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.494 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 97.0 p -99.09 142.31 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.567 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -75.79 43.12 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.268 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -66.56 -174.52 0.3 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -88.24 123.73 33.15 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.465 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.93 -175.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.779 0.323 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 66.4 m -44.98 144.34 1.24 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.119 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 48.4 p90 -96.29 126.9 41.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.817 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -141.49 130.99 23.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.42 97.13 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.071 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.2 mm -107.65 -38.32 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.88 124.01 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.55 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.53 -130.67 2.09 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.476 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 24.8 t -75.29 155.87 36.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.663 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 26.4 m -142.94 93.8 2.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.522 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 1.8 mp -98.75 116.18 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.59 132.59 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.012 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.76 94.69 6.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 189' ' ' CYS . 17.8 p -47.38 -26.68 1.37 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.878 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -43.49 -16.23 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.509 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 187' ' ' THR . 13.0 m -148.43 12.59 0.93 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.63 91.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.678 0.751 . . . . 0.0 110.563 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.95 -53.88 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.391 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.432 ' H ' ' HG1' ' A' ' 33' ' ' THR . 12.0 m-20 -131.99 148.44 52.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.601 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 tt -148.13 110.56 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.044 0.449 . . . . 0.0 111.425 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -93.41 135.76 34.34 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -130.02 135.69 48.56 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.968 0.413 . . . . 0.0 111.106 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.2 t -144.31 141.06 29.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.488 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 198' ' ' ARG . 4.1 p -137.73 163.48 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.494 ' NH1' ' O ' ' A' ' 170' ' ' SER . 60.4 ttt180 -171.7 115.94 0.38 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.361 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 tt -114.95 126.05 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -168.54 -149.24 6.07 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.228 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.51 140.31 33.4 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.913 0.387 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -103.98 -2.58 25.86 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.914 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 70.7 m -107.33 -56.54 2.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.679 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -146.42 126.4 13.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.483 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.72 144.96 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 208' ' ' GLU . 20.7 m -127.06 9.09 6.77 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.25 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.4 m 58.29 -76.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.716 0.293 . . . . 0.0 111.476 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' SER . 71.6 mm-40 -49.35 -50.19 40.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.64 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.1 mt -75.1 -1.36 22.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.368 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.22 130.05 44.49 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.865 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.8 m -142.68 -179.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.473 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 48.6 tttm -171.04 161.94 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.369 0.604 . . . . 0.0 111.611 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 15.4 t70 -158.95 169.52 24.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.711 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.64 138.35 2.43 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.935 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -118.39 168.65 10.44 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -132.63 103.06 5.94 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -97.63 113.38 25.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.109 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.61 116.16 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.3 0.572 . . . . 0.0 110.726 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 1.2 m-20 52.82 28.28 6.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.861 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.4 66.15 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.994 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.5 t -98.61 116.22 30.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.31 158.66 15.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.8 m -168.28 117.69 0.75 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.992 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -85.05 96.64 9.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.089 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -129.33 133.93 7.74 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.56 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.34 97.69 10.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 86.0 m -123.96 156.21 36.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -57.68 95.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.2 30.0 0.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.4 m -70.38 -49.28 50.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.2 t -90.01 2.21 55.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 tp -39.2 -33.14 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.875 0.369 . . . . 0.0 111.15 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.54 144.43 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.894 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 234' ' ' ASP . 1.5 p30 -74.97 102.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.044 0.45 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 92.6 p -68.94 -4.14 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.478 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 69.9 p -83.21 -15.68 49.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -102.01 11.41 38.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.585 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.58 153.89 34.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -142.33 121.16 12.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.14 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 123.24 16.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.728 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 15.0 m -88.15 4.72 44.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.436 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 11.1 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.375 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.822 0.344 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.51 116.82 3.9 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.749 2.299 . . . . 0.0 111.859 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -65.01 148.49 51.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.38 169.79 2.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.07 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.0 m -78.32 -76.49 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.786 0.327 . . . . 0.0 110.695 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -119.71 84.18 30.33 Favored Pre-proline 0 N--CA 1.472 0.631 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.719 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.459 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 23.4 Cg_exo -61.36 -174.29 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.463 2.109 . . . . 0.0 112.727 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 34.7 Cg_exo -58.03 -138.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.288 2.658 . . . . 0.0 113.876 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.497 ' O ' ' N ' ' B' ' 11' ' ' CYS . 2.9 t -178.53 31.07 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.897 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.36 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.779 0.323 . . . . 0.0 110.959 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.51 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 63.5 m -138.39 128.35 25.44 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.026 0.441 . . . . 0.0 110.528 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 80.1 m -45.37 141.37 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.808 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.51 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 24.9 m-85 -114.1 -26.24 8.17 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.785 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.6 m -155.42 157.22 36.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.88 162.56 15.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.377 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -85.28 139.52 31.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.651 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.46 -26.19 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.338 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.75 125.9 41.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 0.0 111.522 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -77.95 122.68 25.84 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -87.14 112.71 49.64 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.725 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.45 148.4 1.3 Allowed 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 121.909 1.74 . . . . 0.0 112.289 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -44.99 -41.83 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.353 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.56 -32.39 0.55 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 7.0 m-85 -108.53 41.67 1.53 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.66 0.267 . . . . 0.0 110.473 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -151.4 92.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.68 -25.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 35.1 t70 -155.11 -179.19 7.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.743 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.5 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 9.1 p90 -161.86 173.93 13.85 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.338 0.589 . . . . 0.0 111.848 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.493 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 45.2 t80 -156.64 179.75 8.97 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.265 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.493 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 13.1 pt-20 -128.76 152.23 48.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.267 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.587 ' HG1' ' H ' ' B' ' 39' ' ' ALA . 35.7 p -57.2 -113.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -151.66 -142.56 0.12 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.514 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.468 ' C ' ' H ' ' B' ' 35' ' ' CYS . 13.2 t -143.32 -16.78 0.65 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.91 -3.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.018 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' B' ' 33' ' ' SER . 2.9 p -123.3 122.9 39.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -74.49 44.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -173.31 57.85 0.22 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.61 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.964 2.443 . . . . 0.0 113.137 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . 0.587 ' H ' ' HG1' ' B' ' 31' ' ' THR . . . 174.62 176.96 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.029 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.93 133.98 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.187 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 140.86 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.768 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -115.09 150.87 35.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -93.1 170.26 9.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.0 p -137.95 -145.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.18 0.514 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.469 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.94 -38.32 2.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.37 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.17 46.07 2.43 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.065 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 32.3 t -154.05 -83.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.61 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 159.21 -87.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -144.65 148.19 33.98 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.835 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 38.5 t -150.79 121.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.394 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.476 ' H ' ' CB ' ' A' ' 182' ' ' SER . 99.6 m -57.75 161.59 3.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.86 132.37 12.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.83 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -68.74 116.11 37.54 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.74 0.38 7.12 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 120.935 1.09 . . . . 0.0 111.112 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 13.0 m -71.59 -6.06 38.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.962 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -105.77 128.04 53.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -48.38 -49.25 35.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -56.12 -30.43 62.1 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.736 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.04 -36.92 70.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.996 0.427 . . . . 0.0 110.092 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.1 -36.63 66.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.72 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.24 -35.53 78.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.338 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.54 -37.94 89.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.91 -45.76 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -59.64 -38.44 81.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.0 110.771 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -64.94 -24.88 67.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.785 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -71.63 -30.89 66.26 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.258 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.26 -81.78 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.272 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.54 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.748 0.309 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.07 111.15 2.88 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.79 2.327 . . . . 0.0 111.824 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.42 147.31 51.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.513 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 t -71.13 117.39 12.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.562 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.502 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 2.3 mm? -70.67 165.37 23.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.165 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -148.51 158.62 44.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.34 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -61.56 -139.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.471 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.5 m -158.26 -44.11 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.458 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.1 p -74.81 -14.93 60.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.585 ' HG ' ' H ' ' A' ' 12' ' ' SER . 47.9 t -50.88 126.14 15.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.658 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.6 p -59.28 -10.61 3.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.378 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.585 ' H ' ' HG ' ' A' ' 10' ' ' SER . 79.1 p -92.51 -25.36 18.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.559 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p -81.08 -45.58 16.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 m -167.8 173.06 8.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.38 146.57 50.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.943 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.29 173.22 10.52 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -114.0 21.28 15.0 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.432 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -87.71 86.49 7.19 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 18' ' ' GLU . 49.3 mt-10 -17.71 -61.06 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.55 52.12 0.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.8 149.15 27.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -168.1 120.9 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.242 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CE1' ' OG ' ' A' ' 127' ' ' SER . 7.0 t-80 -67.79 78.73 0.2 Allowed 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.758 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -54.28 138.19 39.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.041 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.56 162.68 27.31 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 pt -109.15 169.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.077 0.439 . . . . 0.0 110.959 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -154.12 105.62 2.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.295 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 t -99.08 128.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.751 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.6 mm -123.59 123.11 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.52 133.64 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.32 92.8 3.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.22 135.44 25.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.117 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 m -103.75 124.72 49.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.638 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' CG ' ' OG1' ' A' ' 38' ' ' THR . 18.9 ttpp -76.14 151.62 36.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.805 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.494 ' C ' ' H ' ' A' ' 37' ' ' GLN . 49.7 tt0 -74.24 148.28 41.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.168 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -74.12 36.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.85 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.494 ' H ' ' C ' ' A' ' 35' ' ' GLN . 14.7 tt0 -136.56 -46.98 0.61 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.377 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 34' ' ' LYS . 1.4 p -53.25 151.66 9.32 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.22 157.47 59.4 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.21 1.94 . . . . 0.0 111.875 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -65.06 141.67 58.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -158.82 97.41 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.468 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 13.5 t70 -91.56 -18.6 23.84 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -51.43 87.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 9.9 tp -96.19 150.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.376 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 17.1 t 58.81 67.05 0.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.87 -42.39 33.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.7 p -173.65 163.42 4.28 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.777 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.39 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -123.4 115.15 21.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -82.78 135.59 34.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.728 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.59 150.21 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -152.75 121.86 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.18 114.24 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.92 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t 69.87 -48.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.396 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' O ' ' OG ' ' A' ' 56' ' ' SER . 34.4 tt0 -48.55 -85.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 55' ' ' GLU . 54.0 p 51.9 -91.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.197 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -163.89 -61.95 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.628 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -55.58 -93.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.809 1.673 . . . . 0.0 111.861 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -163.3 151.95 11.99 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -36.33 152.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.37 2.047 . . . . 0.0 112.498 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -168.46 56.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.497 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.0 m -136.48 -106.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.818 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -89.18 10.5 21.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 110.333 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 65' ' ' GLU . 96.9 p -50.99 179.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.651 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 64' ' ' SER . 6.8 pt-20 38.79 98.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.058 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -175.83 -22.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.13 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' O ' ' OG ' ' A' ' 68' ' ' SER . 20.5 m-20 -81.3 -127.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.54 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 67' ' ' ASP . 58.4 m -169.09 -104.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.453 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -80.56 -2.02 44.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.988 0.423 . . . . 0.0 110.19 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -108.67 109.04 20.13 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.298 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.11 7.52 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.736 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 43.94 80.34 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.743 0.306 . . . . 0.0 111.29 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -51.55 -16.38 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.532 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.6 p -132.14 124.6 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.15 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 38.5 t0 -173.06 50.45 0.11 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.576 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 75' ' ' ASP . 19.0 Cg_endo -55.95 106.99 0.22 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.287 2.658 . . . . 0.0 112.194 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.67 -159.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.758 1.639 . . . . 0.0 112.358 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -140.37 138.24 34.67 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.345 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.505 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 10.8 p -101.35 138.22 38.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.643 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 10.4 m-85 -119.03 160.84 21.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.327 0.584 . . . . 0.0 110.976 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -142.43 118.93 10.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.444 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 t -97.66 65.55 1.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.364 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.451 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -71.43 109.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.705 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.2 148.1 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.978 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.48 23.08 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.94 26.94 43.04 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.001 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.28 72.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.435 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -132.75 158.71 41.7 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.889 0.376 . . . . 0.0 110.453 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.67 109.07 13.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.802 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 mtt -103.41 107.11 17.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -90.37 107.18 18.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 56.4 t80 -92.42 163.23 13.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.763 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.09 143.16 8.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.505 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 4.6 p90 -147.28 157.86 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.948 0.404 . . . . 0.0 110.328 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.2 t -142.16 127.46 18.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.96 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' SD ' ' A' ' 138' ' ' MET . 30.1 mtpt 56.89 33.11 22.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.473 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.5 141.3 40.5 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -32.71 135.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.777 2.318 . . . . 0.0 113.195 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.505 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -70.06 147.73 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.563 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -91.77 137.31 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.957 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -124.68 3.74 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.123 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 t -137.7 135.04 36.07 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.128 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.95 98.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.302 0.572 . . . . 0.0 109.681 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.3 p -113.35 158.75 20.2 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.932 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -151.06 169.37 21.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 p -166.51 163.07 17.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.61 134.23 42.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -151.89 113.85 4.45 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.3 -122.41 8.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.812 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.71 22.91 15.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.664 0.269 . . . . 0.0 110.633 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.63 ' HG1' ' N ' ' A' ' 112' ' ' VAL . 1.4 t -133.52 159.24 41.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 110.518 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.63 ' N ' ' HG1' ' A' ' 111' ' ' THR . 1.5 m -137.62 136.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -104.25 167.43 9.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.15 0.5 . . . . 0.0 111.299 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.017 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -116.55 122.9 46.01 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.503 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.89 117.13 28.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.9 p -161.41 152.09 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.127 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.5 t -71.03 170.25 13.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.13 147.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 111.256 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 m -69.79 150.84 96.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.149 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.406 ' CD ' ' SD ' ' A' ' 202' ' ' MET . 35.5 Cg_endo -62.57 142.61 90.59 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.743 1.629 . . . . 0.0 111.252 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.67 53.64 2.38 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -143.67 -33.65 0.42 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.968 -0.137 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.18 20.38 0.51 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.142 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.607 ' HZ2' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -144.78 177.69 8.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.91 0.355 . . . . 0.0 110.72 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.503 ' C ' ' HZ2' ' A' ' 125' ' ' LYS . 14.3 m-20 -90.36 135.79 33.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.217 0.532 . . . . 0.0 112.189 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.607 ' CB ' ' HZ2' ' A' ' 125' ' ' LYS . 1.1 m -133.58 67.24 75.27 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.548 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -42.09 129.88 4.44 Favored 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.066 2.511 . . . . 0.0 113.404 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.82 26.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.559 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 mm -141.5 153.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.518 ' HG1' ' N ' ' A' ' 132' ' ' HIS . 0.9 OUTLIER -84.44 166.99 16.85 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 111.003 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.518 ' N ' ' HG1' ' A' ' 131' ' ' THR . 27.0 m170 -60.23 -35.68 76.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.201 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.55 -52.39 46.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.475 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -65.59 -41.94 92.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.968 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.06 -56.85 16.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.539 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.3 tp -49.72 -32.78 14.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.087 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.2 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.975 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 96' ' ' LYS . 23.7 mmt -64.8 -49.47 70.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -46.92 -22.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 111.071 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -87.52 -47.94 8.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.89 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -34.27 55.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -40.27 110.27 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.007 0.432 . . . . 0.0 111.493 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 42.9 tp10 -141.16 114.14 8.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.997 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 m -108.01 130.8 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.538 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -108.6 164.18 12.58 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.904 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.4 tp -154.76 149.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.945 0.402 . . . . 0.0 110.533 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -148.9 95.02 2.34 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.015 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.7 mm -80.5 136.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.64 175.71 9.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.8 t -91.96 130.16 37.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.9 p -120.26 148.36 43.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -131.3 34.66 3.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.499 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.72 101.4 10.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -71.96 -3.98 25.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.685 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -48.71 149.44 1.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.839 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.27 176.46 1.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.924 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.2 m -98.51 142.06 30.58 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.467 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 26.8 t70 -119.03 92.61 3.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.665 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -121.48 161.59 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -108.31 139.26 43.28 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.133 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.6 p -73.53 4.51 4.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -80.5 127.27 76.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.316 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -39.06 162.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.921 1.747 . . . . 0.0 112.297 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.37 133.51 29.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.961 0.41 . . . . 0.0 110.521 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.86 123.69 33.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.99 173.16 16.39 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.593 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 169' ' ' ILE . 16.1 t -99.95 3.87 44.61 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 50.2 t30 67.07 -10.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.4 mt -73.43 143.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.166 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 172' ' ' LYS . 95.5 p -102.44 141.54 35.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -77.22 33.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.079 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 170' ' ' SER . 76.9 tttt -62.05 172.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -88.13 132.76 34.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.713 0.292 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.58 -162.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.319 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 m -47.59 149.89 1.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.678 0.275 . . . . 0.0 110.569 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 53.5 p90 -107.48 135.4 49.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.952 0.406 . . . . 0.0 111.379 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.494 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 4.0 tm-20 -146.03 141.67 27.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.014 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.494 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 6.3 p-10 -76.68 96.86 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.618 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.4 tt -112.72 -29.84 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.192 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 13.6 mt -76.01 111.36 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.85 -117.68 0.47 Allowed Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.703 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.489 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 12.4 t -77.7 141.89 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.1 m -139.22 85.83 2.09 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 9.9 tp -104.17 120.03 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 110.131 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.0 m -136.69 131.66 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.883 0.373 . . . . 0.0 111.379 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.34 108.3 18.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.955 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.7 p -48.55 -27.88 3.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.346 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.05 -26.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.002 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 68.3 m -142.49 27.99 1.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.796 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -165.18 99.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.498 0.666 . . . . 0.0 109.855 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -72.29 -55.91 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.41 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -133.19 142.65 48.71 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.282 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.12 138.08 31.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 111.029 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 4.1 mp0 -105.19 156.81 17.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 133.57 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 0.0 110.869 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.05 18.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.3 t -136.6 112.77 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.439 HH12 ' H ' ' A' ' 211' ' ' VAL . 12.9 ttt85 -108.43 163.27 13.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -160.96 109.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -162.52 -150.85 6.14 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.754 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 1.1 m-20 -89.37 140.63 29.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.535 ' SD ' ' SG ' ' A' ' 203' ' ' CYS . 0.0 OUTLIER -97.64 1.52 48.79 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.3 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.535 ' SG ' ' SD ' ' A' ' 202' ' ' MET . 24.1 m -115.37 -58.11 2.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -134.39 108.91 8.43 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.145 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.504 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 9.4 mp0 -58.39 121.9 11.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 209' ' ' LEU . 25.3 m -116.43 110.26 18.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.572 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 63.1 p -33.55 -46.86 0.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.617 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.88 -40.93 94.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.57 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 209' ' ' LEU . 2.3 mm? -88.05 0.59 55.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -86.64 137.44 32.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.21 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.439 ' H ' HH12 ' A' ' 198' ' ' ARG . 0.2 OUTLIER -170.09 152.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -161.68 153.75 19.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.313 0.578 . . . . 0.0 111.89 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 16.9 t70 -134.37 172.75 12.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.489 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 164.11 144.53 4.07 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.207 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -131.17 -178.26 4.76 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -149.67 105.82 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.201 0.524 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' B' ' 13' ' ' PHE . 5.3 t80 -96.44 128.38 43.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.573 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 220' ' ' GLY . 18.4 m -139.27 107.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.95 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 8.7 t70 64.58 -12.68 0.11 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.39 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 144.06 -0.36 1.14 Allowed Glycine 0 N--CA 1.461 0.366 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.687 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.4 m -105.2 121.39 43.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.37 160.24 14.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.7 t -173.83 120.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.438 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -74.42 135.93 42.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.24 103.66 0.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.413 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.91 95.75 2.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 51.4 m -123.42 150.81 43.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -55.33 95.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -88.75 36.18 0.8 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.6 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -75.36 -41.7 55.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.792 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 92.1 p -96.05 1.47 52.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.5 tp -42.26 -34.44 0.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.912 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.0 mt -148.37 145.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.013 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -75.18 94.6 2.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.988 0.423 . . . . 0.0 109.936 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -13.76 2.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.826 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.46 -7.81 58.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -103.9 9.12 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.563 0.221 . . . . 0.0 110.964 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 238' ' ' LEU . 7.3 mp -84.86 142.14 29.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -129.11 132.8 47.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.007 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.67 141.23 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 48.5 t -108.08 -4.47 17.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.628 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.443 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 10.4 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.129 -1.415 . . . . 0.0 111.503 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.764 0.316 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.63 109.94 3.0 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.553 2.168 . . . . 0.0 111.641 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' MET . . . . . 0.404 ' O ' ' O ' ' B' ' 4' ' ' GLY . 15.5 ptt? -48.24 174.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.855 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' B' ' 3' ' ' MET . . . -60.17 -143.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' B' ' 6' ' ' ASP . 36.0 p -169.14 25.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.122 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.49 ' H ' ' CD ' ' B' ' 7' ' ' PRO . 1.9 m-20 161.38 50.24 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.49 ' CD ' ' H ' ' B' ' 6' ' ' ASP . 12.3 Cg_endo -53.11 166.25 1.05 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 122.536 2.157 . . . . 0.0 112.035 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.43 -123.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.603 2.202 . . . . 0.0 110.833 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.451 ' O ' ' N ' ' B' ' 11' ' ' CYS . 2.1 t 175.53 47.33 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.321 0.509 . . . . 0.0 110.774 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.44 95.35 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.272 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 71.1 m -140.64 143.45 35.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.757 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -69.08 148.0 50.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.667 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 3.3 m-85 -122.71 -19.01 6.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.499 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 149.5 35.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.142 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -114.23 149.08 36.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -71.78 133.05 45.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.385 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.509 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -78.17 -42.79 30.54 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.877 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 12.4 mmm-85 -81.79 127.91 33.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.081 0.467 . . . . 0.0 111.493 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -68.18 152.97 44.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.624 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 19.6 mt -108.5 94.62 14.16 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.13 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -40.65 152.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.758 1.639 . . . . 0.0 112.343 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' B' ' 22' ' ' ARG . 8.1 tpt85 -45.49 -51.26 11.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.935 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -40.51 -39.22 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -105.77 46.05 0.94 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -155.67 92.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.33 -19.25 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.2 t70 -157.99 -179.55 8.23 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.492 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.499 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.4 p90 -165.48 163.37 19.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 111.287 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -148.06 179.83 7.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.437 ' N ' ' CD2' ' B' ' 29' ' ' TYR . 49.9 mt-10 -123.7 149.06 45.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.041 0.448 . . . . 0.0 111.168 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.472 ' HG1' ' H ' ' B' ' 39' ' ' ALA . 41.3 p -55.58 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.997 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -148.29 -156.15 0.69 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.675 0.274 . . . . 0.0 110.536 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 47.4 t -129.82 -25.69 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.508 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 28.7 mt -58.24 -11.28 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.031 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' B' ' 37' ' ' GLN . 26.9 m -106.72 121.03 43.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.959 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -73.54 34.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.0 pt20 -168.67 63.08 0.54 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.63 -161.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.629 2.22 . . . . 0.0 113.16 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . 0.472 ' H ' ' HG1' ' B' ' 31' ' ' THR . . . 173.35 176.94 0.11 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 82.9 t -108.95 133.6 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.539 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 m -106.29 139.32 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.67 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -115.32 148.18 39.55 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.03 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 44' ' ' THR . 5.3 tt0 -100.18 168.05 10.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 1.7 p -143.84 -142.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.227 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.529 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -119.55 -39.93 2.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.063 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.73 46.65 2.36 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 81.1 p -147.42 -84.58 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.581 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 154.01 -84.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.441 ' NE2' ' C ' ' B' ' 48' ' ' ALA . 21.8 mp0 -139.66 145.22 38.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.718 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.8 117.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.489 ' H ' ' CB ' ' A' ' 182' ' ' SER . 0.1 OUTLIER -73.48 148.82 42.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.377 0.608 . . . . 0.0 112.025 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.75 134.25 28.24 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.53 126.25 89.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.79 -0.73 9.8 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.332 1.354 . . . . 0.0 111.258 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 51.9 m -69.76 -17.39 63.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.99 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.0 125.74 35.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.093 0.473 . . . . 0.0 110.176 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -48.6 -49.04 38.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -56.26 -26.43 51.59 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.677 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -72.91 -35.67 49.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.002 0.429 . . . . 0.0 110.112 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -70.42 -35.51 73.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.693 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -72.14 -35.25 69.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -64.73 -35.37 80.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.12 -45.63 61.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.81 -30.5 71.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.26 -39.35 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.718 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.91 -23.31 59.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.304 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -34.14 65.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -75.04 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.402 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.628 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtm . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.748 0.309 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.09 164.22 31.71 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.52 2.147 . . . . 0.0 111.674 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.72 -17.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.552 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 t 52.44 43.92 30.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.576 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.5 mt 55.75 80.26 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.657 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -79.72 64.91 4.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.526 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 53.69 -142.27 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.612 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t -161.42 -13.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.41 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.5 -21.98 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.602 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.484 ' HG ' ' HG ' ' A' ' 12' ' ' SER . 38.0 p -49.95 127.89 17.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.531 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 6.3 t -54.28 -23.96 17.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.484 ' HG ' ' HG ' ' A' ' 10' ' ' SER . 98.8 p -76.17 -31.54 58.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.448 ' H ' ' HG ' ' A' ' 10' ' ' SER . 59.3 m -74.44 -47.46 33.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.977 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.3 p -167.21 165.79 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.764 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.1 146.72 54.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.432 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 174.69 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 110.834 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -116.99 17.28 14.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.53 97.07 6.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.261 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 6.8 mp0 -32.99 -60.22 0.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.07 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -80.1 52.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.324 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 13.1 tttp -164.24 139.33 5.86 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.107 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 50.4 m80 -155.7 122.61 5.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.644 ' N ' ' HD1' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -57.76 115.53 2.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.752 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -88.94 124.42 34.22 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.056 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' CA ' ' HG ' ' A' ' 118' ' ' SER . . . -128.22 141.02 12.21 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.78 150.83 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.797 0.332 . . . . 0.0 110.253 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 21.2 t0 -139.46 142.82 37.37 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.484 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 27.6 t -137.62 107.52 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.844 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.567 ' CG1' ' HE ' ' A' ' 115' ' ' ARG . 4.1 mp -102.07 128.06 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tt -135.85 130.46 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.429 0.633 . . . . 0.0 111.75 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -116.34 125.11 51.65 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.44 131.53 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.088 0.47 . . . . 0.0 111.406 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.2 m -105.81 132.55 51.79 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -86.58 163.45 17.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.318 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.476 ' C ' ' H ' ' A' ' 37' ' ' GLN . 6.7 tt0 -75.81 137.48 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.675 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -50.52 -10.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.476 ' H ' ' C ' ' A' ' 35' ' ' GLN . 1.2 mp0 -87.83 -41.73 13.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.963 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -46.36 148.29 1.67 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.796 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.57 167.26 25.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.06 1.84 . . . . 0.0 111.519 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.0 p -69.79 135.55 49.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.304 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -158.32 98.21 1.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.404 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 7.0 m-20 -97.55 -13.61 21.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.164 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.1 mmtm -54.93 85.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.963 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.1 tp -89.46 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.281 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 21.2 t 57.93 64.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.234 0.54 . . . . 0.0 110.402 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.4 ' NE2' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -72.86 -33.5 66.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.546 ' HG ' ' H ' ' A' ' 48' ' ' VAL . 12.4 t -173.09 -172.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.579 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.546 ' H ' ' HG ' ' A' ' 47' ' ' SER . 3.5 p -167.7 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.38 0.61 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 m -82.54 155.24 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.723 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -152.22 124.34 8.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 110.682 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.8 168.97 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.26 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' GLU . 10.1 t -153.36 154.29 34.22 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.458 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 2.6 pm0 -38.74 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.667 0.27 . . . . 0.0 110.675 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 56' ' ' SER . 29.7 t -76.02 -14.07 60.22 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.58 39.0 0.12 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.031 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 54' ' ' SER . 27.7 t -64.02 -91.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.223 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.602 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 10.5 m-20 -118.09 -33.13 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 95.5 Cg_endo -85.82 -96.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.74 1.627 . . . . 0.0 112.038 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -150.7 150.75 29.03 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.395 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.43 179.23 4.76 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.947 1.764 . . . . 0.0 111.638 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -175.72 31.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.551 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 m -73.34 18.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 61' ' ' GLU . 45.8 tt0 -155.51 -55.52 0.09 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.778 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 63' ' ' GLU . 58.7 m -168.58 -103.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.682 0.277 . . . . 0.0 110.661 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.74 137.08 24.92 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.874 0.368 . . . . 0.0 110.474 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -168.5 166.84 11.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.582 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.79 159.83 33.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.31 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 t -164.21 73.59 0.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.894 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 70' ' ' SER . 20.5 m -50.38 -44.5 54.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.373 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 69' ' ' THR . 10.9 p 61.98 105.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.855 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -163.51 -34.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.395 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -74.55 -51.2 15.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.208 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.23 81.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.218 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 t -73.51 -64.24 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.631 ' H ' ' CD ' ' A' ' 76' ' ' PRO . 2.5 p30 -175.6 31.81 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.949 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.631 ' CD ' ' H ' ' A' ' 75' ' ' ASP . 71.9 Cg_endo -69.24 -14.45 37.75 Favored 'Trans proline' 0 CA--C 1.558 1.677 0 N-CA-C 117.632 2.128 . . . . 0.0 117.632 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -93.51 116.74 0.3 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 CA-C-N 123.086 2.138 . . . . 0.0 114.13 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.1 p -118.66 117.44 28.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.056 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -86.54 129.84 34.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' B' ' 47' ' ' SER . 49.2 t80 -113.52 143.3 44.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.695 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -138.01 118.61 13.95 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.743 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 t -101.02 67.0 1.17 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.909 0.385 . . . . 0.0 110.61 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.23 111.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.727 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -98.84 145.89 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.45 161.44 11.77 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.68 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.88 26.85 48.96 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.323 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.51 3.03 61.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.923 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -115.94 149.4 38.81 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.04 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.584 ' CZ ' HD22 ' A' ' 91' ' ' ASN . 44.7 ttt-85 -111.91 115.05 28.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.9 mpt? -101.07 145.48 28.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.175 0.512 . . . . 0.0 110.847 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.584 HD22 ' CZ ' ' A' ' 89' ' ' ARG . 72.0 m-80 -138.4 129.76 27.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.051 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -112.05 -167.04 1.13 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.788 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.11 67.5 0.07 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.028 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.24 132.53 39.95 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -135.89 115.58 12.92 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? 70.22 30.91 3.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.865 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.92 149.16 50.33 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.6 148.04 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.898 1.732 . . . . 0.0 111.97 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.16 138.69 54.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.384 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.1 pp -92.74 159.43 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -156.8 -22.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.303 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.1 p -101.1 121.73 42.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 130.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.9 p -152.52 160.62 43.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -148.19 170.54 17.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -165.29 161.89 19.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.61 124.91 30.93 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.63 107.72 6.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.138 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.78 -127.73 19.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -97.98 19.52 13.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.581 0.229 . . . . 0.0 110.867 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.3 p -127.21 155.5 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.887 0.375 . . . . 0.0 110.754 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.27 133.19 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.437 ' CG ' ' N ' ' A' ' 114' ' ' ALA . 10.1 t30 -99.05 165.18 11.86 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.752 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 113' ' ' ASN . . . -164.41 118.72 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.498 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.567 ' HE ' ' CG1' ' A' ' 29' ' ' ILE . 12.2 mmt85 -112.13 130.58 55.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.809 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tt -137.97 116.23 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.7 p -160.31 170.46 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 111.603 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.468 ' HG ' ' CA ' ' A' ' 25' ' ' GLY . 80.4 p -84.61 163.73 19.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.906 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.3 149.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.795 0.331 . . . . 0.0 110.808 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 121' ' ' PRO . 37.3 p -98.14 149.78 36.07 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 120' ' ' SER . 72.7 Cg_exo -40.08 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.54 2.16 . . . . 0.0 113.046 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.65 3.06 61.98 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.492 ' CG ' ' H ' ' A' ' 124' ' ' GLY . 2.3 pt20 -81.84 -115.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 0.0 110.421 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.492 ' H ' ' CG ' ' A' ' 123' ' ' GLN . . . -161.16 20.84 0.21 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.488 ' H ' ' CD ' ' A' ' 123' ' ' GLN . 7.2 tptm -144.83 -179.26 6.48 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.99 152.0 26.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.372 0.606 . . . . 0.0 112.04 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 11' ' ' SER . 14.2 p -146.9 70.0 12.12 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.386 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.74 134.02 2.41 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.228 2.619 . . . . 0.0 114.135 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.3 161.49 16.35 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.154 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -153.56 154.72 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.262 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 132' ' ' HIS . 62.2 m -82.54 162.31 22.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.427 0.632 . . . . 0.0 111.695 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.429 ' N ' ' CG2' ' A' ' 131' ' ' THR . 38.3 t60 -50.88 -40.67 57.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.168 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.07 -57.42 11.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.143 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.7 OUTLIER -56.48 -44.38 80.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.038 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.51 -56.58 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 109.896 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.1 mt -53.81 -35.08 61.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.781 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.11 -28.6 61.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.423 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 mmt -74.78 -61.82 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.036 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -53.61 -20.41 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.189 -178.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' N ' ' CD1' ' A' ' 139' ' ' ILE . 34.9 ttpt -77.64 -55.16 5.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.634 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.1 -31.76 56.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.6 t -43.89 118.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.996 0.426 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 144' ' ' VAL . 1.6 tm-20 -141.23 126.44 18.51 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.46 ' N ' ' OE2' ' A' ' 143' ' ' GLU . 7.2 p -122.07 128.5 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.83 0.348 . . . . 0.0 110.59 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.2 p -101.39 167.67 10.02 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.55 146.74 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -166.99 94.95 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 1.9 pt -92.68 127.31 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.29 0.567 . . . . 0.0 112.273 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -103.0 -179.33 3.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.946 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 8.0 m -93.35 129.29 39.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.451 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 p -103.45 -179.07 3.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.788 0.328 . . . . 0.0 110.29 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -155.49 -2.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 153' ' ' GLU . 6.1 mp0 -62.1 100.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.793 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.04 11.91 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -56.51 149.75 16.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.576 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.2 m-20 -55.74 172.8 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.3 t -98.8 145.65 26.74 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.637 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p-10 -119.99 93.43 4.06 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.693 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.583 ' H ' ' CD1' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -119.03 176.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -130.08 135.28 48.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.7 m -70.16 2.81 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -80.74 117.98 70.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -40.35 155.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.698 1.598 . . . . 0.0 112.05 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -81.64 138.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.935 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 2.3 mm? -83.84 114.69 21.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.05 171.56 46.61 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.492 -0.385 . . . . 0.0 112.197 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 169' ' ' ILE . 9.3 t -101.95 7.32 41.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.8 t30 64.15 -8.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.508 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.1 pp -80.35 161.27 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.218 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.483 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 13.0 t -123.57 137.46 54.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.468 ' ND1' ' N ' ' A' ' 171' ' ' HIS . 1.0 OUTLIER -74.19 38.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.106 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 170' ' ' SER . 58.8 mttp -67.62 -170.79 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.217 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -102.76 127.5 49.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.998 0.428 . . . . 0.0 110.509 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.462 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 12.1 m -151.64 -168.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.896 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -43.97 144.08 0.98 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.344 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -111.78 141.97 44.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -162.29 151.6 15.69 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.534 177.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.98 104.5 2.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.161 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.3 mt -107.09 -42.76 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.0 tt -72.59 138.08 22.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.087 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -101.13 -118.52 4.34 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.9 t -72.84 143.91 47.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.1 m -137.78 84.17 2.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.93 103.95 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.1 m -124.16 143.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.551 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.37 110.3 21.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.499 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 189' ' ' CYS . 7.0 m -50.75 -28.47 9.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.484 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -36.4 -28.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.077 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 187' ' ' THR . 30.2 p -149.34 24.23 0.91 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 24.9 t -143.25 81.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -69.19 -57.47 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.266 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 14.0 t-20 -111.7 162.08 15.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.403 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.452 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 6.9 tt -169.22 106.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 110.419 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.89 130.87 46.96 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -125.24 133.44 52.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.809 0.338 . . . . 0.0 110.514 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.8 p -143.92 139.0 28.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.951 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.7 t -135.03 160.34 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.483 ' NH1' ' O ' ' A' ' 170' ' ' SER . 57.0 ttt180 -170.67 111.54 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.124 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.3 tt -110.45 128.52 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.669 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.96 -155.24 8.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.878 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -91.39 119.98 31.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.464 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -82.01 2.37 31.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 92.2 m -100.77 -55.85 2.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 109.861 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.498 ' CB ' ' NZ ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -150.58 122.25 8.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.677 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -42.94 141.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.147 0.499 . . . . 0.0 111.754 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 208' ' ' GLU . 12.7 t -140.83 89.3 2.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.272 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.1 m -37.11 -27.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.25 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 206' ' ' SER . 85.0 mt-10 -73.06 -52.33 14.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.01 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 39.3 mt -91.5 7.81 39.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.305 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -97.21 119.03 34.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.2 m -145.29 168.21 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.462 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -154.22 167.71 28.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 112.557 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -151.12 163.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.295 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 171.29 160.21 19.28 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.156 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -148.02 172.64 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -139.6 104.74 5.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -103.31 122.96 45.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.703 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 5.7 m -143.59 120.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.252 0.548 . . . . 0.0 110.918 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.5 37.99 10.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.101 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.12 -4.86 83.14 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.726 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -100.08 116.18 31.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.23 0.515 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.28 154.6 19.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.356 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 42.2 t -169.7 127.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.329 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -77.53 140.55 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -169.25 111.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.452 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.24 100.91 8.56 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 69.7 p -131.63 166.26 21.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.631 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.14 96.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.781 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.92 18.2 4.34 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.589 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -62.7 -38.18 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 84.0 p -98.01 -2.28 40.72 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.297 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -41.68 -36.34 0.95 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.992 0.425 . . . . 0.0 110.541 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 8.6 mt -148.26 142.81 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 236' ' ' THR . 0.9 OUTLIER -75.99 101.5 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.213 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.431 ' CB ' HH12 ' A' ' 115' ' ' ARG . 84.9 p -65.58 4.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.481 ' H ' ' C ' ' A' ' 234' ' ' ASP . 46.9 p -91.19 -18.38 24.54 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.456 ' CB ' ' NZ ' ' A' ' 237' ' ' LYS . 9.1 mtmp? -104.64 8.44 35.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.94 161.8 26.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -145.21 134.6 23.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.69 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.39 134.04 55.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.151 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 41.0 t -100.92 -7.03 23.81 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.275 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.414 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 117.641 -1.171 . . . . 0.0 111.751 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.755 0.312 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.34 112.79 0.89 Allowed 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 122.697 2.265 . . . . 0.0 112.138 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 158.49 5.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.49 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.7 171.24 30.66 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.874 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 58.3 m -73.63 -84.3 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 110.632 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -131.88 78.44 69.93 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.613 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.411 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 38.1 Cg_exo -57.19 -175.06 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.517 2.145 . . . . 0.0 112.31 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 58.1 Cg_exo -54.19 -132.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 123.23 2.62 . . . . 0.0 113.925 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t 175.81 50.83 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.391 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.83 97.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.534 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 98.0 m -142.53 142.24 32.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.22 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 14' ' ' SER . 2.7 t -73.43 147.07 44.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 110.685 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.534 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -114.68 -20.86 10.49 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 12' ' ' CYS . 7.9 m -146.23 148.82 32.89 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.049 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.493 ' CD2' ' OD2' ' B' ' 53' ' ' ASP . 9.5 m-85 -107.92 164.5 12.21 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -86.94 138.15 31.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.784 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.39 23.51 3.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.925 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.25 125.46 18.71 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.721 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -80.53 119.19 22.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.755 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 2.6 mm? -80.57 113.56 40.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.343 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -46.66 149.34 3.04 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.38 1.387 . . . . 0.0 111.786 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -43.87 -47.3 8.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.315 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -38.3 -32.25 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.0 44.33 1.23 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.775 0.322 . . . . 0.0 110.735 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -149.8 86.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.796 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -89.11 -28.23 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -153.26 -179.41 7.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.998 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -164.11 164.1 22.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.527 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.509 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 57.1 t80 -148.12 -179.98 7.32 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.509 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 44.3 mt-10 -123.0 149.62 44.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 110.789 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.409 ' O ' ' O ' ' B' ' 30' ' ' GLU . 40.8 p -55.67 -111.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.815 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.9 t -152.01 -153.84 0.5 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.781 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.447 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.4 m -132.98 -25.51 1.81 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.399 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -59.36 -7.08 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.451 ' C ' ' H ' ' B' ' 37' ' ' GLN . 25.2 m -112.54 120.92 43.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 m -74.08 36.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.305 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.4 pt20 -169.91 61.68 0.41 Allowed Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.14 -162.06 0.12 Allowed 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.793 2.329 . . . . 0.0 113.319 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.96 176.93 0.13 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.972 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -107.77 135.79 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.136 0.493 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.01 137.83 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.605 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.07 146.08 42.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.369 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -92.79 169.97 10.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.2 p -138.59 -143.34 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 110.742 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -128.69 -38.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.278 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.27 41.66 3.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.76 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 11.6 t -147.06 -84.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.568 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 156.08 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.321 0.388 . . . . 0.0 110.044 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -144.0 145.94 32.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.344 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 24.1 t -153.2 125.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' B' ' 14' ' ' SER . 13.8 p -77.55 148.84 35.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.169 0.509 . . . . 0.0 111.395 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.89 142.37 42.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.493 ' OD2' ' CD2' ' B' ' 15' ' ' TYR . 9.2 m-20 -64.15 122.78 79.64 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.07 0.46 8.37 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.062 1.175 . . . . 0.0 110.863 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 44.5 t -77.27 -5.25 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.702 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 57' ' ' SER . 1.1 tp10 -105.4 125.18 50.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.526 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 19.2 m -44.83 -43.86 9.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -56.4 -34.36 66.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.2 t -69.94 -38.87 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.334 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.04 -52.49 59.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.796 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.85 -35.64 75.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.06 -35.91 81.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.19 -45.55 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.832 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -63.13 -32.31 73.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -71.48 -41.82 68.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.29 -19.45 63.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.265 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -34.08 67.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.98 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.51 -77.62 0.15 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.813 0.339 . . . . 0.0 110.361 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 53.0 p30 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.537 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.815 0.34 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -43.27 -53.97 3.83 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.699 2.266 . . . . 0.0 112.152 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.93 127.03 22.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.8 m -164.16 83.57 0.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.565 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 pp -168.13 133.1 1.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.42 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -166.29 -33.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.532 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -168.0 143.5 3.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.487 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m -105.14 -21.37 13.27 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.819 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.6 m -65.37 -27.87 68.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.985 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.2 m -49.5 132.2 20.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -56.93 -25.36 57.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.581 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m -74.74 -29.45 61.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.609 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -74.35 -56.36 4.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.273 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -159.25 173.17 16.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 110.791 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.4 m -62.9 161.3 13.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.828 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 p -74.32 163.58 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.86 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 30.1 mp0 -112.15 7.47 19.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.529 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -67.32 -149.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.211 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -135.38 -68.87 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.461 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 41.8 t30 -79.02 52.07 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.424 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' O ' ' ND1' ' A' ' 22' ' ' HIS . 10.5 tptm -148.86 137.5 21.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.819 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 21' ' ' LYS . 22.9 m-70 -143.24 158.05 43.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 76.76 2.05 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.415 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 46.6 tpp -65.71 128.33 35.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 0.0 111.441 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -135.67 149.04 19.89 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.79 148.21 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -135.15 139.12 44.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.501 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.15 101.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.984 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.0 131.9 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.39 140.1 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.506 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.97 0.414 . . . . 0.0 110.056 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.48 135.06 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.746 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -102.15 120.1 39.89 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.636 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -74.58 152.87 39.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.853 0.358 . . . . 0.0 110.858 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 37' ' ' GLN . 33.7 mm-40 -70.63 158.82 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.284 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.33 28.62 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.737 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' A' ' 35' ' ' GLN . 22.8 tt0 -141.05 -19.44 0.8 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -67.72 115.68 29.98 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.168 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 61.5 Cg_exo -40.0 157.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.0 p -73.42 136.13 44.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 20.0 m-80 -156.58 101.77 2.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.169 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.65 7.56 46.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.668 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -67.47 88.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.401 ' O ' ' OG ' ' A' ' 157' ' ' SER . 20.1 pt -85.12 141.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.02 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 22.1 t 55.43 67.82 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 46' ' ' GLN . 10.2 tm0? -78.73 -25.99 44.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 t 177.48 159.34 0.42 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.589 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.25 125.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -119.76 123.34 43.5 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.643 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 19.1 mp0 -102.69 129.43 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mm -134.71 159.61 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.2 m -152.63 108.41 3.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.927 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 78' ' ' THR . 4.3 pt-20 -52.3 120.97 6.09 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 22.6 t 112.14 -1.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 56' ' ' SER . 72.6 tt0 -28.97 -52.8 0.11 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 112.741 -2.027 . . . . 0.0 112.067 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 55' ' ' GLU . 5.5 m 29.48 -123.65 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.511 0.507 . . . . 0.0 112.138 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.65 -54.47 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -85.75 -104.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.254 1.969 . . . . 0.0 111.64 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.05 132.42 95.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.16 125.45 6.48 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.842 1.695 . . . . 0.0 113.048 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.439 ' N ' ' OG ' ' A' ' 54' ' ' SER . 21.9 mt-10 70.74 52.96 0.29 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.12 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 64' ' ' SER . 2.1 t -148.78 15.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.838 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' SER . 6.3 tp10 -41.14 84.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.213 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 62' ' ' VAL . 48.2 m 48.64 108.16 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.84 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 64' ' ' SER . 19.7 tt0 90.54 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -75.88 54.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 59.75 171.66 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.304 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 t -148.2 133.14 18.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.517 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m 75.08 -47.79 0.62 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.723 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -44.0 155.55 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 111.107 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -108.93 39.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.224 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 53.19 84.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.124 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -137.25 19.32 2.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.374 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.05 145.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.977 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 1.1 m-20 -178.64 -62.42 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.43 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -27.82 94.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.358 2.706 . . . . 0.0 113.588 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.24 176.32 8.21 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.392 2.061 . . . . 0.0 111.185 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.574 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 16.1 p -130.3 139.59 50.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.858 0.361 . . . . 0.0 110.869 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 m -98.83 132.15 44.4 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -113.72 143.24 44.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 110.429 -178.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 86.3 m-85 -129.57 124.87 34.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.652 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 82' ' ' SER . 25.2 p -103.91 62.66 0.76 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.662 0.267 . . . . 0.0 110.859 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.1 tt -71.22 102.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -102.14 148.05 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.956 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.51 144.52 5.18 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.31 9.22 57.05 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.28 2.52 57.88 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.758 -0.258 . . . . 0.0 113.098 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 173.95 13.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.307 0.554 . . . . 0.0 111.367 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -129.09 117.18 20.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.738 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.5 mtt -101.99 122.0 43.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.297 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.476 ' ND2' ' HH ' ' A' ' 80' ' ' TYR . 7.2 m120 -109.93 122.57 47.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.493 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.8 178.03 4.68 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.617 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.01 74.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.037 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -76.9 143.26 39.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.045 0.423 . . . . 0.0 110.441 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -127.75 105.53 8.52 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.474 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.8 tttt 67.08 40.14 2.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.759 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.8 m -119.02 148.86 45.67 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.28 129.95 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.882 1.721 . . . . 0.0 111.937 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.64 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.9 mp0 -50.39 144.99 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.9 mt -96.39 142.56 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.78 -11.54 1.15 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.016 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -113.17 116.48 29.88 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 pt -128.58 120.02 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.0 p -135.82 172.22 13.32 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.928 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 64.0 tt0 -161.57 152.83 18.53 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 t -155.47 152.23 28.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.033 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.23 121.83 28.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -133.41 108.61 8.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.006 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.68 -119.06 6.35 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -112.58 26.35 10.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.806 0.336 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 p -130.34 157.36 42.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.511 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.64 136.68 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.601 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.1 OUTLIER -124.48 158.22 33.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.967 0.413 . . . . 0.0 110.728 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.49 135.82 13.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -114.0 123.66 50.26 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.02 118.83 34.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 t -167.05 161.22 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.902 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.634 ' HG ' ' H ' ' A' ' 119' ' ' VAL . 12.9 t -82.69 174.59 10.86 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.634 ' H ' ' HG ' ' A' ' 118' ' ' SER . 34.2 m -110.06 144.43 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.013 0.435 . . . . 0.0 110.982 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.452 ' HG ' ' ND2' ' A' ' 168' ' ' ASN . 16.4 p -79.73 151.02 73.58 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.047 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.77 163.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.921 1.747 . . . . 0.0 112.185 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.55 61.78 7.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.209 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -139.31 -52.27 0.54 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.07 -12.78 0.37 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.696 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -126.92 172.46 10.42 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -74.56 150.7 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.644 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.0 m -143.41 63.05 12.09 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.292 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.52 131.54 2.52 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.116 2.544 . . . . 0.0 113.339 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.8 152.46 23.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.38 176.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.699 0.285 . . . . 0.0 110.735 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.2 p -81.19 172.33 13.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.183 0.516 . . . . 0.0 111.692 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.461 ' CG ' ' OD1' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -61.26 -37.35 82.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -63.65 -57.07 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.44 -57.24 8.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.039 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -53.54 -31.57 47.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.219 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.48 73.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.68 -52.34 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.54 -22.84 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.453 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -87.28 -54.51 4.27 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -79.89 -36.02 37.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 t -44.26 116.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.721 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 49.9 mt-10 -145.02 156.61 44.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.12 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.9 136.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.965 0.412 . . . . 0.0 110.374 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.0 p -102.37 163.91 11.97 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.71 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.56 137.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.88 0.372 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -143.95 92.89 2.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.7 mm -79.23 139.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.648 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.452 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 58.3 ttt180 -134.17 165.36 25.27 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 7.1 t -90.67 118.09 29.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.318 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 152' ' ' GLU . 31.2 t -100.3 -176.05 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.706 0.289 . . . . 0.0 110.262 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.429 ' N ' ' OG ' ' A' ' 151' ' ' SER . 16.0 tp10 -162.45 17.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.043 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.12 103.38 7.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.485 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.16 8.7 3.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -56.01 138.38 49.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.112 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.09 174.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.975 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 44' ' ' ILE . 10.8 t -94.66 143.9 26.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.498 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.464 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 m-20 -117.6 91.44 3.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.955 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.5 pt -124.51 170.3 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.689 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.95 -160.88 0.78 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.034 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.7 t -130.53 -3.48 4.26 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -83.45 130.6 55.65 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -39.29 158.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.876 1.717 . . . . 0.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.6 p -80.25 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.257 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 18.0 mt -82.07 125.04 30.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.591 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.89 163.96 17.29 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.562 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 t -94.72 5.61 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.801 0.334 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.452 ' ND2' ' HG ' ' A' ' 120' ' ' SER . 1.2 m-20 60.31 9.5 1.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.988 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.2 pp -98.01 154.65 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 172' ' ' LYS . 80.1 p -117.49 129.17 55.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.21 35.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 170' ' ' SER . 19.3 tttp -59.21 -164.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.481 ' CB ' ' HZ1' ' A' ' 173' ' ' LYS . 7.8 ttpm? -99.31 119.9 38.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.7 t -148.02 171.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.3 p -31.48 149.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.495 0.497 . . . . 0.0 111.529 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -106.58 141.69 37.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.191 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 3.8 tm-20 -150.85 137.42 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.619 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.433 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.1 t70 -65.92 96.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.1 mt -107.26 -52.99 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.388 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.5 tp -63.45 124.95 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.048 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.61 -117.38 2.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.574 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 41.5 m -74.18 139.25 44.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.793 -0.203 . . . . 0.0 111.16 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.552 ' OG1' ' CE1' ' B' ' 13' ' ' PHE . 15.7 p -138.3 91.58 2.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.21 0.529 . . . . 0.0 110.77 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.1 mm -99.13 115.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.051 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.27 138.48 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.155 0.502 . . . . 0.0 111.497 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.84 92.81 7.61 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.519 ' HG1' ' N ' ' A' ' 188' ' ' LYS . 1.3 p -47.27 -44.15 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.061 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.519 ' N ' ' HG1' ' A' ' 187' ' ' THR . 3.0 ttmp? -37.55 -27.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.038 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 187' ' ' THR . 81.6 m -146.17 31.43 1.02 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.4 t -149.75 100.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.711 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -77.02 -60.64 2.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.843 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -117.91 177.94 4.59 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.567 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.1 tt -174.07 108.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -93.44 137.65 32.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.553 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -117.37 130.77 56.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.713 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.0 m -144.3 119.73 10.3 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 45.3 t -131.06 157.87 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.326 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.433 ' CZ ' ' O ' ' A' ' 170' ' ' SER . 45.5 ttt180 -158.31 156.13 30.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.56 112.71 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.21 167.89 40.91 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.078 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -49.28 141.14 8.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.7 mtm -95.66 3.81 53.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.2 t -118.57 -47.92 2.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.719 0.295 . . . . 0.0 110.867 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.79 108.84 4.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 110.164 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -48.28 156.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.6 p -156.54 112.27 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.982 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 t -33.16 -59.3 0.36 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.582 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -52.19 -53.34 44.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.0 61.87 4.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -163.8 105.59 0.94 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.717 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.15 174.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.969 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -171.38 147.3 2.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.567 . . . . 0.0 111.584 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.3 t70 -121.73 171.2 9.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.39 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . -179.83 158.57 22.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.888 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . 0.429 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 46.7 m-85 -150.31 165.45 32.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -134.03 104.92 6.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -101.93 117.58 35.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.79 104.04 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.061 0.458 . . . . 0.0 110.703 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.6 t0 55.23 52.17 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.255 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.63 -9.52 50.24 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.908 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.8 p -89.6 109.11 20.09 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.63 -0.335 . . . . 0.0 110.944 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -103.08 147.65 26.71 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 73.1 m -166.79 129.53 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -82.2 141.14 33.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -171.07 108.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.272 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.1 97.28 2.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.242 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.6 p -126.06 154.18 43.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.91 95.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.55 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.2 35.6 0.81 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.353 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.6 m -74.65 -41.62 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.714 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -93.61 5.04 52.93 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.149 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -38.52 -37.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.135 0.493 . . . . 0.0 110.767 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 7.7 tp -159.66 148.88 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.728 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.65 100.57 4.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.3 t -68.23 -0.82 5.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.2 p -82.58 -21.15 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -105.2 10.06 33.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.241 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.7 mt -92.84 129.27 38.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -113.67 143.85 43.91 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.068 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.75 171.32 0.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 40.1 t -126.21 -6.13 6.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.71 179.695 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.785 0.326 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.21 118.04 5.23 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.536 2.157 . . . . 0.0 111.718 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -59.47 152.04 22.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.618 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.15 173.39 3.02 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.956 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -67.27 -88.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.727 0.298 . . . . 0.0 110.616 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 6' ' ' ASP . 31.6 p-10 -151.1 59.17 3.2 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.359 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' B' ' 8' ' ' PRO . 73.2 Cg_endo -73.92 118.16 5.31 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.397 2.065 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' B' ' 7' ' ' PRO . 83.0 Cg_exo -42.72 172.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.852 1.701 . . . . 0.0 111.413 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.487 ' CG2' ' H ' ' B' ' 10' ' ' ALA . 6.5 m -134.34 173.21 11.87 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.425 0.631 . . . . 0.0 111.631 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.487 ' H ' ' CG2' ' B' ' 9' ' ' THR . . . -80.59 123.09 27.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.875 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 87.8 m -149.29 116.23 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . 0.402 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 0.1 OUTLIER -62.94 137.53 58.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.96 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.552 ' CE1' ' OG1' ' A' ' 183' ' ' THR . 25.4 p90 -114.94 -20.62 10.46 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.985 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -122.43 143.58 49.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.483 ' CD2' ' OD1' ' B' ' 53' ' ' ASP . 16.4 m-85 -121.73 152.48 39.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 111.808 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -80.29 141.27 35.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.503 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -89.15 -28.02 20.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -87.54 126.03 34.68 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.724 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -85.85 114.61 22.91 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' B' ' 20' ' ' LEU . 9.3 mp -75.33 115.08 41.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -41.93 151.04 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.134 1.889 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 25' ' ' VAL . 39.7 ttm180 -45.87 -50.0 14.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.386 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -28.99 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -109.6 50.26 0.8 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.941 0.4 . . . . 0.0 110.241 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 22' ' ' ARG . 66.1 t -150.22 88.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -95.42 -21.14 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.35 179.21 8.52 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.499 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -166.98 163.38 15.99 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.287 0.565 . . . . 0.0 112.037 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -152.16 167.25 29.14 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.165 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' B' ' 31' ' ' THR . 50.9 mt-10 -114.08 152.18 31.44 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.422 ' O ' ' O ' ' B' ' 30' ' ' GLU . 73.0 p -55.92 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.091 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -147.84 -149.29 0.29 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.676 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.473 ' C ' ' H ' ' B' ' 35' ' ' CYS . 91.1 p -135.51 -24.38 1.37 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.276 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.24 -3.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.46 . . . . 0.0 109.788 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.473 ' H ' ' C ' ' B' ' 33' ' ' SER . 58.0 m -114.99 117.31 30.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.503 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -73.65 37.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.964 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.466 ' H ' ' C ' ' B' ' 35' ' ' CYS . 10.2 pt20 -169.22 64.3 0.54 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.95 -162.86 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.422 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.32 176.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.971 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.14 144.06 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.224 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.44 130.47 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.505 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -112.14 144.21 41.9 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -111.51 115.19 28.79 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.066 0.46 . . . . 0.0 111.047 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.4 p -79.52 -140.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.48 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.85 -27.91 2.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.87 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.97 46.44 2.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.435 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 48.0 t -157.26 -84.95 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.944 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 154.76 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.715 0.635 . . . . 0.0 109.777 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -131.17 140.68 49.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.726 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.0 t -150.19 112.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 110.827 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.574 ' N ' ' OG ' ' A' ' 182' ' ' SER . 2.6 t -73.33 152.16 41.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.605 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.13 135.79 22.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.893 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.483 ' OD1' ' CD2' ' B' ' 15' ' ' TYR . 69.3 m-20 -61.74 125.9 85.81 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.99 2.64 5.24 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.433 1.422 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 30.2 m -73.39 -3.49 27.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.292 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.404 ' O ' ' OE1' ' B' ' 60' ' ' GLN . 39.0 mt-10 -109.53 125.13 52.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.93 0.395 . . . . 0.0 110.363 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -50.12 -36.19 28.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.113 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -56.14 -36.18 67.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.936 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 t -70.72 -36.88 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.001 0.429 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . 0.404 ' OE1' ' O ' ' B' ' 56' ' ' GLU . 2.2 mp0 -70.07 -36.79 75.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.99 -37.56 69.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.225 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.31 -41.03 94.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.628 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.47 -44.21 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.919 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -60.13 -28.9 68.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.746 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -75.33 -43.7 49.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.946 0.403 . . . . 0.0 110.728 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.74 -22.75 63.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.457 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.57 -36.53 68.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -75.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.581 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 mtt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.01 -4.82 16.04 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.019 1.812 . . . . 0.0 111.533 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.57 148.7 2.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.423 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 t -170.18 12.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.579 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.54 174.92 12.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.612 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -166.48 -72.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.509 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -70.65 122.09 19.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.546 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t -66.28 -17.12 64.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.579 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -72.37 -20.77 61.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.592 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.9 t -50.42 131.98 24.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.565 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.5 p -57.77 -29.59 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -76.83 -23.54 52.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.721 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -79.08 -48.05 15.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -165.35 171.27 13.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.093 0.473 . . . . 0.0 111.05 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.66 148.75 48.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.553 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.7 p -70.93 176.18 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.548 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.6 5.71 6.81 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 19' ' ' GLU . 43.1 mt-10 -83.03 92.9 7.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.411 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' GLU . 37.1 tt0 -23.54 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.171 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -76.22 50.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.358 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -158.49 135.71 9.99 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -145.53 166.43 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.82 0.343 . . . . 0.0 111.003 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -95.03 107.05 19.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.64 107.21 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.297 0.57 . . . . 0.0 110.581 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.86 148.32 18.71 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.98 151.86 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' CD1' ' A' ' 29' ' ' ILE . 59.0 t0 -147.25 130.83 16.81 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -138.67 99.8 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.846 0.355 . . . . 0.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.438 ' CD1' ' OD1' ' A' ' 27' ' ' ASP . 1.7 mp -95.23 139.54 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 pt -148.71 135.13 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.471 0.653 . . . . 0.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -115.98 123.19 47.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.589 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.63 110.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.784 0.326 . . . . 0.0 111.162 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -87.58 122.24 31.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.758 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' NZ ' ' C ' ' A' ' 110' ' ' ASN . 25.1 mtmm -80.55 154.31 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.758 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.642 ' NE2' ' H ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.06 154.06 39.38 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' H ' ' CD ' ' A' ' 35' ' ' GLN . 15.2 t70 -62.1 -19.47 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.4 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.642 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 70.6 mt-30 -82.75 -36.71 25.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.193 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.8 p -48.04 147.21 3.71 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.742 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.09 168.47 24.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.113 1.876 . . . . 0.0 111.575 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -75.36 128.46 35.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.63 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.475 ' ND2' ' OE1' ' A' ' 154' ' ' GLU . 29.7 m120 -158.24 101.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.73 -0.27 21.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.643 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -72.69 71.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.06 170.36 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 110.383 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 32.6 t 50.35 57.86 6.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.48 0.657 . . . . 0.0 110.443 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.98 -21.2 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 t 173.14 154.12 0.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.905 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.16 135.06 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.524 ' HG1' ' H ' ' A' ' 82' ' ' SER . 17.5 p -114.29 153.93 28.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -136.22 109.73 7.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.531 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 mt -122.01 154.02 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 t -153.59 151.32 29.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 37.8 tt0 -52.96 171.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 p -83.28 -19.37 36.42 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -48.89 -67.03 0.3 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.435 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 t -33.59 115.3 0.22 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.572 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.627 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -92.17 -24.99 0.27 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 57' ' ' ASP . 93.0 Cg_exo -45.79 -5.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.221 1.948 . . . . 0.0 114.008 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -177.53 -50.68 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.809 178.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 38.2 Cg_exo -59.11 -143.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 121.939 1.759 . . . . 0.0 111.88 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 62' ' ' VAL . 9.4 tm-20 91.47 160.23 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.473 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 1.9 m -143.5 -104.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.491 0.186 . . . . 0.0 110.692 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 64' ' ' SER . 17.0 tp10 -160.45 156.7 26.41 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 0.9 OUTLIER 82.99 130.78 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.733 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -159.02 -175.73 5.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.829 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -161.82 153.56 18.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.359 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 68' ' ' SER . 1.8 p-10 -87.68 -94.84 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.516 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.483 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.6 p 52.62 56.96 6.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.661 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 78.4 p 50.43 80.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.616 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 p -46.49 140.84 4.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 p -160.97 37.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.802 0.811 . . . . 0.0 109.55 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.44 41.64 1.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.429 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -132.11 15.09 4.68 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.521 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.48 -62.69 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.671 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.92 97.46 49.52 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.644 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -38.9 157.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.315 2.01 . . . . 0.0 112.071 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.97 -170.01 0.26 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.875 2.383 . . . . 0.0 113.105 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 94' ' ' PHE . 1.4 t -140.67 149.56 42.4 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.032 0.444 . . . . 0.0 111.498 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.2 m -101.37 129.85 47.45 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 63.8 t80 -118.39 101.8 8.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -108.96 117.56 34.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.915 0.388 . . . . 0.0 110.277 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.524 ' H ' ' HG1' ' A' ' 49' ' ' THR . 13.8 t -95.95 85.32 4.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.327 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.59 118.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.069 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 tt -106.62 146.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.796 0.331 . . . . 0.0 110.109 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 157.57 7.77 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.31 7.95 82.02 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.99 60.29 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.829 -0.224 . . . . 0.0 112.582 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.56 174.47 15.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 111.045 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -115.81 123.88 49.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.719 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.2 mpp? -102.71 97.94 8.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.415 ' ND2' ' OH ' ' A' ' 80' ' ' TYR . 84.3 m-20 -86.88 133.89 33.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.456 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 78.6 m-85 -116.27 -164.91 1.0 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.76 71.94 0.03 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.07 140.54 40.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.166 0.508 . . . . 0.0 110.641 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -131.97 108.27 9.25 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? 69.04 36.5 2.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 31.9 m -122.38 149.65 55.53 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -34.91 153.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.408 2.072 . . . . 0.0 112.573 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -76.21 106.43 7.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -62.48 146.05 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.21 -12.05 0.42 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.861 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -106.09 113.79 27.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.2 mt -124.03 108.2 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -139.48 153.92 47.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.77 0.319 . . . . 0.0 111.815 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 17.0 mp0 -145.11 169.69 17.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.6 p -157.83 153.95 27.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.87 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.27 118.2 20.97 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.853 0.358 . . . . 0.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.4 107.63 8.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.99 -138.7 25.96 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.442 ' C ' ' NZ ' ' A' ' 34' ' ' LYS . 24.5 p30 -91.99 26.29 2.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 110.494 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.0 m -129.63 156.47 44.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.772 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.07 138.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.316 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.47 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -119.57 168.08 11.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.115 0.483 . . . . 0.0 111.194 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.25 127.33 9.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.105 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.477 ' NH1' ' OG ' ' A' ' 235' ' ' SER . 76.9 ttt180 -113.52 110.79 20.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.656 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -115.19 124.9 52.62 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 p -168.07 161.75 12.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.938 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -77.93 171.0 15.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.623 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.83 145.56 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.043 0.449 . . . . 0.0 111.338 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.15 163.38 53.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.43 150.23 84.37 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 122.209 1.939 . . . . 0.0 111.664 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.37 9.67 85.59 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.329 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -82.96 -60.51 2.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.35 -16.73 0.29 Allowed Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -110.42 179.0 4.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.48 158.74 35.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.108 0.48 . . . . 0.0 111.242 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.4 p -155.04 61.03 2.86 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -40.36 135.55 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.936 2.424 . . . . 0.0 113.286 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -114.99 145.87 41.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.272 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.8 tp -140.71 168.35 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -73.14 178.58 4.32 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 111.475 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -71.23 -34.3 70.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.54 -57.61 11.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.64 -31.89 73.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.993 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.89 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.505 ' O ' ' NZ ' ' A' ' 140' ' ' LYS . 35.3 tp -74.23 -32.82 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.595 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.18 -52.02 18.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.55 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -64.12 -54.53 32.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.587 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.585 ' N ' ' SD ' ' A' ' 138' ' ' MET . 20.7 tt -45.87 -22.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 136' ' ' LEU . 26.4 mtmm -92.96 -26.35 17.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.283 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.47 -30.84 14.83 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.0 t -47.3 117.02 1.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -138.74 121.57 16.52 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.349 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.26 125.77 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.621 ' HG ' ' N ' ' A' ' 146' ' ' ILE . 10.4 t -100.78 159.2 15.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.906 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.621 ' N ' ' HG ' ' A' ' 145' ' ' SER . 3.2 mt -148.78 156.86 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.938 0.399 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -166.1 85.76 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.59 144.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.495 . . . . 0.0 111.793 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -135.8 175.41 9.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.812 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.7 t -91.46 134.88 34.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.45 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 p -111.39 166.16 11.35 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.771 0.319 . . . . 0.0 110.169 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.89 6.99 2.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.93 99.45 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.096 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.475 ' OE1' ' ND2' ' A' ' 41' ' ' ASN . 9.8 mm-40 -83.23 18.88 1.6 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -63.71 148.84 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.613 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 157' ' ' SER . 38.4 t70 -52.16 171.79 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.194 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.443 ' H ' ' CG ' ' A' ' 156' ' ' ASP . 35.2 p -100.02 149.82 23.07 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.086 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.2 m-20 -116.73 88.83 2.98 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.3 pt -103.25 177.13 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.388 0.613 . . . . 0.0 111.528 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.758 ' HZ2' ' H ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -108.36 -173.29 2.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.06 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.8 m -124.56 -9.26 7.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.401 ' O ' ' NZ ' ' A' ' 160' ' ' LYS . 14.6 m-70 -100.14 127.56 33.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.787 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -39.42 159.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.03 1.82 . . . . 0.0 112.705 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.09 140.38 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 20.2 mt -85.2 125.29 32.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.366 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 159.85 20.32 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.469 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.3 m -93.8 12.0 27.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.4 t30 58.08 9.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.719 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.22 148.58 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 20.5 m -112.6 140.06 47.68 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.412 ' NE2' ' OD2' ' A' ' 27' ' ' ASP . 22.0 m80 -74.95 43.95 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.535 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -71.53 162.68 29.06 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -77.39 128.02 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.7 m -149.29 -166.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.0 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.1 p -48.08 145.06 3.3 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.423 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -112.47 144.38 42.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.906 0.384 . . . . 0.0 111.239 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -158.74 152.1 22.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.483 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -68.61 106.33 2.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.274 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -116.93 -59.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.724 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.1 mt -61.26 122.05 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.14 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.4 -119.81 2.11 Favored Glycine 0 C--O 1.225 -0.412 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.955 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.538 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 52.2 p -72.07 141.86 49.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.508 ' OG1' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -145.02 83.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.68 97.04 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.991 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 18.1 m -112.18 131.65 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.953 0.406 . . . . 0.0 111.59 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -79.44 114.99 18.8 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.112 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.9 p -52.25 -28.04 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -39.21 -30.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.514 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 65.1 m -143.95 26.43 1.53 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.732 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 44.0 t -149.22 89.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 110.483 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -67.71 -56.44 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.648 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -133.65 146.32 50.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.0 tp -144.14 120.81 11.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 12.7 mp0 -105.92 130.78 53.8 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . 0.512 ' N ' ' CD1' ' A' ' 195' ' ' PHE . 0.2 OUTLIER -107.23 138.63 43.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.912 0.387 . . . . 0.0 110.528 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.2 t -144.35 120.64 10.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.62 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 198' ' ' ARG . 6.7 p -131.93 159.64 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.416 ' N ' ' CG2' ' A' ' 197' ' ' VAL . 11.4 ttt85 -171.25 112.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.241 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 8.5 tt -113.3 129.84 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.819 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -168.83 -148.97 5.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.862 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -95.95 119.83 35.15 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 167' ' ' SER . 21.8 mmt -82.85 3.86 27.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.29 -54.31 2.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.689 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -153.76 120.73 5.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.726 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -49.2 129.22 17.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.148 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.4 t -124.8 113.33 17.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.797 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.9 p -35.58 -39.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.859 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -79.21 -45.58 19.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 61.21 3.98 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.07 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.34 128.17 7.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.185 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.477 ' CG1' ' N ' ' A' ' 212' ' ' LYS . 3.8 t -142.9 164.35 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.03 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.477 ' N ' ' CG1' ' A' ' 211' ' ' VAL . 0.9 OUTLIER -161.13 127.34 3.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.03 171.51 11.79 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.448 ' C ' ' CD1' ' A' ' 215' ' ' PHE . . . 155.76 160.49 10.01 Favored Glycine 0 CA--C 1.511 -0.166 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 215' ' ' PHE . 14.5 m-85 -141.57 -176.8 4.88 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -134.73 105.99 6.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.203 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.66 113.55 25.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.401 ' O ' ' OD1' ' A' ' 219' ' ' ASP . 31.8 m -135.98 120.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 0.0 110.523 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 218' ' ' VAL . 4.5 p-10 46.09 51.32 11.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.979 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.24 2.96 68.53 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.668 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.7 t -104.41 119.89 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.066 0.433 . . . . 0.0 110.678 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.07 155.87 18.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.121 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 79.3 p -170.87 129.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -80.14 141.9 35.29 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -170.86 101.6 0.17 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.17 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.39 96.55 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.714 0.292 . . . . 0.0 110.387 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 77.2 p -126.04 160.43 30.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.64 99.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -91.66 21.96 4.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 87.5 m -63.24 -35.4 80.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.746 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.1 p -97.95 -4.75 35.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.1 tp -43.45 -31.8 0.76 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.852 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.3 tt -143.53 144.35 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.203 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 236' ' ' THR . 31.5 m-20 -83.15 91.4 7.23 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 115' ' ' ARG . 14.2 t -56.78 -0.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.202 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 234' ' ' ASP . 58.4 m -88.36 -20.24 25.59 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -101.6 11.42 38.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.747 0.308 . . . . 0.0 111.465 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -84.78 133.23 34.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.694 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -127.09 132.3 50.67 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.361 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.758 ' H ' ' HZ2' ' A' ' 160' ' ' LYS . . . -55.67 165.48 0.85 Allowed 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.156 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 38.1 t -126.23 -2.9 6.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.971 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.765 0.317 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.93 111.68 0.72 Allowed 'Trans proline' 0 N--CA 1.475 0.438 0 C-N-CA 122.628 2.219 . . . . 0.0 112.15 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 154.5 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.539 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.53 170.15 10.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.761 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 p -72.61 -84.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 110.618 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -136.23 75.9 51.93 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.636 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' B' ' 8' ' ' PRO . 27.4 Cg_exo -60.27 176.9 0.66 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.534 2.156 . . . . 0.0 112.355 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' B' ' 7' ' ' PRO . 86.7 Cg_exo -51.37 -124.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.268 2.646 . . . . 0.0 113.547 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.624 ' CG2' ' H ' ' B' ' 10' ' ' ALA . 1.2 t -170.59 -74.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.599 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.624 ' H ' ' CG2' ' B' ' 9' ' ' THR . . . 74.0 64.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.324 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 33.3 m -116.29 135.49 53.84 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.603 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 t -41.31 138.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.779 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.508 ' CD2' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -125.17 -26.79 3.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.305 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.6 m -138.66 143.02 39.03 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.506 ' N ' ' CD1' ' B' ' 15' ' ' TYR . 1.1 m-85 -107.18 149.12 28.04 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.2 t -74.94 133.72 41.69 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.463 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.06 -45.44 20.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.589 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -79.33 126.13 30.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.87 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.61 150.22 48.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.118 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 20.8 mt -105.01 100.06 22.51 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.513 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -42.23 146.44 0.68 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.69 1.594 . . . . 0.0 111.968 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -46.12 -48.21 17.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.643 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -49.37 -22.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 111.291 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.407 ' CE1' ' OE1' ' A' ' 53' ' ' GLU . 9.6 t80 -109.42 33.57 4.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.201 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 66.3 t -153.47 93.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.686 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 32.0 m -88.42 -23.72 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.5 t70 -156.76 -179.52 8.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.163 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.492 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 7.9 p90 -158.51 170.61 21.81 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.084 0.469 . . . . 0.0 111.36 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.45 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -154.02 179.28 9.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.12 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.45 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 85.9 mt-10 -124.14 147.37 48.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.873 0.368 . . . . 0.0 110.364 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -55.82 -109.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.5 m -153.86 -147.96 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.669 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.507 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.1 t -136.47 -32.43 0.84 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.308 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 4.3 mp -51.79 -10.99 0.13 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.507 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.6 p -111.04 118.63 36.57 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 79.4 p -72.58 37.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.723 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.4 pt20 -171.27 61.83 0.35 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.66 -167.66 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.669 2.246 . . . . 0.0 113.386 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.45 176.02 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.639 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.25 131.85 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.683 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.08 132.94 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.597 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -103.74 147.7 26.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.167 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -94.05 169.57 10.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.2 p -142.0 -145.82 0.18 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.719 0.691 . . . . 0.0 111.499 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.468 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -127.62 -40.12 1.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.33 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.75 43.09 3.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.361 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 8.5 t -149.04 -83.78 0.1 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.435 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -87.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.004 0.43 . . . . 0.0 109.878 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -139.53 147.37 41.13 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.65 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -150.39 119.09 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 111.098 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.538 ' H ' ' CB ' ' A' ' 182' ' ' SER . 7.2 t -59.8 157.51 12.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.664 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.485 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.1 134.79 13.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.811 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -73.01 121.28 84.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.32 1.4 6.15 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.223 1.282 . . . . 0.0 111.863 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 27.7 t -76.05 -4.05 39.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.957 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' B' ' 57' ' ' SER . 0.8 OUTLIER -106.87 124.87 50.24 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.511 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 22.1 p -44.32 -47.34 9.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.4 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 85.9 m95 -55.11 -27.79 47.75 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.22 -43.98 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 109.646 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -62.05 -41.67 98.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.97 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -70.66 -34.86 72.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -66.45 -37.57 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 73.3 t -71.11 -47.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.95 -31.72 70.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -72.56 -37.44 68.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.58 -22.09 61.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.558 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -73.17 -32.2 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.235 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.63 -78.07 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.8 t30 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.549 -180.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.98 -51.94 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.129 1.886 . . . . 0.0 111.682 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.16 127.46 1.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.563 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.2 t -68.26 -84.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.59 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 7' ' ' GLN . 11.1 tp -168.23 -75.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.442 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -62.92 79.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.43 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 5' ' ' LEU . 22.9 mt-30 -148.07 139.78 23.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.546 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 99.6 p -165.37 -33.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.162 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 m -79.14 -25.48 42.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.625 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 p -47.93 128.52 13.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 127' ' ' SER . 3.2 t -61.28 -19.94 62.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.1 p -77.4 -30.9 53.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.379 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.523 ' HG ' ' N ' ' A' ' 14' ' ' SER . 66.0 p -77.24 -46.68 22.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.523 ' N ' ' HG ' ' A' ' 13' ' ' SER . 33.6 m -163.15 158.88 22.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.912 0.387 . . . . 0.0 110.669 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.11 154.34 10.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.5 p -68.62 165.5 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.514 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 34.9 mp0 -115.42 7.94 15.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.258 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.24 -163.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 15.3 mp0 -114.56 -73.01 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.023 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -87.61 60.26 5.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.145 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 21.7 tttm -157.78 141.46 15.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.258 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -149.42 179.13 8.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.387 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.508 ' CD2' ' OG ' ' A' ' 127' ' ' SER . 32.1 t60 -108.93 90.23 3.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 53.9 tpp -71.92 126.72 30.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.903 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.44 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -136.07 167.13 24.48 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.5 pt -111.32 150.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.23 121.04 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.8 146.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.184 0.516 . . . . 0.0 111.254 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.1 mt -137.27 140.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tt -130.77 122.26 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.138 0.494 . . . . 0.0 111.429 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -107.69 111.28 23.41 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.7 t -112.32 122.1 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.952 0.406 . . . . 0.0 111.643 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.0 m -97.25 114.62 26.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -68.3 151.8 46.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.82 179.35 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -80.63 -28.43 36.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.737 0.303 . . . . 0.0 110.71 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -85.31 -34.75 21.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.2 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.3 m -40.3 104.1 0.32 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.87 161.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.931 1.754 . . . . 0.0 112.039 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.8 p -67.99 140.14 56.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.639 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.401 ' C ' HD21 ' A' ' 41' ' ' ASN . 0.4 OUTLIER -165.3 96.21 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.42 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -99.32 10.62 41.07 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.35 82.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.125 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.6 pt -81.26 142.74 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.634 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.489 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 33.9 t 56.21 67.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.5 tp60 -78.47 -31.45 47.88 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.4 p -178.32 167.47 1.9 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.504 ' CG1' ' SG ' ' A' ' 241' ' ' CYS . 4.0 m -145.95 130.04 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.918 0.39 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 82' ' ' SER . 41.6 p -102.99 172.89 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.933 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -159.93 116.02 2.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.73 158.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -150.87 110.64 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.497 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 7.4 pt-20 -57.17 84.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 123.566 1.65 . . . . 0.0 109.601 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' THR . 9.9 p -145.55 17.05 1.48 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.571 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.4 pm0 -135.24 14.02 3.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.405 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.6 p -164.78 30.9 0.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.422 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.3 p-10 -172.89 150.38 2.01 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.653 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 59' ' ' ASP . 32.0 Cg_exo -35.15 86.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.598 2.198 . . . . 0.0 112.775 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.9 m-20 164.12 64.5 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.14 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.16 65.25 7.86 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.704 2.27 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -139.96 81.13 1.8 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.092 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -173.2 -27.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.297 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -172.59 30.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.7 p 177.73 -177.61 0.2 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.347 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.7 155.73 37.82 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.085 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 67' ' ' ASP . 30.7 t70 -136.0 -127.31 0.15 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 18.9 p-10 -162.94 136.26 5.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.943 0.401 . . . . 0.0 110.832 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.0 t 52.22 65.67 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.76 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 p -79.7 -14.02 59.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.4 t -76.52 48.44 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.047 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -51.75 -46.96 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.301 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.91 -33.78 0.25 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 69.76 47.96 0.6 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.792 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.51 46.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.064 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -158.35 66.8 3.38 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.76 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.72 158.34 2.97 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.495 2.13 . . . . 0.0 111.937 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.84 167.61 22.0 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.462 2.108 . . . . 0.0 111.707 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.501 ' N ' ' OE2' ' A' ' 53' ' ' GLU . 32.8 m -119.14 131.28 55.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.793 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.9 p -87.72 126.17 34.83 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 59.8 t80 -136.72 107.8 6.75 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CD2' ' CE1' ' A' ' 92' ' ' PHE . 4.8 p90 -106.8 -179.03 3.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.496 ' N ' ' OG1' ' A' ' 49' ' ' THR . 15.8 m -152.53 75.42 1.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 pt -72.4 119.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.51 0.671 . . . . 0.0 110.753 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.1 mt -101.26 145.13 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.518 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.46 166.1 16.32 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.37 22.36 50.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.09 14.18 76.32 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.36 156.57 48.27 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.938 0.399 . . . . 0.0 110.502 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -122.57 114.87 21.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.314 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 36.5 mtt -101.3 123.06 44.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.78 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -115.48 119.97 37.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.256 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.655 ' CE1' ' CD2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -108.15 169.36 8.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.77 77.63 0.19 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.337 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.45 145.35 29.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.642 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -141.63 122.21 14.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 66.45 34.26 6.3 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.378 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.55 143.72 49.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -34.39 144.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.387 2.058 . . . . 0.0 112.74 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -68.59 154.87 41.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.338 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.65 144.62 9.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.221 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.437 ' NZ ' ' OD2' ' A' ' 126' ' ' ASP . 4.0 tppt? -143.27 -15.96 0.66 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.717 0.294 . . . . 0.0 110.331 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -113.16 118.06 33.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.278 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.9 tp -135.05 128.68 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 p -142.79 179.41 7.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 60.0 tt0 -164.22 154.58 14.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.2 t -157.63 153.03 26.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.414 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.24 123.65 30.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -135.3 107.9 7.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.966 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.31 -124.69 7.35 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -106.61 27.78 8.5 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.732 0.301 . . . . 0.0 110.511 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -133.72 159.83 39.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 110.731 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.35 134.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.476 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.86 155.08 27.47 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.06 128.44 8.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -108.24 122.99 48.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.033 0.444 . . . . 0.0 111.154 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -112.98 114.6 27.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.41 ' HG ' ' N ' ' A' ' 118' ' ' SER . 20.4 t -157.58 170.0 23.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.593 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.41 ' N ' ' HG ' ' A' ' 117' ' ' SER . 31.3 p -94.52 166.17 12.18 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.438 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.98 150.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.374 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 p -99.43 150.42 36.74 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.867 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -38.84 163.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.121 1.88 . . . . 0.0 112.543 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 50.23 73.54 0.36 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.215 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -152.89 -27.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.088 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.88 12.62 13.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.193 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -134.95 155.42 50.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.437 ' OD2' ' NZ ' ' A' ' 101' ' ' LYS . 4.6 p30 -56.31 151.33 13.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.527 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.508 ' OG ' ' CD2' ' A' ' 23' ' ' HIS . 2.2 t -153.19 67.13 6.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.53 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.22 130.0 27.19 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.887 2.391 . . . . 0.0 113.331 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -96.2 158.07 15.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.694 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.8 pt -145.34 160.87 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.82 0.343 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.8 p -75.78 178.53 6.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.047 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -69.27 -35.95 76.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.503 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.31 -57.85 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.989 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.995 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.29 -56.96 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.769 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.0 tp -54.46 -32.61 58.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.127 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.51 -52.46 18.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.646 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mtt -57.16 -52.72 64.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.145 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.2 mm -45.98 -21.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.296 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -91.43 -41.55 10.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.79 -31.06 56.73 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 m -41.47 111.15 0.2 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.48 116.96 11.35 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.055 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.57 127.35 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.055 0.455 . . . . 0.0 110.659 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 m -101.06 162.9 12.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.4 tp -145.47 136.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.992 0.425 . . . . 0.0 110.646 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -146.99 90.42 1.9 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.882 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.9 tt -83.73 140.33 16.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.72 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 35.8 ttm180 -133.39 170.45 15.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 5.8 t -90.48 126.64 35.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.187 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.7 p -120.38 133.45 55.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -100.57 21.23 13.64 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.622 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -50.29 158.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -144.54 -0.74 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.197 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 26.8 mtmm -63.89 171.58 2.74 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.632 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.23 173.89 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.5 t -92.54 144.28 25.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.6 t70 -120.18 89.86 3.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.999 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 pt -120.53 172.25 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.428 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.592 ' NZ ' ' NE2' ' A' ' 162' ' ' HIS . 31.0 tttm -124.32 136.4 54.08 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.005 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.8 m -64.26 0.43 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.592 ' NE2' ' NZ ' ' A' ' 160' ' ' LYS . 1.8 m-70 -79.3 119.14 76.03 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.11 157.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.811 1.674 . . . . 0.0 112.281 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.45 134.7 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.47 120.02 21.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.18 162.42 22.77 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.491 ' HG ' ' H ' ' A' ' 169' ' ' ILE . 10.3 p -98.08 5.37 48.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.091 0.472 . . . . 0.0 109.766 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 58.5 t30 60.31 -0.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.815 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.491 ' H ' ' HG ' ' A' ' 167' ' ' SER . 0.2 OUTLIER -88.98 133.62 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.7 t -79.12 -176.49 5.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.271 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.525 ' CD2' HH21 ' A' ' 198' ' ' ARG . 0.0 OUTLIER -124.52 22.23 8.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -59.63 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -93.5 123.97 37.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.613 ' CG2' ' H ' ' A' ' 175' ' ' SER . 14.4 p -146.97 -176.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.931 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.613 ' H ' ' CG2' ' A' ' 174' ' ' VAL . 58.6 m -38.65 143.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.744 0.307 . . . . 0.0 111.228 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -104.35 140.64 37.61 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.056 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -151.09 144.81 25.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.58 89.18 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.1 -42.74 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.964 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.8 tp -64.03 124.84 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.22 -128.73 3.79 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.448 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.74 ' HG ' ' H ' ' B' ' 51' ' ' CYS . 10.1 t -73.26 148.54 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 69.0 m -129.58 133.85 47.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.8 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 7.6 mm -138.42 128.16 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 2.3 m -144.56 124.49 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.0 97.82 11.42 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 26.1 p -45.27 -27.84 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.386 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -44.56 -20.96 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.961 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 97.0 m -147.33 16.75 1.17 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.7 m -148.27 108.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.485 0.66 . . . . 0.0 111.119 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -79.42 -56.19 4.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.586 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -109.69 170.1 8.29 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.545 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -169.74 105.84 0.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -108.36 130.81 55.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -114.81 140.48 48.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.594 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.46 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 14.4 t -143.95 124.2 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.484 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.46 150.19 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.525 HH21 ' CD2' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -166.41 108.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.674 -179.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.0 mt -104.51 148.64 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.233 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.29 34.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.575 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -88.07 121.22 30.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.905 0.384 . . . . 0.0 110.303 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -79.48 1.15 26.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.731 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.62 -47.36 5.12 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.121 0.486 . . . . 0.0 109.9 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -168.09 127.21 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.65 148.05 0.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.848 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 47.9 p -136.69 12.81 3.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.924 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.6 m 58.39 -75.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.4 mt-10 -46.24 -54.38 8.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.681 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.4 mt -76.99 -0.83 25.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.785 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.88 134.83 37.09 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.669 0.271 . . . . 0.0 110.491 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m -154.62 -179.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.295 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.59 ' HZ1' ' CB ' ' A' ' 226' ' ' ALA . 13.9 pttp -170.67 167.5 7.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.431 0.634 . . . . 0.0 112.136 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.2 t70 -155.26 168.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.7 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 172.1 168.13 33.14 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 10.4 m-85 -153.4 167.3 29.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 2.7 ttmp? -133.42 104.0 6.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.035 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -100.57 118.13 36.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.866 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.38 111.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.614 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.4 t70 53.12 47.47 24.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.692 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.28 -5.61 71.72 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.356 -0.45 . . . . 0.0 113.408 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.7 t -96.95 116.66 29.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.099 0.45 . . . . 0.0 110.716 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.402 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -104.63 153.51 21.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.079 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 60.4 m -167.83 129.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.276 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -83.01 142.62 31.21 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.66 116.74 0.61 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.587 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.59 ' CB ' ' HZ1' ' A' ' 212' ' ' LYS . . . -73.86 111.45 9.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 28.5 m -140.99 153.07 45.4 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.924 0.392 . . . . 0.0 110.581 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 95.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.617 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -87.27 30.03 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.3 t -71.34 -39.1 71.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 55.6 m -96.94 2.67 51.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.9 tp -44.38 -40.64 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.788 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 27.5 mm -141.18 146.33 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.777 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 236' ' ' THR . 34.4 m-20 -78.18 92.86 4.49 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 m -56.6 -6.5 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 234' ' ' ASP . 26.0 m -86.68 -17.05 34.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.411 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -99.04 7.43 45.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.503 0.192 . . . . 0.0 111.347 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.67 144.77 35.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.407 . . . . 0.0 110.809 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -133.49 133.49 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.536 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.71 156.73 4.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 48' ' ' VAL . 53.7 t -126.5 -10.28 6.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.457 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.857 -1.068 . . . . 0.0 110.434 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.747 0.308 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -70.69 116.69 4.77 Favored 'Trans proline' 0 N--CA 1.473 0.303 0 C-N-CA 122.497 2.132 . . . . 0.0 111.639 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 14.8 ptt? -54.33 154.91 4.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.51 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.76 -150.51 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.93 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 74.4 m -151.49 119.63 6.3 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 110.437 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 40.89 70.4 1.59 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.355 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' B' ' 8' ' ' PRO . 58.1 Cg_endo -87.53 157.6 7.86 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.73 2.287 . . . . 0.0 110.924 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' B' ' 7' ' ' PRO . 17.4 Cg_exo -36.11 -116.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.628 2.886 . . . . 0.0 114.546 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.433 ' OG1' ' SG ' ' B' ' 11' ' ' CYS . 0.1 OUTLIER 172.64 -73.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.071 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . 80.0 63.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.488 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.499 ' O ' ' CE2' ' B' ' 13' ' ' PHE . 85.6 m -106.4 161.42 14.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.67 135.48 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.346 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' B' ' 11' ' ' CYS . 6.8 m-85 -114.01 -26.91 7.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -149.66 153.76 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.261 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -111.52 155.07 23.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.74 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -77.49 137.17 38.5 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -27.17 41.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.62 0.248 . . . . 0.0 110.99 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -92.5 127.09 37.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.385 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -77.43 116.24 17.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.825 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.01 139.87 97.75 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.505 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.49 147.67 32.46 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.859 1.706 . . . . 0.0 111.367 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.517 ' C ' ' H ' ' B' ' 24' ' ' PHE . 41.5 ttp180 -44.68 -49.53 10.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.73 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' B' ' 23' ' ' ASN . 46.0 t-20 -69.67 29.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' B' ' 22' ' ' ARG . 57.8 t80 -155.45 33.33 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 86.4 t -155.97 97.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.751 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.42 -7.19 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 25.3 t0 -166.67 -178.74 4.49 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.096 -0.641 . . . . 0.0 111.259 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.498 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.7 p90 -158.24 163.52 37.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.097 0.475 . . . . 0.0 111.303 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -155.39 141.6 18.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.893 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' B' ' 31' ' ' THR . 88.8 mt-10 -90.0 142.5 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.91 0.386 . . . . 0.0 111.287 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 67.4 p -51.45 -108.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -154.47 -167.37 2.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.477 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.8 t -117.32 -30.4 5.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.502 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.536 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 4.4 mp -49.59 -13.14 0.08 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.477 ' H ' ' C ' ' B' ' 33' ' ' SER . 27.8 m -111.06 127.12 55.45 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.049 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -76.44 35.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -163.98 59.27 0.74 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.4 -164.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 122.59 2.194 . . . . 0.0 112.862 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.14 176.69 0.25 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.089 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.43 127.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.99 134.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -105.3 151.52 24.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.65 ' NE2' ' H ' ' B' ' 44' ' ' THR . 41.5 tp60 -93.67 164.56 13.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.687 ' HG1' ' H ' ' B' ' 48' ' ' ALA . 56.5 p -136.57 -168.42 2.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.289 0.566 . . . . 0.0 111.528 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.78 -41.82 4.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.713 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.91 47.11 2.02 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.374 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 3.0 m -158.47 -79.61 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.227 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.687 ' H ' ' HG1' ' B' ' 44' ' ' THR . . . 155.8 -90.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.397 0.436 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -136.86 151.45 49.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -150.08 124.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.74 ' H ' ' HG ' ' A' ' 182' ' ' SER . 10.2 t -64.18 159.5 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.298 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.496 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.0 130.59 10.68 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.238 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -67.76 116.88 42.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.33 0.57 5.87 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 120.938 1.092 . . . . 0.0 111.71 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 53.4 m -73.89 -16.07 61.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.983 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -91.61 127.25 36.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.168 0.509 . . . . 0.0 110.666 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 52.9 m -47.22 -49.8 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -56.15 -25.05 44.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.14 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 62.2 t -73.77 -37.38 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.181 0.515 . . . . 0.0 110.302 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.14 -37.56 78.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.504 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -72.07 -35.36 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.242 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.99 -36.1 82.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.477 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.06 -44.87 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.978 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -63.49 -27.59 69.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.018 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.41 -39.17 62.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.812 0.339 . . . . 0.0 110.934 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.43 -29.76 62.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.347 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OH ' ' B' ' 28' ' ' TYR . 32.1 mm-40 -69.7 -32.94 71.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.85 -74.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.336 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.553 179.891 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.748 0.309 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.08 178.52 7.09 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.687 2.258 . . . . 0.0 111.898 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.18 138.71 3.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.526 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' LEU . 70.2 m -166.37 25.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.605 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 5' ' ' LEU . 7.9 mp 57.45 150.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.571 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.45 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 2.8 pm0 -169.62 149.47 3.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.646 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -72.75 142.86 48.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.505 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p -74.08 -8.26 55.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.718 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -75.44 -24.59 57.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.748 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 12' ' ' SER . 15.3 t -50.57 134.47 24.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -57.62 -29.39 64.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.45 ' H ' ' HG ' ' A' ' 10' ' ' SER . 85.4 p -74.35 -25.94 59.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.656 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.23 -57.08 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.974 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -159.01 175.94 12.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.922 0.392 . . . . 0.0 110.907 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -61.92 159.92 13.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.887 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.494 ' OG1' ' NE2' ' A' ' 23' ' ' HIS . 2.2 m -75.2 165.89 24.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 1.4 pm0 -114.75 3.16 14.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.777 0.323 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.64 -165.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.35 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -116.05 -75.92 0.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.901 0.382 . . . . 0.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.494 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 64.8 t30 -77.81 53.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.627 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -154.63 132.13 11.27 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.577 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 34.3 m170 -140.9 165.49 27.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.201 0.524 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.494 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 32.3 m-70 -97.75 76.19 2.46 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.965 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.2 ttm -68.88 133.69 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.29 25.03 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.0 tp -111.17 142.37 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -149.89 106.31 3.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.556 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.29 134.53 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.68 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.5 pt -113.99 163.33 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.92 132.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.437 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -120.68 133.08 55.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.538 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.4 116.71 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.872 0.368 . . . . 0.0 111.326 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -81.76 112.41 18.89 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.59 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -68.22 150.14 48.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.888 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -58.89 168.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -91.3 5.02 50.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.843 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -120.48 -33.38 3.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.846 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.4 t -54.17 119.28 19.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.463 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -39.25 157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.976 1.784 . . . . 0.0 112.544 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 p -75.49 143.91 42.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.46 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -157.33 107.1 2.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.424 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' ILE . 2.7 p30 -101.16 -2.56 31.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.064 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 154' ' ' GLU . 4.8 mmmm -63.51 83.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.3 tp -90.53 150.62 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.078 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.451 ' SG ' ' CG ' ' A' ' 105' ' ' GLU . 1.7 m 56.17 62.09 2.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.139 0.495 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -78.19 -40.02 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 t -172.51 163.32 5.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.04 0.448 . . . . 0.0 111.181 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.06 140.36 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.489 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -129.54 105.29 7.98 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.847 0.356 . . . . 0.0 110.857 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.08 128.87 34.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.494 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 mm -132.36 154.7 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.456 ' HG1' ' N ' ' A' ' 53' ' ' GLU . 0.1 OUTLIER -152.62 142.57 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' N ' ' HG1' ' A' ' 52' ' ' THR . 4.6 tp10 -51.11 176.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 26.6 m -55.08 -39.95 69.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 54' ' ' SER . 3.5 pt-20 113.62 -151.23 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 O-C-N 125.929 2.018 . . . . 0.0 111.112 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.468 ' N ' ' CG ' ' A' ' 55' ' ' GLU . 13.8 t -138.68 -66.53 0.48 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.416 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.613 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 3.5 p30 -124.95 -23.7 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.613 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 31.5 Cg_exo -38.16 -68.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.647 1.564 . . . . 0.0 113.621 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER 169.27 -64.62 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.355 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 59' ' ' ASP . 11.1 Cg_exo -24.05 -105.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.85 3.033 . . . . 0.0 114.219 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.441 ' N ' ' OE2' ' A' ' 55' ' ' GLU . 39.7 tt0 51.3 83.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.507 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.85 8.97 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.277 0.56 . . . . 0.0 109.499 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.477 ' C ' ' HG ' ' A' ' 64' ' ' SER . 36.4 tt0 -77.67 169.33 18.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.211 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.477 ' HG ' ' C ' ' A' ' 63' ' ' GLU . 13.6 m -162.18 34.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.435 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -171.37 66.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.412 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -171.27 56.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -69.24 93.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.616 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.7 p -63.25 -178.55 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.622 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 t -162.18 27.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.363 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.6 p -75.69 107.67 8.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.96 59.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.3 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -165.82 -27.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -157.48 148.42 21.41 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.532 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.7 -135.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.677 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -147.74 82.17 8.1 Favored Pre-proline 0 N--CA 1.465 0.317 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.85 106.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.557 2.171 . . . . 0.0 112.58 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.2 165.68 12.84 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.312 2.008 . . . . 0.0 111.363 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -123.76 141.46 52.01 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 p -107.59 127.0 53.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.755 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -112.25 148.02 35.01 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.201 0.524 . . . . 0.0 110.285 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -139.89 116.85 11.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.9 p -103.45 69.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.821 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.0 tt -74.37 102.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.185 0.517 . . . . 0.0 110.534 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 pt -88.08 147.84 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.181 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.5 170.06 19.91 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.7 37.8 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.77 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.09 86.47 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.618 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.08 159.2 40.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.057 0.456 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -117.4 108.98 16.22 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.312 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 45.7 mtt -101.23 112.13 24.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.45 124.1 48.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 84.7 m-85 -100.97 -176.03 3.05 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.1 71.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.249 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -75.92 138.54 41.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.385 . . . . 0.0 110.367 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.7 m -144.42 119.89 10.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.248 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? 66.87 26.74 9.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.214 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 m -120.72 149.83 51.33 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -40.06 154.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.815 1.677 . . . . 0.0 111.942 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.06 137.9 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.508 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -95.54 138.5 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -137.4 -10.6 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.738 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.9 t -112.21 122.77 48.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.0 tt -141.57 129.6 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.844 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.1 p -158.01 171.39 20.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.451 ' CG ' ' SG ' ' A' ' 45' ' ' CYS . 7.7 pt-20 -168.07 -172.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.6 t -171.56 165.96 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.445 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -127.01 116.68 21.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.172 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -127.93 107.9 10.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.029 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.81 -127.78 16.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -102.6 23.73 11.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.737 0.304 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 p -131.33 158.69 40.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.521 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.45 136.04 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.687 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -112.26 163.04 14.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.41 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -160.9 129.41 4.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.661 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -116.85 113.31 22.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.52 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.29 123.62 50.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -164.06 175.02 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.157 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.3 m -95.28 171.77 8.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.145 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.4 149.03 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.136 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 t -93.23 144.56 28.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -37.62 144.68 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.05 1.833 . . . . 0.0 112.516 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 57.11 6.16 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.187 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -138.75 -5.13 1.54 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.48 -8.35 64.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.81 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -115.56 168.82 9.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.98 147.06 39.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.288 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.5 m -148.73 65.56 8.42 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.689 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.27 148.03 1.32 Allowed 'Trans proline' 0 N--CA 1.474 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.903 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -117.87 146.68 43.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.311 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.42 171.11 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.844 0.354 . . . . 0.0 110.087 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -81.73 162.61 22.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.429 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.577 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 36.4 m170 -58.0 -36.45 72.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -54.38 -47.63 72.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.479 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -72.94 -33.21 65.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.97 9.39 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -56.14 -32.86 64.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.17 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.777 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 tpp -71.18 -63.17 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.102 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.3 -21.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.455 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -79.39 -55.11 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 41.4 t0 -79.14 -30.26 43.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.9 t -45.74 117.78 1.59 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.503 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.18 124.29 16.4 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.04 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 p -116.67 131.24 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.87 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.4 m -103.09 157.59 16.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.201 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.0 mm -140.43 145.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' OD2' ' NE2' ' B' ' 49' ' ' GLN . 2.0 m-20 -152.88 92.86 1.69 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.877 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.4 mt -89.26 142.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.301 0.572 . . . . 0.0 111.075 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -138.53 177.25 8.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.639 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.3 m -91.58 132.23 36.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.739 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -103.79 -173.98 2.44 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.47 11.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.861 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -79.92 103.59 9.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.495 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 11.1 pt-20 -77.52 7.75 5.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -49.73 145.66 5.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.93 0.395 . . . . 0.0 110.365 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.21 173.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.99 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.1 t -94.97 142.1 27.88 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -120.04 91.6 3.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.589 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.4 pt -121.06 168.69 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 162' ' ' HIS . 40.5 tptt -119.5 139.6 51.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.0 p -72.29 5.55 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.426 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.54 ' HD1' ' N ' ' A' ' 163' ' ' PRO . 3.3 t-80 -80.5 121.06 81.0 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.4 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.54 ' N ' ' HD1' ' A' ' 162' ' ' HIS . 66.9 Cg_exo -40.1 154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.826 1.684 . . . . 0.0 112.064 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.2 t -80.05 133.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.422 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.71 123.35 30.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.25 162.4 19.03 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.363 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.4 t -91.15 9.42 31.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 109.94 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.6 5.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.825 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.423 ' H ' ' C ' ' A' ' 167' ' ' SER . 9.9 tp -101.93 141.31 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.5 m -100.77 149.04 24.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.748 0.309 . . . . 0.0 110.35 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.448 ' NE2' ' N ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -83.13 39.55 0.65 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.019 0.438 . . . . 0.0 110.547 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.664 ' N ' HH12 ' A' ' 198' ' ' ARG . 74.7 tttt -65.16 173.5 2.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.295 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -84.18 123.81 30.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.427 HG21 ' H ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -149.11 -170.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.427 ' H ' HG21 ' A' ' 174' ' ' VAL . 25.3 p -44.71 146.87 0.69 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.571 0.224 . . . . 0.0 110.752 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -112.64 145.52 40.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.986 0.422 . . . . 0.0 111.437 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 1.6 tm-20 -157.88 145.73 18.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.447 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 9.9 t0 -70.34 100.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.403 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.4 mm -109.37 -50.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -61.67 125.35 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' B' ' 14' ' ' SER . . . -91.44 -123.11 2.87 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.191 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.2 t -73.3 140.58 46.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.628 0.251 . . . . 0.0 111.16 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.528 ' OG1' ' CE2' ' B' ' 13' ' ' PHE . 18.0 p -139.08 87.83 2.23 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.0 tt -102.65 129.1 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.418 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.6 137.67 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.556 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 109.41 19.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.22 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 189' ' ' CYS . 12.7 p -51.55 -27.48 11.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.573 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -38.36 -28.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.291 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 187' ' ' THR . 27.5 p -148.42 29.39 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.323 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.1 88.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.092 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -68.16 -58.33 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.167 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -123.07 179.38 4.69 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.403 ' C ' ' CD2' ' A' ' 193' ' ' LEU . 5.7 tt -173.22 106.65 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 25.2 mp0 -97.24 128.83 44.46 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -128.08 134.69 49.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.093 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.0 m -143.42 144.08 31.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.448 ' N ' ' NE2' ' A' ' 171' ' ' HIS . 18.1 m -140.6 167.39 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.124 0.488 . . . . 0.0 111.34 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.664 HH12 ' N ' ' A' ' 172' ' ' LYS . 21.8 ttm180 -164.09 156.32 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.154 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.6 mt -148.5 120.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.54 174.37 46.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.277 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -56.26 129.34 39.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.923 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 57.0 mtm -86.23 8.14 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.6 t -112.88 -48.2 3.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.239 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -159.19 115.02 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 7.9 mp0 -47.63 158.71 0.18 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 208' ' ' GLU . 69.9 m -143.38 23.02 1.84 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.01 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 t 57.68 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.822 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.5 mm-40 -48.68 -48.39 40.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.729 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -77.54 -0.65 27.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.445 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.79 155.36 19.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.971 0.415 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.8 p -175.55 158.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.409 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.428 ' HZ1' ' CB ' ' A' ' 226' ' ' ALA . 1.2 pptp? -168.56 136.83 2.16 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.401 0.62 . . . . 0.0 111.767 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 9.3 t70 -124.95 172.6 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 172.4 164.58 28.13 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.946 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -148.97 170.22 18.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -135.69 104.34 5.74 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.315 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -101.44 119.83 39.37 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.85 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.48 123.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.126 0.488 . . . . 0.0 110.442 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.62 37.88 27.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.31 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.32 89.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.91 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 26.4 p -103.19 120.9 41.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.843 0.321 . . . . 0.0 110.576 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.74 165.15 12.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.019 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.6 t -174.97 120.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.564 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -78.44 136.71 37.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.95 116.22 0.66 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.702 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.428 ' CB ' ' HZ1' ' A' ' 212' ' ' LYS . . . -81.61 96.56 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.3 m -129.55 151.41 50.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.989 0.423 . . . . 0.0 110.767 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.406 ' OD1' ' OG1' ' A' ' 230' ' ' THR . 14.3 t70 -57.32 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.553 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -93.26 31.0 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.406 ' OG1' ' OD1' ' A' ' 228' ' ' ASP . 50.6 p -73.71 -34.81 64.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.768 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -99.89 -2.55 34.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.896 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -43.42 -29.27 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.21 143.38 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.628 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.76 101.13 4.95 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -63.9 -5.68 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.147 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -47.28 12.67 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -71.4 9.43 0.8 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 238' ' ' LEU . 7.5 mp -72.98 152.28 41.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.493 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -137.15 135.16 37.11 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.561 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.19 144.71 23.42 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.49 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . 0.452 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 0.1 OUTLIER -104.34 -17.88 14.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.452 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 1.5 m . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.606 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.44 -107.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.088 1.859 . . . . 0.0 111.358 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 4.0 ptt? 163.25 20.79 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.15 -129.35 49.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.336 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 28.0 t -162.24 -97.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.842 0.353 . . . . 0.0 110.173 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -117.25 61.99 3.13 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.778 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' B' ' 8' ' ' PRO . 21.0 Cg_endo -58.34 164.12 9.32 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.078 1.852 . . . . 0.0 112.276 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' B' ' 7' ' ' PRO . 35.7 Cg_exo -38.65 -124.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 124.287 3.325 . . . . 0.0 115.254 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 159.3 67.67 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.133 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.73 103.03 0.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.146 0.498 . . . . 0.0 110.455 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -144.6 118.0 9.07 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.426 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 85.5 m -63.93 131.32 47.33 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE2' ' OG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -93.44 -26.78 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.018 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 181' ' ' GLY . 28.0 p -122.9 155.05 37.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.375 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.86 158.94 25.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.392 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -82.92 139.22 33.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.184 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.06 19.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.612 0.244 . . . . 0.0 111.32 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -80.2 127.83 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.785 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -81.92 128.68 34.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.38 52.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.808 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -42.04 153.08 0.13 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.208 1.938 . . . . 0.0 112.878 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' B' ' 25' ' ' VAL . 13.3 tpt180 -46.07 -50.46 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.353 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -35.95 -35.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 3.3 m-85 -105.58 43.23 1.14 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.102 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 22' ' ' ARG . 49.9 t -151.61 92.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.937 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -97.72 -22.95 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.265 -0.272 . . . . 0.0 110.823 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.455 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 6.3 p90 -166.06 168.91 15.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.253 0.549 . . . . 0.0 111.871 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 89.0 m-85 -157.34 178.26 10.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.243 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' B' ' 31' ' ' THR . 11.3 pt-20 -127.64 149.62 50.11 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.804 0.335 . . . . 0.0 110.501 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.414 ' O ' ' O ' ' B' ' 30' ' ' GLU . 77.8 p -53.93 -111.4 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -154.98 -148.68 0.24 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.425 ' C ' ' H ' ' B' ' 35' ' ' CYS . 10.5 m -135.82 -24.02 1.34 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.103 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.3 mm? -53.67 -13.56 0.7 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.794 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.443 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.3 p -115.94 122.16 44.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.58 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.3 m -73.31 38.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.402 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.5 pt20 -164.29 61.1 0.87 Allowed Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.14 -161.82 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.887 2.391 . . . . 0.0 113.294 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 170.76 176.53 0.06 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.217 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -111.59 136.74 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.73 143.2 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.618 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -115.69 149.9 37.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -92.97 169.26 10.57 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.3 p -138.17 -144.85 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.196 0.522 . . . . 0.0 110.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.501 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -126.27 -39.0 2.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.81 46.48 2.32 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.143 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 52.1 m -152.83 -83.17 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.428 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.586 0.554 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 49' ' ' GLN . 3.4 pp0? -145.31 147.87 32.8 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.12 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 t -150.26 115.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 71.7 m -68.05 144.72 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.785 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.69 139.3 41.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.998 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.69 126.33 92.49 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.54 -0.52 9.41 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.368 1.379 . . . . 0.0 111.554 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -65.18 -14.54 60.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.06 127.74 47.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.513 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 42.2 t -50.42 -46.89 56.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -55.99 -28.12 55.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.374 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.92 -36.16 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.112 0.482 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.72 -39.23 64.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.569 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -67.89 -35.7 78.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.47 -42.55 87.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.619 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.74 -46.01 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.841 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.66 -31.49 66.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.32 -35.67 63.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.585 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.336 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.52 -35.19 70.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' B' ' 68' ' ' LEU . 7.3 mp -79.79 -83.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.225 0.536 . . . . 0.0 109.64 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.643 -179.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 mmt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.706 0.288 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -44.08 104.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.674 2.249 . . . . 0.0 111.997 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.95 85.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.614 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -68.93 77.05 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.409 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.562 ' CD2' ' H ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -57.48 -161.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.85 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.562 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 25.9 mt-30 51.72 -165.44 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.574 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 58.16 159.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.625 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.5 p -163.06 -27.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.516 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.7 t -79.44 -18.15 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.5 t -50.5 134.36 23.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.652 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -58.25 -27.41 63.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 95.8 p -73.76 -23.9 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.63 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -80.0 -53.43 6.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 p -168.07 169.38 11.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.866 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.1 m -55.3 155.8 4.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.537 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -76.46 173.19 11.8 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -112.84 5.59 17.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -62.44 -167.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.246 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 17.2 mp0 -119.21 -65.48 1.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.874 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.0 54.29 3.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.392 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' C ' ' ND1' ' A' ' 22' ' ' HIS . 3.6 tppt? -151.17 140.06 20.93 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.42 ' ND1' ' C ' ' A' ' 21' ' ' LYS . 53.5 m80 -145.67 158.59 43.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.888 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -95.65 76.41 3.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 29.9 ttp -64.74 133.0 51.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.47 . . . . 0.0 111.181 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.74 160.89 26.21 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.258 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -114.68 158.49 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.98 0.419 . . . . 0.0 110.586 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -151.35 137.48 18.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.69 109.26 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.325 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.2 mt -97.5 134.2 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.29 134.41 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.174 0.511 . . . . 0.0 112.003 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -121.05 127.49 51.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.79 112.89 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.449 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 35.9 p -84.71 121.3 27.47 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -75.32 151.82 38.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.782 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 37' ' ' GLN . 51.8 tt0 -67.85 144.5 55.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.215 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 47.7 p30 -76.26 43.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.599 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 35' ' ' GLN . 45.0 tt0 -152.3 -28.33 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.377 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.8 m -71.16 125.45 91.94 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -38.47 156.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.026 1.817 . . . . 0.0 112.542 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -76.27 140.08 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.42 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -157.17 107.29 2.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.366 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.84 8.82 37.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.258 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 12.0 mptt -69.0 82.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -77.5 -177.92 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.9 m 32.82 40.29 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -55.56 -34.44 64.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.289 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 t -178.12 168.99 1.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.1 t -149.14 112.27 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.942 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.2 m -111.39 116.46 30.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.323 . . . . 0.0 110.87 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -95.38 135.42 37.01 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.184 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 mp -139.76 151.44 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -150.76 149.11 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 54' ' ' SER . 18.5 tp10 -51.7 171.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.082 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.524 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 58.1 m -70.09 -21.91 63.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.981 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 56' ' ' SER . 35.6 tt0 -39.53 158.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.285 0.366 . . . . 0.0 110.415 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 57' ' ' ASP . 75.0 m -27.31 -103.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.698 0.624 . . . . 0.0 112.557 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.8 m-20 55.27 153.56 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.6 39.97 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.738 1.626 . . . . 0.0 110.916 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 57' ' ' ASP . 28.7 t70 -174.03 72.53 0.34 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.441 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.09 -178.5 4.68 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.422 2.081 . . . . 0.0 111.867 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -133.11 -9.77 2.98 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.082 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -164.86 -34.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.821 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 64' ' ' SER . 0.9 OUTLIER 71.88 124.85 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.356 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.479 ' N ' ' OE2' ' A' ' 63' ' ' GLU . 4.8 p 69.77 105.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.448 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -78.04 -64.03 1.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.741 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 67' ' ' ASP . 39.0 t70 -162.05 160.9 28.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.672 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' THR . 32.7 t70 -41.86 165.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.492 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.9 m -44.25 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.18 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' ASP . 19.1 m -43.82 -45.65 7.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.209 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.9 m -166.91 -119.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.1 m -102.74 37.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.494 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 47.88 96.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.644 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -157.71 43.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.285 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.12 177.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.462 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -112.71 137.05 21.61 Favored Pre-proline 0 N--CA 1.469 0.518 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -37.18 157.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.097 1.865 . . . . 0.0 112.371 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.02 171.38 15.34 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.504 2.136 . . . . 0.0 111.025 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.9 m -125.93 131.03 52.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.3 m -107.16 123.95 49.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -121.64 112.98 19.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.947 0.403 . . . . 0.0 111.112 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -93.83 127.41 39.55 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 t -103.07 69.38 1.02 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.24 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.5 tt -74.54 122.25 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 110.566 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.44 147.46 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.94 169.53 20.94 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.209 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.47 22.34 23.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.239 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.8 4.06 69.91 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.187 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.48 149.15 41.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' NH2' ' OG ' ' A' ' 151' ' ' SER . 45.6 ttm-85 -115.83 105.15 12.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 92' ' ' PHE . 18.8 ttt -101.71 135.63 42.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.116 0.484 . . . . 0.0 110.882 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -127.44 120.44 28.4 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.043 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 90' ' ' MET . 67.1 m-85 -90.42 -168.4 2.09 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.74 67.7 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.08 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -90.28 162.08 15.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.163 0.506 . . . . 0.0 111.448 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 t -150.91 131.82 14.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.942 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 62.95 33.65 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.529 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 98' ' ' PRO . 33.5 m -124.04 145.6 48.59 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 97' ' ' CYS . 78.2 Cg_exo -38.55 162.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.012 1.808 . . . . 0.0 112.423 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -71.33 142.54 50.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -97.1 118.09 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.33 -21.67 4.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 117' ' ' SER . 5.7 p -100.45 111.16 23.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.771 0.319 . . . . 0.0 110.862 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.23 121.83 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.556 ' HG ' ' N ' ' A' ' 105' ' ' GLU . 28.3 t -142.45 177.56 8.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.064 0.459 . . . . 0.0 111.171 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.556 ' N ' ' HG ' ' A' ' 104' ' ' SER . 34.9 tt0 -165.83 161.68 17.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.42 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.4 t -163.9 158.67 20.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.588 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.06 132.75 46.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.331 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -144.73 111.66 5.86 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.155 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.73 -110.87 3.31 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -122.21 23.88 9.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 p -128.74 156.16 43.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.64 132.99 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.573 ' ND2' ' H ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -117.96 155.76 29.68 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.885 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.52 133.07 12.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -118.0 125.76 51.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 111.333 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.7 121.48 40.97 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 102' ' ' SER . 1.8 m -164.94 156.67 15.3 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.58 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.8 p -74.19 173.85 9.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.39 134.37 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 110.999 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -59.55 155.15 40.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.0 157.6 28.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.254 1.969 . . . . 0.0 111.486 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.419 ' N ' ' OE1' ' A' ' 123' ' ' GLN . . . 73.68 59.73 3.97 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.738 HE21 ' H ' ' A' ' 125' ' ' LYS . 4.3 pm0 -141.24 -37.35 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.739 0.304 . . . . 0.0 110.348 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.03 5.97 2.93 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.265 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.738 ' H ' HE21 ' A' ' 123' ' ' GLN . 51.7 mttp -129.45 -173.48 3.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.782 0.325 . . . . 0.0 110.463 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 156.17 21.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.49 . . . . 0.0 111.456 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.4 t -159.19 63.42 2.31 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.439 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.78 142.31 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.112 2.541 . . . . 0.0 113.447 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.26 28.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.46 162.56 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 110.24 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.7 p -78.69 164.6 24.46 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -60.51 -34.71 74.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -63.15 -55.1 28.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.31 -44.71 92.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.335 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.29 -56.58 20.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.123 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 tp -49.37 -35.63 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.46 -49.24 43.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.557 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 140' ' ' LYS . 44.2 mtt -60.09 -60.42 3.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.7 mt -44.64 -21.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.13 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' MET . 31.5 ttmt -87.5 -33.81 18.85 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.595 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -94.92 -23.33 17.47 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.98 122.9 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.889 0.376 . . . . 0.0 110.758 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -139.1 123.26 18.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.218 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.31 128.21 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.06 0.457 . . . . 0.0 111.114 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.6 m -109.33 167.24 10.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.548 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.8 pt -151.2 149.17 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -147.9 88.47 1.68 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 tt -83.35 145.24 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.506 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.417 ' HG3' ' H ' ' A' ' 150' ' ' CYS . 5.0 tpt180 -145.59 -177.2 5.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.417 ' H ' ' HG3' ' A' ' 149' ' ' ARG . 7.1 m -90.61 134.44 34.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.698 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' NH2' ' A' ' 89' ' ' ARG . 5.6 t -117.3 119.58 35.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.075 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -93.62 14.81 17.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.161 0.505 . . . . 0.0 109.82 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.2 OUTLIER -50.68 150.62 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.155 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.55 -10.08 3.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.466 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.78 158.06 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.93 175.49 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -90.48 143.33 26.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -114.07 92.23 3.9 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 pt -119.03 165.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.147 0.499 . . . . 0.0 111.323 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -119.54 134.63 55.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 m -76.52 54.59 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.538 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.424 ' HD1' ' N ' ' A' ' 163' ' ' PRO . 6.0 t-80 -130.77 123.74 20.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.424 ' N ' ' HD1' ' A' ' 162' ' ' HIS . 48.6 Cg_exo -38.14 147.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.916 1.744 . . . . 0.0 112.344 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 20.3 m -73.4 130.46 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.422 ' CD1' ' HZ1' ' A' ' 125' ' ' LYS . 34.8 mt -79.32 115.46 18.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.315 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.97 159.55 22.85 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.117 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.457 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 0.1 OUTLIER -95.2 11.14 33.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 110.295 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 168' ' ' ASN . 10.9 t30 58.72 21.19 8.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.343 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.1 pp -76.63 -176.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.601 ' H ' ' HE ' ' A' ' 198' ' ' ARG . 51.1 m -147.94 113.82 5.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.619 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -68.6 28.22 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.284 -178.254 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 170' ' ' SER . 16.9 mmmt -67.6 175.27 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.125 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.42 ' CB ' ' NZ ' ' A' ' 173' ' ' LYS . 0.2 OUTLIER -90.86 124.7 35.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.12 -165.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.041 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.4 p -50.55 145.77 6.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.807 0.337 . . . . 0.0 110.53 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -95.69 132.52 40.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -141.45 127.07 18.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.209 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -68.45 95.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.65 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.9 mt -107.35 -40.61 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.475 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 tp -66.84 114.42 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.468 . . . . 0.0 110.502 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.22 -122.91 0.7 Allowed Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.4 m -77.21 150.8 35.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 93.07 2.1 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.093 0.473 . . . . 0.0 110.263 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.3 tt -98.86 133.26 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.914 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.2 m -146.76 131.29 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.99 0.424 . . . . 0.0 111.86 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 34.0 p-10 -85.93 103.34 14.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.754 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.7 m -46.99 -27.12 1.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.845 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -41.92 -26.38 0.09 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.966 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 9.8 m -142.78 36.23 1.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.4 p -169.43 105.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.4 0.619 . . . . 0.0 110.756 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -74.56 -54.43 7.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.729 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.449 ' H ' ' HG1' ' A' ' 33' ' ' THR . 2.6 m-20 -118.31 173.83 6.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.137 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.7 tt -173.56 106.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.228 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 19.2 mp0 -93.24 149.74 21.0 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -140.83 134.32 29.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.253 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.429 ' HG ' ' CD2' ' A' ' 232' ' ' LEU . 69.4 m -143.19 129.54 19.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.8 t -122.61 153.47 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . 0.601 ' HE ' ' H ' ' A' ' 170' ' ' SER . 14.4 ttt85 -154.55 144.42 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.871 0.367 . . . . 0.0 110.155 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.94 119.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.652 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -169.57 -156.59 11.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.063 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 58.3 t0 -79.21 123.78 27.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.865 0.364 . . . . 0.0 110.434 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.457 ' SD ' ' OG ' ' A' ' 167' ' ' SER . 24.2 mmt -81.14 -3.24 51.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.4 -50.05 3.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.466 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.486 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 20.2 tptp -157.38 112.35 2.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 198' ' ' ARG . 2.0 mm-40 -43.65 156.17 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' GLU . 2.5 p -156.86 67.08 0.54 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 208' ' ' GLU . 41.1 p 30.84 -88.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 206' ' ' SER . 17.8 mm-40 -40.52 -50.93 2.95 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.453 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 209' ' ' LEU . 1.9 mm? -81.68 54.27 2.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.527 ' CG ' HH22 ' A' ' 198' ' ' ARG . 1.3 tp10 -156.22 120.25 4.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.083 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.74 179.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.96 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -171.01 146.67 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.143 0.496 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 10.2 t70 -144.17 169.43 17.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.017 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 159.58 154.07 7.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.613 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.7 177.52 7.72 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -132.48 103.68 6.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -98.31 113.81 25.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.596 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.25 111.81 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.957 0.408 . . . . 0.0 110.691 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.13 43.39 30.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.98 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.16 74.77 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.455 -0.402 . . . . 0.0 112.561 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.8 p -89.84 112.9 24.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.67 149.45 23.3 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.714 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.6 m -166.29 124.29 1.44 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.623 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -77.99 138.99 39.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.424 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.75 108.22 0.27 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.52 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.11 104.23 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.6 p -129.53 159.22 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.468 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -62.13 95.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.29 12.65 4.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.0 m -45.29 -51.45 10.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.706 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 233' ' ' ILE . 20.4 m -97.18 6.37 48.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.429 ' CD2' ' HG ' ' A' ' 196' ' ' SER . 43.8 tp -42.64 -24.44 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.936 0.398 . . . . 0.0 110.84 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 231' ' ' SER . 0.4 OUTLIER -163.93 142.91 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -74.87 100.52 4.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -64.28 -6.35 6.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.916 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.04 -10.35 50.53 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.531 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -100.94 0.21 37.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.477 0.18 . . . . 0.0 111.145 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.02 142.06 35.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.152 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 104' ' ' SER . 63.8 mttp -130.44 136.83 49.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.837 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.84 138.03 57.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.733 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 74.6 m -100.17 -8.73 23.28 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.088 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.516 -179.324 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.745 0.307 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.08 120.29 5.67 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.573 2.182 . . . . 0.0 111.527 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' B' ' 4' ' ' GLY . 0.0 OUTLIER -51.66 175.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.47 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' B' ' 3' ' ' MET . . . -60.68 -131.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.641 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' B' ' 6' ' ' ASP . 13.2 p -175.74 20.85 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.732 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' B' ' 5' ' ' SER . 4.8 m-20 148.31 70.73 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 124.314 1.009 . . . . 0.0 109.031 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.04 176.44 6.98 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.336 2.024 . . . . 0.0 110.348 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' B' ' 9' ' ' THR . 93.9 Cg_endo -74.9 -110.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 121.711 1.607 . . . . 0.0 110.725 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' B' ' 9' ' ' THR . 0.0 OUTLIER 160.65 65.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.82 84.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.507 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.548 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 76.2 m -119.29 155.8 31.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.21 134.51 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.677 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.548 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 23.5 m-85 -111.89 -27.52 8.42 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -152.05 155.07 37.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.991 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.5 OUTLIER -110.42 160.53 16.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.894 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -84.0 139.08 32.77 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.48 5.53 38.56 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.453 -178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.73 126.56 47.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.822 0.344 . . . . 0.0 111.247 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -77.89 133.42 38.12 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.687 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 3.8 mm? -93.7 111.11 51.22 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.908 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.05 149.51 1.25 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.164 1.909 . . . . 0.0 112.599 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.552 ' C ' ' H ' ' B' ' 24' ' ' PHE . 7.5 ptp85 -45.46 -43.07 11.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.677 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -70.2 26.31 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.552 ' H ' ' C ' ' B' ' 22' ' ' ARG . 14.9 t80 -146.22 27.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -152.27 100.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.013 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 20.4 m -84.15 -27.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.647 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -165.61 -178.34 4.83 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.755 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 8.6 p90 -154.08 173.48 15.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 74.2 m-85 -160.91 141.12 11.14 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.802 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' B' ' 30' ' ' GLU . 2.1 mp0 -84.83 146.24 27.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 111.636 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 32.0 p -52.51 -108.57 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.948 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -150.57 -149.45 0.3 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.496 ' C ' ' H ' ' B' ' 35' ' ' CYS . 67.9 m -142.2 -24.6 0.67 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.279 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -54.77 -10.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.732 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.496 ' H ' ' C ' ' B' ' 33' ' ' SER . 4.1 p -118.71 123.03 43.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.505 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 45.2 p -72.61 35.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.347 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' B' ' 35' ' ' CYS . 26.0 mt-30 -155.04 56.16 1.35 Allowed Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -64.98 -167.86 0.1 Allowed 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 122.712 2.275 . . . . 0.0 112.827 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 173.21 176.57 0.11 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.787 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.1 t -107.82 131.85 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.95 129.81 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.657 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -110.82 146.16 36.91 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.972 0.415 . . . . 0.0 111.147 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -93.85 169.79 10.03 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 15.8 p -140.08 -143.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 111.089 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.36 -36.95 2.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.297 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.03 46.86 2.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.557 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 18.4 m -156.09 -80.48 0.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.532 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 154.72 -90.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.679 0.612 . . . . 0.0 109.759 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -143.68 144.18 31.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.439 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -149.31 120.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.636 . . . . 0.0 110.73 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 6.9 t -54.61 159.06 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.776 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.463 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.13 131.29 11.09 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.62 120.5 71.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 0.1 8.66 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.114 1.21 . . . . 0.0 111.242 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 90.0 p -67.99 -18.55 64.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.169 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -93.02 124.38 36.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.006 0.431 . . . . 0.0 110.29 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -50.87 -40.69 56.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.909 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.449 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 88.9 m95 -56.43 -33.48 65.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.047 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.89 -35.79 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.185 0.516 . . . . 0.0 109.706 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -68.7 -48.05 64.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.606 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -64.9 -35.79 82.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -62.02 -37.76 86.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.25 -44.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.85 -32.81 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.86 -38.29 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.42 -22.22 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.23 -31.06 63.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.416 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.44 -84.51 0.09 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.572 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.596 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.817 0.341 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -44.3 149.37 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.677 2.252 . . . . 0.0 112.154 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.03 87.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.502 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.4 p -169.66 68.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.479 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.1 mt 52.3 179.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.449 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -146.84 -175.34 4.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.349 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -57.48 130.37 45.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -72.89 -2.95 22.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -75.7 -33.47 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.6 m -49.47 131.06 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.498 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 127' ' ' SER . 4.9 t -59.84 -20.52 57.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.662 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 m -75.86 -21.39 57.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.283 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -87.37 -41.39 13.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.112 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -167.94 179.71 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.994 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.19 157.37 37.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.448 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -78.93 175.58 10.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.993 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -125.26 7.56 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.859 0.361 . . . . 0.0 110.302 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' GLU . 42.4 mm-40 -83.68 89.81 7.19 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.573 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' GLU . 42.2 mt-10 -23.51 -63.6 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.059 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.0 OUTLIER -76.68 49.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.594 0.235 . . . . 0.0 111.014 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -155.85 125.56 6.41 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 132' ' ' HIS . 27.5 m-70 -125.61 152.44 45.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' SD ' ' A' ' 202' ' ' MET . 11.6 t-160 -93.7 82.57 4.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.47 ' O ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -47.05 174.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.617 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.99 133.79 1.61 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.3 tt -111.17 146.1 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.381 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.99 140.04 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.66 139.82 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.152 0.501 . . . . 0.0 111.837 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.0 mt -114.58 149.19 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.189 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.46 107.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 232' ' ' LEU . 32.3 ttmt -110.69 95.05 5.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.38 133.72 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.933 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 m -107.97 124.85 50.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.024 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -76.61 149.48 36.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 37' ' ' GLN . 3.9 pt20 -73.14 159.12 34.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.38 40.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.798 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 35' ' ' GLN . 56.5 mt-30 -145.3 -28.51 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.2 m -68.32 115.72 32.29 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.414 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -40.29 158.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.79 1.66 . . . . 0.0 112.229 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.497 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 67.0 p -69.03 136.39 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 40' ' ' THR . 25.9 m120 -153.94 102.35 2.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.114 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -102.75 11.05 38.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 1.8 mptp? -70.36 88.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 pt -90.96 157.73 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.347 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m 57.18 39.44 28.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.307 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -55.51 -50.67 69.34 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.976 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.4 p -173.26 156.56 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.85 134.8 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.7 p -133.41 106.3 7.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.178 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -81.84 146.4 29.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.181 0.515 . . . . 0.0 110.862 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -142.06 156.22 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.255 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -152.53 151.67 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 54' ' ' SER . 19.4 tp10 -56.27 174.72 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -72.81 -28.26 62.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.938 0.399 . . . . 0.0 110.215 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 63.1 mm-40 -51.5 -62.7 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.303 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.1 t -60.06 -27.53 67.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.171 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -156.0 87.17 3.05 Favored Pre-proline 0 N--CA 1.464 0.251 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' SER . 85.7 Cg_endo -79.85 69.44 7.94 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.933 1.755 . . . . 0.0 112.779 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.635 ' H ' ' CD ' ' A' ' 60' ' ' PRO . 2.3 t70 -121.78 -38.75 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.884 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 59' ' ' ASP . 27.9 Cg_exo -61.72 -49.97 6.14 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.055 1.837 . . . . 0.0 112.137 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -49.5 -96.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.746 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.571 ' CG1' ' H ' ' A' ' 63' ' ' GLU . 3.6 p 178.17 -65.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.571 ' H ' ' CG1' ' A' ' 62' ' ' VAL . 4.3 tm-20 -173.05 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.273 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.5 t -43.79 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.63 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 63' ' ' GLU . 33.0 tt0 -166.54 105.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -60.8 139.84 57.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.66 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.03 -115.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.547 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.0 p -168.29 167.31 12.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.057 0.455 . . . . 0.0 111.054 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 70' ' ' SER . 2.1 m -162.57 22.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.646 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 69' ' ' THR . 1.9 m 165.15 -177.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.821 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.507 ' C ' ' H ' ' A' ' 73' ' ' ASP . 2.4 p 36.64 85.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 111.433 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -54.98 -7.4 0.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 71' ' ' VAL . 20.5 t70 -100.01 63.49 1.18 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.252 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -65.33 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.364 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -159.63 93.31 1.75 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -42.84 129.54 5.42 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.019 1.813 . . . . 0.0 112.09 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.85 150.45 21.07 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.225 1.95 . . . . 0.0 111.886 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 p -118.81 125.68 50.12 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.458 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 p -94.37 119.27 32.86 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.513 ' CE1' ' OD1' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -126.72 113.66 16.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.733 0.301 . . . . 0.0 110.569 -178.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 92' ' ' PHE . 11.9 p90 -113.01 122.22 46.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.967 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -92.07 76.88 5.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.318 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.74 110.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.402 0.62 . . . . 0.0 109.725 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.3 mt -93.21 145.84 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.437 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.28 159.11 10.28 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.211 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.65 27.54 68.37 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.046 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.23 18.25 72.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.94 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -134.61 159.02 42.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 110.544 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -122.3 110.24 15.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.1 mtt -100.17 99.59 10.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.124 0.487 . . . . 0.0 110.808 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' OD1' ' CE1' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -84.02 129.28 34.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.1 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 70.3 m-85 -112.94 -173.45 2.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.0 0.429 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.64 72.49 0.05 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.643 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.62 147.25 35.69 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.7 t -146.57 128.45 15.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm 59.3 29.94 19.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.515 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.2 146.47 40.73 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.47 153.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.681 1.587 . . . . 0.0 111.933 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.49 ' OE1' ' NZ ' ' A' ' 101' ' ' LYS . 3.4 pt20 -67.81 140.28 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.642 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.67 122.51 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.49 ' NZ ' ' OE1' ' A' ' 99' ' ' GLN . 47.1 mttp -126.36 -1.39 6.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.125 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 t -123.42 126.14 46.24 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.271 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.2 pt -147.89 139.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.858 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.1 p -146.46 177.06 9.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -158.64 155.36 28.06 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 p -155.45 151.63 28.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.229 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.47 110.34 11.79 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.639 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.401 ' O ' ' OG1' ' A' ' 111' ' ' THR . 11.1 p-10 -118.91 107.7 13.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.68 -126.8 18.73 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -100.79 24.06 9.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 110.24 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 108' ' ' ASP . 24.5 p -126.12 154.07 43.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.7 t -133.39 132.73 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -123.38 155.68 36.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.886 0.374 . . . . 0.0 110.768 -178.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.05 142.25 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.101 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -118.05 125.13 49.74 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -112.59 119.34 37.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.038 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 t -164.47 168.62 18.2 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.083 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.0 m -83.77 172.93 11.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.607 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -105.39 132.87 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.583 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.473 ' CB ' ' ND2' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -70.18 164.49 52.48 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.952 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.25 139.21 23.4 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.455 2.104 . . . . 0.0 112.103 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.24 -11.63 40.13 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.562 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.499 ' OE1' ' N ' ' A' ' 123' ' ' GLN . 12.2 mp0 -76.29 -50.79 13.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.82 -2.17 1.18 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.404 -0.427 . . . . 0.0 112.419 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -103.97 -176.89 3.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.89 161.44 30.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 1.9 t -156.48 68.33 4.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.809 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.16 115.24 2.23 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 122.68 2.253 . . . . 0.0 112.861 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.9 141.59 29.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.5 pt -137.88 175.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 111.128 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.9 m -83.48 161.16 21.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.788 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.579 ' NE2' ' CD2' ' A' ' 22' ' ' HIS . 21.0 m170 -58.63 -34.2 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.416 ' CD ' ' N ' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -61.34 -53.06 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.214 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -60.73 -43.95 97.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 138' ' ' MET . . . -59.95 -57.17 14.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.124 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -47.05 -39.07 12.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.988 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.82 62.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.344 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 135' ' ' ALA . 36.3 tpp -73.59 -29.67 62.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.83 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.35 -21.13 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.7 -37.37 18.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD2' ' CZ ' ' B' ' 18' ' ' ARG . 10.4 m-20 -85.43 -33.96 21.79 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.5 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.406 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 30.6 t -51.39 114.38 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.08 0.467 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 141' ' ' ASP . 0.3 OUTLIER -127.25 164.26 22.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 145' ' ' SER . 96.1 t -141.4 162.78 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.45 ' N ' ' CG1' ' A' ' 144' ' ' VAL . 88.0 p -143.37 145.66 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.637 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 mp -140.2 144.32 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.025 0.44 . . . . 0.0 110.594 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -157.89 79.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.612 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.4 mt -73.8 142.29 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.535 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -134.37 171.99 13.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.446 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.06 118.72 30.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.842 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 t -85.94 -173.51 4.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.26 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.401 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 6.9 tp10 -165.52 7.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -81.57 105.76 12.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.769 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 154' ' ' GLU . 20.1 mp0 -78.35 12.97 1.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -49.45 155.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.771 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.54 167.6 14.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.667 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.0 p -89.51 143.31 26.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.868 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -117.07 88.49 2.91 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.678 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.7 pt -110.14 177.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.119 0.485 . . . . 0.0 111.424 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 162' ' ' HIS . 73.7 tttt -137.33 125.95 23.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.781 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.4 m -59.22 -0.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.526 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.9 m80 -82.07 114.88 54.05 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.104 -0.239 . . . . 0.0 110.375 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -40.77 154.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.729 1.619 . . . . 0.0 112.184 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 49.2 t -77.28 136.56 24.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.577 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.8 mt -83.61 124.31 30.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.659 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 164.94 32.68 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.4 t -99.12 9.12 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.473 ' ND2' ' CB ' ' A' ' 120' ' ' SER . 7.1 m-20 59.11 -0.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.523 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.432 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.5 pp -82.03 173.56 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.989 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 172' ' ' LYS . 19.9 m -133.28 129.38 37.54 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -73.13 31.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.48 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 170' ' ' SER . 3.1 mmmm -64.61 -178.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -90.63 121.37 32.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.413 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.44 -167.3 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.727 0.299 . . . . 0.0 110.477 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.1 t -48.24 142.95 4.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.922 0.391 . . . . 0.0 110.88 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -95.72 129.09 43.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -141.43 141.07 33.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.033 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.1 91.6 4.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.581 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.08 -59.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 16.3 tt -50.26 122.28 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.48 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -91.66 -122.26 2.8 Favored Glycine 0 C--O 1.228 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.82 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.471 ' OG ' ' SG ' ' B' ' 51' ' ' CYS . 7.6 t -76.61 143.73 40.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.108 0.48 . . . . 0.0 112.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 62.8 m -139.89 84.97 2.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.103 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mt -103.89 103.83 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.942 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.1 m -120.83 134.27 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.8 p-10 -78.89 116.5 19.25 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.6 m -52.09 -29.24 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -36.18 -36.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.54 32.74 1.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.643 0.259 . . . . 0.0 110.486 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 92.4 t -149.71 95.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.35 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -61.92 1.81 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.498 ' ND2' ' OE1' ' A' ' 194' ' ' GLU . 22.3 t30 -122.55 137.41 54.9 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -145.27 122.51 11.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.498 ' OE1' ' ND2' ' A' ' 192' ' ' ASN . 2.7 mp0 -109.8 161.35 15.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.89 139.25 17.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.9 p -144.15 140.07 29.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.341 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.2 m -128.12 158.23 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -159.76 104.09 1.55 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.878 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 36.1 mt -106.99 118.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.67 -157.16 9.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.316 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 53.6 t0 -86.2 123.34 31.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 23' ' ' HIS . 55.2 mtp -78.12 0.26 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.326 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 5.7 t -112.4 -48.77 3.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.773 0.321 . . . . 0.0 110.628 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.44 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 3.2 tppp? -158.29 113.4 2.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.165 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -46.1 145.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 208' ' ' GLU . 7.5 t -130.23 25.25 5.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.495 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 84.1 p 52.93 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.602 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 206' ' ' SER . 33.5 tt0 -51.58 -34.24 36.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 209' ' ' LEU . 2.0 mm? -88.59 -4.18 58.63 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.787 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 206' ' ' SER . 14.5 mp0 -96.15 144.84 26.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.983 0.421 . . . . 0.0 110.793 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.0 m -153.98 175.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.592 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 227' ' ' THR . 25.1 tttt -170.23 147.01 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.478 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -140.86 168.54 19.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 174.68 145.08 5.17 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.624 -1.274 . . . . 0.0 113.052 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . 0.441 ' CZ ' ' OG ' ' B' ' 14' ' ' SER . 27.9 m-85 -129.37 164.9 22.6 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.45 103.27 5.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.427 ' O ' ' OD1' ' A' ' 192' ' ' ASN . 21.9 m-85 -97.44 116.5 29.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.817 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.76 101.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.311 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.6 t70 56.29 37.61 28.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.938 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.35 75.02 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.639 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.9 t -89.23 112.47 23.52 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.699 -0.295 . . . . 0.0 110.452 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.25 167.5 11.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.5 t -174.49 116.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.82 95.03 9.94 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -136.96 129.27 4.71 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 116.416 -0.357 . . . . 0.0 112.448 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -90.67 102.07 14.82 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.494 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.499 ' O ' ' NZ ' ' A' ' 212' ' ' LYS . 69.4 p -123.71 153.13 41.29 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.8 95.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -90.71 35.55 0.89 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.8 t -75.29 -39.62 59.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.309 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 99.3 p -102.56 3.78 37.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.339 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.488 ' O ' ' NZ ' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -48.41 -32.87 8.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.133 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.6 tt -135.06 150.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.242 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 236' ' ' THR . 4.0 p30 -87.41 92.39 9.06 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 45.8 m -60.66 -3.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.332 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 234' ' ' ASP . 30.7 p -91.01 -21.56 21.21 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -101.55 8.45 41.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.65 153.09 31.32 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.148 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -141.12 133.88 28.82 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.727 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.63 55.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.379 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 59.8 m -110.42 -1.93 16.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.528 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.817 0.342 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.56 115.84 2.0 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.762 2.308 . . . . 0.0 112.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -59.38 153.54 18.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.511 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.11 166.24 24.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.939 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 25.8 p -70.95 -86.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.694 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -127.91 80.88 71.38 Favored Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.738 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 27.2 Cg_exo -59.38 -174.91 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.502 2.135 . . . . 0.0 112.337 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 72.8 Cg_exo -53.79 -131.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.37 2.713 . . . . 0.0 113.818 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.493 ' O ' ' N ' ' B' ' 11' ' ' CYS . 1.8 t 177.21 41.93 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.731 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.53 93.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.538 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.539 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.6 m -134.76 146.33 49.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . 0.469 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 55.7 m -67.47 140.54 57.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.215 0.531 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 38.7 m-85 -117.33 -31.02 5.41 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.766 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 215' ' ' PHE . 2.7 m -140.88 145.29 35.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.04 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -109.28 152.22 25.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -78.43 139.56 38.73 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.599 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.1 -42.86 20.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.778 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.438 ' CZ ' ' OD2' ' A' ' 141' ' ' ASP . 0.9 OUTLIER -75.9 126.29 30.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.682 -179.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -77.12 137.85 39.16 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -92.79 110.71 47.29 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -44.62 150.09 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.041 1.827 . . . . 0.0 112.68 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.562 ' C ' ' H ' ' B' ' 24' ' ' PHE . 50.1 mtt85 -46.02 -44.03 14.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.751 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' B' ' 23' ' ' ASN . 2.0 m-20 -68.45 27.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.562 ' H ' ' C ' ' B' ' 22' ' ' ARG . 22.2 t80 -151.98 27.3 0.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -155.97 104.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.353 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.14 -10.75 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.7 t0 -161.88 -178.61 6.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.897 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.498 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 12.6 p90 -163.2 175.74 10.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.217 0.532 . . . . 0.0 111.658 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 59.9 t80 -167.18 140.81 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.837 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.3 pt-20 -89.44 147.33 24.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.781 0.324 . . . . 0.0 111.17 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.469 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 41.1 p -50.51 -107.29 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -151.7 -132.93 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.52 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.487 ' C ' ' H ' ' B' ' 35' ' ' CYS . 23.8 t -152.47 -25.28 0.17 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.684 0.278 . . . . 0.0 110.588 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 20.3 mt -57.7 -7.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.057 0.456 . . . . 0.0 109.921 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.487 ' H ' ' C ' ' B' ' 33' ' ' SER . 37.8 m -113.42 118.59 34.95 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.524 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 87.4 p -72.33 35.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.533 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.9 pt20 -167.59 61.71 0.57 Allowed Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.94 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.803 2.335 . . . . 0.0 113.134 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.57 176.37 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.834 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 72.7 t -103.4 139.15 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.038 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.44 124.26 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.794 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -100.64 148.78 24.45 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.035 0.445 . . . . 0.0 110.542 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.465 ' CG ' ' N ' ' B' ' 44' ' ' THR . 26.9 tt0 -93.15 169.22 10.57 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.465 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 17.6 p -138.11 -145.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 111.709 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.49 -40.24 1.96 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.736 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.17 47.05 2.14 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.794 -0.184 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 8.6 t -156.2 -79.23 0.08 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.504 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 155.59 -90.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -143.76 147.97 34.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.438 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.6 t -150.28 114.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.259 0.552 . . . . 0.0 111.021 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.471 ' SG ' ' OG ' ' A' ' 182' ' ' SER . 74.5 m -50.12 159.99 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.704 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 130.59 10.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.34 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' B' ' 53' ' ' ASP . 23.4 p-10 -66.17 125.45 90.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.33 -2.06 11.84 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.141 1.227 . . . . 0.0 111.011 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 36.2 t -69.2 -12.22 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.199 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -101.02 122.65 43.92 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.132 0.491 . . . . 0.0 110.307 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 45.2 t -48.17 -46.86 35.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.496 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 35.4 p-90 -56.27 -24.71 44.71 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.572 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -75.26 -38.08 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 109.771 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -66.6 -48.43 69.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.41 -34.98 77.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -61.8 -40.81 96.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.36 -47.71 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.06 -31.43 65.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.748 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -73.7 -35.16 65.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.91 -20.01 59.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -73.27 -35.76 66.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.77 -77.46 0.14 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.342 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 p30 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.524 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.9 tpt . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 1' ' ' MET . 60.6 Cg_endo -89.43 -49.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.225 1.95 . . . . 0.0 111.986 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.93 86.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.603 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 m -166.28 61.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.505 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.4 mt 50.7 -177.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.461 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -170.02 69.13 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.613 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' C ' ' H ' ' A' ' 9' ' ' SER . 78.6 mt-30 -70.49 -20.21 62.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.52 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 7' ' ' GLN . 3.7 p 74.22 -26.86 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.787 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 7' ' ' GLN . 10.1 t -72.82 -25.5 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.796 0.331 . . . . 0.0 110.755 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.403 ' O ' ' OG ' ' A' ' 13' ' ' SER . 13.3 t -51.53 144.16 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.54 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -68.07 -28.57 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -76.88 -22.68 53.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.628 ' HG ' ' N ' ' A' ' 14' ' ' SER . 90.8 p -81.11 -49.0 11.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.628 ' N ' ' HG ' ' A' ' 13' ' ' SER . 15.6 m -162.24 169.98 19.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.026 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 t -63.84 153.43 36.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.68 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.7 p -72.84 172.36 10.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.461 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.68 2.69 9.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 1.6 mp0 -77.78 98.17 5.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.439 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -31.17 -53.53 0.21 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.694 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -86.65 52.06 2.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 110.682 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 16.7 tttm -160.26 133.46 6.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 110.246 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.44 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 70.6 m-70 -154.35 124.31 6.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.523 ' CE1' ' CG ' ' A' ' 121' ' ' PRO . 11.1 p80 -76.68 97.2 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.53 149.13 40.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.61 158.38 26.56 Favored Glycine 0 CA--C 1.508 -0.388 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 tt -110.33 150.73 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -152.1 106.44 3.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 110.008 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.86 126.7 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.991 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.97 166.47 4.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 tt -161.2 110.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.796 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -98.3 132.9 43.4 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.03 120.67 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.995 0.426 . . . . 0.0 110.844 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.525 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 68.4 p -88.33 121.26 30.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CB ' ' HZ1' ' A' ' 34' ' ' LYS . 9.6 mtmp? -75.81 150.76 37.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.75 136.44 40.3 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.82 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -46.77 -19.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 1.3 mp0 -81.31 -43.89 18.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.547 0.213 . . . . 0.0 111.16 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -42.7 147.77 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.067 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.71 172.1 16.81 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.122 1.881 . . . . 0.0 111.446 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.7 p -74.02 135.23 43.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.474 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -167.09 99.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.47 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -103.64 -1.08 28.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.535 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -67.87 91.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.8 160.49 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.907 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 36.9 t 55.26 62.87 2.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.507 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.557 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.4 tp60 -77.44 -27.55 52.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.1 p -174.2 -176.19 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.888 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 p -170.36 101.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 109.956 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.8 p -103.38 126.7 50.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 1.5 pm0 -104.39 142.51 34.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.964 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.99 157.9 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -153.37 151.61 30.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 52.0 tt0 -48.0 168.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 p -70.07 -23.73 63.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.006 0.432 . . . . 0.0 110.06 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -42.77 -61.51 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.045 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 m -27.15 -96.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.393 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.629 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 18.9 t70 -170.99 -33.15 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.629 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 91.9 Cg_endo -90.62 -65.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.993 1.796 . . . . 0.0 113.437 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -40.73 103.11 0.28 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -90.9 60.42 1.3 Allowed 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.221 1.947 . . . . 0.0 112.02 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 63' ' ' GLU . 21.2 mt-10 -62.29 89.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 61' ' ' GLU . 17.1 m 10.32 55.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 124.255 0.972 . . . . 0.0 113.517 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 61' ' ' GLU . 6.6 tp10 -43.12 172.75 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.871 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 3.5 p 145.53 50.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.942 0.776 . . . . 0.0 109.736 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -170.8 159.75 6.54 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.035 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 69.85 62.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.025 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.96 -122.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.904 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.6 t -74.68 85.47 2.13 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.4 p -151.67 158.71 43.8 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.734 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 93.2 p 50.7 -162.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.764 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -153.71 67.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.985 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 59.55 75.77 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.425 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 74' ' ' VAL . 25.0 t70 -76.86 -139.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.323 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 60.7 t -91.84 -40.27 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.782 0.325 . . . . 0.0 110.596 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 43.1 75.84 0.59 Allowed Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.966 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -89.51 110.68 0.48 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.203 2.602 . . . . 0.0 112.638 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -87.6 164.3 7.87 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.474 2.116 . . . . 0.0 111.039 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -124.27 121.95 36.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 111.001 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 p -97.76 125.45 42.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -121.47 110.49 16.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.248 0.547 . . . . 0.0 111.019 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -93.73 124.09 37.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.519 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' ' CZ ' ' A' ' 80' ' ' TYR . 4.9 m -94.53 72.9 3.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.051 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.3 mm -74.67 101.73 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.801 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.6 mm -94.25 145.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.021 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.55 169.71 18.17 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.502 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.1 20.48 54.1 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.22 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.28 10.84 84.41 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 mt -131.98 155.62 47.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.58 115.45 27.2 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.3 mtt -102.07 124.16 47.2 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.04 0.448 . . . . 0.0 110.939 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.512 ' C ' HD21 ' A' ' 91' ' ' ASN . 0.2 OUTLIER -114.18 133.1 55.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.729 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.38 -174.73 2.86 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.821 0.343 . . . . 0.0 110.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.52 74.13 0.1 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.077 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -76.98 135.35 38.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.7 m -143.65 121.12 11.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.449 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? 65.0 31.72 11.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.979 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.2 m -126.42 149.81 68.58 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.22 143.51 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.999 1.799 . . . . 0.0 111.978 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.434 ' CD ' ' N ' ' A' ' 99' ' ' GLN . 4.2 mp0 -73.21 110.03 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.849 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.4 pt -69.13 142.1 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -135.34 -6.89 2.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.349 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.2 m -107.36 119.54 39.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.81 0.338 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 34.8 mt -132.04 120.02 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.1 p -146.58 162.87 37.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 111.015 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -148.39 164.83 32.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -155.12 151.86 28.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.911 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.08 124.9 33.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.424 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -145.22 111.43 5.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.002 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 -127.14 8.96 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -108.29 24.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.753 0.311 . . . . 0.0 110.32 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 p -129.16 159.17 36.88 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.637 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t -139.09 137.17 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 106' ' ' SER . 50.9 p30 -120.93 153.21 37.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.465 . . . . 0.0 111.006 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.21 130.66 19.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.605 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -116.52 116.49 27.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 110.899 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.3 mt -116.25 126.72 53.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 p -166.68 167.42 15.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.508 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 167' ' ' SER . 74.0 m -84.28 172.82 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.686 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 m -96.18 147.92 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 111.024 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.466 ' OG ' ' ND2' ' A' ' 168' ' ' ASN . 1.6 t -92.71 152.2 41.63 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CG ' ' CE1' ' A' ' 23' ' ' HIS . 74.0 Cg_exo -37.89 158.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.21 64.45 3.81 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.175 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -140.99 -1.12 1.41 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 11.15 82.59 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.439 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -136.47 150.14 48.56 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.53 154.72 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.982 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -158.44 60.72 1.84 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.384 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -35.53 143.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.333 2.689 . . . . 0.0 113.715 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.45 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -109.96 146.56 35.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.568 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.01 165.81 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 110.186 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -87.44 174.48 8.49 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' OG1' ' A' ' 131' ' ' THR . 2.0 t60 -63.92 -39.33 93.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.34 -57.52 12.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.28 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -63.18 -42.26 99.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.538 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.16 -57.01 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.177 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.86 -36.68 59.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.056 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.48 -37.66 71.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 21.1 mtt -62.34 -58.43 7.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -24.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.859 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -78.29 -55.27 5.38 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.376 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.41 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 33.9 m-20 -77.82 -23.65 48.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 19.0 t -58.07 113.59 1.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.526 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.511 ' CD ' ' HE ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -143.51 148.3 35.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.269 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.95 131.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.931 0.396 . . . . 0.0 110.309 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.6 p -103.19 173.12 6.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 15.1 pt -150.78 148.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.776 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -152.19 83.37 1.26 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.879 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.58 154.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 34.1 ttt85 -145.36 172.17 13.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.022 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 6.2 t -91.02 116.16 28.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.774 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.8 p -92.94 -176.85 4.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.208 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.9 6.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.295 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.469 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 63.8 tt0 -70.24 107.01 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.95 16.25 6.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.557 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 3.9 mmmm -60.73 172.72 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.674 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -76.55 169.65 17.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.636 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 71.6 m -96.6 147.65 23.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.47 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 16.3 t70 -113.18 90.94 3.48 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 160' ' ' LYS . 63.6 mt -115.11 159.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.17 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 162' ' ' HIS . 6.7 mmtp -121.9 128.93 52.13 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.9 p -62.55 1.97 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 160' ' ' LYS . 80.1 t60 -78.72 116.91 63.36 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -40.39 150.12 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.654 1.569 . . . . 0.0 111.939 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.85 137.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.898 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.6 mt -78.01 147.43 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.753 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -119.46 156.96 15.61 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.091 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 169' ' ' ILE . 3.5 m -89.57 10.31 23.43 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.466 ' ND2' ' OG ' ' A' ' 120' ' ' SER . 10.6 m-20 56.5 1.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.502 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.52 ' H ' ' C ' ' A' ' 167' ' ' SER . 8.4 tp -94.33 144.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 26.6 p -105.65 149.91 25.92 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -83.83 46.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.373 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -73.0 -177.16 2.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -93.55 117.56 30.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.538 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.502 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 13.3 m -139.83 -171.24 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.145 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.1 t -43.31 138.15 2.41 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.77 0.319 . . . . 0.0 110.898 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.502 ' CE1' ' O ' ' A' ' 174' ' ' VAL . 2.3 m-85 -98.95 136.79 38.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.252 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 178' ' ' ASP . 5.1 tm-20 -151.84 158.11 42.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.506 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 4.5 p-10 -92.94 93.36 8.33 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.42 17.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.126 0.488 . . . . 0.0 110.016 178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 pp -113.14 119.11 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.292 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.59 -142.67 2.64 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.876 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.438 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 37.5 t -69.33 158.96 34.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.434 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -144.6 95.06 2.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.114 0.483 . . . . 0.0 110.151 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.8 132.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.655 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.426 ' O ' ' CG2' ' A' ' 185' ' ' VAL . 3.3 m -142.74 123.02 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.691 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.6 p-10 -85.08 98.06 10.21 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 189' ' ' CYS . 31.3 m -47.58 -26.88 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.592 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -39.82 -26.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 187' ' ' THR . 94.0 m -146.31 24.94 1.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.185 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 23.3 t -148.5 95.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.74 -54.9 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.525 ' H ' ' HG1' ' A' ' 33' ' ' THR . 7.2 m-20 -125.35 -176.57 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.753 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.7 tt -172.88 109.16 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -96.12 121.3 37.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -120.73 129.88 53.82 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.038 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.9 p -144.58 134.22 23.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.88 154.91 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.53 144.77 30.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.237 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.8 mt -148.99 117.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.568 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.44 172.53 45.55 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.416 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.43 119.92 10.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 0.0 111.326 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 49.7 mtm -77.17 4.18 10.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.7 t -97.23 -61.74 1.36 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.437 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -147.49 115.02 6.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.323 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -43.64 123.23 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.633 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.0 t -117.16 105.05 11.83 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.652 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.3 m -38.21 -36.97 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.156 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.83 -48.98 62.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.527 ' N ' ' CD2' ' A' ' 209' ' ' LEU . 2.5 mm? -90.42 13.88 14.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.245 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 128.16 42.65 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 212' ' ' LYS . 74.6 t -153.31 161.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.374 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.479 ' HZ1' ' CA ' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -167.38 160.34 13.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.473 0.654 . . . . 0.0 112.444 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.6 t70 -146.5 171.39 15.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.352 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 162.89 145.4 4.34 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.902 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.23 -171.4 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -152.93 108.14 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.439 0.638 . . . . 0.0 111.439 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 217' ' ' TYR . 0.1 OUTLIER -96.85 123.66 40.61 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.601 ' C ' ' H ' ' A' ' 220' ' ' GLY . 6.2 p -141.06 118.31 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.4 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.0 t70 59.92 -13.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.308 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.601 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 140.08 0.44 1.93 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 t -104.11 117.5 34.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.58 156.24 17.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.906 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.3 t -166.17 123.26 1.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -81.28 99.09 8.44 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -120.55 134.51 10.36 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.934 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.479 ' CA ' ' HZ1' ' A' ' 212' ' ' LYS . . . -98.39 98.09 9.36 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 70.0 p -134.73 163.34 30.0 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.401 ' OD2' ' OG1' ' A' ' 230' ' ' THR . 22.4 t70 -66.16 95.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.486 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.69 28.96 0.73 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.712 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.401 ' OG1' ' OD2' ' A' ' 228' ' ' ASP . 27.6 m -64.21 -57.09 10.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.165 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 m -84.57 1.25 46.79 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.544 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.35 -29.5 0.15 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.75 0.31 . . . . 0.0 111.413 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.4 pp -152.29 145.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.304 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.79 93.08 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' SER . . . . . 0.428 ' O ' ' CD2' ' A' ' 238' ' ' LEU . 31.4 t -64.42 -2.54 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.188 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 74.3 m -93.73 -19.41 21.1 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 237' ' ' LYS . 3.3 mptp? -98.76 -2.38 38.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 235' ' ' SER . 1.1 pt? -91.04 158.2 16.82 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.363 0.983 . . . . 0.0 111.223 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -131.92 151.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.617 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.57 161.62 1.96 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.723 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 54.0 t -124.19 -13.78 7.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.017 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.588 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.731 0.3 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -45.65 121.45 4.07 Favored 'Trans proline' 0 N--CA 1.473 0.317 0 C-N-CA 122.732 2.288 . . . . 0.0 112.265 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -56.71 144.29 33.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.482 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.1 152.17 48.16 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.141 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.4 t -60.11 173.88 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 121.153 -0.219 . . . . 0.0 110.43 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -31.27 96.96 0.1 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' B' ' 8' ' ' PRO . 63.9 Cg_endo -87.62 161.39 7.9 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.351 2.034 . . . . 0.0 110.903 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' B' ' 7' ' ' PRO . 25.1 Cg_exo -34.61 -118.81 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.838 3.026 . . . . 0.0 114.296 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.629 ' CG2' ' H ' ' B' ' 10' ' ' ALA . 0.9 OUTLIER 177.42 -75.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.019 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.629 ' H ' ' CG2' ' B' ' 9' ' ' THR . . . 80.72 57.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.0 m -104.57 151.8 23.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -55.48 139.94 41.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.133 0.492 . . . . 0.0 112.008 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 8.8 m-85 -112.17 -27.26 8.43 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.7 t -158.42 158.8 34.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.489 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.39 -178.2 3.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.18 0.514 . . . . 0.0 111.778 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.564 ' HG1' HH11 ' B' ' 18' ' ' ARG . 9.8 t -99.05 135.83 39.9 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.78 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.4 12.12 4.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.564 HH11 ' HG1' ' B' ' 16' ' ' THR . 0.0 OUTLIER -148.92 136.64 20.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.023 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -79.54 130.31 35.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -84.12 114.46 54.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.546 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.34 141.87 1.97 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.783 1.655 . . . . 0.0 112.168 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.544 ' C ' ' H ' ' B' ' 24' ' ' PHE . 46.0 mtt85 -44.18 -42.62 6.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.597 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -69.77 28.24 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.544 ' H ' ' C ' ' B' ' 22' ' ' ARG . 23.2 t80 -153.12 29.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -155.03 99.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.902 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.48 -9.35 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.6 t70 -163.85 -178.97 6.0 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.883 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . 0.504 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.2 p90 -165.09 172.44 12.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.285 0.564 . . . . 0.0 111.652 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.441 ' CZ ' ' OD2' ' B' ' 27' ' ' ASP . 76.7 m-85 -153.87 179.63 8.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.064 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -125.5 147.38 49.26 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.843 0.354 . . . . 0.0 110.081 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.439 ' HG1' ' H ' ' B' ' 32' ' ' SER . 36.9 p -53.92 -106.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.439 ' H ' ' HG1' ' B' ' 31' ' ' THR . 14.5 t -157.7 -142.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.595 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.495 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.3 m -145.65 -22.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.296 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -56.83 -7.46 0.45 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.495 ' H ' ' C ' ' B' ' 33' ' ' SER . 3.6 p -121.29 122.51 40.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 86.1 p -74.55 42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.195 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -167.69 57.0 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -68.94 -164.2 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 175.59 176.82 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.972 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.47 135.05 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.021 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.71 134.28 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.217 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -108.34 151.74 25.58 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.707 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.13 168.84 10.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 7.5 p -135.6 -144.96 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.343 0.592 . . . . 0.0 111.132 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ALA . . . . . 0.412 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.46 -38.82 1.33 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.988 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.47 46.24 2.34 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.728 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 15.5 t -156.58 -81.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.532 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' B' ' 47' ' ' SER . . . 156.16 -87.79 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.93 148.02 32.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.98 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -152.32 123.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 109.844 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.438 ' H ' ' CB ' ' A' ' 182' ' ' SER . 5.4 t -58.36 164.44 2.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.979 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.9 134.62 13.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.717 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -68.21 120.13 72.43 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.05 -0.02 8.49 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.065 1.177 . . . . 0.0 111.318 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 59.5 p -74.11 -9.1 58.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.28 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -102.28 125.65 49.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 110.422 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -47.47 -50.07 24.04 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 64.4 p-90 -56.13 -27.56 54.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.758 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.48 -38.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -67.12 -51.6 52.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.357 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.81 -35.46 70.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.517 ' HH ' HH21 ' B' ' 22' ' ' ARG . 3.0 m-85 -62.88 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -71.01 -46.38 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.92 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.17 -28.85 69.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.27 -41.07 61.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.699 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.34 -22.5 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -69.93 -33.56 72.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.2 -102.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.6 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.0 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.809 0.338 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -76.0 -29.29 58.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 m -49.26 129.8 18.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.511 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -58.6 -21.89 54.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.536 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.2 p -77.44 -20.12 55.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 m -82.95 -50.47 8.54 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.989 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -165.42 173.43 11.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.972 0.415 . . . . 0.0 111.095 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.86 159.28 3.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.4 p -85.06 173.76 10.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.917 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -119.25 5.36 11.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.319 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.29 92.87 7.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.75 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 19' ' ' GLU . 17.9 mp0 -27.6 -63.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.506 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -77.16 53.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 22' ' ' HIS . 19.9 tttp -163.08 137.13 6.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 63.0 m80 -157.42 123.22 4.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.81 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 128' ' ' PRO . 2.0 t60 -64.67 109.26 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 111.219 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.627 ' HE2' HD11 ' A' ' 139' ' ' ILE . 72.9 mmm -84.43 137.44 33.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.381 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.57 156.56 22.51 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' CG1' ' A' ' 197' ' ' VAL . 7.5 tp -110.7 151.25 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -157.27 106.56 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 110.253 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.86 148.97 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.313 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' A' ' 171' ' ' HIS . 10.1 mt -117.45 145.77 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.69 108.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.992 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -106.3 96.07 6.21 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -91.18 134.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.466 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 192' ' ' ASN . 29.8 m -113.92 121.68 44.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.692 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -77.5 151.04 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.721 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.462 ' CD ' ' N ' ' A' ' 36' ' ' ASP . 13.5 tm0? -80.07 148.96 30.83 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 15.4 t70 -72.76 65.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.721 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -172.09 -23.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 0.0 110.114 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.2 m -75.14 121.78 85.97 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.214 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.444 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 63.2 Cg_exo -39.62 159.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.87 1.713 . . . . 0.0 112.318 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -73.57 147.14 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.353 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 2.0 p30 -174.08 101.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -112.27 25.42 11.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -86.12 54.62 3.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.83 176.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.007 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.9 m 55.6 34.99 24.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.48 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 29.8 tp60 -59.72 -43.06 94.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.054 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 t 178.71 165.52 0.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.055 0.455 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.2 134.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.538 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.4 m -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -82.98 141.62 31.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.588 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -143.39 154.37 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.92 110.73 4.06 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 78' ' ' THR . 0.9 OUTLIER -64.79 115.59 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.298 -178.031 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.52 -0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.094 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 CA--C 1.54 0.797 0 N-CA-C 113.111 0.389 . . . . 0.0 113.111 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.412 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 19.4 p -131.32 150.66 52.06 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.619 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.9 m -121.05 128.22 52.44 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -127.37 153.88 45.67 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.0 0.429 . . . . 0.0 110.496 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 64.4 m-85 -128.85 137.45 51.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.964 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.5 p -105.03 66.18 0.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.062 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.68 98.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.842 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.73 145.09 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.63 161.97 11.5 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.3 25.62 65.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.187 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.06 65.3 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.595 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.2 163.0 30.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.934 0.397 . . . . 0.0 110.084 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -129.95 112.46 13.53 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.445 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 mpt? -101.09 106.95 18.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.958 0.408 . . . . 0.0 110.662 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -88.84 128.63 35.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.74 -162.95 1.0 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.624 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.1 70.45 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 5.0 p90 -89.0 156.16 19.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -141.46 125.64 17.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm 61.93 35.08 16.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.531 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 m -121.84 146.02 44.88 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -39.1 148.03 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.928 1.752 . . . . 0.0 112.159 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -64.46 145.05 56.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.5 mt -108.47 116.64 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -119.28 0.8 11.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -115.38 118.26 32.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.503 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.33 120.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.8 m -144.91 159.25 43.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.857 0.36 . . . . 0.0 110.738 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -148.76 168.33 23.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.82 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.71 159.34 24.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.511 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.18 127.7 36.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.545 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -142.25 107.6 5.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.482 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.23 -134.38 19.61 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -96.43 23.38 6.83 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.778 0.323 . . . . 0.0 110.383 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -130.54 159.34 37.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.434 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.03 138.86 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.471 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -108.34 171.38 7.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 111.647 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.5 120.44 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.482 ' NH2' ' OG ' ' A' ' 235' ' ' SER . 7.3 tpp85 -113.97 114.9 26.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.826 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 115' ' ' ARG . 10.8 mp -115.84 127.42 55.03 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.4 p -164.7 175.96 9.26 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.664 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.421 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 73.6 p -92.79 166.36 12.47 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 119' ' ' VAL . 12.6 m -92.55 145.5 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 0.0 110.879 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.2 p -89.26 150.09 44.15 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.32 162.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.776 1.65 . . . . 0.0 112.21 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.13 69.99 0.84 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.136 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.11 -46.13 0.43 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.21 -8.09 2.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.081 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -117.57 -176.86 3.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.63 170.13 12.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -163.21 61.89 1.1 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.946 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.501 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 97.1 Cg_exo -42.87 125.16 3.84 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.84 2.36 . . . . 0.0 113.484 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.31 149.92 21.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -149.57 163.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 p -79.61 177.42 8.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -71.25 -34.74 71.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.42 -43.88 80.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.95 -30.57 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.41 -56.52 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.162 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -32.58 39.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.163 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.1 66.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.512 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.1 mtt -63.69 -56.72 13.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.626 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.627 HD11 ' HE2' ' A' ' 24' ' ' MET . 50.5 mt -46.35 -22.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -86.19 -42.06 14.14 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.72 -27.16 25.45 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.53 119.38 3.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -138.72 125.0 20.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.338 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 145' ' ' SER . 93.4 t -94.49 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.479 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.573 ' N ' HG12 ' A' ' 144' ' ' VAL . 12.4 p -140.22 144.54 36.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.386 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.1 mt -140.83 143.1 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.984 0.421 . . . . 0.0 110.595 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -158.29 77.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.027 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.62 152.0 6.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -134.7 -149.11 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.344 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.4 t -132.67 108.97 9.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.216 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 m -97.25 173.08 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.5 10.79 0.97 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.927 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -64.22 104.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.759 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.24 1.93 30.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -52.34 150.15 4.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.565 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.03 171.59 1.69 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.162 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 80.5 p -97.83 149.62 22.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.922 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -121.5 93.35 3.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.735 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.476 ' C ' HD12 ' A' ' 159' ' ' ILE . 1.6 pp -110.35 178.1 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.807 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 162' ' ' HIS . 42.9 tttp -135.64 125.9 26.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.831 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 161' ' ' THR . 35.3 m -57.95 -2.33 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.24 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.3 t-80 -75.08 116.36 53.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.376 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -40.49 160.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.81 1.674 . . . . 0.0 111.97 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.31 129.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 mt -79.03 121.26 24.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.56 160.68 22.76 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.303 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -92.04 8.08 39.36 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 58.75 -0.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.494 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.493 ' H ' ' C ' ' A' ' 167' ' ' SER . 9.4 tp -90.73 141.82 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -88.58 -176.53 5.32 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.454 ' CD2' HD11 ' A' ' 29' ' ' ILE . 4.6 m-70 -123.73 24.2 8.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -58.26 -166.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -101.8 122.94 44.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.07 -168.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.254 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.7 m -49.78 148.54 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.425 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 54.5 p90 -98.34 133.38 42.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.07 132.34 23.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.39 97.85 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.568 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.5 mt -107.86 -51.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -56.23 115.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.946 0.403 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.78 -123.86 0.7 Allowed Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.1 t -75.2 148.7 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.763 0.316 . . . . 0.0 110.759 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.3 p -141.81 87.23 2.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.556 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.468 HD11 ' HB1' ' B' ' 10' ' ' ALA . 8.8 tp -98.87 135.58 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.9 129.96 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.711 0.291 . . . . 0.0 111.526 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -81.79 90.02 6.35 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -46.25 -27.22 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.279 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -44.93 -16.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.76 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 187' ' ' THR . 57.0 m -143.71 24.55 1.69 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 p -163.98 104.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.512 0.672 . . . . 0.0 110.313 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -72.21 -56.52 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.493 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.456 ' H ' ' HB ' ' A' ' 33' ' ' THR . 10.6 m-20 -125.71 141.1 52.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.236 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.1 tt -145.34 106.74 4.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.66 151.86 19.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.05 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -140.77 138.03 33.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 110.242 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.8 m -143.85 135.92 26.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.347 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 198' ' ' ARG . 21.3 t -134.2 160.06 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.462 ' N ' HG12 ' A' ' 197' ' ' VAL . 39.8 ttt180 -171.79 113.87 0.34 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.985 0.421 . . . . 0.0 110.842 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.3 128.96 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.791 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.76 167.71 40.36 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.224 -0.512 . . . . 0.0 111.938 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -53.46 123.34 11.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.421 ' SD ' ' OG ' ' A' ' 118' ' ' SER . 77.9 mtm -82.74 4.67 24.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 34.8 t -106.88 -46.76 3.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.69 117.56 2.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 6.0 mp0 -43.98 156.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.701 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 208' ' ' GLU . 17.9 t -141.11 17.8 2.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.646 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 208' ' ' GLU . 73.7 p 56.28 -74.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.0 mm-40 -49.25 -54.41 16.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.57 0.224 . . . . 0.0 111.597 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.4 mp -74.57 4.38 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -104.0 124.21 48.61 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.8 m -146.56 -179.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.22 167.55 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.485 0.66 . . . . 0.0 111.834 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 213' ' ' ASP . 0.6 OUTLIER -157.3 172.9 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.956 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 157.3 143.4 3.65 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.496 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -121.15 179.28 4.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.98 104.16 5.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.406 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -97.72 118.71 34.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.877 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.1 t -138.34 100.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.38 52.45 13.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.923 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.99 48.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.646 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.9 t -85.63 106.03 16.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 111.479 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.5 143.96 32.03 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.2 m -164.63 130.85 2.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.647 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -82.25 140.91 33.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.351 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -177.71 110.8 0.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.63 127.39 32.85 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 47.1 p -150.21 161.07 43.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.09 95.52 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.607 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -87.21 26.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.286 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.6 m -67.13 -29.57 69.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.6 t -116.57 5.89 13.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.664 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.7 OUTLIER -42.28 -28.43 0.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 35.9 pt -156.39 152.01 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.33 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.11 98.92 4.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.482 ' OG ' ' NH2' ' A' ' 115' ' ' ARG . 23.3 t -64.08 -9.58 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.298 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 64.3 p -82.79 -12.37 57.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -102.74 7.44 39.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.576 0.227 . . . . 0.0 111.386 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -81.32 132.04 35.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.097 0.475 . . . . 0.0 110.786 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -123.15 135.55 54.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.388 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.74 127.3 31.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.104 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 34.0 m -88.58 -3.72 58.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.695 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 242' ' ' VAL . 11.7 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.434 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 1.8 t -97.11 154.06 17.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.691 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.65 146.59 48.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -116.84 -23.46 8.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.335 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -151.54 154.9 37.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.108 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -114.95 154.82 28.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.91 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -76.38 139.75 41.1 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 -20.94 40.54 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.149 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -105.54 127.88 53.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -84.51 114.34 21.87 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.465 HD12 ' N ' ' B' ' 20' ' ' LEU . 10.9 mp -75.45 115.15 42.84 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.903 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.67 153.44 0.15 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.045 1.83 . . . . 0.0 112.606 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 25' ' ' VAL . 84.5 mtp180 -45.7 -49.89 14.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.67 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -38.89 -34.69 0.16 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 0.9 OUTLIER -106.08 38.18 2.09 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.934 0.397 . . . . 0.0 109.983 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' B' ' 22' ' ' ARG . 48.8 t -152.95 97.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.571 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.7 -13.86 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.88 179.48 9.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.189 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.492 ' O ' ' CD2' ' B' ' 29' ' ' TYR . 13.4 p90 -165.56 169.92 14.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.187 0.518 . . . . 0.0 111.796 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' B' ' 28' ' ' TYR . 94.5 m-85 -159.0 153.62 24.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.601 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' B' ' 31' ' ' THR . 41.6 mt-10 -97.71 147.31 24.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.854 0.359 . . . . 0.0 111.11 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 41.9 p -53.11 -110.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.146 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.7 m -150.81 -145.72 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.666 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.457 ' C ' ' H ' ' B' ' 35' ' ' CYS . 65.9 p -141.38 -22.9 0.74 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.424 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.23 -5.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.1 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.458 ' C ' ' H ' ' B' ' 37' ' ' GLN . 8.6 p -117.5 120.83 39.3 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 34.4 t -72.66 36.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.245 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' B' ' 35' ' ' CYS . 11.9 pt20 -167.51 60.86 0.53 Allowed Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 68.7 Cg_endo -70.16 -161.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.665 2.243 . . . . 0.0 112.83 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.48 176.92 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 134.98 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.67 130.32 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.018 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -111.26 146.51 36.87 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.48 169.06 10.63 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -136.12 -142.92 0.18 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.249 0.547 . . . . 0.0 111.092 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.499 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.53 -40.46 2.22 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.848 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.47 47.88 2.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.39 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 59.6 p -151.48 -79.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.422 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.58 -90.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.76 147.67 35.95 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.954 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.63 123.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.021 0.438 . . . . 0.0 110.111 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.76 162.26 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.242 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.5 125.71 7.32 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.762 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.14 123.06 82.99 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 0.37 8.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.235 1.29 . . . . 0.0 111.357 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 62.2 p -68.22 -14.7 63.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -100.08 124.02 44.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -50.86 -38.38 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.989 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -56.4 -33.69 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.744 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.89 -36.35 57.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.123 0.487 . . . . 0.0 109.887 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.72 -37.94 73.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.482 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -71.01 -35.69 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.176 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.05 -37.65 88.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.71 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 60.9 t -70.67 -45.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.93 -38.97 80.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.986 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.1 -41.72 90.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.932 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.25 -19.81 63.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.51 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.33 66.2 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.9 mt -76.4 -77.49 0.14 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.896 0.379 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.529 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.824 0.345 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -76.58 -23.91 53.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.685 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -51.08 139.59 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.6 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 p -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.702 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -77.59 -28.7 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.71 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.9 p -78.55 -50.79 10.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.999 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -161.92 172.6 15.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.705 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.41 150.59 47.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.346 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.43 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 12.4 t -63.48 170.45 3.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 0.0 110.742 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 23.8 mp0 -113.06 4.88 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.593 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -61.98 -164.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.964 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -127.01 -62.85 1.09 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.0 110.72 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -82.15 34.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.535 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.93 142.5 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -144.43 159.75 42.22 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.0 OUTLIER -88.02 81.56 7.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.852 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.605 ' N ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -69.33 123.67 21.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.65 179.31 17.03 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 tt -136.0 154.92 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.747 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 53.8 t0 -145.67 137.65 25.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG13 ' CZ ' ' A' ' 195' ' ' PHE . 91.9 t -137.95 107.87 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.538 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.3 mp -94.28 142.62 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.659 ' H ' HH21 ' A' ' 115' ' ' ARG . 9.1 tt -155.62 117.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.54 0.686 . . . . 0.0 111.482 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -104.52 127.65 52.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.663 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -125.31 117.1 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.043 0.449 . . . . 0.0 111.89 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 m -96.79 132.98 41.96 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -94.54 164.0 13.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.926 0.394 . . . . 0.0 109.971 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.76 157.1 37.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.019 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -83.02 -34.67 26.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.993 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.2 m -45.04 110.77 1.14 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.03 159.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.725 1.616 . . . . 0.0 111.998 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -70.04 137.92 51.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.796 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -157.68 102.87 1.89 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 44' ' ' ILE . 14.5 t70 -101.6 -12.93 18.08 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.762 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -58.4 81.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.977 0.418 . . . . 0.0 110.548 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.5 tp -86.56 156.25 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 12.4 t 57.08 61.8 2.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.539 0.685 . . . . 0.0 110.048 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 155' ' ' LYS . 7.9 tt0 -80.26 -30.07 38.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.0 m -171.54 166.76 6.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.488 ' CG2' ' SG ' ' A' ' 241' ' ' CYS . 6.7 t -148.7 105.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -106.71 112.16 25.02 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.869 0.366 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -89.09 138.61 31.26 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.284 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.1 mt -140.39 151.25 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.9 p -149.59 138.65 21.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.224 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -45.26 169.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.961 179.913 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 N--CA 1.463 -0.323 0 N-CA-C 110.791 -0.504 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -130.82 145.69 52.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.936 0.398 . . . . 0.0 111.251 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.9 t -121.86 130.95 53.77 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -124.91 114.98 19.88 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.952 0.406 . . . . 0.0 111.252 -177.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.86 124.15 37.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.289 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -96.36 71.58 2.76 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.05 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.41 HG22 ' H ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -72.42 111.97 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.82 169.49 18.1 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.339 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.31 20.36 43.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.851 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.88 10.0 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.75 155.53 46.49 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -121.38 106.9 11.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 mtt -101.57 106.66 17.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.942 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -95.6 127.67 41.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.539 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.75 -169.93 1.73 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.29 72.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -76.21 135.78 39.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 110.972 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.2 m -140.04 122.61 16.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.0 32.66 22.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.3 m -121.42 149.56 52.57 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.644 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -38.7 152.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.98 1.787 . . . . 0.0 112.093 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 99' ' ' GLN . 19.4 mp0 -79.57 109.25 13.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.041 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 127.37 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.848 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 125' ' ' LYS . 1.2 tppp? -123.13 2.78 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.467 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.0 p -130.86 131.24 44.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.25 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.2 tt -144.98 130.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.6 p -150.29 152.84 35.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.182 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -142.28 175.49 9.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 110.689 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 t -168.54 164.36 12.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.948 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.17 131.38 42.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 20.9 p-10 -144.43 107.74 4.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.028 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.41 -122.72 18.7 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.744 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -102.93 20.82 16.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.621 0.248 . . . . 0.0 110.649 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.4 p -128.63 151.84 49.03 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.076 0.465 . . . . 0.0 111.024 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.42 135.88 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.61 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.4 HD22 HH12 ' A' ' 115' ' ' ARG . 2.2 m120 -104.73 165.42 11.08 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 111.458 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.657 ' H ' ' NH2' ' A' ' 115' ' ' ARG . . . -163.46 120.56 1.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.659 HH21 ' H ' ' A' ' 30' ' ' ILE . 13.1 mmp_? -115.34 111.66 21.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.422 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.24 118.91 37.22 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 p -156.75 177.08 11.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.328 0.585 . . . . 0.0 111.763 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 p -93.38 164.96 13.01 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.534 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.457 ' O ' ' CE ' ' A' ' 202' ' ' MET . 8.2 p -97.78 130.49 46.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 111.326 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 p -72.91 153.29 91.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.797 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.17 151.53 58.68 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.934 1.756 . . . . 0.0 111.5 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.35 50.12 8.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.23 -0.509 . . . . 0.0 111.845 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -134.75 -22.76 1.63 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.778 0.323 . . . . 0.0 110.281 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.73 14.97 11.53 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 101' ' ' LYS . 35.9 mmtm -135.04 164.48 27.54 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.24 148.01 45.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.509 . . . . 0.0 111.757 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.0 m -155.43 62.66 3.37 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.705 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.4 142.26 2.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.877 2.385 . . . . 0.0 113.361 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.56 150.22 22.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.231 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 tp -131.01 164.61 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.649 0.261 . . . . 0.0 110.62 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 132' ' ' HIS . 26.8 m -81.66 154.92 25.86 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 121.182 0.515 . . . . 0.0 111.322 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.407 ' N ' HG22 ' A' ' 131' ' ' THR . 16.9 t-80 -50.73 -38.43 47.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.724 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -56.53 -42.34 78.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.14 -56.84 16.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 tp -51.65 -35.44 42.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.909 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.19 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.737 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.403 ' C ' ' N ' ' A' ' 140' ' ' LYS . 48.5 mtt -69.07 -62.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.526 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.5 mt -44.96 -20.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.728 0.299 . . . . 0.0 111.218 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 138' ' ' MET . 19.7 tptm -87.47 -33.65 18.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.396 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -94.36 -26.03 16.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.433 ' SG ' HD11 ' A' ' 199' ' ' ILE . 34.0 t -49.61 118.62 2.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -137.72 118.93 14.53 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.2 t -115.16 126.89 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.5 p -100.96 165.14 11.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.9 mp -142.96 150.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.11 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -160.77 86.89 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.705 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.8 tt -83.32 151.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 111.904 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.443 ' CG ' ' H ' ' A' ' 150' ' ' CYS . 57.2 ttt180 -149.01 176.07 10.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.075 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.46 ' SG ' ' OD2' ' A' ' 186' ' ' ASP . 11.8 m -90.99 143.35 26.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 65.3 p -129.91 124.77 33.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.311 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.22 -10.09 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.498 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.583 ' H ' ' CD ' ' A' ' 153' ' ' GLU . 1.5 mp0 -51.34 101.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -89.21 17.22 6.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.949 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.491 ' N ' ' OE1' ' A' ' 46' ' ' GLN . 63.6 mmtt -58.47 162.18 3.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.496 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 168.87 8.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.73 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.6 p -97.38 148.89 22.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 85.2 m-20 -117.21 91.11 3.48 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.65 177.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.141 0.496 . . . . 0.0 111.232 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' HG2' ' H ' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -105.88 -171.39 1.89 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -127.32 -6.01 5.95 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.475 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 37.1 m80 -108.88 129.05 24.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.895 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -39.18 157.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.176 1.917 . . . . 0.0 112.807 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.21 143.91 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.173 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.39 116.33 22.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.891 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.02 172.68 49.85 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.624 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 169' ' ' ILE . 11.4 m -105.18 8.88 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.8 m-20 59.24 -3.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 167' ' ' SER . 56.4 mt -86.96 154.3 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.406 ' N ' HG22 ' A' ' 169' ' ' ILE . 53.9 p -118.33 135.52 54.26 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.512 ' NE2' ' OG ' ' A' ' 196' ' ' SER . 0.1 OUTLIER -73.55 39.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.583 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -67.12 179.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.15 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -90.97 122.02 33.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -146.43 -160.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 174' ' ' VAL . 42.8 t -50.81 140.83 14.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.138 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -104.95 139.86 39.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 11.3 tm-20 -161.22 146.21 13.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.481 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.437 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 41.8 t0 -66.94 104.17 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.859 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.4 mt -114.19 -23.86 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 215' ' ' PHE . 17.9 pt -90.91 137.95 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 110.876 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.38 -134.47 7.05 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -71.59 154.78 41.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.415 ' C ' HD12 ' A' ' 184' ' ' ILE . 84.8 m -149.74 94.54 2.19 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.7 mp -97.39 138.11 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.61 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 185' ' ' VAL . 1.5 m -140.92 123.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.032 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.46 ' OD2' ' SG ' ' A' ' 150' ' ' CYS . 34.6 p-10 -79.39 110.23 14.49 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.2 m -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -34.97 -46.17 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.09 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 26.5 p -143.09 40.29 1.49 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.299 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.4 t -149.4 96.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -80.12 -58.93 2.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.137 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 36.3 t-20 -127.28 137.65 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.118 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.432 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 7.7 tt -138.61 106.67 5.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.934 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -93.48 140.25 29.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.444 ' CZ ' HG13 ' A' ' 28' ' ' VAL . 34.1 t80 -137.77 133.43 34.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.993 0.425 . . . . 0.0 111.259 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 171' ' ' HIS . 1.2 t -144.02 144.25 31.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.934 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.558 HG22 ' N ' ' A' ' 198' ' ' ARG . 2.7 p -139.43 166.62 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.937 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.558 ' N ' HG22 ' A' ' 197' ' ' VAL . 21.3 ttt180 -169.35 111.27 0.48 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.783 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.433 HD11 ' SG ' ' A' ' 142' ' ' CYS . 25.6 mt -102.37 122.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -163.24 -161.28 12.3 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -78.86 137.71 37.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.496 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 22.6 mtp -92.09 -6.37 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.258 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.45 -57.8 2.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.544 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -155.22 136.03 13.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -42.72 158.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.198 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 9.6 t -147.15 6.56 0.88 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.504 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.2 m 58.44 -75.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.0 mt-10 -47.84 -48.85 30.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.867 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 209' ' ' LEU . 10.2 mp -83.23 0.42 45.58 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 207' ' ' SER . 10.0 mp0 -95.72 118.03 31.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.96 163.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.077 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.414 ' HD3' ' H ' ' A' ' 174' ' ' VAL . 12.2 ptmt -164.28 168.01 19.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.573 0.701 . . . . 0.0 112.188 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.7 t70 -141.53 171.33 14.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.861 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 173.13 148.13 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.145 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 180' ' ' ILE . 8.8 m-85 -139.62 174.22 10.74 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -139.17 104.14 4.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.964 0.411 . . . . 0.0 110.592 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.57 116.8 30.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.477 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 218' ' ' VAL . 11.8 p -140.65 118.88 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.391 0.615 . . . . 0.0 110.959 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 15.5 t70 48.25 43.04 18.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.769 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.32 -3.9 85.09 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.469 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.1 t -100.4 116.7 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.027 0.413 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.77 150.55 23.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 70.9 m -166.24 128.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.455 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -77.61 141.5 39.44 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.86 101.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.267 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.28 98.02 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.3 p -129.28 160.09 34.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.405 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -63.32 95.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -89.95 35.92 0.85 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.608 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.6 p -71.51 -45.22 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 233' ' ' ILE . 44.4 t -94.34 -1.9 53.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 53.5 tp -42.15 -20.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.757 0.313 . . . . 0.0 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.561 ' C ' HD12 ' A' ' 233' ' ' ILE . 2.2 pp -149.16 174.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.329 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.93 93.87 5.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.004 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 82.3 p -66.18 -6.2 12.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 60.0 p -91.78 -17.21 25.7 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -105.05 4.71 31.85 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.52 ' O ' HD12 ' A' ' 238' ' ' LEU . 0.3 OUTLIER -76.18 161.15 29.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.159 0.504 . . . . 0.0 110.863 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.427 ' HA ' ' HZ1' ' A' ' 160' ' ' LYS . 2.1 mppt? -144.6 129.73 18.58 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.962 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.469 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . . . -57.66 155.75 9.46 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 48' ' ' VAL . 28.3 t -119.2 -3.85 10.55 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.62 179.725 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.4 m -119.1 128.37 54.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 p -71.21 135.2 47.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.218 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -110.34 -15.48 13.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.569 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 75.7 m -122.98 147.24 46.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.316 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.487 ' CE2' ' OD1' ' B' ' 53' ' ' ASP . 16.8 m-85 -118.89 153.6 34.3 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.244 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -78.97 134.88 36.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.905 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.66 27.94 4.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.788 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.02 126.64 21.89 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.943 0.401 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -57.51 164.01 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.91 89.95 33.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -41.91 142.87 1.32 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.737 1.625 . . . . 0.0 111.987 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -42.9 -48.51 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.45 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -37.72 -34.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -107.54 42.4 1.34 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.675 0.274 . . . . 0.0 111.227 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -144.44 86.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.038 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.54 -28.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 26.7 t0 -157.83 -179.77 8.46 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.648 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.48 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.4 p90 -163.06 169.06 20.07 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.233 0.539 . . . . 0.0 112.071 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 55.7 t80 -159.06 164.45 35.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.132 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.6 pt-20 -114.38 152.21 31.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.72 0.295 . . . . 0.0 110.588 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.426 ' O ' ' O ' ' B' ' 30' ' ' GLU . 36.3 p -55.69 -116.1 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.078 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -149.43 -156.07 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.473 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.451 ' C ' ' H ' ' B' ' 35' ' ' CYS . 75.2 m -126.09 -24.62 3.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.343 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.4 mm? -53.09 -9.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.227 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.451 ' H ' ' C ' ' B' ' 33' ' ' SER . 4.1 p -120.13 123.65 43.85 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -74.57 42.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -166.31 56.86 0.42 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 59.8 Cg_endo -67.97 -161.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 122.795 2.33 . . . . 0.0 113.013 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 167.83 177.39 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.67 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.77 134.07 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.137 0.494 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.94 141.83 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.474 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -119.33 150.32 40.34 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.683 0.277 . . . . 0.0 110.649 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -115.63 112.13 21.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 109.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 4.7 p -75.62 -138.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.027 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.485 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -131.02 -32.22 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.062 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.39 40.5 3.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.043 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 27.4 t -142.94 -83.35 0.17 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 121.378 -0.129 . . . . 0.0 110.704 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.58 -90.73 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.704 0.627 . . . . 0.0 109.612 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' O ' ' B' ' 48' ' ' ALA . 15.4 mm100 -141.11 135.98 31.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 t -148.57 124.0 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.424 0.631 . . . . 0.0 110.26 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 39' ' ' ALA . 2.3 t -72.35 155.57 40.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.468 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 135.24 17.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.271 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASP . . . . . 0.487 ' OD1' ' CE2' ' B' ' 15' ' ' TYR . 60.9 m-20 -63.86 128.16 92.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.237 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.25 0.6 9.23 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.423 1.415 . . . . 0.0 110.889 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 71.0 m -70.57 -12.55 61.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.198 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -96.46 129.21 43.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.205 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 31.9 t -48.75 -51.97 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.041 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -56.5 -32.46 65.07 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.001 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.98 -35.89 76.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.819 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -73.95 -37.84 64.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.628 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.4 -36.91 79.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.859 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.7 -36.68 84.66 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.64 -42.83 86.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' OE2' ' B' ' 67' ' ' GLU . 57.4 t80 -62.67 -34.17 76.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.472 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -70.05 -48.35 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.9 -19.62 66.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -71.77 -32.69 67.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.1 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.813 HD23 ' N ' ' B' ' 69' ' ' ASN . 7.5 tt -83.66 -79.51 0.2 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.813 ' N ' HD23 ' B' ' 68' ' ' LEU . 49.3 t30 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.51 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.884 0.373 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 m -76.87 -19.49 57.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -50.08 141.24 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.615 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.8 p -68.96 -5.77 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -101.86 -18.31 15.79 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.563 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -86.75 -48.85 7.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -156.71 177.1 11.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.012 0.434 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.71 141.78 39.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.613 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -61.39 166.67 3.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.884 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.4 9.71 12.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.017 0.437 . . . . 0.0 109.903 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 21' ' ' LYS . 49.9 mt-10 -86.02 91.5 8.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -33.98 -41.73 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.812 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -80.6 25.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.532 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.4 mmtp -138.43 136.52 36.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.847 0.356 . . . . 0.0 110.08 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.578 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 27.9 m170 -130.92 135.33 47.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -80.62 102.8 10.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -66.41 175.56 2.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.268 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 199' ' ' ILE . . . 166.39 126.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 tt -109.91 150.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.876 0.37 . . . . 0.0 110.454 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.419 ' CB ' HD11 ' A' ' 169' ' ' ILE . 7.5 t70 -132.86 141.82 48.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.66 97.47 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.8 0.334 . . . . 0.0 111.246 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mm -91.69 136.43 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.402 HD11 ' SD ' ' A' ' 90' ' ' MET . 2.0 pp -143.15 126.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.33 0.586 . . . . 0.0 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -115.82 126.87 54.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.76 133.21 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.744 0.307 . . . . 0.0 111.383 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -105.79 130.72 53.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -80.42 155.09 27.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.232 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -66.88 179.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -77.85 -31.34 51.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.707 0.289 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.38 -34.01 31.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.218 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 p -40.98 104.96 0.36 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.5 164.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.9 1.733 . . . . 0.0 111.941 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 p -68.21 145.87 53.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -171.64 97.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -103.02 0.09 31.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.653 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.1 87.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.402 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.45 ' CG2' ' HB2' ' A' ' 107' ' ' ALA . 20.8 pt -85.07 150.79 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.501 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 39.2 t 57.18 64.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.644 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.526 HE22 ' C ' ' A' ' 156' ' ' ASP . 37.8 mm-40 -77.29 -26.89 52.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 t 174.29 164.63 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.72 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -144.21 139.04 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.73 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.2 m -136.54 102.71 5.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.811 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -82.3 126.24 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.338 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.431 HD12 ' CE2' ' A' ' 80' ' ' TYR . 7.7 mt -126.07 152.83 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.8 137.94 16.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 54' ' ' SER . 1.4 tm-20 -52.95 -176.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.5 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 31.1 t . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.534 0.521 0 N-CA-C 111.388 -0.274 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.6 t -139.43 144.82 38.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.731 0.3 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 1.6 p -105.35 130.92 53.35 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -123.79 111.63 16.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.74 0.305 . . . . 0.0 110.91 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.2 120.38 40.36 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -91.16 77.82 5.93 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.632 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.32 106.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 tt -98.08 146.96 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.116 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.63 173.37 20.68 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.08 18.37 26.9 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.341 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.15 3.53 88.4 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.095 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.9 mt -129.88 158.07 40.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.913 0.387 . . . . 0.0 110.337 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -126.02 113.09 16.66 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.53 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.402 ' SD ' HD11 ' A' ' 30' ' ' ILE . 16.7 mtt -101.91 111.39 23.63 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.766 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -99.84 124.52 45.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.755 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.17 -167.09 1.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.03 71.91 0.05 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.912 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 0.2 OUTLIER -77.68 148.29 35.06 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.227 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.576 HG21 ' HE ' ' B' ' 18' ' ' ARG . 41.9 m -136.02 114.28 11.55 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.6 tttt 64.27 40.18 6.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.97 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.6 m -124.59 149.72 62.82 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -37.79 147.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.068 1.845 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -74.85 109.91 8.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 133.51 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.086 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 -13.59 6.77 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.544 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t -105.6 121.81 44.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.922 0.391 . . . . 0.0 110.835 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 mt -135.37 121.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.572 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 10.9 t -137.63 178.22 7.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 111.017 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.501 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 55.3 tt0 -161.68 154.44 20.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.428 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.31 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.45 ' HB2' ' CG2' ' A' ' 44' ' ' ILE . . . -132.68 133.46 43.58 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -148.68 115.15 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.251 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.83 -104.5 1.55 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.209 -0.519 . . . . 0.0 111.941 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -129.35 24.84 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 110.349 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.68 159.22 40.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.38 138.25 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.69 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.537 HD21 HD11 ' A' ' 238' ' ' LEU . 39.8 t30 -116.88 147.06 42.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.537 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 113' ' ' ASN . . . -143.19 129.76 20.19 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.873 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -115.26 115.41 26.62 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.121 0.486 . . . . 0.0 111.459 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.794 ' N ' HD12 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -115.88 120.5 39.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -159.09 -178.83 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.206 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.2 p -91.82 159.66 15.69 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.45 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.88 147.16 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.045 0.45 . . . . 0.0 111.528 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 p -87.39 152.1 51.9 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.729 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.32 162.89 18.83 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.943 1.762 . . . . 0.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.79 -1.51 58.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.99 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -81.05 -56.08 4.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.547 0.213 . . . . 0.0 110.55 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.17 -9.02 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.638 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -113.85 175.67 5.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -77.14 152.01 35.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 111.265 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.5 m -154.38 63.2 4.02 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.65 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.54 151.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.061 2.507 . . . . 0.0 113.273 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.08 150.2 41.56 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.113 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.495 HD11 ' OE2' ' A' ' 134' ' ' GLU . 7.7 tp -144.82 164.57 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.554 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 48.6 p -68.91 171.62 7.76 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.239 0.543 . . . . 0.0 111.436 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.578 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 5.0 m170 -68.07 -33.79 75.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.171 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.51 -57.19 12.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.845 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.495 ' OE2' HD11 ' A' ' 130' ' ' ILE . 47.8 mt-10 -62.95 -42.98 99.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.607 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -57.02 11.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.952 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.14 -34.52 66.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.933 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.14 -30.44 65.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.3 mtt -74.33 -61.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.634 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.0 pt -47.24 -21.8 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.663 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -82.54 -30.61 29.61 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.27 -28.09 13.16 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 48.6 t -49.54 119.21 3.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 0.0 111.313 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -137.0 118.03 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.99 125.34 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.8 t -100.79 158.21 16.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.129 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.7 mm -140.76 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.912 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.411 ' OD1' HD13 ' A' ' 184' ' ' ILE . 3.2 m-20 -152.32 88.83 1.39 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 mt -85.93 148.41 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.013 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -148.41 178.41 8.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.481 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.0 t -91.75 125.14 36.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 t -109.54 162.23 14.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 152' ' ' GLU . 27.0 mp0 -139.7 19.12 2.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.62 0.247 . . . . 0.0 110.939 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -75.86 103.28 5.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.273 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.98 8.7 11.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 4.0 mptp? -52.81 173.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.526 ' C ' HE22 ' A' ' 46' ' ' GLN . 28.0 m-20 -81.66 171.42 14.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -95.12 143.62 26.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.462 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 77.8 m-20 -114.78 92.72 4.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.755 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 160' ' ' LYS . 96.6 mt -123.47 163.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.56 ' N ' HG22 ' A' ' 159' ' ' ILE . 21.7 pttm -125.12 138.43 54.17 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.62 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 161' ' ' THR . 54.2 m -65.09 6.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.554 ' ND1' ' N ' ' A' ' 162' ' ' HIS . 0.2 OUTLIER -76.18 117.62 65.44 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.434 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.87 158.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.661 1.574 . . . . 0.0 111.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 164' ' ' VAL . 13.7 p -78.75 128.77 38.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.0 112.15 17.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.69 171.07 40.97 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.526 -0.369 . . . . 0.0 112.509 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ILE . 5.8 t -103.8 8.9 37.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.007 0.432 . . . . 0.0 109.91 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 60.48 -5.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.95 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.2 pp -80.38 164.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.759 -0.377 . . . . 0.0 109.991 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 6.1 t -126.82 130.64 50.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -72.45 37.86 0.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.813 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 170' ' ' SER . 49.4 pttt -66.64 -173.4 0.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.004 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.04 119.83 35.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.0 110.715 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.523 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 0.2 OUTLIER -142.08 -166.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.443 ' H ' HG12 ' A' ' 174' ' ' VAL . 22.4 m -50.89 145.32 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.853 0.359 . . . . 0.0 110.551 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -98.25 131.37 44.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.57 114.66 8.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.901 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.8 OUTLIER -61.77 99.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.52 6.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.451 HD12 ' OD2' ' A' ' 213' ' ' ASP . 82.6 mt -100.6 113.61 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.97 -137.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.994 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.536 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 6.1 t -72.81 158.45 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.5 p -143.59 90.02 2.12 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.411 HD13 ' OD1' ' A' ' 147' ' ' ASP . 4.8 mp -96.91 128.03 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.099 0.476 . . . . 0.0 109.76 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 185' ' ' VAL . 33.7 m -145.38 123.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.157 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 190' ' ' VAL . 48.8 t0 -82.65 109.52 16.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 28.1 m -45.93 -27.06 0.81 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.506 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -34.58 -38.37 0.07 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.199 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 79.7 m -142.15 31.32 1.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 190' ' ' VAL . 28.4 m -155.9 103.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.127 0.489 . . . . 0.0 110.65 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.49 -56.2 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.641 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' A' ' 193' ' ' LEU . 4.2 t30 -115.07 171.46 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 192' ' ' ASN . 0.3 OUTLIER 179.45 105.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.49 . . . . 0.0 109.804 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.62 142.07 36.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.347 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -127.99 142.74 51.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.595 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 5.9 p -143.51 136.68 27.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.1 t -131.42 158.38 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.446 ' CD ' ' O ' ' A' ' 170' ' ' SER . 14.1 ttt85 -166.3 106.6 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.251 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 25' ' ' GLY . 2.3 tp -109.42 124.46 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -167.96 -151.97 7.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.86 118.57 30.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.534 ' H ' ' HG3' ' A' ' 202' ' ' MET . 0.0 OUTLIER -84.61 4.83 30.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.445 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 1.3 m -99.63 -50.73 3.97 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -161.36 127.81 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.708 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -43.64 145.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.1 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.518 ' H ' ' CD ' ' A' ' 210' ' ' GLU . 3.2 t -131.6 5.99 4.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.488 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.491 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.4 t 58.31 -76.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.662 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' SER . 50.5 mt-10 -48.81 -50.19 35.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.774 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.0 mp -80.63 0.84 32.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.243 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 206' ' ' SER . 13.6 mp0 -101.67 124.85 48.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.837 0.351 . . . . 0.0 110.801 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.96 -178.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.523 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 16.8 ptmt -165.54 167.79 17.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.531 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.451 ' OD2' HD12 ' A' ' 180' ' ' ILE . 44.3 t0 -159.59 169.61 23.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 146.69 140.25 3.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.24 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -119.69 -168.94 1.68 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -144.98 110.0 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -103.41 122.07 44.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.103 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 218' ' ' VAL . 28.9 m -135.8 117.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.191 0.52 . . . . 0.0 110.583 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 219' ' ' ASP . 1.1 m-20 51.87 42.33 30.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.486 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.27 -0.71 87.22 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.4 -0.429 . . . . 0.0 113.145 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.0 m -97.49 117.03 30.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.935 0.368 . . . . 0.0 110.158 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.58 159.14 17.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.483 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 65.8 m -168.13 110.43 0.59 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.24 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -78.51 141.75 37.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.62 123.14 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.573 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.07 103.96 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.326 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 61.2 p -129.83 151.76 50.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 0.8 OUTLIER -51.16 95.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -90.69 27.32 1.79 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.2 m -74.0 -32.49 63.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.97 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 233' ' ' ILE . 13.9 m -103.12 -3.91 25.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.204 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.527 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -40.79 -27.84 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 0.0 110.749 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.682 ' H ' HD13 ' A' ' 233' ' ' ILE . 0.0 OUTLIER -144.01 -177.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.585 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 236' ' ' THR . 12.3 m-20 -118.51 91.93 3.69 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.1 m -62.22 1.51 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.291 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 234' ' ' ASP . 44.6 p -90.24 -22.9 21.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.36 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.87 6.66 39.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.607 0.241 . . . . 0.0 111.049 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.537 HD11 HD21 ' A' ' 113' ' ' ASN . 6.9 mp -85.82 138.26 32.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.947 0.403 . . . . 0.0 110.269 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 104' ' ' SER . 46.5 mttm -126.43 142.55 51.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.07 167.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 242' ' ' VAL . 40.7 t -132.39 -11.51 3.18 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.491 HG22 ' OXT' ' A' ' 242' ' ' VAL . 13.4 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.295 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.516 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 94.1 m -137.27 128.07 27.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.099 0.476 . . . . 0.0 111.34 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 t -39.71 135.82 1.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.638 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.516 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 12.4 m-85 -117.17 -25.85 6.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.317 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -151.94 150.77 30.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -107.81 157.59 18.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -78.79 135.8 37.19 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.08 24.82 2.0 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.69 0.281 . . . . 0.0 110.388 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.576 ' HE ' HG21 ' A' ' 95' ' ' THR . 0.0 OUTLIER -145.75 127.88 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 110.74 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -79.0 122.19 25.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.612 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.54 111.0 45.09 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.79 148.45 0.48 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.857 1.705 . . . . 0.0 112.478 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 -47.27 -47.45 25.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.545 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -37.36 -34.73 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 2.4 m-85 -106.78 44.32 1.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.495 0.188 . . . . 0.0 110.926 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -149.22 95.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.78 -25.9 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -168.67 170.82 9.18 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.408 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.2 163.58 21.28 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.95 0.881 . . . . 0.0 112.369 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -154.99 134.87 12.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.514 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' B' ' 31' ' ' THR . 18.4 pt-20 -99.43 148.96 23.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.257 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 30' ' ' GLU . 46.9 p -55.03 -112.39 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 7.0 m -150.28 -141.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.701 0.286 . . . . 0.0 110.597 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 35' ' ' CYS . 26.1 t -143.04 -24.42 0.61 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -58.12 -6.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' B' ' 33' ' ' SER . 22.0 m -114.91 118.58 33.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.549 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -73.12 38.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -165.74 58.99 0.57 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -170.48 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.721 2.281 . . . . 0.0 113.25 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.24 176.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 49.4 t -109.49 129.81 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.59 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.6 128.84 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.064 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.425 ' C ' ' NE2' ' B' ' 43' ' ' GLN . 30.5 p90 -107.93 145.88 33.18 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.211 0.529 . . . . 0.0 111.225 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' B' ' 43' ' ' GLN . 1.7 mp0 -93.34 170.17 9.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.403 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 9.8 p -140.1 -143.22 0.15 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.202 0.525 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.403 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -125.79 -38.57 2.2 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.854 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.65 2.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.88 -0.145 . . . . 0.0 111.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 23.3 t -153.54 -82.24 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.458 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.05 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.418 0.449 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -140.96 147.76 39.29 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.7 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.1 t -151.62 117.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.876 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.536 ' H ' ' CB ' ' A' ' 182' ' ' SER . 22.9 t -52.13 157.99 1.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.19 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.47 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.45 127.91 8.55 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -68.57 123.81 88.58 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.04 0.36 8.48 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.279 1.319 . . . . 0.0 111.271 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -66.57 -13.82 61.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.097 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -100.07 123.46 44.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -50.8 -38.35 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.965 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -56.72 -33.23 66.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.224 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.22 -35.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.111 0.482 . . . . 0.0 110.195 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -73.35 -39.9 64.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.845 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -69.5 -38.66 77.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -63.11 -39.95 96.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.954 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.01 -42.58 79.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.938 0.399 . . . . 0.0 110.117 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -63.74 -21.72 66.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.99 -36.38 36.08 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.96 -19.42 37.19 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.361 -0.536 . . . . 0.0 109.667 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.57 -35.47 77.42 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.01 -70.25 0.42 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.919 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.575 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.799 0.333 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.3 m -75.39 -34.48 61.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.583 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.4 p -50.21 125.71 13.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.519 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -55.66 -20.31 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.769 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.7 m -75.59 -27.6 58.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 t -82.62 -39.73 21.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 p -166.07 172.99 10.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 0.0 110.698 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.75 155.92 39.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 p -71.94 171.92 10.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -121.19 5.44 10.29 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.333 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 20' ' ' ASN . 43.2 mm-40 -80.88 91.88 6.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 2.9 pm0 -32.42 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.982 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' GLU . 23.0 p-10 -95.49 38.65 1.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.565 0.221 . . . . 0.0 111.308 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -154.1 139.31 17.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.533 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -135.54 158.97 43.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.213 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CE1' ' CE ' ' A' ' 202' ' ' MET . 0.9 OUTLIER -96.53 76.88 2.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 24' ' ' MET . 3.8 mpp? -57.04 117.31 3.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.503 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.98 149.72 17.35 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.888 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -111.57 135.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.559 ' N ' HD13 ' A' ' 26' ' ' ILE . 63.2 t0 -140.46 137.82 34.2 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 11.5 t -138.66 142.78 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.046 0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.01 132.61 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.248 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.43 135.31 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.178 0.513 . . . . 0.0 110.831 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -121.12 94.67 4.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.552 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.95 112.52 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.038 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -86.42 127.81 34.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.518 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' NZ ' ' CB ' ' A' ' 34' ' ' LYS . 5.0 mtpm? -80.37 151.76 29.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.73 164.21 25.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.71 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.01 -35.49 80.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.272 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.439 ' N ' ' CD ' ' A' ' 37' ' ' GLN . 4.4 mp0 -75.34 -35.17 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.023 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.6 m -44.14 106.9 0.55 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.245 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 92.6 Cg_exo -43.79 161.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.817 1.678 . . . . 0.0 112.021 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.3 p -70.06 148.7 48.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 5.4 p30 -173.49 102.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -103.1 -4.29 24.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.551 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 11.0 ptpt -64.93 89.39 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.409 0.623 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 45' ' ' CYS . 6.1 mm -96.3 164.1 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.807 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.499 ' N ' HG22 ' A' ' 44' ' ' ILE . 90.1 m 58.82 49.38 10.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.551 ' NE2' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -65.87 -44.36 85.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.861 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.3 t -167.7 176.8 6.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 0.0 111.461 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.88 103.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.717 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.9 p -103.92 96.82 6.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.527 0.204 . . . . 0.0 111.178 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.27 142.27 32.23 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.427 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 79' ' ' THR . 7.2 mt -144.51 151.2 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.938 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 m -151.47 144.98 24.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' CD ' ' CE1' ' B' ' 24' ' ' PHE . 29.5 mt-10 -52.15 179.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 CA--C 1.53 0.322 0 CA-C-O 120.748 0.228 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 38.7 p -123.75 126.9 47.32 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.452 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 51' ' ' ILE . 6.9 m -102.87 126.23 49.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -126.46 119.6 27.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -112.54 121.17 44.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.62 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -90.58 78.43 6.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.296 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 83' ' ' ILE . 3.1 tp -71.72 114.41 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.068 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.14 144.63 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.87 166.64 16.83 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.43 21.82 49.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.661 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.64 14.96 79.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.129 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.18 157.24 45.85 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.102 0.477 . . . . 0.0 110.676 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -124.53 105.92 9.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.266 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -101.25 123.23 45.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 111.06 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -106.64 128.41 54.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 25.5 m-85 -100.11 -169.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.257 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.01 67.84 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.422 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.51 145.84 36.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.256 0.528 . . . . 0.0 110.182 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.9 m -132.2 102.6 5.85 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.529 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt 70.85 45.31 0.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.337 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.5 m -124.23 149.64 61.41 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.53 142.72 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.878 1.719 . . . . 0.0 112.228 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -55.06 143.86 25.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 tp -98.01 135.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HZ2' ' H ' ' A' ' 126' ' ' ASP . 87.6 mttt -145.5 -7.66 0.59 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.921 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -111.02 111.1 21.97 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.09 114.08 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.5 t -142.33 161.11 38.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.304 0.573 . . . . 0.0 112.067 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -155.42 173.22 16.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.72 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 t -170.65 165.24 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.039 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.42 136.61 46.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.928 0.394 . . . . 0.0 110.292 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -143.94 110.97 5.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.023 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.15 -91.0 0.36 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -142.86 21.33 1.97 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.5 m -114.69 138.42 50.72 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.787 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.33 120.58 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.841 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' HD11 ' A' ' 233' ' ' ILE . 23.7 m-20 -104.42 164.63 11.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.829 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -168.43 125.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.073 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -113.82 114.36 26.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.424 HD12 ' CE2' ' A' ' 81' ' ' TYR . 2.5 mm? -110.41 118.79 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 t -161.55 173.12 15.24 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.507 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.0 p -89.4 170.5 10.48 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.824 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.84 133.16 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.003 0.43 . . . . 0.0 111.259 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.15 164.06 39.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.87 144.29 43.03 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.162 1.908 . . . . 0.0 111.406 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.03 9.13 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -126.4 -51.82 1.5 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.97 0.47 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.642 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -108.39 -178.54 3.63 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 2.2 m-20 -63.96 -179.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.895 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.0 m -171.29 59.76 0.3 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.416 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.11 146.11 0.4 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.465 2.11 . . . . 0.0 112.654 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.43 127.07 20.31 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 131' ' ' THR . 5.1 mm -132.8 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 110.109 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.502 ' H ' HG22 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -69.17 166.04 19.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.931 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -59.15 -33.96 71.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.556 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.51 -51.96 50.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 138' ' ' MET . 8.5 tp10 -66.52 -47.79 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.755 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.77 8.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.412 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.9 mt -51.3 -42.29 61.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.71 -21.07 59.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.593 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.3 ttt -79.05 -64.19 1.24 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.94 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.953 HD13 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -54.55 -20.9 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.919 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.953 ' N ' HD13 ' A' ' 139' ' ' ILE . 56.0 tttp -74.3 -33.42 63.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.5 ' OD2' ' NE ' ' B' ' 18' ' ' ARG . 12.3 t70 -102.72 -21.33 14.11 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.5 t -51.64 119.83 4.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.65 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -138.65 125.55 21.12 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.24 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 t -120.23 125.89 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -101.75 164.67 11.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.102 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.37 146.92 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.896 0.379 . . . . 0.0 110.139 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 90.29 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.73 HD11 ' CG2' ' A' ' 190' ' ' VAL . 0.5 OUTLIER -89.7 146.33 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 111.758 -178.217 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.472 ' N ' HD12 ' A' ' 148' ' ' ILE . 59.7 mtp85 -130.57 170.44 14.26 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.788 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.6 t -91.5 105.3 17.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.659 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.6 p -85.83 169.32 13.45 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.796 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.51 14.18 1.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.505 ' N ' ' OE2' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -67.54 111.22 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.269 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.71 1.83 28.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -46.29 158.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.891 0.377 . . . . 0.0 111.226 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -75.75 170.65 15.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.587 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.8 m -87.23 135.52 33.28 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.046 0.451 . . . . 0.0 110.781 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -113.32 89.55 3.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.75 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 pt -119.85 171.22 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -159.42 0.68 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.2 t -129.77 -4.32 4.65 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.707 0.289 . . . . 0.0 110.46 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -84.55 124.57 73.18 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -39.36 155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.884 1.723 . . . . 0.0 112.335 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.8 p -74.93 133.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 165' ' ' LEU . 6.4 mp -79.05 134.23 36.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.324 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.31 179.71 27.07 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.668 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 169' ' ' ILE . 17.3 m -113.56 8.36 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.8 t30 62.73 -11.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.374 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 167' ' ' SER . 14.1 pt -93.33 139.89 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.225 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.406 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 40.4 t -100.94 150.52 22.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.264 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -79.05 47.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -71.1 169.57 14.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.757 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -83.8 119.24 24.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 175' ' ' SER . 13.8 p -151.49 163.34 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.089 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.55 ' N ' HG22 ' A' ' 174' ' ' VAL . 53.3 p -14.73 132.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.036 0.835 . . . . 0.0 113.197 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 45.1 p90 -90.6 134.38 34.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.423 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.54 134.57 20.33 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.9 OUTLIER -69.86 101.09 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.52 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.428 ' O ' HG22 ' A' ' 179' ' ' ILE . 41.1 mm -114.09 -14.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.65 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.8 mt -91.23 127.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.816 0.341 . . . . 0.0 111.031 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.66 -134.06 6.6 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 69.9 p -69.25 150.77 47.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.94 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.533 ' OG1' ' CE1' ' B' ' 13' ' ' PHE . 0.8 OUTLIER -142.43 95.06 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.239 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 18.4 mt -99.32 134.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.062 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 185' ' ' VAL . 27.9 m -149.32 114.05 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.11 106.96 3.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.0 m -48.08 -27.48 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -39.4 -37.66 0.48 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.622 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.7 m -137.95 37.45 2.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.732 0.301 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.73 ' CG2' HD11 ' A' ' 148' ' ' ILE . 45.4 t -150.74 103.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -85.39 -61.0 1.87 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.446 ' C ' ' ND2' ' A' ' 192' ' ' ASN . 0.4 OUTLIER -130.04 140.79 50.81 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.714 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.5 tt -139.91 114.73 9.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.888 0.375 . . . . 0.0 110.817 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -94.47 152.67 18.39 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -147.55 131.69 17.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.149 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.2 m -144.26 138.08 27.73 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.434 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 198' ' ' ARG . 2.8 p -138.09 163.91 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 197' ' ' VAL . 55.1 ttt-85 -164.96 111.22 0.96 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.837 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.8 mm -94.1 126.7 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.18 173.25 46.14 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.402 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -72.24 131.85 43.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.691 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 23' ' ' HIS . 28.8 mtm -86.49 4.59 39.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.724 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 85.5 m -97.74 -61.32 1.41 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -152.64 122.83 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.484 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.84 148.52 0.37 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.589 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 4.7 t -133.91 13.41 3.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.793 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.1 m 58.81 -76.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.735 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 35.1 tt0 -49.59 -54.33 18.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.609 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -73.69 4.92 4.44 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.115 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 175' ' ' SER . 9.0 mm-40 -104.14 125.5 50.5 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.759 0.314 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.5 168.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 45.7 tttm -157.18 159.97 38.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.312 0.577 . . . . 0.0 111.224 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 9.7 t70 -153.59 170.35 21.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.034 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.14 166.22 25.85 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.758 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -148.89 169.73 19.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 7.7 mtpm? -131.84 103.42 6.32 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -100.02 116.4 31.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.61 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 218' ' ' VAL . 8.6 p -140.69 118.87 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.256 0.55 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 50.54 43.26 27.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.516 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.32 80.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.09 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -98.29 117.97 33.89 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.673 -0.31 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.85 15.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.0 t -169.97 123.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.528 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -78.39 139.02 38.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.53 108.2 0.27 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.481 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -72.06 104.89 3.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.0 t -132.16 152.98 50.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.139 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 95.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.406 ' OD2' HD23 ' A' ' 232' ' ' LEU . 3.4 m-20 -86.84 34.02 0.66 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.986 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.4 t -73.02 -35.0 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.912 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 233' ' ' ILE . 68.9 p -105.12 -0.36 26.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.978 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -42.01 -24.58 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.085 0.469 . . . . 0.0 110.526 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.558 HD11 ' ND2' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -165.11 137.79 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.0 108.18 7.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.055 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 66.2 m -76.23 6.36 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.61 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -20.37 25.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -103.33 4.98 37.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.595 0.236 . . . . 0.0 111.339 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.66 147.81 29.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.042 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -132.9 142.83 49.12 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.4 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.46 134.82 49.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 242' ' ' VAL . 34.7 m -91.37 1.66 56.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.767 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.648 -0.692 . . . . 0.0 111.482 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.451 0 CA-C-O 121.021 0.439 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -105.85 127.18 52.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -65.73 142.06 58.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.334 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.533 ' CE1' ' OG1' ' A' ' 183' ' ' THR . 11.1 p90 -116.19 -11.54 11.31 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 29.5 m -131.8 144.68 51.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.248 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -114.94 158.67 21.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.04 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -83.22 144.92 29.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.871 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.74 -47.59 11.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.903 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.5 ' NE ' ' OD2' ' A' ' 141' ' ' ASP . 5.3 tpt85 -70.9 126.2 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -83.74 118.95 24.24 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' B' ' 20' ' ' LEU . 6.1 mp -75.48 145.53 79.42 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.693 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.7 152.07 37.15 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.382 2.055 . . . . 0.0 112.558 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' B' ' 24' ' ' PHE . 11.4 ptp180 -45.64 -43.84 12.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.38 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -68.09 24.82 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' B' ' 22' ' ' ARG . 12.2 t80 -150.88 32.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.371 0.605 . . . . 0.0 109.555 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -151.04 92.44 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.149 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.16 -25.28 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -156.42 -179.74 8.46 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.068 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 9.2 p90 -163.35 167.7 21.42 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.981 0.419 . . . . 0.0 111.256 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 57.4 m-85 -158.12 156.15 30.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' B' ' 31' ' ' THR . 69.7 mt-10 -98.53 145.58 26.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.812 0.339 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.425 ' O ' ' O ' ' B' ' 30' ' ' GLU . 63.2 p -52.35 -107.44 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -146.93 -128.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.453 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.477 ' C ' ' H ' ' B' ' 35' ' ' CYS . 18.2 t -158.95 -40.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.693 0.282 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.525 HD22 ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -59.08 -2.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.573 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.477 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.8 m -80.25 -34.48 37.1 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.224 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m 75.05 23.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.402 0.62 . . . . 0.0 110.087 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.523 ' N ' ' CD ' ' B' ' 38' ' ' PRO . 9.2 pt20 -173.56 49.61 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.533 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 29.7 Cg_endo -58.63 -158.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.191 2.594 . . . . 0.0 112.974 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 168.36 176.95 0.03 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.25 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.33 131.31 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.8 t -110.45 133.87 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.658 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' B' ' 42' ' ' PHE . 29.9 p90 -113.16 146.02 39.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.075 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.37 169.74 10.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 5.1 p -138.84 -142.73 0.16 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.187 0.517 . . . . 0.0 110.68 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.472 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.33 -36.33 1.71 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.177 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.97 46.43 2.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.287 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 23.6 m -153.72 -80.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.54 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.688 0.618 . . . . 0.0 109.475 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -161.34 143.71 12.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -148.9 136.19 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 0.0 109.781 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.65 162.22 13.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.631 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 124.79 7.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.318 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -62.33 122.58 74.05 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 1.28 7.07 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.225 1.284 . . . . 0.0 111.161 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -67.82 -18.22 64.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.108 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -95.31 125.88 40.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -51.56 -39.75 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.976 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -56.39 -34.92 67.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.078 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.92 -35.22 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.93 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.03 -35.69 66.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -72.14 -35.89 69.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -65.09 -36.48 84.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.689 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.02 -44.47 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.04 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -62.11 -28.7 69.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -74.65 -40.87 61.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.959 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.12 -21.69 63.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.26 -29.37 62.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.17 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt -79.11 -84.5 0.08 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.374 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.562 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.2 p -75.02 -22.15 58.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.117 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 t -48.22 133.13 15.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -60.07 -29.39 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.438 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 t -76.2 -27.42 56.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.8 t -72.04 -51.1 23.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.8 t -169.66 178.82 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.143 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -61.45 160.8 10.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.676 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 2.9 p -81.58 166.67 20.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.192 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.41 4.37 12.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.436 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 56.5 mt-10 -62.52 -152.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.749 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.16 -72.15 0.7 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.562 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -83.09 59.33 4.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.277 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HD3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -130.38 135.8 48.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.134 0.492 . . . . 0.0 111.242 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.93 123.35 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.438 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.676 ' CE1' ' H ' ' A' ' 16' ' ' THR . 67.5 m80 -75.27 76.18 2.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 tpt -46.54 170.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.358 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 158.19 132.94 1.48 Allowed Glycine 0 CA--C 1.512 -0.149 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 26' ' ' ILE . 16.4 tt -110.68 129.26 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.079 0.466 . . . . 0.0 110.921 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 -105.04 135.61 46.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.83 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.46 128.86 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.8 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.449 HG22 ' HE ' ' A' ' 115' ' ' ARG . 19.9 pt -124.42 162.86 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 tt -164.01 135.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.147 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -123.47 94.64 4.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.615 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.48 115.18 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.479 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -90.06 127.47 36.08 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -82.21 154.71 25.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.643 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -68.85 -170.55 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.8 -31.11 18.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.938 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -79.01 -39.72 33.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.237 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 p -40.7 106.48 0.42 Allowed Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -43.68 170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.963 1.776 . . . . 0.0 112.277 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p -75.49 134.88 40.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.923 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -158.1 95.31 1.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.106 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.77 -7.31 25.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -63.74 92.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 110.407 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -90.55 154.75 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 34.9 t 53.7 65.46 1.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.122 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -79.2 -24.62 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 m 178.09 164.82 0.71 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.417 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.65 132.14 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.404 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 p -134.17 104.4 6.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.177 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -83.29 136.79 34.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.282 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 52' ' ' THR . 8.1 mm -132.7 162.67 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.484 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 51' ' ' ILE . 93.0 m -154.18 151.25 28.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' B' ' 24' ' ' PHE . 91.4 mt-10 -52.71 175.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.6 p . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 109.818 179.837 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 CA--C 1.528 0.202 0 N-CA-C 111.365 -0.283 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -122.45 114.87 21.31 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.806 0.336 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 p -96.35 129.96 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.56 141.7 50.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -136.31 134.44 37.95 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.428 1.109 . . . . 0.0 110.845 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' NE ' ' A' ' 89' ' ' ARG . 33.1 t -96.12 73.87 2.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.064 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 pt -71.13 98.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 tp -86.88 146.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.603 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.91 166.79 17.1 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.302 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.71 23.39 44.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.208 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 7.98 74.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -127.99 153.82 46.31 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.439 ' NE ' ' OG ' ' A' ' 82' ' ' SER . 63.3 ttt180 -122.65 113.91 19.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.36 152.08 21.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 110.147 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -149.06 126.95 11.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.413 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -116.81 -169.99 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.947 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.05 81.53 0.16 Allowed Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.293 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.548 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 1.8 m-30 -73.35 115.01 12.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.6 m -124.69 111.79 16.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.686 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.1 tptp 64.84 31.3 11.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.02 150.32 44.88 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -38.64 160.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.956 1.771 . . . . 0.0 112.123 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -81.67 107.07 14.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.533 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.57 144.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.923 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -147.14 -21.92 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 p -98.18 122.02 40.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.361 . . . . 0.0 110.317 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 tp -139.89 133.53 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 239' ' ' LYS . 11.2 t -150.11 165.41 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.248 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -148.86 161.5 41.72 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.085 0.469 . . . . 0.0 110.789 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.14 156.64 22.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.228 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.5 137.95 44.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.219 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -151.06 108.04 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.337 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.35 -103.53 2.17 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.168 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 110' ' ' ASN . 17.5 p-10 -130.67 23.29 5.04 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.668 0.271 . . . . 0.0 110.552 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.1 155.63 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.645 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.7 t -127.31 129.73 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.064 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.609 ' ND2' ' H ' ' A' ' 114' ' ' ALA . 2.9 t-20 -107.54 154.99 20.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.525 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.609 ' H ' ' ND2' ' A' ' 113' ' ' ASN . . . -154.83 121.73 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.56 HH21 ' CD2' ' A' ' 238' ' ' LEU . 19.5 tpp85 -105.07 113.0 26.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.811 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.1 114.21 22.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.9 t -158.85 171.73 19.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.164 0.507 . . . . 0.0 112.029 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -87.83 163.83 16.22 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.1 141.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.141 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 p -83.22 152.6 65.12 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.616 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.52 152.35 33.81 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 121.921 1.747 . . . . 0.0 111.584 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.1 50.22 13.52 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.71 -53.96 0.88 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.59 0.233 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 160.87 -11.35 0.14 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.232 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -129.94 151.12 50.84 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 117.278 0.539 . . . . 0.0 110.114 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.0 146.51 42.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.787 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.0 p -139.76 62.36 22.31 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.957 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.17 129.63 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.227 2.618 . . . . 0.0 113.427 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.48 165.08 13.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.2 pt -145.05 165.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -82.67 154.84 24.67 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.738 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -51.35 -37.07 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.55 -51.82 68.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 110.436 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.05 -43.66 91.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.133 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.49 -56.55 19.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 110.319 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tp -51.65 -35.84 43.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.903 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.09 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.5 mmt -71.3 -62.43 1.4 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.7 pt -46.9 -21.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.462 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -91.02 -28.72 17.8 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.622 0.248 . . . . 0.0 110.894 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.527 ' CG ' ' HE ' ' B' ' 18' ' ' ARG . 15.1 t0 -92.19 -44.12 8.95 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.4 t -43.43 120.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.937 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -141.5 132.93 26.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.699 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.41 132.08 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.033 0.444 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.7 p -103.14 171.02 7.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.362 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.9 mm -139.4 154.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -163.58 88.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.272 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.97 147.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.083 0.468 . . . . 0.0 111.292 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -137.04 171.68 14.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.804 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 m -100.31 116.21 31.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.197 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.1 m -104.85 -176.84 3.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.929 0.395 . . . . 0.0 110.256 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -149.47 0.69 0.5 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.888 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -55.37 99.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.56 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.64 9.72 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.952 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -45.43 156.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.92 170.24 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.1 m -90.46 135.87 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.634 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.472 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 9.8 t70 -115.56 89.13 3.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.768 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -124.29 168.18 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -113.18 155.14 25.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.559 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 161' ' ' THR . 69.0 m -83.43 -3.92 58.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.903 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.546 ' NE2' ' CB ' ' A' ' 240' ' ' ALA . 0.5 OUTLIER -77.49 147.48 75.43 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.972 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.94 160.45 33.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.561 1.507 . . . . 0.0 110.988 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.63 134.92 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 165' ' ' LEU . 6.6 mp -82.51 117.89 22.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.11 171.27 40.42 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.759 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 169' ' ' ILE . 2.0 p -101.12 7.29 43.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 60.97 -3.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.2 tt -98.24 139.2 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.323 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.5 p -98.34 145.62 26.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -75.59 40.88 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.499 ' NZ ' ' CB ' ' A' ' 172' ' ' LYS . 5.6 ttpm? -65.11 171.87 3.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 172' ' ' LYS . 36.7 pttt -87.27 128.24 35.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.307 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.734 HG22 ' H ' ' A' ' 175' ' ' SER . 14.9 p -157.13 177.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.773 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.734 ' H ' HG22 ' A' ' 174' ' ' VAL . 71.4 m -27.54 141.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.506 0.503 . . . . 0.0 112.018 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -100.24 134.09 43.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.07 138.85 33.88 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.006 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.75 86.78 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.772 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 37.8 mt -100.77 -36.89 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.303 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -71.58 124.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.231 0.538 . . . . 0.0 110.601 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.77 -125.41 2.81 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 12.0 m -79.76 153.05 29.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.164 0.507 . . . . 0.0 111.086 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 22.4 p -141.09 95.04 2.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.457 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.8 mp -98.44 117.09 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 185' ' ' VAL . 6.0 m -131.74 117.64 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.287 0.565 . . . . 0.0 111.602 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 190' ' ' VAL . 7.3 m-20 -78.66 111.89 15.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.823 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.6 m -46.34 -32.3 3.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.232 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.439 ' CD ' ' H ' ' A' ' 188' ' ' LYS . 12.0 mptt -34.97 -34.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.201 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 189' ' ' CYS . 32.1 p -152.1 56.93 0.84 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.305 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 190' ' ' VAL . 7.5 p -173.77 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.487 . . . . 0.0 110.009 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.78 -57.39 4.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.631 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 37.9 t-20 -127.16 137.92 53.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 2.2 tt -134.13 128.14 33.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.926 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -113.57 135.81 53.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -137.01 134.59 36.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.019 0.437 . . . . 0.0 111.071 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.6 t -142.79 141.44 31.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.778 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 198' ' ' ARG . 44.4 t -134.69 159.16 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.069 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 197' ' ' VAL . 44.2 ttt180 -174.19 116.59 0.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.903 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.4 tt -119.02 136.08 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -171.65 -150.13 6.97 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.568 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 43.3 t0 -88.49 119.15 28.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -78.38 3.57 15.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.08 -178.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 23.9 t -111.15 -51.3 2.87 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.742 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.479 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 67.6 mttm -146.94 109.93 4.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -44.52 147.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.372 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 3.2 m -148.75 96.14 2.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 206' ' ' SER . 69.1 m -23.45 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.339 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 36.3 mt-10 -58.65 -73.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.845 0.355 . . . . 0.0 111.629 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.3 9.6 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -96.5 126.1 41.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.834 0.349 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.69 178.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.5 164.86 19.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.105 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD2' HD12 ' A' ' 180' ' ' ILE . 16.4 t0 -158.92 168.63 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.178 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 165.34 171.03 31.07 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.8 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 12.7 m-85 -151.9 172.7 15.81 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -136.83 103.75 5.28 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.28 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -101.84 122.33 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.69 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 220' ' ' GLY . 7.3 p -140.48 115.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.298 0.571 . . . . 0.0 111.556 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.39 -8.87 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.768 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 137.99 -2.12 2.92 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 12.3 m -101.3 117.08 34.26 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.638 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.38 150.01 23.46 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.3 m -164.98 127.63 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.519 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -78.04 139.28 39.1 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.83 109.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.655 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.81 97.31 4.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 228' ' ' ASP . 59.3 m -126.75 157.23 39.69 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 227' ' ' THR . 9.6 m-20 -60.04 95.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -90.61 30.66 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -73.25 -30.12 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.285 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.0 t -111.4 1.34 16.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.5 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -44.31 -28.79 0.57 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.99 0.424 . . . . 0.0 110.478 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.42 143.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.179 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 236' ' ' THR . 6.1 p30 -75.75 97.04 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.042 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.0 m -59.29 -4.14 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 238' ' ' LEU . 41.1 p -78.96 -53.5 6.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.9 13.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.56 ' CD2' HH21 ' A' ' 115' ' ' ARG . 8.3 mp -77.05 140.23 40.26 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 110.444 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.46 ' N ' ' OG ' ' A' ' 104' ' ' SER . 18.7 mtpp -131.64 131.59 43.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.616 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.546 ' CB ' ' NE2' ' A' ' 162' ' ' HIS . . . -54.87 155.73 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 46.9 t -123.98 -8.37 7.75 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.638 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 241' ' ' CYS . 2.0 p . . . . . 0 C--O 1.218 -0.564 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.379 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.685 0.279 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.512 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 18.8 m -129.85 120.92 25.73 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 33.7 t -38.37 129.17 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.658 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 29.0 m-85 -109.63 -32.46 7.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.19 157.79 36.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.032 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.81 161.15 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.9 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -83.52 136.44 34.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.02 7.78 17.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.065 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.527 ' HE ' ' CG ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -134.0 127.48 32.41 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.812 0.339 . . . . 0.0 111.006 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -83.43 127.37 33.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.602 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.407 HD12 ' N ' ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.69 54.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.34 152.76 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.787 1.658 . . . . 0.0 111.942 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.686 HH21 HD21 ' B' ' 69' ' ' ASN . 8.5 tpt180 -45.14 -47.19 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.299 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -37.57 -33.59 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CE2' ' OE1' ' A' ' 53' ' ' GLU . 3.1 m-85 -109.5 43.19 1.34 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.795 0.331 . . . . 0.0 110.585 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -153.12 92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.707 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.28 -24.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -157.69 -179.03 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.168 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -157.78 170.69 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.223 0.535 . . . . 0.0 112.04 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 57.6 t80 -158.39 151.47 22.72 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.444 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 49.4 mt-10 -99.33 148.69 23.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -54.31 -109.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -152.58 -141.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.698 0.285 . . . . 0.0 110.526 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -146.53 -23.29 0.43 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.405 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' B' ' 34' ' ' LEU . 16.7 mt -57.63 -10.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.403 ' C ' ' H ' ' B' ' 37' ' ' GLN . 83.1 m -112.8 122.04 46.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.575 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -72.75 37.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.84 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' B' ' 35' ' ' CYS . 9.1 pt20 -168.51 60.17 0.44 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.6 -164.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.713 2.275 . . . . 0.0 113.059 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 178.9 176.64 0.54 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.499 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.51 131.75 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.938 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.62 132.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.036 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -112.72 151.44 30.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.458 ' OE1' ' NE2' ' B' ' 49' ' ' GLN . 15.1 mm100 -92.66 169.39 10.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -137.11 -145.09 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 110.703 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.99 -39.48 1.39 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.99 46.82 2.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.301 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 9.8 m -155.33 -83.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.375 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.35 -90.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.458 ' NE2' ' OE1' ' B' ' 43' ' ' GLN . 7.6 mt-30 -138.86 148.62 43.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.796 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 t -151.84 113.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.289 0.566 . . . . 0.0 110.446 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.555 ' N ' ' OG ' ' A' ' 182' ' ' SER . 54.0 t -50.53 161.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.439 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -153.58 139.97 18.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.187 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -74.64 115.36 43.12 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.29 -0.64 8.41 Favored 'Trans proline' 0 C--N 1.356 0.933 0 CA-C-N 120.145 1.087 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -74.72 -10.08 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.888 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 37.4 mt-10 -98.97 125.55 44.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.21 0.529 . . . . 0.0 110.317 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.8 m -46.89 -50.58 18.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 63.9 p-90 -55.99 -25.29 43.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.077 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.99 -36.67 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.971 0.415 . . . . 0.0 110.139 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 56' ' ' GLU . 2.5 mp0 -68.3 -44.27 75.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.908 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.14 -35.31 80.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.294 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -63.1 -46.78 85.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 80.3 t -65.16 -47.64 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.725 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.5 -33.85 68.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -73.12 -34.49 66.16 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.982 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.7 -21.65 61.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.424 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -78.56 -77.27 0.17 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.686 HD21 HH21 ' B' ' 22' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.53 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.5 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 p -79.68 -27.85 40.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.55 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.9 m -49.91 130.23 21.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -56.61 -25.89 54.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -73.67 -28.42 61.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.355 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -76.15 -55.6 5.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -158.91 162.79 36.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.75 149.62 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.4 p -73.27 171.26 13.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.4 15.93 16.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.215 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -90.21 90.87 8.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -44.43 -23.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.164 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -80.99 18.92 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' C ' ' CG ' ' A' ' 22' ' ' HIS . 9.9 ptmm? -170.11 165.63 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.679 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.4 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 81.6 m-70 -152.94 -178.38 6.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.793 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.453 ' O ' ' SD ' ' A' ' 202' ' ' MET . 21.2 t60 -101.51 93.43 5.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.81 120.98 20.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.669 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -125.37 160.15 19.92 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.55 134.02 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 171' ' ' HIS . 58.6 t0 -124.68 124.29 41.86 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.041 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.463 ' H ' ' HG ' ' A' ' 117' ' ' SER . 11.9 t -137.61 142.07 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.6 pt -146.29 138.46 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.722 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -138.08 134.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -118.38 94.01 4.33 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 190' ' ' VAL . 7.7 p -90.13 135.7 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.483 0.658 . . . . 0.0 112.084 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -113.0 130.67 56.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.697 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -89.34 164.45 14.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.851 0.358 . . . . 0.0 110.741 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -77.81 151.31 34.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.712 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.06 -3.76 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.68 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -91.7 -41.45 10.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.004 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.6 p -48.26 146.08 4.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.832 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.21 162.36 28.57 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.023 1.816 . . . . 0.0 111.306 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.2 p -54.63 146.07 17.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.183 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.573 HD21 ' HA3' ' A' ' 87' ' ' GLY . 20.2 p30 -167.02 90.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 110.836 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.31 -5.77 32.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.05 0.452 . . . . 0.0 110.036 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -61.05 83.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.658 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tp -96.4 159.96 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.775 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.1 m 60.87 40.19 16.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 110.443 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 155' ' ' LYS . 3.7 tp60 -55.44 -55.05 36.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.921 0.391 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.1 t -178.87 150.97 0.51 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -115.31 142.72 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.232 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.5 m -127.7 102.11 6.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.92 129.01 34.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.678 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -138.94 149.54 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -153.37 145.94 24.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' SER . 1.5 mp0 -54.63 -176.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 6.2 t . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.478 0.618 0 CA-C-O 120.732 0.222 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 p -123.63 137.53 54.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.56 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -93.1 126.72 38.34 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -122.59 101.6 7.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 0.0 111.275 -178.179 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 9.9 m -143.45 68.38 1.29 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.409 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 83' ' ' ILE . 4.0 tp -73.65 107.09 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.225 0.536 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.2 mt -89.14 148.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.56 169.86 20.39 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.264 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.82 23.58 51.16 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' A' ' 41' ' ' ASN . . . 72.41 8.73 71.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.925 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -130.07 156.75 44.01 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.911 0.386 . . . . 0.0 110.403 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.7 ttm105 -115.95 117.84 31.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.472 ' SD ' HD12 ' A' ' 148' ' ' ILE . 68.4 mmm -102.22 108.35 19.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -100.98 120.44 40.19 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.122 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -100.9 -169.7 1.74 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.853 0.359 . . . . 0.0 110.89 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -178.92 70.65 0.07 OUTLIER Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.031 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -76.68 137.38 39.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.711 0.291 . . . . 0.0 110.776 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.9 m -138.83 118.46 13.04 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 60.09 32.34 20.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.133 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -119.81 149.72 49.09 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -38.61 145.55 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.851 . . . . 0.0 111.986 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -71.12 137.06 48.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 0.0 110.889 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.89 145.65 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -143.04 -9.56 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.636 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -124.08 123.25 39.92 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.16 106.99 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -140.16 145.83 38.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -142.35 -173.23 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 t -170.03 164.6 9.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.1 114.69 16.06 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -128.81 110.97 12.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.174 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.79 -127.48 22.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.857 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -100.98 21.42 13.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.66 0.267 . . . . 0.0 110.544 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -129.66 159.02 37.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 t -131.47 136.3 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.911 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -91.99 174.47 7.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -164.79 121.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.504 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.437 ' C ' HD22 ' A' ' 116' ' ' LEU . 8.4 tpt180 -121.97 102.43 8.16 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.437 HD22 ' C ' ' A' ' 115' ' ' ARG . 2.6 mm? -115.58 111.86 21.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.463 ' HG ' ' H ' ' A' ' 28' ' ' VAL . 12.1 m -166.34 168.01 15.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.168 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -90.2 176.09 6.89 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 120' ' ' SER . 7.9 p -116.9 155.13 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.094 0.473 . . . . 0.0 111.565 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 119' ' ' VAL . 8.4 t -91.22 146.31 33.26 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.748 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.487 ' HA ' HE22 ' A' ' 123' ' ' GLN . 33.9 Cg_exo -34.81 155.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 122.669 2.246 . . . . 0.0 112.778 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.586 ' N ' HE22 ' A' ' 123' ' ' GLN . . . 72.29 70.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.586 HE22 ' N ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -154.75 -40.67 0.09 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.662 0.268 . . . . 0.0 110.876 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.417 ' H ' ' CD ' ' A' ' 123' ' ' GLN . . . 124.89 7.16 6.17 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 123' ' ' GLN . 31.4 mmtp -125.33 170.34 11.43 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 23.0 p-10 -73.61 156.12 38.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.83 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 p -155.7 66.18 4.5 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.894 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -48.24 134.31 25.0 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 122.893 2.395 . . . . 0.0 113.256 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.97 156.73 18.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.317 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.6 pt -150.46 166.54 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.178 0.513 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.5 p -72.69 164.66 26.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.347 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -60.74 -34.32 74.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.259 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 4.3 mp0 -56.62 -57.17 13.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.142 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.467 ' O ' ' SD ' ' A' ' 138' ' ' MET . 39.6 mt-10 -57.3 -46.14 83.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.26 -55.4 18.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.05 -36.12 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.63 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.37 -30.23 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -76.35 -61.89 1.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.0 pp -47.21 -21.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.186 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -83.79 -55.05 4.47 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.565 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -76.67 -37.8 55.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.9 t -39.31 120.42 1.04 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.59 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.34 124.85 16.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.0 t -117.99 126.97 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.101 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.0 t -102.63 166.24 10.62 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.2 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.64 144.5 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.99 0.424 . . . . 0.0 110.719 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.546 ' OD2' ' NE2' ' B' ' 49' ' ' GLN . 34.1 t0 -154.38 88.67 1.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.848 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.472 HD12 ' SD ' ' A' ' 90' ' ' MET . 15.9 tt -77.47 151.27 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -145.25 -177.44 5.55 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.884 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.5 m -91.3 135.08 34.06 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.829 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.9 p -127.87 130.56 48.76 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -117.38 40.21 3.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.44 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.465 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -81.5 100.9 9.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.159 0.504 . . . . 0.0 110.704 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -72.13 -2.59 19.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.525 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.487 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.8 mmtm -51.53 161.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.855 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -77.09 177.51 7.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.8 p -96.59 142.02 29.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.55 92.04 3.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.55 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.84 177.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -132.92 134.52 44.65 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.3 p -70.18 4.17 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.399 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -83.2 121.6 77.08 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -39.89 161.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.785 1.657 . . . . 0.0 112.076 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.47 134.26 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 165' ' ' LEU . 8.1 mp -84.38 121.29 27.33 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.49 168.3 25.23 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.482 -0.327 . . . . 0.0 112.675 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.5 p -95.83 6.92 47.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.76 0.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.029 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 167' ' ' SER . 10.2 tp -100.84 138.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.494 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 97.0 p -99.09 142.31 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.567 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 27' ' ' ASP . 22.2 m80 -75.79 43.12 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.268 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -66.56 -174.52 0.3 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.4 ' HE3' ' H ' ' A' ' 228' ' ' ASP . 77.4 mttt -88.24 123.73 33.15 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.465 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.93 -175.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.779 0.323 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 66.4 m -44.98 144.34 1.24 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.119 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.434 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 48.4 p90 -96.29 126.9 41.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.817 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -141.49 130.99 23.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.42 97.13 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.071 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.2 mm -107.65 -38.32 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.88 124.01 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.55 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.53 -130.67 2.09 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.512 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 24.8 t -75.29 155.87 36.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.663 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.417 ' C ' HD12 ' A' ' 184' ' ' ILE . 26.4 m -142.94 93.8 2.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.8 mp -98.75 116.18 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 185' ' ' VAL . 3.0 m -124.59 132.59 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.012 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.76 94.69 6.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 189' ' ' CYS . 17.8 p -47.38 -26.68 1.37 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.878 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -43.49 -16.23 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.509 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 187' ' ' THR . 13.0 m -148.43 12.59 0.93 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 190' ' ' VAL . 0.4 OUTLIER -153.63 91.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.678 0.751 . . . . 0.0 110.563 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.95 -53.88 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.391 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -131.99 148.44 52.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.601 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 tt -148.13 110.56 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.044 0.449 . . . . 0.0 111.425 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -93.41 135.76 34.34 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -130.02 135.69 48.56 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.968 0.413 . . . . 0.0 111.106 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.2 t -144.31 141.06 29.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.488 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 198' ' ' ARG . 4.1 p -137.73 163.48 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.564 ' N ' HG22 ' A' ' 197' ' ' VAL . 60.4 ttt180 -171.7 115.94 0.38 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.361 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 tt -114.95 126.05 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -168.54 -149.24 6.07 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.228 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.51 140.31 33.4 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.913 0.387 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -103.98 -2.58 25.86 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.914 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 70.7 m -107.33 -56.54 2.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.679 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -146.42 126.4 13.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.483 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.72 144.96 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 208' ' ' GLU . 20.7 m -127.06 9.09 6.77 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.25 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.4 m 58.29 -76.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.716 0.293 . . . . 0.0 111.476 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' SER . 71.6 mm-40 -49.35 -50.19 40.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.64 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.1 mt -75.1 -1.36 22.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.368 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.22 130.05 44.49 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.865 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.8 m -142.68 -179.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.473 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 48.6 tttm -171.04 161.94 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.369 0.604 . . . . 0.0 111.611 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 15.4 t70 -158.95 169.52 24.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.711 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.64 138.35 2.43 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.935 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -118.39 168.65 10.44 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -132.63 103.06 5.94 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -97.63 113.38 25.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.109 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 218' ' ' VAL . 11.8 p -139.61 116.16 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.3 0.572 . . . . 0.0 110.726 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 219' ' ' ASP . 1.2 m-20 52.82 28.28 6.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.861 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.4 66.15 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.994 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.5 t -98.61 116.22 30.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.31 158.66 15.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.8 m -168.28 117.69 0.75 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.992 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -85.05 96.64 9.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.089 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -129.33 133.93 7.74 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.56 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.34 97.69 10.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 228' ' ' ASP . 86.0 m -123.96 156.21 36.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.291 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 227' ' ' THR . 5.6 p-10 -57.68 95.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.2 30.0 0.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.4 m -70.38 -49.28 50.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.2 t -90.01 2.21 55.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 tp -39.2 -33.14 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.875 0.369 . . . . 0.0 111.15 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.54 144.43 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.894 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 1.5 p30 -74.97 102.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.044 0.45 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 92.6 p -68.94 -4.14 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.478 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 69.9 p -83.21 -15.68 49.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -102.01 11.41 38.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.585 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.58 153.89 34.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -142.33 121.16 12.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.14 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 123.24 16.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.728 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 15.0 m -88.15 4.72 44.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 242' ' ' VAL . 11.1 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.375 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 120.779 0.323 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.51 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 63.5 m -138.39 128.35 25.44 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.026 0.441 . . . . 0.0 110.528 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 80.1 m -45.37 141.37 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.808 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.51 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 24.9 m-85 -114.1 -26.24 8.17 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.785 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.6 m -155.42 157.22 36.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.88 162.56 15.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.377 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -85.28 139.52 31.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.651 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.46 -26.19 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.338 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.75 125.9 41.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 0.0 111.522 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -77.95 122.68 25.84 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -87.14 112.71 49.64 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.725 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.45 148.4 1.3 Allowed 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 121.909 1.74 . . . . 0.0 112.289 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -44.99 -41.83 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.353 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.56 -32.39 0.55 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 7.0 m-85 -108.53 41.67 1.53 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.66 0.267 . . . . 0.0 110.473 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -151.4 92.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.68 -25.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 35.1 t70 -155.11 -179.19 7.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.743 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.478 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 9.1 p90 -161.86 173.93 13.85 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.338 0.589 . . . . 0.0 111.848 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.493 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 45.2 t80 -156.64 179.75 8.97 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.265 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.493 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 13.1 pt-20 -128.76 152.23 48.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.267 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.474 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 35.7 p -57.2 -113.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -151.66 -142.56 0.12 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.514 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.421 ' C ' ' H ' ' B' ' 35' ' ' CYS . 13.2 t -143.32 -16.78 0.65 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.91 -3.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.018 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.421 ' H ' ' C ' ' B' ' 33' ' ' SER . 2.9 p -123.3 122.9 39.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -74.49 44.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -173.31 57.85 0.22 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 91.5 Cg_endo -72.61 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.964 2.443 . . . . 0.0 113.137 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 174.62 176.96 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.029 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.93 133.98 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.187 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 140.86 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.768 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -115.09 150.87 35.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -93.1 170.26 9.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.0 p -137.95 -145.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.18 0.514 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.469 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.94 -38.32 2.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.37 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.17 46.07 2.43 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.065 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.613 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 32.3 t -154.05 -83.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.61 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 159.21 -87.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.546 ' NE2' ' OD2' ' A' ' 147' ' ' ASP . 23.5 pt20 -144.65 148.19 33.98 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.835 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 38.5 t -150.79 121.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.394 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.512 ' H ' ' CB ' ' A' ' 182' ' ' SER . 99.6 m -57.75 161.59 3.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.86 132.37 12.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.83 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -68.74 116.11 37.54 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.74 0.38 7.12 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 120.935 1.09 . . . . 0.0 111.112 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 13.0 m -71.59 -6.06 38.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.962 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -105.77 128.04 53.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -48.38 -49.25 35.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -56.12 -30.43 62.1 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.736 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.04 -36.92 70.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.996 0.427 . . . . 0.0 110.092 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.1 -36.63 66.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.72 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.24 -35.53 78.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.338 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.54 -37.94 89.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.91 -45.76 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -59.64 -38.44 81.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.0 110.771 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -64.94 -24.88 67.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.785 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -71.63 -30.89 66.26 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.258 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.26 -81.78 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.272 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.54 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.766 0.317 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.1 p -74.81 -14.93 60.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -50.88 126.14 15.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.6 p -59.28 -10.61 3.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.378 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 79.1 p -92.51 -25.36 18.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.559 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p -81.08 -45.58 16.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 m -167.8 173.06 8.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.38 146.57 50.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.943 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.401 ' H ' ' HE2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -74.29 173.22 10.52 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -114.0 21.28 15.0 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.432 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -87.71 86.49 7.19 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 18' ' ' GLU . 49.3 mt-10 -17.71 -61.06 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -77.55 52.12 0.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE2' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -153.8 149.15 27.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.408 ' N ' ' HD1' ' A' ' 22' ' ' HIS . 10.1 p-80 -168.1 120.9 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.242 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CD2' ' HB3' ' A' ' 127' ' ' SER . 12.7 t60 -67.79 78.73 0.2 Allowed 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.758 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -54.28 138.19 39.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.041 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 199' ' ' ILE . . . -142.56 162.68 27.31 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 pt -109.15 169.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.077 0.439 . . . . 0.0 110.959 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -154.12 105.62 2.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.295 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 t -99.08 128.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.751 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.587 HD11 ' NE2' ' A' ' 171' ' ' HIS . 2.6 mm -123.59 123.11 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.52 133.64 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.32 92.8 3.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.22 135.44 25.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.117 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 m -103.75 124.72 49.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.638 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' CG ' ' OG1' ' A' ' 38' ' ' THR . 18.9 ttpp -76.14 151.62 36.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.805 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.461 ' C ' ' H ' ' A' ' 37' ' ' GLN . 49.7 tt0 -74.24 148.28 41.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.168 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -74.12 36.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.85 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 35' ' ' GLN . 14.7 tt0 -136.56 -46.98 0.61 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.377 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 34' ' ' LYS . 1.4 p -53.25 151.66 9.32 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.22 157.47 59.4 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.21 1.94 . . . . 0.0 111.875 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -65.06 141.67 58.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -158.82 97.41 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.468 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 13.5 t70 -91.56 -18.6 23.84 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -51.43 87.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 9.9 tp -96.19 150.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.376 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 17.1 t 58.81 67.05 0.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.87 -42.39 33.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.7 p -173.65 163.42 4.28 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.777 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.39 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -123.4 115.15 21.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -82.78 135.59 34.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.728 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.59 150.21 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -152.75 121.86 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.18 114.24 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.92 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.396 178.871 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 N--CA 1.479 0.657 0 CA-C-O 120.905 0.294 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -140.37 138.24 34.67 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.345 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.504 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 10.8 p -101.35 138.22 38.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.643 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 10.4 m-85 -119.03 160.84 21.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.327 0.584 . . . . 0.0 110.976 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -142.43 118.93 10.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.444 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 t -97.66 65.55 1.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.364 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -71.43 109.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.705 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -97.2 148.1 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.978 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.48 23.08 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.94 26.94 43.04 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.001 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.28 72.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.435 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -132.75 158.71 41.7 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.889 0.376 . . . . 0.0 110.453 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.67 109.07 13.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.802 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 mtt -103.41 107.11 17.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -90.37 107.18 18.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 56.4 t80 -92.42 163.23 13.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.763 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.09 143.16 8.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.504 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 4.6 p90 -147.28 157.86 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.948 0.404 . . . . 0.0 110.328 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 95' ' ' THR . 9.2 t -142.16 127.46 18.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.96 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' SD ' ' A' ' 138' ' ' MET . 30.1 mtpt 56.89 33.11 22.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.473 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.5 141.3 40.5 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -32.71 135.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.777 2.318 . . . . 0.0 113.195 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.578 ' CD ' ' H ' ' A' ' 99' ' ' GLN . 1.2 pm0 -70.06 147.73 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.563 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -91.77 137.31 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.957 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -124.68 3.74 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.123 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 t -137.7 135.04 36.07 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.128 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.95 98.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.302 0.572 . . . . 0.0 109.681 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.3 p -113.35 158.75 20.2 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.932 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -151.06 169.37 21.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 p -166.51 163.07 17.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.61 134.23 42.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -151.89 113.85 4.45 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.3 -122.41 8.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.812 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.71 22.91 15.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.664 0.269 . . . . 0.0 110.633 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -133.52 159.24 41.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.62 136.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -104.25 167.43 9.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.15 0.5 . . . . 0.0 111.299 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.017 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -116.55 122.9 46.01 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.503 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.89 117.13 28.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.9 p -161.41 152.09 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.127 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.5 t -71.03 170.25 13.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.13 147.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 111.256 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 m -69.79 150.84 96.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.149 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.406 ' CD ' ' SD ' ' A' ' 202' ' ' MET . 35.5 Cg_endo -62.57 142.61 90.59 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.743 1.629 . . . . 0.0 111.252 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.67 53.64 2.38 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -143.67 -33.65 0.42 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.968 -0.137 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.18 20.38 0.51 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.142 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.813 ' HZ1' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -144.78 177.69 8.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.91 0.355 . . . . 0.0 110.72 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -90.36 135.79 33.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.217 0.532 . . . . 0.0 112.189 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.813 ' CB ' ' HZ1' ' A' ' 125' ' ' LYS . 1.1 m -133.58 67.24 75.27 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.548 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -42.09 129.88 4.44 Favored 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.066 2.511 . . . . 0.0 113.404 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.82 26.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.559 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 131' ' ' THR . 14.3 mm -141.5 153.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -84.44 166.99 16.85 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 111.003 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -60.23 -35.68 76.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.201 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.55 -52.39 46.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.475 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -65.59 -41.94 92.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.968 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.06 -56.85 16.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.539 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.3 tp -49.72 -32.78 14.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.087 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.2 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.975 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 96' ' ' LYS . 23.7 mmt -64.8 -49.47 70.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -46.92 -22.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 111.071 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -87.52 -47.94 8.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.89 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -34.27 55.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -40.27 110.27 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.007 0.432 . . . . 0.0 111.493 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 42.9 tp10 -141.16 114.14 8.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.997 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 144' ' ' VAL . 12.1 m -108.01 130.8 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.538 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -108.6 164.18 12.58 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.904 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.4 tp -154.76 149.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.945 0.402 . . . . 0.0 110.533 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -148.9 95.02 2.34 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.015 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.7 mm -80.5 136.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.64 175.71 9.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.8 t -91.96 130.16 37.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.9 p -120.26 148.36 43.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -131.3 34.66 3.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.499 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.72 101.4 10.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -71.96 -3.98 25.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.685 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -48.71 149.44 1.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.839 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.27 176.46 1.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.924 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.2 m -98.51 142.06 30.58 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.467 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 26.8 t70 -119.03 92.61 3.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.665 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -121.48 161.59 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -108.31 139.26 43.28 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.133 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.6 p -73.53 4.51 4.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -80.5 127.27 76.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.316 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -39.06 162.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.921 1.747 . . . . 0.0 112.297 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.37 133.51 29.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.961 0.41 . . . . 0.0 110.521 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.86 123.69 33.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.99 173.16 16.39 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.593 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 169' ' ' ILE . 16.1 t -99.95 3.87 44.61 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 50.2 t30 67.07 -10.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.4 mt -73.43 143.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.166 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 172' ' ' LYS . 95.5 p -102.44 141.54 35.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.587 ' NE2' HD11 ' A' ' 29' ' ' ILE . 7.8 m80 -77.22 33.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.079 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 170' ' ' SER . 76.9 tttt -62.05 172.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -88.13 132.76 34.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.713 0.292 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.58 -162.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.319 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 m -47.59 149.89 1.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.678 0.275 . . . . 0.0 110.569 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 53.5 p90 -107.48 135.4 49.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.952 0.406 . . . . 0.0 111.379 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.494 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 4.0 tm-20 -146.03 141.67 27.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.014 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.494 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 6.3 p-10 -76.68 96.86 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.618 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.4 tt -112.72 -29.84 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.192 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.401 HD12 ' OD1' ' A' ' 213' ' ' ASP . 13.6 mt -76.01 111.36 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.85 -117.68 0.47 Allowed Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.703 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.511 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 12.4 t -77.7 141.89 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.1 m -139.22 85.83 2.09 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 184' ' ' ILE . 9.9 tp -104.17 120.03 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 110.131 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 185' ' ' VAL . 10.0 m -136.69 131.66 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.883 0.373 . . . . 0.0 111.379 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.34 108.3 18.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.955 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 187' ' ' THR . 2.7 p -48.55 -27.88 3.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.346 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.05 -26.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.002 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 68.3 m -142.49 27.99 1.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.796 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -165.18 99.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.498 0.666 . . . . 0.0 109.855 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -72.29 -55.91 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.41 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -133.19 142.65 48.71 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.282 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.12 138.08 31.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 111.029 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 4.1 mp0 -105.19 156.81 17.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 133.57 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 0.0 110.869 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.05 18.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.3 t -136.6 112.77 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.448 HH12 ' H ' ' A' ' 211' ' ' VAL . 12.9 ttt85 -108.43 163.27 13.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.424 HG23 HG13 ' A' ' 211' ' ' VAL . 0.9 OUTLIER -160.96 109.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -162.52 -150.85 6.14 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.754 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 1.1 m-20 -89.37 140.63 29.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.535 ' SD ' ' SG ' ' A' ' 203' ' ' CYS . 0.0 OUTLIER -97.64 1.52 48.79 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.3 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.535 ' SG ' ' SD ' ' A' ' 202' ' ' MET . 24.1 m -115.37 -58.11 2.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -134.39 108.91 8.43 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.145 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 9.4 mp0 -58.39 121.9 11.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 209' ' ' LEU . 25.3 m -116.43 110.26 18.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.572 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 63.1 p -33.55 -46.86 0.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.617 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.88 -40.93 94.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.57 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.614 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.3 mm? -88.05 0.59 55.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.542 ' C ' HG12 ' A' ' 211' ' ' VAL . 50.2 mt-10 -86.64 137.44 32.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.21 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.542 HG12 ' C ' ' A' ' 210' ' ' GLU . 0.2 OUTLIER -170.09 152.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -161.68 153.75 19.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.313 0.578 . . . . 0.0 111.89 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 16.9 t70 -134.37 172.75 12.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.489 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 164.11 144.53 4.07 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.207 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -131.17 -178.26 4.76 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -149.67 105.82 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.201 0.524 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' B' ' 13' ' ' PHE . 5.3 t80 -96.44 128.38 43.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.573 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 220' ' ' GLY . 18.4 m -139.27 107.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.95 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 8.7 t70 64.58 -12.68 0.11 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.39 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 144.06 -0.36 1.14 Allowed Glycine 0 N--CA 1.461 0.366 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.687 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.4 m -105.2 121.39 43.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.37 160.24 14.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.7 t -173.83 120.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.438 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -74.42 135.93 42.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.24 103.66 0.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.413 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.91 95.75 2.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 51.4 m -123.42 150.81 43.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -55.33 95.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -88.75 36.18 0.8 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.6 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 231' ' ' SER . 5.7 t -75.36 -41.7 55.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.792 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 230' ' ' THR . 92.1 p -96.05 1.47 52.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.844 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.5 tp -42.26 -34.44 0.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.912 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.0 mt -148.37 145.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.013 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -75.18 94.6 2.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.988 0.423 . . . . 0.0 109.936 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -13.76 2.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.826 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.46 -7.81 58.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -103.9 9.12 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.563 0.221 . . . . 0.0 110.964 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 238' ' ' LEU . 7.3 mp -84.86 142.14 29.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -129.11 132.8 47.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.007 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.67 141.23 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 48.5 t -108.08 -4.47 17.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.628 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 242' ' ' VAL . 10.4 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.129 -1.415 . . . . 0.0 111.503 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 71.1 m -140.64 143.45 35.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.757 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -69.08 148.0 50.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.667 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 3.3 m-85 -122.71 -19.01 6.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.499 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 149.5 35.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.142 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -114.23 149.08 36.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -71.78 133.05 45.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.385 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.556 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -78.17 -42.79 30.54 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.877 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 12.4 mmm-85 -81.79 127.91 33.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.081 0.467 . . . . 0.0 111.493 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -68.18 152.97 44.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.624 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 19.6 mt -108.5 94.62 14.16 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.13 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -40.65 152.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.758 1.639 . . . . 0.0 112.343 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' B' ' 22' ' ' ARG . 8.1 tpt85 -45.49 -51.26 11.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.935 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -40.51 -39.22 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -105.77 46.05 0.94 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -155.67 92.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.33 -19.25 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.2 t70 -157.99 -179.55 8.23 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.492 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.484 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.4 p90 -165.48 163.37 19.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 111.287 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -148.06 179.83 7.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.437 ' N ' ' CD2' ' B' ' 29' ' ' TYR . 49.9 mt-10 -123.7 149.06 45.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.041 0.448 . . . . 0.0 111.168 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 41.3 p -55.58 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.997 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -148.29 -156.15 0.69 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.675 0.274 . . . . 0.0 110.536 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 47.4 t -129.82 -25.69 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.508 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 28.7 mt -58.24 -11.28 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.031 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.47 ' C ' ' H ' ' B' ' 37' ' ' GLN . 26.9 m -106.72 121.03 43.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.959 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -73.54 34.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.0 pt20 -168.67 63.08 0.54 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 73.3 Cg_endo -71.63 -161.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.629 2.22 . . . . 0.0 113.16 -178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.35 176.94 0.11 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 82.9 t -108.95 133.6 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.539 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 m -106.29 139.32 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.67 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -115.32 148.18 39.55 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.03 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 44' ' ' THR . 5.3 tt0 -100.18 168.05 10.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 1.7 p -143.84 -142.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.227 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.529 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -119.55 -39.93 2.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.063 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.73 46.65 2.36 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 81.1 p -147.42 -84.58 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.581 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.01 -84.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -139.66 145.22 38.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.718 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.8 117.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.511 ' H ' ' CB ' ' A' ' 182' ' ' SER . 0.1 OUTLIER -73.48 148.82 42.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.377 0.608 . . . . 0.0 112.025 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.75 134.25 28.24 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.53 126.25 89.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.79 -0.73 9.8 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.332 1.354 . . . . 0.0 111.258 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 51.9 m -69.76 -17.39 63.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.99 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.0 125.74 35.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.093 0.473 . . . . 0.0 110.176 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -48.6 -49.04 38.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -56.26 -26.43 51.59 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.677 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -72.91 -35.67 49.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.002 0.429 . . . . 0.0 110.112 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -70.42 -35.51 73.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.693 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -72.14 -35.25 69.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -64.73 -35.37 80.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.12 -45.63 61.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.81 -30.5 71.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.26 -39.35 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.718 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.91 -23.31 59.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.304 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -34.14 65.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -75.04 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.402 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.628 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.862 0.363 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.5 -21.98 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.602 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 p -49.95 127.89 17.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.531 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' CD2' ' A' ' 23' ' ' HIS . 6.3 t -54.28 -23.96 17.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -76.17 -31.54 58.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 m -74.44 -47.46 33.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.977 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.3 p -167.21 165.79 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.764 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.1 146.72 54.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.432 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 174.69 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 110.834 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -116.99 17.28 14.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.53 97.07 6.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.261 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 19' ' ' GLU . 6.8 mp0 -32.99 -60.22 0.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.07 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -80.1 52.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.324 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CG ' ' A' ' 22' ' ' HIS . 13.1 tttp -164.24 139.33 5.86 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.107 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 92.3 m-70 -155.7 122.61 5.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -57.76 115.53 2.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.752 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -88.94 124.42 34.22 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.056 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.22 141.02 12.21 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.78 150.83 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.797 0.332 . . . . 0.0 110.253 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 21.2 t0 -139.46 142.82 37.37 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.484 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 27.6 t -137.62 107.52 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.844 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.598 ' CG1' ' HE ' ' A' ' 115' ' ' ARG . 4.1 mp -102.07 128.06 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 30' ' ' ILE . 8.5 tt -135.85 130.46 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.429 0.633 . . . . 0.0 111.75 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -116.34 125.11 51.65 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.44 131.53 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.088 0.47 . . . . 0.0 111.406 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.2 m -105.81 132.55 51.79 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 110' ' ' ASN . 11.8 pttm -86.58 163.45 17.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.318 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 37' ' ' GLN . 6.7 tt0 -75.81 137.48 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.675 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -50.52 -10.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 35' ' ' GLN . 2.3 mp0 -87.83 -41.73 13.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.963 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -46.36 148.29 1.67 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.796 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.57 167.26 25.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.06 1.84 . . . . 0.0 111.519 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.0 p -69.79 135.55 49.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.304 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -158.32 98.21 1.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.404 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 7.0 m-20 -97.55 -13.61 21.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.164 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.1 mmtm -54.93 85.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.963 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.1 tp -89.46 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.281 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 21.2 t 57.93 64.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.234 0.54 . . . . 0.0 110.402 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.4 ' NE2' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -72.86 -33.5 66.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 t -173.09 -172.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.579 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.5 p -167.7 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.38 0.61 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 m -82.54 155.24 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.723 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -152.22 124.34 8.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 110.682 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.8 168.97 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.26 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' GLU . 10.1 t -153.36 154.29 34.22 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 2.6 pm0 -38.74 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.667 0.27 . . . . 0.0 110.675 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.262 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 CA--C 1.527 0.131 0 N-CA-C 114.13 0.781 . . . . 0.0 114.13 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.1 p -118.66 117.44 28.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.056 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -86.54 129.84 34.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' B' ' 47' ' ' SER . 49.2 t80 -113.52 143.3 44.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.695 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.42 ' OH ' HD11 ' A' ' 100' ' ' ILE . 70.0 m-85 -138.01 118.61 13.95 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.743 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 t -101.02 67.0 1.17 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.909 0.385 . . . . 0.0 110.61 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.23 111.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.727 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -98.84 145.89 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.45 161.44 11.77 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.68 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.88 26.85 48.96 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.323 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.41 ' O ' HD22 ' A' ' 88' ' ' LEU . . . 73.51 3.03 61.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.923 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.41 HD22 ' O ' ' A' ' 87' ' ' GLY . 2.8 mm? -115.94 149.4 38.81 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.04 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.622 ' CZ ' HD21 ' A' ' 91' ' ' ASN . 44.7 ttt-85 -111.91 115.05 28.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.9 mpt? -101.07 145.48 28.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.175 0.512 . . . . 0.0 110.847 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.622 HD21 ' CZ ' ' A' ' 89' ' ' ARG . 72.0 m-80 -138.4 129.76 27.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.051 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -112.05 -167.04 1.13 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.788 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.11 67.5 0.07 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.028 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.24 132.53 39.95 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -135.89 115.58 12.92 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? 70.22 30.91 3.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.865 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.92 149.16 50.33 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.6 148.04 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.898 1.732 . . . . 0.0 111.97 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.16 138.69 54.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.384 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.636 ' C ' HD12 ' A' ' 100' ' ' ILE . 2.1 pp -92.74 159.43 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' A' ' 102' ' ' SER . 6.5 tmtm? -156.8 -22.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.303 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.403 ' H ' ' H ' ' A' ' 101' ' ' LYS . 53.1 p -101.1 121.73 42.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 130.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.9 p -152.52 160.62 43.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -148.19 170.54 17.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -165.29 161.89 19.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.61 124.91 30.93 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.63 107.72 6.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.138 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.78 -127.73 19.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.543 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 31.3 m-80 -97.98 19.52 13.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.581 0.229 . . . . 0.0 110.867 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.3 p -127.21 155.5 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.887 0.375 . . . . 0.0 110.754 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.27 133.19 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.437 ' CG ' ' N ' ' A' ' 114' ' ' ALA . 10.1 t30 -99.05 165.18 11.86 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.752 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 113' ' ' ASN . . . -164.41 118.72 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.498 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.598 ' HE ' ' CG1' ' A' ' 29' ' ' ILE . 12.2 mmt85 -112.13 130.58 55.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.809 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tt -137.97 116.23 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.7 p -160.31 170.46 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 111.603 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.4 p -84.61 163.73 19.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.906 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.3 149.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.795 0.331 . . . . 0.0 110.808 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 121' ' ' PRO . 37.3 p -98.14 149.78 36.07 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 120' ' ' SER . 72.7 Cg_exo -40.08 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.54 2.16 . . . . 0.0 113.046 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.65 3.06 61.98 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' CD ' ' H ' ' A' ' 125' ' ' LYS . 2.3 pt20 -81.84 -115.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 0.0 110.421 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 123' ' ' GLN . . . -161.16 20.84 0.21 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.555 ' H ' ' CD ' ' A' ' 123' ' ' GLN . 7.2 tptm -144.83 -179.26 6.48 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.99 152.0 26.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.372 0.606 . . . . 0.0 112.04 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.2 p -146.9 70.0 12.12 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.386 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.74 134.02 2.41 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.228 2.619 . . . . 0.0 114.135 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.462 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . . . -89.3 161.49 16.35 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -153.56 154.72 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.262 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.565 HG22 ' N ' ' A' ' 132' ' ' HIS . 62.2 m -82.54 162.31 22.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.427 0.632 . . . . 0.0 111.695 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.565 ' N ' HG22 ' A' ' 131' ' ' THR . 38.3 t60 -50.88 -40.67 57.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.168 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.07 -57.42 11.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.143 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.7 OUTLIER -56.48 -44.38 80.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.038 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.51 -56.58 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 109.896 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.402 HD11 ' CD2' ' A' ' 132' ' ' HIS . 23.1 mt -53.81 -35.08 61.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.781 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.11 -28.6 61.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.423 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 mmt -74.78 -61.82 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.036 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.964 HD13 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -53.61 -20.41 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.189 -178.099 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.964 ' N ' HD13 ' A' ' 139' ' ' ILE . 34.9 ttpt -77.64 -55.16 5.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.634 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.1 -31.76 56.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.6 t -43.89 118.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.996 0.426 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 144' ' ' VAL . 1.6 tm-20 -141.23 126.44 18.51 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.46 ' N ' ' OE2' ' A' ' 143' ' ' GLU . 7.2 p -122.07 128.5 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.83 0.348 . . . . 0.0 110.59 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.2 p -101.39 167.67 10.02 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.55 146.74 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -166.99 94.95 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.452 ' H ' HG12 ' A' ' 185' ' ' VAL . 1.9 pt -92.68 127.31 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.29 0.567 . . . . 0.0 112.273 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -103.0 -179.33 3.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.946 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 8.0 m -93.35 129.29 39.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.451 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 p -103.45 -179.07 3.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.788 0.328 . . . . 0.0 110.29 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -155.49 -2.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 153' ' ' GLU . 6.1 mp0 -62.1 100.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.793 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.04 11.91 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -56.51 149.75 16.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.576 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.2 m-20 -55.74 172.8 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.3 t -98.8 145.65 26.74 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.637 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p-10 -119.99 93.43 4.06 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.693 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.754 HD13 ' H ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -119.03 176.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -130.08 135.28 48.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 161' ' ' THR . 24.7 m -70.16 2.81 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -80.74 117.98 70.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -40.35 155.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.698 1.598 . . . . 0.0 112.05 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -81.64 138.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.935 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.507 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 2.3 mm? -83.84 114.69 21.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.05 171.56 46.61 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.492 -0.385 . . . . 0.0 112.197 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ILE . 9.3 t -101.95 7.32 41.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.8 t30 64.15 -8.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.1 pp -80.35 161.27 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.218 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.502 ' H ' ' NH1' ' A' ' 198' ' ' ARG . 13.0 t -123.57 137.46 54.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.491 ' CE1' HD11 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -74.19 38.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.106 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.417 ' NZ ' ' CB ' ' A' ' 170' ' ' SER . 58.8 mttp -67.62 -170.79 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.217 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -102.76 127.5 49.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.998 0.428 . . . . 0.0 110.509 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.486 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 12.1 m -151.64 -168.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.896 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -43.97 144.08 0.98 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.344 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -111.78 141.97 44.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -162.29 151.6 15.69 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.534 177.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.98 104.5 2.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.161 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.3 mt -107.09 -42.76 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 195' ' ' PHE . 9.0 tt -72.59 138.08 22.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.087 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -101.13 -118.52 4.34 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.9 t -72.84 143.91 47.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.1 m -137.78 84.17 2.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.93 103.95 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 148' ' ' ILE . 25.1 m -124.16 143.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.551 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.37 110.3 21.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.499 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 189' ' ' CYS . 7.0 m -50.75 -28.47 9.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.484 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -36.4 -28.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.077 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 187' ' ' THR . 30.2 p -149.34 24.23 0.91 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 24.9 t -143.25 81.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -69.19 -57.47 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.266 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 14.0 t-20 -111.7 162.08 15.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.403 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.613 ' C ' HD23 ' A' ' 193' ' ' LEU . 6.9 tt -169.22 106.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 110.419 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.89 130.87 46.96 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.481 ' CD1' HD12 ' A' ' 180' ' ' ILE . 5.2 t80 -125.24 133.44 52.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.809 0.338 . . . . 0.0 110.514 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.8 p -143.92 139.0 28.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.951 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 198' ' ' ARG . 18.7 t -135.03 160.34 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.502 ' NH1' ' H ' ' A' ' 170' ' ' SER . 57.0 ttt180 -170.67 111.54 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.124 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.3 tt -110.45 128.52 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.669 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.96 -155.24 8.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.878 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -91.39 119.98 31.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.464 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -82.01 2.37 31.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 92.2 m -100.77 -55.85 2.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 109.861 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.498 ' NZ ' ' CB ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -150.58 122.25 8.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.677 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -42.94 141.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.147 0.499 . . . . 0.0 111.754 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 208' ' ' GLU . 12.7 t -140.83 89.3 2.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.272 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.1 m -37.11 -27.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.25 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 206' ' ' SER . 85.0 mt-10 -73.06 -52.33 14.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.01 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.502 HD21 ' CE1' ' A' ' 132' ' ' HIS . 39.3 mt -91.5 7.81 39.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.305 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -97.21 119.03 34.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.2 m -145.29 168.21 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.486 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -154.22 167.71 28.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 112.557 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -151.12 163.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.295 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 171.29 160.21 19.28 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.156 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -148.02 172.64 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -139.6 104.74 5.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -103.31 122.96 45.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.703 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 218' ' ' VAL . 5.7 m -143.59 120.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.252 0.548 . . . . 0.0 110.918 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.5 37.99 10.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.101 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.12 -4.86 83.14 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.726 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -100.08 116.18 31.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.23 0.515 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.28 154.6 19.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.356 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 42.2 t -169.7 127.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.329 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -77.53 140.55 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -169.25 111.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.452 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.24 100.91 8.56 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 69.7 p -131.63 166.26 21.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.631 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.14 96.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.781 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.92 18.2 4.34 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.589 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -62.7 -38.18 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 84.0 p -98.01 -2.28 40.72 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.297 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -41.68 -36.34 0.95 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.992 0.425 . . . . 0.0 110.541 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 8.6 mt -148.26 142.81 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 236' ' ' THR . 0.9 OUTLIER -75.99 101.5 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.213 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.45 ' CB ' HH12 ' A' ' 115' ' ' ARG . 84.9 p -65.58 4.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 234' ' ' ASP . 46.9 p -91.19 -18.38 24.54 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.456 ' NZ ' ' CB ' ' A' ' 237' ' ' LYS . 9.1 mtmp? -104.64 8.44 35.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 238' ' ' LEU . 0.3 OUTLIER -78.94 161.8 26.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -145.21 134.6 23.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.69 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.39 134.04 55.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.151 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 41.0 t -100.92 -7.03 23.81 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.275 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.414 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 117.641 -1.171 . . . . 0.0 111.751 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.534 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 98.0 m -142.53 142.24 32.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.22 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 14' ' ' SER . 2.7 t -73.43 147.07 44.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 110.685 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.534 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -114.68 -20.86 10.49 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 12' ' ' CYS . 7.9 m -146.23 148.82 32.89 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.049 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.493 ' CD2' ' OD2' ' B' ' 53' ' ' ASP . 9.5 m-85 -107.92 164.5 12.21 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -86.94 138.15 31.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.784 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.39 23.51 3.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.925 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.25 125.46 18.71 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.721 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -80.53 119.19 22.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.755 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 2.6 mm? -80.57 113.56 40.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.343 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -46.66 149.34 3.04 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.38 1.387 . . . . 0.0 111.786 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -43.87 -47.3 8.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.315 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -38.3 -32.25 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.0 44.33 1.23 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.775 0.322 . . . . 0.0 110.735 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -149.8 86.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.796 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -89.11 -28.23 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -153.26 -179.41 7.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.998 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -164.11 164.1 22.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.527 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.509 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 57.1 t80 -148.12 -179.98 7.32 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.509 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 44.3 mt-10 -123.0 149.62 44.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 110.789 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.409 ' O ' ' O ' ' B' ' 30' ' ' GLU . 40.8 p -55.67 -111.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.815 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.9 t -152.01 -153.84 0.5 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.781 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.417 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.4 m -132.98 -25.51 1.81 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.399 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -59.36 -7.08 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.438 ' C ' ' H ' ' B' ' 37' ' ' GLN . 25.2 m -112.54 120.92 43.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 m -74.08 36.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.305 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.4 pt20 -169.91 61.68 0.41 Allowed Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 86.6 Cg_endo -73.14 -162.06 0.12 Allowed 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.793 2.329 . . . . 0.0 113.319 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.96 176.93 0.13 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.972 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -107.77 135.79 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.136 0.493 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.01 137.83 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.605 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.07 146.08 42.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.369 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -92.79 169.97 10.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.2 p -138.59 -143.34 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 110.742 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -128.69 -38.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.278 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.27 41.66 3.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.76 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 11.6 t -147.06 -84.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.568 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.08 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.321 0.388 . . . . 0.0 110.044 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -144.0 145.94 32.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.344 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 24.1 t -153.2 125.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' B' ' 14' ' ' SER . 13.8 p -77.55 148.84 35.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.169 0.509 . . . . 0.0 111.395 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.89 142.37 42.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASP . . . . . 0.493 ' OD2' ' CD2' ' B' ' 15' ' ' TYR . 9.2 m-20 -64.15 122.78 79.64 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.07 0.46 8.37 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.062 1.175 . . . . 0.0 110.863 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 44.5 t -77.27 -5.25 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.702 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 57' ' ' SER . 1.1 tp10 -105.4 125.18 50.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.526 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 19.2 m -44.83 -43.86 9.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -56.4 -34.36 66.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.401 HG21 ' O ' ' B' ' 53' ' ' ASP . 40.2 t -69.94 -38.87 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.334 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.04 -52.49 59.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.796 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.85 -35.64 75.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.06 -35.91 81.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.19 -45.55 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.832 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -63.13 -32.31 73.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -71.48 -41.82 68.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.29 -19.45 63.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.265 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -34.08 67.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.98 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.51 -77.62 0.15 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.813 0.339 . . . . 0.0 110.361 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 53.0 p30 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.537 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.729 0.299 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.6 m -65.37 -27.87 68.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.985 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.2 m -49.5 132.2 20.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -56.93 -25.36 57.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.581 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m -74.74 -29.45 61.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.609 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -74.35 -56.36 4.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.273 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -159.25 173.17 16.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 110.791 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.4 m -62.9 161.3 13.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.828 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 p -74.32 163.58 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.86 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 30.1 mp0 -112.15 7.47 19.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.529 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -67.32 -149.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.211 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -135.38 -68.87 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.461 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 41.8 t30 -79.02 52.07 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.424 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' O ' ' ND1' ' A' ' 22' ' ' HIS . 10.5 tptm -148.86 137.5 21.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.819 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 21' ' ' LYS . 22.9 m-70 -143.24 158.05 43.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 76.76 2.05 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.415 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.523 ' CE ' ' HB1' ' A' ' 135' ' ' ALA . 46.6 tpp -65.71 128.33 35.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 0.0 111.441 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -135.67 149.04 19.89 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.79 148.21 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' CB ' HD11 ' A' ' 169' ' ' ILE . 15.7 t0 -135.15 139.12 44.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.15 101.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.984 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.0 131.9 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.39 140.1 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.506 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.97 0.414 . . . . 0.0 110.056 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.48 135.06 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.746 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -102.15 120.1 39.89 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.636 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -74.58 152.87 39.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.853 0.358 . . . . 0.0 110.858 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 37' ' ' GLN . 33.7 mm-40 -70.63 158.82 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.284 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.33 28.62 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.737 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 35' ' ' GLN . 22.8 tt0 -141.05 -19.44 0.8 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -67.72 115.68 29.98 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.168 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -40.0 157.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.0 p -73.42 136.13 44.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -156.58 101.77 2.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.169 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.65 7.56 46.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.668 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -67.47 88.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 44' ' ' ILE . 20.1 pt -85.12 141.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.02 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 22.1 t 55.43 67.82 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 10.2 tm0? -78.73 -25.99 44.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 t 177.48 159.34 0.42 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.589 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.25 125.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -119.76 123.34 43.5 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.643 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 19.1 mp0 -102.69 129.43 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 52' ' ' THR . 7.3 mm -134.71 159.61 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 51' ' ' ILE . 22.2 m -152.63 108.41 3.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.621 ' CG ' ' H ' ' A' ' 78' ' ' THR . 4.3 pt-20 -52.3 120.97 6.09 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 22.6 t . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 CA--C 1.53 0.307 0 N-CA-C 111.185 -0.352 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.621 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 16.1 p -130.3 139.59 50.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.858 0.361 . . . . 0.0 110.869 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 m -98.83 132.15 44.4 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -113.72 143.24 44.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 110.429 -178.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 86.3 m-85 -129.57 124.87 34.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.652 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.2 p -103.91 62.66 0.76 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.662 0.267 . . . . 0.0 110.859 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.476 ' O ' HG23 ' A' ' 83' ' ' ILE . 13.1 tt -71.22 102.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 110.12 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -102.14 148.05 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.956 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.51 144.52 5.18 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.31 9.22 57.05 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.28 2.52 57.88 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.758 -0.258 . . . . 0.0 113.098 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.501 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -151.16 173.95 13.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.307 0.554 . . . . 0.0 111.367 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -129.09 117.18 20.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.738 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.5 mtt -101.99 122.0 43.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.297 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -109.93 122.57 47.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.493 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.8 178.03 4.68 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.617 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.01 74.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.037 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -76.9 143.26 39.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.045 0.423 . . . . 0.0 110.441 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -127.75 105.53 8.52 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.474 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.8 tttt 67.08 40.14 2.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.759 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.8 m -119.02 148.86 45.67 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.28 129.95 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.882 1.721 . . . . 0.0 111.937 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.568 ' CD ' ' H ' ' A' ' 99' ' ' GLN . 24.7 mp0 -50.39 144.99 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.9 mt -96.39 142.56 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.78 -11.54 1.15 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.016 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -113.17 116.48 29.88 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 pt -128.58 120.02 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.0 p -135.82 172.22 13.32 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.928 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 64.0 tt0 -161.57 152.83 18.53 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 t -155.47 152.23 28.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.033 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.23 121.83 28.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -133.41 108.61 8.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.006 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.68 -119.06 6.35 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -112.58 26.35 10.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.806 0.336 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 p -130.34 157.36 42.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.511 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.64 136.68 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.601 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.509 ' N ' HD22 ' A' ' 113' ' ' ASN . 0.1 OUTLIER -124.48 158.22 33.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.967 0.413 . . . . 0.0 110.728 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.49 135.82 13.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.461 HH21 HG21 ' A' ' 164' ' ' VAL . 53.9 ttp180 -114.0 123.66 50.26 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.02 118.83 34.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 t -167.05 161.22 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.902 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.9 t -82.69 174.59 10.86 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.06 144.43 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.013 0.435 . . . . 0.0 110.982 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 p -79.73 151.02 73.58 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.047 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.77 163.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.921 1.747 . . . . 0.0 112.185 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.55 61.78 7.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.209 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -139.31 -52.27 0.54 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.07 -12.78 0.37 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.696 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -126.92 172.46 10.42 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -74.56 150.7 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.644 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.0 m -143.41 63.05 12.09 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.292 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.52 131.54 2.52 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.116 2.544 . . . . 0.0 113.339 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.8 152.46 23.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.38 176.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.699 0.285 . . . . 0.0 110.735 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.2 p -81.19 172.33 13.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.183 0.516 . . . . 0.0 111.692 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.461 ' CG ' ' OD1' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -61.26 -37.35 82.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -63.65 -57.07 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.523 ' HB1' ' CE ' ' A' ' 24' ' ' MET . . . -65.44 -57.24 8.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.039 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -53.54 -31.57 47.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.219 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.48 73.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.68 -52.34 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.54 -22.84 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.453 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -87.28 -54.51 4.27 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -79.89 -36.02 37.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 t -44.26 116.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.721 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 49.9 mt-10 -145.02 156.61 44.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.12 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.9 136.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.965 0.412 . . . . 0.0 110.374 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.0 p -102.37 163.91 11.97 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.71 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.56 137.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.88 0.372 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -143.95 92.89 2.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.7 mm -79.23 139.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.648 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.452 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 58.3 ttt180 -134.17 165.36 25.27 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 7.1 t -90.67 118.09 29.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.318 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 152' ' ' GLU . 31.2 t -100.3 -176.05 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.706 0.289 . . . . 0.0 110.262 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.431 ' N ' ' OG ' ' A' ' 151' ' ' SER . 16.0 tp10 -162.45 17.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.043 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.12 103.38 7.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.485 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.16 8.7 3.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -56.01 138.38 49.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.112 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.09 174.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.975 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 t -94.66 143.9 26.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.498 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.464 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 m-20 -117.6 91.44 3.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.955 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.5 pt -124.51 170.3 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.689 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.492 ' CD ' ' HB3' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -104.95 -160.88 0.78 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.034 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.7 t -130.53 -3.48 4.26 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -83.45 130.6 55.65 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -39.29 158.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.876 1.717 . . . . 0.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.461 HG21 HH21 ' A' ' 115' ' ' ARG . 14.6 p -80.25 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.257 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 18.0 mt -82.07 125.04 30.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.591 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.89 163.96 17.29 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.562 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 t -94.72 5.61 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.801 0.334 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.2 m-20 60.31 9.5 1.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.988 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.516 HD11 ' CB ' ' A' ' 27' ' ' ASP . 2.2 pp -98.01 154.65 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 172' ' ' LYS . 80.1 p -117.49 129.17 55.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.21 35.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 170' ' ' SER . 19.3 tttp -59.21 -164.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -99.31 119.9 38.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 175' ' ' SER . 2.7 t -148.02 171.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.554 ' H ' HG12 ' A' ' 174' ' ' VAL . 6.3 p -31.48 149.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.495 0.497 . . . . 0.0 111.529 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -106.58 141.69 37.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.191 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 3.8 tm-20 -150.85 137.42 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.619 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.433 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.1 t70 -65.92 96.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.1 mt -107.26 -52.99 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.388 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 180' ' ' ILE . 5.5 tp -63.45 124.95 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.61 -117.38 2.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.574 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 41.5 m -74.18 139.25 44.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.793 -0.203 . . . . 0.0 111.16 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.7 p -138.3 91.58 2.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.21 0.529 . . . . 0.0 110.77 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.1 mm -99.13 115.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.051 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.27 138.48 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.155 0.502 . . . . 0.0 111.497 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.84 92.81 7.61 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 189' ' ' CYS . 1.3 p -47.27 -44.15 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.061 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -37.55 -27.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.038 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 187' ' ' THR . 81.6 m -146.17 31.43 1.02 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.4 t -149.75 100.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.711 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -77.02 -60.64 2.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.843 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -117.91 177.94 4.59 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.567 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 195' ' ' PHE . 1.1 tt -174.07 108.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.474 ' OE1' HD21 ' A' ' 232' ' ' LEU . 48.3 mt-10 -93.44 137.65 32.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 193' ' ' LEU . 88.7 m-85 -117.37 130.77 56.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.713 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.0 m -144.3 119.73 10.3 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 198' ' ' ARG . 45.3 t -131.06 157.87 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.326 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.475 ' N ' HG12 ' A' ' 197' ' ' VAL . 45.5 ttt180 -158.31 156.13 30.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.56 112.71 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.21 167.89 40.91 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.078 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -49.28 141.14 8.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.7 mtm -95.66 3.81 53.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.2 t -118.57 -47.92 2.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.719 0.295 . . . . 0.0 110.867 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.79 108.84 4.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 110.164 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -48.28 156.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.6 p -156.54 112.27 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.982 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 t -33.16 -59.3 0.36 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.582 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -52.19 -53.34 44.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -92.0 61.87 4.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -163.8 105.59 0.94 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.717 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.15 174.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.969 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -171.38 147.3 2.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.567 . . . . 0.0 111.584 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.3 t70 -121.73 171.2 9.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.39 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . -179.83 158.57 22.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.888 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.429 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 46.7 m-85 -150.31 165.45 32.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -134.03 104.92 6.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -101.93 117.58 35.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.79 104.04 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.061 0.458 . . . . 0.0 110.703 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.6 t0 55.23 52.17 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.255 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.63 -9.52 50.24 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.908 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.8 p -89.6 109.11 20.09 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.63 -0.335 . . . . 0.0 110.944 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -103.08 147.65 26.71 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 73.1 m -166.79 129.53 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -82.2 141.14 33.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -171.07 108.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.272 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.1 97.28 2.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.242 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.6 p -126.06 154.18 43.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.91 95.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.55 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.2 35.6 0.81 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.353 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.6 m -74.65 -41.62 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.714 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -93.61 5.04 52.93 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.149 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -38.52 -37.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.135 0.493 . . . . 0.0 110.767 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 7.7 tp -159.66 148.88 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.728 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.65 100.57 4.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.3 t -68.23 -0.82 5.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.2 p -82.58 -21.15 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -105.2 10.06 33.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.241 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.7 mt -92.84 129.27 38.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -113.67 143.85 43.91 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.068 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' LYS . . . -55.75 171.32 0.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 241' ' ' CYS . 40.1 t -126.21 -6.13 6.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.71 179.695 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.837 0.351 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 87.8 m -149.29 116.23 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' CYS . . . . . 0.402 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 0.1 OUTLIER -62.94 137.53 58.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.96 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.94 -20.62 10.46 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.985 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -122.43 143.58 49.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.483 ' CD2' ' OD1' ' B' ' 53' ' ' ASP . 16.4 m-85 -121.73 152.48 39.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 111.808 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -80.29 141.27 35.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.572 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -89.15 -28.02 20.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -87.54 126.03 34.68 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.724 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -85.85 114.61 22.91 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.553 HD12 ' N ' ' B' ' 20' ' ' LEU . 9.3 mp -75.33 115.08 41.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -41.93 151.04 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.134 1.889 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 25' ' ' VAL . 39.7 ttm180 -45.87 -50.0 14.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.386 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -28.99 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -109.6 50.26 0.8 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.941 0.4 . . . . 0.0 110.241 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 22' ' ' ARG . 66.1 t -150.22 88.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -95.42 -21.14 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.35 179.21 8.52 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.499 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -166.98 163.38 15.99 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.287 0.565 . . . . 0.0 112.037 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -152.16 167.25 29.14 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.165 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' B' ' 31' ' ' THR . 50.9 mt-10 -114.08 152.18 31.44 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.422 ' O ' ' O ' ' B' ' 30' ' ' GLU . 73.0 p -55.92 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.091 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -147.84 -149.29 0.29 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.676 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 35' ' ' CYS . 91.1 p -135.51 -24.38 1.37 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.276 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.24 -3.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.46 . . . . 0.0 109.788 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.446 ' C ' ' H ' ' B' ' 37' ' ' GLN . 58.0 m -114.99 117.31 30.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.503 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -73.65 37.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.964 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' B' ' 35' ' ' CYS . 10.2 pt20 -169.22 64.3 0.54 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 86.0 Cg_endo -75.95 -162.86 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.422 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' B' ' 51' ' ' CYS . . . 174.32 176.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.971 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.14 144.06 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.224 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.44 130.47 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.505 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -112.14 144.21 41.9 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -111.51 115.19 28.79 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.066 0.46 . . . . 0.0 111.047 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.4 p -79.52 -140.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.48 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.85 -27.91 2.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.87 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.97 46.44 2.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.435 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 48.0 t -157.26 -84.95 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.944 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.76 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.715 0.635 . . . . 0.0 109.777 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -131.17 140.68 49.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.726 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.0 t -150.19 112.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 110.827 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.574 ' N ' ' OG ' ' A' ' 182' ' ' SER . 2.6 t -73.33 152.16 41.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.605 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.13 135.79 22.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.893 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASP . . . . . 0.483 ' OD1' ' CD2' ' B' ' 15' ' ' TYR . 69.3 m-20 -61.74 125.9 85.81 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.54 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 74.3 Cg_endo -72.99 2.64 5.24 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.433 1.422 . . . . 0.0 111.448 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 30.2 m -73.39 -3.49 27.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.292 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.553 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 39.0 mt-10 -109.53 125.13 52.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.93 0.395 . . . . 0.0 110.363 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -50.12 -36.19 28.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.113 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -56.14 -36.18 67.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.936 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 t -70.72 -36.88 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.001 0.429 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' B' ' 56' ' ' GLU . 2.9 mp0 -70.07 -36.79 75.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.99 -37.56 69.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.225 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.31 -41.03 94.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.628 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.47 -44.21 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.919 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -60.13 -28.9 68.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.746 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -75.33 -43.7 49.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.946 0.403 . . . . 0.0 110.728 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.74 -22.75 63.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.457 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.57 -36.53 68.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -75.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 59.1 t30 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.581 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.776 0.322 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -72.37 -20.77 61.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.592 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.9 t -50.42 131.98 24.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.565 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.5 p -57.77 -29.59 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -76.83 -23.54 52.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.721 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -79.08 -48.05 15.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -165.35 171.27 13.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.093 0.473 . . . . 0.0 111.05 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.66 148.75 48.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.553 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.7 p -70.93 176.18 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.548 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.6 5.71 6.81 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 19' ' ' GLU . 43.1 mt-10 -83.03 92.9 7.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.411 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' GLU . 37.1 tt0 -23.54 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.171 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -76.22 50.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.358 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -158.49 135.71 9.99 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -145.53 166.43 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.82 0.343 . . . . 0.0 111.003 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -95.03 107.05 19.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.567 ' SD ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -78.64 107.21 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.297 0.57 . . . . 0.0 110.581 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.86 148.32 18.71 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.98 151.86 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' CD1' ' A' ' 29' ' ' ILE . 59.0 t0 -147.25 130.83 16.81 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -138.67 99.8 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.846 0.355 . . . . 0.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.7 mp -95.23 139.54 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 pt -148.71 135.13 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.471 0.653 . . . . 0.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' HD12 ' A' ' 193' ' ' LEU . 36.7 ttmt -115.98 123.19 47.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.589 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.63 110.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.784 0.326 . . . . 0.0 111.162 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -87.58 122.24 31.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.758 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.442 ' NZ ' ' C ' ' A' ' 110' ' ' ASN . 25.1 mtmm -80.55 154.31 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.758 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.546 ' NE2' ' H ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -74.06 154.06 39.38 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.546 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 15.2 t70 -62.1 -19.47 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.4 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -82.75 -36.71 25.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.193 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.8 p -48.04 147.21 3.71 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.742 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.09 168.47 24.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.113 1.876 . . . . 0.0 111.575 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -75.36 128.46 35.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.63 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.475 ' ND2' ' OE1' ' A' ' 154' ' ' GLU . 29.7 m120 -158.24 101.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.73 -0.27 21.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.643 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -72.69 71.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -71.06 170.36 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 110.383 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 32.6 t 50.35 57.86 6.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.48 0.657 . . . . 0.0 110.443 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.532 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 8.7 tm0? -78.98 -21.2 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 t 173.14 154.12 0.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.905 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.16 135.06 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -114.29 153.93 28.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -136.22 109.73 7.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.531 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 79' ' ' THR . 6.0 mt -122.01 154.02 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 t -153.59 151.32 29.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 37.8 tt0 -52.96 171.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 p . . . . . 0 C--N 1.32 -0.706 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.307 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.481 0.784 0 N-CA-C 113.105 0.387 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -140.67 149.56 42.4 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.032 0.444 . . . . 0.0 111.498 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.2 m -101.37 129.85 47.45 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 63.8 t80 -118.39 101.8 8.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -108.96 117.56 34.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.915 0.388 . . . . 0.0 110.277 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 t -95.95 85.32 4.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.59 118.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.069 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 tt -106.62 146.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.796 0.331 . . . . 0.0 110.109 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 157.57 7.77 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.31 7.95 82.02 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.99 60.29 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.829 -0.224 . . . . 0.0 112.582 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.56 174.47 15.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 111.045 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -115.81 123.88 49.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.719 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.2 mpp? -102.71 97.94 8.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' HG23 ' A' ' 146' ' ' ILE . 84.3 m-20 -86.88 133.89 33.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.456 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 78.6 m-85 -116.27 -164.91 1.0 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.76 71.94 0.03 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.07 140.54 40.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.166 0.508 . . . . 0.0 110.641 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -131.97 108.27 9.25 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? 69.04 36.5 2.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 31.9 m -122.38 149.65 55.53 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -34.91 153.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.408 2.072 . . . . 0.0 112.573 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -76.21 106.43 7.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -62.48 146.05 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.21 -12.05 0.42 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.861 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -106.09 113.79 27.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.2 mt -124.03 108.2 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -139.48 153.92 47.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.77 0.319 . . . . 0.0 111.815 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 17.0 mp0 -145.11 169.69 17.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.6 p -157.83 153.95 27.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.87 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.27 118.2 20.97 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.853 0.358 . . . . 0.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.4 107.63 8.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.99 -138.7 25.96 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.442 ' C ' ' NZ ' ' A' ' 34' ' ' LYS . 24.5 p30 -91.99 26.29 2.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 110.494 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 112' ' ' VAL . 87.0 m -129.63 156.47 44.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.772 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.48 ' N ' HG22 ' A' ' 111' ' ' THR . 35.0 m -142.07 138.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.316 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 113' ' ' ASN . 1.3 m120 -119.57 168.08 11.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.115 0.483 . . . . 0.0 111.194 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.25 127.33 9.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.105 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.477 ' NH1' ' OG ' ' A' ' 235' ' ' SER . 76.9 ttt180 -113.52 110.79 20.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.656 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 115' ' ' ARG . 3.2 mm? -115.19 124.9 52.62 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 p -168.07 161.75 12.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.938 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -77.93 171.0 15.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.623 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.83 145.56 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.043 0.449 . . . . 0.0 111.338 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.15 163.38 53.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.43 150.23 84.37 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 122.209 1.939 . . . . 0.0 111.664 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.37 9.67 85.59 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.329 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -82.96 -60.51 2.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.35 -16.73 0.29 Allowed Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -110.42 179.0 4.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.48 158.74 35.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.108 0.48 . . . . 0.0 111.242 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.4 p -155.04 61.03 2.86 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -40.36 135.55 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.936 2.424 . . . . 0.0 113.286 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -114.99 145.87 41.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.272 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.567 HG22 ' SD ' ' A' ' 24' ' ' MET . 5.8 tp -140.71 168.35 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -73.14 178.58 4.32 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 111.475 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -71.23 -34.3 70.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.54 -57.61 11.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.64 -31.89 73.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.993 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.89 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.505 ' O ' ' NZ ' ' A' ' 140' ' ' LYS . 35.3 tp -74.23 -32.82 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.595 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.18 -52.02 18.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.55 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -64.12 -54.53 32.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.587 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.585 ' N ' ' SD ' ' A' ' 138' ' ' MET . 20.7 tt -45.87 -22.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 136' ' ' LEU . 26.4 mtmm -92.96 -26.35 17.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.283 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.47 -30.84 14.83 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.0 t -47.3 117.02 1.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' B' ' 17' ' ' ALA . 8.5 tm-20 -138.74 121.57 16.52 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.349 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.26 125.77 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -100.78 159.2 15.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.906 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 91' ' ' ASN . 3.2 mt -148.78 156.86 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.938 0.399 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -166.1 85.76 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.59 144.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.495 . . . . 0.0 111.793 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -135.8 175.41 9.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.812 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.7 t -91.46 134.88 34.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.45 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 p -111.39 166.16 11.35 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.771 0.319 . . . . 0.0 110.169 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.89 6.99 2.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.93 99.45 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.096 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.475 ' OE1' ' ND2' ' A' ' 41' ' ' ASN . 9.8 mm-40 -83.23 18.88 1.6 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -63.71 148.84 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.613 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 157' ' ' SER . 38.4 t70 -52.16 171.79 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.194 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.433 ' N ' ' CG ' ' A' ' 156' ' ' ASP . 35.2 p -100.02 149.82 23.07 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.086 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.2 m-20 -116.73 88.83 2.98 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.3 pt -103.25 177.13 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.388 0.613 . . . . 0.0 111.528 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.875 ' HZ3' ' H ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -108.36 -173.29 2.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.06 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 161' ' ' THR . 91.8 m -124.56 -9.26 7.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.413 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 11.9 m80 -100.14 127.56 33.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.787 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -39.42 159.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.03 1.82 . . . . 0.0 112.705 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.09 140.38 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 20.2 mt -85.2 125.29 32.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.366 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 159.85 20.32 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.469 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.3 m -93.8 12.0 27.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.4 t30 58.08 9.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.719 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.22 148.58 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 20.5 m -112.6 140.06 47.68 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.495 ' NE2' HD13 ' A' ' 29' ' ' ILE . 22.0 m80 -74.95 43.95 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.535 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -71.53 162.68 29.06 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -77.39 128.02 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.7 m -149.29 -166.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.0 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.1 p -48.08 145.06 3.3 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.423 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -112.47 144.38 42.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.906 0.384 . . . . 0.0 111.239 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -158.74 152.1 22.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.483 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -68.61 106.33 2.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.274 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -116.93 -59.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.724 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.1 mt -61.26 122.05 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.14 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.4 -119.81 2.11 Favored Glycine 0 C--O 1.225 -0.412 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.955 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.552 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 52.2 p -72.07 141.86 49.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.47 ' OG1' ' CE2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -145.02 83.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.68 97.04 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.991 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 185' ' ' VAL . 18.1 m -112.18 131.65 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.953 0.406 . . . . 0.0 111.59 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -79.44 114.99 18.8 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.112 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.9 p -52.25 -28.04 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -39.21 -30.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.514 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 65.1 m -143.95 26.43 1.53 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.732 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 44.0 t -149.22 89.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 110.483 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -67.71 -56.44 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.648 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -133.65 146.32 50.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 31' ' ' LYS . 23.0 tp -144.14 120.81 11.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.839 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 12.7 mp0 -105.92 130.78 53.8 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 195' ' ' PHE . 0.2 OUTLIER -107.23 138.63 43.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.912 0.387 . . . . 0.0 110.528 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.2 t -144.35 120.64 10.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.62 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 198' ' ' ARG . 6.7 p -131.93 159.64 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 197' ' ' VAL . 11.4 ttt85 -171.25 112.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.241 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 199' ' ' ILE . 8.5 tt -113.3 129.84 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.819 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -168.83 -148.97 5.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.862 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -95.95 119.83 35.15 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 167' ' ' SER . 21.8 mmt -82.85 3.86 27.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.29 -54.31 2.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.689 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -153.76 120.73 5.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.726 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -49.2 129.22 17.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.148 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.4 t -124.8 113.33 17.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.797 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.9 p -35.58 -39.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.859 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -79.21 -45.58 19.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 61.21 3.98 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.07 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.34 128.17 7.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.185 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.489 HG23 HD11 ' A' ' 139' ' ' ILE . 3.8 t -142.9 164.35 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.03 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.477 ' N ' ' CG1' ' A' ' 211' ' ' VAL . 0.9 OUTLIER -161.13 127.34 3.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.03 171.51 11.79 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.448 ' C ' ' CD1' ' A' ' 215' ' ' PHE . . . 155.76 160.49 10.01 Favored Glycine 0 CA--C 1.511 -0.166 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 215' ' ' PHE . 14.5 m-85 -141.57 -176.8 4.88 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -134.73 105.99 6.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.203 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.66 113.55 25.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 218' ' ' VAL . 31.8 m -135.98 120.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 0.0 110.523 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 218' ' ' VAL . 4.5 p-10 46.09 51.32 11.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.979 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.24 2.96 68.53 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.668 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.7 t -104.41 119.89 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.066 0.433 . . . . 0.0 110.678 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.07 155.87 18.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.121 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 79.3 p -170.87 129.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -80.14 141.9 35.29 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -170.86 101.6 0.17 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.17 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.39 96.55 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.714 0.292 . . . . 0.0 110.387 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 77.2 p -126.04 160.43 30.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.64 99.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -91.66 21.96 4.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 87.5 m -63.24 -35.4 80.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.746 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.1 p -97.95 -4.75 35.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.1 tp -43.45 -31.8 0.76 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.852 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.3 tt -143.53 144.35 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.203 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 236' ' ' THR . 31.5 m-20 -83.15 91.4 7.23 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 115' ' ' ARG . 14.2 t -56.78 -0.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.202 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 234' ' ' ASP . 58.4 m -88.36 -20.24 25.59 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -101.6 11.42 38.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.747 0.308 . . . . 0.0 111.465 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -84.78 133.23 34.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.694 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -127.09 132.3 50.67 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.361 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.875 ' H ' ' HZ3' ' A' ' 160' ' ' LYS . . . -55.67 165.48 0.85 Allowed 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.156 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 38.1 t -126.23 -2.9 6.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.971 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 121.125 0.488 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 33.3 m -116.29 135.49 53.84 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.603 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 t -41.31 138.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.779 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.47 ' CE2' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -125.17 -26.79 3.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.305 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.6 m -138.66 143.02 39.03 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 1.1 m-85 -107.18 149.12 28.04 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.2 t -74.94 133.72 41.69 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.463 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 143' ' ' GLU . . . -79.06 -45.44 20.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.589 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -79.33 126.13 30.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.87 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.61 150.22 48.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.118 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 20.8 mt -105.01 100.06 22.51 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.513 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -42.23 146.44 0.68 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.69 1.594 . . . . 0.0 111.968 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -46.12 -48.21 17.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.643 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -49.37 -22.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 111.291 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.407 ' CE1' ' OE1' ' A' ' 53' ' ' GLU . 9.6 t80 -109.42 33.57 4.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.201 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 66.3 t -153.47 93.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.686 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 32.0 m -88.42 -23.72 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.5 t70 -156.76 -179.52 8.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.163 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.477 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 7.9 p90 -158.51 170.61 21.81 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.084 0.469 . . . . 0.0 111.36 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.45 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -154.02 179.28 9.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.12 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.45 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 85.9 mt-10 -124.14 147.37 48.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.873 0.368 . . . . 0.0 110.364 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -55.82 -109.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.5 m -153.86 -147.96 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.669 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.455 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.1 t -136.47 -32.43 0.84 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.308 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' B' ' 34' ' ' LEU . 4.3 mp -51.79 -10.99 0.13 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.455 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.6 p -111.04 118.63 36.57 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 79.4 p -72.58 37.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.723 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' B' ' 35' ' ' CYS . 13.2 pt20 -171.27 61.83 0.35 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.66 -167.66 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.669 2.246 . . . . 0.0 113.386 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.45 176.02 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.639 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.25 131.85 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.683 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.448 HG21 ' NE2' ' B' ' 49' ' ' GLN . 2.4 m -110.08 132.94 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.597 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -103.74 147.7 26.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.167 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -94.05 169.57 10.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.2 p -142.0 -145.82 0.18 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.719 0.691 . . . . 0.0 111.499 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.468 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -127.62 -40.12 1.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.33 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.75 43.09 3.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.361 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 8.5 t -149.04 -83.78 0.1 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.435 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -87.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.004 0.43 . . . . 0.0 109.878 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.448 ' NE2' HG21 ' B' ' 41' ' ' VAL . 47.5 tt0 -139.53 147.37 41.13 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.65 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -150.39 119.09 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 111.098 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.552 ' H ' ' CB ' ' A' ' 182' ' ' SER . 7.2 t -59.8 157.51 12.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.664 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.485 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.1 134.79 13.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.811 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -73.01 121.28 84.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.32 1.4 6.15 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.223 1.282 . . . . 0.0 111.863 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 27.7 t -76.05 -4.05 39.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.957 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' B' ' 57' ' ' SER . 0.8 OUTLIER -106.87 124.87 50.24 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.511 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 22.1 p -44.32 -47.34 9.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.4 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 85.9 m95 -55.11 -27.79 47.75 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.22 -43.98 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 109.646 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -62.05 -41.67 98.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.97 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -70.66 -34.86 72.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -66.45 -37.57 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 73.3 t -71.11 -47.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.95 -31.72 70.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -72.56 -37.44 68.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.58 -22.09 61.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.558 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -73.17 -32.2 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.235 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.63 -78.07 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.8 t30 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.549 -180.0 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.913 0.387 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 m -79.14 -25.48 42.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.625 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 p -47.93 128.52 13.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 t -61.28 -19.94 62.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.1 p -77.4 -30.9 53.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.379 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.0 p -77.24 -46.68 22.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.6 m -163.15 158.88 22.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.912 0.387 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.11 154.34 10.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.5 p -68.62 165.5 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.514 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 34.9 mp0 -115.42 7.94 15.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.258 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.24 -163.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 15.3 mp0 -114.56 -73.01 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.023 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -87.61 60.26 5.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.145 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 21.7 tttm -157.78 141.46 15.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.258 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -149.42 179.13 8.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.387 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.508 ' CD2' ' OG ' ' A' ' 127' ' ' SER . 32.1 t60 -108.93 90.23 3.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.506 ' CE ' ' HB1' ' A' ' 135' ' ' ALA . 53.9 tpp -71.92 126.72 30.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.903 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 199' ' ' ILE . . . -136.07 167.13 24.48 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.5 pt -111.32 150.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.23 121.04 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.8 146.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.184 0.516 . . . . 0.0 111.254 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD12 ' NH2' ' A' ' 198' ' ' ARG . 21.1 mt -137.27 140.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 30' ' ' ILE . 7.9 tt -130.77 122.26 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.138 0.494 . . . . 0.0 111.429 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -107.69 111.28 23.41 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.7 t -112.32 122.1 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.952 0.406 . . . . 0.0 111.643 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.0 m -97.25 114.62 26.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -68.3 151.8 46.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.82 179.35 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -80.63 -28.43 36.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.737 0.303 . . . . 0.0 110.71 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -85.31 -34.75 21.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.2 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.3 m -40.3 104.1 0.32 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.87 161.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.931 1.754 . . . . 0.0 112.039 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.8 p -67.99 140.14 56.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.639 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.483 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 22.8 t-20 -165.3 96.21 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.42 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -99.32 10.62 41.07 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.35 82.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.125 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.6 pt -81.26 142.74 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.634 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.53 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 33.9 t 56.21 67.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.5 tp60 -78.47 -31.45 47.88 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.4 p -178.32 167.47 1.9 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.504 ' CG1' ' SG ' ' A' ' 241' ' ' CYS . 4.0 m -145.95 130.04 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.918 0.39 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 82' ' ' SER . 41.6 p -102.99 172.89 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.933 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -159.93 116.02 2.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.73 158.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -150.87 110.64 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.497 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 7.4 pt-20 -57.17 84.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 123.566 1.65 . . . . 0.0 109.601 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' THR . 9.9 p . . . . . 0 C--N 1.305 -1.349 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.571 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 CA--C 1.533 0.468 0 N-CA-C 111.707 -0.151 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.501 ' N ' ' OE2' ' A' ' 53' ' ' GLU . 32.8 m -119.14 131.28 55.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.793 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.9 p -87.72 126.17 34.83 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 59.8 t80 -136.72 107.8 6.75 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CD2' ' CE1' ' A' ' 92' ' ' PHE . 4.8 p90 -106.8 -179.03 3.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.496 ' N ' ' OG1' ' A' ' 49' ' ' THR . 15.8 m -152.53 75.42 1.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 pt -72.4 119.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.51 0.671 . . . . 0.0 110.753 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.1 mt -101.26 145.13 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.518 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.46 166.1 16.32 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.37 22.36 50.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.09 14.18 76.32 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.36 156.57 48.27 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.938 0.399 . . . . 0.0 110.502 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -122.57 114.87 21.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.314 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 36.5 mtt -101.3 123.06 44.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.78 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -115.48 119.97 37.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.256 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.655 ' CE1' ' CD2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -108.15 169.36 8.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.77 77.63 0.19 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.337 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.45 145.35 29.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.642 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -141.63 122.21 14.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 66.45 34.26 6.3 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.378 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.55 143.72 49.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -34.39 144.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.387 2.058 . . . . 0.0 112.74 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -68.59 154.87 41.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.338 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.65 144.62 9.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.221 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -143.27 -15.96 0.66 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.717 0.294 . . . . 0.0 110.331 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -113.16 118.06 33.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.278 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 103' ' ' ILE . 5.9 tp -135.05 128.68 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 p -142.79 179.41 7.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 60.0 tt0 -164.22 154.58 14.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.2 t -157.63 153.03 26.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.414 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.24 123.65 30.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -135.3 107.9 7.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.966 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.31 -124.69 7.35 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -106.61 27.78 8.5 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.732 0.301 . . . . 0.0 110.511 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -133.72 159.83 39.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 110.731 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.35 134.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.476 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CG ' HD12 ' A' ' 233' ' ' ILE . 17.2 m-20 -114.86 155.08 27.47 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.06 128.44 8.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -108.24 122.99 48.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.033 0.444 . . . . 0.0 111.154 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.878 HD22 ' N ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -112.98 114.6 27.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.4 t -157.58 170.0 23.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.593 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.3 p -94.52 166.17 12.18 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.438 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.98 150.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.374 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 p -99.43 150.42 36.74 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.867 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -38.84 163.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.121 1.88 . . . . 0.0 112.543 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 50.23 73.54 0.36 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.215 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -152.89 -27.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.088 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.88 12.62 13.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.193 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -134.95 155.42 50.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -56.31 151.33 13.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.527 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.508 ' OG ' ' CD2' ' A' ' 23' ' ' HIS . 2.2 t -153.19 67.13 6.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.53 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.22 130.0 27.19 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.887 2.391 . . . . 0.0 113.331 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.443 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -96.2 158.07 15.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.694 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.8 pt -145.34 160.87 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.82 0.343 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.8 p -75.78 178.53 6.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.047 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -69.27 -35.95 76.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.503 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.31 -57.85 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.989 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.995 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.506 ' HB1' ' CE ' ' A' ' 24' ' ' MET . . . -68.29 -56.96 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.769 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.0 tp -54.46 -32.61 58.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.127 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.51 -52.46 18.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.646 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mtt -57.16 -52.72 64.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.145 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.2 mm -45.98 -21.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.296 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -91.43 -41.55 10.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.79 -31.06 56.73 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 m -41.47 111.15 0.2 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.48 116.96 11.35 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.055 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 144' ' ' VAL . 12.1 p -117.57 127.35 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.055 0.455 . . . . 0.0 110.659 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 m -101.06 162.9 12.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.4 tp -145.47 136.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.992 0.425 . . . . 0.0 110.646 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -146.99 90.42 1.9 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.882 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.9 tt -83.73 140.33 16.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.72 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 35.8 ttm180 -133.39 170.45 15.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 5.8 t -90.48 126.64 35.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.187 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.7 p -120.38 133.45 55.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -100.57 21.23 13.64 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.622 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.483 ' OE2' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -50.29 158.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -144.54 -0.74 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.197 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 26.8 mtmm -63.89 171.58 2.74 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.632 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.23 173.89 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.5 t -92.54 144.28 25.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.6 t70 -120.18 89.86 3.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.999 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 pt -120.53 172.25 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.428 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.59 ' NZ ' ' NE2' ' A' ' 162' ' ' HIS . 31.0 tttm -124.32 136.4 54.08 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.005 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 161' ' ' THR . 29.8 m -64.26 0.43 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.59 ' NE2' ' NZ ' ' A' ' 160' ' ' LYS . 1.8 m-70 -79.3 119.14 76.03 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.11 157.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.811 1.674 . . . . 0.0 112.281 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.45 134.7 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.47 120.02 21.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.18 162.42 22.77 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 169' ' ' ILE . 10.3 p -98.08 5.37 48.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.091 0.472 . . . . 0.0 109.766 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 58.5 t30 60.31 -0.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.815 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 167' ' ' SER . 0.2 OUTLIER -88.98 133.62 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.7 t -79.12 -176.49 5.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.271 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.541 ' CD2' HH21 ' A' ' 198' ' ' ARG . 0.0 OUTLIER -124.52 22.23 8.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -59.63 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -93.5 123.97 37.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.852 HG22 ' H ' ' A' ' 175' ' ' SER . 14.4 p -146.97 -176.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.931 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.852 ' H ' HG22 ' A' ' 174' ' ' VAL . 58.6 m -38.65 143.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.744 0.307 . . . . 0.0 111.228 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -104.35 140.64 37.61 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.056 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -151.09 144.81 25.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.58 89.18 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.1 -42.74 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.964 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 180' ' ' ILE . 6.8 tp -64.03 124.84 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.22 -128.73 3.79 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.448 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.1 t -73.26 148.54 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 69.0 m -129.58 133.85 47.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.8 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 7.6 mm -138.42 128.16 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 185' ' ' VAL . 2.3 m -144.56 124.49 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.0 97.82 11.42 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 187' ' ' THR . 26.1 p -45.27 -27.84 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.386 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -44.56 -20.96 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.961 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 97.0 m -147.33 16.75 1.17 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 190' ' ' VAL . 35.7 m -148.27 108.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.485 0.66 . . . . 0.0 111.119 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -79.42 -56.19 4.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.586 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 217' ' ' TYR . 8.9 t-20 -109.69 170.1 8.29 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.545 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.672 HD12 ' CZ ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -169.74 105.84 0.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -108.36 130.81 55.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.672 ' CZ ' HD12 ' A' ' 193' ' ' LEU . 15.6 m-85 -114.81 140.48 48.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.594 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.46 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 14.4 t -143.95 124.2 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.484 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.46 150.19 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.541 HH21 ' CD2' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -166.41 108.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.674 -179.224 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 25' ' ' GLY . 12.0 mt -104.51 148.64 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.233 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.29 34.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.575 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -88.07 121.22 30.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.905 0.384 . . . . 0.0 110.303 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -79.48 1.15 26.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.731 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.62 -47.36 5.12 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.121 0.486 . . . . 0.0 109.9 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -168.09 127.21 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.65 148.05 0.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.848 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 47.9 p -136.69 12.81 3.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.924 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.6 m 58.39 -75.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.4 mt-10 -46.24 -54.38 8.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.681 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.4 mt -76.99 -0.83 25.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.785 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.88 134.83 37.09 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.669 0.271 . . . . 0.0 110.491 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m -154.62 -179.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.295 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.46 ' HZ3' ' CB ' ' A' ' 226' ' ' ALA . 13.9 pttp -170.67 167.5 7.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.431 0.634 . . . . 0.0 112.136 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.2 t70 -155.26 168.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.7 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 172.1 168.13 33.14 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 10.4 m-85 -153.4 167.3 29.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 2.7 ttmp? -133.42 104.0 6.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.035 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.504 ' O ' ' ND2' ' A' ' 192' ' ' ASN . 8.1 t80 -100.57 118.13 36.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.866 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.4 p -139.38 111.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.614 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.4 t70 53.12 47.47 24.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.692 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.28 -5.61 71.72 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.356 -0.45 . . . . 0.0 113.408 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.7 t -96.95 116.66 29.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.099 0.45 . . . . 0.0 110.716 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.63 153.51 21.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.079 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.4 m -167.83 129.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.276 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -83.01 142.62 31.21 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.66 116.74 0.61 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.587 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.46 ' CB ' ' HZ3' ' A' ' 212' ' ' LYS . . . -73.86 111.45 9.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 28.5 m -140.99 153.07 45.4 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.924 0.392 . . . . 0.0 110.581 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 95.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.617 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -87.27 30.03 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 231' ' ' SER . 9.3 t -71.34 -39.1 71.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.451 ' N ' HG23 ' A' ' 230' ' ' THR . 55.6 m -96.94 2.67 51.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.9 tp -44.38 -40.64 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.788 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.507 HD12 ' CG ' ' A' ' 113' ' ' ASN . 27.5 mm -141.18 146.33 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.777 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 236' ' ' THR . 34.4 m-20 -78.18 92.86 4.49 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 m -56.6 -6.5 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 234' ' ' ASP . 26.0 m -86.68 -17.05 34.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.411 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -99.04 7.43 45.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.503 0.192 . . . . 0.0 111.347 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.67 144.77 35.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.407 . . . . 0.0 110.809 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -133.49 133.49 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.536 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.71 156.73 4.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 48' ' ' VAL . 53.7 t -126.5 -10.28 6.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.457 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.857 -1.068 . . . . 0.0 110.434 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 121.184 0.516 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.499 ' O ' ' CE2' ' B' ' 13' ' ' PHE . 85.6 m -106.4 161.42 14.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.67 135.48 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.346 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' B' ' 11' ' ' CYS . 6.8 m-85 -114.01 -26.91 7.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -149.66 153.76 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.261 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -111.52 155.07 23.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.74 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -77.49 137.17 38.5 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -27.17 41.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.62 0.248 . . . . 0.0 110.99 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -92.5 127.09 37.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.385 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -77.43 116.24 17.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.825 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.01 139.87 97.75 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.505 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.49 147.67 32.46 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.859 1.706 . . . . 0.0 111.367 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' B' ' 24' ' ' PHE . 41.5 ttp180 -44.68 -49.53 10.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.73 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' B' ' 23' ' ' ASN . 46.0 t-20 -69.67 29.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 57.8 t80 -155.45 33.33 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 86.4 t -155.97 97.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.751 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.42 -7.19 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 25.3 t0 -166.67 -178.74 4.49 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.096 -0.641 . . . . 0.0 111.259 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.482 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.7 p90 -158.24 163.52 37.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.097 0.475 . . . . 0.0 111.303 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -155.39 141.6 18.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.893 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' B' ' 31' ' ' THR . 88.8 mt-10 -90.0 142.5 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.91 0.386 . . . . 0.0 111.287 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 67.4 p -51.45 -108.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -154.47 -167.37 2.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.445 ' C ' ' N ' ' B' ' 35' ' ' CYS . 11.8 t -117.32 -30.4 5.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.502 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' B' ' 34' ' ' LEU . 4.4 mp -49.59 -13.14 0.08 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.445 ' N ' ' C ' ' B' ' 33' ' ' SER . 27.8 m -111.06 127.12 55.45 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.049 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -76.44 35.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -163.98 59.27 0.74 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.4 -164.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 122.59 2.194 . . . . 0.0 112.862 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.14 176.69 0.25 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.089 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.43 127.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.99 134.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -105.3 151.52 24.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.698 ' NE2' ' H ' ' B' ' 44' ' ' THR . 41.5 tp60 -93.67 164.56 13.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.698 ' H ' ' NE2' ' B' ' 43' ' ' GLN . 56.5 p -136.57 -168.42 2.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.289 0.566 . . . . 0.0 111.528 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.78 -41.82 4.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.713 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.91 47.11 2.02 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.374 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 3.0 m -158.47 -79.61 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.227 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.8 -90.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.397 0.436 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -136.86 151.45 49.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -150.08 124.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 10.2 t -64.18 159.5 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.298 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.496 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.0 130.59 10.68 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.238 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -67.76 116.88 42.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.33 0.57 5.87 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 120.938 1.092 . . . . 0.0 111.71 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 53.4 m -73.89 -16.07 61.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.983 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -91.61 127.25 36.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.168 0.509 . . . . 0.0 110.666 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 52.9 m -47.22 -49.8 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -56.15 -25.05 44.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.14 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 62.2 t -73.77 -37.38 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.181 0.515 . . . . 0.0 110.302 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.14 -37.56 78.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.504 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -72.07 -35.36 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.242 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.99 -36.1 82.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.477 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.06 -44.87 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.978 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -63.49 -27.59 69.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.018 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.41 -39.17 62.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.812 0.339 . . . . 0.0 110.934 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.43 -29.76 62.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.347 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OH ' ' B' ' 28' ' ' TYR . 32.1 mm-40 -69.7 -32.94 71.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.85 -74.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.336 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.553 179.891 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.729 0.3 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -75.44 -24.59 57.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.748 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.3 t -50.57 134.47 24.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -57.62 -29.39 64.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p -74.35 -25.94 59.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.23 -57.08 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.974 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -159.01 175.94 12.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.922 0.392 . . . . 0.0 110.907 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -61.92 159.92 13.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.887 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -75.2 165.89 24.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 1.4 pm0 -114.75 3.16 14.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.777 0.323 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.64 -165.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.35 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -116.05 -75.92 0.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.901 0.382 . . . . 0.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.494 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 64.8 t30 -77.81 53.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.627 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -154.63 132.13 11.27 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.56 ' CD2' ' HE2' ' A' ' 132' ' ' HIS . 62.1 m-70 -140.9 165.49 27.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.201 0.524 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -97.75 76.19 2.46 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.965 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.2 ttm -68.88 133.69 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.29 25.03 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.0 tp -111.17 142.37 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -149.89 106.31 3.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.556 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 197' ' ' VAL . 12.2 m -122.29 134.53 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.68 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.5 pt -113.99 163.33 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.92 132.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.437 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -120.68 133.08 55.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.538 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.4 116.71 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.872 0.368 . . . . 0.0 111.326 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -81.76 112.41 18.89 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.59 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -68.22 150.14 48.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.888 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -58.89 168.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -91.3 5.02 50.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.843 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -120.48 -33.38 3.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.846 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 38' ' ' THR . 4.4 t -54.17 119.28 19.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.463 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -39.25 157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.976 1.784 . . . . 0.0 112.544 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 p -75.49 143.91 42.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.46 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -157.33 107.1 2.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.424 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' ILE . 2.7 p30 -101.16 -2.56 31.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.064 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 154' ' ' GLU . 4.8 mmmm -63.51 83.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.3 tp -90.53 150.62 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.078 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.451 ' SG ' ' CG ' ' A' ' 105' ' ' GLU . 1.7 m 56.17 62.09 2.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.139 0.495 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -78.19 -40.02 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 t -172.51 163.32 5.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.04 0.448 . . . . 0.0 111.181 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.06 140.36 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.489 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -129.54 105.29 7.98 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.847 0.356 . . . . 0.0 110.857 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.08 128.87 34.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.494 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 52' ' ' THR . 7.7 mm -132.36 154.7 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -152.62 142.57 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -51.11 176.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.366 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.531 0.349 0 N-CA-C 111.363 -0.284 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -123.76 141.46 52.01 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 p -107.59 127.0 53.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.755 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -112.25 148.02 35.01 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.201 0.524 . . . . 0.0 110.285 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -139.89 116.85 11.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.9 p -103.45 69.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.821 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 103' ' ' ILE . 12.0 tt -74.37 102.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.185 0.517 . . . . 0.0 110.534 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 pt -88.08 147.84 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.181 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.5 170.06 19.91 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.7 37.8 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.77 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.09 86.47 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.618 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.08 159.2 40.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.057 0.456 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -117.4 108.98 16.22 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.312 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 45.7 mtt -101.23 112.13 24.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.45 124.1 48.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 84.7 m-85 -100.97 -176.03 3.05 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.1 71.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.249 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -75.92 138.54 41.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.385 . . . . 0.0 110.367 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.7 m -144.42 119.89 10.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.248 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? 66.87 26.74 9.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.214 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 m -120.72 149.83 51.33 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -40.06 154.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.815 1.677 . . . . 0.0 111.942 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -75.06 137.9 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.508 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -95.54 138.5 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -137.4 -10.6 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.738 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.9 t -112.21 122.77 48.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 83' ' ' ILE . 16.0 tt -141.57 129.6 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.844 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.1 p -158.01 171.39 20.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.451 ' CG ' ' SG ' ' A' ' 45' ' ' CYS . 7.7 pt-20 -168.07 -172.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.6 t -171.56 165.96 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.445 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -127.01 116.68 21.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.172 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -127.93 107.9 10.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.029 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.81 -127.78 16.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -102.6 23.73 11.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.737 0.304 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 p -131.33 158.69 40.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.521 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.45 136.04 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.687 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -112.26 163.04 14.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.41 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -160.9 129.41 4.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.661 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 116' ' ' LEU . 31.0 ttm180 -116.85 113.31 22.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 115' ' ' ARG . 2.5 mm? -110.29 123.62 50.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -164.06 175.02 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.157 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.3 m -95.28 171.77 8.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.145 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.4 149.03 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.136 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 t -93.23 144.56 28.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -37.62 144.68 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.05 1.833 . . . . 0.0 112.516 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 57.11 6.16 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.187 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -138.75 -5.13 1.54 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.48 -8.35 64.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.81 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -115.56 168.82 9.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.98 147.06 39.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.288 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.5 m -148.73 65.56 8.42 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.689 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.27 148.03 1.32 Allowed 'Trans proline' 0 N--CA 1.474 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.903 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -117.87 146.68 43.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.311 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -132.42 171.11 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.844 0.354 . . . . 0.0 110.087 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -81.73 162.61 22.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.429 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.56 ' HE2' ' CD2' ' A' ' 22' ' ' HIS . 36.4 m170 -58.0 -36.45 72.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -54.38 -47.63 72.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.479 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -72.94 -33.21 65.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.97 9.39 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -56.14 -32.86 64.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.17 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.777 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 tpp -71.18 -63.17 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.102 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.3 -21.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.455 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -79.39 -55.11 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 41.4 t0 -79.14 -30.26 43.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.9 t -45.74 117.78 1.59 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.503 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.18 124.29 16.4 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.04 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 144' ' ' VAL . 13.8 p -116.67 131.24 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.87 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.4 m -103.09 157.59 16.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.201 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.0 mm -140.43 145.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' OD2' ' NE2' ' B' ' 49' ' ' GLN . 2.0 m-20 -152.88 92.86 1.69 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.877 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.4 mt -89.26 142.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.301 0.572 . . . . 0.0 111.075 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -138.53 177.25 8.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.639 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.3 m -91.58 132.23 36.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.739 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -103.79 -173.98 2.44 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.47 11.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.861 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -79.92 103.59 9.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.435 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 11.1 pt-20 -77.52 7.75 5.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -49.73 145.66 5.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.93 0.395 . . . . 0.0 110.365 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.21 173.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.99 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.1 t -94.97 142.1 27.88 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -120.04 91.6 3.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.589 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.4 pt -121.06 168.69 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -119.5 139.6 51.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.0 p -72.29 5.55 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.426 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -80.5 121.06 81.0 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.4 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -40.1 154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.826 1.684 . . . . 0.0 112.064 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.2 t -80.05 133.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.422 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.71 123.35 30.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.25 162.4 19.03 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.363 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -91.15 9.42 31.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 109.94 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.6 5.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.825 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.9 tp -101.93 141.31 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.5 m -100.77 149.04 24.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.748 0.309 . . . . 0.0 110.35 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.448 ' NE2' ' N ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -83.13 39.55 0.65 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.019 0.438 . . . . 0.0 110.547 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.681 ' N ' HH12 ' A' ' 198' ' ' ARG . 74.7 tttt -65.16 173.5 2.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.295 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.425 ' HZ3' ' CB ' ' A' ' 226' ' ' ALA . 61.8 tttp -84.18 123.81 30.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.533 HG13 ' N ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -149.11 -170.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.533 ' N ' HG13 ' A' ' 174' ' ' VAL . 25.3 p -44.71 146.87 0.69 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.571 0.224 . . . . 0.0 110.752 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -112.64 145.52 40.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.986 0.422 . . . . 0.0 111.437 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 1.6 tm-20 -157.88 145.73 18.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.447 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 9.9 t0 -70.34 100.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.403 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.4 mm -109.37 -50.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -61.67 125.35 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' B' ' 14' ' ' SER . . . -91.44 -123.11 2.87 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.191 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.2 t -73.3 140.58 46.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.628 0.251 . . . . 0.0 111.16 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.515 ' O ' ' CZ ' ' B' ' 13' ' ' PHE . 18.0 p -139.08 87.83 2.23 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 184' ' ' ILE . 15.0 tt -102.65 129.1 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.6 137.67 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.556 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 109.41 19.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.22 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 189' ' ' CYS . 12.7 p -51.55 -27.48 11.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.573 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -38.36 -28.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.291 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 187' ' ' THR . 27.5 p -148.42 29.39 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.323 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.1 88.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.092 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -68.16 -58.33 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.167 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -123.07 179.38 4.69 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.609 ' C ' HD23 ' A' ' 193' ' ' LEU . 5.7 tt -173.22 106.65 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 25.2 mp0 -97.24 128.83 44.46 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -128.08 134.69 49.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.093 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.0 m -143.42 144.08 31.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 28' ' ' VAL . 18.1 m -140.6 167.39 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.124 0.488 . . . . 0.0 111.34 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.681 HH12 ' N ' ' A' ' 172' ' ' LYS . 21.8 ttm180 -164.09 156.32 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.154 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.6 mt -148.5 120.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.54 174.37 46.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.277 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -56.26 129.34 39.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.923 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 57.0 mtm -86.23 8.14 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.6 t -112.88 -48.2 3.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.239 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -159.19 115.02 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 7.9 mp0 -47.63 158.71 0.18 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 208' ' ' GLU . 69.9 m -143.38 23.02 1.84 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.01 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 t 57.68 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.822 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.5 mm-40 -48.68 -48.39 40.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.729 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -77.54 -0.65 27.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.445 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.79 155.36 19.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.971 0.415 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 212' ' ' LYS . 3.8 p -175.55 158.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.409 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 211' ' ' VAL . 1.2 pptp? -168.56 136.83 2.16 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.401 0.62 . . . . 0.0 111.767 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 9.3 t70 -124.95 172.6 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 172.4 164.58 28.13 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.946 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -148.97 170.22 18.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -135.69 104.34 5.74 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.315 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -101.44 119.83 39.37 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.85 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.2 p -144.48 123.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.126 0.488 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.62 37.88 27.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.31 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.32 89.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.91 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.41 ' OG ' HG13 ' A' ' 218' ' ' VAL . 26.4 p -103.19 120.9 41.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.843 0.321 . . . . 0.0 110.576 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.74 165.15 12.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.019 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.6 t -174.97 120.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.564 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -78.44 136.71 37.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.95 116.22 0.66 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.702 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.425 ' CB ' ' HZ3' ' A' ' 173' ' ' LYS . . . -81.61 96.56 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.3 m -129.55 151.41 50.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.989 0.423 . . . . 0.0 110.767 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.32 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.553 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.443 ' OD1' HD23 ' A' ' 232' ' ' LEU . 74.6 m-20 -93.26 31.0 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.6 p -73.71 -34.81 64.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.768 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -99.89 -2.55 34.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.896 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -43.42 -29.27 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.21 143.38 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.628 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.76 101.13 4.95 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -63.9 -5.68 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.147 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -47.28 12.67 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -71.4 9.43 0.8 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 238' ' ' LEU . 7.5 mp -72.98 152.28 41.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.493 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -137.15 135.16 37.11 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.561 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.19 144.71 23.42 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.49 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' CYS . . . . . 0.537 ' SG ' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -104.34 -17.88 14.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.48 HG13 ' C ' ' A' ' 241' ' ' CYS . 1.5 m . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.606 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 121.146 0.498 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -144.6 118.0 9.07 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.426 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 85.5 m -63.93 131.32 47.33 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.515 ' CZ ' ' O ' ' A' ' 183' ' ' THR . 0.1 OUTLIER -93.44 -26.78 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.018 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 14' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 181' ' ' GLY . 28.0 p -122.9 155.05 37.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.375 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.86 158.94 25.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.392 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -82.92 139.22 33.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.184 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.06 19.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.612 0.244 . . . . 0.0 111.32 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -80.2 127.83 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.785 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -81.92 128.68 34.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.492 HD12 ' N ' ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.38 52.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.808 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -42.04 153.08 0.13 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.208 1.938 . . . . 0.0 112.878 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' B' ' 25' ' ' VAL . 13.3 tpt180 -46.07 -50.46 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.353 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -35.95 -35.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 3.3 m-85 -105.58 43.23 1.14 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.102 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 22' ' ' ARG . 49.9 t -151.61 92.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.937 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -97.72 -22.95 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.265 -0.272 . . . . 0.0 110.823 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.455 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 6.3 p90 -166.06 168.91 15.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.253 0.549 . . . . 0.0 111.871 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 89.0 m-85 -157.34 178.26 10.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.243 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' B' ' 31' ' ' THR . 11.3 pt-20 -127.64 149.62 50.11 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.804 0.335 . . . . 0.0 110.501 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.414 ' O ' ' O ' ' B' ' 30' ' ' GLU . 77.8 p -53.93 -111.4 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -154.98 -148.68 0.24 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.412 ' C ' ' N ' ' B' ' 35' ' ' CYS . 10.5 m -135.82 -24.02 1.34 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.103 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.3 mm? -53.67 -13.56 0.7 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.794 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.423 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.3 p -115.94 122.16 44.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.58 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.3 m -73.31 38.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.402 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.5 pt20 -164.29 61.1 0.87 Allowed Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 97.4 Cg_endo -74.14 -161.82 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.887 2.391 . . . . 0.0 113.294 -177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 170.76 176.53 0.06 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.217 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -111.59 136.74 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.477 HG12 ' SG ' ' B' ' 51' ' ' CYS . 0.8 OUTLIER -113.73 143.2 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.618 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -115.69 149.9 37.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -92.97 169.26 10.57 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.3 p -138.17 -144.85 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.196 0.522 . . . . 0.0 110.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.501 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -126.27 -39.0 2.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.81 46.48 2.32 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.143 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 52.1 m -152.83 -83.17 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.428 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.586 0.554 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 49' ' ' GLN . 3.4 pp0? -145.31 147.87 32.8 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.12 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 t -150.26 115.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' B' ' 41' ' ' VAL . 71.7 m -68.05 144.72 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.785 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.69 139.3 41.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.998 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.69 126.33 92.49 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.54 -0.52 9.41 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.368 1.379 . . . . 0.0 111.554 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -65.18 -14.54 60.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.06 127.74 47.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.513 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 42.2 t -50.42 -46.89 56.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -55.99 -28.12 55.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.374 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.92 -36.16 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.112 0.482 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.72 -39.23 64.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.569 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -67.89 -35.7 78.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.47 -42.55 87.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.619 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.74 -46.01 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.841 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.66 -31.49 66.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.32 -35.67 63.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.585 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.336 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.52 -35.19 70.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.622 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.3 mp -79.79 -83.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.225 0.536 . . . . 0.0 109.64 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.643 -179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.812 0.339 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.7 t -79.44 -18.15 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.5 t -50.5 134.36 23.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.652 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -58.25 -27.41 63.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 95.8 p -73.76 -23.9 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.63 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -80.0 -53.43 6.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 p -168.07 169.38 11.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.866 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.1 m -55.3 155.8 4.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.537 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -76.46 173.19 11.8 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -112.84 5.59 17.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -62.44 -167.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.246 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 17.2 mp0 -119.21 -65.48 1.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.874 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.0 54.29 3.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.392 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' C ' ' ND1' ' A' ' 22' ' ' HIS . 3.6 tppt? -151.17 140.06 20.93 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.42 ' ND1' ' C ' ' A' ' 21' ' ' LYS . 53.5 m80 -145.67 158.59 43.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.888 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.415 ' CD2' ' N ' ' A' ' 23' ' ' HIS . 14.7 m-70 -95.65 76.41 3.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 29.9 ttp -64.74 133.0 51.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.47 . . . . 0.0 111.181 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' H ' ' HE3' ' A' ' 202' ' ' MET . . . -139.74 160.89 26.21 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.258 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -114.68 158.49 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.98 0.419 . . . . 0.0 110.586 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' HA ' ' HG ' ' A' ' 117' ' ' SER . 10.7 t70 -151.35 137.48 18.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.69 109.26 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.325 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.2 mt -97.5 134.2 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.29 134.41 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.174 0.511 . . . . 0.0 112.003 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -121.05 127.49 51.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.79 112.89 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.9 p -84.71 121.3 27.47 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -75.32 151.82 38.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.782 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -67.85 144.5 55.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.215 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 47.7 p30 -76.26 43.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.599 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -152.3 -28.33 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.8 m -71.16 125.45 91.94 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -38.47 156.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.026 1.817 . . . . 0.0 112.542 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -76.27 140.08 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.42 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -157.17 107.29 2.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.366 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.84 8.82 37.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.258 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 12.0 mptt -69.0 82.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -77.5 -177.92 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.9 m 32.82 40.29 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -55.56 -34.44 64.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.289 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 t -178.12 168.99 1.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.1 t -149.14 112.27 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.942 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.2 m -111.39 116.46 30.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.323 . . . . 0.0 110.87 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -95.38 135.42 37.01 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.184 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 79' ' ' THR . 4.2 mp -139.76 151.44 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -150.76 149.11 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 54' ' ' SER . 18.5 tp10 -51.7 171.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.082 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.51 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 58.1 m . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.981 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 N--CA 1.473 0.278 0 N-CA-C 111.025 -0.413 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.9 m -125.93 131.03 52.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 51' ' ' ILE . 16.3 m -107.16 123.95 49.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -121.64 112.98 19.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.947 0.403 . . . . 0.0 111.112 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -93.83 127.41 39.55 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 t -103.07 69.38 1.02 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.24 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.5 tt -74.54 122.25 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 110.566 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.44 147.46 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.94 169.53 20.94 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.209 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.47 22.34 23.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.239 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.407 ' C ' HD22 ' A' ' 88' ' ' LEU . . . 74.8 4.06 69.91 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.187 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 87' ' ' GLY . 4.3 mm? -117.48 149.15 41.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' NH2' ' OG ' ' A' ' 151' ' ' SER . 45.6 ttm-85 -115.83 105.15 12.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 92' ' ' PHE . 18.8 ttt -101.71 135.63 42.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.116 0.484 . . . . 0.0 110.882 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -127.44 120.44 28.4 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.043 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 90' ' ' MET . 67.1 m-85 -90.42 -168.4 2.09 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.74 67.7 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.08 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -90.28 162.08 15.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.163 0.506 . . . . 0.0 111.448 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 t -150.91 131.82 14.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.942 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 62.95 33.65 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.529 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 98' ' ' PRO . 33.5 m -124.04 145.6 48.59 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 97' ' ' CYS . 78.2 Cg_exo -38.55 162.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.012 1.808 . . . . 0.0 112.423 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -71.33 142.54 50.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -97.1 118.09 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -124.33 -21.67 4.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 117' ' ' SER . 5.7 p -100.45 111.16 23.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.771 0.319 . . . . 0.0 110.862 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.23 121.83 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 28.3 t -142.45 177.56 8.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.064 0.459 . . . . 0.0 111.171 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 104' ' ' SER . 34.9 tt0 -165.83 161.68 17.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.42 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.583 ' HB3' HD22 ' A' ' 113' ' ' ASN . 24.4 t -163.9 158.67 20.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.588 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.06 132.75 46.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.331 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -144.73 111.66 5.86 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.155 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.73 -110.87 3.31 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -122.21 23.88 9.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 p -128.74 156.16 43.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.64 132.99 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.583 HD22 ' HB3' ' A' ' 106' ' ' SER . 12.5 p-10 -117.96 155.76 29.68 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.885 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.52 133.07 12.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -118.0 125.76 51.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 111.333 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.7 121.48 40.97 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.424 ' HG ' ' HA ' ' A' ' 27' ' ' ASP . 1.8 m -164.94 156.67 15.3 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.58 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.8 p -74.19 173.85 9.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.39 134.37 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 110.999 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -59.55 155.15 40.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.0 157.6 28.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.254 1.969 . . . . 0.0 111.486 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.419 ' N ' ' OE1' ' A' ' 123' ' ' GLN . . . 73.68 59.73 3.97 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.845 HE21 ' H ' ' A' ' 125' ' ' LYS . 4.3 pm0 -141.24 -37.35 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.739 0.304 . . . . 0.0 110.348 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.03 5.97 2.93 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.265 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.845 ' H ' HE21 ' A' ' 123' ' ' GLN . 51.7 mttp -129.45 -173.48 3.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.782 0.325 . . . . 0.0 110.463 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 156.17 21.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.49 . . . . 0.0 111.456 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.4 t -159.19 63.42 2.31 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.439 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.78 142.31 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.112 2.541 . . . . 0.0 113.447 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.26 28.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -142.46 162.56 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 110.24 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.7 p -78.69 164.6 24.46 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -60.51 -34.71 74.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -63.15 -55.1 28.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.31 -44.71 92.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.335 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.29 -56.58 20.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.123 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 tp -49.37 -35.63 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.46 -49.24 43.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.557 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 140' ' ' LYS . 44.2 mtt -60.09 -60.42 3.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.7 mt -44.64 -21.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.13 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' MET . 31.5 ttmt -87.5 -33.81 18.85 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.595 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -94.92 -23.33 17.47 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.98 122.9 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.889 0.376 . . . . 0.0 110.758 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -139.1 123.26 18.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.218 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 144' ' ' VAL . 10.8 m -114.31 128.21 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.06 0.457 . . . . 0.0 111.114 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.6 m -109.33 167.24 10.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.548 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.8 pt -151.2 149.17 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -147.9 88.47 1.68 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 tt -83.35 145.24 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.506 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.402 ' HG3' ' H ' ' A' ' 150' ' ' CYS . 5.0 tpt180 -145.59 -177.2 5.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 149' ' ' ARG . 7.1 m -90.61 134.44 34.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.698 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' NH2' ' A' ' 89' ' ' ARG . 5.6 t -117.3 119.58 35.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.075 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -93.62 14.81 17.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.161 0.505 . . . . 0.0 109.82 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.2 OUTLIER -50.68 150.62 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.155 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.55 -10.08 3.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.466 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.78 158.06 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.93 175.49 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -90.48 143.33 26.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -114.07 92.23 3.9 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 pt -119.03 165.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.147 0.499 . . . . 0.0 111.323 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -119.54 134.63 55.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 m -76.52 54.59 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.538 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -130.77 123.74 20.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -38.14 147.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.916 1.744 . . . . 0.0 112.344 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 164' ' ' VAL . 20.3 m -73.4 130.46 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.341 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 34.8 mt -79.32 115.46 18.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.315 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.97 159.55 22.85 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.117 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.426 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 0.1 OUTLIER -95.2 11.14 33.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 110.295 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 58.72 21.19 8.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.343 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.413 ' C ' HD12 ' A' ' 169' ' ' ILE . 1.1 pp -76.63 -176.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.66 ' H ' ' HE ' ' A' ' 198' ' ' ARG . 51.1 m -147.94 113.82 5.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -68.6 28.22 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.284 -178.254 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 170' ' ' SER . 16.9 mmmt -67.6 175.27 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.125 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.42 ' NZ ' ' CB ' ' A' ' 173' ' ' LYS . 0.2 OUTLIER -90.86 124.7 35.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.12 -165.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.041 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.4 p -50.55 145.77 6.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.807 0.337 . . . . 0.0 110.53 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -95.69 132.52 40.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -141.45 127.07 18.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.209 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -68.45 95.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.65 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.9 mt -107.35 -40.61 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.475 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 tp -66.84 114.42 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.468 . . . . 0.0 110.502 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.22 -122.91 0.7 Allowed Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.4 m -77.21 150.8 35.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 93.07 2.1 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.093 0.473 . . . . 0.0 110.263 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.3 tt -98.86 133.26 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.914 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 185' ' ' VAL . 14.2 m -146.76 131.29 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.99 0.424 . . . . 0.0 111.86 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 34.0 p-10 -85.93 103.34 14.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.754 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.7 m -46.99 -27.12 1.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.845 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -41.92 -26.38 0.09 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.966 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.404 ' O ' HD11 ' A' ' 88' ' ' LEU . 9.8 m -142.78 36.23 1.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 190' ' ' VAL . 7.4 p -169.43 105.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.4 0.619 . . . . 0.0 110.756 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -74.56 -54.43 7.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.729 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.31 173.83 6.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.137 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 193' ' ' LEU . 1.7 tt -173.56 106.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.228 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 19.2 mp0 -93.24 149.74 21.0 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -140.83 134.32 29.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.253 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -143.19 129.54 19.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.8 t -122.61 153.47 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.66 ' HE ' ' H ' ' A' ' 170' ' ' SER . 14.4 ttt85 -154.55 144.42 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.871 0.367 . . . . 0.0 110.155 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.94 119.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.652 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -169.57 -156.59 11.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.063 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 58.3 t0 -79.21 123.78 27.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.865 0.364 . . . . 0.0 110.434 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.426 ' SD ' ' OG ' ' A' ' 167' ' ' SER . 24.2 mmt -81.14 -3.24 51.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.4 -50.05 3.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.466 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.537 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 20.2 tptp -157.38 112.35 2.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 198' ' ' ARG . 2.0 mm-40 -43.65 156.17 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' GLU . 2.5 p -156.86 67.08 0.54 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.1 p 30.84 -88.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 206' ' ' SER . 17.8 mm-40 -40.52 -50.93 2.95 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.453 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.642 ' N ' HD22 ' A' ' 209' ' ' LEU . 1.9 mm? -81.68 54.27 2.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.547 ' CG ' HH22 ' A' ' 198' ' ' ARG . 1.3 tp10 -156.22 120.25 4.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.083 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.74 179.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.96 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -171.01 146.67 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.143 0.496 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 10.2 t70 -144.17 169.43 17.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.017 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 159.58 154.07 7.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.613 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.7 177.52 7.72 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -132.48 103.68 6.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -98.31 113.81 25.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.596 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.25 111.81 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.957 0.408 . . . . 0.0 110.691 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.13 43.39 30.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.98 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.16 74.77 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.455 -0.402 . . . . 0.0 112.561 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.8 p -89.84 112.9 24.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.67 149.45 23.3 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.714 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.6 m -166.29 124.29 1.44 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.623 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -77.99 138.99 39.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.424 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.75 108.22 0.27 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.52 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.11 104.23 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.6 p -129.53 159.22 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.468 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.577 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 37.6 t70 -62.13 95.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.29 12.65 4.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.577 ' HG1' ' CG ' ' A' ' 228' ' ' ASP . 40.0 m -45.29 -51.45 10.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.706 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 233' ' ' ILE . 20.4 m -97.18 6.37 48.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.8 tp -42.64 -24.44 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.936 0.398 . . . . 0.0 110.84 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 231' ' ' SER . 0.4 OUTLIER -163.93 142.91 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -74.87 100.52 4.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -64.28 -6.35 6.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.916 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 236' ' ' THR . 0.0 OUTLIER -88.04 -10.35 50.53 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.531 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -100.94 0.21 37.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.477 0.18 . . . . 0.0 111.145 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 238' ' ' LEU . 9.0 mp -80.02 142.06 35.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.152 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 104' ' ' SER . 63.8 mttp -130.44 136.83 49.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.837 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.84 138.03 57.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.733 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 74.6 m -100.17 -8.73 23.28 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.088 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.516 -179.324 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.548 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 76.2 m -119.29 155.8 31.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.21 134.51 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.677 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.548 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 23.5 m-85 -111.89 -27.52 8.42 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -152.05 155.07 37.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.991 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.5 OUTLIER -110.42 160.53 16.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.894 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -84.0 139.08 32.77 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.48 5.53 38.56 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.453 -178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.73 126.56 47.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.822 0.344 . . . . 0.0 111.247 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -77.89 133.42 38.12 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.687 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' B' ' 24' ' ' PHE . 3.8 mm? -93.7 111.11 51.22 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.908 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.05 149.51 1.25 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.164 1.909 . . . . 0.0 112.599 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' B' ' 24' ' ' PHE . 7.5 ptp85 -45.46 -43.07 11.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.677 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -70.2 26.31 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.628 ' CD2' HD12 ' B' ' 20' ' ' LEU . 14.9 t80 -146.22 27.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -152.27 100.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.013 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.409 HG22 ' H ' ' B' ' 26' ' ' VAL . 20.4 m -84.15 -27.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.647 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -165.61 -178.34 4.83 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.755 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 8.6 p90 -154.08 173.48 15.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 74.2 m-85 -160.91 141.12 11.14 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.802 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' B' ' 30' ' ' GLU . 2.1 mp0 -84.83 146.24 27.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 111.636 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 32.0 p -52.51 -108.57 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.948 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -150.57 -149.45 0.3 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.45 ' C ' ' H ' ' B' ' 35' ' ' CYS . 67.9 m -142.2 -24.6 0.67 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.279 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -54.77 -10.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.732 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.1 p -118.71 123.03 43.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.505 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 45.2 p -72.61 35.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.347 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' B' ' 35' ' ' CYS . 26.0 mt-30 -155.04 56.16 1.35 Allowed Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 46.5 Cg_endo -64.98 -167.86 0.1 Allowed 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 122.712 2.275 . . . . 0.0 112.827 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.21 176.57 0.11 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.787 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.1 t -107.82 131.85 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.95 129.81 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.657 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -110.82 146.16 36.91 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.972 0.415 . . . . 0.0 111.147 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -93.85 169.79 10.03 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 15.8 p -140.08 -143.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 111.089 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.36 -36.95 2.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.297 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.03 46.86 2.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.557 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 18.4 m -156.09 -80.48 0.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.532 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.72 -90.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.679 0.612 . . . . 0.0 109.759 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -143.68 144.18 31.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.439 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -149.31 120.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.636 . . . . 0.0 110.73 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 6.9 t -54.61 159.06 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.776 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.463 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.13 131.29 11.09 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.62 120.5 71.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 0.1 8.66 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.114 1.21 . . . . 0.0 111.242 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 90.0 p -67.99 -18.55 64.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.169 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -93.02 124.38 36.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.006 0.431 . . . . 0.0 110.29 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -50.87 -40.69 56.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.909 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.449 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 88.9 m95 -56.43 -33.48 65.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.047 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.89 -35.79 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.185 0.516 . . . . 0.0 109.706 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.7 -48.05 64.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.606 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -64.9 -35.79 82.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -62.02 -37.76 86.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.25 -44.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.85 -32.81 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.86 -38.29 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.42 -22.22 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.23 -31.06 63.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.416 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.44 -84.51 0.09 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.572 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.596 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.808 0.337 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -75.7 -33.47 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.6 m -49.47 131.06 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.498 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -59.84 -20.52 57.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.662 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 m -75.86 -21.39 57.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.283 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -87.37 -41.39 13.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.112 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -167.94 179.71 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.994 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.19 157.37 37.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.448 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -78.93 175.58 10.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.993 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -125.26 7.56 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.859 0.361 . . . . 0.0 110.302 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' GLU . 42.4 mm-40 -83.68 89.81 7.19 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.573 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' GLU . 42.2 mt-10 -23.51 -63.6 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.059 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -76.68 49.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.594 0.235 . . . . 0.0 111.014 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -155.85 125.56 6.41 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 132' ' ' HIS . 27.5 m-70 -125.61 152.44 45.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' SD ' ' A' ' 202' ' ' MET . 11.6 t-160 -93.7 82.57 4.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.47 ' O ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -47.05 174.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.617 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.99 133.79 1.61 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.3 tt -111.17 146.1 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.381 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.99 140.04 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.66 139.82 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.152 0.501 . . . . 0.0 111.837 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.0 mt -114.58 149.19 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.189 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' CZ ' ' A' ' 195' ' ' PHE . 0.9 OUTLIER -147.46 107.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 232' ' ' LEU . 32.3 ttmt -110.69 95.05 5.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.38 133.72 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.933 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 m -107.97 124.85 50.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.024 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -76.61 149.48 36.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -73.14 159.12 34.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.38 40.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.798 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -145.3 -28.51 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.425 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.2 m -68.32 115.72 32.29 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.414 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -40.29 158.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.79 1.66 . . . . 0.0 112.229 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.497 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 67.0 p -69.03 136.39 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 40' ' ' THR . 25.9 m120 -153.94 102.35 2.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.114 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -102.75 11.05 38.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 1.8 mptp? -70.36 88.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 pt -90.96 157.73 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.347 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m 57.18 39.44 28.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.307 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -55.51 -50.67 69.34 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.976 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.4 p -173.26 156.56 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.85 134.8 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.7 p -133.41 106.3 7.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.178 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -81.84 146.4 29.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.181 0.515 . . . . 0.0 110.862 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.457 HD12 ' CE2' ' A' ' 80' ' ' TYR . 5.4 mt -142.06 156.22 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.255 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -152.53 151.67 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 54' ' ' SER . 19.4 tp10 -56.27 174.72 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.474 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-O 120.938 0.399 . . . . 0.0 110.215 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 N--CA 1.475 0.413 0 CA-C-O 120.759 0.233 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 p -118.81 125.68 50.12 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.458 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 p -94.37 119.27 32.86 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.663 ' CE1' ' ND2' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -126.72 113.66 16.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.733 0.301 . . . . 0.0 110.569 -178.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 92' ' ' PHE . 11.9 p90 -113.01 122.22 46.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.967 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -92.07 76.88 5.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.318 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.74 110.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.402 0.62 . . . . 0.0 109.725 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 83' ' ' ILE . 71.3 mt -93.21 145.84 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.437 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.28 159.11 10.28 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.211 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.65 27.54 68.37 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.046 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.23 18.25 72.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.94 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -134.61 159.02 42.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 110.544 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -122.3 110.24 15.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.1 mtt -100.17 99.59 10.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.124 0.487 . . . . 0.0 110.808 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.663 ' ND2' ' CE1' ' A' ' 80' ' ' TYR . 17.0 t-20 -84.02 129.28 34.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.1 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 70.3 m-85 -112.94 -173.45 2.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.0 0.429 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.64 72.49 0.05 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.643 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.62 147.25 35.69 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 95' ' ' THR . 11.7 t -146.57 128.45 15.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm 59.3 29.94 19.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.515 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.2 146.47 40.73 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.47 153.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.681 1.587 . . . . 0.0 111.933 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.553 ' CD ' ' HZ3' ' A' ' 101' ' ' LYS . 3.4 pt20 -67.81 140.28 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.642 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.67 122.51 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.553 ' HZ3' ' CD ' ' A' ' 99' ' ' GLN . 47.1 mttp -126.36 -1.39 6.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.125 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 t -123.42 126.14 46.24 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.271 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.2 pt -147.89 139.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.858 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.1 p -146.46 177.06 9.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -158.64 155.36 28.06 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 p -155.45 151.63 28.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.229 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.47 110.34 11.79 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.639 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -118.91 107.7 13.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.68 -126.8 18.73 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -100.79 24.06 9.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 110.24 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 154.07 43.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.7 t -133.39 132.73 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -123.38 155.68 36.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.886 0.374 . . . . 0.0 110.768 -178.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.05 142.25 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.101 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -118.05 125.13 49.74 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.804 HD22 ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -112.59 119.34 37.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.038 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 t -164.47 168.62 18.2 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.083 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.0 m -83.77 172.93 11.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.607 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -105.39 132.87 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.583 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.473 ' CB ' ' ND2' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -70.18 164.49 52.48 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.952 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.413 ' HD3' ' HD1' ' A' ' 23' ' ' HIS . 95.3 Cg_endo -75.25 139.21 23.4 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.455 2.104 . . . . 0.0 112.103 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.24 -11.63 40.13 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.562 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.499 ' OE1' ' N ' ' A' ' 123' ' ' GLN . 12.2 mp0 -76.29 -50.79 13.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.82 -2.17 1.18 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.404 -0.427 . . . . 0.0 112.419 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -103.97 -176.89 3.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.89 161.44 30.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 1.9 t -156.48 68.33 4.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.809 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.16 115.24 2.23 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 122.68 2.253 . . . . 0.0 112.861 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.9 141.59 29.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.5 pt -137.88 175.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 111.128 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 132' ' ' HIS . 25.9 m -83.48 161.16 21.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.788 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.579 ' NE2' ' CD2' ' A' ' 22' ' ' HIS . 21.0 m170 -58.63 -34.2 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.416 ' CD ' ' N ' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -61.34 -53.06 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.214 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -60.73 -43.95 97.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 138' ' ' MET . . . -59.95 -57.17 14.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.124 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -47.05 -39.07 12.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.988 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.82 62.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.344 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 135' ' ' ALA . 36.3 tpp -73.59 -29.67 62.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.83 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.35 -21.13 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.7 -37.37 18.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD2' ' CZ ' ' B' ' 18' ' ' ARG . 10.4 m-20 -85.43 -33.96 21.79 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.5 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.406 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 30.6 t -51.39 114.38 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.08 0.467 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 141' ' ' ASP . 0.3 OUTLIER -127.25 164.26 22.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 145' ' ' SER . 96.1 t -141.4 162.78 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' HG12 ' A' ' 144' ' ' VAL . 88.0 p -143.37 145.66 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.637 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 mp -140.2 144.32 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.025 0.44 . . . . 0.0 110.594 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -157.89 79.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.612 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 185' ' ' VAL . 9.4 mt -73.8 142.29 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.535 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -134.37 171.99 13.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.446 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.06 118.72 30.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.842 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 t -85.94 -173.51 4.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.26 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.401 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 6.9 tp10 -165.52 7.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -81.57 105.76 12.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.769 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 154' ' ' GLU . 20.1 mp0 -78.35 12.97 1.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -49.45 155.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.771 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.54 167.6 14.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.667 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.0 p -89.51 143.31 26.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.868 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -117.07 88.49 2.91 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.678 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.7 pt -110.14 177.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.119 0.485 . . . . 0.0 111.424 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 162' ' ' HIS . 73.7 tttt -137.33 125.95 23.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.781 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 161' ' ' THR . 58.4 m -59.22 -0.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.526 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.9 m80 -82.07 114.88 54.05 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.104 -0.239 . . . . 0.0 110.375 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -40.77 154.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.729 1.619 . . . . 0.0 112.184 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 49.2 t -77.28 136.56 24.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.577 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.8 mt -83.61 124.31 30.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.659 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 164.94 32.68 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.4 t -99.12 9.12 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.473 ' ND2' ' CB ' ' A' ' 120' ' ' SER . 7.1 m-20 59.11 -0.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.523 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.601 ' C ' HD12 ' A' ' 169' ' ' ILE . 2.5 pp -82.03 173.56 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.989 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 172' ' ' LYS . 19.9 m -133.28 129.38 37.54 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -73.13 31.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.48 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 170' ' ' SER . 3.1 mmmm -64.61 -178.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -90.63 121.37 32.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.413 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.497 HG21 ' HE ' ' A' ' 198' ' ' ARG . 17.2 m -141.44 -167.3 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.727 0.299 . . . . 0.0 110.477 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.1 t -48.24 142.95 4.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.922 0.391 . . . . 0.0 110.88 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -95.72 129.09 43.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -141.43 141.07 33.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.033 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.1 91.6 4.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.581 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.08 -59.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 180' ' ' ILE . 16.3 tt -50.26 122.28 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.48 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -91.66 -122.26 2.8 Favored Glycine 0 C--O 1.228 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.82 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.471 ' OG ' ' SG ' ' B' ' 51' ' ' CYS . 7.6 t -76.61 143.73 40.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.108 0.48 . . . . 0.0 112.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 62.8 m -139.89 84.97 2.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.103 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mt -103.89 103.83 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.942 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 148' ' ' ILE . 16.1 m -120.83 134.27 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.8 p-10 -78.89 116.5 19.25 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.6 m -52.09 -29.24 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -36.18 -36.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.54 32.74 1.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.643 0.259 . . . . 0.0 110.486 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 92.4 t -149.71 95.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.35 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -61.92 1.81 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 217' ' ' TYR . 7.9 t-20 -122.55 137.41 54.9 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -145.27 122.51 11.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.549 ' OE2' ' ND2' ' A' ' 192' ' ' ASN . 2.7 mp0 -109.8 161.35 15.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.483 ' CZ ' HD12 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -153.89 139.25 17.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.9 p -144.15 140.07 29.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.341 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.2 m -128.12 158.23 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.497 ' HE ' HG21 ' A' ' 174' ' ' VAL . 7.3 tpt180 -159.76 104.09 1.55 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.878 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 36.1 mt -106.99 118.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.67 -157.16 9.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.316 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 53.6 t0 -86.2 123.34 31.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 23' ' ' HIS . 55.2 mtp -78.12 0.26 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.326 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 5.7 t -112.4 -48.77 3.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.773 0.321 . . . . 0.0 110.628 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.481 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 3.2 tppp? -158.29 113.4 2.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.165 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -46.1 145.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.541 ' H ' ' CD ' ' A' ' 210' ' ' GLU . 7.5 t -130.23 25.25 5.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.495 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 84.1 p 52.93 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.602 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 206' ' ' SER . 33.5 tt0 -51.58 -34.24 36.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.589 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.0 mm? -88.59 -4.18 58.63 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.787 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 206' ' ' SER . 14.5 mp0 -96.15 144.84 26.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.983 0.421 . . . . 0.0 110.793 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.0 m -153.98 175.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.592 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 227' ' ' THR . 25.1 tttt -170.23 147.01 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.478 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -140.86 168.54 19.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 174.68 145.08 5.17 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.624 -1.274 . . . . 0.0 113.052 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PHE . . . . . 0.441 ' CZ ' ' OG ' ' B' ' 14' ' ' SER . 27.9 m-85 -129.37 164.9 22.6 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.45 103.27 5.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.563 ' O ' ' ND2' ' A' ' 192' ' ' ASN . 21.9 m-85 -97.44 116.5 29.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.817 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.48 HG22 ' ND2' ' A' ' 192' ' ' ASN . 44.7 t -128.76 101.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.311 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.6 t70 56.29 37.61 28.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.938 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.35 75.02 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.639 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.9 t -89.23 112.47 23.52 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.699 -0.295 . . . . 0.0 110.452 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.25 167.5 11.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.5 t -174.49 116.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.82 95.03 9.94 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -136.96 129.27 4.71 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 116.416 -0.357 . . . . 0.0 112.448 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -90.67 102.07 14.82 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.494 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.499 ' O ' ' NZ ' ' A' ' 212' ' ' LYS . 69.4 p -123.71 153.13 41.29 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.8 95.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -90.71 35.55 0.89 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 231' ' ' SER . 9.8 t -75.29 -39.62 59.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.309 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.466 ' N ' HG23 ' A' ' 230' ' ' THR . 99.3 p -102.56 3.78 37.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.339 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -48.41 -32.87 8.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.133 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.6 tt -135.06 150.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.242 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.41 92.39 9.06 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.405 ' O ' HD11 ' A' ' 238' ' ' LEU . 45.8 m -60.66 -3.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.332 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 p -91.01 -21.56 21.21 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -101.55 8.45 41.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 238' ' ' LEU . 0.3 OUTLIER -78.65 153.09 31.32 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.148 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -141.12 133.88 28.82 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.727 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.63 55.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.379 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 59.8 m -110.42 -1.93 16.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.528 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.853 0.358 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.539 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.6 m -134.76 146.33 49.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' CYS . . . . . 0.469 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 55.7 m -67.47 140.54 57.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.215 0.531 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 38.7 m-85 -117.33 -31.02 5.41 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.766 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 215' ' ' PHE . 2.7 m -140.88 145.29 35.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.04 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -109.28 152.22 25.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -78.43 139.56 38.73 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.599 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.1 -42.86 20.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.778 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.438 ' CZ ' ' OD2' ' A' ' 141' ' ' ASP . 0.9 OUTLIER -75.9 126.29 30.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.682 -179.029 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -77.12 137.85 39.16 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.601 HD22 ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -92.79 110.71 47.29 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -44.62 150.09 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.041 1.827 . . . . 0.0 112.68 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.519 ' C ' ' H ' ' B' ' 24' ' ' PHE . 50.1 mtt85 -46.02 -44.03 14.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.751 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' B' ' 23' ' ' ASN . 2.0 m-20 -68.45 27.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.519 ' H ' ' C ' ' B' ' 22' ' ' ARG . 22.2 t80 -151.98 27.3 0.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -155.97 104.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.353 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.14 -10.75 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.7 t0 -161.88 -178.61 6.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.897 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.471 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 12.6 p90 -163.2 175.74 10.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.217 0.532 . . . . 0.0 111.658 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 59.9 t80 -167.18 140.81 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.837 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.3 pt-20 -89.44 147.33 24.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.781 0.324 . . . . 0.0 111.17 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.469 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 41.1 p -50.51 -107.29 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -151.7 -132.93 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.52 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.444 ' C ' ' H ' ' B' ' 35' ' ' CYS . 23.8 t -152.47 -25.28 0.17 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.684 0.278 . . . . 0.0 110.588 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 20.3 mt -57.7 -7.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.057 0.456 . . . . 0.0 109.921 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' B' ' 37' ' ' GLN . 37.8 m -113.42 118.59 34.95 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.524 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 87.4 p -72.33 35.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.533 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.456 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.9 pt20 -167.59 61.71 0.57 Allowed Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 95.2 Cg_endo -73.94 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.803 2.335 . . . . 0.0 113.134 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 174.57 176.37 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.834 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 72.7 t -103.4 139.15 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.038 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.44 124.26 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.794 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -100.64 148.78 24.45 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.035 0.445 . . . . 0.0 110.542 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.465 ' CG ' ' N ' ' B' ' 44' ' ' THR . 26.9 tt0 -93.15 169.22 10.57 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.465 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 17.6 p -138.11 -145.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 111.709 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.49 -40.24 1.96 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.736 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.17 47.05 2.14 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.794 -0.184 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 8.6 t -156.2 -79.23 0.08 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.504 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.59 -90.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -143.76 147.97 34.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.438 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.6 t -150.28 114.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.259 0.552 . . . . 0.0 111.021 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.471 ' SG ' ' OG ' ' A' ' 182' ' ' SER . 74.5 m -50.12 159.99 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.704 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 130.59 10.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.34 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' B' ' 53' ' ' ASP . 23.4 p-10 -66.17 125.45 90.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.33 -2.06 11.84 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.141 1.227 . . . . 0.0 111.011 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 36.2 t -69.2 -12.22 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.199 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -101.02 122.65 43.92 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.132 0.491 . . . . 0.0 110.307 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 45.2 t -48.17 -46.86 35.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.496 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 35.4 p-90 -56.27 -24.71 44.71 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.572 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -75.26 -38.08 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 109.771 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -66.6 -48.43 69.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.41 -34.98 77.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -61.8 -40.81 96.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.36 -47.71 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.06 -31.43 65.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.748 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -73.7 -35.16 65.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.91 -20.01 59.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -73.27 -35.76 66.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.77 -77.46 0.14 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.342 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 p30 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.524 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.624 0.25 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 t -72.82 -25.5 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.796 0.331 . . . . 0.0 110.755 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -51.53 144.16 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.54 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -68.07 -28.57 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -76.88 -22.68 53.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.8 p -81.11 -49.0 11.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -162.24 169.98 19.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 t -63.84 153.43 36.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.68 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.7 p -72.84 172.36 10.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.461 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.68 2.69 9.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 1.6 mp0 -77.78 98.17 5.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.439 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -31.17 -53.53 0.21 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.694 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -86.65 52.06 2.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 110.682 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 16.7 tttm -160.26 133.46 6.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 110.246 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.44 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 70.6 m-70 -154.35 124.31 6.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.523 ' CE1' ' CG ' ' A' ' 121' ' ' PRO . 11.1 p80 -76.68 97.2 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.53 149.13 40.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.61 158.38 26.56 Favored Glycine 0 CA--C 1.508 -0.388 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 tt -110.33 150.73 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -152.1 106.44 3.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 110.008 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.86 126.7 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.991 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -107.97 166.47 4.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.274 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 30' ' ' ILE . 12.9 tt -161.2 110.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.796 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -98.3 132.9 43.4 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.03 120.67 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.995 0.426 . . . . 0.0 110.844 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.539 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 68.4 p -88.33 121.26 30.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -75.81 150.76 37.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.75 136.44 40.3 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.82 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -46.77 -19.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 37' ' ' GLN . 1.3 mp0 -81.31 -43.89 18.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.547 0.213 . . . . 0.0 111.16 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -42.7 147.77 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.067 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.71 172.1 16.81 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.122 1.881 . . . . 0.0 111.446 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.7 p -74.02 135.23 43.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.474 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -167.09 99.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.47 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -103.64 -1.08 28.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.535 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -67.87 91.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -89.8 160.49 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.907 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 36.9 t 55.26 62.87 2.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.507 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.557 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.4 tp60 -77.44 -27.55 52.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.1 p -174.2 -176.19 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.888 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 p -170.36 101.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 109.956 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.8 p -103.38 126.7 50.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.5 pm0 -104.39 142.51 34.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.964 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.99 157.9 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -153.37 151.61 30.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 52.0 tt0 -48.0 168.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.006 0.432 . . . . 0.0 110.06 179.74 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 CA--C 1.527 0.144 0 N-CA-C 111.039 -0.408 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -124.27 121.95 36.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 111.001 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 p -97.76 125.45 42.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -121.47 110.49 16.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.248 0.547 . . . . 0.0 111.019 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -93.73 124.09 37.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.519 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' ' CZ ' ' A' ' 80' ' ' TYR . 4.9 m -94.53 72.9 3.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.051 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.3 mm -74.67 101.73 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.801 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.6 mm -94.25 145.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.021 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.55 169.71 18.17 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.502 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.1 20.48 54.1 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.22 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.28 10.84 84.41 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 mt -131.98 155.62 47.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.58 115.45 27.2 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.3 mtt -102.07 124.16 47.2 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.04 0.448 . . . . 0.0 110.939 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.542 ' C ' HD22 ' A' ' 91' ' ' ASN . 0.2 OUTLIER -114.18 133.1 55.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.729 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.38 -174.73 2.86 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.821 0.343 . . . . 0.0 110.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.52 74.13 0.1 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.077 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -76.98 135.35 38.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.404 ' CB ' HH21 ' B' ' 18' ' ' ARG . 91.7 m -143.65 121.12 11.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.449 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? 65.0 31.72 11.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.979 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.2 m -126.42 149.81 68.58 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.22 143.51 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.999 1.799 . . . . 0.0 111.978 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 99' ' ' GLN . 4.2 mp0 -73.21 110.03 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.849 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.4 pt -69.13 142.1 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -135.34 -6.89 2.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.349 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.2 m -107.36 119.54 39.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.81 0.338 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 34.8 mt -132.04 120.02 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.425 ' OG ' HD12 ' A' ' 238' ' ' LEU . 35.1 p -146.58 162.87 37.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 111.015 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -148.39 164.83 32.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -155.12 151.86 28.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.911 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.08 124.9 33.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.424 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -145.22 111.43 5.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.002 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 -127.14 8.96 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -108.29 24.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.753 0.311 . . . . 0.0 110.32 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 p -129.16 159.17 36.88 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.637 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t -139.09 137.17 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 106' ' ' SER . 50.9 p30 -120.93 153.21 37.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.465 . . . . 0.0 111.006 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.21 130.66 19.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.605 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -116.52 116.49 27.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 110.899 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.3 mt -116.25 126.72 53.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 p -166.68 167.42 15.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.508 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 167' ' ' SER . 74.0 m -84.28 172.82 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.686 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 119' ' ' VAL . 10.7 m -96.18 147.92 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 111.024 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 t -92.71 152.2 41.63 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CG ' ' CE1' ' A' ' 23' ' ' HIS . 74.0 Cg_exo -37.89 158.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.21 64.45 3.81 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.175 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -140.99 -1.12 1.41 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 11.15 82.59 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.439 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -136.47 150.14 48.56 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.53 154.72 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.982 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -158.44 60.72 1.84 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.384 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -35.53 143.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.333 2.689 . . . . 0.0 113.715 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.45 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -109.96 146.56 35.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.568 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.01 165.81 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 110.186 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -87.44 174.48 8.49 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' OG1' ' A' ' 131' ' ' THR . 2.0 t60 -63.92 -39.33 93.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.34 -57.52 12.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.28 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.428 ' H ' HG23 ' A' ' 131' ' ' THR . 8.0 tp10 -63.18 -42.26 99.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.538 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.16 -57.01 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.177 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.86 -36.68 59.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.056 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.48 -37.66 71.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 21.1 mtt -62.34 -58.43 7.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -24.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.859 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -78.29 -55.27 5.38 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.376 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.41 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 33.9 m-20 -77.82 -23.65 48.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 19.0 t -58.07 113.59 1.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.526 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.54 ' CD ' ' HE ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -143.51 148.3 35.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.269 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.95 131.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.931 0.396 . . . . 0.0 110.309 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.6 p -103.19 173.12 6.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 15.1 pt -150.78 148.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.776 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -152.19 83.37 1.26 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.879 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.58 154.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 150' ' ' CYS . 34.1 ttt85 -145.36 172.17 13.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.022 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 149' ' ' ARG . 6.2 t -91.02 116.16 28.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.774 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.8 p -92.94 -176.85 4.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.208 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.9 6.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.295 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.469 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 63.8 tt0 -70.24 107.01 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.95 16.25 6.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.557 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 3.9 mmmm -60.73 172.72 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.674 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -76.55 169.65 17.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.636 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 71.6 m -96.6 147.65 23.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.47 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 16.3 t70 -113.18 90.94 3.48 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 160' ' ' LYS . 63.6 mt -115.11 159.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.17 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.521 ' N ' HG22 ' A' ' 159' ' ' ILE . 6.7 mmtp -121.9 128.93 52.13 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.9 p -62.55 1.97 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 160' ' ' LYS . 80.1 t60 -78.72 116.91 63.36 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -40.39 150.12 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.654 1.569 . . . . 0.0 111.939 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.85 137.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.898 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.6 mt -78.01 147.43 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.753 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -119.46 156.96 15.61 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.091 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 169' ' ' ILE . 3.5 m -89.57 10.31 23.43 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 168' ' ' ASN . 1.2 m120 56.5 1.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.502 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.494 ' H ' ' C ' ' A' ' 167' ' ' SER . 8.4 tp -94.33 144.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 26.6 p -105.65 149.91 25.92 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -83.83 46.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.373 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -73.0 -177.16 2.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -93.55 117.56 30.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.538 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.502 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 13.3 m -139.83 -171.24 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.145 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.1 t -43.31 138.15 2.41 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.77 0.319 . . . . 0.0 110.898 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.502 ' CE1' ' O ' ' A' ' 174' ' ' VAL . 2.3 m-85 -98.95 136.79 38.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.252 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 178' ' ' ASP . 5.1 tm-20 -151.84 158.11 42.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.512 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 4.5 p-10 -92.94 93.36 8.33 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 179' ' ' ILE . 0.2 OUTLIER -115.42 17.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.126 0.488 . . . . 0.0 110.016 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.488 ' O ' HD12 ' A' ' 180' ' ' ILE . 2.3 pp -113.14 119.11 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.292 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.59 -142.67 2.64 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.876 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 37.5 t -69.33 158.96 34.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.434 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -144.6 95.06 2.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.114 0.483 . . . . 0.0 110.151 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.8 132.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.655 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.578 HG21 ' CE2' ' A' ' 217' ' ' TYR . 3.3 m -142.74 123.02 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.691 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.6 p-10 -85.08 98.06 10.21 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 189' ' ' CYS . 31.3 m -47.58 -26.88 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.592 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -39.82 -26.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 187' ' ' THR . 94.0 m -146.31 24.94 1.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.185 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 23.3 t -148.5 95.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.74 -54.9 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASN . . . . . 0.539 ' H ' ' HG1' ' A' ' 33' ' ' THR . 7.2 m-20 -125.35 -176.57 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.753 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.509 ' C ' HD23 ' A' ' 193' ' ' LEU . 4.7 tt -172.88 109.16 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -96.12 121.3 37.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -120.73 129.88 53.82 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.038 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.9 p -144.58 134.22 23.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 198' ' ' ARG . 59.1 t -122.88 154.91 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.449 ' N ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -145.53 144.77 30.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.237 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.8 mt -148.99 117.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.568 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.44 172.53 45.55 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.416 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.43 119.92 10.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 0.0 111.326 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 49.7 mtm -77.17 4.18 10.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.7 t -97.23 -61.74 1.36 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.437 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -147.49 115.02 6.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.323 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -43.64 123.23 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.633 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.0 t -117.16 105.05 11.83 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.652 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.3 m -38.21 -36.97 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.156 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.83 -48.98 62.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.677 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.5 mm? -90.42 13.88 14.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.245 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 128.16 42.65 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 212' ' ' LYS . 74.6 t -153.31 161.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.374 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -167.38 160.34 13.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.473 0.654 . . . . 0.0 112.444 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.6 t70 -146.5 171.39 15.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.352 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 162.89 145.4 4.34 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.902 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.23 -171.4 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -152.93 108.14 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.439 0.638 . . . . 0.0 111.439 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.578 ' CE2' HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -96.85 123.66 40.61 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.549 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 220' ' ' GLY . 6.2 p -141.06 118.31 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.4 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.0 t70 59.92 -13.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.308 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 140.08 0.44 1.93 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 t -104.11 117.5 34.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.58 156.24 17.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.906 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.3 t -166.17 123.26 1.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -81.28 99.09 8.44 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -120.55 134.51 10.36 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.934 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.46 ' HA ' ' HZ2' ' A' ' 212' ' ' LYS . . . -98.39 98.09 9.36 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 70.0 p -134.73 163.34 30.0 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.403 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 22.4 t70 -66.16 95.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.486 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.69 28.96 0.73 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.712 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.403 ' HG1' ' CG ' ' A' ' 228' ' ' ASP . 27.6 m -64.21 -57.09 10.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.165 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 m -84.57 1.25 46.79 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.544 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.35 -29.5 0.15 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.75 0.31 . . . . 0.0 111.413 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.4 pp -152.29 145.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.304 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.79 93.08 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' SER . . . . . 0.428 ' O ' ' CD2' ' A' ' 238' ' ' LEU . 31.4 t -64.42 -2.54 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.188 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 74.3 m -93.73 -19.41 21.1 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 237' ' ' LYS . 3.3 mptp? -98.76 -2.38 38.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.514 ' CD2' ' H ' ' A' ' 238' ' ' LEU . 1.1 pt? -91.04 158.2 16.82 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.363 0.983 . . . . 0.0 111.223 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -131.92 151.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.617 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.57 161.62 1.96 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.723 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 54.0 t -124.19 -13.78 7.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.017 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.588 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 121.072 0.463 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.0 m -104.57 151.8 23.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -55.48 139.94 41.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.133 0.492 . . . . 0.0 112.008 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 8.8 m-85 -112.17 -27.26 8.43 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.7 t -158.42 158.8 34.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.489 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.39 -178.2 3.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.18 0.514 . . . . 0.0 111.778 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -99.05 135.83 39.9 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.78 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.4 12.12 4.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.54 ' HE ' ' CD ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -148.92 136.64 20.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.023 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -79.54 130.31 35.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.607 HD22 ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -84.12 114.46 54.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.546 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.34 141.87 1.97 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.783 1.655 . . . . 0.0 112.168 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ARG . . . . . 0.503 ' C ' ' H ' ' B' ' 24' ' ' PHE . 46.0 mtt85 -44.18 -42.62 6.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.597 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -69.77 28.24 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' B' ' 22' ' ' ARG . 23.2 t80 -153.12 29.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -155.03 99.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.902 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.48 -9.35 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.6 t70 -163.85 -178.97 6.0 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.883 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' TYR . . . . . 0.472 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.2 p90 -165.09 172.44 12.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.285 0.564 . . . . 0.0 111.652 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.441 ' CZ ' ' OD2' ' B' ' 27' ' ' ASP . 76.7 m-85 -153.87 179.63 8.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.064 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -125.5 147.38 49.26 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.843 0.354 . . . . 0.0 110.081 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 36.9 p -53.92 -106.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -157.7 -142.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.468 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.3 m -145.65 -22.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.296 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -56.83 -7.46 0.45 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' B' ' 33' ' ' SER . 3.6 p -121.29 122.51 40.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 86.1 p -74.55 42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.195 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -167.69 57.0 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 64.3 Cg_endo -68.94 -164.2 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 175.59 176.82 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.972 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.47 135.05 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.021 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.71 134.28 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.217 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -108.34 151.74 25.58 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.707 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.13 168.84 10.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 7.5 p -135.6 -144.96 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.343 0.592 . . . . 0.0 111.132 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ALA . . . . . 0.412 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.46 -38.82 1.33 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.988 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.47 46.24 2.34 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.728 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.613 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 15.5 t -156.58 -81.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.532 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.16 -87.79 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -145.93 148.02 32.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.98 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -152.32 123.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 109.844 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.479 ' H ' ' CB ' ' A' ' 182' ' ' SER . 5.4 t -58.36 164.44 2.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.979 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.9 134.62 13.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.717 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -68.21 120.13 72.43 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.05 -0.02 8.49 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.065 1.177 . . . . 0.0 111.318 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 59.5 p -74.11 -9.1 58.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.28 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -102.28 125.65 49.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 110.422 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -47.47 -50.07 24.04 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 64.4 p-90 -56.13 -27.56 54.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.758 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.48 -38.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -67.12 -51.6 52.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.357 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.81 -35.46 70.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.0 m-85 -62.88 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -71.01 -46.38 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.92 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.17 -28.85 69.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.27 -41.07 61.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.699 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.34 -22.5 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -69.93 -33.56 72.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.2 -102.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.6 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.597 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 1' ' ' MET . 70.9 Cg_exo -51.77 -171.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.82 1.68 . . . . 0.0 112.085 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.49 175.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.625 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 m -165.61 -8.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.447 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 6' ' ' GLN . 1.6 tt -62.6 110.24 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.163 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.453 ' N ' HD23 ' A' ' 5' ' ' LEU . 24.9 tt0 -167.41 124.85 1.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.577 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -60.95 -143.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.539 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.0 p -158.11 -14.7 0.08 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.419 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -76.0 -29.29 58.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 m -49.26 129.8 18.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.511 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -58.6 -21.89 54.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.536 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.2 p -77.44 -20.12 55.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 m -82.95 -50.47 8.54 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.989 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -165.42 173.43 11.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.972 0.415 . . . . 0.0 111.095 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.86 159.28 3.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.4 p -85.06 173.76 10.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.917 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -119.25 5.36 11.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.319 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.29 92.87 7.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.75 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 19' ' ' GLU . 17.9 mp0 -27.6 -63.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.506 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -77.16 53.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 22' ' ' HIS . 19.9 tttp -163.08 137.13 6.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 63.0 m80 -157.42 123.22 4.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.81 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 128' ' ' PRO . 2.0 t60 -64.67 109.26 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 111.219 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.627 ' HE2' HD11 ' A' ' 139' ' ' ILE . 72.9 mmm -84.43 137.44 33.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.381 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.57 156.56 22.51 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' CG1' ' A' ' 197' ' ' VAL . 7.5 tp -110.7 151.25 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -157.27 106.56 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 110.253 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.86 148.97 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.313 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' A' ' 171' ' ' HIS . 10.1 mt -117.45 145.77 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.69 108.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.992 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -106.3 96.07 6.21 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -91.18 134.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.466 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 192' ' ' ASN . 29.8 m -113.92 121.68 44.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.692 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -77.5 151.04 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.721 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.462 ' CD ' ' N ' ' A' ' 36' ' ' ASP . 13.5 tm0? -80.07 148.96 30.83 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 15.4 t70 -72.76 65.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.721 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -172.09 -23.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 0.0 110.114 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.2 m -75.14 121.78 85.97 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.214 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.444 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 63.2 Cg_exo -39.62 159.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.87 1.713 . . . . 0.0 112.318 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -73.57 147.14 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.353 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 2.0 p30 -174.08 101.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -112.27 25.42 11.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -86.12 54.62 3.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.83 176.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.007 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.9 m 55.6 34.99 24.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.48 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 29.8 tp60 -59.72 -43.06 94.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.054 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 t 178.71 165.52 0.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.055 0.455 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.2 134.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.538 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.4 m -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -82.98 141.62 31.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.588 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -143.39 154.37 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -150.92 110.73 4.06 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 78' ' ' THR . 0.9 OUTLIER -64.79 115.59 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.298 -178.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.15 -46.09 0.61 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.094 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.34 -33.27 67.57 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.211 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.516 ' N ' ' OG1' ' A' ' 52' ' ' THR . 45.5 m 39.71 -105.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.601 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.734 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 6.7 t0 -160.31 -37.82 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.734 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 10.0 Cg_endo -80.92 -94.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.611 1.541 . . . . 0.0 110.895 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 11.7 p30 -176.13 51.67 0.08 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 59' ' ' ASP . 44.8 Cg_endo -98.05 -55.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.395 2.064 . . . . 0.0 111.304 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 63' ' ' GLU . 23.8 tp10 62.72 61.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.982 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.2 t 72.54 -25.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.653 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 61' ' ' GLU . 28.5 tt0 63.35 63.04 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.918 0.389 . . . . 0.0 110.5 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.0 t -88.39 77.41 8.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -77.68 55.94 1.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.387 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 23.8 p-10 -167.81 90.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.2 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.56 167.98 20.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.17 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 p -173.56 -47.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 110.208 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.75 -39.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.123 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 71' ' ' VAL . 98.9 p -46.85 136.68 7.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.486 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 70' ' ' SER . 10.6 m -158.28 33.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.275 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.543 ' OE2' ' ND2' ' B' ' 23' ' ' ASN . 6.4 pt-20 -59.38 -34.31 72.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.497 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 75' ' ' ASP . 80.9 m-20 -34.35 -98.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.1 t 57.33 -80.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.763 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' ASP . 12.9 m-20 -75.77 149.82 83.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.345 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' PRO . 58.6 Cg_endo -68.5 147.89 71.78 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 121.964 1.776 . . . . 0.0 111.467 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' PRO . 31.3 Cg_exo -55.84 -147.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.852 1.702 . . . . 0.0 113.111 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.412 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 19.4 p -131.32 150.66 52.06 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.619 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.9 m -121.05 128.22 52.44 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -127.37 153.88 45.67 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.0 0.429 . . . . 0.0 110.496 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 64.4 m-85 -128.85 137.45 51.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.964 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.5 p -105.03 66.18 0.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.062 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.68 98.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.842 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.73 145.09 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.63 161.97 11.5 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.3 25.62 65.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.187 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.06 65.3 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.595 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.2 163.0 30.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.934 0.397 . . . . 0.0 110.084 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -129.95 112.46 13.53 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.445 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 mpt? -101.09 106.95 18.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.958 0.408 . . . . 0.0 110.662 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -88.84 128.63 35.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.74 -162.95 1.0 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.624 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.1 70.45 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 5.0 p90 -89.0 156.16 19.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -141.46 125.64 17.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm 61.93 35.08 16.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.531 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 m -121.84 146.02 44.88 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -39.1 148.03 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.928 1.752 . . . . 0.0 112.159 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -64.46 145.05 56.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.5 mt -108.47 116.64 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -119.28 0.8 11.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -115.38 118.26 32.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.503 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.33 120.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.8 m -144.91 159.25 43.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.857 0.36 . . . . 0.0 110.738 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -148.76 168.33 23.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.82 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.71 159.34 24.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.511 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.18 127.7 36.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.545 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -142.25 107.6 5.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.482 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.23 -134.38 19.61 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -96.43 23.38 6.83 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.778 0.323 . . . . 0.0 110.383 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -130.54 159.34 37.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.434 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.03 138.86 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.471 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -108.34 171.38 7.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 111.647 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.5 120.44 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.482 ' NH2' ' OG ' ' A' ' 235' ' ' SER . 7.3 tpp85 -113.97 114.9 26.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.826 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 115' ' ' ARG . 10.8 mp -115.84 127.42 55.03 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.4 p -164.7 175.96 9.26 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.664 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.421 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 73.6 p -92.79 166.36 12.47 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 119' ' ' VAL . 12.6 m -92.55 145.5 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 0.0 110.879 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.2 p -89.26 150.09 44.15 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.32 162.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.776 1.65 . . . . 0.0 112.21 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.13 69.99 0.84 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.136 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.11 -46.13 0.43 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.21 -8.09 2.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.081 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -117.57 -176.86 3.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.63 170.13 12.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -163.21 61.89 1.1 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.946 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.501 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 97.1 Cg_exo -42.87 125.16 3.84 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.84 2.36 . . . . 0.0 113.484 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.31 149.92 21.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -149.57 163.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 p -79.61 177.42 8.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -71.25 -34.74 71.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.42 -43.88 80.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.95 -30.57 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.41 -56.52 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.162 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -32.58 39.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.163 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.1 66.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.512 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.1 mtt -63.69 -56.72 13.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.626 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.627 HD11 ' HE2' ' A' ' 24' ' ' MET . 50.5 mt -46.35 -22.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -86.19 -42.06 14.14 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.72 -27.16 25.45 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.53 119.38 3.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -138.72 125.0 20.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.338 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 145' ' ' SER . 93.4 t -94.49 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.479 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.573 ' N ' HG12 ' A' ' 144' ' ' VAL . 12.4 p -140.22 144.54 36.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.386 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.1 mt -140.83 143.1 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.984 0.421 . . . . 0.0 110.595 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -158.29 77.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.027 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.62 152.0 6.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -134.7 -149.11 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.344 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.4 t -132.67 108.97 9.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.216 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 m -97.25 173.08 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.5 10.79 0.97 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.927 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -64.22 104.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.759 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.24 1.93 30.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -52.34 150.15 4.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.565 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.03 171.59 1.69 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.162 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 80.5 p -97.83 149.62 22.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.922 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -121.5 93.35 3.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.735 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.476 ' C ' HD12 ' A' ' 159' ' ' ILE . 1.6 pp -110.35 178.1 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.807 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 162' ' ' HIS . 42.9 tttp -135.64 125.9 26.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.831 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 161' ' ' THR . 35.3 m -57.95 -2.33 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.24 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.3 t-80 -75.08 116.36 53.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.376 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -40.49 160.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.81 1.674 . . . . 0.0 111.97 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.31 129.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 mt -79.03 121.26 24.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.56 160.68 22.76 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.303 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -92.04 8.08 39.36 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 58.75 -0.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.494 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.493 ' H ' ' C ' ' A' ' 167' ' ' SER . 9.4 tp -90.73 141.82 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -88.58 -176.53 5.32 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.454 ' CD2' HD11 ' A' ' 29' ' ' ILE . 4.6 m-70 -123.73 24.2 8.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -58.26 -166.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -101.8 122.94 44.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.07 -168.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.254 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.7 m -49.78 148.54 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.425 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 54.5 p90 -98.34 133.38 42.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.07 132.34 23.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.39 97.85 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.568 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.5 mt -107.86 -51.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -56.23 115.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.946 0.403 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.78 -123.86 0.7 Allowed Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.1 t -75.2 148.7 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.763 0.316 . . . . 0.0 110.759 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.3 p -141.81 87.23 2.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.556 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.468 HD11 ' HB1' ' B' ' 10' ' ' ALA . 8.8 tp -98.87 135.58 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.9 129.96 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.711 0.291 . . . . 0.0 111.526 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -81.79 90.02 6.35 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -46.25 -27.22 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.279 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -44.93 -16.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.76 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 187' ' ' THR . 57.0 m -143.71 24.55 1.69 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 p -163.98 104.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.512 0.672 . . . . 0.0 110.313 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -72.21 -56.52 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.493 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.456 ' H ' ' HB ' ' A' ' 33' ' ' THR . 10.6 m-20 -125.71 141.1 52.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.236 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.1 tt -145.34 106.74 4.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.66 151.86 19.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.05 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -140.77 138.03 33.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 110.242 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.8 m -143.85 135.92 26.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.347 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 198' ' ' ARG . 21.3 t -134.2 160.06 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.462 ' N ' HG12 ' A' ' 197' ' ' VAL . 39.8 ttt180 -171.79 113.87 0.34 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.985 0.421 . . . . 0.0 110.842 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.3 128.96 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.791 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.76 167.71 40.36 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.224 -0.512 . . . . 0.0 111.938 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -53.46 123.34 11.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.421 ' SD ' ' OG ' ' A' ' 118' ' ' SER . 77.9 mtm -82.74 4.67 24.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 34.8 t -106.88 -46.76 3.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.69 117.56 2.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 6.0 mp0 -43.98 156.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.701 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 208' ' ' GLU . 17.9 t -141.11 17.8 2.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.646 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 208' ' ' GLU . 73.7 p 56.28 -74.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.0 mm-40 -49.25 -54.41 16.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.57 0.224 . . . . 0.0 111.597 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.4 mp -74.57 4.38 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -104.0 124.21 48.61 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.8 m -146.56 -179.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.22 167.55 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.485 0.66 . . . . 0.0 111.834 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 213' ' ' ASP . 0.6 OUTLIER -157.3 172.9 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.956 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 157.3 143.4 3.65 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.496 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -121.15 179.28 4.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.98 104.16 5.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.406 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -97.72 118.71 34.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.877 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.1 t -138.34 100.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.38 52.45 13.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.923 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.99 48.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.646 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.9 t -85.63 106.03 16.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 111.479 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.5 143.96 32.03 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.2 m -164.63 130.85 2.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.647 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -82.25 140.91 33.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.351 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -177.71 110.8 0.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.63 127.39 32.85 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 47.1 p -150.21 161.07 43.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.09 95.52 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.607 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -87.21 26.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.286 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.6 m -67.13 -29.57 69.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.6 t -116.57 5.89 13.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.664 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.7 OUTLIER -42.28 -28.43 0.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 35.9 pt -156.39 152.01 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.33 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.11 98.92 4.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.482 ' OG ' ' NH2' ' A' ' 115' ' ' ARG . 23.3 t -64.08 -9.58 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.298 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 64.3 p -82.79 -12.37 57.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -102.74 7.44 39.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.576 0.227 . . . . 0.0 111.386 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -81.32 132.04 35.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.097 0.475 . . . . 0.0 110.786 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -123.15 135.55 54.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.388 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.74 127.3 31.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.104 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 34.0 m -88.58 -3.72 58.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.695 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 242' ' ' VAL . 11.7 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.434 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.768 0.318 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -44.07 120.91 2.68 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.705 2.27 . . . . 0.0 112.277 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.81 155.18 27.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.517 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.84 160.94 44.26 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.064 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.5 p -54.75 -91.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.727 0.299 . . . . 0.0 110.564 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -133.1 68.26 78.02 Favored Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.471 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -41.92 124.64 2.84 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.777 2.318 . . . . 0.0 111.762 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.579 ' C ' HG22 ' B' ' 9' ' ' THR . 10.0 Cg_exo -34.33 -99.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.432 2.088 . . . . 0.0 114.684 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.579 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 163.5 165.2 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.204 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 184' ' ' ILE . . . -142.92 57.93 1.41 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 1.8 t -97.11 154.06 17.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.691 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.65 146.59 48.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -116.84 -23.46 8.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.335 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -151.54 154.9 37.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.108 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -114.95 154.82 28.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.91 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -76.38 139.75 41.1 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 -20.94 40.54 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.149 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -105.54 127.88 53.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -84.51 114.34 21.87 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.465 HD12 ' N ' ' B' ' 20' ' ' LEU . 10.9 mp -75.45 115.15 42.84 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.903 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.67 153.44 0.15 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.045 1.83 . . . . 0.0 112.606 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 25' ' ' VAL . 84.5 mtp180 -45.7 -49.89 14.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.67 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.543 ' ND2' ' OE2' ' A' ' 72' ' ' GLU . 32.4 m-20 -38.89 -34.69 0.16 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 0.9 OUTLIER -106.08 38.18 2.09 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.934 0.397 . . . . 0.0 109.983 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' B' ' 22' ' ' ARG . 48.8 t -152.95 97.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.571 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.7 -13.86 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.88 179.48 9.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.189 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.492 ' O ' ' CD2' ' B' ' 29' ' ' TYR . 13.4 p90 -165.56 169.92 14.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.187 0.518 . . . . 0.0 111.796 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' B' ' 28' ' ' TYR . 94.5 m-85 -159.0 153.62 24.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.601 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' B' ' 31' ' ' THR . 41.6 mt-10 -97.71 147.31 24.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.854 0.359 . . . . 0.0 111.11 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 41.9 p -53.11 -110.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.146 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.7 m -150.81 -145.72 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.666 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.457 ' C ' ' H ' ' B' ' 35' ' ' CYS . 65.9 p -141.38 -22.9 0.74 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.424 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.23 -5.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.1 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.458 ' C ' ' H ' ' B' ' 37' ' ' GLN . 8.6 p -117.5 120.83 39.3 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 34.4 t -72.66 36.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.245 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' B' ' 35' ' ' CYS . 11.9 pt20 -167.51 60.86 0.53 Allowed Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 68.7 Cg_endo -70.16 -161.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.665 2.243 . . . . 0.0 112.83 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.48 176.92 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 134.98 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.67 130.32 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.018 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -111.26 146.51 36.87 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.48 169.06 10.63 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -136.12 -142.92 0.18 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.249 0.547 . . . . 0.0 111.092 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.499 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.53 -40.46 2.22 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.848 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.47 47.88 2.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.39 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 59.6 p -151.48 -79.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.422 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.58 -90.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.76 147.67 35.95 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.954 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.63 123.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.021 0.438 . . . . 0.0 110.111 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.76 162.26 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.242 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.5 125.71 7.32 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.762 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.14 123.06 82.99 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 0.37 8.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.235 1.29 . . . . 0.0 111.357 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 62.2 p -68.22 -14.7 63.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -100.08 124.02 44.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -50.86 -38.38 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.989 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -56.4 -33.69 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.744 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.89 -36.35 57.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.123 0.487 . . . . 0.0 109.887 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.72 -37.94 73.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.482 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -71.01 -35.69 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.176 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.05 -37.65 88.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.71 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 60.9 t -70.67 -45.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.93 -38.97 80.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.986 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.1 -41.72 90.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.932 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.25 -19.81 63.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.51 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.33 66.2 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.9 mt -76.4 -77.49 0.14 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.896 0.379 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.529 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.778 0.323 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -43.04 163.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.71 2.273 . . . . 0.0 112.149 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.43 -174.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.455 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -165.88 -165.3 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.504 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.3 mt 53.86 98.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.404 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 1.8 pm0 -166.74 133.51 2.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -69.17 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.412 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.4 t -168.31 -18.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.583 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -76.58 -23.91 53.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.685 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -51.08 139.59 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.6 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 p -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.702 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -77.59 -28.7 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.71 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.9 p -78.55 -50.79 10.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.999 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -161.92 172.6 15.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.705 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.41 150.59 47.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.346 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.43 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 12.4 t -63.48 170.45 3.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 0.0 110.742 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 23.8 mp0 -113.06 4.88 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.593 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -61.98 -164.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.964 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -127.01 -62.85 1.09 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.0 110.72 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -82.15 34.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.535 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.93 142.5 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -144.43 159.75 42.22 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.0 OUTLIER -88.02 81.56 7.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.852 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.605 ' N ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -69.33 123.67 21.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.65 179.31 17.03 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 tt -136.0 154.92 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.747 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 53.8 t0 -145.67 137.65 25.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG13 ' CZ ' ' A' ' 195' ' ' PHE . 91.9 t -137.95 107.87 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.538 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.3 mp -94.28 142.62 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.659 ' H ' HH21 ' A' ' 115' ' ' ARG . 9.1 tt -155.62 117.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.54 0.686 . . . . 0.0 111.482 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -104.52 127.65 52.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.663 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -125.31 117.1 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.043 0.449 . . . . 0.0 111.89 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 m -96.79 132.98 41.96 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -94.54 164.0 13.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.926 0.394 . . . . 0.0 109.971 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.76 157.1 37.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.019 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -83.02 -34.67 26.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.993 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.2 m -45.04 110.77 1.14 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.03 159.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.725 1.616 . . . . 0.0 111.998 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -70.04 137.92 51.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.796 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -157.68 102.87 1.89 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 44' ' ' ILE . 14.5 t70 -101.6 -12.93 18.08 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.762 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -58.4 81.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.977 0.418 . . . . 0.0 110.548 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.5 tp -86.56 156.25 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 12.4 t 57.08 61.8 2.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.539 0.685 . . . . 0.0 110.048 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 155' ' ' LYS . 7.9 tt0 -80.26 -30.07 38.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.0 m -171.54 166.76 6.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' CG2' ' SG ' ' A' ' 241' ' ' CYS . 6.7 t -148.7 105.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -106.71 112.16 25.02 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.869 0.366 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -89.09 138.61 31.26 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.284 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.1 mt -140.39 151.25 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.9 p -149.59 138.65 21.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.224 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 55' ' ' GLU . 4.4 tp10 -45.26 169.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 56' ' ' SER . 9.0 m -50.04 -10.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.961 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 53' ' ' GLU . 36.5 tt0 -30.85 88.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.641 0.588 . . . . 0.0 111.739 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' SER . 73.2 m 44.17 60.55 2.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.438 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.59 166.97 6.44 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -34.88 107.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.773 2.315 . . . . 0.0 112.307 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 0.5 OUTLIER -77.45 114.71 43.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.743 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.93 -43.91 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.651 1.568 . . . . 0.0 111.91 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -53.76 142.59 23.19 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 63' ' ' GLU . 10.5 m -65.0 -46.26 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' N ' HG23 ' A' ' 62' ' ' VAL . 11.3 pt-20 -83.4 -155.16 0.16 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.487 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.3 p -157.99 159.85 36.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.948 0.404 . . . . 0.0 110.665 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 2.3 pm0 -41.08 -89.78 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t0 58.98 68.56 0.8 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 110.526 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 68' ' ' SER . 52.0 t0 -62.23 -60.23 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.432 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 67' ' ' ASP . 1.2 t 80.54 44.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.7 p -149.79 -14.1 0.27 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.125 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.4 p -168.89 -53.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.268 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 t 51.93 72.72 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.808 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -154.85 -49.92 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.216 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.24 157.72 35.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.584 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.6 m -69.1 -154.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.256 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -156.68 130.31 4.67 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -33.24 95.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.979 2.453 . . . . 0.0 114.172 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -99.08 145.1 0.46 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.129 2.552 . . . . 0.0 110.791 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -130.82 145.69 52.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.936 0.398 . . . . 0.0 111.251 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.9 t -121.86 130.95 53.77 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -124.91 114.98 19.88 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.952 0.406 . . . . 0.0 111.252 -177.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.86 124.15 37.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.289 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -96.36 71.58 2.76 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.05 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.41 HG22 ' H ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -72.42 111.97 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.82 169.49 18.1 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.339 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.31 20.36 43.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.851 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.88 10.0 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.75 155.53 46.49 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -121.38 106.9 11.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 mtt -101.57 106.66 17.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.942 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -95.6 127.67 41.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.539 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.75 -169.93 1.73 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.29 72.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -76.21 135.78 39.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 110.972 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.2 m -140.04 122.61 16.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.0 32.66 22.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.3 m -121.42 149.56 52.57 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.644 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -38.7 152.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.98 1.787 . . . . 0.0 112.093 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 99' ' ' GLN . 19.4 mp0 -79.57 109.25 13.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.041 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 127.37 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.848 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 125' ' ' LYS . 1.2 tppp? -123.13 2.78 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.467 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.0 p -130.86 131.24 44.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.25 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.2 tt -144.98 130.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.6 p -150.29 152.84 35.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.182 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -142.28 175.49 9.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 110.689 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 t -168.54 164.36 12.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.948 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.17 131.38 42.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 20.9 p-10 -144.43 107.74 4.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.028 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.41 -122.72 18.7 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.744 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -102.93 20.82 16.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.621 0.248 . . . . 0.0 110.649 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.4 p -128.63 151.84 49.03 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.076 0.465 . . . . 0.0 111.024 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.42 135.88 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.61 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.4 HD22 HH12 ' A' ' 115' ' ' ARG . 2.2 m120 -104.73 165.42 11.08 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 111.458 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.657 ' H ' ' NH2' ' A' ' 115' ' ' ARG . . . -163.46 120.56 1.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.659 HH21 ' H ' ' A' ' 30' ' ' ILE . 13.1 mmp_? -115.34 111.66 21.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.422 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.24 118.91 37.22 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 p -156.75 177.08 11.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.328 0.585 . . . . 0.0 111.763 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 p -93.38 164.96 13.01 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.534 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.457 ' O ' ' CE ' ' A' ' 202' ' ' MET . 8.2 p -97.78 130.49 46.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 111.326 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 p -72.91 153.29 91.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.797 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.17 151.53 58.68 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.934 1.756 . . . . 0.0 111.5 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.35 50.12 8.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.23 -0.509 . . . . 0.0 111.845 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -134.75 -22.76 1.63 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.778 0.323 . . . . 0.0 110.281 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.73 14.97 11.53 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 101' ' ' LYS . 35.9 mmtm -135.04 164.48 27.54 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.24 148.01 45.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.509 . . . . 0.0 111.757 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.0 m -155.43 62.66 3.37 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.705 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.4 142.26 2.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.877 2.385 . . . . 0.0 113.361 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.56 150.22 22.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.231 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 tp -131.01 164.61 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.649 0.261 . . . . 0.0 110.62 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 132' ' ' HIS . 26.8 m -81.66 154.92 25.86 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 121.182 0.515 . . . . 0.0 111.322 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.407 ' N ' HG22 ' A' ' 131' ' ' THR . 16.9 t-80 -50.73 -38.43 47.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.724 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -56.53 -42.34 78.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.14 -56.84 16.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 tp -51.65 -35.44 42.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.909 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.19 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.737 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.403 ' C ' ' N ' ' A' ' 140' ' ' LYS . 48.5 mtt -69.07 -62.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.526 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.5 mt -44.96 -20.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.728 0.299 . . . . 0.0 111.218 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 138' ' ' MET . 19.7 tptm -87.47 -33.65 18.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.396 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -94.36 -26.03 16.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.433 ' SG ' HD11 ' A' ' 199' ' ' ILE . 34.0 t -49.61 118.62 2.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -137.72 118.93 14.53 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.2 t -115.16 126.89 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.5 p -100.96 165.14 11.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.9 mp -142.96 150.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.11 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -160.77 86.89 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.705 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.8 tt -83.32 151.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 111.904 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.443 ' CG ' ' H ' ' A' ' 150' ' ' CYS . 57.2 ttt180 -149.01 176.07 10.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.075 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.46 ' SG ' ' OD2' ' A' ' 186' ' ' ASP . 11.8 m -90.99 143.35 26.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 65.3 p -129.91 124.77 33.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.311 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.22 -10.09 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.498 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.583 ' H ' ' CD ' ' A' ' 153' ' ' GLU . 1.5 mp0 -51.34 101.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -89.21 17.22 6.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.949 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.491 ' N ' ' OE1' ' A' ' 46' ' ' GLN . 63.6 mmtt -58.47 162.18 3.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.496 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 168.87 8.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.73 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.6 p -97.38 148.89 22.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 85.2 m-20 -117.21 91.11 3.48 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.65 177.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.141 0.496 . . . . 0.0 111.232 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' HG2' ' H ' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -105.88 -171.39 1.89 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -127.32 -6.01 5.95 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.475 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 37.1 m80 -108.88 129.05 24.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.895 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -39.18 157.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.176 1.917 . . . . 0.0 112.807 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.21 143.91 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.173 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.39 116.33 22.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.891 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.02 172.68 49.85 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.624 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 169' ' ' ILE . 11.4 m -105.18 8.88 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.8 m-20 59.24 -3.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 167' ' ' SER . 56.4 mt -86.96 154.3 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.406 ' N ' HG22 ' A' ' 169' ' ' ILE . 53.9 p -118.33 135.52 54.26 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.512 ' NE2' ' OG ' ' A' ' 196' ' ' SER . 0.1 OUTLIER -73.55 39.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.583 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -67.12 179.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.15 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -90.97 122.02 33.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -146.43 -160.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 174' ' ' VAL . 42.8 t -50.81 140.83 14.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.138 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -104.95 139.86 39.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 11.3 tm-20 -161.22 146.21 13.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.481 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.437 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 41.8 t0 -66.94 104.17 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.859 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.4 mt -114.19 -23.86 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 215' ' ' PHE . 17.9 pt -90.91 137.95 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 110.876 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.38 -134.47 7.05 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -71.59 154.78 41.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.415 ' C ' HD12 ' A' ' 184' ' ' ILE . 84.8 m -149.74 94.54 2.19 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.7 mp -97.39 138.11 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.61 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 185' ' ' VAL . 1.5 m -140.92 123.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.032 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.46 ' OD2' ' SG ' ' A' ' 150' ' ' CYS . 34.6 p-10 -79.39 110.23 14.49 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.2 m -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -34.97 -46.17 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.09 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 26.5 p -143.09 40.29 1.49 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.299 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.4 t -149.4 96.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -80.12 -58.93 2.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.137 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 36.3 t-20 -127.28 137.65 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.118 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.432 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 7.7 tt -138.61 106.67 5.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.934 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -93.48 140.25 29.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.444 ' CZ ' HG13 ' A' ' 28' ' ' VAL . 34.1 t80 -137.77 133.43 34.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.993 0.425 . . . . 0.0 111.259 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 171' ' ' HIS . 1.2 t -144.02 144.25 31.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.934 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.558 HG22 ' N ' ' A' ' 198' ' ' ARG . 2.7 p -139.43 166.62 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.937 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.558 ' N ' HG22 ' A' ' 197' ' ' VAL . 21.3 ttt180 -169.35 111.27 0.48 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.783 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.433 HD11 ' SG ' ' A' ' 142' ' ' CYS . 25.6 mt -102.37 122.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -163.24 -161.28 12.3 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -78.86 137.71 37.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.496 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 22.6 mtp -92.09 -6.37 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.258 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.45 -57.8 2.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.544 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -155.22 136.03 13.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -42.72 158.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.198 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 9.6 t -147.15 6.56 0.88 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.504 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.2 m 58.44 -75.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.0 mt-10 -47.84 -48.85 30.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.867 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 209' ' ' LEU . 10.2 mp -83.23 0.42 45.58 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 207' ' ' SER . 10.0 mp0 -95.72 118.03 31.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.96 163.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.077 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.414 ' HD3' ' H ' ' A' ' 174' ' ' VAL . 12.2 ptmt -164.28 168.01 19.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.573 0.701 . . . . 0.0 112.188 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.7 t70 -141.53 171.33 14.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.861 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 173.13 148.13 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.145 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 180' ' ' ILE . 8.8 m-85 -139.62 174.22 10.74 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -139.17 104.14 4.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.964 0.411 . . . . 0.0 110.592 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.57 116.8 30.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.477 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 218' ' ' VAL . 11.8 p -140.65 118.88 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.391 0.615 . . . . 0.0 110.959 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 15.5 t70 48.25 43.04 18.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.769 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.32 -3.9 85.09 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.469 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.1 t -100.4 116.7 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.027 0.413 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.77 150.55 23.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 70.9 m -166.24 128.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.455 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -77.61 141.5 39.44 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.86 101.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.267 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.28 98.02 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.3 p -129.28 160.09 34.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.405 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -63.32 95.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -89.95 35.92 0.85 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.608 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.6 p -71.51 -45.22 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 233' ' ' ILE . 44.4 t -94.34 -1.9 53.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 53.5 tp -42.15 -20.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.757 0.313 . . . . 0.0 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.561 ' C ' HD12 ' A' ' 233' ' ' ILE . 2.2 pp -149.16 174.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.329 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.93 93.87 5.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.004 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 82.3 p -66.18 -6.2 12.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 60.0 p -91.78 -17.21 25.7 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -105.05 4.71 31.85 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.52 ' O ' HD12 ' A' ' 238' ' ' LEU . 0.3 OUTLIER -76.18 161.15 29.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.159 0.504 . . . . 0.0 110.863 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.427 ' HA ' ' HZ1' ' A' ' 160' ' ' LYS . 2.1 mppt? -144.6 129.73 18.58 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.962 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.469 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . . . -57.66 155.75 9.46 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 48' ' ' VAL . 28.3 t -119.2 -3.85 10.55 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.62 179.725 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.719 0.295 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.41 115.52 4.37 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.604 2.203 . . . . 0.0 111.628 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 5.4 tpt -65.55 145.39 56.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.403 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.43 -176.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.979 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 31.8 t -130.15 125.78 35.89 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 110.253 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 48.37 74.73 0.76 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.475 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.531 ' O ' ' O ' ' B' ' 8' ' ' PRO . 62.4 Cg_endo -86.9 161.96 8.95 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.87 2.38 . . . . 0.0 111.018 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.578 ' C ' HG22 ' B' ' 9' ' ' THR . 28.6 Cg_exo -38.18 -122.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.802 3.002 . . . . 0.0 114.743 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.578 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 157.23 68.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.45 82.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.308 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.4 m -119.1 128.37 54.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 p -71.21 135.2 47.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.218 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -110.34 -15.48 13.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.569 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 75.7 m -122.98 147.24 46.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.316 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.487 ' CE2' ' OD1' ' B' ' 53' ' ' ASP . 16.8 m-85 -118.89 153.6 34.3 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.244 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -78.97 134.88 36.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.905 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.66 27.94 4.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.788 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.02 126.64 21.89 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.943 0.401 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -57.51 164.01 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.91 89.95 33.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -41.91 142.87 1.32 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.737 1.625 . . . . 0.0 111.987 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -42.9 -48.51 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.45 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -37.72 -34.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -107.54 42.4 1.34 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.675 0.274 . . . . 0.0 111.227 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -144.44 86.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.038 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.54 -28.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 26.7 t0 -157.83 -179.77 8.46 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.648 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.48 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.4 p90 -163.06 169.06 20.07 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.233 0.539 . . . . 0.0 112.071 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 55.7 t80 -159.06 164.45 35.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.132 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.6 pt-20 -114.38 152.21 31.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.72 0.295 . . . . 0.0 110.588 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.426 ' O ' ' O ' ' B' ' 30' ' ' GLU . 36.3 p -55.69 -116.1 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.078 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -149.43 -156.07 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.473 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.451 ' C ' ' H ' ' B' ' 35' ' ' CYS . 75.2 m -126.09 -24.62 3.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.343 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.4 mm? -53.09 -9.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.227 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.451 ' H ' ' C ' ' B' ' 33' ' ' SER . 4.1 p -120.13 123.65 43.85 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -74.57 42.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -166.31 56.86 0.42 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 59.8 Cg_endo -67.97 -161.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 122.795 2.33 . . . . 0.0 113.013 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 167.83 177.39 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.67 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.77 134.07 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.137 0.494 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.94 141.83 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.474 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -119.33 150.32 40.34 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.683 0.277 . . . . 0.0 110.649 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -115.63 112.13 21.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 109.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 4.7 p -75.62 -138.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.027 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.485 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -131.02 -32.22 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.062 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.39 40.5 3.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.043 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 27.4 t -142.94 -83.35 0.17 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 121.378 -0.129 . . . . 0.0 110.704 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.58 -90.73 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.704 0.627 . . . . 0.0 109.612 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' O ' ' B' ' 48' ' ' ALA . 15.4 mm100 -141.11 135.98 31.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 t -148.57 124.0 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.424 0.631 . . . . 0.0 110.26 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 39' ' ' ALA . 2.3 t -72.35 155.57 40.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.468 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 135.24 17.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.271 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.487 ' OD1' ' CE2' ' B' ' 15' ' ' TYR . 60.9 m-20 -63.86 128.16 92.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.237 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.25 0.6 9.23 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.423 1.415 . . . . 0.0 110.889 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 71.0 m -70.57 -12.55 61.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.198 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -96.46 129.21 43.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.205 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 31.9 t -48.75 -51.97 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.041 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -56.5 -32.46 65.07 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.001 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.98 -35.89 76.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.819 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -73.95 -37.84 64.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.628 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.4 -36.91 79.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.859 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.7 -36.68 84.66 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.64 -42.83 86.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' OE2' ' B' ' 67' ' ' GLU . 57.4 t80 -62.67 -34.17 76.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.472 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -70.05 -48.35 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.9 -19.62 66.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -71.77 -32.69 67.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.1 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.813 HD23 ' N ' ' B' ' 69' ' ' ASN . 7.5 tt -83.66 -79.51 0.2 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.813 ' N ' HD23 ' B' ' 68' ' ' LEU . 49.3 t30 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.51 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.5 mmt . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 1' ' ' MET . 78.0 Cg_exo -51.76 -173.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.982 1.788 . . . . 0.0 111.982 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.02 172.77 2.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.595 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.9 t -61.1 -38.65 87.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.541 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -172.24 159.1 4.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.532 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -149.58 -177.5 5.9 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.559 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -59.86 137.5 58.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.585 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -76.41 -7.38 54.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 m -76.87 -19.49 57.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -50.08 141.24 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.615 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.8 p -68.96 -5.77 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -101.86 -18.31 15.79 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.563 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -86.75 -48.85 7.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -156.71 177.1 11.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.012 0.434 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.71 141.78 39.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.613 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -61.39 166.67 3.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.884 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.4 9.71 12.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.017 0.437 . . . . 0.0 109.903 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 21' ' ' LYS . 49.9 mt-10 -86.02 91.5 8.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -33.98 -41.73 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.812 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -80.6 25.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.532 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.4 mmtp -138.43 136.52 36.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.847 0.356 . . . . 0.0 110.08 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.578 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 27.9 m170 -130.92 135.33 47.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -80.62 102.8 10.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -66.41 175.56 2.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.268 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 199' ' ' ILE . . . 166.39 126.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 tt -109.91 150.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.876 0.37 . . . . 0.0 110.454 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.419 ' CB ' HD11 ' A' ' 169' ' ' ILE . 7.5 t70 -132.86 141.82 48.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.66 97.47 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.8 0.334 . . . . 0.0 111.246 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mm -91.69 136.43 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.402 HD11 ' SD ' ' A' ' 90' ' ' MET . 2.0 pp -143.15 126.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.33 0.586 . . . . 0.0 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -115.82 126.87 54.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.76 133.21 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.744 0.307 . . . . 0.0 111.383 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -105.79 130.72 53.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -80.42 155.09 27.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.232 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -66.88 179.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -77.85 -31.34 51.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.707 0.289 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.38 -34.01 31.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.218 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 p -40.98 104.96 0.36 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.5 164.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.9 1.733 . . . . 0.0 111.941 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 p -68.21 145.87 53.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -171.64 97.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -103.02 0.09 31.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.653 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.1 87.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.402 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.45 ' CG2' ' HB2' ' A' ' 107' ' ' ALA . 20.8 pt -85.07 150.79 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.501 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 39.2 t 57.18 64.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.644 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.526 HE22 ' C ' ' A' ' 156' ' ' ASP . 37.8 mm-40 -77.29 -26.89 52.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 t 174.29 164.63 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.72 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -144.21 139.04 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.73 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.2 m -136.54 102.71 5.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.811 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -82.3 126.24 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.338 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.431 HD12 ' CE2' ' A' ' 80' ' ' TYR . 7.7 mt -126.07 152.83 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.8 137.94 16.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 54' ' ' SER . 1.4 tm-20 -52.95 -176.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.5 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 31.1 t -55.2 -24.77 28.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 56' ' ' SER . 0.8 OUTLIER 50.38 178.23 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.524 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 36.1 t -91.66 59.08 3.67 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.623 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 59' ' ' ASP . 67.7 m-20 -159.22 141.47 10.04 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.505 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -42.49 89.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.835 1.69 . . . . 0.0 112.736 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.1 p30 -179.57 59.6 0.11 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.807 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.02 74.39 5.58 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.592 2.194 . . . . 0.0 111.6 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -58.99 -48.25 82.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.38 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 63' ' ' GLU . 60.6 t -85.24 -64.27 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 13.5 tt0 88.05 168.18 0.05 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.064 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 1.5 t 165.02 -17.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 67' ' ' ASP . 4.8 tm-20 -156.92 147.0 20.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 110.57 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.455 ' N ' ' CD ' ' A' ' 65' ' ' GLU . 33.1 t70 -58.58 -70.09 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.104 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.499 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 10.7 m-20 -158.74 167.03 30.58 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.56 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.0 p -156.92 158.31 36.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.403 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 84.9 m -140.83 -45.22 0.39 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.629 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 72' ' ' GLU . 84.8 p 50.89 -161.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.456 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -75.21 29.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.735 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 70' ' ' SER . 41.9 mt-10 55.13 76.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.687 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -164.28 21.66 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 m -58.28 114.06 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.066 0.46 . . . . 0.0 110.219 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -66.37 150.57 97.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.952 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.89 155.97 48.24 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.908 1.738 . . . . 0.0 111.485 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -79.89 -143.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.511 2.14 . . . . 0.0 111.388 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.6 t -139.43 144.82 38.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.731 0.3 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 1.6 p -105.35 130.92 53.35 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -123.79 111.63 16.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.74 0.305 . . . . 0.0 110.91 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.2 120.38 40.36 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -91.16 77.82 5.93 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.632 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.32 106.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 tt -98.08 146.96 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.116 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.63 173.37 20.68 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.08 18.37 26.9 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.341 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.15 3.53 88.4 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.095 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.9 mt -129.88 158.07 40.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.913 0.387 . . . . 0.0 110.337 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -126.02 113.09 16.66 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.53 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.402 ' SD ' HD11 ' A' ' 30' ' ' ILE . 16.7 mtt -101.91 111.39 23.63 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.766 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -99.84 124.52 45.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.755 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.17 -167.09 1.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.03 71.91 0.05 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.912 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.476 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 0.2 OUTLIER -77.68 148.29 35.06 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.227 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.576 HG21 ' HE ' ' B' ' 18' ' ' ARG . 41.9 m -136.02 114.28 11.55 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.6 tttt 64.27 40.18 6.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.97 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.6 m -124.59 149.72 62.82 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -37.79 147.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.068 1.845 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -74.85 109.91 8.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 133.51 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.086 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 -13.59 6.77 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.544 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t -105.6 121.81 44.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.922 0.391 . . . . 0.0 110.835 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 mt -135.37 121.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.572 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 10.9 t -137.63 178.22 7.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 111.017 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.501 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 55.3 tt0 -161.68 154.44 20.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.428 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.31 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.45 ' HB2' ' CG2' ' A' ' 44' ' ' ILE . . . -132.68 133.46 43.58 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -148.68 115.15 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.251 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.83 -104.5 1.55 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.209 -0.519 . . . . 0.0 111.941 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -129.35 24.84 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 110.349 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.68 159.22 40.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.38 138.25 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.69 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.537 HD21 HD11 ' A' ' 238' ' ' LEU . 39.8 t30 -116.88 147.06 42.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.537 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' A' ' 113' ' ' ASN . . . -143.19 129.76 20.19 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.873 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -115.26 115.41 26.62 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.121 0.486 . . . . 0.0 111.459 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.794 ' N ' HD12 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -115.88 120.5 39.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -159.09 -178.83 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.206 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.2 p -91.82 159.66 15.69 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.45 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.88 147.16 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.045 0.45 . . . . 0.0 111.528 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 p -87.39 152.1 51.9 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.729 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.32 162.89 18.83 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.943 1.762 . . . . 0.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.79 -1.51 58.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.99 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -81.05 -56.08 4.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.547 0.213 . . . . 0.0 110.55 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.17 -9.02 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.638 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -113.85 175.67 5.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -77.14 152.01 35.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 111.265 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.5 m -154.38 63.2 4.02 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.65 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.54 151.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.061 2.507 . . . . 0.0 113.273 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.08 150.2 41.56 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.113 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.495 HD11 ' OE2' ' A' ' 134' ' ' GLU . 7.7 tp -144.82 164.57 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.554 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 48.6 p -68.91 171.62 7.76 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.239 0.543 . . . . 0.0 111.436 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.578 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 5.0 m170 -68.07 -33.79 75.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.171 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.51 -57.19 12.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.845 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.495 ' OE2' HD11 ' A' ' 130' ' ' ILE . 47.8 mt-10 -62.95 -42.98 99.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.607 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -57.02 11.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.952 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.14 -34.52 66.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.933 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.14 -30.44 65.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.3 mtt -74.33 -61.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.634 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.0 pt -47.24 -21.8 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.663 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -82.54 -30.61 29.61 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.27 -28.09 13.16 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 48.6 t -49.54 119.21 3.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 0.0 111.313 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -137.0 118.03 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.99 125.34 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.8 t -100.79 158.21 16.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.129 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.7 mm -140.76 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.912 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.411 ' OD1' HD13 ' A' ' 184' ' ' ILE . 3.2 m-20 -152.32 88.83 1.39 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 mt -85.93 148.41 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.013 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -148.41 178.41 8.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.481 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.0 t -91.75 125.14 36.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 t -109.54 162.23 14.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 152' ' ' GLU . 27.0 mp0 -139.7 19.12 2.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.62 0.247 . . . . 0.0 110.939 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -75.86 103.28 5.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.273 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.98 8.7 11.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 4.0 mptp? -52.81 173.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.526 ' C ' HE22 ' A' ' 46' ' ' GLN . 28.0 m-20 -81.66 171.42 14.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -95.12 143.62 26.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.462 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 77.8 m-20 -114.78 92.72 4.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.755 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 160' ' ' LYS . 96.6 mt -123.47 163.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.56 ' N ' HG22 ' A' ' 159' ' ' ILE . 21.7 pttm -125.12 138.43 54.17 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.62 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 161' ' ' THR . 54.2 m -65.09 6.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.554 ' ND1' ' N ' ' A' ' 162' ' ' HIS . 0.2 OUTLIER -76.18 117.62 65.44 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.434 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.87 158.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.661 1.574 . . . . 0.0 111.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 164' ' ' VAL . 13.7 p -78.75 128.77 38.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.0 112.15 17.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.69 171.07 40.97 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.526 -0.369 . . . . 0.0 112.509 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ILE . 5.8 t -103.8 8.9 37.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.007 0.432 . . . . 0.0 109.91 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 60.48 -5.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.95 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.2 pp -80.38 164.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.759 -0.377 . . . . 0.0 109.991 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 6.1 t -126.82 130.64 50.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -72.45 37.86 0.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.813 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 170' ' ' SER . 49.4 pttt -66.64 -173.4 0.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.004 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.04 119.83 35.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.0 110.715 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.523 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 0.2 OUTLIER -142.08 -166.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.443 ' H ' HG12 ' A' ' 174' ' ' VAL . 22.4 m -50.89 145.32 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.853 0.359 . . . . 0.0 110.551 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -98.25 131.37 44.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.57 114.66 8.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.901 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.8 OUTLIER -61.77 99.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.52 6.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.451 HD12 ' OD2' ' A' ' 213' ' ' ASP . 82.6 mt -100.6 113.61 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.97 -137.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.994 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.536 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 6.1 t -72.81 158.45 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.5 p -143.59 90.02 2.12 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.411 HD13 ' OD1' ' A' ' 147' ' ' ASP . 4.8 mp -96.91 128.03 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.099 0.476 . . . . 0.0 109.76 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 185' ' ' VAL . 33.7 m -145.38 123.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.157 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 190' ' ' VAL . 48.8 t0 -82.65 109.52 16.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 28.1 m -45.93 -27.06 0.81 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.506 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -34.58 -38.37 0.07 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.199 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 79.7 m -142.15 31.32 1.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 190' ' ' VAL . 28.4 m -155.9 103.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.127 0.489 . . . . 0.0 110.65 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.49 -56.2 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.641 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' A' ' 193' ' ' LEU . 4.2 t30 -115.07 171.46 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 192' ' ' ASN . 0.3 OUTLIER 179.45 105.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.49 . . . . 0.0 109.804 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.62 142.07 36.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.347 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -127.99 142.74 51.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.595 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 5.9 p -143.51 136.68 27.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.1 t -131.42 158.38 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.446 ' CD ' ' O ' ' A' ' 170' ' ' SER . 14.1 ttt85 -166.3 106.6 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.251 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 25' ' ' GLY . 2.3 tp -109.42 124.46 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -167.96 -151.97 7.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.86 118.57 30.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.534 ' H ' ' HG3' ' A' ' 202' ' ' MET . 0.0 OUTLIER -84.61 4.83 30.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.445 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 1.3 m -99.63 -50.73 3.97 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -161.36 127.81 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.708 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -43.64 145.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.1 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.518 ' H ' ' CD ' ' A' ' 210' ' ' GLU . 3.2 t -131.6 5.99 4.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.488 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.491 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.4 t 58.31 -76.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.662 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' SER . 50.5 mt-10 -48.81 -50.19 35.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.774 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.0 mp -80.63 0.84 32.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.243 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 206' ' ' SER . 13.6 mp0 -101.67 124.85 48.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.837 0.351 . . . . 0.0 110.801 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.96 -178.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.523 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 16.8 ptmt -165.54 167.79 17.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.531 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.451 ' OD2' HD12 ' A' ' 180' ' ' ILE . 44.3 t0 -159.59 169.61 23.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 146.69 140.25 3.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.24 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -119.69 -168.94 1.68 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -144.98 110.0 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -103.41 122.07 44.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.103 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 218' ' ' VAL . 28.9 m -135.8 117.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.191 0.52 . . . . 0.0 110.583 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 219' ' ' ASP . 1.1 m-20 51.87 42.33 30.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.486 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.27 -0.71 87.22 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.4 -0.429 . . . . 0.0 113.145 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.0 m -97.49 117.03 30.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.935 0.368 . . . . 0.0 110.158 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.58 159.14 17.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.483 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 65.8 m -168.13 110.43 0.59 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.24 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -78.51 141.75 37.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.62 123.14 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.573 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.07 103.96 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.326 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 61.2 p -129.83 151.76 50.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 0.8 OUTLIER -51.16 95.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -90.69 27.32 1.79 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.2 m -74.0 -32.49 63.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.97 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 233' ' ' ILE . 13.9 m -103.12 -3.91 25.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.204 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.527 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -40.79 -27.84 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 0.0 110.749 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.682 ' H ' HD13 ' A' ' 233' ' ' ILE . 0.0 OUTLIER -144.01 -177.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.585 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 236' ' ' THR . 12.3 m-20 -118.51 91.93 3.69 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.1 m -62.22 1.51 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.291 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 234' ' ' ASP . 44.6 p -90.24 -22.9 21.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.36 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.87 6.66 39.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.607 0.241 . . . . 0.0 111.049 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.537 HD11 HD21 ' A' ' 113' ' ' ASN . 6.9 mp -85.82 138.26 32.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.947 0.403 . . . . 0.0 110.269 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 104' ' ' SER . 46.5 mttm -126.43 142.55 51.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.07 167.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 242' ' ' VAL . 40.7 t -132.39 -11.51 3.18 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.491 HG22 ' OXT' ' A' ' 242' ' ' VAL . 13.4 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.295 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.733 0.301 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.78 118.9 3.88 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.644 2.229 . . . . 0.0 111.868 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' MET . . . . . 0.457 ' O ' ' SD ' ' B' ' 3' ' ' MET . 0.0 OUTLIER -56.65 142.49 39.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.472 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.52 161.12 52.69 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.162 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 7' ' ' PRO . 16.3 t -70.17 169.95 12.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.513 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' B' ' 5' ' ' SER . 34.5 t70 -21.0 84.7 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 21.1 Cg_exo -65.85 -173.6 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.463 2.109 . . . . 0.0 111.751 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 74.5 Cg_exo -54.34 -132.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 123.322 2.681 . . . . 0.0 113.215 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.485 ' O ' ' N ' ' B' ' 11' ' ' CYS . 2.8 t 177.73 45.06 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.503 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.32 93.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.762 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.516 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 94.1 m -137.27 128.07 27.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.099 0.476 . . . . 0.0 111.34 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 t -39.71 135.82 1.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.638 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.516 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 12.4 m-85 -117.17 -25.85 6.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.317 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -151.94 150.77 30.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -107.81 157.59 18.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -78.79 135.8 37.19 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.08 24.82 2.0 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.69 0.281 . . . . 0.0 110.388 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.576 ' HE ' HG21 ' A' ' 95' ' ' THR . 0.0 OUTLIER -145.75 127.88 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 110.74 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -79.0 122.19 25.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.612 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.54 111.0 45.09 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.79 148.45 0.48 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.857 1.705 . . . . 0.0 112.478 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 -47.27 -47.45 25.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.545 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -37.36 -34.73 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 2.4 m-85 -106.78 44.32 1.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.495 0.188 . . . . 0.0 110.926 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -149.22 95.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.78 -25.9 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -168.67 170.82 9.18 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.408 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.2 163.58 21.28 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.95 0.881 . . . . 0.0 112.369 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -154.99 134.87 12.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.514 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' B' ' 31' ' ' THR . 18.4 pt-20 -99.43 148.96 23.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.257 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 30' ' ' GLU . 46.9 p -55.03 -112.39 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 7.0 m -150.28 -141.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.701 0.286 . . . . 0.0 110.597 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 35' ' ' CYS . 26.1 t -143.04 -24.42 0.61 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -58.12 -6.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' B' ' 33' ' ' SER . 22.0 m -114.91 118.58 33.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.549 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -73.12 38.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -165.74 58.99 0.57 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -170.48 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.721 2.281 . . . . 0.0 113.25 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.24 176.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 49.4 t -109.49 129.81 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.59 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.6 128.84 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.064 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.425 ' C ' ' NE2' ' B' ' 43' ' ' GLN . 30.5 p90 -107.93 145.88 33.18 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.211 0.529 . . . . 0.0 111.225 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' B' ' 43' ' ' GLN . 1.7 mp0 -93.34 170.17 9.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.403 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 9.8 p -140.1 -143.22 0.15 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.202 0.525 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.403 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -125.79 -38.57 2.2 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.854 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.65 2.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.88 -0.145 . . . . 0.0 111.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 23.3 t -153.54 -82.24 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.458 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.05 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.418 0.449 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -140.96 147.76 39.29 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.7 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.1 t -151.62 117.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.876 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.536 ' H ' ' CB ' ' A' ' 182' ' ' SER . 22.9 t -52.13 157.99 1.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.19 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.47 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.45 127.91 8.55 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -68.57 123.81 88.58 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.04 0.36 8.48 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.279 1.319 . . . . 0.0 111.271 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -66.57 -13.82 61.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.097 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -100.07 123.46 44.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -50.8 -38.35 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.965 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -56.72 -33.23 66.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.224 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.22 -35.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.111 0.482 . . . . 0.0 110.195 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -73.35 -39.9 64.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.845 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -69.5 -38.66 77.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -63.11 -39.95 96.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.954 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.01 -42.58 79.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.938 0.399 . . . . 0.0 110.117 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -63.74 -21.72 66.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.99 -36.38 36.08 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.96 -19.42 37.19 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.361 -0.536 . . . . 0.0 109.667 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.57 -35.47 77.42 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.01 -70.25 0.42 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.919 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.575 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' O ' ' A' ' 2' ' ' PRO . 40.4 mtt . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.793 0.33 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 1' ' ' MET . 76.0 Cg_exo -49.88 -172.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.474 0.356 0 C-N-CA 122.737 2.291 . . . . 0.0 112.221 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.5 -151.91 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.437 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.5 t -170.03 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.627 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 2.3 mm? -70.3 157.21 38.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -164.95 83.17 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.416 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -144.93 -160.6 1.15 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.4 t -167.39 -11.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.545 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.3 m -75.39 -34.48 61.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.583 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.4 p -50.21 125.71 13.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.519 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -55.66 -20.31 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.769 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.7 m -75.59 -27.6 58.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 t -82.62 -39.73 21.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 p -166.07 172.99 10.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 0.0 110.698 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.75 155.92 39.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 p -71.94 171.92 10.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -121.19 5.44 10.29 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.333 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 20' ' ' ASN . 43.2 mm-40 -80.88 91.88 6.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 2.9 pm0 -32.42 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.982 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' GLU . 23.0 p-10 -95.49 38.65 1.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.565 0.221 . . . . 0.0 111.308 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -154.1 139.31 17.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.533 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -135.54 158.97 43.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.213 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CE1' ' CE ' ' A' ' 202' ' ' MET . 0.9 OUTLIER -96.53 76.88 2.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 24' ' ' MET . 3.8 mpp? -57.04 117.31 3.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.503 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.98 149.72 17.35 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.888 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -111.57 135.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.559 ' N ' HD13 ' A' ' 26' ' ' ILE . 63.2 t0 -140.46 137.82 34.2 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 11.5 t -138.66 142.78 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.046 0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.01 132.61 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.248 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.43 135.31 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.178 0.513 . . . . 0.0 110.831 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -121.12 94.67 4.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.552 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.95 112.52 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.038 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -86.42 127.81 34.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.518 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' NZ ' ' CB ' ' A' ' 34' ' ' LYS . 5.0 mtpm? -80.37 151.76 29.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.73 164.21 25.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.71 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.01 -35.49 80.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.272 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.439 ' N ' ' CD ' ' A' ' 37' ' ' GLN . 4.4 mp0 -75.34 -35.17 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.023 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.6 m -44.14 106.9 0.55 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.245 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 92.6 Cg_exo -43.79 161.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.817 1.678 . . . . 0.0 112.021 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.3 p -70.06 148.7 48.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 5.4 p30 -173.49 102.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -103.1 -4.29 24.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.551 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 11.0 ptpt -64.93 89.39 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.409 0.623 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 45' ' ' CYS . 6.1 mm -96.3 164.1 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.807 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.499 ' N ' HG22 ' A' ' 44' ' ' ILE . 90.1 m 58.82 49.38 10.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.551 ' NE2' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -65.87 -44.36 85.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.861 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.3 t -167.7 176.8 6.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 0.0 111.461 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.88 103.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.717 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.9 p -103.92 96.82 6.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.527 0.204 . . . . 0.0 111.178 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.27 142.27 32.23 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.427 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 79' ' ' THR . 7.2 mt -144.51 151.2 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.938 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 m -151.47 144.98 24.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' CD ' ' CE1' ' B' ' 24' ' ' PHE . 29.5 mt-10 -52.15 179.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -65.72 -34.75 78.92 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.24 90.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.729 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 p 175.14 -96.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.173 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.889 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 28.9 t70 -169.48 -4.65 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.889 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 97.5 Cg_endo -79.4 -98.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 CA-C-N 122.02 1.757 . . . . 0.0 111.906 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' H ' ' HD2' ' A' ' 60' ' ' PRO . 4.2 m-20 -155.13 -59.14 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.433 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 59' ' ' ASP . 23.1 Cg_exo -19.86 112.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 123.711 2.941 . . . . 0.0 114.009 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' CD ' ' N ' ' A' ' 61' ' ' GLU . 30.0 mp0 -100.14 -145.03 0.34 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.531 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.74 HG22 ' N ' ' A' ' 63' ' ' GLU . 1.2 p -165.55 -98.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.74 ' N ' HG22 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -125.01 82.33 2.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.1 t 60.01 -172.04 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -147.3 84.05 1.57 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.954 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -156.3 46.42 0.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.541 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -59.12 -67.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.599 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.8 m 62.87 -149.8 0.35 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.598 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t 33.63 65.87 0.26 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.903 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 71' ' ' VAL . 44.1 t -167.04 167.35 14.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.375 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 72' ' ' GLU . 21.9 m -157.21 -46.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.522 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 71' ' ' VAL . 49.6 tt0 -46.59 -95.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.217 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 165.24 84.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.13 103.96 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.132 0.491 . . . . 0.0 110.581 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -166.14 67.24 1.05 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.544 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -89.02 110.6 0.52 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.199 2.6 . . . . 0.0 111.95 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -87.58 163.36 7.96 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.164 1.909 . . . . 0.0 112.39 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 38.7 p -123.75 126.9 47.32 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.452 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 51' ' ' ILE . 6.9 m -102.87 126.23 49.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -126.46 119.6 27.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -112.54 121.17 44.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.62 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -90.58 78.43 6.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.296 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 83' ' ' ILE . 3.1 tp -71.72 114.41 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.068 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.14 144.63 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.87 166.64 16.83 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.43 21.82 49.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.661 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.64 14.96 79.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.129 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.18 157.24 45.85 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.102 0.477 . . . . 0.0 110.676 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -124.53 105.92 9.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.266 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -101.25 123.23 45.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 111.06 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -106.64 128.41 54.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 25.5 m-85 -100.11 -169.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.257 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.01 67.84 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.422 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.51 145.84 36.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.256 0.528 . . . . 0.0 110.182 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.9 m -132.2 102.6 5.85 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.529 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt 70.85 45.31 0.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.337 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.5 m -124.23 149.64 61.41 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.53 142.72 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.878 1.719 . . . . 0.0 112.228 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -55.06 143.86 25.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 tp -98.01 135.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HZ2' ' H ' ' A' ' 126' ' ' ASP . 87.6 mttt -145.5 -7.66 0.59 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.921 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -111.02 111.1 21.97 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.09 114.08 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.5 t -142.33 161.11 38.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.304 0.573 . . . . 0.0 112.067 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -155.42 173.22 16.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.72 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 t -170.65 165.24 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.039 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.42 136.61 46.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.928 0.394 . . . . 0.0 110.292 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -143.94 110.97 5.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.023 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.15 -91.0 0.36 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -142.86 21.33 1.97 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.5 m -114.69 138.42 50.72 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.787 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.33 120.58 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.841 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' HD11 ' A' ' 233' ' ' ILE . 23.7 m-20 -104.42 164.63 11.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.829 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -168.43 125.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.073 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -113.82 114.36 26.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.424 HD12 ' CE2' ' A' ' 81' ' ' TYR . 2.5 mm? -110.41 118.79 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 t -161.55 173.12 15.24 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.507 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.0 p -89.4 170.5 10.48 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.824 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.84 133.16 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.003 0.43 . . . . 0.0 111.259 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.15 164.06 39.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.87 144.29 43.03 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.162 1.908 . . . . 0.0 111.406 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.03 9.13 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -126.4 -51.82 1.5 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.97 0.47 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.642 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -108.39 -178.54 3.63 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 2.2 m-20 -63.96 -179.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.895 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.0 m -171.29 59.76 0.3 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.416 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.11 146.11 0.4 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.465 2.11 . . . . 0.0 112.654 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.43 127.07 20.31 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 131' ' ' THR . 5.1 mm -132.8 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 110.109 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.502 ' H ' HG22 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -69.17 166.04 19.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.931 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -59.15 -33.96 71.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.556 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.51 -51.96 50.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 138' ' ' MET . 8.5 tp10 -66.52 -47.79 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.755 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.77 8.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.412 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.9 mt -51.3 -42.29 61.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.71 -21.07 59.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.593 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.3 ttt -79.05 -64.19 1.24 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.94 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.953 HD13 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -54.55 -20.9 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.919 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.953 ' N ' HD13 ' A' ' 139' ' ' ILE . 56.0 tttp -74.3 -33.42 63.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.5 ' OD2' ' NE ' ' B' ' 18' ' ' ARG . 12.3 t70 -102.72 -21.33 14.11 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.5 t -51.64 119.83 4.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.65 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -138.65 125.55 21.12 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.24 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 t -120.23 125.89 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -101.75 164.67 11.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.102 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.37 146.92 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.896 0.379 . . . . 0.0 110.139 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 90.29 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.73 HD11 ' CG2' ' A' ' 190' ' ' VAL . 0.5 OUTLIER -89.7 146.33 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 111.758 -178.217 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.472 ' N ' HD12 ' A' ' 148' ' ' ILE . 59.7 mtp85 -130.57 170.44 14.26 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.788 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.6 t -91.5 105.3 17.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.659 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.6 p -85.83 169.32 13.45 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.796 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.51 14.18 1.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.505 ' N ' ' OE2' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -67.54 111.22 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.269 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.71 1.83 28.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -46.29 158.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.891 0.377 . . . . 0.0 111.226 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -75.75 170.65 15.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.587 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.8 m -87.23 135.52 33.28 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.046 0.451 . . . . 0.0 110.781 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -113.32 89.55 3.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.75 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 pt -119.85 171.22 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -159.42 0.68 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.2 t -129.77 -4.32 4.65 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.707 0.289 . . . . 0.0 110.46 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -84.55 124.57 73.18 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -39.36 155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.884 1.723 . . . . 0.0 112.335 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.8 p -74.93 133.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 165' ' ' LEU . 6.4 mp -79.05 134.23 36.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.324 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.31 179.71 27.07 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.668 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 169' ' ' ILE . 17.3 m -113.56 8.36 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.8 t30 62.73 -11.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.374 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 167' ' ' SER . 14.1 pt -93.33 139.89 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.225 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.406 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 40.4 t -100.94 150.52 22.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.264 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -79.05 47.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -71.1 169.57 14.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.757 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -83.8 119.24 24.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 175' ' ' SER . 13.8 p -151.49 163.34 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.089 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.55 ' N ' HG22 ' A' ' 174' ' ' VAL . 53.3 p -14.73 132.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.036 0.835 . . . . 0.0 113.197 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 45.1 p90 -90.6 134.38 34.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.423 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.54 134.57 20.33 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.9 OUTLIER -69.86 101.09 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.52 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.428 ' O ' HG22 ' A' ' 179' ' ' ILE . 41.1 mm -114.09 -14.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.65 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.8 mt -91.23 127.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.816 0.341 . . . . 0.0 111.031 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.66 -134.06 6.6 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 69.9 p -69.25 150.77 47.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.94 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.533 ' OG1' ' CE1' ' B' ' 13' ' ' PHE . 0.8 OUTLIER -142.43 95.06 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.239 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 18.4 mt -99.32 134.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.062 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 185' ' ' VAL . 27.9 m -149.32 114.05 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.11 106.96 3.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.0 m -48.08 -27.48 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -39.4 -37.66 0.48 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.622 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.7 m -137.95 37.45 2.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.732 0.301 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.73 ' CG2' HD11 ' A' ' 148' ' ' ILE . 45.4 t -150.74 103.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -85.39 -61.0 1.87 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.446 ' C ' ' ND2' ' A' ' 192' ' ' ASN . 0.4 OUTLIER -130.04 140.79 50.81 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.714 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.5 tt -139.91 114.73 9.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.888 0.375 . . . . 0.0 110.817 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -94.47 152.67 18.39 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -147.55 131.69 17.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.149 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.2 m -144.26 138.08 27.73 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.434 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 198' ' ' ARG . 2.8 p -138.09 163.91 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 197' ' ' VAL . 55.1 ttt-85 -164.96 111.22 0.96 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.837 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.8 mm -94.1 126.7 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.18 173.25 46.14 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.402 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -72.24 131.85 43.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.691 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 23' ' ' HIS . 28.8 mtm -86.49 4.59 39.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.724 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 85.5 m -97.74 -61.32 1.41 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -152.64 122.83 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.484 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.84 148.52 0.37 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.589 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 4.7 t -133.91 13.41 3.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.793 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.1 m 58.81 -76.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.735 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 35.1 tt0 -49.59 -54.33 18.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.609 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -73.69 4.92 4.44 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.115 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 175' ' ' SER . 9.0 mm-40 -104.14 125.5 50.5 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.759 0.314 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.5 168.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 45.7 tttm -157.18 159.97 38.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.312 0.577 . . . . 0.0 111.224 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 9.7 t70 -153.59 170.35 21.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.034 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.14 166.22 25.85 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.758 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -148.89 169.73 19.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 7.7 mtpm? -131.84 103.42 6.32 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -100.02 116.4 31.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.61 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 218' ' ' VAL . 8.6 p -140.69 118.87 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.256 0.55 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 50.54 43.26 27.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.516 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.32 80.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.09 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -98.29 117.97 33.89 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.673 -0.31 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.85 15.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.0 t -169.97 123.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.528 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -78.39 139.02 38.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.53 108.2 0.27 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.481 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -72.06 104.89 3.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.0 t -132.16 152.98 50.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.139 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 95.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.406 ' OD2' HD23 ' A' ' 232' ' ' LEU . 3.4 m-20 -86.84 34.02 0.66 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.986 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.4 t -73.02 -35.0 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.912 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 233' ' ' ILE . 68.9 p -105.12 -0.36 26.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.978 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -42.01 -24.58 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.085 0.469 . . . . 0.0 110.526 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.558 HD11 ' ND2' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -165.11 137.79 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.0 108.18 7.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.055 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 66.2 m -76.23 6.36 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.61 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -20.37 25.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -103.33 4.98 37.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.595 0.236 . . . . 0.0 111.339 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.66 147.81 29.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.042 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -132.9 142.83 49.12 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.4 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.46 134.82 49.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 242' ' ' VAL . 34.7 m -91.37 1.66 56.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.767 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.648 -0.692 . . . . 0.0 111.482 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.731 0.3 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 118.86 5.74 Favored 'Trans proline' 0 N--CA 1.474 0.331 0 C-N-CA 122.501 2.134 . . . . 0.0 111.575 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.27 159.0 30.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.528 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.67 164.69 25.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.266 -0.493 . . . . 0.0 111.999 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 p -76.54 -84.55 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.332 . . . . 0.0 110.671 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -123.36 82.35 52.68 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.421 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 52.0 Cg_exo -53.02 -168.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.538 2.159 . . . . 0.0 110.82 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.585 ' C ' HG22 ' B' ' 9' ' ' THR . 64.9 Cg_endo -88.17 -111.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.997 1.798 . . . . 0.0 111.67 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.585 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 158.01 72.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.34 71.62 1.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.138 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.467 ' SG ' ' OG1' ' B' ' 9' ' ' THR . 4.4 m -105.85 127.18 52.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -65.73 142.06 58.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.334 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.533 ' CE1' ' OG1' ' A' ' 183' ' ' THR . 11.1 p90 -116.19 -11.54 11.31 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 29.5 m -131.8 144.68 51.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.248 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -114.94 158.67 21.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.04 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -83.22 144.92 29.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.871 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.74 -47.59 11.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.903 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.5 ' NE ' ' OD2' ' A' ' 141' ' ' ASP . 5.3 tpt85 -70.9 126.2 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -83.74 118.95 24.24 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' B' ' 20' ' ' LEU . 6.1 mp -75.48 145.53 79.42 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.693 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.7 152.07 37.15 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.382 2.055 . . . . 0.0 112.558 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' B' ' 24' ' ' PHE . 11.4 ptp180 -45.64 -43.84 12.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.38 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -68.09 24.82 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' B' ' 22' ' ' ARG . 12.2 t80 -150.88 32.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.371 0.605 . . . . 0.0 109.555 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -151.04 92.44 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.149 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.16 -25.28 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -156.42 -179.74 8.46 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.068 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 9.2 p90 -163.35 167.7 21.42 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.981 0.419 . . . . 0.0 111.256 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 57.4 m-85 -158.12 156.15 30.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' B' ' 31' ' ' THR . 69.7 mt-10 -98.53 145.58 26.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.812 0.339 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.425 ' O ' ' O ' ' B' ' 30' ' ' GLU . 63.2 p -52.35 -107.44 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -146.93 -128.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.453 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.477 ' C ' ' H ' ' B' ' 35' ' ' CYS . 18.2 t -158.95 -40.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.693 0.282 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.525 HD22 ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -59.08 -2.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.573 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.477 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.8 m -80.25 -34.48 37.1 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.224 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m 75.05 23.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.402 0.62 . . . . 0.0 110.087 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.523 ' N ' ' CD ' ' B' ' 38' ' ' PRO . 9.2 pt20 -173.56 49.61 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.533 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 29.7 Cg_endo -58.63 -158.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.191 2.594 . . . . 0.0 112.974 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 168.36 176.95 0.03 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.25 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.33 131.31 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.8 t -110.45 133.87 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.658 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' B' ' 42' ' ' PHE . 29.9 p90 -113.16 146.02 39.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.075 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.37 169.74 10.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 5.1 p -138.84 -142.73 0.16 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.187 0.517 . . . . 0.0 110.68 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.472 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.33 -36.33 1.71 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.177 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.97 46.43 2.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.287 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 23.6 m -153.72 -80.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.54 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.688 0.618 . . . . 0.0 109.475 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -161.34 143.71 12.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -148.9 136.19 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 0.0 109.781 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.65 162.22 13.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.631 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 124.79 7.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.318 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -62.33 122.58 74.05 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 1.28 7.07 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.225 1.284 . . . . 0.0 111.161 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -67.82 -18.22 64.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.108 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -95.31 125.88 40.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -51.56 -39.75 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.976 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -56.39 -34.92 67.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.078 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.92 -35.22 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.93 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.03 -35.69 66.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -72.14 -35.89 69.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -65.09 -36.48 84.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.689 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.02 -44.47 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.04 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -62.11 -28.7 69.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -74.65 -40.87 61.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.959 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.12 -21.69 63.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.26 -29.37 62.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.17 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt -79.11 -84.5 0.08 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.374 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.562 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 2' ' ' PRO . 46.0 mtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.765 0.317 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 1' ' ' MET . 51.8 Cg_exo -54.4 -157.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 122.803 2.335 . . . . 0.0 112.257 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.76 -42.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.257 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.1 t 56.94 -157.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.1 mt 58.44 108.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -150.06 51.91 0.91 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.501 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 7' ' ' GLN . 1.5 mp0 -61.39 -166.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.4 m -164.62 -58.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.2 p -75.02 -22.15 58.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.117 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 t -48.22 133.13 15.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -60.07 -29.39 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.438 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 t -76.2 -27.42 56.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.8 t -72.04 -51.1 23.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.8 t -169.66 178.82 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.143 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -61.45 160.8 10.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.676 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 2.9 p -81.58 166.67 20.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.192 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.41 4.37 12.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.436 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 56.5 mt-10 -62.52 -152.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.749 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.16 -72.15 0.7 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.562 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -83.09 59.33 4.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.277 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HD3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -130.38 135.8 48.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.134 0.492 . . . . 0.0 111.242 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.93 123.35 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.438 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.676 ' CE1' ' H ' ' A' ' 16' ' ' THR . 67.5 m80 -75.27 76.18 2.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 tpt -46.54 170.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.358 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 158.19 132.94 1.48 Allowed Glycine 0 CA--C 1.512 -0.149 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 26' ' ' ILE . 16.4 tt -110.68 129.26 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.079 0.466 . . . . 0.0 110.921 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 -105.04 135.61 46.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.83 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.46 128.86 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.8 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.449 HG22 ' HE ' ' A' ' 115' ' ' ARG . 19.9 pt -124.42 162.86 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 tt -164.01 135.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.147 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -123.47 94.64 4.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.615 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.48 115.18 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.479 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -90.06 127.47 36.08 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -82.21 154.71 25.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.643 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -68.85 -170.55 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.8 -31.11 18.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.938 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -79.01 -39.72 33.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.237 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 p -40.7 106.48 0.42 Allowed Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -43.68 170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.963 1.776 . . . . 0.0 112.277 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p -75.49 134.88 40.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.923 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -158.1 95.31 1.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.106 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.77 -7.31 25.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -63.74 92.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 110.407 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -90.55 154.75 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 34.9 t 53.7 65.46 1.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.122 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -79.2 -24.62 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 m 178.09 164.82 0.71 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.417 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.65 132.14 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.404 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 p -134.17 104.4 6.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.177 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -83.29 136.79 34.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.282 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 52' ' ' THR . 8.1 mm -132.7 162.67 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.484 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 51' ' ' ILE . 93.0 m -154.18 151.25 28.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' B' ' 24' ' ' PHE . 91.4 mt-10 -52.71 175.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.6 p -62.91 -21.88 66.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 109.818 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 56' ' ' SER . 65.7 mm-40 -44.95 164.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.748 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 2.0 m 159.76 -23.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.848 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.4 p30 -162.01 152.45 14.44 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.879 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -35.49 -27.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.451 2.101 . . . . 0.0 112.581 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' ASP . 73.6 m-20 -118.14 85.24 23.82 Favored Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.184 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 59' ' ' ASP . 74.1 Cg_exo -50.27 -164.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.776 2.317 . . . . 0.0 112.898 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 64' ' ' SER . 39.5 tt0 -119.93 -115.96 0.32 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.033 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p 41.19 91.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.903 0.859 . . . . 0.0 110.996 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 47.37 57.29 5.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.291 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 61' ' ' GLU . 20.1 m 55.95 -120.71 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.571 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 67' ' ' ASP . 12.1 tt0 -161.14 -137.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.34 -3.93 0.96 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 110.368 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 69' ' ' THR . 3.4 p30 -156.6 154.29 29.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.323 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.6 t 73.18 -14.86 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.546 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 67' ' ' ASP . 10.1 t -70.33 -173.01 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.525 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.412 ' N ' ' OG1' ' A' ' 69' ' ' THR . 86.3 p -167.02 153.71 8.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.564 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.8 p -129.66 -30.77 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.175 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -49.62 -61.55 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.414 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -85.45 -175.56 5.73 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.319 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.2 -130.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.919 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -158.59 71.87 3.77 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.84 112.51 1.51 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.922 2.414 . . . . 0.0 112.335 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -87.19 151.21 8.1 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.441 2.094 . . . . 0.0 111.365 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -122.45 114.87 21.31 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.806 0.336 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 p -96.35 129.96 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.56 141.7 50.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -136.31 134.44 37.95 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.428 1.109 . . . . 0.0 110.845 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' NE ' ' A' ' 89' ' ' ARG . 33.1 t -96.12 73.87 2.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.064 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 pt -71.13 98.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 tp -86.88 146.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.603 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.91 166.79 17.1 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.302 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.71 23.39 44.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.208 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 7.98 74.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -127.99 153.82 46.31 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.439 ' NE ' ' OG ' ' A' ' 82' ' ' SER . 63.3 ttt180 -122.65 113.91 19.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.36 152.08 21.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 110.147 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -149.06 126.95 11.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.413 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -116.81 -169.99 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.947 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.05 81.53 0.16 Allowed Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.293 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.548 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 1.8 m-30 -73.35 115.01 12.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.6 m -124.69 111.79 16.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.686 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.1 tptp 64.84 31.3 11.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.02 150.32 44.88 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -38.64 160.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.956 1.771 . . . . 0.0 112.123 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -81.67 107.07 14.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.533 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.57 144.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.923 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -147.14 -21.92 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 p -98.18 122.02 40.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.361 . . . . 0.0 110.317 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 tp -139.89 133.53 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 239' ' ' LYS . 11.2 t -150.11 165.41 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.248 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -148.86 161.5 41.72 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.085 0.469 . . . . 0.0 110.789 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.14 156.64 22.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.228 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.5 137.95 44.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.219 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -151.06 108.04 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.337 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.35 -103.53 2.17 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.168 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 110' ' ' ASN . 17.5 p-10 -130.67 23.29 5.04 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.668 0.271 . . . . 0.0 110.552 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.1 155.63 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.645 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.7 t -127.31 129.73 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.064 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.609 ' ND2' ' H ' ' A' ' 114' ' ' ALA . 2.9 t-20 -107.54 154.99 20.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.525 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.609 ' H ' ' ND2' ' A' ' 113' ' ' ASN . . . -154.83 121.73 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.56 HH21 ' CD2' ' A' ' 238' ' ' LEU . 19.5 tpp85 -105.07 113.0 26.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.811 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.1 114.21 22.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.9 t -158.85 171.73 19.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.164 0.507 . . . . 0.0 112.029 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -87.83 163.83 16.22 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.1 141.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.141 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 p -83.22 152.6 65.12 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.616 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.52 152.35 33.81 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 121.921 1.747 . . . . 0.0 111.584 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.1 50.22 13.52 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.71 -53.96 0.88 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.59 0.233 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 160.87 -11.35 0.14 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.232 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -129.94 151.12 50.84 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 117.278 0.539 . . . . 0.0 110.114 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.0 146.51 42.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.787 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.0 p -139.76 62.36 22.31 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.957 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.17 129.63 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.227 2.618 . . . . 0.0 113.427 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.48 165.08 13.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.2 pt -145.05 165.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -82.67 154.84 24.67 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.738 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -51.35 -37.07 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.55 -51.82 68.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 110.436 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.05 -43.66 91.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.133 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.49 -56.55 19.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 110.319 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tp -51.65 -35.84 43.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.903 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.09 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.5 mmt -71.3 -62.43 1.4 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.7 pt -46.9 -21.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.462 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -91.02 -28.72 17.8 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.622 0.248 . . . . 0.0 110.894 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.527 ' CG ' ' HE ' ' B' ' 18' ' ' ARG . 15.1 t0 -92.19 -44.12 8.95 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.4 t -43.43 120.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.937 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -141.5 132.93 26.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.699 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.41 132.08 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.033 0.444 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.7 p -103.14 171.02 7.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.362 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.9 mm -139.4 154.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -163.58 88.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.272 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.97 147.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.083 0.468 . . . . 0.0 111.292 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -137.04 171.68 14.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.804 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 m -100.31 116.21 31.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.197 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.1 m -104.85 -176.84 3.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.929 0.395 . . . . 0.0 110.256 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -149.47 0.69 0.5 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.888 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -55.37 99.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.56 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.64 9.72 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.952 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -45.43 156.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.92 170.24 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.1 m -90.46 135.87 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.634 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.472 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 9.8 t70 -115.56 89.13 3.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.768 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -124.29 168.18 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -113.18 155.14 25.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.559 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 161' ' ' THR . 69.0 m -83.43 -3.92 58.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.903 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.546 ' NE2' ' CB ' ' A' ' 240' ' ' ALA . 0.5 OUTLIER -77.49 147.48 75.43 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.972 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.94 160.45 33.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.561 1.507 . . . . 0.0 110.988 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.63 134.92 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 165' ' ' LEU . 6.6 mp -82.51 117.89 22.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.11 171.27 40.42 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.759 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 169' ' ' ILE . 2.0 p -101.12 7.29 43.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 60.97 -3.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.2 tt -98.24 139.2 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.323 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.5 p -98.34 145.62 26.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -75.59 40.88 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.499 ' NZ ' ' CB ' ' A' ' 172' ' ' LYS . 5.6 ttpm? -65.11 171.87 3.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 172' ' ' LYS . 36.7 pttt -87.27 128.24 35.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.307 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.734 HG22 ' H ' ' A' ' 175' ' ' SER . 14.9 p -157.13 177.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.773 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.734 ' H ' HG22 ' A' ' 174' ' ' VAL . 71.4 m -27.54 141.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.506 0.503 . . . . 0.0 112.018 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -100.24 134.09 43.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.07 138.85 33.88 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.006 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.75 86.78 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.772 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 37.8 mt -100.77 -36.89 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.303 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -71.58 124.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.231 0.538 . . . . 0.0 110.601 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.77 -125.41 2.81 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 12.0 m -79.76 153.05 29.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.164 0.507 . . . . 0.0 111.086 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 22.4 p -141.09 95.04 2.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.457 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.8 mp -98.44 117.09 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 185' ' ' VAL . 6.0 m -131.74 117.64 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.287 0.565 . . . . 0.0 111.602 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 190' ' ' VAL . 7.3 m-20 -78.66 111.89 15.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.823 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.6 m -46.34 -32.3 3.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.232 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.439 ' CD ' ' H ' ' A' ' 188' ' ' LYS . 12.0 mptt -34.97 -34.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.201 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 189' ' ' CYS . 32.1 p -152.1 56.93 0.84 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.305 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 190' ' ' VAL . 7.5 p -173.77 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.487 . . . . 0.0 110.009 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.78 -57.39 4.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.631 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 37.9 t-20 -127.16 137.92 53.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 2.2 tt -134.13 128.14 33.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.926 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -113.57 135.81 53.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -137.01 134.59 36.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.019 0.437 . . . . 0.0 111.071 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.6 t -142.79 141.44 31.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.778 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 198' ' ' ARG . 44.4 t -134.69 159.16 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.069 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 197' ' ' VAL . 44.2 ttt180 -174.19 116.59 0.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.903 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.4 tt -119.02 136.08 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -171.65 -150.13 6.97 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.568 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 43.3 t0 -88.49 119.15 28.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -78.38 3.57 15.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.08 -178.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 23.9 t -111.15 -51.3 2.87 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.742 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.479 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 67.6 mttm -146.94 109.93 4.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -44.52 147.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.372 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 3.2 m -148.75 96.14 2.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 206' ' ' SER . 69.1 m -23.45 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.339 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 36.3 mt-10 -58.65 -73.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.845 0.355 . . . . 0.0 111.629 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.3 9.6 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -96.5 126.1 41.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.834 0.349 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.69 178.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.5 164.86 19.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.105 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD2' HD12 ' A' ' 180' ' ' ILE . 16.4 t0 -158.92 168.63 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.178 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 165.34 171.03 31.07 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.8 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 12.7 m-85 -151.9 172.7 15.81 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -136.83 103.75 5.28 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.28 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -101.84 122.33 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.69 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 220' ' ' GLY . 7.3 p -140.48 115.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.298 0.571 . . . . 0.0 111.556 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.39 -8.87 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.768 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 137.99 -2.12 2.92 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 12.3 m -101.3 117.08 34.26 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.638 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.38 150.01 23.46 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.3 m -164.98 127.63 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.519 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -78.04 139.28 39.1 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.83 109.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.655 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.81 97.31 4.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 228' ' ' ASP . 59.3 m -126.75 157.23 39.69 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 227' ' ' THR . 9.6 m-20 -60.04 95.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -90.61 30.66 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -73.25 -30.12 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.285 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.0 t -111.4 1.34 16.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.5 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -44.31 -28.79 0.57 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.99 0.424 . . . . 0.0 110.478 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.42 143.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.179 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 236' ' ' THR . 6.1 p30 -75.75 97.04 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.042 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.0 m -59.29 -4.14 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 238' ' ' LEU . 41.1 p -78.96 -53.5 6.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.9 13.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.56 ' CD2' HH21 ' A' ' 115' ' ' ARG . 8.3 mp -77.05 140.23 40.26 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 110.444 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.46 ' N ' ' OG ' ' A' ' 104' ' ' SER . 18.7 mtpp -131.64 131.59 43.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.616 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.546 ' CB ' ' NE2' ' A' ' 162' ' ' HIS . . . -54.87 155.73 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 46.9 t -123.98 -8.37 7.75 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.638 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 241' ' ' CYS . 2.0 p . . . . . 0 C--O 1.218 -0.564 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.379 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.7 0.286 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.88 115.78 4.47 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.538 2.159 . . . . 0.0 111.738 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 39.8 ttm -53.03 150.4 5.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.587 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.09 179.31 1.17 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.162 -0.542 . . . . 0.0 111.916 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 17.7 t -70.88 -88.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.553 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -152.26 66.64 6.6 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.343 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' B' ' 8' ' ' PRO . 98.5 Cg_endo -80.84 113.97 2.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.66 2.24 . . . . 0.0 111.846 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' B' ' 7' ' ' PRO . 82.8 Cg_exo -46.02 176.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.767 1.645 . . . . 0.0 111.181 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 25.3 p -150.5 -170.59 3.7 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.124 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.0 113.24 16.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.88 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.512 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 18.8 m -129.85 120.92 25.73 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 33.7 t -38.37 129.17 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.658 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 29.0 m-85 -109.63 -32.46 7.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.19 157.79 36.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.032 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.81 161.15 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.9 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -83.52 136.44 34.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.02 7.78 17.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.065 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.527 ' HE ' ' CG ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -134.0 127.48 32.41 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.812 0.339 . . . . 0.0 111.006 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -83.43 127.37 33.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.602 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.407 HD12 ' N ' ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.69 54.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.34 152.76 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.787 1.658 . . . . 0.0 111.942 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.686 HH21 HD21 ' B' ' 69' ' ' ASN . 8.5 tpt180 -45.14 -47.19 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.299 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -37.57 -33.59 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CE2' ' OE1' ' A' ' 53' ' ' GLU . 3.1 m-85 -109.5 43.19 1.34 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.795 0.331 . . . . 0.0 110.585 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -153.12 92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.707 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.28 -24.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -157.69 -179.03 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.168 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -157.78 170.69 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.223 0.535 . . . . 0.0 112.04 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 57.6 t80 -158.39 151.47 22.72 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.444 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 49.4 mt-10 -99.33 148.69 23.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -54.31 -109.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -152.58 -141.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.698 0.285 . . . . 0.0 110.526 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -146.53 -23.29 0.43 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.405 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' B' ' 34' ' ' LEU . 16.7 mt -57.63 -10.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.403 ' C ' ' H ' ' B' ' 37' ' ' GLN . 83.1 m -112.8 122.04 46.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.575 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -72.75 37.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.84 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' B' ' 35' ' ' CYS . 9.1 pt20 -168.51 60.17 0.44 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.6 -164.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.713 2.275 . . . . 0.0 113.059 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 178.9 176.64 0.54 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.499 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.51 131.75 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.938 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.62 132.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.036 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -112.72 151.44 30.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.458 ' OE1' ' NE2' ' B' ' 49' ' ' GLN . 15.1 mm100 -92.66 169.39 10.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -137.11 -145.09 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 110.703 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.99 -39.48 1.39 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.99 46.82 2.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.301 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 9.8 m -155.33 -83.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.375 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.35 -90.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.458 ' NE2' ' OE1' ' B' ' 43' ' ' GLN . 7.6 mt-30 -138.86 148.62 43.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.796 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 t -151.84 113.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.289 0.566 . . . . 0.0 110.446 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.555 ' N ' ' OG ' ' A' ' 182' ' ' SER . 54.0 t -50.53 161.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.439 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -153.58 139.97 18.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.187 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -74.64 115.36 43.12 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.29 -0.64 8.41 Favored 'Trans proline' 0 C--N 1.356 0.933 0 CA-C-N 120.145 1.087 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -74.72 -10.08 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.888 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 37.4 mt-10 -98.97 125.55 44.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.21 0.529 . . . . 0.0 110.317 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.8 m -46.89 -50.58 18.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 63.9 p-90 -55.99 -25.29 43.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.077 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.99 -36.67 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.971 0.415 . . . . 0.0 110.139 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 56' ' ' GLU . 2.5 mp0 -68.3 -44.27 75.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.908 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.14 -35.31 80.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.294 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -63.1 -46.78 85.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 80.3 t -65.16 -47.64 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.725 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.5 -33.85 68.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -73.12 -34.49 66.16 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.982 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.7 -21.65 61.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.424 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -78.56 -77.27 0.17 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.686 HD21 HH21 ' B' ' 22' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.53 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.79 0.329 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.63 -49.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.688 2.259 . . . . 0.0 111.801 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.08 101.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.553 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.6 m -166.03 161.95 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.648 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.0 tp 55.74 45.85 23.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.383 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -87.68 177.73 6.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.524 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.594 ' CD ' ' H ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -84.41 -97.7 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.964 179.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.405 ' H ' ' H ' ' A' ' 9' ' ' SER . 95.5 p -154.28 -12.23 0.13 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.323 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.405 ' H ' ' H ' ' A' ' 8' ' ' SER . 56.0 p -79.68 -27.85 40.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.55 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.9 m -49.91 130.23 21.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -56.61 -25.89 54.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -73.67 -28.42 61.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.355 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -76.15 -55.6 5.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -158.91 162.79 36.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.75 149.62 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.4 p -73.27 171.26 13.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.4 15.93 16.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.215 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -90.21 90.87 8.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -44.43 -23.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.164 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -80.99 18.92 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' C ' ' CG ' ' A' ' 22' ' ' HIS . 9.9 ptmm? -170.11 165.63 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.679 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.4 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 81.6 m-70 -152.94 -178.38 6.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.793 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.453 ' O ' ' SD ' ' A' ' 202' ' ' MET . 21.2 t60 -101.51 93.43 5.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.81 120.98 20.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.669 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -125.37 160.15 19.92 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.55 134.02 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 171' ' ' HIS . 58.6 t0 -124.68 124.29 41.86 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.041 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.463 ' H ' ' HG ' ' A' ' 117' ' ' SER . 11.9 t -137.61 142.07 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.6 pt -146.29 138.46 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.722 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -138.08 134.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -118.38 94.01 4.33 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 190' ' ' VAL . 7.7 p -90.13 135.7 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.483 0.658 . . . . 0.0 112.084 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -113.0 130.67 56.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.697 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -89.34 164.45 14.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.851 0.358 . . . . 0.0 110.741 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -77.81 151.31 34.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.712 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.06 -3.76 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.68 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -91.7 -41.45 10.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.004 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.6 p -48.26 146.08 4.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.832 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.21 162.36 28.57 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.023 1.816 . . . . 0.0 111.306 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.2 p -54.63 146.07 17.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.183 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.573 HD21 ' HA3' ' A' ' 87' ' ' GLY . 20.2 p30 -167.02 90.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 110.836 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.31 -5.77 32.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.05 0.452 . . . . 0.0 110.036 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -61.05 83.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.658 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tp -96.4 159.96 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.775 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.1 m 60.87 40.19 16.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 110.443 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 155' ' ' LYS . 3.7 tp60 -55.44 -55.05 36.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.921 0.391 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.1 t -178.87 150.97 0.51 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -115.31 142.72 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.232 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.5 m -127.7 102.11 6.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.92 129.01 34.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.678 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -138.94 149.54 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -153.37 145.94 24.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' SER . 1.5 mp0 -54.63 -176.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 6.2 t 102.22 -2.97 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 2.6 mp0 65.06 167.98 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.454 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 m -102.19 -38.03 7.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.786 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.31 -51.19 65.73 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.369 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -86.53 55.31 3.36 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.391 2.061 . . . . 0.0 112.067 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.88 106.99 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 62' ' ' VAL . 90.2 Cg_exo -43.68 97.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.025 1.817 . . . . 0.0 112.952 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 33.24 29.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 60' ' ' PRO . 13.8 t -76.4 -78.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.043 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.06 170.87 7.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 66' ' ' ASP . 28.8 t -41.08 163.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.875 0.369 . . . . 0.0 111.34 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -60.84 -0.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.032 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 64' ' ' SER . 27.4 t0 51.99 100.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.414 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 29.0 p-10 -171.86 169.01 5.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.774 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.1 p -145.28 -59.48 0.34 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.461 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.78 HG23 ' H ' ' A' ' 70' ' ' SER . 4.8 t -58.48 -63.32 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.541 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.78 ' H ' HG23 ' A' ' 69' ' ' THR . 17.2 t 54.53 60.59 3.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.796 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 t -73.13 -76.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.447 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -172.14 28.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.697 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -110.07 -169.67 1.51 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.893 0.378 . . . . 0.0 110.961 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.7 m 37.42 73.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.157 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -48.28 150.48 2.21 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -35.72 156.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.628 2.218 . . . . 0.0 112.582 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.93 166.01 30.84 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.708 2.272 . . . . 0.0 112.211 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 p -123.63 137.53 54.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.56 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -93.1 126.72 38.34 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -122.59 101.6 7.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 0.0 111.275 -178.179 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 9.9 m -143.45 68.38 1.29 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.409 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 83' ' ' ILE . 4.0 tp -73.65 107.09 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.225 0.536 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.2 mt -89.14 148.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.56 169.86 20.39 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.264 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.82 23.58 51.16 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' A' ' 41' ' ' ASN . . . 72.41 8.73 71.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.925 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -130.07 156.75 44.01 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.911 0.386 . . . . 0.0 110.403 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.7 ttm105 -115.95 117.84 31.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.472 ' SD ' HD12 ' A' ' 148' ' ' ILE . 68.4 mmm -102.22 108.35 19.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -100.98 120.44 40.19 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.122 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -100.9 -169.7 1.74 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.853 0.359 . . . . 0.0 110.89 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -178.92 70.65 0.07 OUTLIER Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.031 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -76.68 137.38 39.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.711 0.291 . . . . 0.0 110.776 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.9 m -138.83 118.46 13.04 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 60.09 32.34 20.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.133 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -119.81 149.72 49.09 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -38.61 145.55 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.851 . . . . 0.0 111.986 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -71.12 137.06 48.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 0.0 110.889 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.89 145.65 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -143.04 -9.56 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.636 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -124.08 123.25 39.92 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.16 106.99 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -140.16 145.83 38.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -142.35 -173.23 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 t -170.03 164.6 9.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.1 114.69 16.06 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -128.81 110.97 12.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.174 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.79 -127.48 22.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.857 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -100.98 21.42 13.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.66 0.267 . . . . 0.0 110.544 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -129.66 159.02 37.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 t -131.47 136.3 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.911 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -91.99 174.47 7.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -164.79 121.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.504 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.437 ' C ' HD22 ' A' ' 116' ' ' LEU . 8.4 tpt180 -121.97 102.43 8.16 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.437 HD22 ' C ' ' A' ' 115' ' ' ARG . 2.6 mm? -115.58 111.86 21.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.463 ' HG ' ' H ' ' A' ' 28' ' ' VAL . 12.1 m -166.34 168.01 15.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.168 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -90.2 176.09 6.89 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 120' ' ' SER . 7.9 p -116.9 155.13 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.094 0.473 . . . . 0.0 111.565 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 119' ' ' VAL . 8.4 t -91.22 146.31 33.26 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.748 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' HA ' HE22 ' A' ' 123' ' ' GLN . 33.9 Cg_exo -34.81 155.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 122.669 2.246 . . . . 0.0 112.778 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.586 ' N ' HE22 ' A' ' 123' ' ' GLN . . . 72.29 70.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.586 HE22 ' N ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -154.75 -40.67 0.09 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.662 0.268 . . . . 0.0 110.876 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.417 ' H ' ' CD ' ' A' ' 123' ' ' GLN . . . 124.89 7.16 6.17 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 123' ' ' GLN . 31.4 mmtp -125.33 170.34 11.43 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 23.0 p-10 -73.61 156.12 38.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.83 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 p -155.7 66.18 4.5 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.894 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -48.24 134.31 25.0 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 122.893 2.395 . . . . 0.0 113.256 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.97 156.73 18.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.317 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.6 pt -150.46 166.54 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.178 0.513 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.5 p -72.69 164.66 26.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.347 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -60.74 -34.32 74.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.259 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 4.3 mp0 -56.62 -57.17 13.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.142 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.467 ' O ' ' SD ' ' A' ' 138' ' ' MET . 39.6 mt-10 -57.3 -46.14 83.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.26 -55.4 18.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.05 -36.12 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.63 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.37 -30.23 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -76.35 -61.89 1.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.0 pp -47.21 -21.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.186 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -83.79 -55.05 4.47 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.565 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -76.67 -37.8 55.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.9 t -39.31 120.42 1.04 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.59 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.34 124.85 16.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.0 t -117.99 126.97 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.101 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.0 t -102.63 166.24 10.62 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.2 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.64 144.5 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.99 0.424 . . . . 0.0 110.719 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.546 ' OD2' ' NE2' ' B' ' 49' ' ' GLN . 34.1 t0 -154.38 88.67 1.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.848 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.472 HD12 ' SD ' ' A' ' 90' ' ' MET . 15.9 tt -77.47 151.27 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -145.25 -177.44 5.55 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.884 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.5 m -91.3 135.08 34.06 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.829 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.9 p -127.87 130.56 48.76 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -117.38 40.21 3.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.44 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.465 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -81.5 100.9 9.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.159 0.504 . . . . 0.0 110.704 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -72.13 -2.59 19.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.525 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.487 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.8 mmtm -51.53 161.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.855 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -77.09 177.51 7.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.8 p -96.59 142.02 29.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.55 92.04 3.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.55 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.84 177.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -132.92 134.52 44.65 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.3 p -70.18 4.17 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.399 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -83.2 121.6 77.08 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -39.89 161.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.785 1.657 . . . . 0.0 112.076 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.47 134.26 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 165' ' ' LEU . 8.1 mp -84.38 121.29 27.33 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.49 168.3 25.23 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.482 -0.327 . . . . 0.0 112.675 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.5 p -95.83 6.92 47.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.76 0.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.029 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 167' ' ' SER . 10.2 tp -100.84 138.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.494 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 97.0 p -99.09 142.31 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.567 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 27' ' ' ASP . 22.2 m80 -75.79 43.12 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.268 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -66.56 -174.52 0.3 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.4 ' HE3' ' H ' ' A' ' 228' ' ' ASP . 77.4 mttt -88.24 123.73 33.15 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.465 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.93 -175.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.779 0.323 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 66.4 m -44.98 144.34 1.24 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.119 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 48.4 p90 -96.29 126.9 41.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.817 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -141.49 130.99 23.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.42 97.13 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.071 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.2 mm -107.65 -38.32 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.88 124.01 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.55 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.53 -130.67 2.09 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.512 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 24.8 t -75.29 155.87 36.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.663 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.417 ' C ' HD12 ' A' ' 184' ' ' ILE . 26.4 m -142.94 93.8 2.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.8 mp -98.75 116.18 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 185' ' ' VAL . 3.0 m -124.59 132.59 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.012 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.76 94.69 6.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 189' ' ' CYS . 17.8 p -47.38 -26.68 1.37 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.878 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -43.49 -16.23 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.509 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 187' ' ' THR . 13.0 m -148.43 12.59 0.93 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 190' ' ' VAL . 0.4 OUTLIER -153.63 91.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.678 0.751 . . . . 0.0 110.563 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.95 -53.88 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.391 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -131.99 148.44 52.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.601 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 tt -148.13 110.56 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.044 0.449 . . . . 0.0 111.425 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -93.41 135.76 34.34 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -130.02 135.69 48.56 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.968 0.413 . . . . 0.0 111.106 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.2 t -144.31 141.06 29.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.488 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 198' ' ' ARG . 4.1 p -137.73 163.48 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.564 ' N ' HG22 ' A' ' 197' ' ' VAL . 60.4 ttt180 -171.7 115.94 0.38 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.361 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 tt -114.95 126.05 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -168.54 -149.24 6.07 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.228 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.51 140.31 33.4 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.913 0.387 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -103.98 -2.58 25.86 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.914 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 70.7 m -107.33 -56.54 2.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.679 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -146.42 126.4 13.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.483 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.72 144.96 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 208' ' ' GLU . 20.7 m -127.06 9.09 6.77 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.25 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.4 m 58.29 -76.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.716 0.293 . . . . 0.0 111.476 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' SER . 71.6 mm-40 -49.35 -50.19 40.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.64 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.1 mt -75.1 -1.36 22.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.368 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.22 130.05 44.49 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.865 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.8 m -142.68 -179.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.473 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 48.6 tttm -171.04 161.94 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.369 0.604 . . . . 0.0 111.611 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 15.4 t70 -158.95 169.52 24.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.711 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.64 138.35 2.43 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.935 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -118.39 168.65 10.44 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -132.63 103.06 5.94 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -97.63 113.38 25.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.109 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 218' ' ' VAL . 11.8 p -139.61 116.16 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.3 0.572 . . . . 0.0 110.726 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 219' ' ' ASP . 1.2 m-20 52.82 28.28 6.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.861 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.4 66.15 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.994 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.5 t -98.61 116.22 30.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.31 158.66 15.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.8 m -168.28 117.69 0.75 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.992 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -85.05 96.64 9.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.089 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -129.33 133.93 7.74 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.56 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.34 97.69 10.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 228' ' ' ASP . 86.0 m -123.96 156.21 36.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.291 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 227' ' ' THR . 5.6 p-10 -57.68 95.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.2 30.0 0.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.4 m -70.38 -49.28 50.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.2 t -90.01 2.21 55.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 tp -39.2 -33.14 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.875 0.369 . . . . 0.0 111.15 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.54 144.43 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.894 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.413 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 1.5 p30 -74.97 102.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.044 0.45 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 92.6 p -68.94 -4.14 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.478 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 69.9 p -83.21 -15.68 49.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -102.01 11.41 38.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.585 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.58 153.89 34.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -142.33 121.16 12.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.14 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 123.24 16.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.728 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 15.0 m -88.15 4.72 44.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 242' ' ' VAL . 11.1 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.375 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.822 0.344 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.51 116.82 3.9 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.749 2.299 . . . . 0.0 111.859 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -65.01 148.49 51.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.38 169.79 2.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.07 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.0 m -78.32 -76.49 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.786 0.327 . . . . 0.0 110.695 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -119.71 84.18 30.33 Favored Pre-proline 0 N--CA 1.472 0.631 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.719 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.459 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 23.4 Cg_exo -61.36 -174.29 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.463 2.109 . . . . 0.0 112.727 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 34.7 Cg_exo -58.03 -138.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.288 2.658 . . . . 0.0 113.876 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.497 ' O ' ' N ' ' B' ' 11' ' ' CYS . 2.9 t -178.53 31.07 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.897 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.36 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.779 0.323 . . . . 0.0 110.959 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.51 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 63.5 m -138.39 128.35 25.44 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.026 0.441 . . . . 0.0 110.528 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 80.1 m -45.37 141.37 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.808 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.51 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 24.9 m-85 -114.1 -26.24 8.17 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.785 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.6 m -155.42 157.22 36.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.88 162.56 15.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.377 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -85.28 139.52 31.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.651 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.46 -26.19 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.338 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.75 125.9 41.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 0.0 111.522 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -77.95 122.68 25.84 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -87.14 112.71 49.64 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.725 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.45 148.4 1.3 Allowed 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 121.909 1.74 . . . . 0.0 112.289 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -44.99 -41.83 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.353 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.56 -32.39 0.55 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 7.0 m-85 -108.53 41.67 1.53 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.66 0.267 . . . . 0.0 110.473 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -151.4 92.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.68 -25.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 35.1 t70 -155.11 -179.19 7.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.743 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.478 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 9.1 p90 -161.86 173.93 13.85 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.338 0.589 . . . . 0.0 111.848 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.493 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 45.2 t80 -156.64 179.75 8.97 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.265 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.493 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 13.1 pt-20 -128.76 152.23 48.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.267 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.474 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 35.7 p -57.2 -113.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -151.66 -142.56 0.12 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.514 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.421 ' C ' ' H ' ' B' ' 35' ' ' CYS . 13.2 t -143.32 -16.78 0.65 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.91 -3.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.018 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.421 ' H ' ' C ' ' B' ' 33' ' ' SER . 2.9 p -123.3 122.9 39.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -74.49 44.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -173.31 57.85 0.22 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 91.5 Cg_endo -72.61 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.964 2.443 . . . . 0.0 113.137 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 174.62 176.96 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.029 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.93 133.98 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.187 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 140.86 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.768 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -115.09 150.87 35.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -93.1 170.26 9.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.0 p -137.95 -145.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.18 0.514 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.469 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.94 -38.32 2.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.37 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.17 46.07 2.43 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.065 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.613 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 32.3 t -154.05 -83.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.61 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 159.21 -87.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.546 ' NE2' ' OD2' ' A' ' 147' ' ' ASP . 23.5 pt20 -144.65 148.19 33.98 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.835 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 38.5 t -150.79 121.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.394 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.512 ' H ' ' CB ' ' A' ' 182' ' ' SER . 99.6 m -57.75 161.59 3.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.86 132.37 12.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.83 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -68.74 116.11 37.54 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.74 0.38 7.12 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 120.935 1.09 . . . . 0.0 111.112 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 13.0 m -71.59 -6.06 38.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.962 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -105.77 128.04 53.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -48.38 -49.25 35.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -56.12 -30.43 62.1 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.736 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.04 -36.92 70.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.996 0.427 . . . . 0.0 110.092 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.1 -36.63 66.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.72 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.24 -35.53 78.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.338 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.54 -37.94 89.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.91 -45.76 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -59.64 -38.44 81.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.0 110.771 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -64.94 -24.88 67.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.785 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -71.63 -30.89 66.26 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.258 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.26 -81.78 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.272 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.54 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.748 0.309 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.07 111.15 2.88 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.79 2.327 . . . . 0.0 111.824 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.42 147.31 51.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.513 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 t -71.13 117.39 12.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.562 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.502 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 2.3 mm? -70.67 165.37 23.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.165 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -148.51 158.62 44.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.34 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -61.56 -139.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.471 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.5 m -158.26 -44.11 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.458 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.1 p -74.81 -14.93 60.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -50.88 126.14 15.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.6 p -59.28 -10.61 3.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.378 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 79.1 p -92.51 -25.36 18.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.559 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p -81.08 -45.58 16.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 m -167.8 173.06 8.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.38 146.57 50.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.943 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.401 ' H ' ' HE2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -74.29 173.22 10.52 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -114.0 21.28 15.0 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.432 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -87.71 86.49 7.19 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 18' ' ' GLU . 49.3 mt-10 -17.71 -61.06 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -77.55 52.12 0.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE2' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -153.8 149.15 27.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.408 ' N ' ' HD1' ' A' ' 22' ' ' HIS . 10.1 p-80 -168.1 120.9 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.242 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.493 ' CD2' ' HB3' ' A' ' 127' ' ' SER . 12.7 t60 -67.79 78.73 0.2 Allowed 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.758 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -54.28 138.19 39.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.041 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 199' ' ' ILE . . . -142.56 162.68 27.31 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 pt -109.15 169.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.077 0.439 . . . . 0.0 110.959 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -154.12 105.62 2.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.295 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 t -99.08 128.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.751 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.587 HD11 ' NE2' ' A' ' 171' ' ' HIS . 2.6 mm -123.59 123.11 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.52 133.64 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.32 92.8 3.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.22 135.44 25.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.117 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 m -103.75 124.72 49.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.638 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' CG ' ' OG1' ' A' ' 38' ' ' THR . 18.9 ttpp -76.14 151.62 36.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.805 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.461 ' C ' ' H ' ' A' ' 37' ' ' GLN . 49.7 tt0 -74.24 148.28 41.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.168 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -74.12 36.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.85 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 35' ' ' GLN . 14.7 tt0 -136.56 -46.98 0.61 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.377 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 34' ' ' LYS . 1.4 p -53.25 151.66 9.32 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.22 157.47 59.4 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.21 1.94 . . . . 0.0 111.875 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -65.06 141.67 58.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -158.82 97.41 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.468 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 13.5 t70 -91.56 -18.6 23.84 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -51.43 87.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 9.9 tp -96.19 150.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.376 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 17.1 t 58.81 67.05 0.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.87 -42.39 33.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.7 p -173.65 163.42 4.28 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.777 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.39 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -123.4 115.15 21.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -82.78 135.59 34.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.728 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.59 150.21 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -152.75 121.86 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.18 114.24 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.92 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t 69.87 -48.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.396 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' O ' ' OG ' ' A' ' 56' ' ' SER . 34.4 tt0 -48.55 -85.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 55' ' ' GLU . 54.0 p 51.9 -91.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.197 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -163.89 -61.95 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.628 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -55.58 -93.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.809 1.673 . . . . 0.0 111.861 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -163.3 151.95 11.99 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -36.33 152.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.37 2.047 . . . . 0.0 112.498 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -168.46 56.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.497 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 63' ' ' GLU . 2.0 m -136.48 -106.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.818 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 62' ' ' VAL . 58.7 mm-40 -89.18 10.5 21.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 110.333 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 65' ' ' GLU . 96.9 p -50.99 179.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.651 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 64' ' ' SER . 6.8 pt-20 38.79 98.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.058 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -175.83 -22.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.13 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -81.3 -127.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.54 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.4 m -169.09 -104.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.453 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -80.56 -2.02 44.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.988 0.423 . . . . 0.0 110.19 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -108.67 109.04 20.13 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.298 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.11 7.52 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.736 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 43.94 80.34 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.743 0.306 . . . . 0.0 111.29 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -51.55 -16.38 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.532 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 74' ' ' VAL . 14.6 p -132.14 124.6 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.15 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 38.5 t0 -173.06 50.45 0.11 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.576 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 75' ' ' ASP . 19.0 Cg_endo -55.95 106.99 0.22 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.287 2.658 . . . . 0.0 112.194 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.67 -159.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.758 1.639 . . . . 0.0 112.358 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -140.37 138.24 34.67 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.345 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.504 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 10.8 p -101.35 138.22 38.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.643 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 10.4 m-85 -119.03 160.84 21.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.327 0.584 . . . . 0.0 110.976 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -142.43 118.93 10.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.444 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 t -97.66 65.55 1.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.364 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -71.43 109.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.705 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -97.2 148.1 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.978 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.48 23.08 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.94 26.94 43.04 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.001 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.28 72.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.435 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -132.75 158.71 41.7 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.889 0.376 . . . . 0.0 110.453 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.67 109.07 13.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.802 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 mtt -103.41 107.11 17.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -90.37 107.18 18.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 56.4 t80 -92.42 163.23 13.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.763 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.09 143.16 8.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.504 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 4.6 p90 -147.28 157.86 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.948 0.404 . . . . 0.0 110.328 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 95' ' ' THR . 9.2 t -142.16 127.46 18.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.96 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' SD ' ' A' ' 138' ' ' MET . 30.1 mtpt 56.89 33.11 22.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.473 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.5 141.3 40.5 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -32.71 135.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.777 2.318 . . . . 0.0 113.195 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.578 ' CD ' ' H ' ' A' ' 99' ' ' GLN . 1.2 pm0 -70.06 147.73 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.563 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -91.77 137.31 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.957 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -124.68 3.74 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.123 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 t -137.7 135.04 36.07 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.128 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.95 98.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.302 0.572 . . . . 0.0 109.681 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.3 p -113.35 158.75 20.2 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.932 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -151.06 169.37 21.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 p -166.51 163.07 17.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.61 134.23 42.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -151.89 113.85 4.45 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.3 -122.41 8.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.812 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.71 22.91 15.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.664 0.269 . . . . 0.0 110.633 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -133.52 159.24 41.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.62 136.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -104.25 167.43 9.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.15 0.5 . . . . 0.0 111.299 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.017 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -116.55 122.9 46.01 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.503 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.89 117.13 28.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.9 p -161.41 152.09 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.127 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.5 t -71.03 170.25 13.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.13 147.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 111.256 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 m -69.79 150.84 96.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.149 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.406 ' CD ' ' SD ' ' A' ' 202' ' ' MET . 35.5 Cg_endo -62.57 142.61 90.59 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.743 1.629 . . . . 0.0 111.252 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.67 53.64 2.38 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -143.67 -33.65 0.42 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.968 -0.137 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.18 20.38 0.51 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.142 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.813 ' HZ1' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -144.78 177.69 8.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.91 0.355 . . . . 0.0 110.72 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -90.36 135.79 33.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.217 0.532 . . . . 0.0 112.189 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.813 ' CB ' ' HZ1' ' A' ' 125' ' ' LYS . 1.1 m -133.58 67.24 75.27 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.548 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -42.09 129.88 4.44 Favored 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.066 2.511 . . . . 0.0 113.404 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.82 26.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.559 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 131' ' ' THR . 14.3 mm -141.5 153.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -84.44 166.99 16.85 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 111.003 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -60.23 -35.68 76.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.201 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.55 -52.39 46.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.475 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -65.59 -41.94 92.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.968 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.06 -56.85 16.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.539 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.3 tp -49.72 -32.78 14.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.087 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.2 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.975 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 96' ' ' LYS . 23.7 mmt -64.8 -49.47 70.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -46.92 -22.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 111.071 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -87.52 -47.94 8.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.89 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -34.27 55.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -40.27 110.27 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.007 0.432 . . . . 0.0 111.493 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 42.9 tp10 -141.16 114.14 8.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.997 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 144' ' ' VAL . 12.1 m -108.01 130.8 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.538 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -108.6 164.18 12.58 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.904 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.4 tp -154.76 149.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.945 0.402 . . . . 0.0 110.533 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -148.9 95.02 2.34 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.015 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.7 mm -80.5 136.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.64 175.71 9.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.8 t -91.96 130.16 37.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.9 p -120.26 148.36 43.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -131.3 34.66 3.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.499 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.72 101.4 10.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -71.96 -3.98 25.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.685 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -48.71 149.44 1.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.839 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.27 176.46 1.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.924 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.2 m -98.51 142.06 30.58 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.467 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 26.8 t70 -119.03 92.61 3.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.665 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -121.48 161.59 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -108.31 139.26 43.28 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.133 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.6 p -73.53 4.51 4.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -80.5 127.27 76.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.316 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -39.06 162.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.921 1.747 . . . . 0.0 112.297 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.37 133.51 29.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.961 0.41 . . . . 0.0 110.521 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.86 123.69 33.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.99 173.16 16.39 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.593 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 169' ' ' ILE . 16.1 t -99.95 3.87 44.61 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 50.2 t30 67.07 -10.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.4 mt -73.43 143.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.166 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 172' ' ' LYS . 95.5 p -102.44 141.54 35.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.587 ' NE2' HD11 ' A' ' 29' ' ' ILE . 7.8 m80 -77.22 33.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.079 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 170' ' ' SER . 76.9 tttt -62.05 172.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -88.13 132.76 34.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.713 0.292 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.58 -162.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.319 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 m -47.59 149.89 1.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.678 0.275 . . . . 0.0 110.569 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 53.5 p90 -107.48 135.4 49.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.952 0.406 . . . . 0.0 111.379 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.494 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 4.0 tm-20 -146.03 141.67 27.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.014 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.494 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 6.3 p-10 -76.68 96.86 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.618 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.4 tt -112.72 -29.84 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.192 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.401 HD12 ' OD1' ' A' ' 213' ' ' ASP . 13.6 mt -76.01 111.36 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.85 -117.68 0.47 Allowed Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.703 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.511 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 12.4 t -77.7 141.89 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.1 m -139.22 85.83 2.09 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 184' ' ' ILE . 9.9 tp -104.17 120.03 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 110.131 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 185' ' ' VAL . 10.0 m -136.69 131.66 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.883 0.373 . . . . 0.0 111.379 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.34 108.3 18.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.955 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 187' ' ' THR . 2.7 p -48.55 -27.88 3.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.346 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.05 -26.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.002 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 68.3 m -142.49 27.99 1.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.796 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -165.18 99.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.498 0.666 . . . . 0.0 109.855 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -72.29 -55.91 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.41 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -133.19 142.65 48.71 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.282 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.12 138.08 31.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 111.029 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 4.1 mp0 -105.19 156.81 17.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 133.57 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 0.0 110.869 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.05 18.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.3 t -136.6 112.77 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.448 HH12 ' H ' ' A' ' 211' ' ' VAL . 12.9 ttt85 -108.43 163.27 13.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.424 HG23 HG13 ' A' ' 211' ' ' VAL . 0.9 OUTLIER -160.96 109.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -162.52 -150.85 6.14 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.754 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 201' ' ' ASP . 1.1 m-20 -89.37 140.63 29.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.535 ' SD ' ' SG ' ' A' ' 203' ' ' CYS . 0.0 OUTLIER -97.64 1.52 48.79 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.3 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.535 ' SG ' ' SD ' ' A' ' 202' ' ' MET . 24.1 m -115.37 -58.11 2.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -134.39 108.91 8.43 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.145 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 9.4 mp0 -58.39 121.9 11.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 209' ' ' LEU . 25.3 m -116.43 110.26 18.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.572 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 63.1 p -33.55 -46.86 0.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.617 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.88 -40.93 94.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.57 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.614 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.3 mm? -88.05 0.59 55.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.542 ' C ' HG12 ' A' ' 211' ' ' VAL . 50.2 mt-10 -86.64 137.44 32.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.21 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.542 HG12 ' C ' ' A' ' 210' ' ' GLU . 0.2 OUTLIER -170.09 152.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -161.68 153.75 19.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.313 0.578 . . . . 0.0 111.89 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 16.9 t70 -134.37 172.75 12.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.489 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 164.11 144.53 4.07 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.207 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -131.17 -178.26 4.76 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -149.67 105.82 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.201 0.524 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' B' ' 13' ' ' PHE . 5.3 t80 -96.44 128.38 43.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.573 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 220' ' ' GLY . 18.4 m -139.27 107.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.95 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 8.7 t70 64.58 -12.68 0.11 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.39 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 144.06 -0.36 1.14 Allowed Glycine 0 N--CA 1.461 0.366 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.687 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.4 m -105.2 121.39 43.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.37 160.24 14.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.7 t -173.83 120.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.438 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -74.42 135.93 42.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.24 103.66 0.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.413 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.91 95.75 2.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 51.4 m -123.42 150.81 43.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -55.33 95.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -88.75 36.18 0.8 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.6 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 231' ' ' SER . 5.7 t -75.36 -41.7 55.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.792 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 230' ' ' THR . 92.1 p -96.05 1.47 52.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.844 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.5 tp -42.26 -34.44 0.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.912 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.0 mt -148.37 145.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.013 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -75.18 94.6 2.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.988 0.423 . . . . 0.0 109.936 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -13.76 2.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.826 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.46 -7.81 58.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -103.9 9.12 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.563 0.221 . . . . 0.0 110.964 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 238' ' ' LEU . 7.3 mp -84.86 142.14 29.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -129.11 132.8 47.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.007 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.67 141.23 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 48.5 t -108.08 -4.47 17.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.628 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 242' ' ' VAL . 10.4 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.129 -1.415 . . . . 0.0 111.503 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.764 0.316 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.63 109.94 3.0 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.553 2.168 . . . . 0.0 111.641 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' MET . . . . . 0.404 ' O ' ' O ' ' B' ' 4' ' ' GLY . 15.5 ptt? -48.24 174.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.855 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' B' ' 3' ' ' MET . . . -60.17 -143.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' B' ' 6' ' ' ASP . 36.0 p -169.14 25.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.122 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.565 ' H ' ' CD ' ' B' ' 7' ' ' PRO . 1.9 m-20 161.38 50.24 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.565 ' CD ' ' H ' ' B' ' 6' ' ' ASP . 12.3 Cg_endo -53.11 166.25 1.05 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 122.536 2.157 . . . . 0.0 112.035 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.43 -123.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.603 2.202 . . . . 0.0 110.833 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.451 ' O ' ' N ' ' B' ' 11' ' ' CYS . 2.1 t 175.53 47.33 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.321 0.509 . . . . 0.0 110.774 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.44 95.35 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.272 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 71.1 m -140.64 143.45 35.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.757 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -69.08 148.0 50.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.667 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 3.3 m-85 -122.71 -19.01 6.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.499 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 149.5 35.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.142 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -114.23 149.08 36.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -71.78 133.05 45.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.385 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.556 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -78.17 -42.79 30.54 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.877 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 12.4 mmm-85 -81.79 127.91 33.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.081 0.467 . . . . 0.0 111.493 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -68.18 152.97 44.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.624 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 19.6 mt -108.5 94.62 14.16 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.13 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -40.65 152.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.758 1.639 . . . . 0.0 112.343 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' B' ' 22' ' ' ARG . 8.1 tpt85 -45.49 -51.26 11.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.935 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -40.51 -39.22 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -105.77 46.05 0.94 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -155.67 92.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.33 -19.25 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.2 t70 -157.99 -179.55 8.23 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.492 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.484 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.4 p90 -165.48 163.37 19.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 111.287 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -148.06 179.83 7.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.437 ' N ' ' CD2' ' B' ' 29' ' ' TYR . 49.9 mt-10 -123.7 149.06 45.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.041 0.448 . . . . 0.0 111.168 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 41.3 p -55.58 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.997 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -148.29 -156.15 0.69 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.675 0.274 . . . . 0.0 110.536 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 47.4 t -129.82 -25.69 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.508 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 28.7 mt -58.24 -11.28 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.031 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.47 ' C ' ' H ' ' B' ' 37' ' ' GLN . 26.9 m -106.72 121.03 43.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.959 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -73.54 34.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.0 pt20 -168.67 63.08 0.54 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 73.3 Cg_endo -71.63 -161.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.629 2.22 . . . . 0.0 113.16 -178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.35 176.94 0.11 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 82.9 t -108.95 133.6 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.539 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 m -106.29 139.32 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.67 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -115.32 148.18 39.55 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.03 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 44' ' ' THR . 5.3 tt0 -100.18 168.05 10.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 1.7 p -143.84 -142.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.227 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.529 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -119.55 -39.93 2.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.063 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.73 46.65 2.36 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 81.1 p -147.42 -84.58 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.581 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.01 -84.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -139.66 145.22 38.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.718 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.8 117.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.511 ' H ' ' CB ' ' A' ' 182' ' ' SER . 0.1 OUTLIER -73.48 148.82 42.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.377 0.608 . . . . 0.0 112.025 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.75 134.25 28.24 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.53 126.25 89.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.79 -0.73 9.8 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.332 1.354 . . . . 0.0 111.258 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 51.9 m -69.76 -17.39 63.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.99 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.0 125.74 35.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.093 0.473 . . . . 0.0 110.176 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -48.6 -49.04 38.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -56.26 -26.43 51.59 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.677 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -72.91 -35.67 49.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.002 0.429 . . . . 0.0 110.112 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -70.42 -35.51 73.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.693 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -72.14 -35.25 69.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -64.73 -35.37 80.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.12 -45.63 61.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.81 -30.5 71.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.26 -39.35 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.718 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.91 -23.31 59.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.304 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -34.14 65.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -75.04 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.402 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.628 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtm . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.748 0.309 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.09 164.22 31.71 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.52 2.147 . . . . 0.0 111.674 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.72 -17.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.552 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 t 52.44 43.92 30.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.576 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.5 mt 55.75 80.26 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.657 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -79.72 64.91 4.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.526 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 53.69 -142.27 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.612 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t -161.42 -13.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.41 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.5 -21.98 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.602 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 p -49.95 127.89 17.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.531 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' CD2' ' A' ' 23' ' ' HIS . 6.3 t -54.28 -23.96 17.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -76.17 -31.54 58.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 m -74.44 -47.46 33.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.977 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.3 p -167.21 165.79 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.764 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.1 146.72 54.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.432 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 174.69 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 110.834 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -116.99 17.28 14.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.53 97.07 6.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.261 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.604 ' CD ' ' H ' ' A' ' 19' ' ' GLU . 6.8 mp0 -32.99 -60.22 0.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.07 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -80.1 52.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.324 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CG ' ' A' ' 22' ' ' HIS . 13.1 tttp -164.24 139.33 5.86 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.107 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.45 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 92.3 m-70 -155.7 122.61 5.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -57.76 115.53 2.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.752 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -88.94 124.42 34.22 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.056 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.22 141.02 12.21 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.78 150.83 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.797 0.332 . . . . 0.0 110.253 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 21.2 t0 -139.46 142.82 37.37 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.484 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 27.6 t -137.62 107.52 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.844 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.598 ' CG1' ' HE ' ' A' ' 115' ' ' ARG . 4.1 mp -102.07 128.06 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 30' ' ' ILE . 8.5 tt -135.85 130.46 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.429 0.633 . . . . 0.0 111.75 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -116.34 125.11 51.65 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.44 131.53 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.088 0.47 . . . . 0.0 111.406 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.2 m -105.81 132.55 51.79 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 110' ' ' ASN . 11.8 pttm -86.58 163.45 17.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.318 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 37' ' ' GLN . 6.7 tt0 -75.81 137.48 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.675 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -50.52 -10.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 35' ' ' GLN . 2.3 mp0 -87.83 -41.73 13.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.963 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -46.36 148.29 1.67 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.796 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.57 167.26 25.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.06 1.84 . . . . 0.0 111.519 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.0 p -69.79 135.55 49.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.304 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -158.32 98.21 1.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.404 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 7.0 m-20 -97.55 -13.61 21.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.164 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.1 mmtm -54.93 85.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.963 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.1 tp -89.46 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.281 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 21.2 t 57.93 64.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.234 0.54 . . . . 0.0 110.402 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.4 ' NE2' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -72.86 -33.5 66.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 t -173.09 -172.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.579 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 48' ' ' VAL . 3.5 p -167.7 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.38 0.61 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 m -82.54 155.24 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.723 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -152.22 124.34 8.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 110.682 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.8 168.97 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.26 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' GLU . 10.1 t -153.36 154.29 34.22 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 2.6 pm0 -38.74 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.667 0.27 . . . . 0.0 110.675 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 56' ' ' SER . 29.7 t -76.02 -14.07 60.22 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.58 39.0 0.12 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.031 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 54' ' ' SER . 27.7 t -64.02 -91.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.223 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.67 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 10.5 m-20 -118.09 -33.13 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.67 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 95.5 Cg_endo -85.82 -96.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.74 1.627 . . . . 0.0 112.038 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -150.7 150.75 29.03 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.395 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.43 179.23 4.76 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.947 1.764 . . . . 0.0 111.638 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -175.72 31.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.551 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 m -73.34 18.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 61' ' ' GLU . 45.8 tt0 -155.51 -55.52 0.09 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.778 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -168.58 -103.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.682 0.277 . . . . 0.0 110.661 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.74 137.08 24.92 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.874 0.368 . . . . 0.0 110.474 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -168.5 166.84 11.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.582 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.79 159.83 33.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.31 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 t -164.21 73.59 0.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.894 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.5 m -50.38 -44.5 54.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.373 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.9 p 61.98 105.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.855 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -163.51 -34.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.395 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -74.55 -51.2 15.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.208 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.23 81.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.218 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 t -73.51 -64.24 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.678 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 2.5 p30 -175.6 31.81 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.949 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.678 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 71.9 Cg_endo -69.24 -14.45 37.75 Favored 'Trans proline' 0 CA--C 1.558 1.677 0 N-CA-C 117.632 2.128 . . . . 0.0 117.632 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -93.51 116.74 0.3 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 CA-C-N 123.086 2.138 . . . . 0.0 114.13 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.1 p -118.66 117.44 28.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.056 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -86.54 129.84 34.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' B' ' 47' ' ' SER . 49.2 t80 -113.52 143.3 44.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.695 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.42 ' OH ' HD11 ' A' ' 100' ' ' ILE . 70.0 m-85 -138.01 118.61 13.95 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.743 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 t -101.02 67.0 1.17 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.909 0.385 . . . . 0.0 110.61 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.23 111.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.727 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -98.84 145.89 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.45 161.44 11.77 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.68 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.88 26.85 48.96 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.323 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.41 ' O ' HD22 ' A' ' 88' ' ' LEU . . . 73.51 3.03 61.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.923 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.41 HD22 ' O ' ' A' ' 87' ' ' GLY . 2.8 mm? -115.94 149.4 38.81 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.04 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.622 ' CZ ' HD21 ' A' ' 91' ' ' ASN . 44.7 ttt-85 -111.91 115.05 28.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.9 mpt? -101.07 145.48 28.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.175 0.512 . . . . 0.0 110.847 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.622 HD21 ' CZ ' ' A' ' 89' ' ' ARG . 72.0 m-80 -138.4 129.76 27.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.051 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -112.05 -167.04 1.13 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.788 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.11 67.5 0.07 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.028 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.24 132.53 39.95 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -135.89 115.58 12.92 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? 70.22 30.91 3.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.865 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.92 149.16 50.33 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.6 148.04 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.898 1.732 . . . . 0.0 111.97 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.16 138.69 54.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.384 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.636 ' C ' HD12 ' A' ' 100' ' ' ILE . 2.1 pp -92.74 159.43 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' A' ' 102' ' ' SER . 6.5 tmtm? -156.8 -22.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.303 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.403 ' H ' ' H ' ' A' ' 101' ' ' LYS . 53.1 p -101.1 121.73 42.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 130.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.9 p -152.52 160.62 43.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -148.19 170.54 17.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -165.29 161.89 19.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.61 124.91 30.93 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.63 107.72 6.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.138 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.78 -127.73 19.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.543 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 31.3 m-80 -97.98 19.52 13.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.581 0.229 . . . . 0.0 110.867 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.3 p -127.21 155.5 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.887 0.375 . . . . 0.0 110.754 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.27 133.19 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.437 ' CG ' ' N ' ' A' ' 114' ' ' ALA . 10.1 t30 -99.05 165.18 11.86 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.752 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 113' ' ' ASN . . . -164.41 118.72 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.498 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.598 ' HE ' ' CG1' ' A' ' 29' ' ' ILE . 12.2 mmt85 -112.13 130.58 55.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.809 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tt -137.97 116.23 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.7 p -160.31 170.46 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 111.603 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.4 p -84.61 163.73 19.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.906 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.3 149.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.795 0.331 . . . . 0.0 110.808 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 121' ' ' PRO . 37.3 p -98.14 149.78 36.07 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 120' ' ' SER . 72.7 Cg_exo -40.08 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.54 2.16 . . . . 0.0 113.046 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.65 3.06 61.98 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' CD ' ' H ' ' A' ' 125' ' ' LYS . 2.3 pt20 -81.84 -115.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 0.0 110.421 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 123' ' ' GLN . . . -161.16 20.84 0.21 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.555 ' H ' ' CD ' ' A' ' 123' ' ' GLN . 7.2 tptm -144.83 -179.26 6.48 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.99 152.0 26.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.372 0.606 . . . . 0.0 112.04 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.2 p -146.9 70.0 12.12 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.386 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.74 134.02 2.41 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.228 2.619 . . . . 0.0 114.135 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.462 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . . . -89.3 161.49 16.35 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -153.56 154.72 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.262 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.565 HG22 ' N ' ' A' ' 132' ' ' HIS . 62.2 m -82.54 162.31 22.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.427 0.632 . . . . 0.0 111.695 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.565 ' N ' HG22 ' A' ' 131' ' ' THR . 38.3 t60 -50.88 -40.67 57.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.168 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.07 -57.42 11.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.143 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.7 OUTLIER -56.48 -44.38 80.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.038 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.51 -56.58 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 109.896 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.402 HD11 ' CD2' ' A' ' 132' ' ' HIS . 23.1 mt -53.81 -35.08 61.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.781 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.11 -28.6 61.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.423 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 mmt -74.78 -61.82 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.036 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.964 HD13 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -53.61 -20.41 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.189 -178.099 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.964 ' N ' HD13 ' A' ' 139' ' ' ILE . 34.9 ttpt -77.64 -55.16 5.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.634 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.1 -31.76 56.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.6 t -43.89 118.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.996 0.426 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 144' ' ' VAL . 1.6 tm-20 -141.23 126.44 18.51 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.46 ' N ' ' OE2' ' A' ' 143' ' ' GLU . 7.2 p -122.07 128.5 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.83 0.348 . . . . 0.0 110.59 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.2 p -101.39 167.67 10.02 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.55 146.74 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -166.99 94.95 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.452 ' H ' HG12 ' A' ' 185' ' ' VAL . 1.9 pt -92.68 127.31 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.29 0.567 . . . . 0.0 112.273 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -103.0 -179.33 3.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.946 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 8.0 m -93.35 129.29 39.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.451 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 p -103.45 -179.07 3.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.788 0.328 . . . . 0.0 110.29 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -155.49 -2.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 153' ' ' GLU . 6.1 mp0 -62.1 100.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.793 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.04 11.91 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -56.51 149.75 16.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.576 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.2 m-20 -55.74 172.8 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.3 t -98.8 145.65 26.74 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.637 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p-10 -119.99 93.43 4.06 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.693 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.754 HD13 ' H ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -119.03 176.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -130.08 135.28 48.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 161' ' ' THR . 24.7 m -70.16 2.81 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -80.74 117.98 70.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -40.35 155.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.698 1.598 . . . . 0.0 112.05 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -81.64 138.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.935 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.507 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 2.3 mm? -83.84 114.69 21.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.05 171.56 46.61 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.492 -0.385 . . . . 0.0 112.197 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ILE . 9.3 t -101.95 7.32 41.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.8 t30 64.15 -8.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.1 pp -80.35 161.27 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.218 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.502 ' H ' ' NH1' ' A' ' 198' ' ' ARG . 13.0 t -123.57 137.46 54.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.491 ' CE1' HD11 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -74.19 38.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.106 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.417 ' NZ ' ' CB ' ' A' ' 170' ' ' SER . 58.8 mttp -67.62 -170.79 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.217 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -102.76 127.5 49.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.998 0.428 . . . . 0.0 110.509 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.486 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 12.1 m -151.64 -168.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.896 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -43.97 144.08 0.98 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.344 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -111.78 141.97 44.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -162.29 151.6 15.69 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.534 177.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.98 104.5 2.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.161 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.3 mt -107.09 -42.76 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 195' ' ' PHE . 9.0 tt -72.59 138.08 22.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.087 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -101.13 -118.52 4.34 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.9 t -72.84 143.91 47.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.1 m -137.78 84.17 2.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.93 103.95 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 148' ' ' ILE . 25.1 m -124.16 143.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.551 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.37 110.3 21.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.499 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 189' ' ' CYS . 7.0 m -50.75 -28.47 9.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.484 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -36.4 -28.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.077 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 187' ' ' THR . 30.2 p -149.34 24.23 0.91 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 24.9 t -143.25 81.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -69.19 -57.47 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.266 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 14.0 t-20 -111.7 162.08 15.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.403 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.613 ' C ' HD23 ' A' ' 193' ' ' LEU . 6.9 tt -169.22 106.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 110.419 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.89 130.87 46.96 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.481 ' CD1' HD12 ' A' ' 180' ' ' ILE . 5.2 t80 -125.24 133.44 52.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.809 0.338 . . . . 0.0 110.514 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.8 p -143.92 139.0 28.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.951 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 198' ' ' ARG . 18.7 t -135.03 160.34 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.502 ' NH1' ' H ' ' A' ' 170' ' ' SER . 57.0 ttt180 -170.67 111.54 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.124 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.3 tt -110.45 128.52 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.669 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.96 -155.24 8.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.878 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -91.39 119.98 31.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.464 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -82.01 2.37 31.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 92.2 m -100.77 -55.85 2.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 109.861 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.498 ' NZ ' ' CB ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -150.58 122.25 8.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.677 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -42.94 141.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.147 0.499 . . . . 0.0 111.754 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 208' ' ' GLU . 12.7 t -140.83 89.3 2.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.272 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.1 m -37.11 -27.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.25 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 206' ' ' SER . 85.0 mt-10 -73.06 -52.33 14.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.01 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.502 HD21 ' CE1' ' A' ' 132' ' ' HIS . 39.3 mt -91.5 7.81 39.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.305 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -97.21 119.03 34.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.2 m -145.29 168.21 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.486 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -154.22 167.71 28.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 112.557 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -151.12 163.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.295 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 171.29 160.21 19.28 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.156 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -148.02 172.64 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -139.6 104.74 5.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -103.31 122.96 45.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.703 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 218' ' ' VAL . 5.7 m -143.59 120.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.252 0.548 . . . . 0.0 110.918 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.5 37.99 10.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.101 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.12 -4.86 83.14 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.726 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -100.08 116.18 31.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.23 0.515 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.28 154.6 19.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.356 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 42.2 t -169.7 127.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.329 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -77.53 140.55 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -169.25 111.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.452 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.24 100.91 8.56 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 69.7 p -131.63 166.26 21.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.631 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.14 96.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.781 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.92 18.2 4.34 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.589 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -62.7 -38.18 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 84.0 p -98.01 -2.28 40.72 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.297 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -41.68 -36.34 0.95 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.992 0.425 . . . . 0.0 110.541 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 8.6 mt -148.26 142.81 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 236' ' ' THR . 0.9 OUTLIER -75.99 101.5 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.213 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.45 ' CB ' HH12 ' A' ' 115' ' ' ARG . 84.9 p -65.58 4.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 234' ' ' ASP . 46.9 p -91.19 -18.38 24.54 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.456 ' NZ ' ' CB ' ' A' ' 237' ' ' LYS . 9.1 mtmp? -104.64 8.44 35.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 238' ' ' LEU . 0.3 OUTLIER -78.94 161.8 26.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -145.21 134.6 23.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.69 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.39 134.04 55.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.151 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 41.0 t -100.92 -7.03 23.81 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.275 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.414 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 117.641 -1.171 . . . . 0.0 111.751 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.755 0.312 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.34 112.79 0.89 Allowed 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 122.697 2.265 . . . . 0.0 112.138 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 158.49 5.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.49 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.7 171.24 30.66 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.874 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 58.3 m -73.63 -84.3 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 110.632 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -131.88 78.44 69.93 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.613 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.411 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 38.1 Cg_exo -57.19 -175.06 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.517 2.145 . . . . 0.0 112.31 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.42 ' HB3' ' H ' ' A' ' 187' ' ' THR . 58.1 Cg_exo -54.19 -132.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 123.23 2.62 . . . . 0.0 113.925 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t 175.81 50.83 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.391 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.83 97.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.534 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 98.0 m -142.53 142.24 32.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.22 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 14' ' ' SER . 2.7 t -73.43 147.07 44.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 110.685 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.534 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -114.68 -20.86 10.49 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 12' ' ' CYS . 7.9 m -146.23 148.82 32.89 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.049 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.493 ' CD2' ' OD2' ' B' ' 53' ' ' ASP . 9.5 m-85 -107.92 164.5 12.21 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -86.94 138.15 31.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.784 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.39 23.51 3.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.925 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.25 125.46 18.71 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.721 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -80.53 119.19 22.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.755 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 2.6 mm? -80.57 113.56 40.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.343 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -46.66 149.34 3.04 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.38 1.387 . . . . 0.0 111.786 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -43.87 -47.3 8.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.315 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -38.3 -32.25 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.0 44.33 1.23 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.775 0.322 . . . . 0.0 110.735 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -149.8 86.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.796 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -89.11 -28.23 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -153.26 -179.41 7.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.998 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -164.11 164.1 22.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.527 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.509 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 57.1 t80 -148.12 -179.98 7.32 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.509 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 44.3 mt-10 -123.0 149.62 44.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 110.789 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.409 ' O ' ' O ' ' B' ' 30' ' ' GLU . 40.8 p -55.67 -111.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.815 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.9 t -152.01 -153.84 0.5 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.781 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.417 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.4 m -132.98 -25.51 1.81 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.399 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -59.36 -7.08 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.438 ' C ' ' H ' ' B' ' 37' ' ' GLN . 25.2 m -112.54 120.92 43.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 m -74.08 36.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.305 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.4 pt20 -169.91 61.68 0.41 Allowed Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 86.6 Cg_endo -73.14 -162.06 0.12 Allowed 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.793 2.329 . . . . 0.0 113.319 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.96 176.93 0.13 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.972 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -107.77 135.79 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.136 0.493 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.01 137.83 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.605 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.07 146.08 42.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.369 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -92.79 169.97 10.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.2 p -138.59 -143.34 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 110.742 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -128.69 -38.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.278 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.27 41.66 3.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.76 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 11.6 t -147.06 -84.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.568 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.08 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.321 0.388 . . . . 0.0 110.044 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -144.0 145.94 32.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.344 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 24.1 t -153.2 125.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' B' ' 14' ' ' SER . 13.8 p -77.55 148.84 35.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.169 0.509 . . . . 0.0 111.395 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.89 142.37 42.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.493 ' OD2' ' CD2' ' B' ' 15' ' ' TYR . 9.2 m-20 -64.15 122.78 79.64 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.07 0.46 8.37 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.062 1.175 . . . . 0.0 110.863 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 44.5 t -77.27 -5.25 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.702 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 57' ' ' SER . 1.1 tp10 -105.4 125.18 50.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.526 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 19.2 m -44.83 -43.86 9.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -56.4 -34.36 66.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.401 HG21 ' O ' ' B' ' 53' ' ' ASP . 40.2 t -69.94 -38.87 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.334 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.04 -52.49 59.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.796 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.85 -35.64 75.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.06 -35.91 81.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.19 -45.55 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.832 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -63.13 -32.31 73.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -71.48 -41.82 68.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.29 -19.45 63.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.265 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -34.08 67.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.98 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.51 -77.62 0.15 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.813 0.339 . . . . 0.0 110.361 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 53.0 p30 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.537 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.815 0.34 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -43.27 -53.97 3.83 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.699 2.266 . . . . 0.0 112.152 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.93 127.03 22.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.8 m -164.16 83.57 0.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.565 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 pp -168.13 133.1 1.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.42 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -166.29 -33.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.532 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -168.0 143.5 3.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.487 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m -105.14 -21.37 13.27 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.819 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.6 m -65.37 -27.87 68.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.985 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.2 m -49.5 132.2 20.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -56.93 -25.36 57.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.581 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m -74.74 -29.45 61.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.609 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -74.35 -56.36 4.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.273 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -159.25 173.17 16.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 110.791 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.4 m -62.9 161.3 13.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.828 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 p -74.32 163.58 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.86 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 30.1 mp0 -112.15 7.47 19.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.529 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -67.32 -149.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.211 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -135.38 -68.87 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.461 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 41.8 t30 -79.02 52.07 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.424 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' O ' ' ND1' ' A' ' 22' ' ' HIS . 10.5 tptm -148.86 137.5 21.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.819 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 21' ' ' LYS . 22.9 m-70 -143.24 158.05 43.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 76.76 2.05 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.415 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.523 ' CE ' ' HB1' ' A' ' 135' ' ' ALA . 46.6 tpp -65.71 128.33 35.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 0.0 111.441 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -135.67 149.04 19.89 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.79 148.21 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' CB ' HD11 ' A' ' 169' ' ' ILE . 15.7 t0 -135.15 139.12 44.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.15 101.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.984 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.0 131.9 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.39 140.1 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.506 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.97 0.414 . . . . 0.0 110.056 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.48 135.06 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.746 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -102.15 120.1 39.89 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.636 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -74.58 152.87 39.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.853 0.358 . . . . 0.0 110.858 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 37' ' ' GLN . 33.7 mm-40 -70.63 158.82 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.284 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.33 28.62 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.737 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 35' ' ' GLN . 22.8 tt0 -141.05 -19.44 0.8 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -67.72 115.68 29.98 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.168 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -40.0 157.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.0 p -73.42 136.13 44.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -156.58 101.77 2.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.169 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.65 7.56 46.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.668 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -67.47 88.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 44' ' ' ILE . 20.1 pt -85.12 141.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.02 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 22.1 t 55.43 67.82 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 10.2 tm0? -78.73 -25.99 44.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 t 177.48 159.34 0.42 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.589 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.25 125.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -119.76 123.34 43.5 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.643 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 19.1 mp0 -102.69 129.43 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 52' ' ' THR . 7.3 mm -134.71 159.61 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 51' ' ' ILE . 22.2 m -152.63 108.41 3.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.621 ' CG ' ' H ' ' A' ' 78' ' ' THR . 4.3 pt-20 -52.3 120.97 6.09 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 22.6 t 112.14 -1.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 56' ' ' SER . 72.6 tt0 -28.97 -52.8 0.11 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 112.741 -2.027 . . . . 0.0 112.067 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 55' ' ' GLU . 5.5 m 29.48 -123.65 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.511 0.507 . . . . 0.0 112.138 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -171.65 -54.47 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 57' ' ' ASP . 41.2 Cg_endo -85.75 -104.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.254 1.969 . . . . 0.0 111.64 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.05 132.42 95.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.16 125.45 6.48 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.842 1.695 . . . . 0.0 113.048 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.439 ' N ' ' OG ' ' A' ' 54' ' ' SER . 21.9 mt-10 70.74 52.96 0.29 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.12 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 64' ' ' SER . 2.1 t -148.78 15.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.838 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' SER . 6.3 tp10 -41.14 84.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.213 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 62' ' ' VAL . 48.2 m 48.64 108.16 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.84 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 64' ' ' SER . 19.7 tt0 90.54 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -75.88 54.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 59.75 171.66 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.304 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 t -148.2 133.14 18.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.517 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m 75.08 -47.79 0.62 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.723 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -44.0 155.55 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 111.107 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -108.93 39.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.224 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 53.19 84.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.124 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -137.25 19.32 2.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.374 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.05 145.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.977 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 1.1 m-20 -178.64 -62.42 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.43 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -27.82 94.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.358 2.706 . . . . 0.0 113.588 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.24 176.32 8.21 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.392 2.061 . . . . 0.0 111.185 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.621 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 16.1 p -130.3 139.59 50.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.858 0.361 . . . . 0.0 110.869 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 m -98.83 132.15 44.4 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -113.72 143.24 44.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 110.429 -178.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 86.3 m-85 -129.57 124.87 34.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.652 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.2 p -103.91 62.66 0.76 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.662 0.267 . . . . 0.0 110.859 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.476 ' O ' HG23 ' A' ' 83' ' ' ILE . 13.1 tt -71.22 102.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 110.12 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -102.14 148.05 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.956 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.51 144.52 5.18 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.31 9.22 57.05 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.28 2.52 57.88 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.758 -0.258 . . . . 0.0 113.098 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.501 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -151.16 173.95 13.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.307 0.554 . . . . 0.0 111.367 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -129.09 117.18 20.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.738 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.5 mtt -101.99 122.0 43.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.297 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -109.93 122.57 47.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.493 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.8 178.03 4.68 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.617 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.01 74.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.037 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -76.9 143.26 39.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.045 0.423 . . . . 0.0 110.441 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -127.75 105.53 8.52 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.474 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.8 tttt 67.08 40.14 2.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.759 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.8 m -119.02 148.86 45.67 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.28 129.95 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.882 1.721 . . . . 0.0 111.937 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.568 ' CD ' ' H ' ' A' ' 99' ' ' GLN . 24.7 mp0 -50.39 144.99 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.9 mt -96.39 142.56 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.78 -11.54 1.15 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.016 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -113.17 116.48 29.88 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 pt -128.58 120.02 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.0 p -135.82 172.22 13.32 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.928 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 64.0 tt0 -161.57 152.83 18.53 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 t -155.47 152.23 28.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.033 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.23 121.83 28.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -133.41 108.61 8.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.006 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.68 -119.06 6.35 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -112.58 26.35 10.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.806 0.336 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 p -130.34 157.36 42.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.511 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.64 136.68 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.601 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.509 ' N ' HD22 ' A' ' 113' ' ' ASN . 0.1 OUTLIER -124.48 158.22 33.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.967 0.413 . . . . 0.0 110.728 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.49 135.82 13.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.461 HH21 HG21 ' A' ' 164' ' ' VAL . 53.9 ttp180 -114.0 123.66 50.26 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.02 118.83 34.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 t -167.05 161.22 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.902 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.9 t -82.69 174.59 10.86 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.06 144.43 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.013 0.435 . . . . 0.0 110.982 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 p -79.73 151.02 73.58 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.047 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.77 163.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.921 1.747 . . . . 0.0 112.185 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.55 61.78 7.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.209 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -139.31 -52.27 0.54 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.07 -12.78 0.37 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.696 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -126.92 172.46 10.42 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -74.56 150.7 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.644 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.0 m -143.41 63.05 12.09 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.292 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.52 131.54 2.52 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.116 2.544 . . . . 0.0 113.339 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.8 152.46 23.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.38 176.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.699 0.285 . . . . 0.0 110.735 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.2 p -81.19 172.33 13.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.183 0.516 . . . . 0.0 111.692 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.461 ' CG ' ' OD1' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -61.26 -37.35 82.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -63.65 -57.07 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.523 ' HB1' ' CE ' ' A' ' 24' ' ' MET . . . -65.44 -57.24 8.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.039 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -53.54 -31.57 47.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.219 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.48 73.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.68 -52.34 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.54 -22.84 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.453 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -87.28 -54.51 4.27 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -79.89 -36.02 37.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 t -44.26 116.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.721 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 49.9 mt-10 -145.02 156.61 44.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.12 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.9 136.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.965 0.412 . . . . 0.0 110.374 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.0 p -102.37 163.91 11.97 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.71 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.56 137.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.88 0.372 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -143.95 92.89 2.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.7 mm -79.23 139.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.648 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.452 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 58.3 ttt180 -134.17 165.36 25.27 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 7.1 t -90.67 118.09 29.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.318 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 152' ' ' GLU . 31.2 t -100.3 -176.05 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.706 0.289 . . . . 0.0 110.262 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.431 ' N ' ' OG ' ' A' ' 151' ' ' SER . 16.0 tp10 -162.45 17.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.043 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.12 103.38 7.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.485 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.16 8.7 3.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -56.01 138.38 49.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.112 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.09 174.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.975 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 t -94.66 143.9 26.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.498 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.464 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 m-20 -117.6 91.44 3.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.955 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.5 pt -124.51 170.3 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.689 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.492 ' CD ' ' HB3' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -104.95 -160.88 0.78 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.034 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.7 t -130.53 -3.48 4.26 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -83.45 130.6 55.65 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -39.29 158.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.876 1.717 . . . . 0.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.461 HG21 HH21 ' A' ' 115' ' ' ARG . 14.6 p -80.25 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.257 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 18.0 mt -82.07 125.04 30.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.591 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.89 163.96 17.29 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.562 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 t -94.72 5.61 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.801 0.334 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.2 m-20 60.31 9.5 1.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.988 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.516 HD11 ' CB ' ' A' ' 27' ' ' ASP . 2.2 pp -98.01 154.65 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 172' ' ' LYS . 80.1 p -117.49 129.17 55.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.21 35.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 170' ' ' SER . 19.3 tttp -59.21 -164.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -99.31 119.9 38.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 175' ' ' SER . 2.7 t -148.02 171.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.554 ' H ' HG12 ' A' ' 174' ' ' VAL . 6.3 p -31.48 149.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.495 0.497 . . . . 0.0 111.529 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -106.58 141.69 37.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.191 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 3.8 tm-20 -150.85 137.42 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.619 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.433 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.1 t70 -65.92 96.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.1 mt -107.26 -52.99 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.388 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 180' ' ' ILE . 5.5 tp -63.45 124.95 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.61 -117.38 2.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.574 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 41.5 m -74.18 139.25 44.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.793 -0.203 . . . . 0.0 111.16 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.7 p -138.3 91.58 2.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.21 0.529 . . . . 0.0 110.77 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.1 mm -99.13 115.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.051 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.27 138.48 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.155 0.502 . . . . 0.0 111.497 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.84 92.81 7.61 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 189' ' ' CYS . 1.3 p -47.27 -44.15 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.061 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -37.55 -27.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.038 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 187' ' ' THR . 81.6 m -146.17 31.43 1.02 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.4 t -149.75 100.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.711 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -77.02 -60.64 2.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.843 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -117.91 177.94 4.59 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.567 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 195' ' ' PHE . 1.1 tt -174.07 108.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.474 ' OE1' HD21 ' A' ' 232' ' ' LEU . 48.3 mt-10 -93.44 137.65 32.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 193' ' ' LEU . 88.7 m-85 -117.37 130.77 56.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.713 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.0 m -144.3 119.73 10.3 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 198' ' ' ARG . 45.3 t -131.06 157.87 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.326 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.475 ' N ' HG12 ' A' ' 197' ' ' VAL . 45.5 ttt180 -158.31 156.13 30.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.56 112.71 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.21 167.89 40.91 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.078 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -49.28 141.14 8.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.7 mtm -95.66 3.81 53.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.2 t -118.57 -47.92 2.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.719 0.295 . . . . 0.0 110.867 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.79 108.84 4.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 110.164 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -48.28 156.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.6 p -156.54 112.27 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.982 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 t -33.16 -59.3 0.36 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.582 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -52.19 -53.34 44.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -92.0 61.87 4.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -163.8 105.59 0.94 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.717 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.15 174.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.969 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -171.38 147.3 2.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.567 . . . . 0.0 111.584 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.3 t70 -121.73 171.2 9.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.39 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . -179.83 158.57 22.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.888 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.429 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 46.7 m-85 -150.31 165.45 32.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -134.03 104.92 6.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -101.93 117.58 35.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.79 104.04 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.061 0.458 . . . . 0.0 110.703 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.6 t0 55.23 52.17 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.255 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.63 -9.52 50.24 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.908 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.8 p -89.6 109.11 20.09 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.63 -0.335 . . . . 0.0 110.944 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -103.08 147.65 26.71 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 73.1 m -166.79 129.53 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -82.2 141.14 33.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -171.07 108.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.272 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.1 97.28 2.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.242 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.6 p -126.06 154.18 43.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.91 95.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.55 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.2 35.6 0.81 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.353 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.6 m -74.65 -41.62 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.714 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -93.61 5.04 52.93 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.149 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -38.52 -37.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.135 0.493 . . . . 0.0 110.767 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 7.7 tp -159.66 148.88 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.728 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.65 100.57 4.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.3 t -68.23 -0.82 5.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.2 p -82.58 -21.15 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -105.2 10.06 33.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.241 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.7 mt -92.84 129.27 38.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -113.67 143.85 43.91 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.068 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' LYS . . . -55.75 171.32 0.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 241' ' ' CYS . 40.1 t -126.21 -6.13 6.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.71 179.695 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.785 0.326 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.21 118.04 5.23 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.536 2.157 . . . . 0.0 111.718 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -59.47 152.04 22.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.618 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.15 173.39 3.02 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.956 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -67.27 -88.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.727 0.298 . . . . 0.0 110.616 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' B' ' 6' ' ' ASP . 31.6 p-10 -151.1 59.17 3.2 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.359 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' B' ' 8' ' ' PRO . 73.2 Cg_endo -73.92 118.16 5.31 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.397 2.065 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' B' ' 7' ' ' PRO . 83.0 Cg_exo -42.72 172.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.852 1.701 . . . . 0.0 111.413 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.698 HG22 ' H ' ' B' ' 10' ' ' ALA . 6.5 m -134.34 173.21 11.87 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.425 0.631 . . . . 0.0 111.631 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.698 ' H ' HG22 ' B' ' 9' ' ' THR . . . -80.59 123.09 27.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.875 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 87.8 m -149.29 116.23 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' CYS . . . . . 0.402 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 0.1 OUTLIER -62.94 137.53 58.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.96 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.94 -20.62 10.46 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.985 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -122.43 143.58 49.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.483 ' CD2' ' OD1' ' B' ' 53' ' ' ASP . 16.4 m-85 -121.73 152.48 39.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 111.808 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -80.29 141.27 35.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.572 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -89.15 -28.02 20.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -87.54 126.03 34.68 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.724 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -85.85 114.61 22.91 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.553 HD12 ' N ' ' B' ' 20' ' ' LEU . 9.3 mp -75.33 115.08 41.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -41.93 151.04 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.134 1.889 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 25' ' ' VAL . 39.7 ttm180 -45.87 -50.0 14.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.386 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -28.99 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -109.6 50.26 0.8 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.941 0.4 . . . . 0.0 110.241 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 22' ' ' ARG . 66.1 t -150.22 88.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -95.42 -21.14 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.35 179.21 8.52 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.499 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -166.98 163.38 15.99 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.287 0.565 . . . . 0.0 112.037 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -152.16 167.25 29.14 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.165 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' B' ' 31' ' ' THR . 50.9 mt-10 -114.08 152.18 31.44 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.422 ' O ' ' O ' ' B' ' 30' ' ' GLU . 73.0 p -55.92 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.091 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -147.84 -149.29 0.29 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.676 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 35' ' ' CYS . 91.1 p -135.51 -24.38 1.37 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.276 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.24 -3.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.46 . . . . 0.0 109.788 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.446 ' C ' ' H ' ' B' ' 37' ' ' GLN . 58.0 m -114.99 117.31 30.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.503 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -73.65 37.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.964 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' B' ' 35' ' ' CYS . 10.2 pt20 -169.22 64.3 0.54 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 86.0 Cg_endo -75.95 -162.86 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.422 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' B' ' 51' ' ' CYS . . . 174.32 176.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.971 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.14 144.06 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.224 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.44 130.47 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.505 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -112.14 144.21 41.9 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -111.51 115.19 28.79 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.066 0.46 . . . . 0.0 111.047 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.4 p -79.52 -140.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.48 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.85 -27.91 2.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.87 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.97 46.44 2.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.435 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 48.0 t -157.26 -84.95 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.944 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.76 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.715 0.635 . . . . 0.0 109.777 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -131.17 140.68 49.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.726 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.0 t -150.19 112.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 110.827 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.574 ' N ' ' OG ' ' A' ' 182' ' ' SER . 2.6 t -73.33 152.16 41.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.605 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.13 135.79 22.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.893 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.483 ' OD1' ' CD2' ' B' ' 15' ' ' TYR . 69.3 m-20 -61.74 125.9 85.81 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.54 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 74.3 Cg_endo -72.99 2.64 5.24 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.433 1.422 . . . . 0.0 111.448 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 30.2 m -73.39 -3.49 27.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.292 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.553 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 39.0 mt-10 -109.53 125.13 52.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.93 0.395 . . . . 0.0 110.363 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -50.12 -36.19 28.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.113 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -56.14 -36.18 67.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.936 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 t -70.72 -36.88 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.001 0.429 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' B' ' 56' ' ' GLU . 2.9 mp0 -70.07 -36.79 75.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.99 -37.56 69.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.225 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.31 -41.03 94.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.628 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.47 -44.21 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.919 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -60.13 -28.9 68.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.746 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -75.33 -43.7 49.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.946 0.403 . . . . 0.0 110.728 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.74 -22.75 63.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.457 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.57 -36.53 68.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -75.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 59.1 t30 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.581 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 mtt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.01 -4.82 16.04 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.019 1.812 . . . . 0.0 111.533 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.57 148.7 2.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.423 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 t -170.18 12.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.579 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.54 174.92 12.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.612 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -166.48 -72.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.509 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -70.65 122.09 19.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.546 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t -66.28 -17.12 64.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.579 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -72.37 -20.77 61.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.592 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.9 t -50.42 131.98 24.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.565 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.5 p -57.77 -29.59 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -76.83 -23.54 52.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.721 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -79.08 -48.05 15.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -165.35 171.27 13.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.093 0.473 . . . . 0.0 111.05 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.66 148.75 48.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.553 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.7 p -70.93 176.18 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.548 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.6 5.71 6.81 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 19' ' ' GLU . 43.1 mt-10 -83.03 92.9 7.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.411 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' GLU . 37.1 tt0 -23.54 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.171 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -76.22 50.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.358 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -158.49 135.71 9.99 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -145.53 166.43 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.82 0.343 . . . . 0.0 111.003 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -95.03 107.05 19.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.567 ' SD ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -78.64 107.21 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.297 0.57 . . . . 0.0 110.581 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.86 148.32 18.71 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.98 151.86 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' CD1' ' A' ' 29' ' ' ILE . 59.0 t0 -147.25 130.83 16.81 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -138.67 99.8 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.846 0.355 . . . . 0.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.7 mp -95.23 139.54 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 pt -148.71 135.13 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.471 0.653 . . . . 0.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' HD12 ' A' ' 193' ' ' LEU . 36.7 ttmt -115.98 123.19 47.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.589 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.63 110.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.784 0.326 . . . . 0.0 111.162 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -87.58 122.24 31.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.758 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' NZ ' ' C ' ' A' ' 110' ' ' ASN . 25.1 mtmm -80.55 154.31 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.758 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.546 ' NE2' ' H ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -74.06 154.06 39.38 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 15.2 t70 -62.1 -19.47 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.4 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -82.75 -36.71 25.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.193 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.8 p -48.04 147.21 3.71 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.742 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.09 168.47 24.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.113 1.876 . . . . 0.0 111.575 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -75.36 128.46 35.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.63 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.475 ' ND2' ' OE1' ' A' ' 154' ' ' GLU . 29.7 m120 -158.24 101.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.73 -0.27 21.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.643 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -72.69 71.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -71.06 170.36 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 110.383 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 32.6 t 50.35 57.86 6.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.48 0.657 . . . . 0.0 110.443 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.532 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 8.7 tm0? -78.98 -21.2 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 t 173.14 154.12 0.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.905 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.16 135.06 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -114.29 153.93 28.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -136.22 109.73 7.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.531 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 79' ' ' THR . 6.0 mt -122.01 154.02 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 t -153.59 151.32 29.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 37.8 tt0 -52.96 171.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 p -83.28 -19.37 36.42 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -48.89 -67.03 0.3 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.435 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 t -33.59 115.3 0.22 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.572 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.627 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -92.17 -24.99 0.27 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 57' ' ' ASP . 93.0 Cg_exo -45.79 -5.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.221 1.948 . . . . 0.0 114.008 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -177.53 -50.68 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.809 178.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 38.2 Cg_exo -59.11 -143.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 121.939 1.759 . . . . 0.0 111.88 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 62' ' ' VAL . 9.4 tm-20 91.47 160.23 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.478 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 1.9 m -143.5 -104.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.491 0.186 . . . . 0.0 110.692 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.465 ' H ' HG23 ' A' ' 62' ' ' VAL . 17.0 tp10 -160.45 156.7 26.41 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 0.9 OUTLIER 82.99 130.78 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.733 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -159.02 -175.73 5.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.829 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -161.82 153.56 18.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.359 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 68' ' ' SER . 1.8 p-10 -87.68 -94.84 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.516 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.427 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.6 p 52.62 56.96 6.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.661 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 78.4 p 50.43 80.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.616 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 p -46.49 140.84 4.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 71' ' ' VAL . 11.8 p -160.97 37.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.802 0.811 . . . . 0.0 109.55 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.44 41.64 1.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.429 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -132.11 15.09 4.68 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.521 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.48 -62.69 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.671 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.92 97.46 49.52 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.644 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -38.9 157.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.315 2.01 . . . . 0.0 112.071 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.97 -170.01 0.26 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.875 2.383 . . . . 0.0 113.105 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -140.67 149.56 42.4 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.032 0.444 . . . . 0.0 111.498 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.2 m -101.37 129.85 47.45 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 63.8 t80 -118.39 101.8 8.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' N ' ' CD1' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -108.96 117.56 34.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.915 0.388 . . . . 0.0 110.277 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 t -95.95 85.32 4.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.59 118.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.069 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 tt -106.62 146.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.796 0.331 . . . . 0.0 110.109 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 157.57 7.77 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.31 7.95 82.02 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.99 60.29 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.829 -0.224 . . . . 0.0 112.582 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.56 174.47 15.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 111.045 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -115.81 123.88 49.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.719 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.2 mpp? -102.71 97.94 8.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' HG23 ' A' ' 146' ' ' ILE . 84.3 m-20 -86.88 133.89 33.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.456 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 78.6 m-85 -116.27 -164.91 1.0 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.76 71.94 0.03 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.07 140.54 40.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.166 0.508 . . . . 0.0 110.641 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -131.97 108.27 9.25 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? 69.04 36.5 2.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 31.9 m -122.38 149.65 55.53 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -34.91 153.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.408 2.072 . . . . 0.0 112.573 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -76.21 106.43 7.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -62.48 146.05 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.21 -12.05 0.42 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.861 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -106.09 113.79 27.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.2 mt -124.03 108.2 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -139.48 153.92 47.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.77 0.319 . . . . 0.0 111.815 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 17.0 mp0 -145.11 169.69 17.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.6 p -157.83 153.95 27.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.87 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.27 118.2 20.97 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.853 0.358 . . . . 0.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.4 107.63 8.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.99 -138.7 25.96 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.442 ' C ' ' NZ ' ' A' ' 34' ' ' LYS . 24.5 p30 -91.99 26.29 2.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 110.494 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 112' ' ' VAL . 87.0 m -129.63 156.47 44.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.772 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.48 ' N ' HG22 ' A' ' 111' ' ' THR . 35.0 m -142.07 138.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.316 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 113' ' ' ASN . 1.3 m120 -119.57 168.08 11.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.115 0.483 . . . . 0.0 111.194 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.25 127.33 9.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.105 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.477 ' NH1' ' OG ' ' A' ' 235' ' ' SER . 76.9 ttt180 -113.52 110.79 20.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.656 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 115' ' ' ARG . 3.2 mm? -115.19 124.9 52.62 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 p -168.07 161.75 12.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.938 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -77.93 171.0 15.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.623 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.83 145.56 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.043 0.449 . . . . 0.0 111.338 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.15 163.38 53.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.43 150.23 84.37 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 122.209 1.939 . . . . 0.0 111.664 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.37 9.67 85.59 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.329 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -82.96 -60.51 2.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.35 -16.73 0.29 Allowed Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -110.42 179.0 4.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.48 158.74 35.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.108 0.48 . . . . 0.0 111.242 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.4 p -155.04 61.03 2.86 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -40.36 135.55 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.936 2.424 . . . . 0.0 113.286 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -114.99 145.87 41.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.272 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.567 HG22 ' SD ' ' A' ' 24' ' ' MET . 5.8 tp -140.71 168.35 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -73.14 178.58 4.32 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 111.475 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -71.23 -34.3 70.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.735 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.54 -57.61 11.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.64 -31.89 73.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.993 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.89 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.505 ' O ' ' NZ ' ' A' ' 140' ' ' LYS . 35.3 tp -74.23 -32.82 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.595 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.18 -52.02 18.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.55 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -64.12 -54.53 32.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.587 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.585 ' N ' ' SD ' ' A' ' 138' ' ' MET . 20.7 tt -45.87 -22.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 136' ' ' LEU . 26.4 mtmm -92.96 -26.35 17.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.283 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.47 -30.84 14.83 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.0 t -47.3 117.02 1.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' B' ' 17' ' ' ALA . 8.5 tm-20 -138.74 121.57 16.52 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.349 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.26 125.77 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -100.78 159.2 15.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.906 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 91' ' ' ASN . 3.2 mt -148.78 156.86 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.938 0.399 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -166.1 85.76 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.59 144.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.495 . . . . 0.0 111.793 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -135.8 175.41 9.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.812 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.7 t -91.46 134.88 34.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.45 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 p -111.39 166.16 11.35 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.771 0.319 . . . . 0.0 110.169 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.89 6.99 2.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.93 99.45 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.096 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.475 ' OE1' ' ND2' ' A' ' 41' ' ' ASN . 9.8 mm-40 -83.23 18.88 1.6 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -63.71 148.84 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.613 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 157' ' ' SER . 38.4 t70 -52.16 171.79 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.194 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.433 ' N ' ' CG ' ' A' ' 156' ' ' ASP . 35.2 p -100.02 149.82 23.07 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.086 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.2 m-20 -116.73 88.83 2.98 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.3 pt -103.25 177.13 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.388 0.613 . . . . 0.0 111.528 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.875 ' HZ3' ' H ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -108.36 -173.29 2.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.06 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 161' ' ' THR . 91.8 m -124.56 -9.26 7.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.413 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 11.9 m80 -100.14 127.56 33.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.787 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -39.42 159.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.03 1.82 . . . . 0.0 112.705 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.09 140.38 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 20.2 mt -85.2 125.29 32.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.366 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 159.85 20.32 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.469 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.3 m -93.8 12.0 27.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.4 t30 58.08 9.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.719 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.22 148.58 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 20.5 m -112.6 140.06 47.68 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.495 ' NE2' HD13 ' A' ' 29' ' ' ILE . 22.0 m80 -74.95 43.95 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.535 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -71.53 162.68 29.06 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -77.39 128.02 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.7 m -149.29 -166.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.0 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.1 p -48.08 145.06 3.3 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.423 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -112.47 144.38 42.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.906 0.384 . . . . 0.0 111.239 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -158.74 152.1 22.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.483 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -68.61 106.33 2.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.274 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -116.93 -59.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.724 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.1 mt -61.26 122.05 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.14 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.4 -119.81 2.11 Favored Glycine 0 C--O 1.225 -0.412 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.955 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.552 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 52.2 p -72.07 141.86 49.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.47 ' OG1' ' CE2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -145.02 83.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.68 97.04 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.991 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 185' ' ' VAL . 18.1 m -112.18 131.65 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.953 0.406 . . . . 0.0 111.59 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -79.44 114.99 18.8 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.112 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.9 p -52.25 -28.04 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -39.21 -30.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.514 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 65.1 m -143.95 26.43 1.53 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.732 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 44.0 t -149.22 89.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 110.483 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -67.71 -56.44 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.648 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -133.65 146.32 50.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 31' ' ' LYS . 23.0 tp -144.14 120.81 11.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.839 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 12.7 mp0 -105.92 130.78 53.8 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 195' ' ' PHE . 0.2 OUTLIER -107.23 138.63 43.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.912 0.387 . . . . 0.0 110.528 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.2 t -144.35 120.64 10.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.62 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 198' ' ' ARG . 6.7 p -131.93 159.64 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 197' ' ' VAL . 11.4 ttt85 -171.25 112.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.241 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 199' ' ' ILE . 8.5 tt -113.3 129.84 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.819 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -168.83 -148.97 5.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.862 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -95.95 119.83 35.15 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 167' ' ' SER . 21.8 mmt -82.85 3.86 27.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.29 -54.31 2.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.689 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -153.76 120.73 5.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.726 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -49.2 129.22 17.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.148 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.4 t -124.8 113.33 17.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.797 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.9 p -35.58 -39.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.859 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -79.21 -45.58 19.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 61.21 3.98 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.07 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.34 128.17 7.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.185 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.489 HG23 HD11 ' A' ' 139' ' ' ILE . 3.8 t -142.9 164.35 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.03 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.477 ' N ' ' CG1' ' A' ' 211' ' ' VAL . 0.9 OUTLIER -161.13 127.34 3.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.03 171.51 11.79 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.448 ' C ' ' CD1' ' A' ' 215' ' ' PHE . . . 155.76 160.49 10.01 Favored Glycine 0 CA--C 1.511 -0.166 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 215' ' ' PHE . 14.5 m-85 -141.57 -176.8 4.88 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -134.73 105.99 6.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.203 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.66 113.55 25.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 218' ' ' VAL . 31.8 m -135.98 120.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 0.0 110.523 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 218' ' ' VAL . 4.5 p-10 46.09 51.32 11.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.979 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.24 2.96 68.53 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.668 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.7 t -104.41 119.89 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.066 0.433 . . . . 0.0 110.678 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.07 155.87 18.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.121 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 79.3 p -170.87 129.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -80.14 141.9 35.29 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -170.86 101.6 0.17 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.17 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.39 96.55 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.714 0.292 . . . . 0.0 110.387 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 77.2 p -126.04 160.43 30.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.64 99.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -91.66 21.96 4.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 87.5 m -63.24 -35.4 80.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.746 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.1 p -97.95 -4.75 35.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.1 tp -43.45 -31.8 0.76 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.852 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.3 tt -143.53 144.35 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.203 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 236' ' ' THR . 31.5 m-20 -83.15 91.4 7.23 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 115' ' ' ARG . 14.2 t -56.78 -0.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.202 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 234' ' ' ASP . 58.4 m -88.36 -20.24 25.59 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -101.6 11.42 38.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.747 0.308 . . . . 0.0 111.465 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -84.78 133.23 34.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.694 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -127.09 132.3 50.67 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.361 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.875 ' H ' ' HZ3' ' A' ' 160' ' ' LYS . . . -55.67 165.48 0.85 Allowed 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.156 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 38.1 t -126.23 -2.9 6.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.971 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.765 0.317 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.93 111.68 0.72 Allowed 'Trans proline' 0 N--CA 1.475 0.438 0 C-N-CA 122.628 2.219 . . . . 0.0 112.15 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 154.5 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.539 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.53 170.15 10.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.761 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 p -72.61 -84.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 110.618 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -136.23 75.9 51.93 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.636 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' B' ' 8' ' ' PRO . 27.4 Cg_exo -60.27 176.9 0.66 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.534 2.156 . . . . 0.0 112.355 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' B' ' 7' ' ' PRO . 86.7 Cg_exo -51.37 -124.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.268 2.646 . . . . 0.0 113.547 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.993 HG23 ' H ' ' B' ' 10' ' ' ALA . 1.2 t -170.59 -74.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.599 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.993 ' H ' HG23 ' B' ' 9' ' ' THR . . . 74.0 64.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.324 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 33.3 m -116.29 135.49 53.84 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.603 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 t -41.31 138.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.779 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.47 ' CE2' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -125.17 -26.79 3.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.305 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.6 m -138.66 143.02 39.03 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 1.1 m-85 -107.18 149.12 28.04 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.2 t -74.94 133.72 41.69 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.463 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 143' ' ' GLU . . . -79.06 -45.44 20.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.589 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -79.33 126.13 30.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.87 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.61 150.22 48.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.118 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 20.8 mt -105.01 100.06 22.51 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.513 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -42.23 146.44 0.68 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.69 1.594 . . . . 0.0 111.968 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -46.12 -48.21 17.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.643 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -49.37 -22.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 111.291 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.407 ' CE1' ' OE1' ' A' ' 53' ' ' GLU . 9.6 t80 -109.42 33.57 4.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.201 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 66.3 t -153.47 93.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.686 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 32.0 m -88.42 -23.72 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.5 t70 -156.76 -179.52 8.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.163 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.477 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 7.9 p90 -158.51 170.61 21.81 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.084 0.469 . . . . 0.0 111.36 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.45 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -154.02 179.28 9.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.12 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.45 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 85.9 mt-10 -124.14 147.37 48.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.873 0.368 . . . . 0.0 110.364 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -55.82 -109.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.5 m -153.86 -147.96 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.669 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.455 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.1 t -136.47 -32.43 0.84 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.308 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' B' ' 34' ' ' LEU . 4.3 mp -51.79 -10.99 0.13 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.455 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.6 p -111.04 118.63 36.57 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 79.4 p -72.58 37.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.723 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' B' ' 35' ' ' CYS . 13.2 pt20 -171.27 61.83 0.35 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.66 -167.66 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.669 2.246 . . . . 0.0 113.386 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.45 176.02 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.639 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.25 131.85 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.683 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.448 HG21 ' NE2' ' B' ' 49' ' ' GLN . 2.4 m -110.08 132.94 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.597 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -103.74 147.7 26.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.167 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -94.05 169.57 10.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.2 p -142.0 -145.82 0.18 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.719 0.691 . . . . 0.0 111.499 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.468 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -127.62 -40.12 1.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.33 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.75 43.09 3.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.361 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 8.5 t -149.04 -83.78 0.1 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.435 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -87.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.004 0.43 . . . . 0.0 109.878 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.448 ' NE2' HG21 ' B' ' 41' ' ' VAL . 47.5 tt0 -139.53 147.37 41.13 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.65 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -150.39 119.09 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 111.098 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.552 ' H ' ' CB ' ' A' ' 182' ' ' SER . 7.2 t -59.8 157.51 12.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.664 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.485 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.1 134.79 13.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.811 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -73.01 121.28 84.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.32 1.4 6.15 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.223 1.282 . . . . 0.0 111.863 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 27.7 t -76.05 -4.05 39.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.957 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' B' ' 57' ' ' SER . 0.8 OUTLIER -106.87 124.87 50.24 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.511 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 22.1 p -44.32 -47.34 9.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.4 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 85.9 m95 -55.11 -27.79 47.75 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.22 -43.98 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 109.646 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -62.05 -41.67 98.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.97 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -70.66 -34.86 72.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -66.45 -37.57 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 73.3 t -71.11 -47.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.95 -31.72 70.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -72.56 -37.44 68.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.58 -22.09 61.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.558 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -73.17 -32.2 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.235 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.63 -78.07 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.8 t30 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.549 -180.0 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.98 -51.94 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.129 1.886 . . . . 0.0 111.682 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.16 127.46 1.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.563 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.2 t -68.26 -84.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.59 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 7' ' ' GLN . 11.1 tp -168.23 -75.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.442 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -62.92 79.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.43 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 5' ' ' LEU . 22.9 mt-30 -148.07 139.78 23.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.546 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 99.6 p -165.37 -33.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.162 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 m -79.14 -25.48 42.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.625 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 p -47.93 128.52 13.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 t -61.28 -19.94 62.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.1 p -77.4 -30.9 53.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.379 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.0 p -77.24 -46.68 22.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.6 m -163.15 158.88 22.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.912 0.387 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.11 154.34 10.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.5 p -68.62 165.5 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.514 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 17' ' ' GLU . 34.9 mp0 -115.42 7.94 15.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.258 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.24 -163.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 15.3 mp0 -114.56 -73.01 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.023 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -87.61 60.26 5.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.145 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 21.7 tttm -157.78 141.46 15.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.258 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -149.42 179.13 8.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.387 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.508 ' CD2' ' OG ' ' A' ' 127' ' ' SER . 32.1 t60 -108.93 90.23 3.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.506 ' CE ' ' HB1' ' A' ' 135' ' ' ALA . 53.9 tpp -71.92 126.72 30.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.903 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 199' ' ' ILE . . . -136.07 167.13 24.48 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.5 pt -111.32 150.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.23 121.04 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.8 146.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.184 0.516 . . . . 0.0 111.254 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD12 ' NH2' ' A' ' 198' ' ' ARG . 21.1 mt -137.27 140.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 30' ' ' ILE . 7.9 tt -130.77 122.26 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.138 0.494 . . . . 0.0 111.429 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -107.69 111.28 23.41 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.7 t -112.32 122.1 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.952 0.406 . . . . 0.0 111.643 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.0 m -97.25 114.62 26.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -68.3 151.8 46.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.82 179.35 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -80.63 -28.43 36.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.737 0.303 . . . . 0.0 110.71 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -85.31 -34.75 21.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.2 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.3 m -40.3 104.1 0.32 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.87 161.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.931 1.754 . . . . 0.0 112.039 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.8 p -67.99 140.14 56.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.639 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.483 ' ND2' ' OE2' ' A' ' 153' ' ' GLU . 22.8 t-20 -165.3 96.21 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.42 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -99.32 10.62 41.07 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.35 82.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.125 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.6 pt -81.26 142.74 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.634 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.53 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 33.9 t 56.21 67.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.5 tp60 -78.47 -31.45 47.88 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.4 p -178.32 167.47 1.9 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.504 ' CG1' ' SG ' ' A' ' 241' ' ' CYS . 4.0 m -145.95 130.04 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.918 0.39 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 82' ' ' SER . 41.6 p -102.99 172.89 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.933 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -159.93 116.02 2.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.73 158.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -150.87 110.64 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.497 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 7.4 pt-20 -57.17 84.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 123.566 1.65 . . . . 0.0 109.601 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' THR . 9.9 p -145.55 17.05 1.48 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.571 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.4 pm0 -135.24 14.02 3.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.405 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.6 p -164.78 30.9 0.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.422 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.3 p-10 -172.89 150.38 2.01 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.653 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 59' ' ' ASP . 32.0 Cg_exo -35.15 86.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.598 2.198 . . . . 0.0 112.775 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.9 m-20 164.12 64.5 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.14 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.16 65.25 7.86 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.704 2.27 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -139.96 81.13 1.8 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.092 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -173.2 -27.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.297 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -172.59 30.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.7 p 177.73 -177.61 0.2 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.347 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.7 155.73 37.82 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.085 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -136.0 -127.31 0.15 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.328 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 18.9 p-10 -162.94 136.26 5.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.943 0.401 . . . . 0.0 110.832 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.0 t 52.22 65.67 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.76 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 p -79.7 -14.02 59.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.4 t -76.52 48.44 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.047 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 72' ' ' GLU . 27.5 m -51.75 -46.96 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.301 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 71' ' ' VAL . 44.2 mt-10 -147.91 -33.78 0.25 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 69.76 47.96 0.6 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.792 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.51 46.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.064 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -158.35 66.8 3.38 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.76 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.72 158.34 2.97 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.495 2.13 . . . . 0.0 111.937 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.84 167.61 22.0 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.462 2.108 . . . . 0.0 111.707 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.501 ' N ' ' OE2' ' A' ' 53' ' ' GLU . 32.8 m -119.14 131.28 55.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.793 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.9 p -87.72 126.17 34.83 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 59.8 t80 -136.72 107.8 6.75 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CD2' ' CE1' ' A' ' 92' ' ' PHE . 4.8 p90 -106.8 -179.03 3.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.496 ' N ' ' OG1' ' A' ' 49' ' ' THR . 15.8 m -152.53 75.42 1.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 pt -72.4 119.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.51 0.671 . . . . 0.0 110.753 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.1 mt -101.26 145.13 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.518 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.46 166.1 16.32 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.37 22.36 50.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.09 14.18 76.32 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.36 156.57 48.27 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.938 0.399 . . . . 0.0 110.502 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -122.57 114.87 21.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.314 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 36.5 mtt -101.3 123.06 44.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.78 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -115.48 119.97 37.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.256 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.655 ' CE1' ' CD2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -108.15 169.36 8.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.77 77.63 0.19 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.337 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.45 145.35 29.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.642 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -141.63 122.21 14.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 66.45 34.26 6.3 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.378 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.55 143.72 49.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -34.39 144.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.387 2.058 . . . . 0.0 112.74 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -68.59 154.87 41.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.338 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.65 144.62 9.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.221 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -143.27 -15.96 0.66 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.717 0.294 . . . . 0.0 110.331 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -113.16 118.06 33.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.278 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 103' ' ' ILE . 5.9 tp -135.05 128.68 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 p -142.79 179.41 7.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 60.0 tt0 -164.22 154.58 14.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.2 t -157.63 153.03 26.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.414 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.24 123.65 30.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -135.3 107.9 7.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.966 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.31 -124.69 7.35 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -106.61 27.78 8.5 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.732 0.301 . . . . 0.0 110.511 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -133.72 159.83 39.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 110.731 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.35 134.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.476 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CG ' HD12 ' A' ' 233' ' ' ILE . 17.2 m-20 -114.86 155.08 27.47 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.06 128.44 8.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -108.24 122.99 48.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.033 0.444 . . . . 0.0 111.154 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.878 HD22 ' N ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -112.98 114.6 27.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.4 t -157.58 170.0 23.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.593 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.3 p -94.52 166.17 12.18 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.438 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.98 150.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.374 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 p -99.43 150.42 36.74 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.867 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -38.84 163.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.121 1.88 . . . . 0.0 112.543 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 50.23 73.54 0.36 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.215 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -152.89 -27.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.088 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.88 12.62 13.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.193 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -134.95 155.42 50.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -56.31 151.33 13.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.527 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.508 ' OG ' ' CD2' ' A' ' 23' ' ' HIS . 2.2 t -153.19 67.13 6.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.53 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.22 130.0 27.19 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.887 2.391 . . . . 0.0 113.331 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -96.2 158.07 15.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.694 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.8 pt -145.34 160.87 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.82 0.343 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.8 p -75.78 178.53 6.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.047 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -69.27 -35.95 76.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.503 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.31 -57.85 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.989 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.995 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.506 ' HB1' ' CE ' ' A' ' 24' ' ' MET . . . -68.29 -56.96 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.769 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.0 tp -54.46 -32.61 58.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.127 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.51 -52.46 18.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.646 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mtt -57.16 -52.72 64.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.145 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.2 mm -45.98 -21.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.296 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -91.43 -41.55 10.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.79 -31.06 56.73 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 m -41.47 111.15 0.2 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.48 116.96 11.35 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.055 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 144' ' ' VAL . 12.1 p -117.57 127.35 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.055 0.455 . . . . 0.0 110.659 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 m -101.06 162.9 12.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.4 tp -145.47 136.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.992 0.425 . . . . 0.0 110.646 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -146.99 90.42 1.9 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.882 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.9 tt -83.73 140.33 16.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.72 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 35.8 ttm180 -133.39 170.45 15.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 5.8 t -90.48 126.64 35.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.187 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.7 p -120.38 133.45 55.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -100.57 21.23 13.64 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.622 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.483 ' OE2' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -50.29 158.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -144.54 -0.74 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.197 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 26.8 mtmm -63.89 171.58 2.74 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.632 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.23 173.89 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.5 t -92.54 144.28 25.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.6 t70 -120.18 89.86 3.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.999 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 pt -120.53 172.25 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.428 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.59 ' NZ ' ' NE2' ' A' ' 162' ' ' HIS . 31.0 tttm -124.32 136.4 54.08 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.005 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 161' ' ' THR . 29.8 m -64.26 0.43 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.59 ' NE2' ' NZ ' ' A' ' 160' ' ' LYS . 1.8 m-70 -79.3 119.14 76.03 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.11 157.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.811 1.674 . . . . 0.0 112.281 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.45 134.7 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.47 120.02 21.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.18 162.42 22.77 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 169' ' ' ILE . 10.3 p -98.08 5.37 48.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.091 0.472 . . . . 0.0 109.766 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 58.5 t30 60.31 -0.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.815 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 167' ' ' SER . 0.2 OUTLIER -88.98 133.62 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.7 t -79.12 -176.49 5.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.271 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.541 ' CD2' HH21 ' A' ' 198' ' ' ARG . 0.0 OUTLIER -124.52 22.23 8.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -59.63 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -93.5 123.97 37.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.852 HG22 ' H ' ' A' ' 175' ' ' SER . 14.4 p -146.97 -176.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.931 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.852 ' H ' HG22 ' A' ' 174' ' ' VAL . 58.6 m -38.65 143.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.744 0.307 . . . . 0.0 111.228 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -104.35 140.64 37.61 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.056 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -151.09 144.81 25.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.58 89.18 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.1 -42.74 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.964 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 180' ' ' ILE . 6.8 tp -64.03 124.84 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.22 -128.73 3.79 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.448 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.1 t -73.26 148.54 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 69.0 m -129.58 133.85 47.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.8 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 7.6 mm -138.42 128.16 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 185' ' ' VAL . 2.3 m -144.56 124.49 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.0 97.82 11.42 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 187' ' ' THR . 26.1 p -45.27 -27.84 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.386 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -44.56 -20.96 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.961 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 97.0 m -147.33 16.75 1.17 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 190' ' ' VAL . 35.7 m -148.27 108.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.485 0.66 . . . . 0.0 111.119 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -79.42 -56.19 4.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.586 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 217' ' ' TYR . 8.9 t-20 -109.69 170.1 8.29 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.545 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.672 HD12 ' CZ ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -169.74 105.84 0.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -108.36 130.81 55.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.672 ' CZ ' HD12 ' A' ' 193' ' ' LEU . 15.6 m-85 -114.81 140.48 48.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.594 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.46 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 14.4 t -143.95 124.2 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.484 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.46 150.19 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.541 HH21 ' CD2' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -166.41 108.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.674 -179.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 25' ' ' GLY . 12.0 mt -104.51 148.64 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.233 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.29 34.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.575 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -88.07 121.22 30.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.905 0.384 . . . . 0.0 110.303 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -79.48 1.15 26.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.731 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.62 -47.36 5.12 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.121 0.486 . . . . 0.0 109.9 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -168.09 127.21 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.65 148.05 0.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.848 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 47.9 p -136.69 12.81 3.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.924 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.6 m 58.39 -75.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.4 mt-10 -46.24 -54.38 8.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.681 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 14.4 mt -76.99 -0.83 25.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.785 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.88 134.83 37.09 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.669 0.271 . . . . 0.0 110.491 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m -154.62 -179.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.295 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.46 ' HZ3' ' CB ' ' A' ' 226' ' ' ALA . 13.9 pttp -170.67 167.5 7.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.431 0.634 . . . . 0.0 112.136 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.2 t70 -155.26 168.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.7 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 172.1 168.13 33.14 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 10.4 m-85 -153.4 167.3 29.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 2.7 ttmp? -133.42 104.0 6.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.035 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.504 ' O ' ' ND2' ' A' ' 192' ' ' ASN . 8.1 t80 -100.57 118.13 36.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.866 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.4 p -139.38 111.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.614 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.4 t70 53.12 47.47 24.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.692 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.28 -5.61 71.72 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.356 -0.45 . . . . 0.0 113.408 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.7 t -96.95 116.66 29.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.099 0.45 . . . . 0.0 110.716 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.63 153.51 21.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.079 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.4 m -167.83 129.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.276 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -83.01 142.62 31.21 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.66 116.74 0.61 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.587 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.46 ' CB ' ' HZ3' ' A' ' 212' ' ' LYS . . . -73.86 111.45 9.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 28.5 m -140.99 153.07 45.4 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.924 0.392 . . . . 0.0 110.581 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 95.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.617 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -87.27 30.03 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 231' ' ' SER . 9.3 t -71.34 -39.1 71.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.451 ' N ' HG23 ' A' ' 230' ' ' THR . 55.6 m -96.94 2.67 51.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.9 tp -44.38 -40.64 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.788 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.507 HD12 ' CG ' ' A' ' 113' ' ' ASN . 27.5 mm -141.18 146.33 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.777 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 236' ' ' THR . 34.4 m-20 -78.18 92.86 4.49 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 m -56.6 -6.5 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 234' ' ' ASP . 26.0 m -86.68 -17.05 34.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.411 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -99.04 7.43 45.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.503 0.192 . . . . 0.0 111.347 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.67 144.77 35.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.407 . . . . 0.0 110.809 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -133.49 133.49 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.536 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.71 156.73 4.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 48' ' ' VAL . 53.7 t -126.5 -10.28 6.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.457 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.857 -1.068 . . . . 0.0 110.434 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.747 0.308 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -70.69 116.69 4.77 Favored 'Trans proline' 0 N--CA 1.473 0.303 0 C-N-CA 122.497 2.132 . . . . 0.0 111.639 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 14.8 ptt? -54.33 154.91 4.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.51 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.76 -150.51 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.93 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 74.4 m -151.49 119.63 6.3 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 110.437 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 40.89 70.4 1.59 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.355 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' B' ' 8' ' ' PRO . 58.1 Cg_endo -87.53 157.6 7.86 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.73 2.287 . . . . 0.0 110.924 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.572 ' C ' HG22 ' B' ' 9' ' ' THR . 17.4 Cg_exo -36.11 -116.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.628 2.886 . . . . 0.0 114.546 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.622 HG23 ' H ' ' B' ' 10' ' ' ALA . 0.1 OUTLIER 172.64 -73.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.071 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.622 ' H ' HG23 ' B' ' 9' ' ' THR . . . 80.0 63.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.488 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.499 ' O ' ' CE2' ' B' ' 13' ' ' PHE . 85.6 m -106.4 161.42 14.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.67 135.48 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.346 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' B' ' 11' ' ' CYS . 6.8 m-85 -114.01 -26.91 7.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -149.66 153.76 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.261 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -111.52 155.07 23.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.74 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -77.49 137.17 38.5 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -27.17 41.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.62 0.248 . . . . 0.0 110.99 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -92.5 127.09 37.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.385 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -77.43 116.24 17.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.825 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.01 139.87 97.75 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.505 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.49 147.67 32.46 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.859 1.706 . . . . 0.0 111.367 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' B' ' 24' ' ' PHE . 41.5 ttp180 -44.68 -49.53 10.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.73 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' B' ' 23' ' ' ASN . 46.0 t-20 -69.67 29.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 57.8 t80 -155.45 33.33 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 86.4 t -155.97 97.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.751 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.42 -7.19 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 25.3 t0 -166.67 -178.74 4.49 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.096 -0.641 . . . . 0.0 111.259 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.482 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.7 p90 -158.24 163.52 37.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.097 0.475 . . . . 0.0 111.303 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -155.39 141.6 18.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.893 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' B' ' 31' ' ' THR . 88.8 mt-10 -90.0 142.5 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.91 0.386 . . . . 0.0 111.287 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 67.4 p -51.45 -108.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -154.47 -167.37 2.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.445 ' C ' ' N ' ' B' ' 35' ' ' CYS . 11.8 t -117.32 -30.4 5.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.502 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' B' ' 34' ' ' LEU . 4.4 mp -49.59 -13.14 0.08 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.445 ' N ' ' C ' ' B' ' 33' ' ' SER . 27.8 m -111.06 127.12 55.45 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.049 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -76.44 35.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -163.98 59.27 0.74 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.4 -164.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 122.59 2.194 . . . . 0.0 112.862 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.14 176.69 0.25 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.089 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.43 127.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.99 134.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -105.3 151.52 24.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.698 ' NE2' ' H ' ' B' ' 44' ' ' THR . 41.5 tp60 -93.67 164.56 13.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.698 ' H ' ' NE2' ' B' ' 43' ' ' GLN . 56.5 p -136.57 -168.42 2.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.289 0.566 . . . . 0.0 111.528 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.78 -41.82 4.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.713 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.91 47.11 2.02 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.374 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 3.0 m -158.47 -79.61 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.227 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.8 -90.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.397 0.436 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -136.86 151.45 49.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -150.08 124.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 10.2 t -64.18 159.5 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.298 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.496 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.0 130.59 10.68 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.238 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -67.76 116.88 42.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.33 0.57 5.87 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 120.938 1.092 . . . . 0.0 111.71 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 53.4 m -73.89 -16.07 61.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.983 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -91.61 127.25 36.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.168 0.509 . . . . 0.0 110.666 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 52.9 m -47.22 -49.8 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -56.15 -25.05 44.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.14 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 62.2 t -73.77 -37.38 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.181 0.515 . . . . 0.0 110.302 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.14 -37.56 78.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.504 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -72.07 -35.36 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.242 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.99 -36.1 82.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.477 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.06 -44.87 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.978 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -63.49 -27.59 69.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.018 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.41 -39.17 62.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.812 0.339 . . . . 0.0 110.934 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.43 -29.76 62.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.347 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OH ' ' B' ' 28' ' ' TYR . 32.1 mm-40 -69.7 -32.94 71.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.85 -74.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.336 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.553 179.891 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.748 0.309 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.08 178.52 7.09 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.687 2.258 . . . . 0.0 111.898 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.18 138.71 3.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.526 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' LEU . 70.2 m -166.37 25.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.605 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.556 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.9 mp 57.45 150.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.571 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.45 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 2.8 pm0 -169.62 149.47 3.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.646 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -72.75 142.86 48.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.505 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p -74.08 -8.26 55.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.718 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -75.44 -24.59 57.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.748 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.3 t -50.57 134.47 24.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -57.62 -29.39 64.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p -74.35 -25.94 59.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.23 -57.08 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.974 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -159.01 175.94 12.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.922 0.392 . . . . 0.0 110.907 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -61.92 159.92 13.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.887 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -75.2 165.89 24.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 1.4 pm0 -114.75 3.16 14.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.777 0.323 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.64 -165.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.35 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -116.05 -75.92 0.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.901 0.382 . . . . 0.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.494 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 64.8 t30 -77.81 53.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.627 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -154.63 132.13 11.27 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.56 ' CD2' ' HE2' ' A' ' 132' ' ' HIS . 62.1 m-70 -140.9 165.49 27.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.201 0.524 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -97.75 76.19 2.46 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.965 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.2 ttm -68.88 133.69 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.29 25.03 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.0 tp -111.17 142.37 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -149.89 106.31 3.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.556 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 197' ' ' VAL . 12.2 m -122.29 134.53 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.68 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.5 pt -113.99 163.33 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.92 132.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.437 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -120.68 133.08 55.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.538 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.4 116.71 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.872 0.368 . . . . 0.0 111.326 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -81.76 112.41 18.89 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.59 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -68.22 150.14 48.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.888 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -58.89 168.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -91.3 5.02 50.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.843 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -120.48 -33.38 3.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.846 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 38' ' ' THR . 4.4 t -54.17 119.28 19.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.463 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -39.25 157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.976 1.784 . . . . 0.0 112.544 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 p -75.49 143.91 42.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.46 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -157.33 107.1 2.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.424 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' ILE . 2.7 p30 -101.16 -2.56 31.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.064 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 154' ' ' GLU . 4.8 mmmm -63.51 83.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.3 tp -90.53 150.62 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.078 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.451 ' SG ' ' CG ' ' A' ' 105' ' ' GLU . 1.7 m 56.17 62.09 2.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.139 0.495 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -78.19 -40.02 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 t -172.51 163.32 5.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.04 0.448 . . . . 0.0 111.181 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.06 140.36 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.489 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -129.54 105.29 7.98 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.847 0.356 . . . . 0.0 110.857 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.08 128.87 34.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.494 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 52' ' ' THR . 7.7 mm -132.36 154.7 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -152.62 142.57 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -51.11 176.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 26.6 m -55.08 -39.95 69.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 54' ' ' SER . 3.5 pt-20 113.62 -151.23 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 O-C-N 125.929 2.018 . . . . 0.0 111.112 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.468 ' N ' ' CG ' ' A' ' 55' ' ' GLU . 13.8 t -138.68 -66.53 0.48 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.416 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.683 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 3.5 p30 -124.95 -23.7 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.683 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 31.5 Cg_exo -38.16 -68.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.647 1.564 . . . . 0.0 113.621 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER 169.27 -64.62 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.355 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 59' ' ' ASP . 11.1 Cg_exo -24.05 -105.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.85 3.033 . . . . 0.0 114.219 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.441 ' N ' ' OE2' ' A' ' 55' ' ' GLU . 39.7 tt0 51.3 83.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.507 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.85 8.97 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.277 0.56 . . . . 0.0 109.499 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -77.67 169.33 18.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.211 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.6 m -162.18 34.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.435 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -171.37 66.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.412 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -171.27 56.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -69.24 93.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.616 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.7 p -63.25 -178.55 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.622 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 t -162.18 27.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.363 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.6 p -75.69 107.67 8.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.96 59.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.3 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -165.82 -27.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -157.48 148.42 21.41 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.532 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.7 -135.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.677 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -147.74 82.17 8.1 Favored Pre-proline 0 N--CA 1.465 0.317 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.85 106.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.557 2.171 . . . . 0.0 112.58 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.2 165.68 12.84 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.312 2.008 . . . . 0.0 111.363 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -123.76 141.46 52.01 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 p -107.59 127.0 53.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.755 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -112.25 148.02 35.01 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.201 0.524 . . . . 0.0 110.285 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -139.89 116.85 11.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.9 p -103.45 69.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.821 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 103' ' ' ILE . 12.0 tt -74.37 102.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.185 0.517 . . . . 0.0 110.534 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 pt -88.08 147.84 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.181 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.5 170.06 19.91 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.7 37.8 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.77 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.09 86.47 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.618 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.08 159.2 40.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.057 0.456 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -117.4 108.98 16.22 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.312 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 45.7 mtt -101.23 112.13 24.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.45 124.1 48.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 84.7 m-85 -100.97 -176.03 3.05 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.1 71.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.249 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -75.92 138.54 41.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.385 . . . . 0.0 110.367 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.7 m -144.42 119.89 10.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.248 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? 66.87 26.74 9.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.214 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 m -120.72 149.83 51.33 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -40.06 154.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.815 1.677 . . . . 0.0 111.942 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -75.06 137.9 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.508 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -95.54 138.5 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -137.4 -10.6 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.738 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.9 t -112.21 122.77 48.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 83' ' ' ILE . 16.0 tt -141.57 129.6 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.844 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.1 p -158.01 171.39 20.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.451 ' CG ' ' SG ' ' A' ' 45' ' ' CYS . 7.7 pt-20 -168.07 -172.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.6 t -171.56 165.96 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.445 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -127.01 116.68 21.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.172 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -127.93 107.9 10.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.029 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.81 -127.78 16.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -102.6 23.73 11.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.737 0.304 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 p -131.33 158.69 40.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.521 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.45 136.04 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.687 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -112.26 163.04 14.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.41 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -160.9 129.41 4.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.661 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 116' ' ' LEU . 31.0 ttm180 -116.85 113.31 22.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 115' ' ' ARG . 2.5 mm? -110.29 123.62 50.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -164.06 175.02 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.157 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.3 m -95.28 171.77 8.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.145 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.4 149.03 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.136 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 t -93.23 144.56 28.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -37.62 144.68 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.05 1.833 . . . . 0.0 112.516 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 57.11 6.16 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.187 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -138.75 -5.13 1.54 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.48 -8.35 64.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.81 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -115.56 168.82 9.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.98 147.06 39.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.288 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.5 m -148.73 65.56 8.42 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.689 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.27 148.03 1.32 Allowed 'Trans proline' 0 N--CA 1.474 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.903 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -117.87 146.68 43.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.311 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -132.42 171.11 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.844 0.354 . . . . 0.0 110.087 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -81.73 162.61 22.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.429 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.56 ' HE2' ' CD2' ' A' ' 22' ' ' HIS . 36.4 m170 -58.0 -36.45 72.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -54.38 -47.63 72.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.479 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -72.94 -33.21 65.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.97 9.39 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -56.14 -32.86 64.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.17 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.777 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 tpp -71.18 -63.17 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.102 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.3 -21.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.455 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -79.39 -55.11 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 41.4 t0 -79.14 -30.26 43.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.9 t -45.74 117.78 1.59 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.503 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.18 124.29 16.4 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.04 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 144' ' ' VAL . 13.8 p -116.67 131.24 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.87 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.4 m -103.09 157.59 16.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.201 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.0 mm -140.43 145.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' OD2' ' NE2' ' B' ' 49' ' ' GLN . 2.0 m-20 -152.88 92.86 1.69 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.877 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.4 mt -89.26 142.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.301 0.572 . . . . 0.0 111.075 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -138.53 177.25 8.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.639 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.3 m -91.58 132.23 36.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.739 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -103.79 -173.98 2.44 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.47 11.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.861 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -79.92 103.59 9.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.435 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 11.1 pt-20 -77.52 7.75 5.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -49.73 145.66 5.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.93 0.395 . . . . 0.0 110.365 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.21 173.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.99 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.1 t -94.97 142.1 27.88 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -120.04 91.6 3.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.589 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.4 pt -121.06 168.69 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -119.5 139.6 51.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.0 p -72.29 5.55 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.426 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -80.5 121.06 81.0 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.4 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -40.1 154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.826 1.684 . . . . 0.0 112.064 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.2 t -80.05 133.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.422 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.71 123.35 30.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.25 162.4 19.03 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.363 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -91.15 9.42 31.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 109.94 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.6 5.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.825 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.9 tp -101.93 141.31 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.5 m -100.77 149.04 24.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.748 0.309 . . . . 0.0 110.35 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.448 ' NE2' ' N ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -83.13 39.55 0.65 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.019 0.438 . . . . 0.0 110.547 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.681 ' N ' HH12 ' A' ' 198' ' ' ARG . 74.7 tttt -65.16 173.5 2.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.295 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.425 ' HZ3' ' CB ' ' A' ' 226' ' ' ALA . 61.8 tttp -84.18 123.81 30.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.533 HG13 ' N ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -149.11 -170.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.533 ' N ' HG13 ' A' ' 174' ' ' VAL . 25.3 p -44.71 146.87 0.69 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.571 0.224 . . . . 0.0 110.752 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -112.64 145.52 40.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.986 0.422 . . . . 0.0 111.437 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 1.6 tm-20 -157.88 145.73 18.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.447 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 9.9 t0 -70.34 100.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.403 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.4 mm -109.37 -50.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -61.67 125.35 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' B' ' 14' ' ' SER . . . -91.44 -123.11 2.87 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.191 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.2 t -73.3 140.58 46.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.628 0.251 . . . . 0.0 111.16 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.515 ' O ' ' CZ ' ' B' ' 13' ' ' PHE . 18.0 p -139.08 87.83 2.23 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 184' ' ' ILE . 15.0 tt -102.65 129.1 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.6 137.67 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.556 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 109.41 19.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.22 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 189' ' ' CYS . 12.7 p -51.55 -27.48 11.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.573 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -38.36 -28.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.291 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 187' ' ' THR . 27.5 p -148.42 29.39 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.323 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.1 88.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.092 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -68.16 -58.33 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.167 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -123.07 179.38 4.69 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.609 ' C ' HD23 ' A' ' 193' ' ' LEU . 5.7 tt -173.22 106.65 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 25.2 mp0 -97.24 128.83 44.46 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -128.08 134.69 49.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.093 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.0 m -143.42 144.08 31.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 28' ' ' VAL . 18.1 m -140.6 167.39 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.124 0.488 . . . . 0.0 111.34 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.681 HH12 ' N ' ' A' ' 172' ' ' LYS . 21.8 ttm180 -164.09 156.32 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.154 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.6 mt -148.5 120.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.54 174.37 46.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.277 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -56.26 129.34 39.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.923 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 57.0 mtm -86.23 8.14 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.6 t -112.88 -48.2 3.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.239 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -159.19 115.02 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 7.9 mp0 -47.63 158.71 0.18 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 208' ' ' GLU . 69.9 m -143.38 23.02 1.84 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.01 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 t 57.68 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.822 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.5 mm-40 -48.68 -48.39 40.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.729 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -77.54 -0.65 27.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.445 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.79 155.36 19.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.971 0.415 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 212' ' ' LYS . 3.8 p -175.55 158.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.409 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 211' ' ' VAL . 1.2 pptp? -168.56 136.83 2.16 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.401 0.62 . . . . 0.0 111.767 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 9.3 t70 -124.95 172.6 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 172.4 164.58 28.13 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.946 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -148.97 170.22 18.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -135.69 104.34 5.74 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.315 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -101.44 119.83 39.37 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.85 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.2 p -144.48 123.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.126 0.488 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.62 37.88 27.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.31 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.32 89.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.91 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.41 ' OG ' HG13 ' A' ' 218' ' ' VAL . 26.4 p -103.19 120.9 41.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.843 0.321 . . . . 0.0 110.576 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.74 165.15 12.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.019 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.6 t -174.97 120.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.564 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -78.44 136.71 37.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.95 116.22 0.66 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.702 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.425 ' CB ' ' HZ3' ' A' ' 173' ' ' LYS . . . -81.61 96.56 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.3 m -129.55 151.41 50.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.989 0.423 . . . . 0.0 110.767 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.32 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.553 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.443 ' OD1' HD23 ' A' ' 232' ' ' LEU . 74.6 m-20 -93.26 31.0 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.6 p -73.71 -34.81 64.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.768 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -99.89 -2.55 34.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.896 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -43.42 -29.27 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.21 143.38 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.628 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.76 101.13 4.95 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -63.9 -5.68 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.147 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -47.28 12.67 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -71.4 9.43 0.8 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 238' ' ' LEU . 7.5 mp -72.98 152.28 41.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.493 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -137.15 135.16 37.11 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.561 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.19 144.71 23.42 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.49 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' CYS . . . . . 0.537 ' SG ' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -104.34 -17.88 14.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.48 HG13 ' C ' ' A' ' 241' ' ' CYS . 1.5 m . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.606 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.44 -107.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.088 1.859 . . . . 0.0 111.358 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 4.0 ptt? 163.25 20.79 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.15 -129.35 49.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.336 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 28.0 t -162.24 -97.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.842 0.353 . . . . 0.0 110.173 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -117.25 61.99 3.13 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.778 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' B' ' 8' ' ' PRO . 21.0 Cg_endo -58.34 164.12 9.32 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.078 1.852 . . . . 0.0 112.276 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.562 ' C ' HG22 ' B' ' 9' ' ' THR . 35.7 Cg_exo -38.65 -124.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 124.287 3.325 . . . . 0.0 115.254 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.562 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 159.3 67.67 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.133 -179.112 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.73 103.03 0.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.146 0.498 . . . . 0.0 110.455 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -144.6 118.0 9.07 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.426 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 85.5 m -63.93 131.32 47.33 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.515 ' CZ ' ' O ' ' A' ' 183' ' ' THR . 0.1 OUTLIER -93.44 -26.78 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.018 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 14' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 181' ' ' GLY . 28.0 p -122.9 155.05 37.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.375 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.86 158.94 25.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.392 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -82.92 139.22 33.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.184 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.06 19.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.612 0.244 . . . . 0.0 111.32 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -80.2 127.83 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.785 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -81.92 128.68 34.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.492 HD12 ' N ' ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.38 52.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.808 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -42.04 153.08 0.13 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.208 1.938 . . . . 0.0 112.878 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' B' ' 25' ' ' VAL . 13.3 tpt180 -46.07 -50.46 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.353 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -35.95 -35.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 3.3 m-85 -105.58 43.23 1.14 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.102 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 22' ' ' ARG . 49.9 t -151.61 92.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.937 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -97.72 -22.95 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.265 -0.272 . . . . 0.0 110.823 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.455 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 6.3 p90 -166.06 168.91 15.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.253 0.549 . . . . 0.0 111.871 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 89.0 m-85 -157.34 178.26 10.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.243 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' B' ' 31' ' ' THR . 11.3 pt-20 -127.64 149.62 50.11 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.804 0.335 . . . . 0.0 110.501 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.414 ' O ' ' O ' ' B' ' 30' ' ' GLU . 77.8 p -53.93 -111.4 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -154.98 -148.68 0.24 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.412 ' C ' ' N ' ' B' ' 35' ' ' CYS . 10.5 m -135.82 -24.02 1.34 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.103 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.3 mm? -53.67 -13.56 0.7 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.794 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.423 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.3 p -115.94 122.16 44.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.58 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.3 m -73.31 38.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.402 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.5 pt20 -164.29 61.1 0.87 Allowed Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 97.4 Cg_endo -74.14 -161.82 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.887 2.391 . . . . 0.0 113.294 -177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 170.76 176.53 0.06 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.217 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -111.59 136.74 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.477 HG12 ' SG ' ' B' ' 51' ' ' CYS . 0.8 OUTLIER -113.73 143.2 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.618 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -115.69 149.9 37.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -92.97 169.26 10.57 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.3 p -138.17 -144.85 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.196 0.522 . . . . 0.0 110.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.501 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -126.27 -39.0 2.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.81 46.48 2.32 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.143 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 52.1 m -152.83 -83.17 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.428 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.586 0.554 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 49' ' ' GLN . 3.4 pp0? -145.31 147.87 32.8 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.12 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 t -150.26 115.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' B' ' 41' ' ' VAL . 71.7 m -68.05 144.72 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.785 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.69 139.3 41.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.998 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.69 126.33 92.49 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.54 -0.52 9.41 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.368 1.379 . . . . 0.0 111.554 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -65.18 -14.54 60.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.06 127.74 47.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.513 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 42.2 t -50.42 -46.89 56.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -55.99 -28.12 55.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.374 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.92 -36.16 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.112 0.482 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.72 -39.23 64.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.569 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -67.89 -35.7 78.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.47 -42.55 87.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.619 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.74 -46.01 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.841 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.66 -31.49 66.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.32 -35.67 63.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.585 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.336 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.52 -35.19 70.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.622 HD12 ' N ' ' B' ' 68' ' ' LEU . 7.3 mp -79.79 -83.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.225 0.536 . . . . 0.0 109.64 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.643 -179.918 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 mmt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.706 0.288 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -44.08 104.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.674 2.249 . . . . 0.0 111.997 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.95 85.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.614 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -68.93 77.05 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.409 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.561 ' CD2' ' H ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -57.48 -161.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.85 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.561 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 95.6 mt-30 51.72 -165.44 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.574 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 58.16 159.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.625 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.5 p -163.06 -27.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.516 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.7 t -79.44 -18.15 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.5 t -50.5 134.36 23.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.652 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -58.25 -27.41 63.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 95.8 p -73.76 -23.9 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.63 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -80.0 -53.43 6.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 p -168.07 169.38 11.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.866 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.1 m -55.3 155.8 4.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.537 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -76.46 173.19 11.8 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -112.84 5.59 17.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -62.44 -167.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.246 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 17.2 mp0 -119.21 -65.48 1.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.874 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.0 54.29 3.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.392 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' C ' ' ND1' ' A' ' 22' ' ' HIS . 3.6 tppt? -151.17 140.06 20.93 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.42 ' ND1' ' C ' ' A' ' 21' ' ' LYS . 53.5 m80 -145.67 158.59 43.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.888 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.415 ' CD2' ' N ' ' A' ' 23' ' ' HIS . 14.7 m-70 -95.65 76.41 3.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 29.9 ttp -64.74 133.0 51.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.47 . . . . 0.0 111.181 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' H ' ' HE3' ' A' ' 202' ' ' MET . . . -139.74 160.89 26.21 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.258 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -114.68 158.49 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.98 0.419 . . . . 0.0 110.586 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' HA ' ' HG ' ' A' ' 117' ' ' SER . 10.7 t70 -151.35 137.48 18.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.69 109.26 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.325 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.2 mt -97.5 134.2 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.29 134.41 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.174 0.511 . . . . 0.0 112.003 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -121.05 127.49 51.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.79 112.89 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.9 p -84.71 121.3 27.47 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -75.32 151.82 38.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.782 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -67.85 144.5 55.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.215 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 47.7 p30 -76.26 43.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.599 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -152.3 -28.33 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.8 m -71.16 125.45 91.94 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -38.47 156.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.026 1.817 . . . . 0.0 112.542 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -76.27 140.08 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.42 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -157.17 107.29 2.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.366 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.84 8.82 37.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.258 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 12.0 mptt -69.0 82.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -77.5 -177.92 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.9 m 32.82 40.29 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -55.56 -34.44 64.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.289 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 t -178.12 168.99 1.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.1 t -149.14 112.27 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.942 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.2 m -111.39 116.46 30.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.323 . . . . 0.0 110.87 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -95.38 135.42 37.01 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.184 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 79' ' ' THR . 4.2 mp -139.76 151.44 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -150.76 149.11 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 54' ' ' SER . 18.5 tp10 -51.7 171.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.082 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.51 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 58.1 m -70.09 -21.91 63.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.981 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 56' ' ' SER . 35.6 tt0 -39.53 158.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.285 0.366 . . . . 0.0 110.415 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 57' ' ' ASP . 75.0 m -27.31 -103.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.698 0.624 . . . . 0.0 112.557 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.8 m-20 55.27 153.56 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.6 39.97 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.738 1.626 . . . . 0.0 110.916 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 57' ' ' ASP . 28.7 t70 -174.03 72.53 0.34 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.441 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.09 -178.5 4.68 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.422 2.081 . . . . 0.0 111.867 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -133.11 -9.77 2.98 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.082 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -164.86 -34.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.821 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 64' ' ' SER . 0.9 OUTLIER 71.88 124.85 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.356 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.479 ' N ' ' OE2' ' A' ' 63' ' ' GLU . 4.8 p 69.77 105.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.448 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -78.04 -64.03 1.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.741 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 67' ' ' ASP . 39.0 t70 -162.05 160.9 28.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.672 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' THR . 32.7 t70 -41.86 165.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.492 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.9 m -44.25 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.18 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' ASP . 19.1 m -43.82 -45.65 7.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.209 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.9 m -166.91 -119.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.1 m -102.74 37.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.494 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 47.88 96.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.644 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -157.71 43.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.285 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.12 177.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.462 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -112.71 137.05 21.61 Favored Pre-proline 0 N--CA 1.469 0.518 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -37.18 157.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.097 1.865 . . . . 0.0 112.371 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.02 171.38 15.34 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.504 2.136 . . . . 0.0 111.025 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.9 m -125.93 131.03 52.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 51' ' ' ILE . 16.3 m -107.16 123.95 49.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -121.64 112.98 19.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.947 0.403 . . . . 0.0 111.112 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -93.83 127.41 39.55 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 t -103.07 69.38 1.02 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.24 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 83' ' ' ILE . 17.5 tt -74.54 122.25 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 110.566 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.44 147.46 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.94 169.53 20.94 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.209 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.47 22.34 23.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.239 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.407 ' C ' HD22 ' A' ' 88' ' ' LEU . . . 74.8 4.06 69.91 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.187 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 87' ' ' GLY . 4.3 mm? -117.48 149.15 41.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' NH2' ' OG ' ' A' ' 151' ' ' SER . 45.6 ttm-85 -115.83 105.15 12.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 92' ' ' PHE . 18.8 ttt -101.71 135.63 42.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.116 0.484 . . . . 0.0 110.882 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -127.44 120.44 28.4 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.043 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 90' ' ' MET . 67.1 m-85 -90.42 -168.4 2.09 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.74 67.7 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.08 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -90.28 162.08 15.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.163 0.506 . . . . 0.0 111.448 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 t -150.91 131.82 14.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.942 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 62.95 33.65 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.529 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 98' ' ' PRO . 33.5 m -124.04 145.6 48.59 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 97' ' ' CYS . 78.2 Cg_exo -38.55 162.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.012 1.808 . . . . 0.0 112.423 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -71.33 142.54 50.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -97.1 118.09 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -124.33 -21.67 4.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 117' ' ' SER . 5.7 p -100.45 111.16 23.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.771 0.319 . . . . 0.0 110.862 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.23 121.83 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 28.3 t -142.45 177.56 8.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.064 0.459 . . . . 0.0 111.171 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 104' ' ' SER . 34.9 tt0 -165.83 161.68 17.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.42 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.583 ' HB3' HD22 ' A' ' 113' ' ' ASN . 24.4 t -163.9 158.67 20.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.588 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.06 132.75 46.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.331 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -144.73 111.66 5.86 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.155 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.73 -110.87 3.31 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -122.21 23.88 9.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 p -128.74 156.16 43.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.64 132.99 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.583 HD22 ' HB3' ' A' ' 106' ' ' SER . 12.5 p-10 -117.96 155.76 29.68 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.885 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.52 133.07 12.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -118.0 125.76 51.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 111.333 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.7 121.48 40.97 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.424 ' HG ' ' HA ' ' A' ' 27' ' ' ASP . 1.8 m -164.94 156.67 15.3 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.58 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.8 p -74.19 173.85 9.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.39 134.37 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 110.999 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -59.55 155.15 40.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.0 157.6 28.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.254 1.969 . . . . 0.0 111.486 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.419 ' N ' ' OE1' ' A' ' 123' ' ' GLN . . . 73.68 59.73 3.97 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.845 HE21 ' H ' ' A' ' 125' ' ' LYS . 4.3 pm0 -141.24 -37.35 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.739 0.304 . . . . 0.0 110.348 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.03 5.97 2.93 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.265 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.845 ' H ' HE21 ' A' ' 123' ' ' GLN . 51.7 mttp -129.45 -173.48 3.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.782 0.325 . . . . 0.0 110.463 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 156.17 21.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.49 . . . . 0.0 111.456 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.4 t -159.19 63.42 2.31 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.439 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.78 142.31 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.112 2.541 . . . . 0.0 113.447 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.26 28.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -142.46 162.56 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 110.24 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.7 p -78.69 164.6 24.46 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -60.51 -34.71 74.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -63.15 -55.1 28.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.31 -44.71 92.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.335 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.29 -56.58 20.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.123 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 tp -49.37 -35.63 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.46 -49.24 43.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.557 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 140' ' ' LYS . 44.2 mtt -60.09 -60.42 3.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.7 mt -44.64 -21.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.13 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' MET . 31.5 ttmt -87.5 -33.81 18.85 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.595 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -94.92 -23.33 17.47 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.98 122.9 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.889 0.376 . . . . 0.0 110.758 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -139.1 123.26 18.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.218 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 144' ' ' VAL . 10.8 m -114.31 128.21 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.06 0.457 . . . . 0.0 111.114 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.6 m -109.33 167.24 10.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.548 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.8 pt -151.2 149.17 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -147.9 88.47 1.68 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 tt -83.35 145.24 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.506 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.402 ' HG3' ' H ' ' A' ' 150' ' ' CYS . 5.0 tpt180 -145.59 -177.2 5.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 149' ' ' ARG . 7.1 m -90.61 134.44 34.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.698 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' NH2' ' A' ' 89' ' ' ARG . 5.6 t -117.3 119.58 35.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.075 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -93.62 14.81 17.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.161 0.505 . . . . 0.0 109.82 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.2 OUTLIER -50.68 150.62 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.155 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.55 -10.08 3.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.466 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.78 158.06 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.93 175.49 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -90.48 143.33 26.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -114.07 92.23 3.9 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 pt -119.03 165.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.147 0.499 . . . . 0.0 111.323 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -119.54 134.63 55.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 m -76.52 54.59 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.538 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -130.77 123.74 20.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -38.14 147.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.916 1.744 . . . . 0.0 112.344 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 164' ' ' VAL . 20.3 m -73.4 130.46 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.341 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 34.8 mt -79.32 115.46 18.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.315 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.97 159.55 22.85 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.117 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.426 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 0.1 OUTLIER -95.2 11.14 33.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 110.295 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 58.72 21.19 8.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.343 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.413 ' C ' HD12 ' A' ' 169' ' ' ILE . 1.1 pp -76.63 -176.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.66 ' H ' ' HE ' ' A' ' 198' ' ' ARG . 51.1 m -147.94 113.82 5.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.619 ' ND1' ' N ' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -68.6 28.22 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.284 -178.254 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 170' ' ' SER . 16.9 mmmt -67.6 175.27 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.125 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.42 ' NZ ' ' CB ' ' A' ' 173' ' ' LYS . 0.2 OUTLIER -90.86 124.7 35.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.12 -165.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.041 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.4 p -50.55 145.77 6.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.807 0.337 . . . . 0.0 110.53 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -95.69 132.52 40.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -141.45 127.07 18.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.209 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -68.45 95.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.65 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.9 mt -107.35 -40.61 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.475 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 tp -66.84 114.42 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.468 . . . . 0.0 110.502 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.22 -122.91 0.7 Allowed Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.4 m -77.21 150.8 35.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 93.07 2.1 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.093 0.473 . . . . 0.0 110.263 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.3 tt -98.86 133.26 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.914 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 185' ' ' VAL . 14.2 m -146.76 131.29 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.99 0.424 . . . . 0.0 111.86 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 34.0 p-10 -85.93 103.34 14.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.754 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.7 m -46.99 -27.12 1.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.845 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -41.92 -26.38 0.09 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.966 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.404 ' O ' HD11 ' A' ' 88' ' ' LEU . 9.8 m -142.78 36.23 1.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 190' ' ' VAL . 7.4 p -169.43 105.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.4 0.619 . . . . 0.0 110.756 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -74.56 -54.43 7.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.729 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.31 173.83 6.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.137 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 193' ' ' LEU . 1.7 tt -173.56 106.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.228 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 19.2 mp0 -93.24 149.74 21.0 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -140.83 134.32 29.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.253 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -143.19 129.54 19.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.8 t -122.61 153.47 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.66 ' HE ' ' H ' ' A' ' 170' ' ' SER . 14.4 ttt85 -154.55 144.42 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.871 0.367 . . . . 0.0 110.155 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.94 119.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.652 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -169.57 -156.59 11.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.063 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 58.3 t0 -79.21 123.78 27.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.865 0.364 . . . . 0.0 110.434 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.426 ' SD ' ' OG ' ' A' ' 167' ' ' SER . 24.2 mmt -81.14 -3.24 51.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.4 -50.05 3.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.466 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.537 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 20.2 tptp -157.38 112.35 2.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 198' ' ' ARG . 2.0 mm-40 -43.65 156.17 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' GLU . 2.5 p -156.86 67.08 0.54 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.1 p 30.84 -88.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 206' ' ' SER . 17.8 mm-40 -40.52 -50.93 2.95 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.453 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.642 ' N ' HD22 ' A' ' 209' ' ' LEU . 1.9 mm? -81.68 54.27 2.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.547 ' CG ' HH22 ' A' ' 198' ' ' ARG . 1.3 tp10 -156.22 120.25 4.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.083 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.74 179.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.96 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -171.01 146.67 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.143 0.496 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 10.2 t70 -144.17 169.43 17.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.017 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 159.58 154.07 7.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.613 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.7 177.52 7.72 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -132.48 103.68 6.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -98.31 113.81 25.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.596 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.25 111.81 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.957 0.408 . . . . 0.0 110.691 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.13 43.39 30.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.98 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.16 74.77 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.455 -0.402 . . . . 0.0 112.561 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.8 p -89.84 112.9 24.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.67 149.45 23.3 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.714 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.6 m -166.29 124.29 1.44 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.623 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -77.99 138.99 39.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.424 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.75 108.22 0.27 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.52 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.11 104.23 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.6 p -129.53 159.22 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.468 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.577 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 37.6 t70 -62.13 95.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.29 12.65 4.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.577 ' HG1' ' CG ' ' A' ' 228' ' ' ASP . 40.0 m -45.29 -51.45 10.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.706 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 233' ' ' ILE . 20.4 m -97.18 6.37 48.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.8 tp -42.64 -24.44 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.936 0.398 . . . . 0.0 110.84 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 231' ' ' SER . 0.4 OUTLIER -163.93 142.91 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -74.87 100.52 4.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -64.28 -6.35 6.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.916 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 236' ' ' THR . 0.0 OUTLIER -88.04 -10.35 50.53 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.531 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -100.94 0.21 37.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.477 0.18 . . . . 0.0 111.145 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 238' ' ' LEU . 9.0 mp -80.02 142.06 35.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.152 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 104' ' ' SER . 63.8 mttp -130.44 136.83 49.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.837 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.84 138.03 57.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.733 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 74.6 m -100.17 -8.73 23.28 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.088 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.516 -179.324 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.745 0.307 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.08 120.29 5.67 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.573 2.182 . . . . 0.0 111.527 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' B' ' 4' ' ' GLY . 0.0 OUTLIER -51.66 175.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.47 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' B' ' 3' ' ' MET . . . -60.68 -131.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.641 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' B' ' 6' ' ' ASP . 13.2 p -175.74 20.85 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.732 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' B' ' 5' ' ' SER . 4.8 m-20 148.31 70.73 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 124.314 1.009 . . . . 0.0 109.031 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.04 176.44 6.98 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.336 2.024 . . . . 0.0 110.348 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.59 ' C ' HG22 ' B' ' 9' ' ' THR . 93.9 Cg_endo -74.9 -110.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 121.711 1.607 . . . . 0.0 110.725 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.59 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 160.65 65.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.82 84.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.507 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.548 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 76.2 m -119.29 155.8 31.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.21 134.51 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.677 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.548 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 23.5 m-85 -111.89 -27.52 8.42 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -152.05 155.07 37.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.991 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.5 OUTLIER -110.42 160.53 16.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.894 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -84.0 139.08 32.77 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.48 5.53 38.56 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.453 -178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.73 126.56 47.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.822 0.344 . . . . 0.0 111.247 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -77.89 133.42 38.12 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.687 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' B' ' 24' ' ' PHE . 3.8 mm? -93.7 111.11 51.22 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.908 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.05 149.51 1.25 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.164 1.909 . . . . 0.0 112.599 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' B' ' 24' ' ' PHE . 7.5 ptp85 -45.46 -43.07 11.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.677 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -70.2 26.31 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.628 ' CD2' HD12 ' B' ' 20' ' ' LEU . 14.9 t80 -146.22 27.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -152.27 100.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.013 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.409 HG22 ' H ' ' B' ' 26' ' ' VAL . 20.4 m -84.15 -27.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.647 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -165.61 -178.34 4.83 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.755 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 8.6 p90 -154.08 173.48 15.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 74.2 m-85 -160.91 141.12 11.14 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.802 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' B' ' 30' ' ' GLU . 2.1 mp0 -84.83 146.24 27.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 111.636 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 32.0 p -52.51 -108.57 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.948 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -150.57 -149.45 0.3 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.45 ' C ' ' H ' ' B' ' 35' ' ' CYS . 67.9 m -142.2 -24.6 0.67 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.279 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -54.77 -10.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.732 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.1 p -118.71 123.03 43.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.505 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 45.2 p -72.61 35.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.347 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' B' ' 35' ' ' CYS . 26.0 mt-30 -155.04 56.16 1.35 Allowed Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 46.5 Cg_endo -64.98 -167.86 0.1 Allowed 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 122.712 2.275 . . . . 0.0 112.827 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.21 176.57 0.11 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.787 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.1 t -107.82 131.85 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.95 129.81 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.657 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -110.82 146.16 36.91 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.972 0.415 . . . . 0.0 111.147 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -93.85 169.79 10.03 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 15.8 p -140.08 -143.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 111.089 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.36 -36.95 2.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.297 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.03 46.86 2.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.557 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 18.4 m -156.09 -80.48 0.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.532 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.72 -90.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.679 0.612 . . . . 0.0 109.759 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -143.68 144.18 31.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.439 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -149.31 120.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.636 . . . . 0.0 110.73 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 6.9 t -54.61 159.06 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.776 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.463 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.13 131.29 11.09 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.62 120.5 71.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 0.1 8.66 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.114 1.21 . . . . 0.0 111.242 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 90.0 p -67.99 -18.55 64.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.169 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -93.02 124.38 36.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.006 0.431 . . . . 0.0 110.29 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -50.87 -40.69 56.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.909 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.449 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 88.9 m95 -56.43 -33.48 65.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.047 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.89 -35.79 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.185 0.516 . . . . 0.0 109.706 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.7 -48.05 64.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.606 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -64.9 -35.79 82.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -62.02 -37.76 86.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.25 -44.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.85 -32.81 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.86 -38.29 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.42 -22.22 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.23 -31.06 63.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.416 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.44 -84.51 0.09 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.572 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.596 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.817 0.341 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -44.3 149.37 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.677 2.252 . . . . 0.0 112.154 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.03 87.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.502 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.4 p -169.66 68.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.479 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.1 mt 52.3 179.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.449 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -146.84 -175.34 4.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.349 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -57.48 130.37 45.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -72.89 -2.95 22.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -75.7 -33.47 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.6 m -49.47 131.06 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.498 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -59.84 -20.52 57.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.662 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 m -75.86 -21.39 57.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.283 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -87.37 -41.39 13.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.112 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -167.94 179.71 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.994 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.19 157.37 37.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.448 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -78.93 175.58 10.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.993 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -125.26 7.56 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.859 0.361 . . . . 0.0 110.302 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' GLU . 42.4 mm-40 -83.68 89.81 7.19 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.573 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' GLU . 42.2 mt-10 -23.51 -63.6 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.059 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -76.68 49.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.594 0.235 . . . . 0.0 111.014 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -155.85 125.56 6.41 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 132' ' ' HIS . 27.5 m-70 -125.61 152.44 45.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' SD ' ' A' ' 202' ' ' MET . 11.6 t-160 -93.7 82.57 4.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.47 ' O ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -47.05 174.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.617 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.99 133.79 1.61 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.3 tt -111.17 146.1 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.381 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.99 140.04 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.66 139.82 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.152 0.501 . . . . 0.0 111.837 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.0 mt -114.58 149.19 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.189 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' CZ ' ' A' ' 195' ' ' PHE . 0.9 OUTLIER -147.46 107.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 232' ' ' LEU . 32.3 ttmt -110.69 95.05 5.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.38 133.72 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.933 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 m -107.97 124.85 50.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.024 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -76.61 149.48 36.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -73.14 159.12 34.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.38 40.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.798 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -145.3 -28.51 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.425 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.2 m -68.32 115.72 32.29 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.414 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -40.29 158.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.79 1.66 . . . . 0.0 112.229 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.497 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 67.0 p -69.03 136.39 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 40' ' ' THR . 25.9 m120 -153.94 102.35 2.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.114 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -102.75 11.05 38.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 1.8 mptp? -70.36 88.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 pt -90.96 157.73 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.347 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m 57.18 39.44 28.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.307 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -55.51 -50.67 69.34 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.976 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.4 p -173.26 156.56 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.85 134.8 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.7 p -133.41 106.3 7.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.178 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -81.84 146.4 29.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.181 0.515 . . . . 0.0 110.862 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.457 HD12 ' CE2' ' A' ' 80' ' ' TYR . 5.4 mt -142.06 156.22 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.255 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -152.53 151.67 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 54' ' ' SER . 19.4 tp10 -56.27 174.72 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -72.81 -28.26 62.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.938 0.399 . . . . 0.0 110.215 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 63.1 mm-40 -51.5 -62.7 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.303 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.1 t -60.06 -27.53 67.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.171 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -156.0 87.17 3.05 Favored Pre-proline 0 N--CA 1.464 0.251 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' SER . 85.7 Cg_endo -79.85 69.44 7.94 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.933 1.755 . . . . 0.0 112.779 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.719 ' H ' ' CD ' ' A' ' 60' ' ' PRO . 2.3 t70 -121.78 -38.75 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.884 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.719 ' CD ' ' H ' ' A' ' 59' ' ' ASP . 27.9 Cg_exo -61.72 -49.97 6.14 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.055 1.837 . . . . 0.0 112.137 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -49.5 -96.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.746 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.81 HG13 ' H ' ' A' ' 63' ' ' GLU . 3.6 p 178.17 -65.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.81 ' H ' HG13 ' A' ' 62' ' ' VAL . 4.3 tm-20 -173.05 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.273 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.5 t -43.79 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.63 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 63' ' ' GLU . 33.0 tt0 -166.54 105.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -60.8 139.84 57.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.66 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.03 -115.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.547 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.0 p -168.29 167.31 12.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.057 0.455 . . . . 0.0 111.054 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -162.57 22.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.646 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 m 165.15 -177.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.821 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 73' ' ' ASP . 2.4 p 36.64 85.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 111.433 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -54.98 -7.4 0.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 71' ' ' VAL . 20.5 t70 -100.01 63.49 1.18 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.252 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -65.33 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.364 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -159.63 93.31 1.75 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -42.84 129.54 5.42 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.019 1.813 . . . . 0.0 112.09 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.85 150.45 21.07 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.225 1.95 . . . . 0.0 111.886 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 p -118.81 125.68 50.12 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.458 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 p -94.37 119.27 32.86 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.663 ' CE1' ' ND2' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -126.72 113.66 16.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.733 0.301 . . . . 0.0 110.569 -178.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 92' ' ' PHE . 11.9 p90 -113.01 122.22 46.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.967 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -92.07 76.88 5.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.318 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.74 110.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.402 0.62 . . . . 0.0 109.725 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 83' ' ' ILE . 71.3 mt -93.21 145.84 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.437 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.28 159.11 10.28 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.211 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.65 27.54 68.37 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.046 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.23 18.25 72.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.94 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -134.61 159.02 42.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 110.544 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -122.3 110.24 15.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.1 mtt -100.17 99.59 10.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.124 0.487 . . . . 0.0 110.808 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.663 ' ND2' ' CE1' ' A' ' 80' ' ' TYR . 17.0 t-20 -84.02 129.28 34.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.1 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 70.3 m-85 -112.94 -173.45 2.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.0 0.429 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.64 72.49 0.05 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.643 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.62 147.25 35.69 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 95' ' ' THR . 11.7 t -146.57 128.45 15.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm 59.3 29.94 19.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.515 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.2 146.47 40.73 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.47 153.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.681 1.587 . . . . 0.0 111.933 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.553 ' CD ' ' HZ3' ' A' ' 101' ' ' LYS . 3.4 pt20 -67.81 140.28 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.642 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.67 122.51 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.553 ' HZ3' ' CD ' ' A' ' 99' ' ' GLN . 47.1 mttp -126.36 -1.39 6.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.125 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 t -123.42 126.14 46.24 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.271 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.2 pt -147.89 139.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.858 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.1 p -146.46 177.06 9.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -158.64 155.36 28.06 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 p -155.45 151.63 28.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.229 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.47 110.34 11.79 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.639 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -118.91 107.7 13.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.68 -126.8 18.73 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -100.79 24.06 9.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 110.24 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 154.07 43.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.7 t -133.39 132.73 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -123.38 155.68 36.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.886 0.374 . . . . 0.0 110.768 -178.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.05 142.25 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.101 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -118.05 125.13 49.74 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.804 HD22 ' N ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -112.59 119.34 37.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.038 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 t -164.47 168.62 18.2 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.083 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.0 m -83.77 172.93 11.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.607 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -105.39 132.87 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.583 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.473 ' CB ' ' ND2' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -70.18 164.49 52.48 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.952 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.413 ' HD3' ' HD1' ' A' ' 23' ' ' HIS . 95.3 Cg_endo -75.25 139.21 23.4 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.455 2.104 . . . . 0.0 112.103 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.24 -11.63 40.13 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.562 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.499 ' OE1' ' N ' ' A' ' 123' ' ' GLN . 12.2 mp0 -76.29 -50.79 13.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.82 -2.17 1.18 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.404 -0.427 . . . . 0.0 112.419 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -103.97 -176.89 3.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.89 161.44 30.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 1.9 t -156.48 68.33 4.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.809 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.16 115.24 2.23 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 122.68 2.253 . . . . 0.0 112.861 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.9 141.59 29.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.5 pt -137.88 175.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 111.128 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 132' ' ' HIS . 25.9 m -83.48 161.16 21.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.788 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.579 ' NE2' ' CD2' ' A' ' 22' ' ' HIS . 21.0 m170 -58.63 -34.2 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.416 ' CD ' ' N ' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -61.34 -53.06 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.214 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -60.73 -43.95 97.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 138' ' ' MET . . . -59.95 -57.17 14.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.124 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -47.05 -39.07 12.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.988 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.82 62.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.344 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 135' ' ' ALA . 36.3 tpp -73.59 -29.67 62.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.83 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.35 -21.13 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.7 -37.37 18.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD2' ' CZ ' ' B' ' 18' ' ' ARG . 10.4 m-20 -85.43 -33.96 21.79 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.5 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.406 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 30.6 t -51.39 114.38 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.08 0.467 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 141' ' ' ASP . 0.3 OUTLIER -127.25 164.26 22.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 145' ' ' SER . 96.1 t -141.4 162.78 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' HG12 ' A' ' 144' ' ' VAL . 88.0 p -143.37 145.66 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.637 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 mp -140.2 144.32 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.025 0.44 . . . . 0.0 110.594 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -157.89 79.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.612 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 185' ' ' VAL . 9.4 mt -73.8 142.29 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.535 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -134.37 171.99 13.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.446 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.06 118.72 30.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.842 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 t -85.94 -173.51 4.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.26 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.401 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 6.9 tp10 -165.52 7.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -81.57 105.76 12.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.769 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 154' ' ' GLU . 20.1 mp0 -78.35 12.97 1.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -49.45 155.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.771 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.54 167.6 14.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.667 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.0 p -89.51 143.31 26.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.868 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -117.07 88.49 2.91 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.678 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.7 pt -110.14 177.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.119 0.485 . . . . 0.0 111.424 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 162' ' ' HIS . 73.7 tttt -137.33 125.95 23.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.781 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 161' ' ' THR . 58.4 m -59.22 -0.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.526 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.9 m80 -82.07 114.88 54.05 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.104 -0.239 . . . . 0.0 110.375 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -40.77 154.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.729 1.619 . . . . 0.0 112.184 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 49.2 t -77.28 136.56 24.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.577 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.8 mt -83.61 124.31 30.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.659 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 164.94 32.68 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.4 t -99.12 9.12 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.473 ' ND2' ' CB ' ' A' ' 120' ' ' SER . 7.1 m-20 59.11 -0.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.523 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.601 ' C ' HD12 ' A' ' 169' ' ' ILE . 2.5 pp -82.03 173.56 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.989 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 172' ' ' LYS . 19.9 m -133.28 129.38 37.54 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -73.13 31.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.48 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 170' ' ' SER . 3.1 mmmm -64.61 -178.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -90.63 121.37 32.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.413 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.497 HG21 ' HE ' ' A' ' 198' ' ' ARG . 17.2 m -141.44 -167.3 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.727 0.299 . . . . 0.0 110.477 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.1 t -48.24 142.95 4.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.922 0.391 . . . . 0.0 110.88 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -95.72 129.09 43.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -141.43 141.07 33.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.033 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.1 91.6 4.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.581 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.08 -59.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 180' ' ' ILE . 16.3 tt -50.26 122.28 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.48 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -91.66 -122.26 2.8 Favored Glycine 0 C--O 1.228 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.82 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.471 ' OG ' ' SG ' ' B' ' 51' ' ' CYS . 7.6 t -76.61 143.73 40.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.108 0.48 . . . . 0.0 112.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 62.8 m -139.89 84.97 2.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.103 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mt -103.89 103.83 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.942 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 148' ' ' ILE . 16.1 m -120.83 134.27 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.8 p-10 -78.89 116.5 19.25 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.6 m -52.09 -29.24 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -36.18 -36.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.54 32.74 1.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.643 0.259 . . . . 0.0 110.486 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 92.4 t -149.71 95.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.35 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -61.92 1.81 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.563 ' ND2' ' O ' ' A' ' 217' ' ' TYR . 7.9 t-20 -122.55 137.41 54.9 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -145.27 122.51 11.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.549 ' OE2' ' ND2' ' A' ' 192' ' ' ASN . 2.7 mp0 -109.8 161.35 15.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.483 ' CZ ' HD12 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -153.89 139.25 17.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.9 p -144.15 140.07 29.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.341 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.2 m -128.12 158.23 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.497 ' HE ' HG21 ' A' ' 174' ' ' VAL . 7.3 tpt180 -159.76 104.09 1.55 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.878 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 36.1 mt -106.99 118.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.67 -157.16 9.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.316 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 53.6 t0 -86.2 123.34 31.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 23' ' ' HIS . 55.2 mtp -78.12 0.26 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.326 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 5.7 t -112.4 -48.77 3.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.773 0.321 . . . . 0.0 110.628 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.481 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 3.2 tppp? -158.29 113.4 2.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.165 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -46.1 145.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.541 ' H ' ' CD ' ' A' ' 210' ' ' GLU . 7.5 t -130.23 25.25 5.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.495 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 84.1 p 52.93 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.602 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 206' ' ' SER . 33.5 tt0 -51.58 -34.24 36.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.589 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.0 mm? -88.59 -4.18 58.63 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.787 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 206' ' ' SER . 14.5 mp0 -96.15 144.84 26.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.983 0.421 . . . . 0.0 110.793 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.0 m -153.98 175.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.592 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 227' ' ' THR . 25.1 tttt -170.23 147.01 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.478 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -140.86 168.54 19.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 174.68 145.08 5.17 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.624 -1.274 . . . . 0.0 113.052 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PHE . . . . . 0.441 ' CZ ' ' OG ' ' B' ' 14' ' ' SER . 27.9 m-85 -129.37 164.9 22.6 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.45 103.27 5.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.563 ' O ' ' ND2' ' A' ' 192' ' ' ASN . 21.9 m-85 -97.44 116.5 29.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.817 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.48 HG22 ' ND2' ' A' ' 192' ' ' ASN . 44.7 t -128.76 101.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.311 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.6 t70 56.29 37.61 28.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.938 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.35 75.02 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.639 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.9 t -89.23 112.47 23.52 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.699 -0.295 . . . . 0.0 110.452 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.25 167.5 11.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.5 t -174.49 116.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.82 95.03 9.94 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -136.96 129.27 4.71 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 116.416 -0.357 . . . . 0.0 112.448 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -90.67 102.07 14.82 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.494 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.499 ' O ' ' NZ ' ' A' ' 212' ' ' LYS . 69.4 p -123.71 153.13 41.29 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.8 95.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -90.71 35.55 0.89 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 231' ' ' SER . 9.8 t -75.29 -39.62 59.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.309 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.466 ' N ' HG23 ' A' ' 230' ' ' THR . 99.3 p -102.56 3.78 37.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.339 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -48.41 -32.87 8.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.133 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.6 tt -135.06 150.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.242 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.41 92.39 9.06 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.405 ' O ' HD11 ' A' ' 238' ' ' LEU . 45.8 m -60.66 -3.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.332 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 p -91.01 -21.56 21.21 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -101.55 8.45 41.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 238' ' ' LEU . 0.3 OUTLIER -78.65 153.09 31.32 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.148 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -141.12 133.88 28.82 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.727 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.63 55.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.379 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 59.8 m -110.42 -1.93 16.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.528 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.817 0.342 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.56 115.84 2.0 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.762 2.308 . . . . 0.0 112.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -59.38 153.54 18.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.511 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.11 166.24 24.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.939 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 25.8 p -70.95 -86.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.694 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -127.91 80.88 71.38 Favored Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.738 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 27.2 Cg_exo -59.38 -174.91 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.502 2.135 . . . . 0.0 112.337 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 72.8 Cg_exo -53.79 -131.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.37 2.713 . . . . 0.0 113.818 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.493 ' O ' ' N ' ' B' ' 11' ' ' CYS . 1.8 t 177.21 41.93 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.731 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.53 93.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.538 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.539 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.6 m -134.76 146.33 49.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' CYS . . . . . 0.469 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 55.7 m -67.47 140.54 57.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.215 0.531 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 38.7 m-85 -117.33 -31.02 5.41 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.766 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 215' ' ' PHE . 2.7 m -140.88 145.29 35.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.04 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -109.28 152.22 25.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -78.43 139.56 38.73 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.599 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.1 -42.86 20.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.778 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.438 ' CZ ' ' OD2' ' A' ' 141' ' ' ASP . 0.9 OUTLIER -75.9 126.29 30.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.682 -179.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -77.12 137.85 39.16 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.601 HD22 ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -92.79 110.71 47.29 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -44.62 150.09 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.041 1.827 . . . . 0.0 112.68 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.519 ' C ' ' H ' ' B' ' 24' ' ' PHE . 50.1 mtt85 -46.02 -44.03 14.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.751 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' B' ' 23' ' ' ASN . 2.0 m-20 -68.45 27.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.519 ' H ' ' C ' ' B' ' 22' ' ' ARG . 22.2 t80 -151.98 27.3 0.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -155.97 104.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.353 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.14 -10.75 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.7 t0 -161.88 -178.61 6.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.897 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.471 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 12.6 p90 -163.2 175.74 10.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.217 0.532 . . . . 0.0 111.658 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 59.9 t80 -167.18 140.81 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.837 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.3 pt-20 -89.44 147.33 24.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.781 0.324 . . . . 0.0 111.17 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.469 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 41.1 p -50.51 -107.29 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -151.7 -132.93 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.52 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.444 ' C ' ' H ' ' B' ' 35' ' ' CYS . 23.8 t -152.47 -25.28 0.17 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.684 0.278 . . . . 0.0 110.588 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 20.3 mt -57.7 -7.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.057 0.456 . . . . 0.0 109.921 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' B' ' 37' ' ' GLN . 37.8 m -113.42 118.59 34.95 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.524 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 87.4 p -72.33 35.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.533 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.456 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.9 pt20 -167.59 61.71 0.57 Allowed Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 95.2 Cg_endo -73.94 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.803 2.335 . . . . 0.0 113.134 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 174.57 176.37 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.834 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 72.7 t -103.4 139.15 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.038 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.44 124.26 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.794 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -100.64 148.78 24.45 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.035 0.445 . . . . 0.0 110.542 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.465 ' CG ' ' N ' ' B' ' 44' ' ' THR . 26.9 tt0 -93.15 169.22 10.57 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.465 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 17.6 p -138.11 -145.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 111.709 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.49 -40.24 1.96 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.736 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.17 47.05 2.14 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.794 -0.184 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 8.6 t -156.2 -79.23 0.08 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.504 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.59 -90.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -143.76 147.97 34.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.438 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.6 t -150.28 114.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.259 0.552 . . . . 0.0 111.021 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.471 ' SG ' ' OG ' ' A' ' 182' ' ' SER . 74.5 m -50.12 159.99 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.704 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 130.59 10.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.34 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' B' ' 53' ' ' ASP . 23.4 p-10 -66.17 125.45 90.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.33 -2.06 11.84 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.141 1.227 . . . . 0.0 111.011 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 36.2 t -69.2 -12.22 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.199 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -101.02 122.65 43.92 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.132 0.491 . . . . 0.0 110.307 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 45.2 t -48.17 -46.86 35.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.496 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 35.4 p-90 -56.27 -24.71 44.71 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.572 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -75.26 -38.08 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 109.771 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -66.6 -48.43 69.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.41 -34.98 77.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -61.8 -40.81 96.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.36 -47.71 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.06 -31.43 65.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.748 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -73.7 -35.16 65.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.91 -20.01 59.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -73.27 -35.76 66.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.77 -77.46 0.14 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.342 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 p30 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.524 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.9 tpt . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 1' ' ' MET . 60.6 Cg_endo -89.43 -49.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.225 1.95 . . . . 0.0 111.986 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.93 86.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.603 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 m -166.28 61.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.505 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.4 mt 50.7 -177.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.461 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -170.02 69.13 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.613 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' C ' ' H ' ' A' ' 9' ' ' SER . 78.6 mt-30 -70.49 -20.21 62.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.52 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 p 74.22 -26.86 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 7' ' ' GLN . 10.1 t -72.82 -25.5 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.796 0.331 . . . . 0.0 110.755 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -51.53 144.16 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.54 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -68.07 -28.57 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -76.88 -22.68 53.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.8 p -81.11 -49.0 11.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -162.24 169.98 19.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 t -63.84 153.43 36.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.68 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.7 p -72.84 172.36 10.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.461 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.68 2.69 9.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 1.6 mp0 -77.78 98.17 5.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.439 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -31.17 -53.53 0.21 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.694 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -86.65 52.06 2.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 110.682 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 16.7 tttm -160.26 133.46 6.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 110.246 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.44 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 70.6 m-70 -154.35 124.31 6.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.523 ' CE1' ' CG ' ' A' ' 121' ' ' PRO . 11.1 p80 -76.68 97.2 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.53 149.13 40.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.61 158.38 26.56 Favored Glycine 0 CA--C 1.508 -0.388 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 tt -110.33 150.73 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -152.1 106.44 3.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 110.008 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.86 126.7 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.991 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -107.97 166.47 4.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.274 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 30' ' ' ILE . 12.9 tt -161.2 110.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.796 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -98.3 132.9 43.4 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.03 120.67 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.995 0.426 . . . . 0.0 110.844 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.539 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 68.4 p -88.33 121.26 30.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -75.81 150.76 37.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.75 136.44 40.3 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.82 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -46.77 -19.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 37' ' ' GLN . 1.3 mp0 -81.31 -43.89 18.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.547 0.213 . . . . 0.0 111.16 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -42.7 147.77 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.067 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.71 172.1 16.81 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.122 1.881 . . . . 0.0 111.446 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.7 p -74.02 135.23 43.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.474 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -167.09 99.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.47 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -103.64 -1.08 28.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.535 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -67.87 91.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -89.8 160.49 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.907 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 36.9 t 55.26 62.87 2.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.507 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.557 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.4 tp60 -77.44 -27.55 52.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.1 p -174.2 -176.19 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.888 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 p -170.36 101.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 109.956 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.8 p -103.38 126.7 50.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 1.5 pm0 -104.39 142.51 34.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.964 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.99 157.9 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -153.37 151.61 30.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 52.0 tt0 -48.0 168.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 p -70.07 -23.73 63.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.006 0.432 . . . . 0.0 110.06 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -42.77 -61.51 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.045 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 m -27.15 -96.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.393 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.717 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 18.9 t70 -170.99 -33.15 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.717 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 91.9 Cg_endo -90.62 -65.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.993 1.796 . . . . 0.0 113.437 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -40.73 103.11 0.28 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -90.9 60.42 1.3 Allowed 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.221 1.947 . . . . 0.0 112.02 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 63' ' ' GLU . 21.2 mt-10 -62.29 89.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 61' ' ' GLU . 17.1 m 10.32 55.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 124.255 0.972 . . . . 0.0 113.517 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 61' ' ' GLU . 6.6 tp10 -43.12 172.75 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.871 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 3.5 p 145.53 50.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.942 0.776 . . . . 0.0 109.736 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -170.8 159.75 6.54 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.035 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 69.85 62.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.025 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.96 -122.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.904 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.6 t -74.68 85.47 2.13 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.4 p -151.67 158.71 43.8 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.734 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 93.2 p 50.7 -162.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.764 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -153.71 67.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.985 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 59.55 75.77 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.425 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 74' ' ' VAL . 25.0 t70 -76.86 -139.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.323 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.477 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 60.7 t -91.84 -40.27 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.782 0.325 . . . . 0.0 110.596 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 43.1 75.84 0.59 Allowed Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.966 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -89.51 110.68 0.48 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.203 2.602 . . . . 0.0 112.638 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -87.6 164.3 7.87 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.474 2.116 . . . . 0.0 111.039 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -124.27 121.95 36.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 111.001 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 p -97.76 125.45 42.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -121.47 110.49 16.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.248 0.547 . . . . 0.0 111.019 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -93.73 124.09 37.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.519 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' ' CZ ' ' A' ' 80' ' ' TYR . 4.9 m -94.53 72.9 3.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.051 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.3 mm -74.67 101.73 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.801 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.6 mm -94.25 145.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.021 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.55 169.71 18.17 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.502 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.1 20.48 54.1 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.22 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.28 10.84 84.41 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 mt -131.98 155.62 47.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.58 115.45 27.2 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.3 mtt -102.07 124.16 47.2 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.04 0.448 . . . . 0.0 110.939 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.542 ' C ' HD22 ' A' ' 91' ' ' ASN . 0.2 OUTLIER -114.18 133.1 55.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.729 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.38 -174.73 2.86 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.821 0.343 . . . . 0.0 110.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.52 74.13 0.1 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.077 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -76.98 135.35 38.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.404 ' CB ' HH21 ' B' ' 18' ' ' ARG . 91.7 m -143.65 121.12 11.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.449 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? 65.0 31.72 11.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.979 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.2 m -126.42 149.81 68.58 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.22 143.51 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.999 1.799 . . . . 0.0 111.978 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 99' ' ' GLN . 4.2 mp0 -73.21 110.03 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.849 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.4 pt -69.13 142.1 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -135.34 -6.89 2.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.349 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.2 m -107.36 119.54 39.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.81 0.338 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 34.8 mt -132.04 120.02 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.425 ' OG ' HD12 ' A' ' 238' ' ' LEU . 35.1 p -146.58 162.87 37.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 111.015 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -148.39 164.83 32.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -155.12 151.86 28.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.911 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.08 124.9 33.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.424 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -145.22 111.43 5.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.002 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 -127.14 8.96 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -108.29 24.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.753 0.311 . . . . 0.0 110.32 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 p -129.16 159.17 36.88 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.637 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t -139.09 137.17 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 106' ' ' SER . 50.9 p30 -120.93 153.21 37.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.465 . . . . 0.0 111.006 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.21 130.66 19.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.605 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -116.52 116.49 27.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 110.899 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.3 mt -116.25 126.72 53.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 p -166.68 167.42 15.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.508 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 167' ' ' SER . 74.0 m -84.28 172.82 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.686 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 119' ' ' VAL . 10.7 m -96.18 147.92 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 111.024 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 t -92.71 152.2 41.63 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CG ' ' CE1' ' A' ' 23' ' ' HIS . 74.0 Cg_exo -37.89 158.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.21 64.45 3.81 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.175 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -140.99 -1.12 1.41 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 11.15 82.59 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.439 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -136.47 150.14 48.56 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.53 154.72 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.982 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -158.44 60.72 1.84 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.384 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -35.53 143.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.333 2.689 . . . . 0.0 113.715 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.45 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -109.96 146.56 35.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.568 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.01 165.81 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 110.186 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -87.44 174.48 8.49 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' OG1' ' A' ' 131' ' ' THR . 2.0 t60 -63.92 -39.33 93.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.34 -57.52 12.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.28 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.428 ' H ' HG23 ' A' ' 131' ' ' THR . 8.0 tp10 -63.18 -42.26 99.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.538 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.16 -57.01 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.177 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.86 -36.68 59.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.056 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.48 -37.66 71.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 21.1 mtt -62.34 -58.43 7.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -24.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.859 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -78.29 -55.27 5.38 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.376 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.41 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 33.9 m-20 -77.82 -23.65 48.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 19.0 t -58.07 113.59 1.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.526 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.54 ' CD ' ' HE ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -143.51 148.3 35.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.269 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.95 131.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.931 0.396 . . . . 0.0 110.309 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.6 p -103.19 173.12 6.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 15.1 pt -150.78 148.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.776 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -152.19 83.37 1.26 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.879 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.58 154.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 150' ' ' CYS . 34.1 ttt85 -145.36 172.17 13.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.022 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 149' ' ' ARG . 6.2 t -91.02 116.16 28.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.774 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.8 p -92.94 -176.85 4.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.208 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.9 6.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.295 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.469 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 63.8 tt0 -70.24 107.01 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.95 16.25 6.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.557 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 3.9 mmmm -60.73 172.72 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.674 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -76.55 169.65 17.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.636 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 71.6 m -96.6 147.65 23.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.47 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 16.3 t70 -113.18 90.94 3.48 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 160' ' ' LYS . 63.6 mt -115.11 159.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.17 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.521 ' N ' HG22 ' A' ' 159' ' ' ILE . 6.7 mmtp -121.9 128.93 52.13 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.9 p -62.55 1.97 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 160' ' ' LYS . 80.1 t60 -78.72 116.91 63.36 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -40.39 150.12 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.654 1.569 . . . . 0.0 111.939 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.85 137.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.898 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.6 mt -78.01 147.43 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.753 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -119.46 156.96 15.61 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.091 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 169' ' ' ILE . 3.5 m -89.57 10.31 23.43 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 168' ' ' ASN . 1.2 m120 56.5 1.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.502 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.494 ' H ' ' C ' ' A' ' 167' ' ' SER . 8.4 tp -94.33 144.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 26.6 p -105.65 149.91 25.92 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -83.83 46.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.373 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -73.0 -177.16 2.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -93.55 117.56 30.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.538 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.502 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 13.3 m -139.83 -171.24 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.145 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.1 t -43.31 138.15 2.41 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.77 0.319 . . . . 0.0 110.898 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.502 ' CE1' ' O ' ' A' ' 174' ' ' VAL . 2.3 m-85 -98.95 136.79 38.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.252 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 178' ' ' ASP . 5.1 tm-20 -151.84 158.11 42.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.512 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 4.5 p-10 -92.94 93.36 8.33 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 179' ' ' ILE . 0.2 OUTLIER -115.42 17.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.126 0.488 . . . . 0.0 110.016 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.488 ' O ' HD12 ' A' ' 180' ' ' ILE . 2.3 pp -113.14 119.11 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.292 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.59 -142.67 2.64 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.876 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 37.5 t -69.33 158.96 34.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.434 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -144.6 95.06 2.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.114 0.483 . . . . 0.0 110.151 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.8 132.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.655 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.578 HG21 ' CE2' ' A' ' 217' ' ' TYR . 3.3 m -142.74 123.02 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.691 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.6 p-10 -85.08 98.06 10.21 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 189' ' ' CYS . 31.3 m -47.58 -26.88 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.592 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -39.82 -26.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 187' ' ' THR . 94.0 m -146.31 24.94 1.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.185 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 23.3 t -148.5 95.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.74 -54.9 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.539 ' H ' ' HG1' ' A' ' 33' ' ' THR . 7.2 m-20 -125.35 -176.57 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.753 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.509 ' C ' HD23 ' A' ' 193' ' ' LEU . 4.7 tt -172.88 109.16 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -96.12 121.3 37.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -120.73 129.88 53.82 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.038 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.9 p -144.58 134.22 23.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 198' ' ' ARG . 59.1 t -122.88 154.91 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.449 ' N ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -145.53 144.77 30.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.237 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.8 mt -148.99 117.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.568 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.44 172.53 45.55 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.416 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.43 119.92 10.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 0.0 111.326 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 49.7 mtm -77.17 4.18 10.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.7 t -97.23 -61.74 1.36 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.437 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -147.49 115.02 6.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.323 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -43.64 123.23 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.633 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.0 t -117.16 105.05 11.83 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.652 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.3 m -38.21 -36.97 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.156 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.83 -48.98 62.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.677 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.5 mm? -90.42 13.88 14.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.245 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 128.16 42.65 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 212' ' ' LYS . 74.6 t -153.31 161.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.374 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -167.38 160.34 13.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.473 0.654 . . . . 0.0 112.444 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.6 t70 -146.5 171.39 15.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.352 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 162.89 145.4 4.34 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.902 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.23 -171.4 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -152.93 108.14 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.439 0.638 . . . . 0.0 111.439 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.578 ' CE2' HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -96.85 123.66 40.61 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.549 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 220' ' ' GLY . 6.2 p -141.06 118.31 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.4 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.0 t70 59.92 -13.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.308 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 140.08 0.44 1.93 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 t -104.11 117.5 34.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.58 156.24 17.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.906 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.3 t -166.17 123.26 1.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -81.28 99.09 8.44 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -120.55 134.51 10.36 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.934 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.46 ' HA ' ' HZ2' ' A' ' 212' ' ' LYS . . . -98.39 98.09 9.36 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 70.0 p -134.73 163.34 30.0 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.403 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 22.4 t70 -66.16 95.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.486 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.69 28.96 0.73 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.712 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.403 ' HG1' ' CG ' ' A' ' 228' ' ' ASP . 27.6 m -64.21 -57.09 10.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.165 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 m -84.57 1.25 46.79 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.544 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.35 -29.5 0.15 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.75 0.31 . . . . 0.0 111.413 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.4 pp -152.29 145.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.304 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.79 93.08 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' SER . . . . . 0.428 ' O ' ' CD2' ' A' ' 238' ' ' LEU . 31.4 t -64.42 -2.54 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.188 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 74.3 m -93.73 -19.41 21.1 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 237' ' ' LYS . 3.3 mptp? -98.76 -2.38 38.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.514 ' CD2' ' H ' ' A' ' 238' ' ' LEU . 1.1 pt? -91.04 158.2 16.82 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.363 0.983 . . . . 0.0 111.223 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -131.92 151.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.617 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.57 161.62 1.96 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.723 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 54.0 t -124.19 -13.78 7.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.017 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.588 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.731 0.3 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -45.65 121.45 4.07 Favored 'Trans proline' 0 N--CA 1.473 0.317 0 C-N-CA 122.732 2.288 . . . . 0.0 112.265 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -56.71 144.29 33.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.482 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.1 152.17 48.16 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.141 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.4 t -60.11 173.88 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 121.153 -0.219 . . . . 0.0 110.43 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -31.27 96.96 0.1 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' B' ' 8' ' ' PRO . 63.9 Cg_endo -87.62 161.39 7.9 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.351 2.034 . . . . 0.0 110.903 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' B' ' 7' ' ' PRO . 25.1 Cg_exo -34.61 -118.81 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.838 3.026 . . . . 0.0 114.296 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.957 HG23 ' H ' ' B' ' 10' ' ' ALA . 0.9 OUTLIER 177.42 -75.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.019 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.957 ' H ' HG23 ' B' ' 9' ' ' THR . . . 80.72 57.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.0 m -104.57 151.8 23.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -55.48 139.94 41.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.133 0.492 . . . . 0.0 112.008 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 8.8 m-85 -112.17 -27.26 8.43 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.7 t -158.42 158.8 34.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.489 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.39 -178.2 3.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.18 0.514 . . . . 0.0 111.778 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -99.05 135.83 39.9 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.78 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.4 12.12 4.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.54 ' HE ' ' CD ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -148.92 136.64 20.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.023 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -79.54 130.31 35.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.607 HD22 ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -84.12 114.46 54.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.546 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.34 141.87 1.97 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.783 1.655 . . . . 0.0 112.168 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.503 ' C ' ' H ' ' B' ' 24' ' ' PHE . 46.0 mtt85 -44.18 -42.62 6.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.597 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -69.77 28.24 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' B' ' 22' ' ' ARG . 23.2 t80 -153.12 29.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -155.03 99.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.902 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.48 -9.35 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.6 t70 -163.85 -178.97 6.0 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.883 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' TYR . . . . . 0.472 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.2 p90 -165.09 172.44 12.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.285 0.564 . . . . 0.0 111.652 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.441 ' CZ ' ' OD2' ' B' ' 27' ' ' ASP . 76.7 m-85 -153.87 179.63 8.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.064 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -125.5 147.38 49.26 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.843 0.354 . . . . 0.0 110.081 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 36.9 p -53.92 -106.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -157.7 -142.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.468 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.3 m -145.65 -22.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.296 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -56.83 -7.46 0.45 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' B' ' 33' ' ' SER . 3.6 p -121.29 122.51 40.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 86.1 p -74.55 42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.195 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -167.69 57.0 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 64.3 Cg_endo -68.94 -164.2 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 175.59 176.82 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.972 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.47 135.05 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.021 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.71 134.28 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.217 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -108.34 151.74 25.58 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.707 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.13 168.84 10.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 7.5 p -135.6 -144.96 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.343 0.592 . . . . 0.0 111.132 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ALA . . . . . 0.412 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.46 -38.82 1.33 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.988 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.47 46.24 2.34 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.728 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.613 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 15.5 t -156.58 -81.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.532 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.16 -87.79 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -145.93 148.02 32.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.98 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -152.32 123.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 109.844 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.479 ' H ' ' CB ' ' A' ' 182' ' ' SER . 5.4 t -58.36 164.44 2.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.979 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.9 134.62 13.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.717 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -68.21 120.13 72.43 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.05 -0.02 8.49 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.065 1.177 . . . . 0.0 111.318 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 59.5 p -74.11 -9.1 58.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.28 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -102.28 125.65 49.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 110.422 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -47.47 -50.07 24.04 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 64.4 p-90 -56.13 -27.56 54.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.758 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.48 -38.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -67.12 -51.6 52.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.357 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.81 -35.46 70.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.0 m-85 -62.88 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -71.01 -46.38 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.92 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.17 -28.85 69.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.27 -41.07 61.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.699 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.34 -22.5 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -69.93 -33.56 72.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.2 -102.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.6 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.0 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.809 0.338 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -76.0 -29.29 58.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 m -49.26 129.8 18.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.511 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -58.6 -21.89 54.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.536 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.2 p -77.44 -20.12 55.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 m -82.95 -50.47 8.54 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.989 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -165.42 173.43 11.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.972 0.415 . . . . 0.0 111.095 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.86 159.28 3.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.4 p -85.06 173.76 10.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.917 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -119.25 5.36 11.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.319 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.29 92.87 7.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.75 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 17.9 mp0 -27.6 -63.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.506 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -77.16 53.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 22' ' ' HIS . 19.9 tttp -163.08 137.13 6.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 63.0 m80 -157.42 123.22 4.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.81 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 128' ' ' PRO . 2.0 t60 -64.67 109.26 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 111.219 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.627 ' HE2' HD11 ' A' ' 139' ' ' ILE . 72.9 mmm -84.43 137.44 33.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.381 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.57 156.56 22.51 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' CG1' ' A' ' 197' ' ' VAL . 7.5 tp -110.7 151.25 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -157.27 106.56 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 110.253 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.86 148.97 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.313 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' A' ' 171' ' ' HIS . 10.1 mt -117.45 145.77 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.69 108.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.992 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -106.3 96.07 6.21 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -91.18 134.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.466 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 192' ' ' ASN . 29.8 m -113.92 121.68 44.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.692 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -77.5 151.04 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.721 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.462 ' CD ' ' N ' ' A' ' 36' ' ' ASP . 13.5 tm0? -80.07 148.96 30.83 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.462 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 15.4 t70 -72.76 65.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.721 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -172.09 -23.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 0.0 110.114 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.2 m -75.14 121.78 85.97 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.214 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -39.62 159.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.87 1.713 . . . . 0.0 112.318 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -73.57 147.14 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.353 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 86' ' ' GLY . 0.6 OUTLIER -174.08 101.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -112.27 25.42 11.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -86.12 54.62 3.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.83 176.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.007 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.9 m 55.6 34.99 24.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 46' ' ' GLN . 29.8 tp60 -59.72 -43.06 94.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.054 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 t 178.71 165.52 0.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.055 0.455 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.2 134.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.538 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.4 m -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -82.98 141.62 31.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.588 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -143.39 154.37 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.92 110.73 4.06 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 78' ' ' THR . 0.9 OUTLIER -64.79 115.59 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.298 -178.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.52 -0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.094 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 CA--C 1.54 0.797 0 N-CA-C 113.111 0.389 . . . . 0.0 113.111 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.412 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 19.4 p -131.32 150.66 52.06 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.619 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.9 m -121.05 128.22 52.44 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -127.37 153.88 45.67 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.0 0.429 . . . . 0.0 110.496 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 64.4 m-85 -128.85 137.45 51.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.964 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.5 p -105.03 66.18 0.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.062 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.68 98.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.842 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.73 145.09 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.63 161.97 11.5 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.404 ' O ' ' ND2' ' A' ' 41' ' ' ASN . . . 61.3 25.62 65.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.187 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.06 65.3 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.595 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.2 163.0 30.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.934 0.397 . . . . 0.0 110.084 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -129.95 112.46 13.53 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.445 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 mpt? -101.09 106.95 18.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.958 0.408 . . . . 0.0 110.662 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -88.84 128.63 35.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.74 -162.95 1.0 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.624 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.1 70.45 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 5.0 p90 -89.0 156.16 19.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -141.46 125.64 17.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm 61.93 35.08 16.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.531 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 m -121.84 146.02 44.88 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -39.1 148.03 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.928 1.752 . . . . 0.0 112.159 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -64.46 145.05 56.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.5 mt -108.47 116.64 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -119.28 0.8 11.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -115.38 118.26 32.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.503 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.33 120.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.8 m -144.91 159.25 43.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.857 0.36 . . . . 0.0 110.738 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -148.76 168.33 23.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.82 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.71 159.34 24.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.511 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.18 127.7 36.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.545 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -142.25 107.6 5.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.482 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.23 -134.38 19.61 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -96.43 23.38 6.83 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.778 0.323 . . . . 0.0 110.383 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -130.54 159.34 37.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.434 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.03 138.86 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.471 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -108.34 171.38 7.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 111.647 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.5 120.44 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.482 ' NH2' ' OG ' ' A' ' 235' ' ' SER . 7.3 tpp85 -113.97 114.9 26.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.826 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 115' ' ' ARG . 10.8 mp -115.84 127.42 55.03 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.4 p -164.7 175.96 9.26 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.664 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.421 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 73.6 p -92.79 166.36 12.47 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 119' ' ' VAL . 12.6 m -92.55 145.5 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 0.0 110.879 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.2 p -89.26 150.09 44.15 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.32 162.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.776 1.65 . . . . 0.0 112.21 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.13 69.99 0.84 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.136 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.11 -46.13 0.43 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.21 -8.09 2.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.081 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -117.57 -176.86 3.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.63 170.13 12.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -163.21 61.89 1.1 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.946 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.501 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 97.1 Cg_exo -42.87 125.16 3.84 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.84 2.36 . . . . 0.0 113.484 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.31 149.92 21.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -149.57 163.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 p -79.61 177.42 8.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -71.25 -34.74 71.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.42 -43.88 80.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.95 -30.57 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.41 -56.52 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.162 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -32.58 39.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.163 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.1 66.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.512 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.1 mtt -63.69 -56.72 13.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.626 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.627 HD11 ' HE2' ' A' ' 24' ' ' MET . 50.5 mt -46.35 -22.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -86.19 -42.06 14.14 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.72 -27.16 25.45 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.53 119.38 3.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -138.72 125.0 20.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.338 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 145' ' ' SER . 93.4 t -94.49 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.479 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.573 ' N ' HG12 ' A' ' 144' ' ' VAL . 12.4 p -140.22 144.54 36.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.386 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.1 mt -140.83 143.1 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.984 0.421 . . . . 0.0 110.595 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -158.29 77.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.027 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.62 152.0 6.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -134.7 -149.11 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.344 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.4 t -132.67 108.97 9.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.216 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 m -97.25 173.08 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.5 10.79 0.97 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.927 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -64.22 104.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.759 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.24 1.93 30.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -52.34 150.15 4.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.565 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.03 171.59 1.69 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.162 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 80.5 p -97.83 149.62 22.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.922 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -121.5 93.35 3.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.735 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.476 ' C ' HD12 ' A' ' 159' ' ' ILE . 1.6 pp -110.35 178.1 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.807 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 162' ' ' HIS . 42.9 tttp -135.64 125.9 26.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.831 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 161' ' ' THR . 35.3 m -57.95 -2.33 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.24 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.3 t-80 -75.08 116.36 53.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.376 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -40.49 160.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.81 1.674 . . . . 0.0 111.97 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.31 129.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 mt -79.03 121.26 24.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.56 160.68 22.76 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.303 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -92.04 8.08 39.36 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 58.75 -0.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.494 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.493 ' H ' ' C ' ' A' ' 167' ' ' SER . 9.4 tp -90.73 141.82 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -88.58 -176.53 5.32 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.454 ' CD2' HD11 ' A' ' 29' ' ' ILE . 4.6 m-70 -123.73 24.2 8.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -58.26 -166.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -101.8 122.94 44.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.07 -168.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.254 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.7 m -49.78 148.54 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 54.5 p90 -98.34 133.38 42.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.07 132.34 23.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.39 97.85 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.568 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.5 mt -107.86 -51.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -56.23 115.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.946 0.403 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.78 -123.86 0.7 Allowed Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.1 t -75.2 148.7 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.763 0.316 . . . . 0.0 110.759 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.3 p -141.81 87.23 2.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.556 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.468 HD11 ' HB1' ' B' ' 10' ' ' ALA . 8.8 tp -98.87 135.58 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.9 129.96 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.711 0.291 . . . . 0.0 111.526 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -81.79 90.02 6.35 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -46.25 -27.22 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.279 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -44.93 -16.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.76 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 187' ' ' THR . 57.0 m -143.71 24.55 1.69 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 p -163.98 104.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.512 0.672 . . . . 0.0 110.313 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -72.21 -56.52 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.493 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.456 ' H ' ' HB ' ' A' ' 33' ' ' THR . 10.6 m-20 -125.71 141.1 52.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.236 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.1 tt -145.34 106.74 4.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.66 151.86 19.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.05 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -140.77 138.03 33.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 110.242 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.8 m -143.85 135.92 26.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.347 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 198' ' ' ARG . 21.3 t -134.2 160.06 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.462 ' N ' HG12 ' A' ' 197' ' ' VAL . 39.8 ttt180 -171.79 113.87 0.34 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.985 0.421 . . . . 0.0 110.842 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.3 128.96 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.791 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.76 167.71 40.36 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.224 -0.512 . . . . 0.0 111.938 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -53.46 123.34 11.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.421 ' SD ' ' OG ' ' A' ' 118' ' ' SER . 77.9 mtm -82.74 4.67 24.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 34.8 t -106.88 -46.76 3.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.69 117.56 2.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 6.0 mp0 -43.98 156.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.701 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 208' ' ' GLU . 17.9 t -141.11 17.8 2.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.646 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 208' ' ' GLU . 73.7 p 56.28 -74.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.0 mm-40 -49.25 -54.41 16.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.57 0.224 . . . . 0.0 111.597 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.4 mp -74.57 4.38 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -104.0 124.21 48.61 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.8 m -146.56 -179.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.22 167.55 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.485 0.66 . . . . 0.0 111.834 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 213' ' ' ASP . 0.6 OUTLIER -157.3 172.9 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.956 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 157.3 143.4 3.65 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.496 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -121.15 179.28 4.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.98 104.16 5.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.406 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -97.72 118.71 34.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.877 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.1 t -138.34 100.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.38 52.45 13.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.923 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.99 48.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.646 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.9 t -85.63 106.03 16.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 111.479 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.5 143.96 32.03 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.2 m -164.63 130.85 2.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.647 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -82.25 140.91 33.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.351 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -177.71 110.8 0.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.63 127.39 32.85 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 47.1 p -150.21 161.07 43.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.09 95.52 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.607 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -87.21 26.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.286 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.6 m -67.13 -29.57 69.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.6 t -116.57 5.89 13.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.664 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.7 OUTLIER -42.28 -28.43 0.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 35.9 pt -156.39 152.01 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.33 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.11 98.92 4.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.482 ' OG ' ' NH2' ' A' ' 115' ' ' ARG . 23.3 t -64.08 -9.58 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.298 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 64.3 p -82.79 -12.37 57.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -102.74 7.44 39.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.576 0.227 . . . . 0.0 111.386 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -81.32 132.04 35.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.097 0.475 . . . . 0.0 110.786 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -123.15 135.55 54.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.388 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.74 127.3 31.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.104 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 34.0 m -88.58 -3.72 58.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.695 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 242' ' ' VAL . 11.7 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.434 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 184' ' ' ILE . . . . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 1.8 t -97.11 154.06 17.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.691 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.65 146.59 48.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -116.84 -23.46 8.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.335 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -151.54 154.9 37.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.108 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -114.95 154.82 28.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.91 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -76.38 139.75 41.1 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 -20.94 40.54 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.149 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -105.54 127.88 53.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -84.51 114.34 21.87 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.465 ' N ' HD12 ' B' ' 20' ' ' LEU . 10.9 mp -75.45 115.15 42.84 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.903 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.67 153.44 0.15 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.045 1.83 . . . . 0.0 112.606 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 25' ' ' VAL . 84.5 mtp180 -45.7 -49.89 14.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.67 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.437 ' N ' HD22 ' B' ' 23' ' ' ASN . 2.3 m120 -38.89 -34.69 0.16 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.9 OUTLIER -106.08 38.18 2.09 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.934 0.397 . . . . 0.0 109.983 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' B' ' 22' ' ' ARG . 48.8 t -152.95 97.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.571 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.7 -13.86 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.88 179.48 9.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.189 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.492 ' O ' ' CD2' ' B' ' 29' ' ' TYR . 13.4 p90 -165.56 169.92 14.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.187 0.518 . . . . 0.0 111.796 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' B' ' 28' ' ' TYR . 94.5 m-85 -159.0 153.62 24.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.601 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' B' ' 31' ' ' THR . 41.6 mt-10 -97.71 147.31 24.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.854 0.359 . . . . 0.0 111.11 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 41.9 p -53.11 -110.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.146 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.7 m -150.81 -145.72 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.666 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.457 ' C ' ' H ' ' B' ' 35' ' ' CYS . 65.9 p -141.38 -22.9 0.74 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.424 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.23 -5.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.1 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.458 ' C ' ' H ' ' B' ' 37' ' ' GLN . 8.6 p -117.5 120.83 39.3 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 34.4 t -72.66 36.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.245 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' B' ' 35' ' ' CYS . 11.9 pt20 -167.51 60.86 0.53 Allowed Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 68.7 Cg_endo -70.16 -161.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.665 2.243 . . . . 0.0 112.83 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.48 176.92 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 134.98 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.67 130.32 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.018 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -111.26 146.51 36.87 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.48 169.06 10.63 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -136.12 -142.92 0.18 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.249 0.547 . . . . 0.0 111.092 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.499 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.53 -40.46 2.22 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.848 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.47 47.88 2.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.39 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 59.6 p -151.48 -79.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.422 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.58 -90.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.76 147.67 35.95 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.954 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.63 123.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.021 0.438 . . . . 0.0 110.111 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.76 162.26 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.242 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.5 125.71 7.32 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.762 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.14 123.06 82.99 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 0.37 8.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.235 1.29 . . . . 0.0 111.357 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 62.2 p -68.22 -14.7 63.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -100.08 124.02 44.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -50.86 -38.38 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.989 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -56.4 -33.69 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.744 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.89 -36.35 57.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.123 0.487 . . . . 0.0 109.887 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.72 -37.94 73.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.482 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -71.01 -35.69 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.176 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.05 -37.65 88.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.71 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 60.9 t -70.67 -45.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.93 -38.97 80.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.986 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.1 -41.72 90.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.932 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.25 -19.81 63.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.51 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.33 66.2 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.9 mt -76.4 -77.49 0.14 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.896 0.379 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.529 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.824 0.345 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -76.58 -23.91 53.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.685 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -51.08 139.59 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.6 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 p -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.702 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -77.59 -28.7 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.71 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.9 p -78.55 -50.79 10.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.999 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -161.92 172.6 15.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.705 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.41 150.59 47.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.346 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.43 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 12.4 t -63.48 170.45 3.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 0.0 110.742 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.435 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 23.8 mp0 -113.06 4.88 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.593 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -61.98 -164.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.964 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -127.01 -62.85 1.09 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.0 110.72 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -82.15 34.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.535 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.93 142.5 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -144.43 159.75 42.22 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.0 OUTLIER -88.02 81.56 7.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.852 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.605 ' N ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -69.33 123.67 21.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.65 179.31 17.03 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 tt -136.0 154.92 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.747 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 53.8 t0 -145.67 137.65 25.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG13 ' CZ ' ' A' ' 195' ' ' PHE . 91.9 t -137.95 107.87 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.538 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.3 mp -94.28 142.62 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.659 ' H ' HH21 ' A' ' 115' ' ' ARG . 9.1 tt -155.62 117.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.54 0.686 . . . . 0.0 111.482 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -104.52 127.65 52.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.663 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -125.31 117.1 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.043 0.449 . . . . 0.0 111.89 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 m -96.79 132.98 41.96 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -94.54 164.0 13.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.926 0.394 . . . . 0.0 109.971 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.76 157.1 37.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.019 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -83.02 -34.67 26.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.993 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.2 m -45.04 110.77 1.14 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.03 159.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.725 1.616 . . . . 0.0 111.998 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -70.04 137.92 51.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.796 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -157.68 102.87 1.89 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 44' ' ' ILE . 14.5 t70 -101.6 -12.93 18.08 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.762 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -58.4 81.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.977 0.418 . . . . 0.0 110.548 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.5 tp -86.56 156.25 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 12.4 t 57.08 61.8 2.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.539 0.685 . . . . 0.0 110.048 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 155' ' ' LYS . 7.9 tt0 -80.26 -30.07 38.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.0 m -171.54 166.76 6.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.488 ' CG2' ' SG ' ' A' ' 241' ' ' CYS . 6.7 t -148.7 105.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -106.71 112.16 25.02 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.869 0.366 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.629 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -89.09 138.61 31.26 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.284 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.1 mt -140.39 151.25 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.9 p -149.59 138.65 21.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.224 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -45.26 169.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.961 179.913 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 N--CA 1.463 -0.323 0 N-CA-C 110.791 -0.504 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -130.82 145.69 52.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.936 0.398 . . . . 0.0 111.251 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.9 t -121.86 130.95 53.77 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -124.91 114.98 19.88 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.952 0.406 . . . . 0.0 111.252 -177.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.86 124.15 37.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.289 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -96.36 71.58 2.76 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.05 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.41 HG22 ' H ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -72.42 111.97 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.82 169.49 18.1 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.339 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.31 20.36 43.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.851 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.88 10.0 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.75 155.53 46.49 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -121.38 106.9 11.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 mtt -101.57 106.66 17.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.942 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -95.6 127.67 41.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.539 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.75 -169.93 1.73 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.29 72.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -76.21 135.78 39.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 110.972 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.2 m -140.04 122.61 16.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.0 32.66 22.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.3 m -121.42 149.56 52.57 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.644 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -38.7 152.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.98 1.787 . . . . 0.0 112.093 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 99' ' ' GLN . 19.4 mp0 -79.57 109.25 13.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.041 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 127.37 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.848 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 125' ' ' LYS . 1.2 tppp? -123.13 2.78 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.467 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.0 p -130.86 131.24 44.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.25 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.2 tt -144.98 130.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.6 p -150.29 152.84 35.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.182 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -142.28 175.49 9.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 110.689 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 t -168.54 164.36 12.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.948 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.17 131.38 42.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 20.9 p-10 -144.43 107.74 4.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.028 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.41 -122.72 18.7 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.744 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -102.93 20.82 16.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.621 0.248 . . . . 0.0 110.649 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.4 p -128.63 151.84 49.03 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.076 0.465 . . . . 0.0 111.024 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.42 135.88 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.61 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.4 HD22 HH12 ' A' ' 115' ' ' ARG . 2.2 m120 -104.73 165.42 11.08 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 111.458 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.657 ' H ' ' NH2' ' A' ' 115' ' ' ARG . . . -163.46 120.56 1.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.659 HH21 ' H ' ' A' ' 30' ' ' ILE . 13.1 mmp_? -115.34 111.66 21.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.422 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.24 118.91 37.22 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 p -156.75 177.08 11.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.328 0.585 . . . . 0.0 111.763 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 p -93.38 164.96 13.01 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.534 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.457 ' O ' ' CE ' ' A' ' 202' ' ' MET . 8.2 p -97.78 130.49 46.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 111.326 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 p -72.91 153.29 91.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.797 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.17 151.53 58.68 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.934 1.756 . . . . 0.0 111.5 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.35 50.12 8.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.23 -0.509 . . . . 0.0 111.845 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -134.75 -22.76 1.63 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.778 0.323 . . . . 0.0 110.281 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.73 14.97 11.53 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 101' ' ' LYS . 35.9 mmtm -135.04 164.48 27.54 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.24 148.01 45.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.509 . . . . 0.0 111.757 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.0 m -155.43 62.66 3.37 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.705 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.4 142.26 2.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.877 2.385 . . . . 0.0 113.361 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.56 150.22 22.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.231 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 tp -131.01 164.61 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.649 0.261 . . . . 0.0 110.62 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 132' ' ' HIS . 26.8 m -81.66 154.92 25.86 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 121.182 0.515 . . . . 0.0 111.322 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.407 ' N ' HG22 ' A' ' 131' ' ' THR . 6.3 t60 -50.73 -38.43 47.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.724 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -56.53 -42.34 78.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.14 -56.84 16.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 tp -51.65 -35.44 42.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.909 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.19 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.737 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.403 ' C ' ' N ' ' A' ' 140' ' ' LYS . 48.5 mtt -69.07 -62.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.526 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.5 mt -44.96 -20.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.728 0.299 . . . . 0.0 111.218 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 138' ' ' MET . 19.7 tptm -87.47 -33.65 18.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.396 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -94.36 -26.03 16.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.433 ' SG ' HD11 ' A' ' 199' ' ' ILE . 34.0 t -49.61 118.62 2.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -137.72 118.93 14.53 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.2 t -115.16 126.89 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.5 p -100.96 165.14 11.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.9 mp -142.96 150.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.11 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -160.77 86.89 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.705 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.8 tt -83.32 151.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 111.904 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.443 ' CG ' ' H ' ' A' ' 150' ' ' CYS . 57.2 ttt180 -149.01 176.07 10.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.075 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.46 ' SG ' ' OD2' ' A' ' 186' ' ' ASP . 11.8 m -90.99 143.35 26.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 65.3 p -129.91 124.77 33.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.311 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.22 -10.09 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.498 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 153' ' ' GLU . 1.5 mp0 -51.34 101.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -89.21 17.22 6.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.949 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.491 ' N ' ' OE1' ' A' ' 46' ' ' GLN . 63.6 mmtt -58.47 162.18 3.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.496 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 168.87 8.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.73 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.6 p -97.38 148.89 22.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 85.2 m-20 -117.21 91.11 3.48 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.65 177.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.141 0.496 . . . . 0.0 111.232 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' HG2' ' H ' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -105.88 -171.39 1.89 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -127.32 -6.01 5.95 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.475 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 37.1 m80 -108.88 129.05 24.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.895 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -39.18 157.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.176 1.917 . . . . 0.0 112.807 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.21 143.91 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.173 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.39 116.33 22.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.891 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.02 172.68 49.85 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.624 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 169' ' ' ILE . 11.4 m -105.18 8.88 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.8 m-20 59.24 -3.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 167' ' ' SER . 56.4 mt -86.96 154.3 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.406 ' N ' HG22 ' A' ' 169' ' ' ILE . 53.9 p -118.33 135.52 54.26 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.512 ' NE2' ' OG ' ' A' ' 196' ' ' SER . 0.1 OUTLIER -73.55 39.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.583 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -67.12 179.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.15 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -90.97 122.02 33.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -146.43 -160.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 174' ' ' VAL . 42.8 t -50.81 140.83 14.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.138 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -104.95 139.86 39.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 11.3 tm-20 -161.22 146.21 13.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.481 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.437 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 41.8 t0 -66.94 104.17 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.859 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.4 mt -114.19 -23.86 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 215' ' ' PHE . 17.9 pt -90.91 137.95 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 110.876 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.38 -134.47 7.05 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -71.59 154.78 41.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.415 ' C ' HD12 ' A' ' 184' ' ' ILE . 84.8 m -149.74 94.54 2.19 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.7 mp -97.39 138.11 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.61 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 185' ' ' VAL . 1.5 m -140.92 123.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.032 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.46 ' OD2' ' SG ' ' A' ' 150' ' ' CYS . 34.6 p-10 -79.39 110.23 14.49 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.2 m -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -34.97 -46.17 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.09 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 26.5 p -143.09 40.29 1.49 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.299 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.4 t -149.4 96.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -80.12 -58.93 2.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.137 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 36.3 t-20 -127.28 137.65 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.118 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.432 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 7.7 tt -138.61 106.67 5.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.934 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -93.48 140.25 29.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.444 ' CZ ' HG13 ' A' ' 28' ' ' VAL . 34.1 t80 -137.77 133.43 34.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.993 0.425 . . . . 0.0 111.259 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 171' ' ' HIS . 1.2 t -144.02 144.25 31.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.934 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.558 HG22 ' N ' ' A' ' 198' ' ' ARG . 2.7 p -139.43 166.62 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.937 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.558 ' N ' HG22 ' A' ' 197' ' ' VAL . 21.3 ttt180 -169.35 111.27 0.48 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.783 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.433 HD11 ' SG ' ' A' ' 142' ' ' CYS . 25.6 mt -102.37 122.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -163.24 -161.28 12.3 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -78.86 137.71 37.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.496 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 22.6 mtp -92.09 -6.37 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.258 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.45 -57.8 2.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.544 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -155.22 136.03 13.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -42.72 158.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.198 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 9.6 t -147.15 6.56 0.88 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.504 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.2 m 58.44 -75.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.0 mt-10 -47.84 -48.85 30.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.867 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 209' ' ' LEU . 10.2 mp -83.23 0.42 45.58 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 207' ' ' SER . 10.0 mp0 -95.72 118.03 31.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.96 163.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.077 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.414 ' HD3' ' H ' ' A' ' 174' ' ' VAL . 12.2 ptmt -164.28 168.01 19.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.573 0.701 . . . . 0.0 112.188 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.7 t70 -141.53 171.33 14.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.861 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 173.13 148.13 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.145 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 180' ' ' ILE . 8.8 m-85 -139.62 174.22 10.74 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -139.17 104.14 4.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.964 0.411 . . . . 0.0 110.592 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.57 116.8 30.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.477 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 218' ' ' VAL . 11.8 p -140.65 118.88 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.391 0.615 . . . . 0.0 110.959 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 15.5 t70 48.25 43.04 18.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.769 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.32 -3.9 85.09 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.469 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.1 t -100.4 116.7 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.027 0.413 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.77 150.55 23.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 70.9 m -166.24 128.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.455 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -77.61 141.5 39.44 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.86 101.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.267 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.28 98.02 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.3 p -129.28 160.09 34.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.405 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -63.32 95.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -89.95 35.92 0.85 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.608 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.6 p -71.51 -45.22 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 233' ' ' ILE . 44.4 t -94.34 -1.9 53.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 53.5 tp -42.15 -20.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.757 0.313 . . . . 0.0 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.561 ' C ' HD12 ' A' ' 233' ' ' ILE . 2.2 pp -149.16 174.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.329 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.93 93.87 5.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.004 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 82.3 p -66.18 -6.2 12.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 60.0 p -91.78 -17.21 25.7 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -105.05 4.71 31.85 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 238' ' ' LEU . 0.3 OUTLIER -76.18 161.15 29.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.159 0.504 . . . . 0.0 110.863 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.427 ' HA ' ' HZ1' ' A' ' 160' ' ' LYS . 2.1 mppt? -144.6 129.73 18.58 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.962 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.469 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . . . -57.66 155.75 9.46 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 48' ' ' VAL . 28.3 t -119.2 -3.85 10.55 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.62 179.725 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.4 m -119.1 128.37 54.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 p -71.21 135.2 47.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.218 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -110.34 -15.48 13.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.569 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 75.7 m -122.98 147.24 46.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.316 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.487 ' CE2' ' OD1' ' B' ' 53' ' ' ASP . 16.8 m-85 -118.89 153.6 34.3 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.244 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -78.97 134.88 36.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.905 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.66 27.94 4.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.788 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.02 126.64 21.89 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.943 0.401 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -57.51 164.01 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.91 89.95 33.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -41.91 142.87 1.32 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.737 1.625 . . . . 0.0 111.987 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -42.9 -48.51 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.45 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -37.72 -34.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -107.54 42.4 1.34 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.675 0.274 . . . . 0.0 111.227 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -144.44 86.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.038 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.54 -28.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 26.7 t0 -157.83 -179.77 8.46 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.648 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.48 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.4 p90 -163.06 169.06 20.07 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.233 0.539 . . . . 0.0 112.071 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 55.7 t80 -159.06 164.45 35.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.132 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.6 pt-20 -114.38 152.21 31.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.72 0.295 . . . . 0.0 110.588 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.426 ' O ' ' O ' ' B' ' 30' ' ' GLU . 36.3 p -55.69 -116.1 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.078 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -149.43 -156.07 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.473 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.451 ' C ' ' H ' ' B' ' 35' ' ' CYS . 75.2 m -126.09 -24.62 3.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.343 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.4 mm? -53.09 -9.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.227 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.451 ' H ' ' C ' ' B' ' 33' ' ' SER . 4.1 p -120.13 123.65 43.85 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -74.57 42.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -166.31 56.86 0.42 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 59.8 Cg_endo -67.97 -161.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 122.795 2.33 . . . . 0.0 113.013 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 167.83 177.39 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.67 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.77 134.07 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.137 0.494 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.94 141.83 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.474 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -119.33 150.32 40.34 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.683 0.277 . . . . 0.0 110.649 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -115.63 112.13 21.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 109.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 4.7 p -75.62 -138.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.027 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.485 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -131.02 -32.22 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.062 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.39 40.5 3.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.043 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 27.4 t -142.94 -83.35 0.17 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 121.378 -0.129 . . . . 0.0 110.704 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.58 -90.73 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.704 0.627 . . . . 0.0 109.612 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' O ' ' B' ' 48' ' ' ALA . 15.4 mm100 -141.11 135.98 31.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 t -148.57 124.0 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.424 0.631 . . . . 0.0 110.26 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 39' ' ' ALA . 2.3 t -72.35 155.57 40.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.468 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 135.24 17.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.271 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . 0.487 ' OD1' ' CE2' ' B' ' 15' ' ' TYR . 60.9 m-20 -63.86 128.16 92.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.237 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.25 0.6 9.23 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.423 1.415 . . . . 0.0 110.889 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 71.0 m -70.57 -12.55 61.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.198 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -96.46 129.21 43.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.205 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 31.9 t -48.75 -51.97 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.041 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -56.5 -32.46 65.07 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.001 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.98 -35.89 76.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.819 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -73.95 -37.84 64.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.628 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.4 -36.91 79.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.859 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.7 -36.68 84.66 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.64 -42.83 86.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' OE2' ' B' ' 67' ' ' GLU . 57.4 t80 -62.67 -34.17 76.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.472 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -70.05 -48.35 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.9 -19.62 66.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -71.77 -32.69 67.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.1 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.813 HD23 ' N ' ' B' ' 69' ' ' ASN . 7.5 tt -83.66 -79.51 0.2 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.813 ' N ' HD23 ' B' ' 68' ' ' LEU . 49.3 t30 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.51 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.884 0.373 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 m -76.87 -19.49 57.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -50.08 141.24 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.615 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.8 p -68.96 -5.77 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -101.86 -18.31 15.79 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.563 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -86.75 -48.85 7.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -156.71 177.1 11.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.012 0.434 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.71 141.78 39.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.613 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -61.39 166.67 3.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.884 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.4 9.71 12.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.017 0.437 . . . . 0.0 109.903 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 21' ' ' LYS . 49.9 mt-10 -86.02 91.5 8.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -33.98 -41.73 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.812 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -80.6 25.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.532 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.4 mmtp -138.43 136.52 36.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.847 0.356 . . . . 0.0 110.08 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.578 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 27.9 m170 -130.92 135.33 47.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -80.62 102.8 10.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -66.41 175.56 2.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.268 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 199' ' ' ILE . . . 166.39 126.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 tt -109.91 150.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.876 0.37 . . . . 0.0 110.454 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.419 ' CB ' HD11 ' A' ' 169' ' ' ILE . 7.5 t70 -132.86 141.82 48.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.66 97.47 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.8 0.334 . . . . 0.0 111.246 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mm -91.69 136.43 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.402 HD11 ' SD ' ' A' ' 90' ' ' MET . 2.0 pp -143.15 126.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.33 0.586 . . . . 0.0 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -115.82 126.87 54.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.76 133.21 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.744 0.307 . . . . 0.0 111.383 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -105.79 130.72 53.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -80.42 155.09 27.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.232 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -66.88 179.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -77.85 -31.34 51.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.707 0.289 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.38 -34.01 31.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.218 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 p -40.98 104.96 0.36 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.5 164.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.9 1.733 . . . . 0.0 111.941 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 p -68.21 145.87 53.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.509 HD22 ' C ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -171.64 97.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -103.02 0.09 31.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.653 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.1 87.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.402 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.45 ' CG2' ' HB2' ' A' ' 107' ' ' ALA . 20.8 pt -85.07 150.79 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.501 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 39.2 t 57.18 64.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.644 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.526 HE22 ' C ' ' A' ' 156' ' ' ASP . 37.8 mm-40 -77.29 -26.89 52.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 t 174.29 164.63 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.72 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -144.21 139.04 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.73 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.2 m -136.54 102.71 5.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.811 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -82.3 126.24 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.338 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.431 HD12 ' CE2' ' A' ' 80' ' ' TYR . 7.7 mt -126.07 152.83 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.8 137.94 16.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 54' ' ' SER . 1.4 tm-20 -52.95 -176.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.5 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 31.1 t . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.534 0.521 0 N-CA-C 111.388 -0.274 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.6 t -139.43 144.82 38.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.731 0.3 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 1.6 p -105.35 130.92 53.35 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -123.79 111.63 16.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.74 0.305 . . . . 0.0 110.91 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.2 120.38 40.36 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -91.16 77.82 5.93 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.632 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.32 106.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 tt -98.08 146.96 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.116 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.63 173.37 20.68 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.08 18.37 26.9 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.341 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.15 3.53 88.4 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.095 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.9 mt -129.88 158.07 40.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.913 0.387 . . . . 0.0 110.337 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -126.02 113.09 16.66 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.53 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.493 ' C ' HD22 ' A' ' 91' ' ' ASN . 16.7 mtt -101.91 111.39 23.63 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.766 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.69 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.7 OUTLIER -99.84 124.52 45.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.755 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.17 -167.09 1.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.03 71.91 0.05 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.912 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.2 OUTLIER -77.68 148.29 35.06 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.227 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.576 HG21 ' HE ' ' B' ' 18' ' ' ARG . 41.9 m -136.02 114.28 11.55 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.6 tttt 64.27 40.18 6.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.97 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.6 m -124.59 149.72 62.82 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -37.79 147.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.068 1.845 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -74.85 109.91 8.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 133.51 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.086 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 -13.59 6.77 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.544 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t -105.6 121.81 44.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.922 0.391 . . . . 0.0 110.835 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 mt -135.37 121.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.572 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 10.9 t -137.63 178.22 7.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 111.017 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.501 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 55.3 tt0 -161.68 154.44 20.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.428 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.31 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.45 ' HB2' ' CG2' ' A' ' 44' ' ' ILE . . . -132.68 133.46 43.58 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -148.68 115.15 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.251 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.83 -104.5 1.55 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.209 -0.519 . . . . 0.0 111.941 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -129.35 24.84 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 110.349 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.68 159.22 40.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.38 138.25 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.69 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.681 HD22 ' H ' ' A' ' 114' ' ' ALA . 1.7 t-20 -116.88 147.06 42.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.537 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.681 ' H ' HD22 ' A' ' 113' ' ' ASN . . . -143.19 129.76 20.19 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.873 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -115.26 115.41 26.62 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.121 0.486 . . . . 0.0 111.459 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.794 ' N ' HD12 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -115.88 120.5 39.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -159.09 -178.83 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.206 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.2 p -91.82 159.66 15.69 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.45 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.88 147.16 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.045 0.45 . . . . 0.0 111.528 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 p -87.39 152.1 51.9 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.729 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.32 162.89 18.83 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.943 1.762 . . . . 0.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.79 -1.51 58.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.99 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -81.05 -56.08 4.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.547 0.213 . . . . 0.0 110.55 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.17 -9.02 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.638 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -113.85 175.67 5.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -77.14 152.01 35.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 111.265 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.5 m -154.38 63.2 4.02 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.65 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.54 151.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.061 2.507 . . . . 0.0 113.273 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.08 150.2 41.56 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.113 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.495 HD11 ' OE2' ' A' ' 134' ' ' GLU . 7.7 tp -144.82 164.57 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.554 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 48.6 p -68.91 171.62 7.76 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.239 0.543 . . . . 0.0 111.436 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.578 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 5.0 m170 -68.07 -33.79 75.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.171 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.51 -57.19 12.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.845 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.495 ' OE2' HD11 ' A' ' 130' ' ' ILE . 47.8 mt-10 -62.95 -42.98 99.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.607 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -57.02 11.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.952 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.14 -34.52 66.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.933 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.14 -30.44 65.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.3 mtt -74.33 -61.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.634 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.0 pt -47.24 -21.8 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.663 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -82.54 -30.61 29.61 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.27 -28.09 13.16 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 48.6 t -49.54 119.21 3.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 0.0 111.313 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -137.0 118.03 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.99 125.34 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.8 t -100.79 158.21 16.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.129 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.7 mm -140.76 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.912 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.411 ' OD1' HD13 ' A' ' 184' ' ' ILE . 3.2 m-20 -152.32 88.83 1.39 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 mt -85.93 148.41 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.013 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -148.41 178.41 8.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.481 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.0 t -91.75 125.14 36.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 t -109.54 162.23 14.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 152' ' ' GLU . 27.0 mp0 -139.7 19.12 2.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.62 0.247 . . . . 0.0 110.939 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -75.86 103.28 5.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.273 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.98 8.7 11.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 4.0 mptp? -52.81 173.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.526 ' C ' HE22 ' A' ' 46' ' ' GLN . 28.0 m-20 -81.66 171.42 14.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -95.12 143.62 26.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.462 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 77.8 m-20 -114.78 92.72 4.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.755 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 160' ' ' LYS . 96.6 mt -123.47 163.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.56 ' N ' HG22 ' A' ' 159' ' ' ILE . 21.7 pttm -125.12 138.43 54.17 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.62 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 161' ' ' THR . 54.2 m -65.09 6.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.554 ' ND1' ' N ' ' A' ' 162' ' ' HIS . 0.2 OUTLIER -76.18 117.62 65.44 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.434 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.87 158.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.661 1.574 . . . . 0.0 111.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 164' ' ' VAL . 13.7 p -78.75 128.77 38.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.0 112.15 17.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.69 171.07 40.97 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.526 -0.369 . . . . 0.0 112.509 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ILE . 5.8 t -103.8 8.9 37.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.007 0.432 . . . . 0.0 109.91 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 60.48 -5.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.95 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.2 pp -80.38 164.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.759 -0.377 . . . . 0.0 109.991 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 6.1 t -126.82 130.64 50.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -72.45 37.86 0.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.813 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 170' ' ' SER . 49.4 pttt -66.64 -173.4 0.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.004 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.04 119.83 35.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.0 110.715 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.523 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 0.2 OUTLIER -142.08 -166.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.443 ' H ' HG12 ' A' ' 174' ' ' VAL . 22.4 m -50.89 145.32 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.853 0.359 . . . . 0.0 110.551 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -98.25 131.37 44.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.57 114.66 8.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.901 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.8 OUTLIER -61.77 99.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.52 6.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.451 HD12 ' OD2' ' A' ' 213' ' ' ASP . 82.6 mt -100.6 113.61 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.97 -137.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.994 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.536 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 6.1 t -72.81 158.45 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.5 p -143.59 90.02 2.12 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.411 HD13 ' OD1' ' A' ' 147' ' ' ASP . 4.8 mp -96.91 128.03 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.099 0.476 . . . . 0.0 109.76 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 185' ' ' VAL . 33.7 m -145.38 123.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.157 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 190' ' ' VAL . 48.8 t0 -82.65 109.52 16.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 28.1 m -45.93 -27.06 0.81 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.506 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -34.58 -38.37 0.07 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.199 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 79.7 m -142.15 31.32 1.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 190' ' ' VAL . 28.4 m -155.9 103.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.127 0.489 . . . . 0.0 110.65 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.49 -56.2 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.641 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 217' ' ' TYR . 7.4 t-20 -115.07 171.46 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 192' ' ' ASN . 0.3 OUTLIER 179.45 105.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.49 . . . . 0.0 109.804 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.62 142.07 36.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.347 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -127.99 142.74 51.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.595 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 5.9 p -143.51 136.68 27.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.1 t -131.42 158.38 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.446 ' CD ' ' O ' ' A' ' 170' ' ' SER . 14.1 ttt85 -166.3 106.6 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.251 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 25' ' ' GLY . 2.3 tp -109.42 124.46 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -167.96 -151.97 7.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.86 118.57 30.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.534 ' H ' ' HG3' ' A' ' 202' ' ' MET . 0.0 OUTLIER -84.61 4.83 30.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.445 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 1.3 m -99.63 -50.73 3.97 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -161.36 127.81 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.708 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -43.64 145.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.1 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.518 ' H ' ' CD ' ' A' ' 210' ' ' GLU . 3.2 t -131.6 5.99 4.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.488 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.491 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.4 t 58.31 -76.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.662 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' SER . 50.5 mt-10 -48.81 -50.19 35.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.774 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.0 mp -80.63 0.84 32.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.243 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 206' ' ' SER . 13.6 mp0 -101.67 124.85 48.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.837 0.351 . . . . 0.0 110.801 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.96 -178.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.523 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 16.8 ptmt -165.54 167.79 17.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.531 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.451 ' OD2' HD12 ' A' ' 180' ' ' ILE . 44.3 t0 -159.59 169.61 23.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 146.69 140.25 3.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.24 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -119.69 -168.94 1.68 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -144.98 110.0 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.523 ' O ' ' ND2' ' A' ' 192' ' ' ASN . 97.7 m-85 -103.41 122.07 44.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.103 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 218' ' ' VAL . 28.9 m -135.8 117.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.191 0.52 . . . . 0.0 110.583 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 1.1 m-20 51.87 42.33 30.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.486 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.27 -0.71 87.22 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.4 -0.429 . . . . 0.0 113.145 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.0 m -97.49 117.03 30.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.935 0.368 . . . . 0.0 110.158 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.58 159.14 17.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.483 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 65.8 m -168.13 110.43 0.59 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.24 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -78.51 141.75 37.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.62 123.14 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.573 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.07 103.96 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.326 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 61.2 p -129.83 151.76 50.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 228' ' ' ASP . 0.8 OUTLIER -51.16 95.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -90.69 27.32 1.79 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.2 m -74.0 -32.49 63.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.97 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 233' ' ' ILE . 13.9 m -103.12 -3.91 25.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.204 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.527 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -40.79 -27.84 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 0.0 110.749 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.682 ' H ' HD13 ' A' ' 233' ' ' ILE . 0.0 OUTLIER -144.01 -177.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.585 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 236' ' ' THR . 12.3 m-20 -118.51 91.93 3.69 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.1 m -62.22 1.51 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.291 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 234' ' ' ASP . 44.6 p -90.24 -22.9 21.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.36 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.87 6.66 39.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.607 0.241 . . . . 0.0 111.049 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.82 138.26 32.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.947 0.403 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 104' ' ' SER . 46.5 mttm -126.43 142.55 51.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.07 167.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 242' ' ' VAL . 40.7 t -132.39 -11.51 3.18 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.491 ' OXT' HG22 ' A' ' 242' ' ' VAL . 13.4 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.295 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.516 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 94.1 m -137.27 128.07 27.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.099 0.476 . . . . 0.0 111.34 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 t -39.71 135.82 1.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.638 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.516 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 12.4 m-85 -117.17 -25.85 6.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.317 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -151.94 150.77 30.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -107.81 157.59 18.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -78.79 135.8 37.19 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.08 24.82 2.0 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.69 0.281 . . . . 0.0 110.388 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.576 ' HE ' HG21 ' A' ' 95' ' ' THR . 0.0 OUTLIER -145.75 127.88 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 110.74 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -79.0 122.19 25.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.612 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.54 111.0 45.09 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.79 148.45 0.48 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.857 1.705 . . . . 0.0 112.478 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 -47.27 -47.45 25.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.545 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -37.36 -34.73 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.539 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 2.4 m-85 -106.78 44.32 1.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.495 0.188 . . . . 0.0 110.926 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -149.22 95.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.78 -25.9 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -168.67 170.82 9.18 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.408 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.2 163.58 21.28 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.95 0.881 . . . . 0.0 112.369 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -154.99 134.87 12.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.514 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' B' ' 31' ' ' THR . 18.4 pt-20 -99.43 148.96 23.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.257 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 30' ' ' GLU . 46.9 p -55.03 -112.39 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 7.0 m -150.28 -141.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.701 0.286 . . . . 0.0 110.597 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 35' ' ' CYS . 26.1 t -143.04 -24.42 0.61 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -58.12 -6.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' B' ' 33' ' ' SER . 22.0 m -114.91 118.58 33.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.549 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -73.12 38.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -165.74 58.99 0.57 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -170.48 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.721 2.281 . . . . 0.0 113.25 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.24 176.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 49.4 t -109.49 129.81 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.59 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.6 128.84 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.064 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.425 ' C ' ' NE2' ' B' ' 43' ' ' GLN . 30.5 p90 -107.93 145.88 33.18 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.211 0.529 . . . . 0.0 111.225 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' B' ' 43' ' ' GLN . 1.7 mp0 -93.34 170.17 9.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.403 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 9.8 p -140.1 -143.22 0.15 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.202 0.525 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.403 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -125.79 -38.57 2.2 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.854 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.65 2.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.88 -0.145 . . . . 0.0 111.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 23.3 t -153.54 -82.24 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.458 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.05 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.418 0.449 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -140.96 147.76 39.29 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.7 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.1 t -151.62 117.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.876 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.536 ' H ' ' CB ' ' A' ' 182' ' ' SER . 22.9 t -52.13 157.99 1.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.19 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.47 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.45 127.91 8.55 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -68.57 123.81 88.58 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.04 0.36 8.48 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.279 1.319 . . . . 0.0 111.271 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -66.57 -13.82 61.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.097 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -100.07 123.46 44.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -50.8 -38.35 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.965 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -56.72 -33.23 66.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.224 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.22 -35.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.111 0.482 . . . . 0.0 110.195 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -73.35 -39.9 64.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.845 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -69.5 -38.66 77.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -63.11 -39.95 96.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.954 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.01 -42.58 79.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.938 0.399 . . . . 0.0 110.117 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -63.74 -21.72 66.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.99 -36.38 36.08 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.96 -19.42 37.19 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.361 -0.536 . . . . 0.0 109.667 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.57 -35.47 77.42 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.01 -70.25 0.42 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.919 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.575 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.799 0.333 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.3 m -75.39 -34.48 61.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.583 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.4 p -50.21 125.71 13.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.519 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -55.66 -20.31 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.769 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.7 m -75.59 -27.6 58.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 t -82.62 -39.73 21.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 p -166.07 172.99 10.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 0.0 110.698 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.75 155.92 39.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 p -71.94 171.92 10.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -121.19 5.44 10.29 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.333 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 20' ' ' ASN . 43.2 mm-40 -80.88 91.88 6.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 2.9 pm0 -32.42 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.982 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' GLU . 23.0 p-10 -95.49 38.65 1.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.565 0.221 . . . . 0.0 111.308 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -154.1 139.31 17.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.533 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -135.54 158.97 43.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.213 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CE1' ' CE ' ' A' ' 202' ' ' MET . 0.9 OUTLIER -96.53 76.88 2.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 24' ' ' MET . 3.8 mpp? -57.04 117.31 3.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.503 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.98 149.72 17.35 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.888 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -111.57 135.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.559 ' N ' HD13 ' A' ' 26' ' ' ILE . 63.2 t0 -140.46 137.82 34.2 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 11.5 t -138.66 142.78 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.046 0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.01 132.61 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.248 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.43 135.31 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.178 0.513 . . . . 0.0 110.831 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -121.12 94.67 4.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.552 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.95 112.52 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.038 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -86.42 127.81 34.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.518 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' CB ' ' NZ ' ' A' ' 34' ' ' LYS . 5.0 mtpm? -80.37 151.76 29.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.73 164.21 25.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.71 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.01 -35.49 80.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.272 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.439 ' N ' ' CD ' ' A' ' 37' ' ' GLN . 4.4 mp0 -75.34 -35.17 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.023 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.6 m -44.14 106.9 0.55 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.245 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.422 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 92.6 Cg_exo -43.79 161.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.817 1.678 . . . . 0.0 112.021 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.3 p -70.06 148.7 48.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 5.4 p30 -173.49 102.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -103.1 -4.29 24.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.502 ' C ' HE22 ' A' ' 46' ' ' GLN . 11.0 ptpt -64.93 89.39 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.409 0.623 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 45' ' ' CYS . 6.1 mm -96.3 164.1 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.807 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.499 ' N ' HG22 ' A' ' 44' ' ' ILE . 90.1 m 58.82 49.38 10.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.639 ' N ' HE21 ' A' ' 46' ' ' GLN . 0.0 OUTLIER -65.87 -44.36 85.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.861 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.3 t -167.7 176.8 6.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 0.0 111.461 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.88 103.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.717 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.9 p -103.92 96.82 6.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.527 0.204 . . . . 0.0 111.178 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.27 142.27 32.23 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.427 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 79' ' ' THR . 7.2 mt -144.51 151.2 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.938 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 m -151.47 144.98 24.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' CD ' ' CE1' ' B' ' 24' ' ' PHE . 29.5 mt-10 -52.15 179.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 CA--C 1.53 0.322 0 CA-C-O 120.748 0.228 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 38.7 p -123.75 126.9 47.32 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.452 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 51' ' ' ILE . 6.9 m -102.87 126.23 49.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -126.46 119.6 27.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -112.54 121.17 44.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.62 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -90.58 78.43 6.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.296 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 83' ' ' ILE . 3.1 tp -71.72 114.41 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.068 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.14 144.63 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.87 166.64 16.83 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.43 21.82 49.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.661 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.64 14.96 79.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.129 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.18 157.24 45.85 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.102 0.477 . . . . 0.0 110.676 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -124.53 105.92 9.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.266 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -101.25 123.23 45.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 111.06 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -106.64 128.41 54.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.47 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 25.5 m-85 -100.11 -169.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.257 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.01 67.84 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.422 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.486 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.51 145.84 36.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.256 0.528 . . . . 0.0 110.182 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.9 m -132.2 102.6 5.85 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.529 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt 70.85 45.31 0.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.337 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.5 m -124.23 149.64 61.41 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.53 142.72 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.878 1.719 . . . . 0.0 112.228 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -55.06 143.86 25.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 tp -98.01 135.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HZ2' ' H ' ' A' ' 126' ' ' ASP . 87.6 mttt -145.5 -7.66 0.59 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.921 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -111.02 111.1 21.97 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.09 114.08 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.5 t -142.33 161.11 38.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.304 0.573 . . . . 0.0 112.067 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -155.42 173.22 16.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.72 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 t -170.65 165.24 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.039 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.42 136.61 46.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.928 0.394 . . . . 0.0 110.292 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -143.94 110.97 5.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.023 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.15 -91.0 0.36 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -142.86 21.33 1.97 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.5 m -114.69 138.42 50.72 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.787 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.33 120.58 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.841 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' HD11 ' A' ' 233' ' ' ILE . 23.7 m-20 -104.42 164.63 11.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.829 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -168.43 125.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.073 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -113.82 114.36 26.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.424 HD12 ' CE2' ' A' ' 81' ' ' TYR . 2.5 mm? -110.41 118.79 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 t -161.55 173.12 15.24 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.507 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.0 p -89.4 170.5 10.48 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.824 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.84 133.16 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.003 0.43 . . . . 0.0 111.259 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.15 164.06 39.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.87 144.29 43.03 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.162 1.908 . . . . 0.0 111.406 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.03 9.13 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -126.4 -51.82 1.5 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.97 0.47 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.642 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -108.39 -178.54 3.63 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 2.2 m-20 -63.96 -179.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.895 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.0 m -171.29 59.76 0.3 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.416 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.11 146.11 0.4 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.465 2.11 . . . . 0.0 112.654 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.43 127.07 20.31 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 131' ' ' THR . 5.1 mm -132.8 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 110.109 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.502 ' H ' HG22 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -69.17 166.04 19.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.931 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -59.15 -33.96 71.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.556 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.51 -51.96 50.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 138' ' ' MET . 8.5 tp10 -66.52 -47.79 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.755 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.77 8.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.412 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.9 mt -51.3 -42.29 61.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.71 -21.07 59.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.593 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.3 ttt -79.05 -64.19 1.24 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.94 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.953 HD13 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -54.55 -20.9 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.919 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.953 ' N ' HD13 ' A' ' 139' ' ' ILE . 56.0 tttp -74.3 -33.42 63.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.5 ' OD2' ' NE ' ' B' ' 18' ' ' ARG . 12.3 t70 -102.72 -21.33 14.11 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.5 t -51.64 119.83 4.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.65 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -138.65 125.55 21.12 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.24 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 t -120.23 125.89 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -101.75 164.67 11.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.102 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.37 146.92 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.896 0.379 . . . . 0.0 110.139 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 90.29 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.73 HD11 ' CG2' ' A' ' 190' ' ' VAL . 0.5 OUTLIER -89.7 146.33 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 111.758 -178.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.472 ' N ' HD12 ' A' ' 148' ' ' ILE . 59.7 mtp85 -130.57 170.44 14.26 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.788 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.6 t -91.5 105.3 17.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.659 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.6 p -85.83 169.32 13.45 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.796 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.51 14.18 1.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -67.54 111.22 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.269 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.71 1.83 28.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -46.29 158.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.891 0.377 . . . . 0.0 111.226 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -75.75 170.65 15.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.587 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.8 m -87.23 135.52 33.28 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.046 0.451 . . . . 0.0 110.781 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -113.32 89.55 3.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.75 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 pt -119.85 171.22 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -159.42 0.68 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.2 t -129.77 -4.32 4.65 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.707 0.289 . . . . 0.0 110.46 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -84.55 124.57 73.18 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -39.36 155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.884 1.723 . . . . 0.0 112.335 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.8 p -74.93 133.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.4 mp -79.05 134.23 36.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.324 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.31 179.71 27.07 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.668 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 169' ' ' ILE . 17.3 m -113.56 8.36 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.8 t30 62.73 -11.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.374 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 167' ' ' SER . 14.1 pt -93.33 139.89 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.225 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.406 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 40.4 t -100.94 150.52 22.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.264 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -79.05 47.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -71.1 169.57 14.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.757 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -83.8 119.24 24.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 175' ' ' SER . 13.8 p -151.49 163.34 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.089 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.55 ' N ' HG22 ' A' ' 174' ' ' VAL . 53.3 p -14.73 132.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.036 0.835 . . . . 0.0 113.197 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 45.1 p90 -90.6 134.38 34.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.423 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.54 134.57 20.33 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.9 OUTLIER -69.86 101.09 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.52 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 179' ' ' ILE . 41.1 mm -114.09 -14.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.65 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.8 mt -91.23 127.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.816 0.341 . . . . 0.0 111.031 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.66 -134.06 6.6 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 69.9 p -69.25 150.77 47.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.94 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.533 ' OG1' ' CE1' ' B' ' 13' ' ' PHE . 0.8 OUTLIER -142.43 95.06 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.239 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 18.4 mt -99.32 134.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.062 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 185' ' ' VAL . 27.9 m -149.32 114.05 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.11 106.96 3.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.0 m -48.08 -27.48 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -39.4 -37.66 0.48 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.622 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.7 m -137.95 37.45 2.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.732 0.301 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.73 ' CG2' HD11 ' A' ' 148' ' ' ILE . 45.4 t -150.74 103.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -85.39 -61.0 1.87 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.446 ' C ' ' ND2' ' A' ' 192' ' ' ASN . 0.4 OUTLIER -130.04 140.79 50.81 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.714 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.5 tt -139.91 114.73 9.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.888 0.375 . . . . 0.0 110.817 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -94.47 152.67 18.39 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -147.55 131.69 17.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.149 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.2 m -144.26 138.08 27.73 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.434 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 198' ' ' ARG . 2.8 p -138.09 163.91 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 197' ' ' VAL . 55.1 ttt-85 -164.96 111.22 0.96 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.837 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.8 mm -94.1 126.7 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.18 173.25 46.14 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.402 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -72.24 131.85 43.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.691 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 23' ' ' HIS . 28.8 mtm -86.49 4.59 39.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.724 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 85.5 m -97.74 -61.32 1.41 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -152.64 122.83 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.484 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.84 148.52 0.37 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.589 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 4.7 t -133.91 13.41 3.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.793 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.1 m 58.81 -76.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.735 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 35.1 tt0 -49.59 -54.33 18.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.609 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -73.69 4.92 4.44 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.115 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 175' ' ' SER . 9.0 mm-40 -104.14 125.5 50.5 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.759 0.314 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.5 168.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 45.7 tttm -157.18 159.97 38.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.312 0.577 . . . . 0.0 111.224 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 9.7 t70 -153.59 170.35 21.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.034 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.14 166.22 25.85 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.758 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -148.89 169.73 19.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 7.7 mtpm? -131.84 103.42 6.32 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -100.02 116.4 31.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.61 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 218' ' ' VAL . 8.6 p -140.69 118.87 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.256 0.55 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 50.54 43.26 27.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.516 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.32 80.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.09 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -98.29 117.97 33.89 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.673 -0.31 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.85 15.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.0 t -169.97 123.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.528 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -78.39 139.02 38.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.53 108.2 0.27 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.481 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -72.06 104.89 3.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.0 t -132.16 152.98 50.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.139 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 95.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.406 ' OD2' HD23 ' A' ' 232' ' ' LEU . 3.4 m-20 -86.84 34.02 0.66 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.986 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.4 t -73.02 -35.0 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.912 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 233' ' ' ILE . 68.9 p -105.12 -0.36 26.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.978 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -42.01 -24.58 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.085 0.469 . . . . 0.0 110.526 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.558 HD11 ' ND2' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -165.11 137.79 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.0 108.18 7.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.055 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 66.2 m -76.23 6.36 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.61 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -20.37 25.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -103.33 4.98 37.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.595 0.236 . . . . 0.0 111.339 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.66 147.81 29.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.042 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -132.9 142.83 49.12 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.4 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.46 134.82 49.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 242' ' ' VAL . 34.7 m -91.37 1.66 56.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.767 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.648 -0.692 . . . . 0.0 111.482 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.451 0 CA-C-O 121.021 0.439 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 4.4 m -105.85 127.18 52.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -65.73 142.06 58.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.334 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.533 ' CE1' ' OG1' ' A' ' 183' ' ' THR . 11.1 p90 -116.19 -11.54 11.31 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 29.5 m -131.8 144.68 51.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.248 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -114.94 158.67 21.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.04 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -83.22 144.92 29.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.871 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.74 -47.59 11.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.903 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.5 ' NE ' ' OD2' ' A' ' 141' ' ' ASP . 5.3 tpt85 -70.9 126.2 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -83.74 118.95 24.24 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' B' ' 20' ' ' LEU . 6.1 mp -75.48 145.53 79.42 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.693 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.7 152.07 37.15 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.382 2.055 . . . . 0.0 112.558 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' B' ' 24' ' ' PHE . 11.4 ptp180 -45.64 -43.84 12.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.38 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -68.09 24.82 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' B' ' 22' ' ' ARG . 12.2 t80 -150.88 32.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.371 0.605 . . . . 0.0 109.555 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -151.04 92.44 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.149 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.16 -25.28 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -156.42 -179.74 8.46 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.068 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 9.2 p90 -163.35 167.7 21.42 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.981 0.419 . . . . 0.0 111.256 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 57.4 m-85 -158.12 156.15 30.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' B' ' 31' ' ' THR . 69.7 mt-10 -98.53 145.58 26.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.812 0.339 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.425 ' O ' ' O ' ' B' ' 30' ' ' GLU . 63.2 p -52.35 -107.44 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -146.93 -128.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.453 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.477 ' C ' ' H ' ' B' ' 35' ' ' CYS . 18.2 t -158.95 -40.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.693 0.282 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.525 ' N ' HD22 ' B' ' 34' ' ' LEU . 2.2 mm? -59.08 -2.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.573 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.477 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.8 m -80.25 -34.48 37.1 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.224 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m 75.05 23.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.402 0.62 . . . . 0.0 110.087 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.523 ' N ' ' CD ' ' B' ' 38' ' ' PRO . 3.2 pt20 -173.56 49.61 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.533 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 29.7 Cg_endo -58.63 -158.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.191 2.594 . . . . 0.0 112.974 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 168.36 176.95 0.03 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.25 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.33 131.31 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.8 t -110.45 133.87 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.658 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' B' ' 42' ' ' PHE . 29.9 p90 -113.16 146.02 39.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.075 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.37 169.74 10.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 5.1 p -138.84 -142.73 0.16 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.187 0.517 . . . . 0.0 110.68 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.472 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.33 -36.33 1.71 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.177 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.97 46.43 2.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.287 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 23.6 m -153.72 -80.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.54 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.688 0.618 . . . . 0.0 109.475 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -161.34 143.71 12.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -148.9 136.19 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 0.0 109.781 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.65 162.22 13.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.631 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 124.79 7.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.318 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -62.33 122.58 74.05 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 1.28 7.07 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.225 1.284 . . . . 0.0 111.161 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -67.82 -18.22 64.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.108 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -95.31 125.88 40.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -51.56 -39.75 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.976 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -56.39 -34.92 67.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.078 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.92 -35.22 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.93 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.03 -35.69 66.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -72.14 -35.89 69.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -65.09 -36.48 84.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.689 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.02 -44.47 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.04 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -62.11 -28.7 69.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -74.65 -40.87 61.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.959 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.12 -21.69 63.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.26 -29.37 62.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.17 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt -79.11 -84.5 0.08 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.374 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.562 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.2 p -75.02 -22.15 58.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.117 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 t -48.22 133.13 15.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -60.07 -29.39 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.438 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 t -76.2 -27.42 56.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.8 t -72.04 -51.1 23.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.8 t -169.66 178.82 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.143 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -61.45 160.8 10.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.676 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 2.9 p -81.58 166.67 20.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.192 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.41 4.37 12.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.436 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 56.5 mt-10 -62.52 -152.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.749 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.16 -72.15 0.7 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.562 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -83.09 59.33 4.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.277 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HD3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -130.38 135.8 48.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.134 0.492 . . . . 0.0 111.242 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.93 123.35 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.438 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.676 ' CE1' ' H ' ' A' ' 16' ' ' THR . 67.5 m80 -75.27 76.18 2.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 tpt -46.54 170.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.358 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 158.19 132.94 1.48 Allowed Glycine 0 CA--C 1.512 -0.149 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 26' ' ' ILE . 16.4 tt -110.68 129.26 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.079 0.466 . . . . 0.0 110.921 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 -105.04 135.61 46.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.83 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.46 128.86 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.8 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.449 HG22 ' HE ' ' A' ' 115' ' ' ARG . 19.9 pt -124.42 162.86 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 tt -164.01 135.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.147 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -123.47 94.64 4.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.615 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.48 115.18 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.479 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -90.06 127.47 36.08 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -82.21 154.71 25.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.643 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -68.85 -170.55 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.8 -31.11 18.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.938 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -79.01 -39.72 33.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.237 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 p -40.7 106.48 0.42 Allowed Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -43.68 170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.963 1.776 . . . . 0.0 112.277 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p -75.49 134.88 40.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.923 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -158.1 95.31 1.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.106 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.77 -7.31 25.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -63.74 92.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 110.407 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -90.55 154.75 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 34.9 t 53.7 65.46 1.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.122 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 153' ' ' GLU . 23.0 mt-30 -79.2 -24.62 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 m 178.09 164.82 0.71 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.417 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.65 132.14 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.404 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 p -134.17 104.4 6.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.177 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -83.29 136.79 34.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.282 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 52' ' ' THR . 8.1 mm -132.7 162.67 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.484 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 51' ' ' ILE . 93.0 m -154.18 151.25 28.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' B' ' 24' ' ' PHE . 91.4 mt-10 -52.71 175.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.6 p . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 109.818 179.837 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 CA--C 1.528 0.202 0 N-CA-C 111.365 -0.283 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -122.45 114.87 21.31 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.806 0.336 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 p -96.35 129.96 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.56 141.7 50.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -136.31 134.44 37.95 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.428 1.109 . . . . 0.0 110.845 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' NE ' ' A' ' 89' ' ' ARG . 33.1 t -96.12 73.87 2.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.064 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 pt -71.13 98.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 tp -86.88 146.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.603 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.91 166.79 17.1 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.302 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.71 23.39 44.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.208 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 7.98 74.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -127.99 153.82 46.31 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.439 ' NE ' ' OG ' ' A' ' 82' ' ' SER . 63.3 ttt180 -122.65 113.91 19.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.36 152.08 21.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 110.147 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -149.06 126.95 11.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.413 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -116.81 -169.99 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.947 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.05 81.53 0.16 Allowed Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.293 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.548 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 1.8 m-30 -73.35 115.01 12.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.6 m -124.69 111.79 16.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.686 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.1 tptp 64.84 31.3 11.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.02 150.32 44.88 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -38.64 160.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.956 1.771 . . . . 0.0 112.123 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -81.67 107.07 14.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.533 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.57 144.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.923 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -147.14 -21.92 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 p -98.18 122.02 40.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.361 . . . . 0.0 110.317 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 tp -139.89 133.53 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 239' ' ' LYS . 11.2 t -150.11 165.41 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.248 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -148.86 161.5 41.72 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.085 0.469 . . . . 0.0 110.789 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.14 156.64 22.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.228 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.5 137.95 44.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.219 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -151.06 108.04 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.337 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.35 -103.53 2.17 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.168 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 110' ' ' ASN . 17.5 p-10 -130.67 23.29 5.04 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.668 0.271 . . . . 0.0 110.552 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.1 155.63 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.645 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.7 t -127.31 129.73 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.064 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.609 ' ND2' ' H ' ' A' ' 114' ' ' ALA . 2.9 t-20 -107.54 154.99 20.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.525 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.609 ' H ' ' ND2' ' A' ' 113' ' ' ASN . . . -154.83 121.73 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.56 HH21 ' CD2' ' A' ' 238' ' ' LEU . 19.5 tpp85 -105.07 113.0 26.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.811 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.1 114.21 22.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.9 t -158.85 171.73 19.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.164 0.507 . . . . 0.0 112.029 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -87.83 163.83 16.22 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.1 141.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.141 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 p -83.22 152.6 65.12 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.616 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.52 152.35 33.81 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 121.921 1.747 . . . . 0.0 111.584 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.1 50.22 13.52 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.71 -53.96 0.88 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.59 0.233 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 160.87 -11.35 0.14 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.232 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -129.94 151.12 50.84 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 117.278 0.539 . . . . 0.0 110.114 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.0 146.51 42.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.787 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.0 p -139.76 62.36 22.31 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.957 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.17 129.63 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.227 2.618 . . . . 0.0 113.427 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.48 165.08 13.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.2 pt -145.05 165.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -82.67 154.84 24.67 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.738 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -51.35 -37.07 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.55 -51.82 68.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 110.436 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.05 -43.66 91.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.133 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.49 -56.55 19.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 110.319 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tp -51.65 -35.84 43.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.903 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.09 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.5 mmt -71.3 -62.43 1.4 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.7 pt -46.9 -21.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.462 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -91.02 -28.72 17.8 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.622 0.248 . . . . 0.0 110.894 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.527 ' CG ' ' HE ' ' B' ' 18' ' ' ARG . 15.1 t0 -92.19 -44.12 8.95 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.4 t -43.43 120.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.937 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -141.5 132.93 26.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.699 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.41 132.08 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.033 0.444 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.7 p -103.14 171.02 7.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.362 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.9 mm -139.4 154.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -163.58 88.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.272 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.97 147.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.083 0.468 . . . . 0.0 111.292 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -137.04 171.68 14.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.804 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 m -100.31 116.21 31.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.197 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.1 m -104.85 -176.84 3.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.929 0.395 . . . . 0.0 110.256 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -149.47 0.69 0.5 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.888 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -55.37 99.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.56 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.64 9.72 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.952 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -45.43 156.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.92 170.24 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.1 m -90.46 135.87 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.634 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.472 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 9.8 t70 -115.56 89.13 3.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.768 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -124.29 168.18 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -113.18 155.14 25.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.559 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 161' ' ' THR . 69.0 m -83.43 -3.92 58.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.903 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.546 ' NE2' ' CB ' ' A' ' 240' ' ' ALA . 0.5 OUTLIER -77.49 147.48 75.43 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.972 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.94 160.45 33.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.561 1.507 . . . . 0.0 110.988 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.63 134.92 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.6 mp -82.51 117.89 22.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.11 171.27 40.42 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.759 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 169' ' ' ILE . 2.0 p -101.12 7.29 43.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 60.97 -3.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.2 tt -98.24 139.2 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.323 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.5 p -98.34 145.62 26.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -75.59 40.88 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.499 ' NZ ' ' CB ' ' A' ' 172' ' ' LYS . 5.6 ttpm? -65.11 171.87 3.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 172' ' ' LYS . 36.7 pttt -87.27 128.24 35.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.307 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.734 HG22 ' H ' ' A' ' 175' ' ' SER . 14.9 p -157.13 177.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.773 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.734 ' H ' HG22 ' A' ' 174' ' ' VAL . 71.4 m -27.54 141.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.506 0.503 . . . . 0.0 112.018 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -100.24 134.09 43.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.07 138.85 33.88 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.006 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.75 86.78 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.772 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 37.8 mt -100.77 -36.89 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.303 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -71.58 124.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.231 0.538 . . . . 0.0 110.601 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.77 -125.41 2.81 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 12.0 m -79.76 153.05 29.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.164 0.507 . . . . 0.0 111.086 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 22.4 p -141.09 95.04 2.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.457 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.8 mp -98.44 117.09 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 185' ' ' VAL . 6.0 m -131.74 117.64 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.287 0.565 . . . . 0.0 111.602 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 190' ' ' VAL . 7.3 m-20 -78.66 111.89 15.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.823 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.6 m -46.34 -32.3 3.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.232 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.439 ' CD ' ' H ' ' A' ' 188' ' ' LYS . 12.0 mptt -34.97 -34.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.201 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 189' ' ' CYS . 32.1 p -152.1 56.93 0.84 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.305 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 190' ' ' VAL . 7.5 p -173.77 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.487 . . . . 0.0 110.009 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.78 -57.39 4.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.631 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 37.9 t-20 -127.16 137.92 53.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 2.2 tt -134.13 128.14 33.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.926 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -113.57 135.81 53.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -137.01 134.59 36.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.019 0.437 . . . . 0.0 111.071 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.6 t -142.79 141.44 31.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.778 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 198' ' ' ARG . 44.4 t -134.69 159.16 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.069 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 197' ' ' VAL . 44.2 ttt180 -174.19 116.59 0.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.903 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.4 tt -119.02 136.08 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -171.65 -150.13 6.97 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.568 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 43.3 t0 -88.49 119.15 28.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.622 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -78.38 3.57 15.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.08 -178.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 23.9 t -111.15 -51.3 2.87 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.742 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.479 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 67.6 mttm -146.94 109.93 4.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -44.52 147.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.372 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 3.2 m -148.75 96.14 2.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 206' ' ' SER . 69.1 m -23.45 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.339 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 36.3 mt-10 -58.65 -73.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.845 0.355 . . . . 0.0 111.629 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.3 9.6 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -96.5 126.1 41.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.834 0.349 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.69 178.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.5 164.86 19.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.105 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD2' HD12 ' A' ' 180' ' ' ILE . 16.4 t0 -158.92 168.63 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.178 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 165.34 171.03 31.07 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.8 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 12.7 m-85 -151.9 172.7 15.81 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -136.83 103.75 5.28 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.28 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -101.84 122.33 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.69 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 220' ' ' GLY . 7.3 p -140.48 115.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.298 0.571 . . . . 0.0 111.556 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.39 -8.87 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.768 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 137.99 -2.12 2.92 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 12.3 m -101.3 117.08 34.26 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.638 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.38 150.01 23.46 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.3 m -164.98 127.63 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.519 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -78.04 139.28 39.1 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.83 109.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.655 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.81 97.31 4.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 228' ' ' ASP . 59.3 m -126.75 157.23 39.69 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 227' ' ' THR . 9.6 m-20 -60.04 95.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -90.61 30.66 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -73.25 -30.12 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.285 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.0 t -111.4 1.34 16.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.5 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -44.31 -28.79 0.57 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.99 0.424 . . . . 0.0 110.478 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.42 143.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.179 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 236' ' ' THR . 6.1 p30 -75.75 97.04 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.042 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.0 m -59.29 -4.14 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 238' ' ' LEU . 41.1 p -78.96 -53.5 6.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.9 13.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.56 ' CD2' HH21 ' A' ' 115' ' ' ARG . 8.3 mp -77.05 140.23 40.26 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 110.444 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.46 ' N ' ' OG ' ' A' ' 104' ' ' SER . 18.7 mtpp -131.64 131.59 43.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.616 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.546 ' CB ' ' NE2' ' A' ' 162' ' ' HIS . . . -54.87 155.73 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 46.9 t -123.98 -8.37 7.75 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.638 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 241' ' ' CYS . 2.0 p . . . . . 0 C--O 1.218 -0.564 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.379 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.685 0.279 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.512 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 18.8 m -129.85 120.92 25.73 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 33.7 t -38.37 129.17 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.658 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 29.0 m-85 -109.63 -32.46 7.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.19 157.79 36.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.032 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.81 161.15 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.9 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -83.52 136.44 34.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.02 7.78 17.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.065 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.527 ' HE ' ' CG ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -134.0 127.48 32.41 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.812 0.339 . . . . 0.0 111.006 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -83.43 127.37 33.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.602 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.69 54.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.34 152.76 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.787 1.658 . . . . 0.0 111.942 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.686 HH21 HD21 ' B' ' 69' ' ' ASN . 8.5 tpt180 -45.14 -47.19 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.299 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -37.57 -33.59 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CE2' ' OE1' ' A' ' 53' ' ' GLU . 3.1 m-85 -109.5 43.19 1.34 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.795 0.331 . . . . 0.0 110.585 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -153.12 92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.707 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.28 -24.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -157.69 -179.03 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.168 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -157.78 170.69 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.223 0.535 . . . . 0.0 112.04 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 57.6 t80 -158.39 151.47 22.72 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.444 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 49.4 mt-10 -99.33 148.69 23.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -54.31 -109.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -152.58 -141.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.698 0.285 . . . . 0.0 110.526 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -146.53 -23.29 0.43 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.405 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' B' ' 34' ' ' LEU . 16.7 mt -57.63 -10.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.403 ' C ' ' H ' ' B' ' 37' ' ' GLN . 83.1 m -112.8 122.04 46.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.575 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -72.75 37.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.84 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.2 pt20 -168.51 60.17 0.44 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.6 -164.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.713 2.275 . . . . 0.0 113.059 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 178.9 176.64 0.54 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.499 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.51 131.75 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.938 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.62 132.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.036 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -112.72 151.44 30.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -92.66 169.39 10.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -137.11 -145.09 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 110.703 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.99 -39.48 1.39 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.99 46.82 2.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.301 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 9.8 m -155.33 -83.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.375 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.35 -90.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -138.86 148.62 43.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 t -151.84 113.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.289 0.566 . . . . 0.0 110.446 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.555 ' N ' ' OG ' ' A' ' 182' ' ' SER . 54.0 t -50.53 161.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.439 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -153.58 139.97 18.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.187 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -74.64 115.36 43.12 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.29 -0.64 8.41 Favored 'Trans proline' 0 C--N 1.356 0.933 0 CA-C-N 120.145 1.087 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -74.72 -10.08 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.888 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 37.4 mt-10 -98.97 125.55 44.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.21 0.529 . . . . 0.0 110.317 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.8 m -46.89 -50.58 18.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 63.9 p-90 -55.99 -25.29 43.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.077 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.99 -36.67 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.971 0.415 . . . . 0.0 110.139 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 56' ' ' GLU . 2.5 mp0 -68.3 -44.27 75.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.908 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.14 -35.31 80.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.294 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -63.1 -46.78 85.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 80.3 t -65.16 -47.64 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.725 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.5 -33.85 68.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -73.12 -34.49 66.16 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.982 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.7 -21.65 61.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.424 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -78.56 -77.27 0.17 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.686 HD21 HH21 ' B' ' 22' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.53 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.5 p . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.833 0.349 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.0 p -79.68 -27.85 40.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.55 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.9 m -49.91 130.23 21.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -56.61 -25.89 54.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -73.67 -28.42 61.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.355 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -76.15 -55.6 5.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -158.91 162.79 36.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.75 149.62 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.4 p -73.27 171.26 13.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.4 15.93 16.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.215 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -90.21 90.87 8.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -44.43 -23.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.164 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -80.99 18.92 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' C ' ' CG ' ' A' ' 22' ' ' HIS . 9.9 ptmm? -170.11 165.63 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.679 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.4 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 81.6 m-70 -152.94 -178.38 6.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.793 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.453 ' O ' ' SD ' ' A' ' 202' ' ' MET . 21.2 t60 -101.51 93.43 5.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.81 120.98 20.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.669 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -125.37 160.15 19.92 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.55 134.02 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 171' ' ' HIS . 58.6 t0 -124.68 124.29 41.86 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.041 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.463 ' H ' ' HG ' ' A' ' 117' ' ' SER . 11.9 t -137.61 142.07 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.6 pt -146.29 138.46 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.722 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -138.08 134.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -118.38 94.01 4.33 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 190' ' ' VAL . 7.7 p -90.13 135.7 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.483 0.658 . . . . 0.0 112.084 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -113.0 130.67 56.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.697 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -89.34 164.45 14.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.851 0.358 . . . . 0.0 110.741 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -77.81 151.31 34.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.712 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.06 -3.76 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.68 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -91.7 -41.45 10.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.004 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.6 p -48.26 146.08 4.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.832 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.21 162.36 28.57 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.023 1.816 . . . . 0.0 111.306 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.2 p -54.63 146.07 17.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.183 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.488 ' N ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -167.02 90.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 110.836 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.31 -5.77 32.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.05 0.452 . . . . 0.0 110.036 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -61.05 83.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.658 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tp -96.4 159.96 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.775 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.1 m 60.87 40.19 16.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 110.443 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 155' ' ' LYS . 3.7 tp60 -55.44 -55.05 36.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.921 0.391 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.1 t -178.87 150.97 0.51 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -115.31 142.72 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.232 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.5 m -127.7 102.11 6.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.92 129.01 34.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.678 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -138.94 149.54 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -153.37 145.94 24.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' SER . 1.5 mp0 -54.63 -176.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 6.2 t . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.478 0.618 0 CA-C-O 120.732 0.222 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 p -123.63 137.53 54.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.56 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -93.1 126.72 38.34 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -122.59 101.6 7.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 0.0 111.275 -178.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 9.9 m -143.45 68.38 1.29 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.409 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 83' ' ' ILE . 4.0 tp -73.65 107.09 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.225 0.536 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.2 mt -89.14 148.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.56 169.86 20.39 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.264 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.82 23.58 51.16 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.41 8.73 71.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.925 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -130.07 156.75 44.01 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.911 0.386 . . . . 0.0 110.403 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.7 ttm105 -115.95 117.84 31.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.472 ' SD ' HD12 ' A' ' 148' ' ' ILE . 68.4 mmm -102.22 108.35 19.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -100.98 120.44 40.19 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.122 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -100.9 -169.7 1.74 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.853 0.359 . . . . 0.0 110.89 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -178.92 70.65 0.07 OUTLIER Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.031 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -76.68 137.38 39.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.711 0.291 . . . . 0.0 110.776 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.9 m -138.83 118.46 13.04 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 60.09 32.34 20.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.133 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -119.81 149.72 49.09 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -38.61 145.55 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.851 . . . . 0.0 111.986 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -71.12 137.06 48.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 0.0 110.889 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.89 145.65 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -143.04 -9.56 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.636 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -124.08 123.25 39.92 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.16 106.99 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -140.16 145.83 38.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -142.35 -173.23 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 t -170.03 164.6 9.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.1 114.69 16.06 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -128.81 110.97 12.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.174 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.79 -127.48 22.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.857 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -100.98 21.42 13.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.66 0.267 . . . . 0.0 110.544 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -129.66 159.02 37.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 t -131.47 136.3 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.911 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -91.99 174.47 7.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -164.79 121.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.504 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.437 ' C ' HD22 ' A' ' 116' ' ' LEU . 8.4 tpt180 -121.97 102.43 8.16 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.437 HD22 ' C ' ' A' ' 115' ' ' ARG . 2.6 mm? -115.58 111.86 21.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.463 ' HG ' ' H ' ' A' ' 28' ' ' VAL . 12.1 m -166.34 168.01 15.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.168 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -90.2 176.09 6.89 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 120' ' ' SER . 7.9 p -116.9 155.13 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.094 0.473 . . . . 0.0 111.565 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 119' ' ' VAL . 8.4 t -91.22 146.31 33.26 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.748 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.487 ' HA ' HE22 ' A' ' 123' ' ' GLN . 33.9 Cg_exo -34.81 155.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 122.669 2.246 . . . . 0.0 112.778 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.586 ' N ' HE22 ' A' ' 123' ' ' GLN . . . 72.29 70.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.586 HE22 ' N ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -154.75 -40.67 0.09 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.662 0.268 . . . . 0.0 110.876 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.417 ' H ' ' CD ' ' A' ' 123' ' ' GLN . . . 124.89 7.16 6.17 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 123' ' ' GLN . 31.4 mmtp -125.33 170.34 11.43 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 23.0 p-10 -73.61 156.12 38.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.83 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 p -155.7 66.18 4.5 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.894 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -48.24 134.31 25.0 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 122.893 2.395 . . . . 0.0 113.256 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.97 156.73 18.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.317 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.6 pt -150.46 166.54 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.178 0.513 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.5 p -72.69 164.66 26.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.347 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -60.74 -34.32 74.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.259 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 4.3 mp0 -56.62 -57.17 13.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.142 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.467 ' O ' ' SD ' ' A' ' 138' ' ' MET . 39.6 mt-10 -57.3 -46.14 83.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.26 -55.4 18.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.05 -36.12 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.63 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.37 -30.23 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -76.35 -61.89 1.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.0 pp -47.21 -21.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.186 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -83.79 -55.05 4.47 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.565 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -76.67 -37.8 55.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.9 t -39.31 120.42 1.04 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.59 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.34 124.85 16.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.0 t -117.99 126.97 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.101 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.0 t -102.63 166.24 10.62 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.2 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.64 144.5 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.99 0.424 . . . . 0.0 110.719 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.38 88.67 1.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.848 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.472 HD12 ' SD ' ' A' ' 90' ' ' MET . 15.9 tt -77.47 151.27 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -145.25 -177.44 5.55 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.884 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.5 m -91.3 135.08 34.06 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.829 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.9 p -127.87 130.56 48.76 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -117.38 40.21 3.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.44 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.465 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -81.5 100.9 9.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.159 0.504 . . . . 0.0 110.704 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -72.13 -2.59 19.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.525 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.487 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.8 mmtm -51.53 161.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.855 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -77.09 177.51 7.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.8 p -96.59 142.02 29.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.55 92.04 3.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.55 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.84 177.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -132.92 134.52 44.65 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.3 p -70.18 4.17 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.399 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -83.2 121.6 77.08 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -39.89 161.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.785 1.657 . . . . 0.0 112.076 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.47 134.26 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 165' ' ' LEU . 8.1 mp -84.38 121.29 27.33 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.49 168.3 25.23 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.482 -0.327 . . . . 0.0 112.675 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.5 p -95.83 6.92 47.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.76 0.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.029 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 167' ' ' SER . 10.2 tp -100.84 138.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.494 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 97.0 p -99.09 142.31 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.567 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 27' ' ' ASP . 22.2 m80 -75.79 43.12 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.268 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -66.56 -174.52 0.3 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.4 ' HE3' ' H ' ' A' ' 228' ' ' ASP . 77.4 mttt -88.24 123.73 33.15 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.465 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.93 -175.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.779 0.323 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 66.4 m -44.98 144.34 1.24 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.119 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 48.4 p90 -96.29 126.9 41.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.817 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -141.49 130.99 23.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.42 97.13 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.071 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.2 mm -107.65 -38.32 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.88 124.01 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.55 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.53 -130.67 2.09 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.512 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 24.8 t -75.29 155.87 36.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.663 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.417 ' C ' HD12 ' A' ' 184' ' ' ILE . 26.4 m -142.94 93.8 2.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.8 mp -98.75 116.18 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 185' ' ' VAL . 3.0 m -124.59 132.59 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.012 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.76 94.69 6.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 189' ' ' CYS . 17.8 p -47.38 -26.68 1.37 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.878 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -43.49 -16.23 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.509 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 187' ' ' THR . 13.0 m -148.43 12.59 0.93 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 190' ' ' VAL . 0.4 OUTLIER -153.63 91.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.678 0.751 . . . . 0.0 110.563 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.95 -53.88 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.391 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -131.99 148.44 52.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.601 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 tt -148.13 110.56 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.044 0.449 . . . . 0.0 111.425 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -93.41 135.76 34.34 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -130.02 135.69 48.56 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.968 0.413 . . . . 0.0 111.106 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.2 t -144.31 141.06 29.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.488 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 198' ' ' ARG . 4.1 p -137.73 163.48 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.564 ' N ' HG22 ' A' ' 197' ' ' VAL . 60.4 ttt180 -171.7 115.94 0.38 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.361 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 tt -114.95 126.05 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -168.54 -149.24 6.07 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.228 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.51 140.31 33.4 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.913 0.387 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -103.98 -2.58 25.86 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.914 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 70.7 m -107.33 -56.54 2.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.679 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -146.42 126.4 13.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.483 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.72 144.96 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 208' ' ' GLU . 20.7 m -127.06 9.09 6.77 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.25 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.4 m 58.29 -76.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.716 0.293 . . . . 0.0 111.476 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' SER . 71.6 mm-40 -49.35 -50.19 40.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.64 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.1 mt -75.1 -1.36 22.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.368 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.22 130.05 44.49 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.865 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.8 m -142.68 -179.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.473 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 48.6 tttm -171.04 161.94 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.369 0.604 . . . . 0.0 111.611 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 15.4 t70 -158.95 169.52 24.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.711 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.64 138.35 2.43 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.935 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -118.39 168.65 10.44 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -132.63 103.06 5.94 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -97.63 113.38 25.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.109 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 218' ' ' VAL . 11.8 p -139.61 116.16 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.3 0.572 . . . . 0.0 110.726 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 1.2 m-20 52.82 28.28 6.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.861 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.4 66.15 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.994 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.5 t -98.61 116.22 30.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.31 158.66 15.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.8 m -168.28 117.69 0.75 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.992 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -85.05 96.64 9.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.089 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -129.33 133.93 7.74 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.56 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.34 97.69 10.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 228' ' ' ASP . 86.0 m -123.96 156.21 36.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.291 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 227' ' ' THR . 5.6 p-10 -57.68 95.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.2 30.0 0.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.4 m -70.38 -49.28 50.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.2 t -90.01 2.21 55.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 tp -39.2 -33.14 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.875 0.369 . . . . 0.0 111.15 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.54 144.43 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.894 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 234' ' ' ASP . 1.5 p30 -74.97 102.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.044 0.45 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 92.6 p -68.94 -4.14 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.478 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 69.9 p -83.21 -15.68 49.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -102.01 11.41 38.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.585 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.58 153.89 34.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -142.33 121.16 12.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.14 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 123.24 16.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.728 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 15.0 m -88.15 4.72 44.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 242' ' ' VAL . 11.1 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.375 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.407 0 CA-C-O 120.779 0.323 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.51 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 63.5 m -138.39 128.35 25.44 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.026 0.441 . . . . 0.0 110.528 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 80.1 m -45.37 141.37 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.808 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.51 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 24.9 m-85 -114.1 -26.24 8.17 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.785 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.6 m -155.42 157.22 36.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.88 162.56 15.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.377 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -85.28 139.52 31.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.651 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.46 -26.19 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.338 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.75 125.9 41.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 0.0 111.522 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -77.95 122.68 25.84 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -87.14 112.71 49.64 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.725 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.45 148.4 1.3 Allowed 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 121.909 1.74 . . . . 0.0 112.289 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -44.99 -41.83 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.353 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.56 -32.39 0.55 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 7.0 m-85 -108.53 41.67 1.53 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.66 0.267 . . . . 0.0 110.473 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -151.4 92.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.68 -25.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 35.1 t70 -155.11 -179.19 7.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.743 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.478 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 9.1 p90 -161.86 173.93 13.85 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.338 0.589 . . . . 0.0 111.848 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.493 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 45.2 t80 -156.64 179.75 8.97 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.265 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.493 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 13.1 pt-20 -128.76 152.23 48.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.267 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.474 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 35.7 p -57.2 -113.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -151.66 -142.56 0.12 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.514 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.421 ' C ' ' H ' ' B' ' 35' ' ' CYS . 13.2 t -143.32 -16.78 0.65 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.91 -3.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.018 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.421 ' H ' ' C ' ' B' ' 33' ' ' SER . 2.9 p -123.3 122.9 39.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -74.49 44.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -173.31 57.85 0.22 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 91.5 Cg_endo -72.61 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.964 2.443 . . . . 0.0 113.137 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 174.62 176.96 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.029 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.93 133.98 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.187 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 140.86 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.768 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -115.09 150.87 35.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -93.1 170.26 9.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.0 p -137.95 -145.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.18 0.514 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.469 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.94 -38.32 2.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.37 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.17 46.07 2.43 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.065 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.613 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 32.3 t -154.05 -83.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.61 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 159.21 -87.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -144.65 148.19 33.98 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.835 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 38.5 t -150.79 121.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.394 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.512 ' H ' ' CB ' ' A' ' 182' ' ' SER . 99.6 m -57.75 161.59 3.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.86 132.37 12.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.83 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -68.74 116.11 37.54 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.74 0.38 7.12 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 120.935 1.09 . . . . 0.0 111.112 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 13.0 m -71.59 -6.06 38.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.962 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -105.77 128.04 53.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -48.38 -49.25 35.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -56.12 -30.43 62.1 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.736 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.04 -36.92 70.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.996 0.427 . . . . 0.0 110.092 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.1 -36.63 66.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.72 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.24 -35.53 78.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.338 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.54 -37.94 89.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.91 -45.76 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -59.64 -38.44 81.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.0 110.771 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -64.94 -24.88 67.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.785 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -71.63 -30.89 66.26 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.258 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.26 -81.78 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.272 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.54 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 120.766 0.317 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.1 p -74.81 -14.93 60.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -50.88 126.14 15.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.6 p -59.28 -10.61 3.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.378 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 79.1 p -92.51 -25.36 18.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.559 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p -81.08 -45.58 16.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 m -167.8 173.06 8.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.38 146.57 50.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.943 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.401 ' H ' ' HE2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -74.29 173.22 10.52 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -114.0 21.28 15.0 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.432 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -87.71 86.49 7.19 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 18' ' ' GLU . 49.3 mt-10 -17.71 -61.06 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.55 52.12 0.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE2' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -153.8 149.15 27.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.408 ' HD1' ' N ' ' A' ' 22' ' ' HIS . 10.1 p-80 -168.1 120.9 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.242 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CE1' ' OG ' ' A' ' 127' ' ' SER . 7.0 t-80 -67.79 78.73 0.2 Allowed 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.758 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -54.28 138.19 39.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.041 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 199' ' ' ILE . . . -142.56 162.68 27.31 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 pt -109.15 169.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.077 0.439 . . . . 0.0 110.959 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -154.12 105.62 2.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.295 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 t -99.08 128.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.751 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.587 HD11 ' NE2' ' A' ' 171' ' ' HIS . 2.6 mm -123.59 123.11 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.52 133.64 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.32 92.8 3.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.22 135.44 25.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.117 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 m -103.75 124.72 49.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.638 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' CG ' ' OG1' ' A' ' 38' ' ' THR . 18.9 ttpp -76.14 151.62 36.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.805 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.461 ' C ' ' H ' ' A' ' 37' ' ' GLN . 49.7 tt0 -74.24 148.28 41.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.168 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -74.12 36.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.85 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 35' ' ' GLN . 14.7 tt0 -136.56 -46.98 0.61 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.377 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 34' ' ' LYS . 1.4 p -53.25 151.66 9.32 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.22 157.47 59.4 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.21 1.94 . . . . 0.0 111.875 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -65.06 141.67 58.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -158.82 97.41 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.468 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 13.5 t70 -91.56 -18.6 23.84 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -51.43 87.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 9.9 tp -96.19 150.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.376 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 17.1 t 58.81 67.05 0.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.87 -42.39 33.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.7 p -173.65 163.42 4.28 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.777 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.39 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -123.4 115.15 21.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -82.78 135.59 34.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.728 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.59 150.21 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -152.75 121.86 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.18 114.24 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.92 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.396 178.871 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 N--CA 1.479 0.657 0 CA-C-O 120.905 0.294 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -140.37 138.24 34.67 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.345 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.504 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 10.8 p -101.35 138.22 38.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.643 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 10.4 m-85 -119.03 160.84 21.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.327 0.584 . . . . 0.0 110.976 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -142.43 118.93 10.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.444 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 t -97.66 65.55 1.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.364 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -71.43 109.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.705 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -97.2 148.1 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.978 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.48 23.08 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.94 26.94 43.04 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.001 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.28 72.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.435 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -132.75 158.71 41.7 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.889 0.376 . . . . 0.0 110.453 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.67 109.07 13.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.802 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 mtt -103.41 107.11 17.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -90.37 107.18 18.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 56.4 t80 -92.42 163.23 13.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.763 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.09 143.16 8.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.504 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 4.6 p90 -147.28 157.86 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.948 0.404 . . . . 0.0 110.328 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 95' ' ' THR . 9.2 t -142.16 127.46 18.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.96 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' SD ' ' A' ' 138' ' ' MET . 30.1 mtpt 56.89 33.11 22.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.473 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.5 141.3 40.5 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -32.71 135.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.777 2.318 . . . . 0.0 113.195 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.578 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -70.06 147.73 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.563 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -91.77 137.31 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.957 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -124.68 3.74 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.123 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 t -137.7 135.04 36.07 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.128 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.95 98.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.302 0.572 . . . . 0.0 109.681 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.3 p -113.35 158.75 20.2 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.932 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -151.06 169.37 21.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 p -166.51 163.07 17.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.61 134.23 42.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -151.89 113.85 4.45 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.3 -122.41 8.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.812 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.71 22.91 15.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.664 0.269 . . . . 0.0 110.633 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -133.52 159.24 41.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.62 136.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -104.25 167.43 9.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.15 0.5 . . . . 0.0 111.299 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.017 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -116.55 122.9 46.01 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.503 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.89 117.13 28.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.9 p -161.41 152.09 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.127 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.5 t -71.03 170.25 13.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.13 147.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 111.256 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 m -69.79 150.84 96.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.149 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.406 ' CD ' ' SD ' ' A' ' 202' ' ' MET . 35.5 Cg_endo -62.57 142.61 90.59 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.743 1.629 . . . . 0.0 111.252 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.67 53.64 2.38 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -143.67 -33.65 0.42 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.968 -0.137 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.18 20.38 0.51 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.142 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.813 ' HZ1' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -144.78 177.69 8.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.91 0.355 . . . . 0.0 110.72 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -90.36 135.79 33.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.217 0.532 . . . . 0.0 112.189 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.813 ' CB ' ' HZ1' ' A' ' 125' ' ' LYS . 1.1 m -133.58 67.24 75.27 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.548 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -42.09 129.88 4.44 Favored 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.066 2.511 . . . . 0.0 113.404 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.82 26.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.559 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 131' ' ' THR . 14.3 mm -141.5 153.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -84.44 166.99 16.85 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 111.003 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -60.23 -35.68 76.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.201 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.55 -52.39 46.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.475 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -65.59 -41.94 92.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.968 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.06 -56.85 16.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.539 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.3 tp -49.72 -32.78 14.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.087 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.2 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.975 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 96' ' ' LYS . 23.7 mmt -64.8 -49.47 70.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -46.92 -22.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 111.071 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -87.52 -47.94 8.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.89 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -34.27 55.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -40.27 110.27 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.007 0.432 . . . . 0.0 111.493 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 42.9 tp10 -141.16 114.14 8.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.997 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 144' ' ' VAL . 12.1 m -108.01 130.8 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.538 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -108.6 164.18 12.58 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.904 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.4 tp -154.76 149.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.945 0.402 . . . . 0.0 110.533 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -148.9 95.02 2.34 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.015 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.7 mm -80.5 136.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.64 175.71 9.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.8 t -91.96 130.16 37.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.9 p -120.26 148.36 43.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -131.3 34.66 3.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.499 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.72 101.4 10.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -71.96 -3.98 25.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.685 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -48.71 149.44 1.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.839 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.27 176.46 1.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.924 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.2 m -98.51 142.06 30.58 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.467 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 26.8 t70 -119.03 92.61 3.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.665 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -121.48 161.59 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -108.31 139.26 43.28 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.133 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.6 p -73.53 4.51 4.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -80.5 127.27 76.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.316 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -39.06 162.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.921 1.747 . . . . 0.0 112.297 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.37 133.51 29.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.961 0.41 . . . . 0.0 110.521 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.86 123.69 33.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.99 173.16 16.39 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.593 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 169' ' ' ILE . 16.1 t -99.95 3.87 44.61 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 50.2 t30 67.07 -10.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.4 mt -73.43 143.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.166 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 172' ' ' LYS . 95.5 p -102.44 141.54 35.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.587 ' NE2' HD11 ' A' ' 29' ' ' ILE . 7.8 m80 -77.22 33.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.079 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 170' ' ' SER . 76.9 tttt -62.05 172.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -88.13 132.76 34.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.713 0.292 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.58 -162.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.319 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 m -47.59 149.89 1.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.678 0.275 . . . . 0.0 110.569 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 53.5 p90 -107.48 135.4 49.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.952 0.406 . . . . 0.0 111.379 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.494 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 4.0 tm-20 -146.03 141.67 27.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.014 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.494 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 6.3 p-10 -76.68 96.86 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.618 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.4 tt -112.72 -29.84 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.192 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.401 HD12 ' OD1' ' A' ' 213' ' ' ASP . 13.6 mt -76.01 111.36 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.85 -117.68 0.47 Allowed Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.703 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.511 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 12.4 t -77.7 141.89 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.1 m -139.22 85.83 2.09 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 184' ' ' ILE . 9.9 tp -104.17 120.03 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 110.131 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 185' ' ' VAL . 10.0 m -136.69 131.66 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.883 0.373 . . . . 0.0 111.379 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.34 108.3 18.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.955 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 187' ' ' THR . 2.7 p -48.55 -27.88 3.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.346 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.05 -26.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.002 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 68.3 m -142.49 27.99 1.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.796 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -165.18 99.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.498 0.666 . . . . 0.0 109.855 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -72.29 -55.91 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.41 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -133.19 142.65 48.71 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.282 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.12 138.08 31.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 111.029 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 4.1 mp0 -105.19 156.81 17.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 133.57 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 0.0 110.869 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.05 18.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.3 t -136.6 112.77 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.448 HH12 ' H ' ' A' ' 211' ' ' VAL . 12.9 ttt85 -108.43 163.27 13.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.424 HG23 HG13 ' A' ' 211' ' ' VAL . 0.9 OUTLIER -160.96 109.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -162.52 -150.85 6.14 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.754 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 1.1 m-20 -89.37 140.63 29.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.535 ' SD ' ' SG ' ' A' ' 203' ' ' CYS . 0.0 OUTLIER -97.64 1.52 48.79 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.3 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.535 ' SG ' ' SD ' ' A' ' 202' ' ' MET . 24.1 m -115.37 -58.11 2.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -134.39 108.91 8.43 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.145 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 9.4 mp0 -58.39 121.9 11.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 209' ' ' LEU . 25.3 m -116.43 110.26 18.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.572 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 63.1 p -33.55 -46.86 0.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.617 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.88 -40.93 94.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.57 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.614 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.3 mm? -88.05 0.59 55.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.542 ' C ' HG12 ' A' ' 211' ' ' VAL . 50.2 mt-10 -86.64 137.44 32.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.21 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.542 HG12 ' C ' ' A' ' 210' ' ' GLU . 0.2 OUTLIER -170.09 152.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -161.68 153.75 19.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.313 0.578 . . . . 0.0 111.89 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 16.9 t70 -134.37 172.75 12.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.489 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 164.11 144.53 4.07 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.207 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -131.17 -178.26 4.76 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -149.67 105.82 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.201 0.524 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' B' ' 13' ' ' PHE . 5.3 t80 -96.44 128.38 43.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.573 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 220' ' ' GLY . 18.4 m -139.27 107.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.95 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 8.7 t70 64.58 -12.68 0.11 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.39 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 144.06 -0.36 1.14 Allowed Glycine 0 N--CA 1.461 0.366 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.687 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.4 m -105.2 121.39 43.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.37 160.24 14.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.7 t -173.83 120.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.438 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -74.42 135.93 42.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.24 103.66 0.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.413 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.91 95.75 2.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 51.4 m -123.42 150.81 43.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -55.33 95.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -88.75 36.18 0.8 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.6 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 231' ' ' SER . 5.7 t -75.36 -41.7 55.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.792 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 230' ' ' THR . 92.1 p -96.05 1.47 52.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.844 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.5 tp -42.26 -34.44 0.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.912 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.0 mt -148.37 145.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.013 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -75.18 94.6 2.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.988 0.423 . . . . 0.0 109.936 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -13.76 2.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.826 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.46 -7.81 58.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -103.9 9.12 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.563 0.221 . . . . 0.0 110.964 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 238' ' ' LEU . 7.3 mp -84.86 142.14 29.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -129.11 132.8 47.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.007 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.67 141.23 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 48.5 t -108.08 -4.47 17.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.628 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 242' ' ' VAL . 10.4 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.129 -1.415 . . . . 0.0 111.503 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.38 0 CA-C-O 121.077 0.465 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 71.1 m -140.64 143.45 35.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.757 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -69.08 148.0 50.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.667 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 3.3 m-85 -122.71 -19.01 6.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.499 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 149.5 35.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.142 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -114.23 149.08 36.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -71.78 133.05 45.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.385 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.556 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -78.17 -42.79 30.54 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.877 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 12.4 mmm-85 -81.79 127.91 33.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.081 0.467 . . . . 0.0 111.493 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -68.18 152.97 44.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.624 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 19.6 mt -108.5 94.62 14.16 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.13 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -40.65 152.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.758 1.639 . . . . 0.0 112.343 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' B' ' 22' ' ' ARG . 8.1 tpt85 -45.49 -51.26 11.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.935 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -40.51 -39.22 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -105.77 46.05 0.94 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -155.67 92.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.33 -19.25 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.2 t70 -157.99 -179.55 8.23 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.492 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.484 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.4 p90 -165.48 163.37 19.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 111.287 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -148.06 179.83 7.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.437 ' N ' ' CD2' ' B' ' 29' ' ' TYR . 49.9 mt-10 -123.7 149.06 45.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.041 0.448 . . . . 0.0 111.168 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 41.3 p -55.58 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.997 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -148.29 -156.15 0.69 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.675 0.274 . . . . 0.0 110.536 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 47.4 t -129.82 -25.69 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.508 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 28.7 mt -58.24 -11.28 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.031 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.47 ' C ' ' H ' ' B' ' 37' ' ' GLN . 26.9 m -106.72 121.03 43.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.959 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -73.54 34.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.0 pt20 -168.67 63.08 0.54 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 73.3 Cg_endo -71.63 -161.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.629 2.22 . . . . 0.0 113.16 -178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.35 176.94 0.11 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 82.9 t -108.95 133.6 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.539 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 m -106.29 139.32 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.67 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -115.32 148.18 39.55 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.03 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 44' ' ' THR . 5.3 tt0 -100.18 168.05 10.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 1.7 p -143.84 -142.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.227 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.529 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -119.55 -39.93 2.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.063 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.73 46.65 2.36 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 81.1 p -147.42 -84.58 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.581 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.01 -84.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.441 ' NE2' ' C ' ' B' ' 48' ' ' ALA . 21.8 mp0 -139.66 145.22 38.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.718 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.8 117.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.511 ' H ' ' CB ' ' A' ' 182' ' ' SER . 0.1 OUTLIER -73.48 148.82 42.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.377 0.608 . . . . 0.0 112.025 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.75 134.25 28.24 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.53 126.25 89.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.79 -0.73 9.8 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.332 1.354 . . . . 0.0 111.258 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 51.9 m -69.76 -17.39 63.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.99 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.0 125.74 35.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.093 0.473 . . . . 0.0 110.176 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -48.6 -49.04 38.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -56.26 -26.43 51.59 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.677 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -72.91 -35.67 49.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.002 0.429 . . . . 0.0 110.112 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -70.42 -35.51 73.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.693 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -72.14 -35.25 69.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -64.73 -35.37 80.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.12 -45.63 61.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.81 -30.5 71.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.26 -39.35 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.718 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.91 -23.31 59.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.304 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -34.14 65.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -75.04 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.402 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.628 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.862 0.363 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.5 -21.98 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.602 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 p -49.95 127.89 17.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.531 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 6.3 t -54.28 -23.96 17.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -76.17 -31.54 58.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 m -74.44 -47.46 33.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.977 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.3 p -167.21 165.79 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.764 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.1 146.72 54.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.432 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 174.69 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 110.834 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -116.99 17.28 14.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.53 97.07 6.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.261 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.604 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 6.8 mp0 -32.99 -60.22 0.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.07 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -80.1 52.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.324 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 13.1 tttp -164.24 139.33 5.86 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.107 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 50.4 m80 -155.7 122.61 5.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -57.76 115.53 2.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.752 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -88.94 124.42 34.22 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.056 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.22 141.02 12.21 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.78 150.83 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.797 0.332 . . . . 0.0 110.253 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 21.2 t0 -139.46 142.82 37.37 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.484 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 27.6 t -137.62 107.52 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.844 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.598 ' CG1' ' HE ' ' A' ' 115' ' ' ARG . 4.1 mp -102.07 128.06 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 30' ' ' ILE . 8.5 tt -135.85 130.46 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.429 0.633 . . . . 0.0 111.75 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -116.34 125.11 51.65 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.44 131.53 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.088 0.47 . . . . 0.0 111.406 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.2 m -105.81 132.55 51.79 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 110' ' ' ASN . 11.8 pttm -86.58 163.45 17.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.318 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 37' ' ' GLN . 6.7 tt0 -75.81 137.48 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.675 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -50.52 -10.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 35' ' ' GLN . 1.2 mp0 -87.83 -41.73 13.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.963 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -46.36 148.29 1.67 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.796 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.57 167.26 25.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.06 1.84 . . . . 0.0 111.519 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.0 p -69.79 135.55 49.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.304 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -158.32 98.21 1.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.404 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 7.0 m-20 -97.55 -13.61 21.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.164 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.1 mmtm -54.93 85.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.963 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.1 tp -89.46 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.281 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 21.2 t 57.93 64.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.234 0.54 . . . . 0.0 110.402 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.4 ' NE2' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -72.86 -33.5 66.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 t -173.09 -172.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.579 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 48' ' ' VAL . 3.5 p -167.7 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.38 0.61 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 m -82.54 155.24 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.723 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -152.22 124.34 8.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 110.682 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.8 168.97 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.26 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' GLU . 10.1 t -153.36 154.29 34.22 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 2.6 pm0 -38.74 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.667 0.27 . . . . 0.0 110.675 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.262 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 CA--C 1.527 0.131 0 N-CA-C 114.13 0.781 . . . . 0.0 114.13 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.1 p -118.66 117.44 28.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.056 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -86.54 129.84 34.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' B' ' 47' ' ' SER . 49.2 t80 -113.52 143.3 44.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.695 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.42 ' OH ' HD11 ' A' ' 100' ' ' ILE . 70.0 m-85 -138.01 118.61 13.95 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.743 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 t -101.02 67.0 1.17 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.909 0.385 . . . . 0.0 110.61 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.23 111.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.727 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -98.84 145.89 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.45 161.44 11.77 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.68 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.88 26.85 48.96 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.323 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.41 ' O ' HD22 ' A' ' 88' ' ' LEU . . . 73.51 3.03 61.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.923 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.41 HD22 ' O ' ' A' ' 87' ' ' GLY . 2.8 mm? -115.94 149.4 38.81 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.04 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.622 ' CZ ' HD21 ' A' ' 91' ' ' ASN . 44.7 ttt-85 -111.91 115.05 28.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.9 mpt? -101.07 145.48 28.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.175 0.512 . . . . 0.0 110.847 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.622 HD21 ' CZ ' ' A' ' 89' ' ' ARG . 72.0 m-80 -138.4 129.76 27.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.051 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -112.05 -167.04 1.13 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.788 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.11 67.5 0.07 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.028 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.24 132.53 39.95 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -135.89 115.58 12.92 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? 70.22 30.91 3.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.865 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.92 149.16 50.33 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.6 148.04 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.898 1.732 . . . . 0.0 111.97 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.16 138.69 54.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.384 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.636 ' C ' HD12 ' A' ' 100' ' ' ILE . 2.1 pp -92.74 159.43 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' A' ' 102' ' ' SER . 6.5 tmtm? -156.8 -22.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.303 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.403 ' H ' ' H ' ' A' ' 101' ' ' LYS . 53.1 p -101.1 121.73 42.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 130.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.9 p -152.52 160.62 43.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -148.19 170.54 17.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -165.29 161.89 19.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.61 124.91 30.93 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.63 107.72 6.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.138 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.78 -127.73 19.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.543 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 31.3 m-80 -97.98 19.52 13.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.581 0.229 . . . . 0.0 110.867 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.3 p -127.21 155.5 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.887 0.375 . . . . 0.0 110.754 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.27 133.19 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.437 ' CG ' ' N ' ' A' ' 114' ' ' ALA . 10.1 t30 -99.05 165.18 11.86 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.752 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 113' ' ' ASN . . . -164.41 118.72 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.498 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.598 ' HE ' ' CG1' ' A' ' 29' ' ' ILE . 12.2 mmt85 -112.13 130.58 55.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.809 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tt -137.97 116.23 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.7 p -160.31 170.46 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 111.603 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.4 p -84.61 163.73 19.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.906 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.3 149.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.795 0.331 . . . . 0.0 110.808 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 121' ' ' PRO . 37.3 p -98.14 149.78 36.07 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 120' ' ' SER . 72.7 Cg_exo -40.08 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.54 2.16 . . . . 0.0 113.046 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.65 3.06 61.98 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' CD ' ' H ' ' A' ' 125' ' ' LYS . 2.3 pt20 -81.84 -115.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 0.0 110.421 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 123' ' ' GLN . . . -161.16 20.84 0.21 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.555 ' H ' ' CD ' ' A' ' 123' ' ' GLN . 7.2 tptm -144.83 -179.26 6.48 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.99 152.0 26.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.372 0.606 . . . . 0.0 112.04 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.2 p -146.9 70.0 12.12 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.386 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.74 134.02 2.41 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.228 2.619 . . . . 0.0 114.135 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.462 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . . . -89.3 161.49 16.35 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -153.56 154.72 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.262 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.565 HG22 ' N ' ' A' ' 132' ' ' HIS . 62.2 m -82.54 162.31 22.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.427 0.632 . . . . 0.0 111.695 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.565 ' N ' HG22 ' A' ' 131' ' ' THR . 38.3 t60 -50.88 -40.67 57.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.168 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.07 -57.42 11.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.143 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.7 OUTLIER -56.48 -44.38 80.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.038 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.51 -56.58 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 109.896 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.402 HD11 ' CD2' ' A' ' 132' ' ' HIS . 23.1 mt -53.81 -35.08 61.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.781 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.11 -28.6 61.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.423 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 mmt -74.78 -61.82 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.036 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.964 HD13 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -53.61 -20.41 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.189 -178.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.964 ' N ' HD13 ' A' ' 139' ' ' ILE . 34.9 ttpt -77.64 -55.16 5.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.634 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.1 -31.76 56.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.6 t -43.89 118.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.996 0.426 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 144' ' ' VAL . 1.6 tm-20 -141.23 126.44 18.51 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.46 ' N ' ' OE2' ' A' ' 143' ' ' GLU . 7.2 p -122.07 128.5 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.83 0.348 . . . . 0.0 110.59 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.2 p -101.39 167.67 10.02 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.55 146.74 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -166.99 94.95 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.452 ' H ' HG12 ' A' ' 185' ' ' VAL . 1.9 pt -92.68 127.31 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.29 0.567 . . . . 0.0 112.273 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -103.0 -179.33 3.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.946 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 8.0 m -93.35 129.29 39.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.451 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 p -103.45 -179.07 3.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.788 0.328 . . . . 0.0 110.29 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -155.49 -2.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 153' ' ' GLU . 6.1 mp0 -62.1 100.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.793 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.04 11.91 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -56.51 149.75 16.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.576 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.2 m-20 -55.74 172.8 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.3 t -98.8 145.65 26.74 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.637 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p-10 -119.99 93.43 4.06 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.693 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.754 HD13 ' H ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -119.03 176.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -130.08 135.28 48.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 161' ' ' THR . 24.7 m -70.16 2.81 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -80.74 117.98 70.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -40.35 155.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.698 1.598 . . . . 0.0 112.05 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -81.64 138.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.935 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 2.3 mm? -83.84 114.69 21.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.05 171.56 46.61 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.492 -0.385 . . . . 0.0 112.197 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ILE . 9.3 t -101.95 7.32 41.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.8 t30 64.15 -8.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.1 pp -80.35 161.27 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.218 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.502 ' H ' ' NH1' ' A' ' 198' ' ' ARG . 13.0 t -123.57 137.46 54.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.491 ' CE1' HD11 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -74.19 38.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.106 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.417 ' NZ ' ' CB ' ' A' ' 170' ' ' SER . 58.8 mttp -67.62 -170.79 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.217 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -102.76 127.5 49.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.998 0.428 . . . . 0.0 110.509 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.486 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 12.1 m -151.64 -168.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.896 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -43.97 144.08 0.98 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.344 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -111.78 141.97 44.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -162.29 151.6 15.69 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.534 177.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.98 104.5 2.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.161 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.3 mt -107.09 -42.76 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 195' ' ' PHE . 9.0 tt -72.59 138.08 22.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.087 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -101.13 -118.52 4.34 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.9 t -72.84 143.91 47.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.1 m -137.78 84.17 2.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.93 103.95 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 148' ' ' ILE . 25.1 m -124.16 143.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.551 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.37 110.3 21.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.499 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 189' ' ' CYS . 7.0 m -50.75 -28.47 9.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.484 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -36.4 -28.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.077 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 187' ' ' THR . 30.2 p -149.34 24.23 0.91 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 24.9 t -143.25 81.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -69.19 -57.47 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.266 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 14.0 t-20 -111.7 162.08 15.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.403 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 193' ' ' LEU . 6.9 tt -169.22 106.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 110.419 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.89 130.87 46.96 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.481 ' CD1' HD12 ' A' ' 180' ' ' ILE . 5.2 t80 -125.24 133.44 52.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.809 0.338 . . . . 0.0 110.514 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.8 p -143.92 139.0 28.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.951 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 198' ' ' ARG . 18.7 t -135.03 160.34 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.502 ' NH1' ' H ' ' A' ' 170' ' ' SER . 57.0 ttt180 -170.67 111.54 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.124 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.3 tt -110.45 128.52 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.669 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.96 -155.24 8.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.878 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -91.39 119.98 31.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.464 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -82.01 2.37 31.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 92.2 m -100.77 -55.85 2.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 109.861 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.498 ' CB ' ' NZ ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -150.58 122.25 8.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.677 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -42.94 141.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.147 0.499 . . . . 0.0 111.754 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 208' ' ' GLU . 12.7 t -140.83 89.3 2.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.272 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.1 m -37.11 -27.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.25 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 206' ' ' SER . 85.0 mt-10 -73.06 -52.33 14.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.01 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.502 HD21 ' CE1' ' A' ' 132' ' ' HIS . 39.3 mt -91.5 7.81 39.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.305 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -97.21 119.03 34.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.2 m -145.29 168.21 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.486 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -154.22 167.71 28.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 112.557 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -151.12 163.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.295 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 171.29 160.21 19.28 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.156 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -148.02 172.64 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -139.6 104.74 5.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -103.31 122.96 45.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.703 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 218' ' ' VAL . 5.7 m -143.59 120.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.252 0.548 . . . . 0.0 110.918 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.5 37.99 10.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.101 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.12 -4.86 83.14 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.726 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -100.08 116.18 31.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.23 0.515 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.28 154.6 19.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.356 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 42.2 t -169.7 127.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.329 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -77.53 140.55 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -169.25 111.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.452 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.24 100.91 8.56 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 69.7 p -131.63 166.26 21.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.631 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.14 96.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.781 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.92 18.2 4.34 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.589 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -62.7 -38.18 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 84.0 p -98.01 -2.28 40.72 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.297 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -41.68 -36.34 0.95 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.992 0.425 . . . . 0.0 110.541 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 8.6 mt -148.26 142.81 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 236' ' ' THR . 0.9 OUTLIER -75.99 101.5 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.213 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.45 ' CB ' HH12 ' A' ' 115' ' ' ARG . 84.9 p -65.58 4.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 234' ' ' ASP . 46.9 p -91.19 -18.38 24.54 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.456 ' CB ' ' NZ ' ' A' ' 237' ' ' LYS . 9.1 mtmp? -104.64 8.44 35.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 238' ' ' LEU . 0.3 OUTLIER -78.94 161.8 26.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -145.21 134.6 23.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.69 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.39 134.04 55.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.151 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 41.0 t -100.92 -7.03 23.81 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.275 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.414 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 117.641 -1.171 . . . . 0.0 111.751 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.534 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 98.0 m -142.53 142.24 32.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.22 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 14' ' ' SER . 2.7 t -73.43 147.07 44.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 110.685 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.534 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -114.68 -20.86 10.49 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 12' ' ' CYS . 7.9 m -146.23 148.82 32.89 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.049 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.493 ' CD2' ' OD2' ' B' ' 53' ' ' ASP . 9.5 m-85 -107.92 164.5 12.21 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -86.94 138.15 31.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.784 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.39 23.51 3.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.925 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.25 125.46 18.71 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.721 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -80.53 119.19 22.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.755 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 2.6 mm? -80.57 113.56 40.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.343 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -46.66 149.34 3.04 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.38 1.387 . . . . 0.0 111.786 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -43.87 -47.3 8.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.315 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -38.3 -32.25 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.0 44.33 1.23 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.775 0.322 . . . . 0.0 110.735 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -149.8 86.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.796 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -89.11 -28.23 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -153.26 -179.41 7.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.998 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -164.11 164.1 22.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.527 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.509 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 57.1 t80 -148.12 -179.98 7.32 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.509 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 44.3 mt-10 -123.0 149.62 44.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 110.789 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.409 ' O ' ' O ' ' B' ' 30' ' ' GLU . 40.8 p -55.67 -111.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.815 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.9 t -152.01 -153.84 0.5 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.781 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.417 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.4 m -132.98 -25.51 1.81 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.399 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -59.36 -7.08 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.438 ' C ' ' H ' ' B' ' 37' ' ' GLN . 25.2 m -112.54 120.92 43.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 m -74.08 36.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.305 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.4 pt20 -169.91 61.68 0.41 Allowed Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 86.6 Cg_endo -73.14 -162.06 0.12 Allowed 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.793 2.329 . . . . 0.0 113.319 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.96 176.93 0.13 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.972 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -107.77 135.79 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.136 0.493 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.01 137.83 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.605 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.07 146.08 42.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.369 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -92.79 169.97 10.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.2 p -138.59 -143.34 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 110.742 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -128.69 -38.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.278 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.27 41.66 3.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.76 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 11.6 t -147.06 -84.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.568 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.08 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.321 0.388 . . . . 0.0 110.044 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -144.0 145.94 32.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.344 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 24.1 t -153.2 125.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' B' ' 14' ' ' SER . 13.8 p -77.55 148.84 35.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.169 0.509 . . . . 0.0 111.395 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.89 142.37 42.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . 0.493 ' OD2' ' CD2' ' B' ' 15' ' ' TYR . 9.2 m-20 -64.15 122.78 79.64 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.07 0.46 8.37 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.062 1.175 . . . . 0.0 110.863 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 44.5 t -77.27 -5.25 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.702 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 57' ' ' SER . 1.1 tp10 -105.4 125.18 50.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.526 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 19.2 m -44.83 -43.86 9.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -56.4 -34.36 66.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.401 HG21 ' O ' ' B' ' 53' ' ' ASP . 40.2 t -69.94 -38.87 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.334 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.04 -52.49 59.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.796 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.85 -35.64 75.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.06 -35.91 81.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.19 -45.55 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.832 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -63.13 -32.31 73.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -71.48 -41.82 68.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.29 -19.45 63.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.265 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -34.08 67.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.98 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.51 -77.62 0.15 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.813 0.339 . . . . 0.0 110.361 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 53.0 p30 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.537 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.729 0.299 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.6 m -65.37 -27.87 68.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.985 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.2 m -49.5 132.2 20.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -56.93 -25.36 57.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.581 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m -74.74 -29.45 61.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.609 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -74.35 -56.36 4.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.273 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -159.25 173.17 16.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 110.791 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.4 m -62.9 161.3 13.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.828 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 p -74.32 163.58 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.86 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 30.1 mp0 -112.15 7.47 19.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.529 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -67.32 -149.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.211 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -135.38 -68.87 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.461 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 41.8 t30 -79.02 52.07 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.424 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' O ' ' ND1' ' A' ' 22' ' ' HIS . 10.5 tptm -148.86 137.5 21.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.819 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 21' ' ' LYS . 22.9 m-70 -143.24 158.05 43.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 76.76 2.05 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.415 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.523 ' CE ' ' HB1' ' A' ' 135' ' ' ALA . 46.6 tpp -65.71 128.33 35.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 0.0 111.441 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -135.67 149.04 19.89 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.79 148.21 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' CB ' HD11 ' A' ' 169' ' ' ILE . 15.7 t0 -135.15 139.12 44.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.15 101.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.984 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.0 131.9 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.39 140.1 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.506 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.97 0.414 . . . . 0.0 110.056 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.48 135.06 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.746 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -102.15 120.1 39.89 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.636 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -74.58 152.87 39.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.853 0.358 . . . . 0.0 110.858 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 37' ' ' GLN . 33.7 mm-40 -70.63 158.82 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.284 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.33 28.62 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.737 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 35' ' ' GLN . 22.8 tt0 -141.05 -19.44 0.8 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -67.72 115.68 29.98 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.168 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 61.5 Cg_exo -40.0 157.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.0 p -73.42 136.13 44.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 20.0 m-80 -156.58 101.77 2.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.169 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.65 7.56 46.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.668 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -67.47 88.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 44' ' ' ILE . 20.1 pt -85.12 141.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.02 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 22.1 t 55.43 67.82 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 46' ' ' GLN . 10.2 tm0? -78.73 -25.99 44.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 t 177.48 159.34 0.42 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.589 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.25 125.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -119.76 123.34 43.5 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.643 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 19.1 mp0 -102.69 129.43 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 52' ' ' THR . 7.3 mm -134.71 159.61 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 51' ' ' ILE . 22.2 m -152.63 108.41 3.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.621 ' CG ' ' H ' ' A' ' 78' ' ' THR . 4.3 pt-20 -52.3 120.97 6.09 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 22.6 t . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 CA--C 1.53 0.307 0 N-CA-C 111.185 -0.352 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.621 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 16.1 p -130.3 139.59 50.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.858 0.361 . . . . 0.0 110.869 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 m -98.83 132.15 44.4 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -113.72 143.24 44.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 110.429 -178.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 86.3 m-85 -129.57 124.87 34.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.652 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.2 p -103.91 62.66 0.76 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.662 0.267 . . . . 0.0 110.859 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 83' ' ' ILE . 13.1 tt -71.22 102.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 110.12 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -102.14 148.05 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.956 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.51 144.52 5.18 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.31 9.22 57.05 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.28 2.52 57.88 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.758 -0.258 . . . . 0.0 113.098 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.501 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -151.16 173.95 13.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.307 0.554 . . . . 0.0 111.367 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -129.09 117.18 20.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.738 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.5 mtt -101.99 122.0 43.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.297 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -109.93 122.57 47.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.493 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.8 178.03 4.68 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.617 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.01 74.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.037 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -76.9 143.26 39.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.045 0.423 . . . . 0.0 110.441 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -127.75 105.53 8.52 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.474 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.8 tttt 67.08 40.14 2.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.759 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.8 m -119.02 148.86 45.67 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.28 129.95 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.882 1.721 . . . . 0.0 111.937 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.706 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.9 mp0 -50.39 144.99 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.9 mt -96.39 142.56 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.78 -11.54 1.15 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.016 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -113.17 116.48 29.88 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 pt -128.58 120.02 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.0 p -135.82 172.22 13.32 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.928 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 64.0 tt0 -161.57 152.83 18.53 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 t -155.47 152.23 28.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.033 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.23 121.83 28.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -133.41 108.61 8.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.006 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.68 -119.06 6.35 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -112.58 26.35 10.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.806 0.336 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 p -130.34 157.36 42.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.511 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.64 136.68 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.601 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -124.48 158.22 33.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.967 0.413 . . . . 0.0 110.728 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.49 135.82 13.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.461 HH21 HG21 ' A' ' 164' ' ' VAL . 53.9 ttp180 -114.0 123.66 50.26 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.02 118.83 34.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 t -167.05 161.22 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.902 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.9 t -82.69 174.59 10.86 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.06 144.43 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.013 0.435 . . . . 0.0 110.982 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 p -79.73 151.02 73.58 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.047 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.77 163.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.921 1.747 . . . . 0.0 112.185 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.55 61.78 7.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.209 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -139.31 -52.27 0.54 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.07 -12.78 0.37 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.696 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -126.92 172.46 10.42 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -74.56 150.7 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.644 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.0 m -143.41 63.05 12.09 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.292 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.52 131.54 2.52 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.116 2.544 . . . . 0.0 113.339 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.8 152.46 23.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.38 176.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.699 0.285 . . . . 0.0 110.735 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.2 p -81.19 172.33 13.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.183 0.516 . . . . 0.0 111.692 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.461 ' CG ' ' OD1' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -61.26 -37.35 82.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -63.65 -57.07 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.523 ' HB1' ' CE ' ' A' ' 24' ' ' MET . . . -65.44 -57.24 8.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.039 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -53.54 -31.57 47.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.219 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.48 73.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.68 -52.34 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.54 -22.84 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.453 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -87.28 -54.51 4.27 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -79.89 -36.02 37.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 t -44.26 116.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.721 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 49.9 mt-10 -145.02 156.61 44.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.12 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.9 136.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.965 0.412 . . . . 0.0 110.374 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.0 p -102.37 163.91 11.97 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.71 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.56 137.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.88 0.372 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -143.95 92.89 2.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.7 mm -79.23 139.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.648 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.452 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 58.3 ttt180 -134.17 165.36 25.27 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 7.1 t -90.67 118.09 29.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.318 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 152' ' ' GLU . 31.2 t -100.3 -176.05 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.706 0.289 . . . . 0.0 110.262 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.431 ' N ' ' OG ' ' A' ' 151' ' ' SER . 16.0 tp10 -162.45 17.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.043 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.12 103.38 7.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.485 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.16 8.7 3.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -56.01 138.38 49.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.112 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.09 174.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.975 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 t -94.66 143.9 26.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.498 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.464 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 m-20 -117.6 91.44 3.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.955 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.5 pt -124.51 170.3 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.689 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.492 ' CD ' ' HB3' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -104.95 -160.88 0.78 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.034 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.7 t -130.53 -3.48 4.26 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -83.45 130.6 55.65 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -39.29 158.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.876 1.717 . . . . 0.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.461 HG21 HH21 ' A' ' 115' ' ' ARG . 14.6 p -80.25 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.257 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 18.0 mt -82.07 125.04 30.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.591 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.89 163.96 17.29 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.562 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 t -94.72 5.61 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.801 0.334 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.2 m-20 60.31 9.5 1.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.988 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.516 HD11 ' CB ' ' A' ' 27' ' ' ASP . 2.2 pp -98.01 154.65 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 172' ' ' LYS . 80.1 p -117.49 129.17 55.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.21 35.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 170' ' ' SER . 19.3 tttp -59.21 -164.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -99.31 119.9 38.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 175' ' ' SER . 2.7 t -148.02 171.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.554 ' H ' HG12 ' A' ' 174' ' ' VAL . 6.3 p -31.48 149.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.495 0.497 . . . . 0.0 111.529 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -106.58 141.69 37.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.191 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 3.8 tm-20 -150.85 137.42 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.619 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.433 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.1 t70 -65.92 96.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.1 mt -107.26 -52.99 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.388 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 180' ' ' ILE . 5.5 tp -63.45 124.95 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.61 -117.38 2.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.574 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 41.5 m -74.18 139.25 44.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.793 -0.203 . . . . 0.0 111.16 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.7 p -138.3 91.58 2.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.21 0.529 . . . . 0.0 110.77 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.1 mm -99.13 115.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.051 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.27 138.48 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.155 0.502 . . . . 0.0 111.497 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.84 92.81 7.61 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 189' ' ' CYS . 1.3 p -47.27 -44.15 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.061 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -37.55 -27.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.038 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 187' ' ' THR . 81.6 m -146.17 31.43 1.02 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.4 t -149.75 100.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.711 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -77.02 -60.64 2.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.843 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -117.91 177.94 4.59 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.567 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 195' ' ' PHE . 1.1 tt -174.07 108.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.474 ' OE1' HD21 ' A' ' 232' ' ' LEU . 48.3 mt-10 -93.44 137.65 32.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 193' ' ' LEU . 88.7 m-85 -117.37 130.77 56.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.713 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.0 m -144.3 119.73 10.3 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 198' ' ' ARG . 45.3 t -131.06 157.87 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.326 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.475 ' N ' HG12 ' A' ' 197' ' ' VAL . 45.5 ttt180 -158.31 156.13 30.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.56 112.71 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.21 167.89 40.91 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.078 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -49.28 141.14 8.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.7 mtm -95.66 3.81 53.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.2 t -118.57 -47.92 2.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.719 0.295 . . . . 0.0 110.867 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.79 108.84 4.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 110.164 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -48.28 156.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.6 p -156.54 112.27 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.982 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 t -33.16 -59.3 0.36 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.582 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -52.19 -53.34 44.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -92.0 61.87 4.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -163.8 105.59 0.94 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.717 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.15 174.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.969 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -171.38 147.3 2.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.567 . . . . 0.0 111.584 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.3 t70 -121.73 171.2 9.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.39 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . -179.83 158.57 22.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.888 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.429 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 46.7 m-85 -150.31 165.45 32.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -134.03 104.92 6.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -101.93 117.58 35.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.79 104.04 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.061 0.458 . . . . 0.0 110.703 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.6 t0 55.23 52.17 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.255 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.63 -9.52 50.24 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.908 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.8 p -89.6 109.11 20.09 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.63 -0.335 . . . . 0.0 110.944 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -103.08 147.65 26.71 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 73.1 m -166.79 129.53 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -82.2 141.14 33.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -171.07 108.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.272 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.1 97.28 2.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.242 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.6 p -126.06 154.18 43.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.91 95.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.55 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.2 35.6 0.81 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.353 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.6 m -74.65 -41.62 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.714 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -93.61 5.04 52.93 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.149 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -38.52 -37.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.135 0.493 . . . . 0.0 110.767 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 7.7 tp -159.66 148.88 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.728 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.65 100.57 4.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.3 t -68.23 -0.82 5.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.2 p -82.58 -21.15 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -105.2 10.06 33.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.241 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.7 mt -92.84 129.27 38.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -113.67 143.85 43.91 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.068 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' LYS . . . -55.75 171.32 0.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 40.1 t -126.21 -6.13 6.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.71 179.695 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.092 0 CA-C-O 120.837 0.351 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 87.8 m -149.29 116.23 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . 0.402 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 0.1 OUTLIER -62.94 137.53 58.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.96 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.94 -20.62 10.46 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.985 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -122.43 143.58 49.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.483 ' CD2' ' OD1' ' B' ' 53' ' ' ASP . 16.4 m-85 -121.73 152.48 39.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 111.808 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -80.29 141.27 35.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.572 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -89.15 -28.02 20.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -87.54 126.03 34.68 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.724 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -85.85 114.61 22.91 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.553 ' N ' HD12 ' B' ' 20' ' ' LEU . 9.3 mp -75.33 115.08 41.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -41.93 151.04 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.134 1.889 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 25' ' ' VAL . 39.7 ttm180 -45.87 -50.0 14.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.386 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -28.99 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -109.6 50.26 0.8 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.941 0.4 . . . . 0.0 110.241 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 22' ' ' ARG . 66.1 t -150.22 88.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -95.42 -21.14 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.35 179.21 8.52 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.499 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -166.98 163.38 15.99 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.287 0.565 . . . . 0.0 112.037 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -152.16 167.25 29.14 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.165 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' B' ' 31' ' ' THR . 50.9 mt-10 -114.08 152.18 31.44 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.422 ' O ' ' O ' ' B' ' 30' ' ' GLU . 73.0 p -55.92 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.091 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -147.84 -149.29 0.29 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.676 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 35' ' ' CYS . 91.1 p -135.51 -24.38 1.37 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.276 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.24 -3.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.46 . . . . 0.0 109.788 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.446 ' C ' ' H ' ' B' ' 37' ' ' GLN . 58.0 m -114.99 117.31 30.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.503 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -73.65 37.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.964 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' B' ' 35' ' ' CYS . 10.2 pt20 -169.22 64.3 0.54 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 86.0 Cg_endo -75.95 -162.86 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.422 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' B' ' 51' ' ' CYS . . . 174.32 176.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.971 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.14 144.06 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.224 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.44 130.47 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.505 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -112.14 144.21 41.9 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -111.51 115.19 28.79 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.066 0.46 . . . . 0.0 111.047 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.4 p -79.52 -140.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.48 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.85 -27.91 2.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.87 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.97 46.44 2.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.435 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 48.0 t -157.26 -84.95 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.944 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.76 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.715 0.635 . . . . 0.0 109.777 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -131.17 140.68 49.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.726 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.0 t -150.19 112.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 110.827 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.574 ' N ' ' OG ' ' A' ' 182' ' ' SER . 2.6 t -73.33 152.16 41.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.605 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.13 135.79 22.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.893 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . 0.483 ' OD1' ' CD2' ' B' ' 15' ' ' TYR . 69.3 m-20 -61.74 125.9 85.81 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.99 2.64 5.24 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.433 1.422 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 30.2 m -73.39 -3.49 27.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.292 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.404 ' O ' ' OE1' ' B' ' 60' ' ' GLN . 39.0 mt-10 -109.53 125.13 52.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.93 0.395 . . . . 0.0 110.363 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -50.12 -36.19 28.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.113 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -56.14 -36.18 67.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.936 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 t -70.72 -36.88 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.001 0.429 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . 0.404 ' OE1' ' O ' ' B' ' 56' ' ' GLU . 2.2 mp0 -70.07 -36.79 75.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.99 -37.56 69.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.225 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.31 -41.03 94.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.628 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.47 -44.21 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.919 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -60.13 -28.9 68.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.746 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -75.33 -43.7 49.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.946 0.403 . . . . 0.0 110.728 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.74 -22.75 63.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.457 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.57 -36.53 68.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -75.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.581 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.776 0.322 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -72.37 -20.77 61.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.592 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.9 t -50.42 131.98 24.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.565 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.5 p -57.77 -29.59 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -76.83 -23.54 52.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.721 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -79.08 -48.05 15.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -165.35 171.27 13.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.093 0.473 . . . . 0.0 111.05 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.66 148.75 48.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.553 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.7 p -70.93 176.18 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.548 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.6 5.71 6.81 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 19' ' ' GLU . 43.1 mt-10 -83.03 92.9 7.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.411 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' GLU . 37.1 tt0 -23.54 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.171 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.408 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 5.0 p30 -76.22 50.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.358 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -158.49 135.71 9.99 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -145.53 166.43 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.82 0.343 . . . . 0.0 111.003 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -95.03 107.05 19.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.567 ' SD ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -78.64 107.21 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.297 0.57 . . . . 0.0 110.581 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.86 148.32 18.71 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.98 151.86 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' CD1' ' A' ' 29' ' ' ILE . 59.0 t0 -147.25 130.83 16.81 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -138.67 99.8 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.846 0.355 . . . . 0.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.7 mp -95.23 139.54 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 pt -148.71 135.13 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.471 0.653 . . . . 0.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' HD12 ' A' ' 193' ' ' LEU . 36.7 ttmt -115.98 123.19 47.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.589 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.63 110.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.784 0.326 . . . . 0.0 111.162 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -87.58 122.24 31.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.758 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.442 ' NZ ' ' C ' ' A' ' 110' ' ' ASN . 25.1 mtmm -80.55 154.31 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.758 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.653 ' NE2' ' H ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.06 154.06 39.38 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.496 ' H ' ' CD ' ' A' ' 35' ' ' GLN . 15.2 t70 -62.1 -19.47 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.4 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.653 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 70.6 mt-30 -82.75 -36.71 25.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.193 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.8 p -48.04 147.21 3.71 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.742 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.09 168.47 24.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.113 1.876 . . . . 0.0 111.575 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -75.36 128.46 35.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.63 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.475 ' ND2' ' OE1' ' A' ' 154' ' ' GLU . 29.7 m120 -158.24 101.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.73 -0.27 21.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.643 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -72.69 71.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -71.06 170.36 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 110.383 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 32.6 t 50.35 57.86 6.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.48 0.657 . . . . 0.0 110.443 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.98 -21.2 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 t 173.14 154.12 0.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.905 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.16 135.06 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -114.29 153.93 28.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -136.22 109.73 7.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.531 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 79' ' ' THR . 6.0 mt -122.01 154.02 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 t -153.59 151.32 29.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 37.8 tt0 -52.96 171.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 p . . . . . 0 C--N 1.32 -0.706 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.307 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.481 0.784 0 N-CA-C 113.105 0.387 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -140.67 149.56 42.4 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.032 0.444 . . . . 0.0 111.498 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.2 m -101.37 129.85 47.45 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 63.8 t80 -118.39 101.8 8.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -108.96 117.56 34.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.915 0.388 . . . . 0.0 110.277 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 t -95.95 85.32 4.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.59 118.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.069 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 tt -106.62 146.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.796 0.331 . . . . 0.0 110.109 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 157.57 7.77 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.31 7.95 82.02 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.99 60.29 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.829 -0.224 . . . . 0.0 112.582 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.56 174.47 15.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 111.045 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -115.81 123.88 49.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.719 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.2 mpp? -102.71 97.94 8.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' HG23 ' A' ' 146' ' ' ILE . 84.3 m-20 -86.88 133.89 33.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.456 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 78.6 m-85 -116.27 -164.91 1.0 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.76 71.94 0.03 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.07 140.54 40.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.166 0.508 . . . . 0.0 110.641 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -131.97 108.27 9.25 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? 69.04 36.5 2.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 31.9 m -122.38 149.65 55.53 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -34.91 153.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.408 2.072 . . . . 0.0 112.573 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -76.21 106.43 7.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -62.48 146.05 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.21 -12.05 0.42 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.861 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -106.09 113.79 27.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.2 mt -124.03 108.2 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -139.48 153.92 47.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.77 0.319 . . . . 0.0 111.815 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 17.0 mp0 -145.11 169.69 17.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.6 p -157.83 153.95 27.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.87 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.27 118.2 20.97 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.853 0.358 . . . . 0.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.4 107.63 8.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.99 -138.7 25.96 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.442 ' C ' ' NZ ' ' A' ' 34' ' ' LYS . 24.5 p30 -91.99 26.29 2.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 110.494 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 112' ' ' VAL . 87.0 m -129.63 156.47 44.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.772 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.48 ' N ' HG22 ' A' ' 111' ' ' THR . 35.0 m -142.07 138.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.316 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.47 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -119.57 168.08 11.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.115 0.483 . . . . 0.0 111.194 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.25 127.33 9.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.105 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.477 ' NH1' ' OG ' ' A' ' 235' ' ' SER . 76.9 ttt180 -113.52 110.79 20.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.656 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 115' ' ' ARG . 3.2 mm? -115.19 124.9 52.62 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 p -168.07 161.75 12.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.938 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -77.93 171.0 15.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.623 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.83 145.56 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.043 0.449 . . . . 0.0 111.338 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.15 163.38 53.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.43 150.23 84.37 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 122.209 1.939 . . . . 0.0 111.664 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.37 9.67 85.59 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.329 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -82.96 -60.51 2.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.35 -16.73 0.29 Allowed Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -110.42 179.0 4.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.48 158.74 35.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.108 0.48 . . . . 0.0 111.242 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.4 p -155.04 61.03 2.86 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -40.36 135.55 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.936 2.424 . . . . 0.0 113.286 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -114.99 145.87 41.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.272 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.567 HG22 ' SD ' ' A' ' 24' ' ' MET . 5.8 tp -140.71 168.35 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -73.14 178.58 4.32 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 111.475 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.437 ' H ' ' CD2' ' A' ' 132' ' ' HIS . 14.0 p80 -71.23 -34.3 70.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.735 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.54 -57.61 11.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.64 -31.89 73.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.993 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.89 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.505 ' O ' ' NZ ' ' A' ' 140' ' ' LYS . 35.3 tp -74.23 -32.82 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.595 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.18 -52.02 18.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.55 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -64.12 -54.53 32.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.587 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.585 ' N ' ' SD ' ' A' ' 138' ' ' MET . 20.7 tt -45.87 -22.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 136' ' ' LEU . 26.4 mtmm -92.96 -26.35 17.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.283 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.47 -30.84 14.83 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.0 t -47.3 117.02 1.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' B' ' 17' ' ' ALA . 8.5 tm-20 -138.74 121.57 16.52 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.349 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.26 125.77 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -100.78 159.2 15.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.906 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 91' ' ' ASN . 3.2 mt -148.78 156.86 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.938 0.399 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -166.1 85.76 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.59 144.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.495 . . . . 0.0 111.793 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -135.8 175.41 9.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.812 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.7 t -91.46 134.88 34.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.45 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 p -111.39 166.16 11.35 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.771 0.319 . . . . 0.0 110.169 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.89 6.99 2.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.93 99.45 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.096 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.475 ' OE1' ' ND2' ' A' ' 41' ' ' ASN . 9.8 mm-40 -83.23 18.88 1.6 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -63.71 148.84 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.613 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 157' ' ' SER . 38.4 t70 -52.16 171.79 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.194 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.433 ' N ' ' CG ' ' A' ' 156' ' ' ASP . 35.2 p -100.02 149.82 23.07 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.086 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.2 m-20 -116.73 88.83 2.98 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.3 pt -103.25 177.13 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.388 0.613 . . . . 0.0 111.528 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.875 ' HZ3' ' H ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -108.36 -173.29 2.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.06 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 161' ' ' THR . 91.8 m -124.56 -9.26 7.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.413 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 14.6 m-70 -100.14 127.56 33.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.787 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -39.42 159.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.03 1.82 . . . . 0.0 112.705 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.09 140.38 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 20.2 mt -85.2 125.29 32.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.366 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 159.85 20.32 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.469 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.3 m -93.8 12.0 27.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.4 t30 58.08 9.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.719 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.22 148.58 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 20.5 m -112.6 140.06 47.68 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.495 ' NE2' HD13 ' A' ' 29' ' ' ILE . 22.0 m80 -74.95 43.95 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.535 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -71.53 162.68 29.06 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -77.39 128.02 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.7 m -149.29 -166.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.0 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.1 p -48.08 145.06 3.3 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.423 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -112.47 144.38 42.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.906 0.384 . . . . 0.0 111.239 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -158.74 152.1 22.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.483 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -68.61 106.33 2.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.274 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -116.93 -59.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.724 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.1 mt -61.26 122.05 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.14 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.4 -119.81 2.11 Favored Glycine 0 C--O 1.225 -0.412 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.955 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.552 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 52.2 p -72.07 141.86 49.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.47 ' OG1' ' CE2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -145.02 83.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.68 97.04 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.991 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 185' ' ' VAL . 18.1 m -112.18 131.65 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.953 0.406 . . . . 0.0 111.59 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -79.44 114.99 18.8 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.112 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.9 p -52.25 -28.04 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -39.21 -30.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.514 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 65.1 m -143.95 26.43 1.53 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.732 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 44.0 t -149.22 89.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 110.483 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -67.71 -56.44 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.648 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -133.65 146.32 50.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 31' ' ' LYS . 23.0 tp -144.14 120.81 11.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.839 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 12.7 mp0 -105.92 130.78 53.8 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.512 ' N ' ' CD1' ' A' ' 195' ' ' PHE . 0.2 OUTLIER -107.23 138.63 43.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.912 0.387 . . . . 0.0 110.528 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.2 t -144.35 120.64 10.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.62 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 198' ' ' ARG . 6.7 p -131.93 159.64 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 197' ' ' VAL . 11.4 ttt85 -171.25 112.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.241 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 199' ' ' ILE . 8.5 tt -113.3 129.84 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.819 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -168.83 -148.97 5.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.862 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -95.95 119.83 35.15 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 167' ' ' SER . 21.8 mmt -82.85 3.86 27.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.29 -54.31 2.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.689 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -153.76 120.73 5.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.726 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -49.2 129.22 17.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.148 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.4 t -124.8 113.33 17.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.797 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.9 p -35.58 -39.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.859 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -79.21 -45.58 19.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 61.21 3.98 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.07 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.34 128.17 7.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.185 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.489 HG23 HD11 ' A' ' 139' ' ' ILE . 3.8 t -142.9 164.35 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.03 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.477 ' N ' ' CG1' ' A' ' 211' ' ' VAL . 0.9 OUTLIER -161.13 127.34 3.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.03 171.51 11.79 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.448 ' C ' ' CD1' ' A' ' 215' ' ' PHE . . . 155.76 160.49 10.01 Favored Glycine 0 CA--C 1.511 -0.166 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 215' ' ' PHE . 14.5 m-85 -141.57 -176.8 4.88 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -134.73 105.99 6.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.203 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.66 113.55 25.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 218' ' ' VAL . 31.8 m -135.98 120.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 0.0 110.523 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 218' ' ' VAL . 4.5 p-10 46.09 51.32 11.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.979 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.24 2.96 68.53 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.668 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.7 t -104.41 119.89 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.066 0.433 . . . . 0.0 110.678 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.07 155.87 18.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.121 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 79.3 p -170.87 129.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -80.14 141.9 35.29 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -170.86 101.6 0.17 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.17 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.39 96.55 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.714 0.292 . . . . 0.0 110.387 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 77.2 p -126.04 160.43 30.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.64 99.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -91.66 21.96 4.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 87.5 m -63.24 -35.4 80.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.746 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.1 p -97.95 -4.75 35.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.1 tp -43.45 -31.8 0.76 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.852 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.3 tt -143.53 144.35 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.203 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 236' ' ' THR . 31.5 m-20 -83.15 91.4 7.23 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 115' ' ' ARG . 14.2 t -56.78 -0.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.202 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 234' ' ' ASP . 58.4 m -88.36 -20.24 25.59 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -101.6 11.42 38.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.747 0.308 . . . . 0.0 111.465 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -84.78 133.23 34.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.694 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -127.09 132.3 50.67 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.361 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.875 ' H ' ' HZ3' ' A' ' 160' ' ' LYS . . . -55.67 165.48 0.85 Allowed 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.156 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 38.1 t -126.23 -2.9 6.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.971 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 121.125 0.488 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 33.3 m -116.29 135.49 53.84 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.603 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 t -41.31 138.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.779 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.47 ' CE2' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -125.17 -26.79 3.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.305 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.6 m -138.66 143.02 39.03 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.506 ' N ' ' CD1' ' B' ' 15' ' ' TYR . 1.1 m-85 -107.18 149.12 28.04 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.2 t -74.94 133.72 41.69 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.463 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 143' ' ' GLU . . . -79.06 -45.44 20.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.589 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -79.33 126.13 30.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.87 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.61 150.22 48.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.118 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 20.8 mt -105.01 100.06 22.51 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.513 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -42.23 146.44 0.68 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.69 1.594 . . . . 0.0 111.968 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -46.12 -48.21 17.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.643 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' B' ' 23' ' ' ASN . 11.5 m-80 -49.37 -22.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 111.291 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.407 ' CE1' ' OE1' ' A' ' 53' ' ' GLU . 9.6 t80 -109.42 33.57 4.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.201 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 66.3 t -153.47 93.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.686 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 32.0 m -88.42 -23.72 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.5 t70 -156.76 -179.52 8.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.163 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.477 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 7.9 p90 -158.51 170.61 21.81 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.084 0.469 . . . . 0.0 111.36 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.45 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -154.02 179.28 9.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.12 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.45 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 85.9 mt-10 -124.14 147.37 48.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.873 0.368 . . . . 0.0 110.364 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -55.82 -109.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.5 m -153.86 -147.96 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.669 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.455 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.1 t -136.47 -32.43 0.84 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.308 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 4.3 mp -51.79 -10.99 0.13 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.455 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.6 p -111.04 118.63 36.57 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 79.4 p -72.58 37.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.723 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.4 pt20 -171.27 61.83 0.35 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.66 -167.66 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.669 2.246 . . . . 0.0 113.386 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.45 176.02 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.639 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.25 131.85 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.683 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.08 132.94 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.597 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -103.74 147.7 26.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.167 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -94.05 169.57 10.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.2 p -142.0 -145.82 0.18 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.719 0.691 . . . . 0.0 111.499 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.468 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -127.62 -40.12 1.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.33 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.75 43.09 3.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.361 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 8.5 t -149.04 -83.78 0.1 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.435 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -87.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.004 0.43 . . . . 0.0 109.878 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -139.53 147.37 41.13 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.65 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -150.39 119.09 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 111.098 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.552 ' H ' ' CB ' ' A' ' 182' ' ' SER . 7.2 t -59.8 157.51 12.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.664 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.485 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.1 134.79 13.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.811 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -73.01 121.28 84.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.32 1.4 6.15 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.223 1.282 . . . . 0.0 111.863 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 27.7 t -76.05 -4.05 39.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.957 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' B' ' 57' ' ' SER . 0.8 OUTLIER -106.87 124.87 50.24 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.511 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 22.1 p -44.32 -47.34 9.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.4 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 85.9 m95 -55.11 -27.79 47.75 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.22 -43.98 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 109.646 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -62.05 -41.67 98.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.97 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -70.66 -34.86 72.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -66.45 -37.57 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 73.3 t -71.11 -47.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.95 -31.72 70.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -72.56 -37.44 68.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.58 -22.09 61.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.558 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -73.17 -32.2 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.235 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.63 -78.07 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.8 t30 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.549 -180.0 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.913 0.387 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 m -79.14 -25.48 42.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.625 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 p -47.93 128.52 13.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 t -61.28 -19.94 62.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.1 p -77.4 -30.9 53.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.379 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.0 p -77.24 -46.68 22.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.6 m -163.15 158.88 22.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.912 0.387 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.11 154.34 10.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.5 p -68.62 165.5 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.514 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 34.9 mp0 -115.42 7.94 15.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.258 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.24 -163.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 15.3 mp0 -114.56 -73.01 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.023 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -87.61 60.26 5.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.145 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 21.7 tttm -157.78 141.46 15.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.258 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -149.42 179.13 8.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.387 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.508 ' CD2' ' OG ' ' A' ' 127' ' ' SER . 32.1 t60 -108.93 90.23 3.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.506 ' CE ' ' HB1' ' A' ' 135' ' ' ALA . 53.9 tpp -71.92 126.72 30.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.903 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 199' ' ' ILE . . . -136.07 167.13 24.48 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.5 pt -111.32 150.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.23 121.04 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.8 146.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.184 0.516 . . . . 0.0 111.254 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD12 ' NH2' ' A' ' 198' ' ' ARG . 21.1 mt -137.27 140.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 30' ' ' ILE . 7.9 tt -130.77 122.26 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.138 0.494 . . . . 0.0 111.429 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -107.69 111.28 23.41 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.7 t -112.32 122.1 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.952 0.406 . . . . 0.0 111.643 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.0 m -97.25 114.62 26.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -68.3 151.8 46.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.82 179.35 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -80.63 -28.43 36.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.737 0.303 . . . . 0.0 110.71 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -85.31 -34.75 21.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.2 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.3 m -40.3 104.1 0.32 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.87 161.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.931 1.754 . . . . 0.0 112.039 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.8 p -67.99 140.14 56.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.639 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.419 HD22 ' C ' ' A' ' 41' ' ' ASN . 0.4 OUTLIER -165.3 96.21 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.42 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -99.32 10.62 41.07 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.35 82.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.125 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.6 pt -81.26 142.74 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.634 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.53 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 33.9 t 56.21 67.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.5 tp60 -78.47 -31.45 47.88 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.4 p -178.32 167.47 1.9 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.504 ' CG1' ' SG ' ' A' ' 241' ' ' CYS . 4.0 m -145.95 130.04 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.918 0.39 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 82' ' ' SER . 41.6 p -102.99 172.89 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.933 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -159.93 116.02 2.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.73 158.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -150.87 110.64 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.497 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 7.4 pt-20 -57.17 84.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 123.566 1.65 . . . . 0.0 109.601 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' THR . 9.9 p . . . . . 0 C--N 1.305 -1.349 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.571 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 CA--C 1.533 0.468 0 N-CA-C 111.707 -0.151 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.501 ' N ' ' OE2' ' A' ' 53' ' ' GLU . 32.8 m -119.14 131.28 55.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.793 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.9 p -87.72 126.17 34.83 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 59.8 t80 -136.72 107.8 6.75 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CD2' ' CE1' ' A' ' 92' ' ' PHE . 4.8 p90 -106.8 -179.03 3.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.496 ' N ' ' OG1' ' A' ' 49' ' ' THR . 15.8 m -152.53 75.42 1.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 pt -72.4 119.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.51 0.671 . . . . 0.0 110.753 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.1 mt -101.26 145.13 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.518 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.46 166.1 16.32 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.37 22.36 50.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.09 14.18 76.32 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.36 156.57 48.27 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.938 0.399 . . . . 0.0 110.502 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -122.57 114.87 21.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.314 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 36.5 mtt -101.3 123.06 44.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.78 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -115.48 119.97 37.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.256 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.655 ' CE1' ' CD2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -108.15 169.36 8.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.77 77.63 0.19 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.337 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.45 145.35 29.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.642 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -141.63 122.21 14.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 66.45 34.26 6.3 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.378 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.55 143.72 49.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -34.39 144.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.387 2.058 . . . . 0.0 112.74 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -68.59 154.87 41.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.338 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.65 144.62 9.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.221 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -143.27 -15.96 0.66 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.717 0.294 . . . . 0.0 110.331 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -113.16 118.06 33.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.278 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 103' ' ' ILE . 5.9 tp -135.05 128.68 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 p -142.79 179.41 7.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 60.0 tt0 -164.22 154.58 14.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.2 t -157.63 153.03 26.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.414 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.24 123.65 30.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -135.3 107.9 7.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.966 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.31 -124.69 7.35 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -106.61 27.78 8.5 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.732 0.301 . . . . 0.0 110.511 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -133.72 159.83 39.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 110.731 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.35 134.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.476 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CG ' HD12 ' A' ' 233' ' ' ILE . 4.9 m120 -114.86 155.08 27.47 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.06 128.44 8.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -108.24 122.99 48.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.033 0.444 . . . . 0.0 111.154 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.878 ' N ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -112.98 114.6 27.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.4 t -157.58 170.0 23.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.593 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.3 p -94.52 166.17 12.18 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.438 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.98 150.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.374 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 p -99.43 150.42 36.74 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.867 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -38.84 163.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.121 1.88 . . . . 0.0 112.543 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 50.23 73.54 0.36 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.215 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -152.89 -27.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.088 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.88 12.62 13.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.193 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -134.95 155.42 50.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -56.31 151.33 13.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.527 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.508 ' OG ' ' CD2' ' A' ' 23' ' ' HIS . 2.2 t -153.19 67.13 6.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.53 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.22 130.0 27.19 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.887 2.391 . . . . 0.0 113.331 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.443 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -96.2 158.07 15.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.694 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.8 pt -145.34 160.87 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.82 0.343 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.8 p -75.78 178.53 6.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.047 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.422 ' CE1' HD21 ' A' ' 209' ' ' LEU . 10.0 t60 -69.27 -35.95 76.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.503 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.31 -57.85 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.989 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.995 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.506 ' HB1' ' CE ' ' A' ' 24' ' ' MET . . . -68.29 -56.96 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.769 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.0 tp -54.46 -32.61 58.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.127 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.51 -52.46 18.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.646 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mtt -57.16 -52.72 64.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.145 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.2 mm -45.98 -21.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.296 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -91.43 -41.55 10.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.79 -31.06 56.73 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 m -41.47 111.15 0.2 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.48 116.96 11.35 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.055 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 144' ' ' VAL . 12.1 p -117.57 127.35 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.055 0.455 . . . . 0.0 110.659 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 m -101.06 162.9 12.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.4 tp -145.47 136.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.992 0.425 . . . . 0.0 110.646 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -146.99 90.42 1.9 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.882 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.9 tt -83.73 140.33 16.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.72 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 35.8 ttm180 -133.39 170.45 15.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 5.8 t -90.48 126.64 35.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.187 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.7 p -120.38 133.45 55.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -100.57 21.23 13.64 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.622 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -50.29 158.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -144.54 -0.74 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.197 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 26.8 mtmm -63.89 171.58 2.74 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.632 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.23 173.89 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.5 t -92.54 144.28 25.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.6 t70 -120.18 89.86 3.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.999 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 pt -120.53 172.25 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.428 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.59 ' NZ ' ' NE2' ' A' ' 162' ' ' HIS . 31.0 tttm -124.32 136.4 54.08 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.005 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 161' ' ' THR . 29.8 m -64.26 0.43 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.59 ' NE2' ' NZ ' ' A' ' 160' ' ' LYS . 1.8 m-70 -79.3 119.14 76.03 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.11 157.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.811 1.674 . . . . 0.0 112.281 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.45 134.7 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.47 120.02 21.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.18 162.42 22.77 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 169' ' ' ILE . 10.3 p -98.08 5.37 48.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.091 0.472 . . . . 0.0 109.766 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 58.5 t30 60.31 -0.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.815 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 167' ' ' SER . 0.2 OUTLIER -88.98 133.62 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.7 t -79.12 -176.49 5.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.271 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.541 ' CD2' HH21 ' A' ' 198' ' ' ARG . 0.0 OUTLIER -124.52 22.23 8.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -59.63 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -93.5 123.97 37.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.852 HG22 ' H ' ' A' ' 175' ' ' SER . 14.4 p -146.97 -176.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.931 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.852 ' H ' HG22 ' A' ' 174' ' ' VAL . 58.6 m -38.65 143.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.744 0.307 . . . . 0.0 111.228 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -104.35 140.64 37.61 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.056 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -151.09 144.81 25.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.58 89.18 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.1 -42.74 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.964 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 180' ' ' ILE . 6.8 tp -64.03 124.84 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.22 -128.73 3.79 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.448 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.1 t -73.26 148.54 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 69.0 m -129.58 133.85 47.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.8 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 7.6 mm -138.42 128.16 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 185' ' ' VAL . 2.3 m -144.56 124.49 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.0 97.82 11.42 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 187' ' ' THR . 26.1 p -45.27 -27.84 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.386 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -44.56 -20.96 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.961 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 97.0 m -147.33 16.75 1.17 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 190' ' ' VAL . 35.7 m -148.27 108.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.485 0.66 . . . . 0.0 111.119 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -79.42 -56.19 4.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.586 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -109.69 170.1 8.29 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.545 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.672 HD12 ' CZ ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -169.74 105.84 0.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -108.36 130.81 55.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.672 ' CZ ' HD12 ' A' ' 193' ' ' LEU . 15.6 m-85 -114.81 140.48 48.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.594 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.46 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 14.4 t -143.95 124.2 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.484 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.46 150.19 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.541 HH21 ' CD2' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -166.41 108.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.674 -179.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 25' ' ' GLY . 12.0 mt -104.51 148.64 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.233 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.29 34.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.575 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -88.07 121.22 30.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.905 0.384 . . . . 0.0 110.303 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -79.48 1.15 26.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.731 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.62 -47.36 5.12 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.121 0.486 . . . . 0.0 109.9 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -168.09 127.21 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.65 148.05 0.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.848 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 47.9 p -136.69 12.81 3.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.924 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.6 m 58.39 -75.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.4 mt-10 -46.24 -54.38 8.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.681 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.422 HD21 ' CE1' ' A' ' 132' ' ' HIS . 14.4 mt -76.99 -0.83 25.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.785 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.88 134.83 37.09 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.669 0.271 . . . . 0.0 110.491 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m -154.62 -179.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.295 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.46 ' HZ3' ' CB ' ' A' ' 226' ' ' ALA . 13.9 pttp -170.67 167.5 7.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.431 0.634 . . . . 0.0 112.136 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.2 t70 -155.26 168.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.7 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 172.1 168.13 33.14 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 10.4 m-85 -153.4 167.3 29.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 2.7 ttmp? -133.42 104.0 6.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.035 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -100.57 118.13 36.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.866 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.4 p -139.38 111.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.614 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.4 t70 53.12 47.47 24.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.692 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.28 -5.61 71.72 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.356 -0.45 . . . . 0.0 113.408 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.7 t -96.95 116.66 29.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.099 0.45 . . . . 0.0 110.716 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.63 153.51 21.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.079 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.4 m -167.83 129.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.276 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -83.01 142.62 31.21 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.66 116.74 0.61 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.587 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.46 ' CB ' ' HZ3' ' A' ' 212' ' ' LYS . . . -73.86 111.45 9.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 28.5 m -140.99 153.07 45.4 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.924 0.392 . . . . 0.0 110.581 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 95.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.617 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -87.27 30.03 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 231' ' ' SER . 9.3 t -71.34 -39.1 71.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.451 ' N ' HG23 ' A' ' 230' ' ' THR . 55.6 m -96.94 2.67 51.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.9 tp -44.38 -40.64 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.788 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.507 HD12 ' CG ' ' A' ' 113' ' ' ASN . 27.5 mm -141.18 146.33 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.777 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 236' ' ' THR . 34.4 m-20 -78.18 92.86 4.49 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 m -56.6 -6.5 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 234' ' ' ASP . 26.0 m -86.68 -17.05 34.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.411 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -99.04 7.43 45.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.503 0.192 . . . . 0.0 111.347 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.67 144.77 35.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.407 . . . . 0.0 110.809 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -133.49 133.49 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.536 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.71 156.73 4.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 48' ' ' VAL . 53.7 t -126.5 -10.28 6.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.457 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.857 -1.068 . . . . 0.0 110.434 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 121.184 0.516 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.499 ' O ' ' CE2' ' B' ' 13' ' ' PHE . 85.6 m -106.4 161.42 14.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.67 135.48 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.346 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' B' ' 11' ' ' CYS . 6.8 m-85 -114.01 -26.91 7.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -149.66 153.76 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.261 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -111.52 155.07 23.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.74 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -77.49 137.17 38.5 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -27.17 41.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.62 0.248 . . . . 0.0 110.99 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -92.5 127.09 37.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.385 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -77.43 116.24 17.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.825 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.01 139.87 97.75 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.505 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.49 147.67 32.46 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.859 1.706 . . . . 0.0 111.367 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' B' ' 24' ' ' PHE . 41.5 ttp180 -44.68 -49.53 10.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.73 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' B' ' 23' ' ' ASN . 46.0 t-20 -69.67 29.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 57.8 t80 -155.45 33.33 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 86.4 t -155.97 97.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.751 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.42 -7.19 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 25.3 t0 -166.67 -178.74 4.49 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.096 -0.641 . . . . 0.0 111.259 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.482 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.7 p90 -158.24 163.52 37.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.097 0.475 . . . . 0.0 111.303 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -155.39 141.6 18.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.893 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' B' ' 31' ' ' THR . 88.8 mt-10 -90.0 142.5 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.91 0.386 . . . . 0.0 111.287 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 67.4 p -51.45 -108.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -154.47 -167.37 2.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.445 ' C ' ' N ' ' B' ' 35' ' ' CYS . 11.8 t -117.32 -30.4 5.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.502 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.536 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 4.4 mp -49.59 -13.14 0.08 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.445 ' N ' ' C ' ' B' ' 33' ' ' SER . 27.8 m -111.06 127.12 55.45 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.049 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -76.44 35.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -163.98 59.27 0.74 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.4 -164.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 122.59 2.194 . . . . 0.0 112.862 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.14 176.69 0.25 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.089 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.43 127.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.99 134.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -105.3 151.52 24.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.698 ' NE2' ' H ' ' B' ' 44' ' ' THR . 41.5 tp60 -93.67 164.56 13.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.698 ' H ' ' NE2' ' B' ' 43' ' ' GLN . 56.5 p -136.57 -168.42 2.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.289 0.566 . . . . 0.0 111.528 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.78 -41.82 4.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.713 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.91 47.11 2.02 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.374 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 3.0 m -158.47 -79.61 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.227 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.8 -90.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.397 0.436 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -136.86 151.45 49.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -150.08 124.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 10.2 t -64.18 159.5 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.298 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.496 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.0 130.59 10.68 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.238 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -67.76 116.88 42.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.33 0.57 5.87 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 120.938 1.092 . . . . 0.0 111.71 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 53.4 m -73.89 -16.07 61.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.983 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -91.61 127.25 36.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.168 0.509 . . . . 0.0 110.666 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 52.9 m -47.22 -49.8 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -56.15 -25.05 44.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.14 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 62.2 t -73.77 -37.38 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.181 0.515 . . . . 0.0 110.302 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.14 -37.56 78.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.504 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -72.07 -35.36 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.242 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.99 -36.1 82.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.477 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.06 -44.87 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.978 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -63.49 -27.59 69.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.018 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.41 -39.17 62.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.812 0.339 . . . . 0.0 110.934 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.43 -29.76 62.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.347 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OH ' ' B' ' 28' ' ' TYR . 32.1 mm-40 -69.7 -32.94 71.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.85 -74.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.336 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.553 179.891 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.729 0.3 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -75.44 -24.59 57.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.748 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.3 t -50.57 134.47 24.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -57.62 -29.39 64.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p -74.35 -25.94 59.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.23 -57.08 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.974 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -159.01 175.94 12.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.922 0.392 . . . . 0.0 110.907 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -61.92 159.92 13.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.887 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -75.2 165.89 24.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 1.4 pm0 -114.75 3.16 14.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.777 0.323 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.64 -165.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.35 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -116.05 -75.92 0.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.901 0.382 . . . . 0.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.494 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 64.8 t30 -77.81 53.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.627 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -154.63 132.13 11.27 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.577 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 34.3 m170 -140.9 165.49 27.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.201 0.524 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -97.75 76.19 2.46 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.965 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.2 ttm -68.88 133.69 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.29 25.03 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.0 tp -111.17 142.37 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -149.89 106.31 3.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.556 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 197' ' ' VAL . 12.2 m -122.29 134.53 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.68 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.5 pt -113.99 163.33 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.92 132.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.437 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -120.68 133.08 55.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.538 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.4 116.71 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.872 0.368 . . . . 0.0 111.326 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -81.76 112.41 18.89 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.59 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -68.22 150.14 48.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.888 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -58.89 168.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -91.3 5.02 50.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.843 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -120.48 -33.38 3.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.846 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 38' ' ' THR . 4.4 t -54.17 119.28 19.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.463 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -39.25 157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.976 1.784 . . . . 0.0 112.544 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 p -75.49 143.91 42.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.46 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -157.33 107.1 2.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.424 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' ILE . 2.7 p30 -101.16 -2.56 31.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.064 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 154' ' ' GLU . 4.8 mmmm -63.51 83.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.3 tp -90.53 150.62 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.078 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.451 ' SG ' ' CG ' ' A' ' 105' ' ' GLU . 1.7 m 56.17 62.09 2.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.139 0.495 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -78.19 -40.02 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 t -172.51 163.32 5.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.04 0.448 . . . . 0.0 111.181 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.06 140.36 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.489 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -129.54 105.29 7.98 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.847 0.356 . . . . 0.0 110.857 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.08 128.87 34.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.494 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 52' ' ' THR . 7.7 mm -132.36 154.7 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -152.62 142.57 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -51.11 176.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.366 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.531 0.349 0 N-CA-C 111.363 -0.284 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -123.76 141.46 52.01 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 p -107.59 127.0 53.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.755 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -112.25 148.02 35.01 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.201 0.524 . . . . 0.0 110.285 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -139.89 116.85 11.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.9 p -103.45 69.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.821 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 103' ' ' ILE . 12.0 tt -74.37 102.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.185 0.517 . . . . 0.0 110.534 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 pt -88.08 147.84 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.181 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.5 170.06 19.91 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.7 37.8 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.77 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.09 86.47 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.618 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.08 159.2 40.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.057 0.456 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -117.4 108.98 16.22 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.312 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 45.7 mtt -101.23 112.13 24.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.45 124.1 48.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 84.7 m-85 -100.97 -176.03 3.05 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.1 71.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.249 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -75.92 138.54 41.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.385 . . . . 0.0 110.367 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.7 m -144.42 119.89 10.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.248 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? 66.87 26.74 9.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.214 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 m -120.72 149.83 51.33 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -40.06 154.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.815 1.677 . . . . 0.0 111.942 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.06 137.9 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.508 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -95.54 138.5 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -137.4 -10.6 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.738 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.9 t -112.21 122.77 48.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 83' ' ' ILE . 16.0 tt -141.57 129.6 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.844 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.1 p -158.01 171.39 20.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.451 ' CG ' ' SG ' ' A' ' 45' ' ' CYS . 7.7 pt-20 -168.07 -172.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.6 t -171.56 165.96 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.445 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -127.01 116.68 21.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.172 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -127.93 107.9 10.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.029 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.81 -127.78 16.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -102.6 23.73 11.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.737 0.304 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 p -131.33 158.69 40.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.521 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.45 136.04 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.687 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -112.26 163.04 14.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.41 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -160.9 129.41 4.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.661 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 116' ' ' LEU . 31.0 ttm180 -116.85 113.31 22.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 115' ' ' ARG . 2.5 mm? -110.29 123.62 50.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -164.06 175.02 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.157 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.3 m -95.28 171.77 8.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.145 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.4 149.03 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.136 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 t -93.23 144.56 28.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -37.62 144.68 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.05 1.833 . . . . 0.0 112.516 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 57.11 6.16 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.187 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -138.75 -5.13 1.54 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.48 -8.35 64.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.81 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -115.56 168.82 9.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.98 147.06 39.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.288 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.5 m -148.73 65.56 8.42 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.689 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.27 148.03 1.32 Allowed 'Trans proline' 0 N--CA 1.474 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.903 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -117.87 146.68 43.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.311 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -132.42 171.11 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.844 0.354 . . . . 0.0 110.087 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -81.73 162.61 22.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.429 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.577 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 36.4 m170 -58.0 -36.45 72.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -54.38 -47.63 72.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.479 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -72.94 -33.21 65.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.97 9.39 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -56.14 -32.86 64.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.17 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.777 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 tpp -71.18 -63.17 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.102 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.3 -21.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.455 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -79.39 -55.11 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 41.4 t0 -79.14 -30.26 43.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.9 t -45.74 117.78 1.59 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.503 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.18 124.29 16.4 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.04 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 144' ' ' VAL . 13.8 p -116.67 131.24 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.87 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.4 m -103.09 157.59 16.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.201 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.0 mm -140.43 145.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' OD2' ' NE2' ' B' ' 49' ' ' GLN . 2.0 m-20 -152.88 92.86 1.69 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.877 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.4 mt -89.26 142.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.301 0.572 . . . . 0.0 111.075 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -138.53 177.25 8.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.639 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.3 m -91.58 132.23 36.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.739 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -103.79 -173.98 2.44 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.47 11.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.861 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -79.92 103.59 9.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.435 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 11.1 pt-20 -77.52 7.75 5.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -49.73 145.66 5.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.93 0.395 . . . . 0.0 110.365 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.21 173.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.99 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.1 t -94.97 142.1 27.88 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -120.04 91.6 3.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.589 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.4 pt -121.06 168.69 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -119.5 139.6 51.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.0 p -72.29 5.55 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.426 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -80.5 121.06 81.0 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.4 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -40.1 154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.826 1.684 . . . . 0.0 112.064 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.2 t -80.05 133.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.422 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.71 123.35 30.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.25 162.4 19.03 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.363 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -91.15 9.42 31.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 109.94 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.6 5.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.825 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.9 tp -101.93 141.31 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.5 m -100.77 149.04 24.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.748 0.309 . . . . 0.0 110.35 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.448 ' NE2' ' N ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -83.13 39.55 0.65 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.019 0.438 . . . . 0.0 110.547 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.681 ' N ' HH12 ' A' ' 198' ' ' ARG . 74.7 tttt -65.16 173.5 2.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.295 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.425 ' HZ3' ' CB ' ' A' ' 226' ' ' ALA . 61.8 tttp -84.18 123.81 30.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.533 HG13 ' N ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -149.11 -170.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.533 ' N ' HG13 ' A' ' 174' ' ' VAL . 25.3 p -44.71 146.87 0.69 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.571 0.224 . . . . 0.0 110.752 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -112.64 145.52 40.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.986 0.422 . . . . 0.0 111.437 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 1.6 tm-20 -157.88 145.73 18.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.447 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 9.9 t0 -70.34 100.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.403 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.4 mm -109.37 -50.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -61.67 125.35 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' B' ' 14' ' ' SER . . . -91.44 -123.11 2.87 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.191 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.2 t -73.3 140.58 46.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.628 0.251 . . . . 0.0 111.16 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.515 ' O ' ' CZ ' ' B' ' 13' ' ' PHE . 18.0 p -139.08 87.83 2.23 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 184' ' ' ILE . 15.0 tt -102.65 129.1 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.6 137.67 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.556 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 109.41 19.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.22 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 189' ' ' CYS . 12.7 p -51.55 -27.48 11.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.573 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -38.36 -28.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.291 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 187' ' ' THR . 27.5 p -148.42 29.39 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.323 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.1 88.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.092 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -68.16 -58.33 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.167 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -123.07 179.38 4.69 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 193' ' ' LEU . 5.7 tt -173.22 106.65 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 25.2 mp0 -97.24 128.83 44.46 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -128.08 134.69 49.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.093 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.0 m -143.42 144.08 31.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 28' ' ' VAL . 18.1 m -140.6 167.39 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.124 0.488 . . . . 0.0 111.34 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.681 HH12 ' N ' ' A' ' 172' ' ' LYS . 21.8 ttm180 -164.09 156.32 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.154 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.6 mt -148.5 120.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.54 174.37 46.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.277 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -56.26 129.34 39.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.923 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 57.0 mtm -86.23 8.14 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.6 t -112.88 -48.2 3.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.239 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -159.19 115.02 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 7.9 mp0 -47.63 158.71 0.18 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 208' ' ' GLU . 69.9 m -143.38 23.02 1.84 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.01 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 t 57.68 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.822 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.5 mm-40 -48.68 -48.39 40.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.729 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -77.54 -0.65 27.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.445 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.79 155.36 19.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.971 0.415 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 212' ' ' LYS . 3.8 p -175.55 158.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.409 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 211' ' ' VAL . 1.2 pptp? -168.56 136.83 2.16 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.401 0.62 . . . . 0.0 111.767 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 9.3 t70 -124.95 172.6 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 172.4 164.58 28.13 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.946 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -148.97 170.22 18.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -135.69 104.34 5.74 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.315 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -101.44 119.83 39.37 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.85 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.2 p -144.48 123.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.126 0.488 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.62 37.88 27.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.31 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.32 89.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.91 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.41 ' OG ' HG13 ' A' ' 218' ' ' VAL . 26.4 p -103.19 120.9 41.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.843 0.321 . . . . 0.0 110.576 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.74 165.15 12.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.019 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.6 t -174.97 120.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.564 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -78.44 136.71 37.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.95 116.22 0.66 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.702 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.425 ' CB ' ' HZ3' ' A' ' 173' ' ' LYS . . . -81.61 96.56 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.3 m -129.55 151.41 50.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.989 0.423 . . . . 0.0 110.767 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.32 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.553 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.443 ' OD1' HD23 ' A' ' 232' ' ' LEU . 74.6 m-20 -93.26 31.0 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.6 p -73.71 -34.81 64.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.768 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -99.89 -2.55 34.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.896 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -43.42 -29.27 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.21 143.38 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.628 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.76 101.13 4.95 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -63.9 -5.68 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.147 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -47.28 12.67 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -71.4 9.43 0.8 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 238' ' ' LEU . 7.5 mp -72.98 152.28 41.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.493 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -137.15 135.16 37.11 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.561 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.19 144.71 23.42 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.49 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . 0.537 ' SG ' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -104.34 -17.88 14.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.48 HG13 ' C ' ' A' ' 241' ' ' CYS . 1.5 m . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.606 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 121.146 0.498 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -144.6 118.0 9.07 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.426 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 85.5 m -63.93 131.32 47.33 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.515 ' CZ ' ' O ' ' A' ' 183' ' ' THR . 0.1 OUTLIER -93.44 -26.78 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.018 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 181' ' ' GLY . 28.0 p -122.9 155.05 37.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.375 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.86 158.94 25.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.392 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -82.92 139.22 33.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.184 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.06 19.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.612 0.244 . . . . 0.0 111.32 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -80.2 127.83 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.785 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -81.92 128.68 34.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.492 ' N ' HD12 ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.38 52.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.808 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -42.04 153.08 0.13 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.208 1.938 . . . . 0.0 112.878 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' B' ' 25' ' ' VAL . 13.3 tpt180 -46.07 -50.46 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.353 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -35.95 -35.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 3.3 m-85 -105.58 43.23 1.14 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.102 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 22' ' ' ARG . 49.9 t -151.61 92.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.937 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -97.72 -22.95 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.265 -0.272 . . . . 0.0 110.823 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.455 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 6.3 p90 -166.06 168.91 15.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.253 0.549 . . . . 0.0 111.871 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 89.0 m-85 -157.34 178.26 10.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.243 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' B' ' 31' ' ' THR . 11.3 pt-20 -127.64 149.62 50.11 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.804 0.335 . . . . 0.0 110.501 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.414 ' O ' ' O ' ' B' ' 30' ' ' GLU . 77.8 p -53.93 -111.4 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -154.98 -148.68 0.24 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.412 ' C ' ' N ' ' B' ' 35' ' ' CYS . 10.5 m -135.82 -24.02 1.34 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.103 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.3 mm? -53.67 -13.56 0.7 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.794 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.423 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.3 p -115.94 122.16 44.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.58 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.3 m -73.31 38.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.402 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.5 pt20 -164.29 61.1 0.87 Allowed Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 97.4 Cg_endo -74.14 -161.82 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.887 2.391 . . . . 0.0 113.294 -177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 170.76 176.53 0.06 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.217 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -111.59 136.74 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.477 HG12 ' SG ' ' B' ' 51' ' ' CYS . 0.8 OUTLIER -113.73 143.2 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.618 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -115.69 149.9 37.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -92.97 169.26 10.57 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.3 p -138.17 -144.85 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.196 0.522 . . . . 0.0 110.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.501 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -126.27 -39.0 2.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.81 46.48 2.32 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.143 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 52.1 m -152.83 -83.17 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.428 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.586 0.554 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 49' ' ' GLN . 3.4 pp0? -145.31 147.87 32.8 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.12 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 t -150.26 115.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' B' ' 41' ' ' VAL . 71.7 m -68.05 144.72 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.785 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.69 139.3 41.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.998 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.69 126.33 92.49 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.54 -0.52 9.41 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.368 1.379 . . . . 0.0 111.554 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -65.18 -14.54 60.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.06 127.74 47.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.513 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 42.2 t -50.42 -46.89 56.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -55.99 -28.12 55.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.374 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.92 -36.16 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.112 0.482 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.72 -39.23 64.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.569 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -67.89 -35.7 78.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.47 -42.55 87.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.619 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.74 -46.01 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.841 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.66 -31.49 66.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.32 -35.67 63.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.585 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.336 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.52 -35.19 70.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.622 ' N ' HD12 ' B' ' 68' ' ' LEU . 7.3 mp -79.79 -83.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.225 0.536 . . . . 0.0 109.64 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.643 -179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.812 0.339 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.7 t -79.44 -18.15 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.5 t -50.5 134.36 23.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.652 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -58.25 -27.41 63.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 95.8 p -73.76 -23.9 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.63 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -80.0 -53.43 6.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 p -168.07 169.38 11.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.866 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.1 m -55.3 155.8 4.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.537 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -76.46 173.19 11.8 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -112.84 5.59 17.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -62.44 -167.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.246 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.443 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 17.2 mp0 -119.21 -65.48 1.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.874 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.0 54.29 3.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.392 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' C ' ' ND1' ' A' ' 22' ' ' HIS . 3.6 tppt? -151.17 140.06 20.93 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.42 ' ND1' ' C ' ' A' ' 21' ' ' LYS . 53.5 m80 -145.67 158.59 43.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.888 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -95.65 76.41 3.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 29.9 ttp -64.74 133.0 51.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.47 . . . . 0.0 111.181 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' H ' ' HE3' ' A' ' 202' ' ' MET . . . -139.74 160.89 26.21 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.258 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -114.68 158.49 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.98 0.419 . . . . 0.0 110.586 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' HA ' ' HG ' ' A' ' 117' ' ' SER . 10.7 t70 -151.35 137.48 18.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.69 109.26 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.325 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.2 mt -97.5 134.2 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.29 134.41 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.174 0.511 . . . . 0.0 112.003 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -121.05 127.49 51.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.79 112.89 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.9 p -84.71 121.3 27.47 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -75.32 151.82 38.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.782 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -67.85 144.5 55.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.215 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 47.7 p30 -76.26 43.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.599 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -152.3 -28.33 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.8 m -71.16 125.45 91.94 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -38.47 156.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.026 1.817 . . . . 0.0 112.542 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -76.27 140.08 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.42 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -157.17 107.29 2.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.366 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.84 8.82 37.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.258 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 12.0 mptt -69.0 82.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -77.5 -177.92 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.9 m 32.82 40.29 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -55.56 -34.44 64.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.289 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 t -178.12 168.99 1.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.1 t -149.14 112.27 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.942 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.2 m -111.39 116.46 30.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.323 . . . . 0.0 110.87 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -95.38 135.42 37.01 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.184 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 79' ' ' THR . 4.2 mp -139.76 151.44 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -150.76 149.11 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 54' ' ' SER . 18.5 tp10 -51.7 171.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.082 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.51 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 58.1 m . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.981 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 N--CA 1.473 0.278 0 N-CA-C 111.025 -0.413 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.9 m -125.93 131.03 52.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 51' ' ' ILE . 16.3 m -107.16 123.95 49.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -121.64 112.98 19.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.947 0.403 . . . . 0.0 111.112 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -93.83 127.41 39.55 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 t -103.07 69.38 1.02 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.24 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 83' ' ' ILE . 17.5 tt -74.54 122.25 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 110.566 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.44 147.46 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.94 169.53 20.94 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.209 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.47 22.34 23.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.239 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.407 ' C ' HD22 ' A' ' 88' ' ' LEU . . . 74.8 4.06 69.91 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.187 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 87' ' ' GLY . 4.3 mm? -117.48 149.15 41.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' NH2' ' OG ' ' A' ' 151' ' ' SER . 45.6 ttm-85 -115.83 105.15 12.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 92' ' ' PHE . 18.8 ttt -101.71 135.63 42.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.116 0.484 . . . . 0.0 110.882 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -127.44 120.44 28.4 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.043 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 90' ' ' MET . 67.1 m-85 -90.42 -168.4 2.09 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.74 67.7 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.08 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -90.28 162.08 15.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.163 0.506 . . . . 0.0 111.448 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 t -150.91 131.82 14.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.942 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 62.95 33.65 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.529 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 98' ' ' PRO . 33.5 m -124.04 145.6 48.59 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 97' ' ' CYS . 78.2 Cg_exo -38.55 162.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.012 1.808 . . . . 0.0 112.423 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -71.33 142.54 50.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -97.1 118.09 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -124.33 -21.67 4.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 117' ' ' SER . 5.7 p -100.45 111.16 23.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.771 0.319 . . . . 0.0 110.862 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.23 121.83 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 28.3 t -142.45 177.56 8.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.064 0.459 . . . . 0.0 111.171 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 104' ' ' SER . 34.9 tt0 -165.83 161.68 17.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.42 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.4 t -163.9 158.67 20.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.588 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.06 132.75 46.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.331 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -144.73 111.66 5.86 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.155 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.73 -110.87 3.31 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -122.21 23.88 9.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 p -128.74 156.16 43.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.64 132.99 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.632 ' ND2' ' H ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -117.96 155.76 29.68 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.885 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.52 133.07 12.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -118.0 125.76 51.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 111.333 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.7 121.48 40.97 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.424 ' HG ' ' HA ' ' A' ' 27' ' ' ASP . 1.8 m -164.94 156.67 15.3 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.58 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.8 p -74.19 173.85 9.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.39 134.37 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 110.999 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -59.55 155.15 40.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.0 157.6 28.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.254 1.969 . . . . 0.0 111.486 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.419 ' N ' ' OE1' ' A' ' 123' ' ' GLN . . . 73.68 59.73 3.97 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.845 HE21 ' H ' ' A' ' 125' ' ' LYS . 4.3 pm0 -141.24 -37.35 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.739 0.304 . . . . 0.0 110.348 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.03 5.97 2.93 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.265 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.845 ' H ' HE21 ' A' ' 123' ' ' GLN . 51.7 mttp -129.45 -173.48 3.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.782 0.325 . . . . 0.0 110.463 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 156.17 21.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.49 . . . . 0.0 111.456 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.4 t -159.19 63.42 2.31 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.439 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.78 142.31 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.112 2.541 . . . . 0.0 113.447 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.26 28.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -142.46 162.56 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 110.24 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.7 p -78.69 164.6 24.46 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.535 ' CD2' HD21 ' A' ' 209' ' ' LEU . 16.4 t-160 -60.51 -34.71 74.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -63.15 -55.1 28.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.31 -44.71 92.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.335 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.29 -56.58 20.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.123 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 tp -49.37 -35.63 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.46 -49.24 43.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.557 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 140' ' ' LYS . 44.2 mtt -60.09 -60.42 3.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.7 mt -44.64 -21.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.13 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' MET . 31.5 ttmt -87.5 -33.81 18.85 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.595 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -94.92 -23.33 17.47 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.98 122.9 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.889 0.376 . . . . 0.0 110.758 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -139.1 123.26 18.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.218 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 144' ' ' VAL . 10.8 m -114.31 128.21 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.06 0.457 . . . . 0.0 111.114 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.6 m -109.33 167.24 10.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.548 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.8 pt -151.2 149.17 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -147.9 88.47 1.68 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 tt -83.35 145.24 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.506 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.402 ' HG3' ' H ' ' A' ' 150' ' ' CYS . 5.0 tpt180 -145.59 -177.2 5.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 149' ' ' ARG . 7.1 m -90.61 134.44 34.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.698 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' NH2' ' A' ' 89' ' ' ARG . 5.6 t -117.3 119.58 35.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.075 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -93.62 14.81 17.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.161 0.505 . . . . 0.0 109.82 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.2 OUTLIER -50.68 150.62 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.155 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.55 -10.08 3.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.466 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.78 158.06 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.93 175.49 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -90.48 143.33 26.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -114.07 92.23 3.9 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 pt -119.03 165.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.147 0.499 . . . . 0.0 111.323 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -119.54 134.63 55.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 m -76.52 54.59 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.538 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -130.77 123.74 20.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -38.14 147.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.916 1.744 . . . . 0.0 112.344 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 164' ' ' VAL . 20.3 m -73.4 130.46 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.341 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 34.8 mt -79.32 115.46 18.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.315 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.97 159.55 22.85 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.117 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.426 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 0.1 OUTLIER -95.2 11.14 33.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 110.295 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 168' ' ' ASN . 10.9 t30 58.72 21.19 8.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.343 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.413 ' C ' HD12 ' A' ' 169' ' ' ILE . 1.1 pp -76.63 -176.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.66 ' H ' ' HE ' ' A' ' 198' ' ' ARG . 51.1 m -147.94 113.82 5.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.619 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -68.6 28.22 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.284 -178.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 170' ' ' SER . 16.9 mmmt -67.6 175.27 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.125 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.42 ' CB ' ' NZ ' ' A' ' 173' ' ' LYS . 0.2 OUTLIER -90.86 124.7 35.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.12 -165.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.041 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.4 p -50.55 145.77 6.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.807 0.337 . . . . 0.0 110.53 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -95.69 132.52 40.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -141.45 127.07 18.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.209 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -68.45 95.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.65 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.9 mt -107.35 -40.61 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.475 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 tp -66.84 114.42 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.468 . . . . 0.0 110.502 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.22 -122.91 0.7 Allowed Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.4 m -77.21 150.8 35.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 93.07 2.1 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.093 0.473 . . . . 0.0 110.263 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.3 tt -98.86 133.26 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.914 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 185' ' ' VAL . 14.2 m -146.76 131.29 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.99 0.424 . . . . 0.0 111.86 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 34.0 p-10 -85.93 103.34 14.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.754 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.7 m -46.99 -27.12 1.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.845 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -41.92 -26.38 0.09 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.966 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.404 ' O ' HD11 ' A' ' 88' ' ' LEU . 9.8 m -142.78 36.23 1.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 190' ' ' VAL . 7.4 p -169.43 105.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.4 0.619 . . . . 0.0 110.756 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -74.56 -54.43 7.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.729 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.31 173.83 6.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.137 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 193' ' ' LEU . 1.7 tt -173.56 106.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.228 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 19.2 mp0 -93.24 149.74 21.0 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -140.83 134.32 29.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.253 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -143.19 129.54 19.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.8 t -122.61 153.47 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.66 ' HE ' ' H ' ' A' ' 170' ' ' SER . 14.4 ttt85 -154.55 144.42 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.871 0.367 . . . . 0.0 110.155 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.94 119.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.652 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -169.57 -156.59 11.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.063 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 58.3 t0 -79.21 123.78 27.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.865 0.364 . . . . 0.0 110.434 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.426 ' SD ' ' OG ' ' A' ' 167' ' ' SER . 24.2 mmt -81.14 -3.24 51.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.4 -50.05 3.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.466 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.537 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 20.2 tptp -157.38 112.35 2.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 198' ' ' ARG . 2.0 mm-40 -43.65 156.17 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' GLU . 2.5 p -156.86 67.08 0.54 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.1 p 30.84 -88.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 206' ' ' SER . 17.8 mm-40 -40.52 -50.93 2.95 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.453 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.642 ' N ' HD22 ' A' ' 209' ' ' LEU . 1.9 mm? -81.68 54.27 2.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.547 ' CG ' HH22 ' A' ' 198' ' ' ARG . 1.3 tp10 -156.22 120.25 4.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.083 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.74 179.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.96 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -171.01 146.67 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.143 0.496 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 10.2 t70 -144.17 169.43 17.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.017 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 159.58 154.07 7.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.613 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.7 177.52 7.72 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -132.48 103.68 6.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -98.31 113.81 25.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.596 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.25 111.81 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.957 0.408 . . . . 0.0 110.691 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.13 43.39 30.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.98 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.16 74.77 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.455 -0.402 . . . . 0.0 112.561 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.8 p -89.84 112.9 24.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.67 149.45 23.3 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.714 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.6 m -166.29 124.29 1.44 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.623 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -77.99 138.99 39.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.424 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.75 108.22 0.27 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.52 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.11 104.23 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.6 p -129.53 159.22 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.468 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.577 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 37.6 t70 -62.13 95.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.29 12.65 4.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.577 ' HG1' ' CG ' ' A' ' 228' ' ' ASP . 40.0 m -45.29 -51.45 10.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.706 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 233' ' ' ILE . 20.4 m -97.18 6.37 48.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.8 tp -42.64 -24.44 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.936 0.398 . . . . 0.0 110.84 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 231' ' ' SER . 0.4 OUTLIER -163.93 142.91 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -74.87 100.52 4.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -64.28 -6.35 6.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.916 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 236' ' ' THR . 0.0 OUTLIER -88.04 -10.35 50.53 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.531 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -100.94 0.21 37.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.477 0.18 . . . . 0.0 111.145 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 238' ' ' LEU . 9.0 mp -80.02 142.06 35.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.152 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 104' ' ' SER . 63.8 mttp -130.44 136.83 49.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.837 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.84 138.03 57.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.733 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 74.6 m -100.17 -8.73 23.28 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.088 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.516 -179.324 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.548 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 76.2 m -119.29 155.8 31.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.21 134.51 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.677 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.548 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 23.5 m-85 -111.89 -27.52 8.42 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -152.05 155.07 37.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.991 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.5 OUTLIER -110.42 160.53 16.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.894 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -84.0 139.08 32.77 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.48 5.53 38.56 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.453 -178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.73 126.56 47.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.822 0.344 . . . . 0.0 111.247 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -77.89 133.42 38.12 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.687 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' B' ' 24' ' ' PHE . 3.8 mm? -93.7 111.11 51.22 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.908 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.05 149.51 1.25 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.164 1.909 . . . . 0.0 112.599 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' B' ' 24' ' ' PHE . 7.5 ptp85 -45.46 -43.07 11.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.677 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -70.2 26.31 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.628 ' CD2' HD12 ' B' ' 20' ' ' LEU . 14.9 t80 -146.22 27.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -152.27 100.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.013 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.409 HG22 ' H ' ' B' ' 26' ' ' VAL . 20.4 m -84.15 -27.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.647 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -165.61 -178.34 4.83 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.755 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 8.6 p90 -154.08 173.48 15.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 74.2 m-85 -160.91 141.12 11.14 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.802 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' B' ' 30' ' ' GLU . 2.1 mp0 -84.83 146.24 27.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 111.636 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 32.0 p -52.51 -108.57 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.948 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -150.57 -149.45 0.3 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.45 ' C ' ' H ' ' B' ' 35' ' ' CYS . 67.9 m -142.2 -24.6 0.67 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.279 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -54.77 -10.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.732 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.1 p -118.71 123.03 43.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.505 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 45.2 p -72.61 35.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.347 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' B' ' 35' ' ' CYS . 26.0 mt-30 -155.04 56.16 1.35 Allowed Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 46.5 Cg_endo -64.98 -167.86 0.1 Allowed 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 122.712 2.275 . . . . 0.0 112.827 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.21 176.57 0.11 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.787 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.1 t -107.82 131.85 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.95 129.81 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.657 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -110.82 146.16 36.91 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.972 0.415 . . . . 0.0 111.147 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -93.85 169.79 10.03 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 15.8 p -140.08 -143.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 111.089 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.36 -36.95 2.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.297 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.03 46.86 2.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.557 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 18.4 m -156.09 -80.48 0.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.532 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.72 -90.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.679 0.612 . . . . 0.0 109.759 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -143.68 144.18 31.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.439 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -149.31 120.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.636 . . . . 0.0 110.73 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 6.9 t -54.61 159.06 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.776 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.463 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.13 131.29 11.09 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.62 120.5 71.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 0.1 8.66 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.114 1.21 . . . . 0.0 111.242 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 90.0 p -67.99 -18.55 64.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.169 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -93.02 124.38 36.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.006 0.431 . . . . 0.0 110.29 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -50.87 -40.69 56.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.909 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.449 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 88.9 m95 -56.43 -33.48 65.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.047 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.89 -35.79 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.185 0.516 . . . . 0.0 109.706 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -68.7 -48.05 64.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.606 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -64.9 -35.79 82.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -62.02 -37.76 86.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.25 -44.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.85 -32.81 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.86 -38.29 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.42 -22.22 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.23 -31.06 63.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.416 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.44 -84.51 0.09 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.572 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.596 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.808 0.337 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -75.7 -33.47 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.6 m -49.47 131.06 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.498 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -59.84 -20.52 57.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.662 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 m -75.86 -21.39 57.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.283 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -87.37 -41.39 13.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.112 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -167.94 179.71 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.994 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.19 157.37 37.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.448 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -78.93 175.58 10.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.993 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -125.26 7.56 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.859 0.361 . . . . 0.0 110.302 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' GLU . 42.4 mm-40 -83.68 89.81 7.19 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.573 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' GLU . 42.2 mt-10 -23.51 -63.6 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.059 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.663 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -76.68 49.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.594 0.235 . . . . 0.0 111.014 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -155.85 125.56 6.41 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 132' ' ' HIS . 27.5 m-70 -125.61 152.44 45.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' SD ' ' A' ' 202' ' ' MET . 11.6 t-160 -93.7 82.57 4.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.47 ' O ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -47.05 174.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.617 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.99 133.79 1.61 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.3 tt -111.17 146.1 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.381 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.99 140.04 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.66 139.82 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.152 0.501 . . . . 0.0 111.837 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.0 mt -114.58 149.19 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.189 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' CZ ' ' A' ' 195' ' ' PHE . 0.9 OUTLIER -147.46 107.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 232' ' ' LEU . 32.3 ttmt -110.69 95.05 5.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.38 133.72 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.933 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 m -107.97 124.85 50.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.024 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -76.61 149.48 36.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -73.14 159.12 34.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.38 40.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.798 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -145.3 -28.51 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.425 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.2 m -68.32 115.72 32.29 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.414 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -40.29 158.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.79 1.66 . . . . 0.0 112.229 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.497 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 67.0 p -69.03 136.39 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 40' ' ' THR . 25.9 m120 -153.94 102.35 2.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.114 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -102.75 11.05 38.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 1.8 mptp? -70.36 88.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 pt -90.96 157.73 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.347 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m 57.18 39.44 28.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.307 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -55.51 -50.67 69.34 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.976 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.4 p -173.26 156.56 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.85 134.8 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.7 p -133.41 106.3 7.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.178 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -81.84 146.4 29.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.181 0.515 . . . . 0.0 110.862 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.457 HD12 ' CE2' ' A' ' 80' ' ' TYR . 5.4 mt -142.06 156.22 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.255 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -152.53 151.67 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 54' ' ' SER . 19.4 tp10 -56.27 174.72 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.474 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.677 0 CA-C-O 120.938 0.399 . . . . 0.0 110.215 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 N--CA 1.475 0.413 0 CA-C-O 120.759 0.233 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 p -118.81 125.68 50.12 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.458 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 p -94.37 119.27 32.86 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.513 ' CE1' ' OD1' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -126.72 113.66 16.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.733 0.301 . . . . 0.0 110.569 -178.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 92' ' ' PHE . 11.9 p90 -113.01 122.22 46.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.967 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -92.07 76.88 5.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.318 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.74 110.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.402 0.62 . . . . 0.0 109.725 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 83' ' ' ILE . 71.3 mt -93.21 145.84 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.437 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.28 159.11 10.28 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.211 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.65 27.54 68.37 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.046 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.23 18.25 72.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.94 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -134.61 159.02 42.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 110.544 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -122.3 110.24 15.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.1 mtt -100.17 99.59 10.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.124 0.487 . . . . 0.0 110.808 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.531 ' C ' HD22 ' A' ' 91' ' ' ASN . 0.3 OUTLIER -84.02 129.28 34.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.1 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 70.3 m-85 -112.94 -173.45 2.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.0 0.429 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.64 72.49 0.05 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.643 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.62 147.25 35.69 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 95' ' ' THR . 11.7 t -146.57 128.45 15.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm 59.3 29.94 19.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.515 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.2 146.47 40.73 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.47 153.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.681 1.587 . . . . 0.0 111.933 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.553 ' CD ' ' HZ3' ' A' ' 101' ' ' LYS . 3.4 pt20 -67.81 140.28 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.642 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.67 122.51 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.553 ' HZ3' ' CD ' ' A' ' 99' ' ' GLN . 47.1 mttp -126.36 -1.39 6.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.125 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 t -123.42 126.14 46.24 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.271 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.2 pt -147.89 139.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.858 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.1 p -146.46 177.06 9.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -158.64 155.36 28.06 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 p -155.45 151.63 28.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.229 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.47 110.34 11.79 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.639 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -118.91 107.7 13.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.68 -126.8 18.73 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -100.79 24.06 9.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 110.24 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 154.07 43.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.7 t -133.39 132.73 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -123.38 155.68 36.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.886 0.374 . . . . 0.0 110.768 -178.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.05 142.25 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.101 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -118.05 125.13 49.74 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.804 ' N ' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -112.59 119.34 37.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 t -164.47 168.62 18.2 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.083 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.0 m -83.77 172.93 11.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.607 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -105.39 132.87 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.583 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.473 ' CB ' ' ND2' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -70.18 164.49 52.48 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.952 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.413 ' HD3' ' HD1' ' A' ' 23' ' ' HIS . 95.3 Cg_endo -75.25 139.21 23.4 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.455 2.104 . . . . 0.0 112.103 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.24 -11.63 40.13 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.562 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.499 ' OE1' ' N ' ' A' ' 123' ' ' GLN . 12.2 mp0 -76.29 -50.79 13.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.82 -2.17 1.18 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.404 -0.427 . . . . 0.0 112.419 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -103.97 -176.89 3.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.89 161.44 30.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 1.9 t -156.48 68.33 4.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.809 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.16 115.24 2.23 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 122.68 2.253 . . . . 0.0 112.861 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.9 141.59 29.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.5 pt -137.88 175.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 111.128 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 132' ' ' HIS . 25.9 m -83.48 161.16 21.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.788 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.579 ' NE2' ' CD2' ' A' ' 22' ' ' HIS . 21.0 m170 -58.63 -34.2 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.416 ' CD ' ' N ' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -61.34 -53.06 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.214 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -60.73 -43.95 97.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 138' ' ' MET . . . -59.95 -57.17 14.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.124 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -47.05 -39.07 12.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.988 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.82 62.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.344 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 135' ' ' ALA . 36.3 tpp -73.59 -29.67 62.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.83 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.35 -21.13 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.7 -37.37 18.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD2' ' CZ ' ' B' ' 18' ' ' ARG . 10.4 m-20 -85.43 -33.96 21.79 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.5 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.406 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 30.6 t -51.39 114.38 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.08 0.467 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 141' ' ' ASP . 0.3 OUTLIER -127.25 164.26 22.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 145' ' ' SER . 96.1 t -141.4 162.78 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' HG12 ' A' ' 144' ' ' VAL . 88.0 p -143.37 145.66 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.637 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 mp -140.2 144.32 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.025 0.44 . . . . 0.0 110.594 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -157.89 79.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.612 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 185' ' ' VAL . 9.4 mt -73.8 142.29 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.535 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -134.37 171.99 13.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.446 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.06 118.72 30.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.842 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 t -85.94 -173.51 4.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.26 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.401 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 6.9 tp10 -165.52 7.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -81.57 105.76 12.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.769 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 154' ' ' GLU . 20.1 mp0 -78.35 12.97 1.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -49.45 155.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.771 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.54 167.6 14.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.667 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.0 p -89.51 143.31 26.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.868 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -117.07 88.49 2.91 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.678 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.7 pt -110.14 177.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.119 0.485 . . . . 0.0 111.424 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 162' ' ' HIS . 73.7 tttt -137.33 125.95 23.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.781 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 161' ' ' THR . 58.4 m -59.22 -0.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.526 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.9 m80 -82.07 114.88 54.05 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.104 -0.239 . . . . 0.0 110.375 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -40.77 154.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.729 1.619 . . . . 0.0 112.184 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 49.2 t -77.28 136.56 24.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.577 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.8 mt -83.61 124.31 30.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.659 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 164.94 32.68 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.4 t -99.12 9.12 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.473 ' ND2' ' CB ' ' A' ' 120' ' ' SER . 7.1 m-20 59.11 -0.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.523 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.601 ' C ' HD12 ' A' ' 169' ' ' ILE . 2.5 pp -82.03 173.56 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.989 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 172' ' ' LYS . 19.9 m -133.28 129.38 37.54 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -73.13 31.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.48 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 170' ' ' SER . 3.1 mmmm -64.61 -178.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -90.63 121.37 32.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.413 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.497 HG21 ' HE ' ' A' ' 198' ' ' ARG . 17.2 m -141.44 -167.3 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.727 0.299 . . . . 0.0 110.477 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.1 t -48.24 142.95 4.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.922 0.391 . . . . 0.0 110.88 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -95.72 129.09 43.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -141.43 141.07 33.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.033 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.1 91.6 4.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.581 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.08 -59.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 180' ' ' ILE . 16.3 tt -50.26 122.28 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.48 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -91.66 -122.26 2.8 Favored Glycine 0 C--O 1.228 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.82 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.471 ' OG ' ' SG ' ' B' ' 51' ' ' CYS . 7.6 t -76.61 143.73 40.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.108 0.48 . . . . 0.0 112.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 62.8 m -139.89 84.97 2.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.103 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mt -103.89 103.83 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.942 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 148' ' ' ILE . 16.1 m -120.83 134.27 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.8 p-10 -78.89 116.5 19.25 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.6 m -52.09 -29.24 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -36.18 -36.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.54 32.74 1.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.643 0.259 . . . . 0.0 110.486 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 92.4 t -149.71 95.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.35 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -61.92 1.81 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.498 ' ND2' ' OE1' ' A' ' 194' ' ' GLU . 22.3 t30 -122.55 137.41 54.9 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -145.27 122.51 11.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.498 ' OE1' ' ND2' ' A' ' 192' ' ' ASN . 2.7 mp0 -109.8 161.35 15.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.483 ' CZ ' HD12 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -153.89 139.25 17.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.9 p -144.15 140.07 29.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.341 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.2 m -128.12 158.23 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.497 ' HE ' HG21 ' A' ' 174' ' ' VAL . 7.3 tpt180 -159.76 104.09 1.55 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.878 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 36.1 mt -106.99 118.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.67 -157.16 9.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.316 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 53.6 t0 -86.2 123.34 31.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 23' ' ' HIS . 55.2 mtp -78.12 0.26 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.326 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 5.7 t -112.4 -48.77 3.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.773 0.321 . . . . 0.0 110.628 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.481 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 3.2 tppp? -158.29 113.4 2.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.165 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -46.1 145.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.541 ' H ' ' CD ' ' A' ' 210' ' ' GLU . 7.5 t -130.23 25.25 5.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.495 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 84.1 p 52.93 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.602 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 206' ' ' SER . 33.5 tt0 -51.58 -34.24 36.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.589 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.0 mm? -88.59 -4.18 58.63 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.787 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 206' ' ' SER . 14.5 mp0 -96.15 144.84 26.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.983 0.421 . . . . 0.0 110.793 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.0 m -153.98 175.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.592 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 227' ' ' THR . 25.1 tttt -170.23 147.01 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.478 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -140.86 168.54 19.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 174.68 145.08 5.17 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.624 -1.274 . . . . 0.0 113.052 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . 0.441 ' CZ ' ' OG ' ' B' ' 14' ' ' SER . 27.9 m-85 -129.37 164.9 22.6 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.45 103.27 5.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.427 ' O ' ' OD1' ' A' ' 192' ' ' ASN . 21.9 m-85 -97.44 116.5 29.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.817 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.76 101.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.311 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.6 t70 56.29 37.61 28.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.938 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.35 75.02 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.639 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.9 t -89.23 112.47 23.52 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.699 -0.295 . . . . 0.0 110.452 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.25 167.5 11.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.5 t -174.49 116.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.82 95.03 9.94 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -136.96 129.27 4.71 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 116.416 -0.357 . . . . 0.0 112.448 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -90.67 102.07 14.82 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.494 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.499 ' O ' ' NZ ' ' A' ' 212' ' ' LYS . 69.4 p -123.71 153.13 41.29 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.8 95.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -90.71 35.55 0.89 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 231' ' ' SER . 9.8 t -75.29 -39.62 59.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.309 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.466 ' N ' HG23 ' A' ' 230' ' ' THR . 99.3 p -102.56 3.78 37.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.339 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -48.41 -32.87 8.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.133 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.6 tt -135.06 150.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.242 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.41 92.39 9.06 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.405 ' O ' HD11 ' A' ' 238' ' ' LEU . 45.8 m -60.66 -3.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.332 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 p -91.01 -21.56 21.21 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -101.55 8.45 41.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 238' ' ' LEU . 0.3 OUTLIER -78.65 153.09 31.32 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.148 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -141.12 133.88 28.82 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.727 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.63 55.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.379 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 59.8 m -110.42 -1.93 16.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.528 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 120.853 0.358 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.539 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.6 m -134.76 146.33 49.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . 0.469 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 55.7 m -67.47 140.54 57.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.215 0.531 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 38.7 m-85 -117.33 -31.02 5.41 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.766 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 215' ' ' PHE . 2.7 m -140.88 145.29 35.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.04 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -109.28 152.22 25.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -78.43 139.56 38.73 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.599 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.1 -42.86 20.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.778 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.438 ' CZ ' ' OD2' ' A' ' 141' ' ' ASP . 0.9 OUTLIER -75.9 126.29 30.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.682 -179.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -77.12 137.85 39.16 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.601 HD22 ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -92.79 110.71 47.29 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -44.62 150.09 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.041 1.827 . . . . 0.0 112.68 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.519 ' C ' ' H ' ' B' ' 24' ' ' PHE . 50.1 mtt85 -46.02 -44.03 14.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.751 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' B' ' 23' ' ' ASN . 2.0 m-20 -68.45 27.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.519 ' H ' ' C ' ' B' ' 22' ' ' ARG . 22.2 t80 -151.98 27.3 0.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -155.97 104.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.353 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.14 -10.75 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.7 t0 -161.88 -178.61 6.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.897 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.471 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 12.6 p90 -163.2 175.74 10.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.217 0.532 . . . . 0.0 111.658 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 59.9 t80 -167.18 140.81 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.837 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.3 pt-20 -89.44 147.33 24.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.781 0.324 . . . . 0.0 111.17 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.469 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 41.1 p -50.51 -107.29 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -151.7 -132.93 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.52 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.444 ' C ' ' H ' ' B' ' 35' ' ' CYS . 23.8 t -152.47 -25.28 0.17 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.684 0.278 . . . . 0.0 110.588 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 20.3 mt -57.7 -7.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.057 0.456 . . . . 0.0 109.921 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' B' ' 37' ' ' GLN . 37.8 m -113.42 118.59 34.95 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.524 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 87.4 p -72.33 35.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.533 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.456 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.9 pt20 -167.59 61.71 0.57 Allowed Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 95.2 Cg_endo -73.94 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.803 2.335 . . . . 0.0 113.134 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 174.57 176.37 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.834 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 72.7 t -103.4 139.15 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.038 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.44 124.26 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.794 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -100.64 148.78 24.45 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.035 0.445 . . . . 0.0 110.542 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.465 ' CG ' ' N ' ' B' ' 44' ' ' THR . 26.9 tt0 -93.15 169.22 10.57 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.465 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 17.6 p -138.11 -145.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 111.709 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.49 -40.24 1.96 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.736 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.17 47.05 2.14 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.794 -0.184 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 8.6 t -156.2 -79.23 0.08 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.504 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.59 -90.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -143.76 147.97 34.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.438 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.6 t -150.28 114.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.259 0.552 . . . . 0.0 111.021 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.471 ' SG ' ' OG ' ' A' ' 182' ' ' SER . 74.5 m -50.12 159.99 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.704 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 130.59 10.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.34 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' B' ' 53' ' ' ASP . 23.4 p-10 -66.17 125.45 90.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.33 -2.06 11.84 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.141 1.227 . . . . 0.0 111.011 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 36.2 t -69.2 -12.22 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.199 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -101.02 122.65 43.92 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.132 0.491 . . . . 0.0 110.307 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 45.2 t -48.17 -46.86 35.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.496 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 35.4 p-90 -56.27 -24.71 44.71 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.572 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -75.26 -38.08 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 109.771 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -66.6 -48.43 69.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.41 -34.98 77.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -61.8 -40.81 96.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.36 -47.71 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.06 -31.43 65.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.748 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -73.7 -35.16 65.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.91 -20.01 59.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -73.27 -35.76 66.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.77 -77.46 0.14 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.342 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 p30 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.524 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.624 0.25 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.1 t -72.82 -25.5 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.796 0.331 . . . . 0.0 110.755 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -51.53 144.16 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.54 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -68.07 -28.57 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -76.88 -22.68 53.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.8 p -81.11 -49.0 11.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -162.24 169.98 19.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 t -63.84 153.43 36.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.68 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.7 p -72.84 172.36 10.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.461 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.68 2.69 9.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 1.6 mp0 -77.78 98.17 5.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.439 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -31.17 -53.53 0.21 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.694 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -86.65 52.06 2.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 110.682 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 16.7 tttm -160.26 133.46 6.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 110.246 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.44 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 70.6 m-70 -154.35 124.31 6.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.523 ' CE1' ' CG ' ' A' ' 121' ' ' PRO . 11.1 p80 -76.68 97.2 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.53 149.13 40.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.61 158.38 26.56 Favored Glycine 0 CA--C 1.508 -0.388 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 tt -110.33 150.73 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -152.1 106.44 3.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 110.008 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.86 126.7 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.991 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -107.97 166.47 4.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 30' ' ' ILE . 12.9 tt -161.2 110.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.796 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -98.3 132.9 43.4 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.03 120.67 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.995 0.426 . . . . 0.0 110.844 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.539 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 68.4 p -88.33 121.26 30.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -75.81 150.76 37.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.75 136.44 40.3 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.82 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -46.77 -19.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 1.3 mp0 -81.31 -43.89 18.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.547 0.213 . . . . 0.0 111.16 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -42.7 147.77 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.067 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.71 172.1 16.81 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.122 1.881 . . . . 0.0 111.446 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.7 p -74.02 135.23 43.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.474 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -167.09 99.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.47 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -103.64 -1.08 28.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.535 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -67.87 91.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -89.8 160.49 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.907 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 36.9 t 55.26 62.87 2.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.507 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.557 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.4 tp60 -77.44 -27.55 52.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.1 p -174.2 -176.19 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.888 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 p -170.36 101.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 109.956 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.8 p -103.38 126.7 50.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 1.5 pm0 -104.39 142.51 34.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.964 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.99 157.9 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -153.37 151.61 30.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 52.0 tt0 -48.0 168.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.006 0.432 . . . . 0.0 110.06 179.74 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 CA--C 1.527 0.144 0 N-CA-C 111.039 -0.408 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -124.27 121.95 36.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 111.001 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 p -97.76 125.45 42.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -121.47 110.49 16.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.248 0.547 . . . . 0.0 111.019 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -93.73 124.09 37.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.519 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' ' CZ ' ' A' ' 80' ' ' TYR . 4.9 m -94.53 72.9 3.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.051 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.3 mm -74.67 101.73 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.801 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.6 mm -94.25 145.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.021 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.55 169.71 18.17 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.502 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.1 20.48 54.1 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.22 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.28 10.84 84.41 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 mt -131.98 155.62 47.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.58 115.45 27.2 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.3 mtt -102.07 124.16 47.2 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.04 0.448 . . . . 0.0 110.939 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.542 ' C ' HD22 ' A' ' 91' ' ' ASN . 0.2 OUTLIER -114.18 133.1 55.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.729 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.38 -174.73 2.86 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.821 0.343 . . . . 0.0 110.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.52 74.13 0.1 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.077 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -76.98 135.35 38.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.404 ' CB ' HH21 ' B' ' 18' ' ' ARG . 91.7 m -143.65 121.12 11.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.449 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? 65.0 31.72 11.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.979 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.2 m -126.42 149.81 68.58 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.22 143.51 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.999 1.799 . . . . 0.0 111.978 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.434 ' CD ' ' N ' ' A' ' 99' ' ' GLN . 4.2 mp0 -73.21 110.03 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.849 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.4 pt -69.13 142.1 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -135.34 -6.89 2.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.349 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.2 m -107.36 119.54 39.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.81 0.338 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 34.8 mt -132.04 120.02 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.425 ' OG ' HD12 ' A' ' 238' ' ' LEU . 35.1 p -146.58 162.87 37.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 111.015 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -148.39 164.83 32.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -155.12 151.86 28.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.911 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.08 124.9 33.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.424 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -145.22 111.43 5.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.002 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 -127.14 8.96 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -108.29 24.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.753 0.311 . . . . 0.0 110.32 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 p -129.16 159.17 36.88 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.637 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t -139.09 137.17 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 106' ' ' SER . 50.9 p30 -120.93 153.21 37.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.465 . . . . 0.0 111.006 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.21 130.66 19.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.605 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -116.52 116.49 27.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 110.899 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.3 mt -116.25 126.72 53.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 p -166.68 167.42 15.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.508 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 167' ' ' SER . 74.0 m -84.28 172.82 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.686 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 119' ' ' VAL . 10.7 m -96.18 147.92 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 111.024 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.466 ' OG ' ' ND2' ' A' ' 168' ' ' ASN . 1.6 t -92.71 152.2 41.63 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CG ' ' CE1' ' A' ' 23' ' ' HIS . 74.0 Cg_exo -37.89 158.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.21 64.45 3.81 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.175 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -140.99 -1.12 1.41 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 11.15 82.59 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.439 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -136.47 150.14 48.56 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.53 154.72 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.982 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -158.44 60.72 1.84 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.384 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -35.53 143.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.333 2.689 . . . . 0.0 113.715 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.45 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -109.96 146.56 35.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.568 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.01 165.81 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 110.186 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -87.44 174.48 8.49 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' OG1' ' A' ' 131' ' ' THR . 2.0 t60 -63.92 -39.33 93.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.34 -57.52 12.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.28 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.428 ' H ' HG23 ' A' ' 131' ' ' THR . 8.0 tp10 -63.18 -42.26 99.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.538 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.16 -57.01 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.177 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.86 -36.68 59.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.056 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.48 -37.66 71.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 21.1 mtt -62.34 -58.43 7.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -24.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.859 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -78.29 -55.27 5.38 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.376 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.41 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 33.9 m-20 -77.82 -23.65 48.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 19.0 t -58.07 113.59 1.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.526 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.54 ' CD ' ' HE ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -143.51 148.3 35.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.269 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.95 131.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.931 0.396 . . . . 0.0 110.309 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.6 p -103.19 173.12 6.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 15.1 pt -150.78 148.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.776 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -152.19 83.37 1.26 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.879 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.58 154.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 150' ' ' CYS . 34.1 ttt85 -145.36 172.17 13.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.022 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 149' ' ' ARG . 6.2 t -91.02 116.16 28.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.774 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.8 p -92.94 -176.85 4.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.208 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.9 6.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.295 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.469 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 63.8 tt0 -70.24 107.01 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.95 16.25 6.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.557 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 3.9 mmmm -60.73 172.72 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.674 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -76.55 169.65 17.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.636 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 71.6 m -96.6 147.65 23.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.47 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 16.3 t70 -113.18 90.94 3.48 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 160' ' ' LYS . 63.6 mt -115.11 159.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.17 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.521 ' N ' HG22 ' A' ' 159' ' ' ILE . 6.7 mmtp -121.9 128.93 52.13 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.9 p -62.55 1.97 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 160' ' ' LYS . 80.1 t60 -78.72 116.91 63.36 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -40.39 150.12 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.654 1.569 . . . . 0.0 111.939 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.85 137.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.898 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.6 mt -78.01 147.43 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.753 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -119.46 156.96 15.61 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.091 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 169' ' ' ILE . 3.5 m -89.57 10.31 23.43 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.466 ' ND2' ' OG ' ' A' ' 120' ' ' SER . 10.6 m-20 56.5 1.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.502 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.494 ' H ' ' C ' ' A' ' 167' ' ' SER . 8.4 tp -94.33 144.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 26.6 p -105.65 149.91 25.92 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -83.83 46.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.373 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -73.0 -177.16 2.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -93.55 117.56 30.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.538 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.502 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 13.3 m -139.83 -171.24 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.145 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.1 t -43.31 138.15 2.41 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.77 0.319 . . . . 0.0 110.898 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.502 ' CE1' ' O ' ' A' ' 174' ' ' VAL . 2.3 m-85 -98.95 136.79 38.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.252 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 178' ' ' ASP . 5.1 tm-20 -151.84 158.11 42.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.512 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 4.5 p-10 -92.94 93.36 8.33 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 179' ' ' ILE . 0.2 OUTLIER -115.42 17.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.126 0.488 . . . . 0.0 110.016 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 180' ' ' ILE . 2.3 pp -113.14 119.11 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.292 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.59 -142.67 2.64 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.876 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 37.5 t -69.33 158.96 34.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.434 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -144.6 95.06 2.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.114 0.483 . . . . 0.0 110.151 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.8 132.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.655 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.578 HG21 ' CE2' ' A' ' 217' ' ' TYR . 3.3 m -142.74 123.02 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.691 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.6 p-10 -85.08 98.06 10.21 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 189' ' ' CYS . 31.3 m -47.58 -26.88 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.592 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -39.82 -26.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 187' ' ' THR . 94.0 m -146.31 24.94 1.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.185 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 23.3 t -148.5 95.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.74 -54.9 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASN . . . . . 0.539 ' H ' ' HG1' ' A' ' 33' ' ' THR . 7.2 m-20 -125.35 -176.57 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.753 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.509 HD23 ' C ' ' A' ' 193' ' ' LEU . 4.7 tt -172.88 109.16 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -96.12 121.3 37.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -120.73 129.88 53.82 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.038 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.9 p -144.58 134.22 23.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 198' ' ' ARG . 59.1 t -122.88 154.91 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.449 ' N ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -145.53 144.77 30.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.237 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.8 mt -148.99 117.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.568 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.44 172.53 45.55 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.416 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.43 119.92 10.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 0.0 111.326 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 49.7 mtm -77.17 4.18 10.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.7 t -97.23 -61.74 1.36 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.437 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -147.49 115.02 6.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.323 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -43.64 123.23 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.633 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.0 t -117.16 105.05 11.83 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.652 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.3 m -38.21 -36.97 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.156 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.83 -48.98 62.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.677 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.5 mm? -90.42 13.88 14.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.245 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 128.16 42.65 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 212' ' ' LYS . 74.6 t -153.31 161.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.374 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -167.38 160.34 13.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.473 0.654 . . . . 0.0 112.444 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.6 t70 -146.5 171.39 15.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.352 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 162.89 145.4 4.34 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.902 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.23 -171.4 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -152.93 108.14 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.439 0.638 . . . . 0.0 111.439 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.578 ' CE2' HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -96.85 123.66 40.61 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 220' ' ' GLY . 6.2 p -141.06 118.31 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.4 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.0 t70 59.92 -13.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.308 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 140.08 0.44 1.93 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 t -104.11 117.5 34.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.58 156.24 17.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.906 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.3 t -166.17 123.26 1.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -81.28 99.09 8.44 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -120.55 134.51 10.36 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.934 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.46 ' HA ' ' HZ2' ' A' ' 212' ' ' LYS . . . -98.39 98.09 9.36 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 70.0 p -134.73 163.34 30.0 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.403 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 22.4 t70 -66.16 95.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.486 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.69 28.96 0.73 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.712 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.403 ' HG1' ' CG ' ' A' ' 228' ' ' ASP . 27.6 m -64.21 -57.09 10.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.165 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 m -84.57 1.25 46.79 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.544 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.35 -29.5 0.15 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.75 0.31 . . . . 0.0 111.413 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.4 pp -152.29 145.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.304 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.79 93.08 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' SER . . . . . 0.428 ' O ' ' CD2' ' A' ' 238' ' ' LEU . 31.4 t -64.42 -2.54 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.188 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 74.3 m -93.73 -19.41 21.1 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 237' ' ' LYS . 3.3 mptp? -98.76 -2.38 38.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.514 ' CD2' ' H ' ' A' ' 238' ' ' LEU . 1.1 pt? -91.04 158.2 16.82 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.363 0.983 . . . . 0.0 111.223 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -131.92 151.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.617 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.57 161.62 1.96 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.723 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 54.0 t -124.19 -13.78 7.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.017 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.588 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 121.072 0.463 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.0 m -104.57 151.8 23.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -55.48 139.94 41.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.133 0.492 . . . . 0.0 112.008 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 8.8 m-85 -112.17 -27.26 8.43 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.7 t -158.42 158.8 34.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.489 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.39 -178.2 3.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.18 0.514 . . . . 0.0 111.778 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -99.05 135.83 39.9 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.78 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.4 12.12 4.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.54 ' HE ' ' CD ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -148.92 136.64 20.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.023 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -79.54 130.31 35.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.607 HD22 ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -84.12 114.46 54.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.546 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.34 141.87 1.97 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.783 1.655 . . . . 0.0 112.168 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ARG . . . . . 0.503 ' C ' ' H ' ' B' ' 24' ' ' PHE . 46.0 mtt85 -44.18 -42.62 6.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.597 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -69.77 28.24 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' B' ' 22' ' ' ARG . 23.2 t80 -153.12 29.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -155.03 99.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.902 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.48 -9.35 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.6 t70 -163.85 -178.97 6.0 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.883 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . 0.472 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.2 p90 -165.09 172.44 12.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.285 0.564 . . . . 0.0 111.652 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.441 ' CZ ' ' OD2' ' B' ' 27' ' ' ASP . 76.7 m-85 -153.87 179.63 8.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.064 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -125.5 147.38 49.26 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.843 0.354 . . . . 0.0 110.081 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 36.9 p -53.92 -106.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -157.7 -142.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.468 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.3 m -145.65 -22.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.296 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -56.83 -7.46 0.45 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' B' ' 33' ' ' SER . 3.6 p -121.29 122.51 40.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 86.1 p -74.55 42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.195 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -167.69 57.0 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 64.3 Cg_endo -68.94 -164.2 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 175.59 176.82 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.972 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.47 135.05 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.021 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.71 134.28 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.217 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -108.34 151.74 25.58 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.707 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.13 168.84 10.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 7.5 p -135.6 -144.96 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.343 0.592 . . . . 0.0 111.132 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ALA . . . . . 0.412 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.46 -38.82 1.33 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.988 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.47 46.24 2.34 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.728 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.613 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 15.5 t -156.58 -81.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.532 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.16 -87.79 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.93 148.02 32.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.98 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -152.32 123.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 109.844 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.479 ' H ' ' CB ' ' A' ' 182' ' ' SER . 5.4 t -58.36 164.44 2.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.979 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.9 134.62 13.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.717 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -68.21 120.13 72.43 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.05 -0.02 8.49 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.065 1.177 . . . . 0.0 111.318 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 59.5 p -74.11 -9.1 58.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.28 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -102.28 125.65 49.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 110.422 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -47.47 -50.07 24.04 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 64.4 p-90 -56.13 -27.56 54.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.758 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.48 -38.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -67.12 -51.6 52.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.357 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.81 -35.46 70.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.0 m-85 -62.88 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -71.01 -46.38 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.92 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.17 -28.85 69.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.27 -41.07 61.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.699 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.34 -22.5 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -69.93 -33.56 72.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.2 -102.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.6 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.597 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 1' ' ' MET . 70.9 Cg_exo -51.77 -171.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.82 1.68 . . . . 0.0 112.085 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.49 175.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.625 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.5 m -165.61 -8.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.447 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 6' ' ' GLN . 1.6 tt -62.6 110.24 1.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.163 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.453 ' N ' HD23 ' A' ' 5' ' ' LEU . 24.9 tt0 -167.41 124.85 1.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.577 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -60.95 -143.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.539 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 57.0 p -158.11 -14.7 0.08 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.419 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 t -76.0 -29.29 58.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.8 m -49.26 129.8 18.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.511 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -58.6 -21.89 54.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.536 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.2 p -77.44 -20.12 55.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.4 m -82.95 -50.47 8.54 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.989 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -165.42 173.43 11.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.972 0.415 . . . . 0.0 111.095 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 98.8 m -55.86 159.28 3.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.785 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.4 p -85.06 173.76 10.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.917 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -119.25 5.36 11.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.319 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.29 92.87 7.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.75 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 17.9 mp0 -27.6 -63.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.506 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -77.16 53.89 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.81 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 22' ' ' HIS . 19.9 tttp -163.08 137.13 6.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 21' ' ' LYS . 63.0 m80 -157.42 123.22 4.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.81 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 128' ' ' PRO . 2.0 t60 -64.67 109.26 1.96 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 111.219 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.627 ' HE2' HD11 ' A' ' 139' ' ' ILE . 72.9 mmm -84.43 137.44 33.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.381 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.57 156.56 22.51 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' CG1' ' A' ' 197' ' ' VAL . 7.5 tp -110.7 151.25 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -157.27 106.56 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 110.253 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.86 148.97 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.313 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' A' ' 171' ' ' HIS . 10.1 mt -117.45 145.77 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -145.69 108.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.992 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -106.3 96.07 6.21 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 t -91.18 134.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.466 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 192' ' ' ASN . 29.8 m -113.92 121.68 44.68 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.692 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -77.5 151.04 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.721 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.462 ' CD ' ' N ' ' A' ' 36' ' ' ASP . 13.5 tm0? -80.07 148.96 30.83 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 15.4 t70 -72.76 65.56 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.764 0.316 . . . . 0.0 110.721 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -172.09 -23.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.961 0.41 . . . . 0.0 110.114 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.2 m -75.14 121.78 85.97 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.214 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -39.62 159.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.87 1.713 . . . . 0.0 112.318 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.5 t -73.57 147.14 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.353 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 86' ' ' GLY . 0.6 OUTLIER -174.08 101.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.489 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 p30 -112.27 25.42 11.55 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -86.12 54.62 3.21 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.919 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -57.83 176.09 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.007 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.9 m 55.6 34.99 24.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.681 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 46' ' ' GLN . 29.8 tp60 -59.72 -43.06 94.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.054 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 t 178.71 165.52 0.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.055 0.455 . . . . 0.0 110.754 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.2 134.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.538 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.4 m -129.75 111.45 12.65 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -82.98 141.62 31.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.588 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mt -143.39 154.37 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -150.92 110.73 4.06 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 78' ' ' THR . 0.9 OUTLIER -64.79 115.59 5.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.298 -178.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.15 -46.09 0.61 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.094 178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.34 -33.27 67.57 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.211 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.516 ' N ' ' OG1' ' A' ' 52' ' ' THR . 45.5 m 39.71 -105.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.601 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.734 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 6.7 t0 -160.31 -37.82 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.734 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 10.0 Cg_endo -80.92 -94.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.611 1.541 . . . . 0.0 110.895 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 11.7 p30 -176.13 51.67 0.08 OUTLIER Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 59' ' ' ASP . 44.8 Cg_endo -98.05 -55.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.395 2.064 . . . . 0.0 111.304 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 63' ' ' GLU . 23.8 tp10 62.72 61.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.982 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.2 t 72.54 -25.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.653 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 61' ' ' GLU . 28.5 tt0 63.35 63.04 0.92 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.918 0.389 . . . . 0.0 110.5 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.0 t -88.39 77.41 8.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.67 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -77.68 55.94 1.41 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.387 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 23.8 p-10 -167.81 90.89 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 0.0 111.2 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.56 167.98 20.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.17 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.9 p -173.56 -47.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 110.208 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.75 -39.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.123 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 71' ' ' VAL . 98.9 p -46.85 136.68 7.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.486 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 70' ' ' SER . 10.6 m -158.28 33.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.275 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 73' ' ' ASP . 6.4 pt-20 -59.38 -34.31 72.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.497 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 75' ' ' ASP . 80.9 m-20 -34.35 -98.6 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.1 t 57.33 -80.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.763 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' ASP . 12.9 m-20 -75.77 149.82 83.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.345 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 77' ' ' PRO . 58.6 Cg_endo -68.5 147.89 71.78 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 121.964 1.776 . . . . 0.0 111.467 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 76' ' ' PRO . 31.3 Cg_exo -55.84 -147.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.852 1.702 . . . . 0.0 113.111 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.412 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 19.4 p -131.32 150.66 52.06 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.619 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.9 m -121.05 128.22 52.44 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -127.37 153.88 45.67 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.0 0.429 . . . . 0.0 110.496 -178.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 64.4 m-85 -128.85 137.45 51.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.964 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.5 p -105.03 66.18 0.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.062 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.68 98.93 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.25 0.548 . . . . 0.0 110.842 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.73 145.09 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.63 161.97 11.5 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.404 ' O ' ' ND2' ' A' ' 41' ' ' ASN . . . 61.3 25.62 65.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.187 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.06 65.3 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.595 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -134.2 163.0 30.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.934 0.397 . . . . 0.0 110.084 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -129.95 112.46 13.53 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.445 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 mpt? -101.09 106.95 18.26 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.958 0.408 . . . . 0.0 110.662 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -88.84 128.63 35.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -96.74 -162.95 1.0 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.624 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.1 70.45 0.01 OUTLIER Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 94' ' ' PHE . 5.0 p90 -89.0 156.16 19.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.226 0.536 . . . . 0.0 111.059 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.3 p -141.46 125.64 17.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.891 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm 61.93 35.08 16.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.531 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 m -121.84 146.02 44.88 Favored Pre-proline 0 N--CA 1.472 0.65 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -39.1 148.03 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.928 1.752 . . . . 0.0 112.159 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -64.46 145.05 56.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 14.5 mt -108.47 116.64 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -119.28 0.8 11.23 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -115.38 118.26 32.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 110.503 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.33 120.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.8 m -144.91 159.25 43.21 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.857 0.36 . . . . 0.0 110.738 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -148.76 168.33 23.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.82 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.71 159.34 24.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.511 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.18 127.7 36.43 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.545 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -142.25 107.6 5.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.482 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.23 -134.38 19.61 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -96.43 23.38 6.83 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.778 0.323 . . . . 0.0 110.383 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -130.54 159.34 37.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.434 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.2 m -144.03 138.86 24.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.471 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -108.34 171.38 7.45 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 111.647 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.5 120.44 2.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.63 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.482 ' NH2' ' OG ' ' A' ' 235' ' ' SER . 7.3 tpp85 -113.97 114.9 26.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.826 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 115' ' ' ARG . 10.8 mp -115.84 127.42 55.03 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.4 p -164.7 175.96 9.26 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.664 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.421 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 73.6 p -92.79 166.36 12.47 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.608 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 119' ' ' VAL . 12.6 m -92.55 145.5 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 0.0 110.879 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.2 p -89.26 150.09 44.15 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.32 162.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.776 1.65 . . . . 0.0 112.21 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 48.13 69.99 0.84 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.136 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -140.11 -46.13 0.43 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.21 -8.09 2.92 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.081 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -117.57 -176.86 3.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.63 170.13 12.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.047 0.451 . . . . 0.0 111.302 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -163.21 61.89 1.1 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.946 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.501 ' O ' ' ND1' ' A' ' 23' ' ' HIS . 97.1 Cg_exo -42.87 125.16 3.84 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.84 2.36 . . . . 0.0 113.484 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.31 149.92 21.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -149.57 163.29 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.898 0.38 . . . . 0.0 111.001 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.5 p -79.61 177.42 8.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.916 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -71.25 -34.74 71.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.42 -43.88 80.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.95 -30.57 67.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.41 -56.52 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.162 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -32.58 39.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.163 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.9 -44.1 66.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.512 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.1 mtt -63.69 -56.72 13.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.626 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.627 HD11 ' HE2' ' A' ' 24' ' ' MET . 50.5 mt -46.35 -22.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -86.19 -42.06 14.14 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.72 -27.16 25.45 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 40.9 t -49.53 119.38 3.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.833 0.349 . . . . 0.0 111.141 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -138.72 125.0 20.3 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.338 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 145' ' ' SER . 93.4 t -94.49 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.479 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.573 ' N ' HG12 ' A' ' 144' ' ' VAL . 12.4 p -140.22 144.54 36.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.386 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.1 mt -140.83 143.1 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.984 0.421 . . . . 0.0 110.595 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -158.29 77.07 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.027 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.5 tt -75.62 152.0 6.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.985 0.421 . . . . 0.0 110.538 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -134.7 -149.11 0.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.344 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.4 t -132.67 108.97 9.38 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.216 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 m -97.25 173.08 7.4 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -147.5 10.79 0.97 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.927 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -64.22 104.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.759 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -81.24 1.93 30.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -52.34 150.15 4.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.93 0.395 . . . . 0.0 110.565 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.03 171.59 1.69 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.162 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 80.5 p -97.83 149.62 22.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.922 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -121.5 93.35 3.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.735 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.476 ' C ' HD12 ' A' ' 159' ' ' ILE . 1.6 pp -110.35 178.1 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.807 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 162' ' ' HIS . 42.9 tttp -135.64 125.9 26.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.831 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 161' ' ' THR . 35.3 m -57.95 -2.33 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.24 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.3 t-80 -75.08 116.36 53.45 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.376 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -40.49 160.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.81 1.674 . . . . 0.0 111.97 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.31 129.28 37.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.609 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.4 mt -79.03 121.26 24.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.56 160.68 22.76 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.303 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 169' ' ' ILE . 0.2 OUTLIER -92.04 8.08 39.36 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 58.75 -0.65 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.494 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.493 ' H ' ' C ' ' A' ' 167' ' ' SER . 9.4 tp -90.73 141.82 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 13.4 m -88.58 -176.53 5.32 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.454 ' CD2' HD11 ' A' ' 29' ' ' ILE . 4.6 m-70 -123.73 24.2 8.51 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -58.26 -166.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.558 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -101.8 122.94 44.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.739 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.07 -168.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.254 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.7 m -49.78 148.54 3.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 54.5 p90 -98.34 133.38 42.82 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.283 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.07 132.34 23.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.39 97.85 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.568 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.5 mt -107.86 -51.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -56.23 115.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.946 0.403 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.78 -123.86 0.7 Allowed Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.1 t -75.2 148.7 39.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.763 0.316 . . . . 0.0 110.759 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.3 p -141.81 87.23 2.04 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.556 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.468 HD11 ' HB1' ' B' ' 10' ' ' ALA . 8.8 tp -98.87 135.58 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.9 129.96 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.711 0.291 . . . . 0.0 111.526 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -81.79 90.02 6.35 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 189' ' ' CYS . 0.0 OUTLIER -46.25 -27.22 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.279 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -44.93 -16.98 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.76 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.479 ' N ' ' O ' ' A' ' 187' ' ' THR . 57.0 m -143.71 24.55 1.69 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.4 p -163.98 104.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.512 0.672 . . . . 0.0 110.313 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -72.21 -56.52 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.493 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.456 ' H ' ' HB ' ' A' ' 33' ' ' THR . 10.6 m-20 -125.71 141.1 52.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.236 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.1 tt -145.34 106.74 4.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.823 0.344 . . . . 0.0 110.754 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.66 151.86 19.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.05 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -140.77 138.03 33.81 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.989 0.423 . . . . 0.0 110.242 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 1.8 m -143.85 135.92 26.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.347 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 198' ' ' ARG . 21.3 t -134.2 160.06 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.462 ' N ' HG12 ' A' ' 197' ' ' VAL . 39.8 ttt180 -171.79 113.87 0.34 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.985 0.421 . . . . 0.0 110.842 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.7 tt -106.3 128.96 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.791 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.76 167.71 40.36 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 121.224 -0.512 . . . . 0.0 111.938 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -53.46 123.34 11.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.421 ' SD ' ' OG ' ' A' ' 118' ' ' SER . 77.9 mtm -82.74 4.67 24.18 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.577 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 34.8 t -106.88 -46.76 3.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.093 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.69 117.56 2.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.239 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 6.0 mp0 -43.98 156.4 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.701 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 208' ' ' GLU . 17.9 t -141.11 17.8 2.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.646 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.441 ' OG ' ' N ' ' A' ' 208' ' ' GLU . 73.7 p 56.28 -74.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.126 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.0 mm-40 -49.25 -54.41 16.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.57 0.224 . . . . 0.0 111.597 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.4 mp -74.57 4.38 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.044 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -104.0 124.21 48.61 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.814 0.34 . . . . 0.0 111.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.8 m -146.56 -179.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.22 167.55 10.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.485 0.66 . . . . 0.0 111.834 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 213' ' ' ASP . 0.6 OUTLIER -157.3 172.9 17.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.956 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 157.3 143.4 3.65 Favored Glycine 0 C--N 1.328 0.104 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.496 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -121.15 179.28 4.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -137.98 104.16 5.17 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 110.406 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -97.72 118.71 34.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.877 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 26.1 t -138.34 100.92 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.38 52.45 13.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.923 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.45 -13.99 48.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.646 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 11.9 t -85.63 106.03 16.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 111.479 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.5 143.96 32.03 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.2 m -164.63 130.85 2.91 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.647 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -82.25 140.91 33.38 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.351 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -177.71 110.8 0.31 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.63 127.39 32.85 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 47.1 p -150.21 161.07 43.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.567 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -67.09 95.52 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.607 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -87.21 26.38 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.286 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 27.6 m -67.13 -29.57 69.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 25.6 t -116.57 5.89 13.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.664 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.7 OUTLIER -42.28 -28.43 0.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.928 0.394 . . . . 0.0 110.565 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 35.9 pt -156.39 152.01 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.33 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -76.11 98.92 4.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.482 ' OG ' ' NH2' ' A' ' 115' ' ' ARG . 23.3 t -64.08 -9.58 17.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.298 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 64.3 p -82.79 -12.37 57.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -102.74 7.44 39.66 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.576 0.227 . . . . 0.0 111.386 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -81.32 132.04 35.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.097 0.475 . . . . 0.0 110.786 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -123.15 135.55 54.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.388 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -65.74 127.3 31.41 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.104 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.432 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 34.0 m -88.58 -3.72 58.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.695 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 242' ' ' VAL . 11.7 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.143 -1.408 . . . . 0.0 111.434 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.768 0.318 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -44.07 120.91 2.68 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.705 2.27 . . . . 0.0 112.277 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ttt -62.81 155.18 27.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.517 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.84 160.94 44.26 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.064 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.5 p -54.75 -91.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.727 0.299 . . . . 0.0 110.564 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -133.1 68.26 78.02 Favored Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.471 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -41.92 124.64 2.84 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.777 2.318 . . . . 0.0 111.762 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.579 ' C ' HG22 ' B' ' 9' ' ' THR . 10.0 Cg_exo -34.33 -99.34 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.432 2.088 . . . . 0.0 114.684 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.579 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 163.5 165.2 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 184' ' ' ILE . . . -142.92 57.93 1.41 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.53 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 1.8 t -97.11 154.06 17.58 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.691 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.65 146.59 48.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.108 0.48 . . . . 0.0 111.793 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.53 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -116.84 -23.46 8.07 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.335 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 7.2 p -151.54 154.9 37.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.108 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -114.95 154.82 28.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.91 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -76.38 139.75 41.1 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 -20.94 40.54 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 121.168 -0.213 . . . . 0.0 111.149 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -105.54 127.88 53.27 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.87 0.367 . . . . 0.0 111.284 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -84.51 114.34 21.87 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.465 ' N ' HD12 ' B' ' 20' ' ' LEU . 10.9 mp -75.45 115.15 42.84 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.903 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.67 153.44 0.15 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.045 1.83 . . . . 0.0 112.606 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 25' ' ' VAL . 84.5 mtp180 -45.7 -49.89 14.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.67 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.437 ' N ' HD22 ' B' ' 23' ' ' ASN . 2.3 m120 -38.89 -34.69 0.16 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.9 OUTLIER -106.08 38.18 2.09 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.934 0.397 . . . . 0.0 109.983 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' B' ' 22' ' ' ARG . 48.8 t -152.95 97.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.571 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -102.7 -13.86 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.88 179.48 9.25 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.189 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.492 ' O ' ' CD2' ' B' ' 29' ' ' TYR . 13.4 p90 -165.56 169.92 14.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.187 0.518 . . . . 0.0 111.796 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' B' ' 28' ' ' TYR . 94.5 m-85 -159.0 153.62 24.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.601 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' B' ' 31' ' ' THR . 41.6 mt-10 -97.71 147.31 24.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.854 0.359 . . . . 0.0 111.11 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 41.9 p -53.11 -110.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.146 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 12.7 m -150.81 -145.72 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.747 0.308 . . . . 0.0 110.666 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.457 ' C ' ' H ' ' B' ' 35' ' ' CYS . 65.9 p -141.38 -22.9 0.74 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.424 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.23 -5.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.1 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.458 ' C ' ' H ' ' B' ' 37' ' ' GLN . 8.6 p -117.5 120.83 39.3 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 34.4 t -72.66 36.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.245 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.458 ' H ' ' C ' ' B' ' 35' ' ' CYS . 11.9 pt20 -167.51 60.86 0.53 Allowed Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 68.7 Cg_endo -70.16 -161.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.665 2.243 . . . . 0.0 112.83 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.48 176.92 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.39 134.98 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.67 130.32 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.018 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -111.26 146.51 36.87 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.071 0.462 . . . . 0.0 111.173 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.469 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.48 169.06 10.63 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -136.12 -142.92 0.18 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.249 0.547 . . . . 0.0 111.092 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.499 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.53 -40.46 2.22 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.848 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.47 47.88 2.23 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.39 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 59.6 p -151.48 -79.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.422 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.58 -90.22 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -142.76 147.67 35.95 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.954 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.6 t -149.63 123.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.021 0.438 . . . . 0.0 110.111 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 73.3 m -59.76 162.26 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.242 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.5 125.71 7.32 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.762 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.14 123.06 82.99 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.31 0.37 8.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 121.235 1.29 . . . . 0.0 111.357 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 62.2 p -68.22 -14.7 63.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -100.08 124.02 44.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.994 0.426 . . . . 0.0 110.372 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -50.86 -38.38 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.989 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -56.4 -33.69 66.01 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.744 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.2 t -71.89 -36.35 57.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.123 0.487 . . . . 0.0 109.887 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -70.72 -37.94 73.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.482 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -71.01 -35.69 72.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.176 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.05 -37.65 88.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.71 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 60.9 t -70.67 -45.1 75.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.93 -38.97 80.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.986 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.1 -41.72 90.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.932 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -70.25 -19.81 63.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.51 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -35.33 66.2 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.9 mt -76.4 -77.49 0.14 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.896 0.379 . . . . 0.0 110.348 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.529 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.778 0.323 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -43.04 163.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.71 2.273 . . . . 0.0 112.149 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.43 -174.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.455 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -165.88 -165.3 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.504 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.3 mt 53.86 98.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.404 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 1.8 pm0 -166.74 133.51 2.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -69.17 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.412 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.4 t -168.31 -18.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.583 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.4 m -76.58 -23.91 53.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.685 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -51.08 139.59 17.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.6 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.5 p -63.34 -21.79 66.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.702 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.9 t -77.59 -28.7 51.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.71 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.9 p -78.55 -50.79 10.94 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.999 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.0 t -161.92 172.6 15.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.705 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.41 150.59 47.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.346 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.43 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 12.4 t -63.48 170.45 3.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 0.0 110.742 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.435 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 23.8 mp0 -113.06 4.88 16.88 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.593 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -61.98 -164.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.964 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -127.01 -62.85 1.09 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.0 110.72 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -82.15 34.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.535 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.93 142.5 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -144.43 159.75 42.22 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.0 OUTLIER -88.02 81.56 7.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.852 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.605 ' N ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -69.33 123.67 21.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.749 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.65 179.31 17.03 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 tt -136.0 154.92 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.015 0.436 . . . . 0.0 110.747 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 53.8 t0 -145.67 137.65 25.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG13 ' CZ ' ' A' ' 195' ' ' PHE . 91.9 t -137.95 107.87 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.123 0.487 . . . . 0.0 111.538 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.3 mp -94.28 142.62 13.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.659 ' H ' HH21 ' A' ' 115' ' ' ARG . 9.1 tt -155.62 117.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.54 0.686 . . . . 0.0 111.482 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -104.52 127.65 52.29 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.663 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -125.31 117.1 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.043 0.449 . . . . 0.0 111.89 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 m -96.79 132.98 41.96 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.6 ptpp? -94.54 164.0 13.16 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.926 0.394 . . . . 0.0 109.971 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.76 157.1 37.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.18 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.019 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -83.02 -34.67 26.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.993 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.2 m -45.04 110.77 1.14 Allowed Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.03 159.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.725 1.616 . . . . 0.0 111.998 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -70.04 137.92 51.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.796 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -157.68 102.87 1.89 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 44' ' ' ILE . 14.5 t70 -101.6 -12.93 18.08 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.762 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -58.4 81.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.977 0.418 . . . . 0.0 110.548 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.494 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.5 tp -86.56 156.25 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 12.4 t 57.08 61.8 2.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.539 0.685 . . . . 0.0 110.048 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 155' ' ' LYS . 7.9 tt0 -80.26 -30.07 38.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.0 m -171.54 166.76 6.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' CG2' ' SG ' ' A' ' 241' ' ' CYS . 6.7 t -148.7 105.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.846 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -106.71 112.16 25.02 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.869 0.366 . . . . 0.0 111.275 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.629 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -89.09 138.61 31.26 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.284 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.1 mt -140.39 151.25 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.9 p -149.59 138.65 21.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.915 0.388 . . . . 0.0 110.224 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 55' ' ' GLU . 4.4 tp10 -45.26 169.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 56' ' ' SER . 9.0 m -50.04 -10.35 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.15 -0.22 . . . . 0.0 110.961 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 53' ' ' GLU . 36.5 tt0 -30.85 88.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.641 0.588 . . . . 0.0 111.739 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' SER . 73.2 m 44.17 60.55 2.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.438 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.59 166.97 6.44 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -34.88 107.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.773 2.315 . . . . 0.0 112.307 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 59' ' ' ASP . 0.5 OUTLIER -77.45 114.71 43.08 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.743 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.93 -43.91 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.651 1.568 . . . . 0.0 111.91 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -53.76 142.59 23.19 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 63' ' ' GLU . 10.5 m -65.0 -46.26 92.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.542 ' N ' HG23 ' A' ' 62' ' ' VAL . 11.3 pt-20 -83.4 -155.16 0.16 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.487 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 77.3 p -157.99 159.85 36.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.948 0.404 . . . . 0.0 110.665 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 2.3 pm0 -41.08 -89.78 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t0 58.98 68.56 0.8 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 110.526 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' ' CB ' ' A' ' 68' ' ' SER . 52.0 t0 -62.23 -60.23 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.432 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 67' ' ' ASP . 1.2 t 80.54 44.39 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.7 p -149.79 -14.1 0.27 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.125 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.4 p -168.89 -53.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.268 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.9 t 51.93 72.72 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.808 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -154.85 -49.92 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.216 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -74.24 157.72 35.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.584 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.6 m -69.1 -154.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.256 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -156.68 130.31 4.67 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -33.24 95.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.172 0 C-N-CA 122.979 2.453 . . . . 0.0 114.172 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -99.08 145.1 0.46 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.129 2.552 . . . . 0.0 110.791 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 t -130.82 145.69 52.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.936 0.398 . . . . 0.0 111.251 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.9 t -121.86 130.95 53.77 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -124.91 114.98 19.88 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.952 0.406 . . . . 0.0 111.252 -177.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -93.86 124.15 37.67 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.289 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -96.36 71.58 2.76 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.05 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.41 HG22 ' H ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -72.42 111.97 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.997 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 mm -100.18 145.27 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.82 169.49 18.1 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.339 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.31 20.36 43.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.851 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.88 10.0 76.45 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.7 mt -130.75 155.53 46.49 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.055 0.455 . . . . 0.0 110.54 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -121.38 106.9 11.87 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 mtt -101.57 106.66 17.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.006 0.432 . . . . 0.0 110.942 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -95.6 127.67 41.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.539 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -102.75 -169.93 1.73 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.32 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.29 72.65 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -76.21 135.78 39.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 110.972 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.2 m -140.04 122.61 16.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.005 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 58.0 32.66 22.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 61.3 m -121.42 149.56 52.57 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.644 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -38.7 152.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.98 1.787 . . . . 0.0 112.093 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.437 ' CD ' ' N ' ' A' ' 99' ' ' GLN . 19.4 mp0 -79.57 109.25 13.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.041 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 127.37 28.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.848 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.416 ' HZ2' ' HB3' ' A' ' 125' ' ' LYS . 1.2 tppp? -123.13 2.78 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.467 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.0 p -130.86 131.24 44.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.25 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.2 tt -144.98 130.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 93.6 p -150.29 152.84 35.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.182 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -142.28 175.49 9.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 110.689 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 t -168.54 164.36 12.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.948 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.17 131.38 42.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.388 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 108' ' ' ASP . 20.9 p-10 -144.43 107.74 4.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.028 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.41 -122.72 18.7 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.744 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -102.93 20.82 16.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.621 0.248 . . . . 0.0 110.649 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.4 p -128.63 151.84 49.03 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.076 0.465 . . . . 0.0 111.024 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.42 135.88 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.61 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.4 HD22 HH12 ' A' ' 115' ' ' ARG . 2.2 m120 -104.73 165.42 11.08 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.12 0.486 . . . . 0.0 111.458 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.657 ' H ' ' NH2' ' A' ' 115' ' ' ARG . . . -163.46 120.56 1.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.858 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.659 HH21 ' H ' ' A' ' 30' ' ' ILE . 13.1 mmp_? -115.34 111.66 21.21 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.422 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mp -111.24 118.91 37.22 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.4 p -156.75 177.08 11.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.328 0.585 . . . . 0.0 111.763 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 p -93.38 164.96 13.01 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.534 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.457 ' O ' ' CE ' ' A' ' 202' ' ' MET . 8.2 p -97.78 130.49 46.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 111.326 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 p -72.91 153.29 91.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.797 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -58.17 151.53 58.68 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.934 1.756 . . . . 0.0 111.5 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.35 50.12 8.64 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.23 -0.509 . . . . 0.0 111.845 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -134.75 -22.76 1.63 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.778 0.323 . . . . 0.0 110.281 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.73 14.97 11.53 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 101' ' ' LYS . 35.9 mmtm -135.04 164.48 27.54 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -72.24 148.01 45.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.17 0.509 . . . . 0.0 111.757 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.0 m -155.43 62.66 3.37 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.705 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.4 142.26 2.98 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.877 2.385 . . . . 0.0 113.361 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.56 150.22 22.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.231 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 tp -131.01 164.61 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 120.649 0.261 . . . . 0.0 110.62 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 132' ' ' HIS . 26.8 m -81.66 154.92 25.86 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 121.182 0.515 . . . . 0.0 111.322 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.407 ' N ' HG22 ' A' ' 131' ' ' THR . 6.3 t60 -50.73 -38.43 47.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.724 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.99 -57.09 8.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -56.53 -42.34 78.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.375 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.14 -56.84 16.54 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 tp -51.65 -35.44 42.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.909 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.19 68.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.737 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.403 ' C ' ' N ' ' A' ' 140' ' ' LYS . 48.5 mtt -69.07 -62.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.526 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 30.5 mt -44.96 -20.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.728 0.299 . . . . 0.0 111.218 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.403 ' N ' ' C ' ' A' ' 138' ' ' MET . 19.7 tptm -87.47 -33.65 18.95 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.396 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -94.36 -26.03 16.72 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.433 ' SG ' HD11 ' A' ' 199' ' ' ILE . 34.0 t -49.61 118.62 2.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.86 0.362 . . . . 0.0 111.219 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -137.72 118.93 14.53 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.2 t -115.16 126.89 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.713 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.5 p -100.96 165.14 11.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.9 mp -142.96 150.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.11 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -160.77 86.89 0.73 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.705 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 16.8 tt -83.32 151.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.198 0.523 . . . . 0.0 111.904 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.443 ' CG ' ' H ' ' A' ' 150' ' ' CYS . 57.2 ttt180 -149.01 176.07 10.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.075 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.46 ' SG ' ' OD2' ' A' ' 186' ' ' ASP . 11.8 m -90.99 143.35 26.81 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.694 0.283 . . . . 0.0 110.54 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 65.3 p -129.91 124.77 33.94 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.311 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -94.22 -10.09 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.498 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 153' ' ' GLU . 1.5 mp0 -51.34 101.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -89.21 17.22 6.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.949 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.491 ' N ' ' OE1' ' A' ' 46' ' ' GLN . 63.6 mmtt -58.47 162.18 3.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.496 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 168.87 8.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.73 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.6 p -97.38 148.89 22.71 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.495 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 85.2 m-20 -117.21 91.11 3.48 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.4 pt -102.65 177.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.141 0.496 . . . . 0.0 111.232 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' HG2' ' H ' ' A' ' 162' ' ' HIS . 0.0 OUTLIER -105.88 -171.39 1.89 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.995 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -127.32 -6.01 5.95 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.475 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 37.1 m80 -108.88 129.05 24.38 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.895 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -39.18 157.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.176 1.917 . . . . 0.0 112.807 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.21 143.91 12.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.173 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.39 116.33 22.99 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.891 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.02 172.68 49.85 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.624 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 169' ' ' ILE . 11.4 m -105.18 8.88 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.932 0.396 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.8 m-20 59.24 -3.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 167' ' ' SER . 56.4 mt -86.96 154.3 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.406 ' N ' HG22 ' A' ' 169' ' ' ILE . 53.9 p -118.33 135.52 54.26 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.512 ' NE2' ' OG ' ' A' ' 196' ' ' SER . 0.1 OUTLIER -73.55 39.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.765 0.317 . . . . 0.0 111.583 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -67.12 179.89 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.15 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -90.97 122.02 33.29 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -146.43 -160.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 174' ' ' VAL . 42.8 t -50.81 140.83 14.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.138 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.451 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 43.7 p90 -104.95 139.86 39.04 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 11.3 tm-20 -161.22 146.21 13.79 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.874 0.369 . . . . 0.0 110.481 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.437 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 41.8 t0 -66.94 104.17 1.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.859 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 79.4 mt -114.19 -23.86 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.361 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 215' ' ' PHE . 17.9 pt -90.91 137.95 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.02 0.438 . . . . 0.0 110.876 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.38 -134.47 7.05 Favored Glycine 0 C--N 1.331 0.291 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.7 t -71.59 154.78 41.19 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.314 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.415 ' C ' HD12 ' A' ' 184' ' ' ILE . 84.8 m -149.74 94.54 2.19 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.7 mp -97.39 138.11 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.61 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 185' ' ' VAL . 1.5 m -140.92 123.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.032 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.46 ' OD2' ' SG ' ' A' ' 150' ' ' CYS . 34.6 p-10 -79.39 110.23 14.49 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.2 m -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.238 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -34.97 -46.17 0.3 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.09 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 26.5 p -143.09 40.29 1.49 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.299 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 40.4 t -149.4 96.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -80.12 -58.93 2.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.137 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.432 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 36.3 t-20 -127.28 137.65 52.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.118 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.432 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 7.7 tt -138.61 106.67 5.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 110.934 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -93.48 140.25 29.8 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.444 ' CZ ' HG13 ' A' ' 28' ' ' VAL . 34.1 t80 -137.77 133.43 34.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.993 0.425 . . . . 0.0 111.259 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 171' ' ' HIS . 1.2 t -144.02 144.25 31.56 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.934 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.558 HG22 ' N ' ' A' ' 198' ' ' ARG . 2.7 p -139.43 166.62 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.937 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.558 ' N ' HG22 ' A' ' 197' ' ' VAL . 21.3 ttt180 -169.35 111.27 0.48 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.783 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.433 HD11 ' SG ' ' A' ' 142' ' ' CYS . 25.6 mt -102.37 122.86 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -163.24 -161.28 12.3 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -78.86 137.71 37.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.875 0.369 . . . . 0.0 110.496 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.462 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 22.6 mtp -92.09 -6.37 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.258 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 68.8 m -101.45 -57.8 2.01 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.544 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -155.22 136.03 13.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.21 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -42.72 158.3 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.198 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 9.6 t -147.15 6.56 0.88 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.685 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.504 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.2 m 58.44 -75.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.642 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.0 mt-10 -47.84 -48.85 30.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.867 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 209' ' ' LEU . 10.2 mp -83.23 0.42 45.58 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.439 0.163 . . . . 0.0 111.439 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 207' ' ' SER . 10.0 mp0 -95.72 118.03 31.63 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.96 163.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.077 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.414 ' HD3' ' H ' ' A' ' 174' ' ' VAL . 12.2 ptmt -164.28 168.01 19.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.573 0.701 . . . . 0.0 112.188 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.7 t70 -141.53 171.33 14.21 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.861 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 173.13 148.13 6.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.145 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.409 ' CD1' HD11 ' A' ' 180' ' ' ILE . 8.8 m-85 -139.62 174.22 10.74 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 45.2 mttm -139.17 104.14 4.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.964 0.411 . . . . 0.0 110.592 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.57 116.8 30.47 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.477 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 218' ' ' VAL . 11.8 p -140.65 118.88 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.391 0.615 . . . . 0.0 110.959 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 15.5 t70 48.25 43.04 18.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.769 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.32 -3.9 85.09 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.469 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 40.1 t -100.4 116.7 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 117.027 0.413 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.77 150.55 23.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 70.9 m -166.24 128.43 1.89 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.455 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -77.61 141.5 39.44 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.86 101.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.267 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.28 98.02 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.3 p -129.28 160.09 34.09 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.405 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -63.32 95.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.419 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -89.95 35.92 0.85 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.608 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 40.6 p -71.51 -45.22 63.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 233' ' ' ILE . 44.4 t -94.34 -1.9 53.03 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 53.5 tp -42.15 -20.53 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.757 0.313 . . . . 0.0 111.108 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.561 ' C ' HD12 ' A' ' 233' ' ' ILE . 2.2 pp -149.16 174.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.329 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -103.93 93.87 5.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.004 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 82.3 p -66.18 -6.2 12.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 60.0 p -91.78 -17.21 25.7 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -105.05 4.71 31.85 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 238' ' ' LEU . 0.3 OUTLIER -76.18 161.15 29.05 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.159 0.504 . . . . 0.0 110.863 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.427 ' HA ' ' HZ1' ' A' ' 160' ' ' LYS . 2.1 mppt? -144.6 129.73 18.58 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.962 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.469 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . . . -57.66 155.75 9.46 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 48' ' ' VAL . 28.3 t -119.2 -3.85 10.55 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.62 179.725 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.719 0.295 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.41 115.52 4.37 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.604 2.203 . . . . 0.0 111.628 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 5.4 tpt -65.55 145.39 56.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.403 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.43 -176.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.979 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 31.8 t -130.15 125.78 35.89 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.741 0.305 . . . . 0.0 110.253 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 12.5 t70 48.37 74.73 0.76 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.475 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.531 ' O ' ' O ' ' B' ' 8' ' ' PRO . 62.4 Cg_endo -86.9 161.96 8.95 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.87 2.38 . . . . 0.0 111.018 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.578 ' C ' HG22 ' B' ' 9' ' ' THR . 28.6 Cg_exo -38.18 -122.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.802 3.002 . . . . 0.0 114.743 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.578 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 157.23 68.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.45 82.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.308 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.4 m -119.1 128.37 54.24 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 15.8 p -71.21 135.2 47.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.218 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -110.34 -15.48 13.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.569 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 75.7 m -122.98 147.24 46.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.316 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.487 ' CE2' ' OD1' ' B' ' 53' ' ' ASP . 16.8 m-85 -118.89 153.6 34.3 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.244 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -78.97 134.88 36.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.905 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.66 27.94 4.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.788 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.02 126.64 21.89 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.943 0.401 . . . . 0.0 110.657 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -57.51 164.01 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.03 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.91 89.95 33.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -41.91 142.87 1.32 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.737 1.625 . . . . 0.0 111.987 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -42.9 -48.51 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.45 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -37.72 -34.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -107.54 42.4 1.34 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.675 0.274 . . . . 0.0 111.227 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 16.5 t -144.44 86.84 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.038 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.54 -28.54 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 26.7 t0 -157.83 -179.77 8.46 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.648 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.48 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.4 p90 -163.06 169.06 20.07 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.233 0.539 . . . . 0.0 112.071 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.484 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 55.7 t80 -159.06 164.45 35.4 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.132 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.6 pt-20 -114.38 152.21 31.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.72 0.295 . . . . 0.0 110.588 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.426 ' O ' ' O ' ' B' ' 30' ' ' GLU . 36.3 p -55.69 -116.1 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.078 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.9 m -149.43 -156.07 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.793 0.33 . . . . 0.0 110.473 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.451 ' C ' ' H ' ' B' ' 35' ' ' CYS . 75.2 m -126.09 -24.62 3.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.343 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.4 mm? -53.09 -9.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.227 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.451 ' H ' ' C ' ' B' ' 33' ' ' SER . 4.1 p -120.13 123.65 43.85 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 15.6 m -74.57 42.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.364 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -166.31 56.86 0.42 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 59.8 Cg_endo -67.97 -161.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.477 0.523 0 C-N-CA 122.795 2.33 . . . . 0.0 113.013 -178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 167.83 177.39 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.67 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.77 134.07 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.137 0.494 . . . . 0.0 110.063 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 24.1 t -111.94 141.83 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.474 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -119.33 150.32 40.34 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.683 0.277 . . . . 0.0 110.649 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -115.63 112.13 21.67 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 109.788 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 4.7 p -75.62 -138.21 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.027 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.485 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -131.02 -32.22 1.64 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.062 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.39 40.5 3.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.043 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 27.4 t -142.94 -83.35 0.17 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 121.378 -0.129 . . . . 0.0 110.704 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.58 -90.73 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.704 0.627 . . . . 0.0 109.612 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.4 ' OE1' ' O ' ' B' ' 48' ' ' ALA . 15.4 mm100 -141.11 135.98 31.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.789 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.5 t -148.57 124.0 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.424 0.631 . . . . 0.0 110.26 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' B' ' 39' ' ' ALA . 2.3 t -72.35 155.57 40.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.468 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 135.24 17.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.271 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.487 ' OD1' ' CE2' ' B' ' 15' ' ' TYR . 60.9 m-20 -63.86 128.16 92.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.237 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.25 0.6 9.23 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.423 1.415 . . . . 0.0 110.889 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 71.0 m -70.57 -12.55 61.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.198 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -96.46 129.21 43.87 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.189 0.519 . . . . 0.0 110.205 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 31.9 t -48.75 -51.97 26.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.041 -178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -56.5 -32.46 65.07 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.001 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.98 -35.89 76.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.819 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -73.95 -37.84 64.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.628 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.4 -36.91 79.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.859 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -63.7 -36.68 84.66 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.64 -42.83 86.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.493 ' CE1' ' OE2' ' B' ' 67' ' ' GLU . 57.4 t80 -62.67 -34.17 76.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.472 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -70.05 -48.35 58.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.9 -19.62 66.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.493 ' OE2' ' CE1' ' B' ' 64' ' ' TYR . 0.1 OUTLIER -71.77 -32.69 67.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.1 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.813 HD23 ' N ' ' B' ' 69' ' ' ASN . 7.5 tt -83.66 -79.51 0.2 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.813 ' N ' HD23 ' B' ' 68' ' ' LEU . 49.3 t30 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.51 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.5 mmt . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 1' ' ' MET . 78.0 Cg_exo -51.76 -173.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.982 1.788 . . . . 0.0 111.982 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.02 172.77 2.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.595 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.9 t -61.1 -38.65 87.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.541 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 pp -172.24 159.1 4.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.532 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -149.58 -177.5 5.9 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.559 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -59.86 137.5 58.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.585 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -76.41 -7.38 54.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 m -76.87 -19.49 57.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.821 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -50.08 141.24 11.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.615 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.8 p -68.96 -5.77 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.64 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.9 p -101.86 -18.31 15.79 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.563 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.9 m -86.75 -48.85 7.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.089 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -156.71 177.1 11.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.012 0.434 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.71 141.78 39.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.613 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -61.39 166.67 3.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.884 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.4 9.71 12.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.017 0.437 . . . . 0.0 109.903 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 21' ' ' LYS . 49.9 mt-10 -86.02 91.5 8.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -33.98 -41.73 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.812 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -80.6 25.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.532 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.4 mmtp -138.43 136.52 36.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.847 0.356 . . . . 0.0 110.08 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.578 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 27.9 m170 -130.92 135.33 47.57 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.122 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -80.62 102.8 10.05 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ptt? -66.41 175.56 2.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.268 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' HD12 ' A' ' 199' ' ' ILE . . . 166.39 126.77 0.85 Allowed Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 tt -109.91 150.34 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.876 0.37 . . . . 0.0 110.454 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.419 ' CB ' HD11 ' A' ' 169' ' ' ILE . 7.5 t70 -132.86 141.82 48.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -137.66 97.47 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.8 0.334 . . . . 0.0 111.246 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.1 mm -91.69 136.43 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.402 HD11 ' SD ' ' A' ' 90' ' ' MET . 2.0 pp -143.15 126.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.33 0.586 . . . . 0.0 111.501 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -115.82 126.87 54.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.76 133.21 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.744 0.307 . . . . 0.0 111.383 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -105.79 130.72 53.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -80.42 155.09 27.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.232 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -66.88 179.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -77.85 -31.34 51.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.707 0.289 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.38 -34.01 31.95 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.218 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 p -40.98 104.96 0.36 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -44.5 164.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.9 1.733 . . . . 0.0 111.941 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 p -68.21 145.87 53.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.745 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.509 HD22 ' C ' ' A' ' 41' ' ' ASN . 0.3 OUTLIER -171.64 97.01 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.354 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -103.02 0.09 31.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.653 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -65.1 87.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.402 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.45 ' CG2' ' HB2' ' A' ' 107' ' ' ALA . 20.8 pt -85.07 150.79 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.75 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.501 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 39.2 t 57.18 64.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.644 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.526 HE22 ' C ' ' A' ' 156' ' ' ASP . 37.8 mm-40 -77.29 -26.89 52.76 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 t 174.29 164.63 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.72 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 t -144.21 139.04 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.73 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.2 m -136.54 102.71 5.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.811 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -82.3 126.24 31.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.338 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.431 HD12 ' CE2' ' A' ' 80' ' ' TYR . 7.7 mt -126.07 152.83 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.735 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -153.8 137.94 16.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 54' ' ' SER . 1.4 tm-20 -52.95 -176.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.917 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.5 ' N ' ' OE1' ' A' ' 53' ' ' GLU . 31.1 t -55.2 -24.77 28.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 56' ' ' SER . 0.8 OUTLIER 50.38 178.23 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.524 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 36.1 t -91.66 59.08 3.67 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.623 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 59' ' ' ASP . 67.7 m-20 -159.22 141.47 10.04 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.505 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -42.49 89.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.835 1.69 . . . . 0.0 112.736 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.1 p30 -179.57 59.6 0.11 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.807 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.02 74.39 5.58 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.592 2.194 . . . . 0.0 111.6 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -58.99 -48.25 82.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.38 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 63' ' ' GLU . 60.6 t -85.24 -64.27 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 62' ' ' VAL . 13.5 tt0 88.05 168.18 0.05 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.064 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 1.5 t 165.02 -17.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 67' ' ' ASP . 4.8 tm-20 -156.92 147.0 20.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.838 0.351 . . . . 0.0 110.57 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.455 ' N ' ' CD ' ' A' ' 65' ' ' GLU . 33.1 t70 -58.58 -70.09 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.104 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.499 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 10.7 m-20 -158.74 167.03 30.58 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.56 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.0 p -156.92 158.31 36.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.403 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 84.9 m -140.83 -45.22 0.39 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.629 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 72' ' ' GLU . 84.8 p 50.89 -161.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.456 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -75.21 29.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.735 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 70' ' ' SER . 41.9 mt-10 55.13 76.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.687 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -164.28 21.66 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 m -58.28 114.06 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.066 0.46 . . . . 0.0 110.219 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -66.37 150.57 97.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.952 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.89 155.97 48.24 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.908 1.738 . . . . 0.0 111.485 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -79.89 -143.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.511 2.14 . . . . 0.0 111.388 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.6 t -139.43 144.82 38.25 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.731 0.3 . . . . 0.0 110.897 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.469 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 1.6 p -105.35 130.92 53.35 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -123.79 111.63 16.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.74 0.305 . . . . 0.0 110.91 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.2 120.38 40.36 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 t -91.16 77.82 5.93 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.632 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.32 106.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 tt -98.08 146.96 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.116 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.63 173.37 20.68 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.08 18.37 26.9 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.341 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.15 3.53 88.4 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.095 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.9 mt -129.88 158.07 40.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.913 0.387 . . . . 0.0 110.337 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -126.02 113.09 16.66 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.53 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.493 ' C ' HD22 ' A' ' 91' ' ' ASN . 16.7 mtt -101.91 111.39 23.63 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.766 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.69 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.7 OUTLIER -99.84 124.52 45.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.755 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -102.17 -167.09 1.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.565 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.03 71.91 0.05 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.912 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.2 OUTLIER -77.68 148.29 35.06 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.227 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.576 HG21 ' HE ' ' B' ' 18' ' ' ARG . 41.9 m -136.02 114.28 11.55 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.484 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.6 tttt 64.27 40.18 6.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.97 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.6 m -124.59 149.72 62.82 Favored Pre-proline 0 N--CA 1.471 0.607 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -37.79 147.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.068 1.845 . . . . 0.0 112.431 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -74.85 109.91 8.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 pp -67.21 133.51 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.086 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 -13.59 6.77 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.544 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 t -105.6 121.81 44.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.922 0.391 . . . . 0.0 110.835 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 9.5 mt -135.37 121.01 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.572 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 10.9 t -137.63 178.22 7.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 111.017 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.501 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 55.3 tt0 -161.68 154.44 20.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.428 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.31 149.83 27.35 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.53 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.45 ' HB2' ' CG2' ' A' ' 44' ' ' ILE . . . -132.68 133.46 43.58 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.879 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -148.68 115.15 5.91 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.251 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.83 -104.5 1.55 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.209 -0.519 . . . . 0.0 111.941 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -129.35 24.84 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 110.349 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.68 159.22 40.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.628 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.38 138.25 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.69 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.681 HD22 ' H ' ' A' ' 114' ' ' ALA . 1.7 t-20 -116.88 147.06 42.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.537 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.681 ' H ' HD22 ' A' ' 113' ' ' ASN . . . -143.19 129.76 20.19 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.873 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -115.26 115.41 26.62 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.121 0.486 . . . . 0.0 111.459 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.794 ' N ' HD12 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -115.88 120.5 39.41 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 t -159.09 -178.83 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.206 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.2 p -91.82 159.66 15.69 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.45 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.4 p -94.88 147.16 5.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.045 0.45 . . . . 0.0 111.528 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.5 p -87.39 152.1 51.9 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.729 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -61.32 162.89 18.83 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 121.943 1.762 . . . . 0.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.79 -1.51 58.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.99 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -81.05 -56.08 4.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.547 0.213 . . . . 0.0 110.55 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 152.17 -9.02 0.6 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.638 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -113.85 175.67 5.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -77.14 152.01 35.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.116 0.484 . . . . 0.0 111.265 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.5 m -154.38 63.2 4.02 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.65 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.54 151.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.061 2.507 . . . . 0.0 113.273 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.08 150.2 41.56 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.113 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.495 HD11 ' OE2' ' A' ' 134' ' ' GLU . 7.7 tp -144.82 164.57 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.554 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 48.6 p -68.91 171.62 7.76 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.239 0.543 . . . . 0.0 111.436 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.578 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 5.0 m170 -68.07 -33.79 75.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.171 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -55.51 -57.19 12.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.845 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.495 ' OE2' HD11 ' A' ' 130' ' ' ILE . 47.8 mt-10 -62.95 -42.98 99.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.607 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -57.02 11.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.952 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.14 -34.52 66.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.933 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.14 -30.44 65.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.414 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.3 mtt -74.33 -61.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.634 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 10.0 pt -47.24 -21.8 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.663 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -82.54 -30.61 29.61 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.27 -28.09 13.16 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 48.6 t -49.54 119.21 3.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.888 0.375 . . . . 0.0 111.313 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -137.0 118.03 14.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.99 125.34 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.8 t -100.79 158.21 16.14 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.129 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.7 mm -140.76 143.91 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.912 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.411 ' OD1' HD13 ' A' ' 184' ' ' ILE . 3.2 m-20 -152.32 88.83 1.39 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 mt -85.93 148.41 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.013 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -148.41 178.41 8.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.481 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.0 t -91.75 125.14 36.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.374 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.5 t -109.54 162.23 14.59 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 152' ' ' GLU . 27.0 mp0 -139.7 19.12 2.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.62 0.247 . . . . 0.0 110.939 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.3 OUTLIER -75.86 103.28 5.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.273 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -82.98 8.7 11.95 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.171 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 4.0 mptp? -52.81 173.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.526 ' C ' HE22 ' A' ' 46' ' ' GLN . 28.0 m-20 -81.66 171.42 14.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.577 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.9 m -95.12 143.62 26.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.462 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 77.8 m-20 -114.78 92.72 4.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.755 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 160' ' ' LYS . 96.6 mt -123.47 163.14 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.56 ' N ' HG22 ' A' ' 159' ' ' ILE . 21.7 pttm -125.12 138.43 54.17 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.62 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 161' ' ' THR . 54.2 m -65.09 6.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.554 ' ND1' ' N ' ' A' ' 162' ' ' HIS . 0.2 OUTLIER -76.18 117.62 65.44 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.434 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.87 158.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.661 1.574 . . . . 0.0 111.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 164' ' ' VAL . 13.7 p -78.75 128.77 38.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.964 0.411 . . . . 0.0 110.829 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.8 mt -80.0 112.15 17.02 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.182 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.69 171.07 40.97 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.526 -0.369 . . . . 0.0 112.509 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 169' ' ' ILE . 5.8 t -103.8 8.9 37.16 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.007 0.432 . . . . 0.0 109.91 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 60.48 -5.87 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.95 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.486 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.2 pp -80.38 164.07 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 120.759 -0.377 . . . . 0.0 109.991 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.446 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 6.1 t -126.82 130.64 50.64 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -72.45 37.86 0.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.813 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 170' ' ' SER . 49.4 pttt -66.64 -173.4 0.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.004 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.04 119.83 35.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.0 110.715 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.523 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 0.2 OUTLIER -142.08 -166.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.443 ' H ' HG12 ' A' ' 174' ' ' VAL . 22.4 m -50.89 145.32 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.853 0.359 . . . . 0.0 110.551 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -98.25 131.37 44.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.738 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -142.57 114.66 8.26 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.901 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.8 OUTLIER -61.77 99.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.856 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 5.2 pt -123.52 6.7 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.346 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.451 HD12 ' OD2' ' A' ' 213' ' ' ASP . 82.6 mt -100.6 113.61 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.97 -137.67 0.41 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.994 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.536 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 6.1 t -72.81 158.45 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.5 p -143.59 90.02 2.12 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.411 HD13 ' OD1' ' A' ' 147' ' ' ASP . 4.8 mp -96.91 128.03 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 121.099 0.476 . . . . 0.0 109.76 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 185' ' ' VAL . 33.7 m -145.38 123.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.157 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 190' ' ' VAL . 48.8 t0 -82.65 109.52 16.91 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.11 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 28.1 m -45.93 -27.06 0.81 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.506 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -34.58 -38.37 0.07 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.199 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 79.7 m -142.15 31.32 1.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 190' ' ' VAL . 28.4 m -155.9 103.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.127 0.489 . . . . 0.0 110.65 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -75.49 -56.2 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.641 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 217' ' ' TYR . 7.4 t-20 -115.07 171.46 7.65 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 192' ' ' ASN . 0.3 OUTLIER 179.45 105.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.128 0.49 . . . . 0.0 109.804 179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.62 142.07 36.87 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.347 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -127.99 142.74 51.15 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.595 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 5.9 p -143.51 136.68 27.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.469 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.1 t -131.42 158.38 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.446 ' CD ' ' O ' ' A' ' 170' ' ' SER . 14.1 ttt85 -166.3 106.6 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.251 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.443 HD12 ' O ' ' A' ' 25' ' ' GLY . 2.3 tp -109.42 124.46 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -167.96 -151.97 7.32 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -91.86 118.57 30.85 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.534 ' H ' ' HG3' ' A' ' 202' ' ' MET . 0.0 OUTLIER -84.61 4.83 30.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.445 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 1.3 m -99.63 -50.73 3.97 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -161.36 127.81 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.708 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -43.64 145.86 0.6 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.1 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.518 ' H ' ' CD ' ' A' ' 210' ' ' GLU . 3.2 t -131.6 5.99 4.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.488 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.491 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 12.4 t 58.31 -76.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.662 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 206' ' ' SER . 50.5 mt-10 -48.81 -50.19 35.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.774 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.0 mp -80.63 0.84 32.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.243 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 206' ' ' SER . 13.6 mp0 -101.67 124.85 48.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.837 0.351 . . . . 0.0 110.801 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 11.3 m -141.96 -178.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.523 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 16.8 ptmt -165.54 167.79 17.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.531 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.451 ' OD2' HD12 ' A' ' 180' ' ' ILE . 44.3 t0 -159.59 169.61 23.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.982 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 146.69 140.25 3.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.24 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -119.69 -168.94 1.68 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -144.98 110.0 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.523 ' O ' ' ND2' ' A' ' 192' ' ' ASN . 97.7 m-85 -103.41 122.07 44.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.103 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 218' ' ' VAL . 28.9 m -135.8 117.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.191 0.52 . . . . 0.0 110.583 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 1.1 m-20 51.87 42.33 30.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.486 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.27 -0.71 87.22 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.4 -0.429 . . . . 0.0 113.145 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.0 m -97.49 117.03 30.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.935 0.368 . . . . 0.0 110.158 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.58 159.14 17.33 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.483 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 65.8 m -168.13 110.43 0.59 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.24 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -78.51 141.75 37.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.62 123.14 0.78 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.573 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.07 103.96 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.326 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 61.2 p -129.83 151.76 50.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 228' ' ' ASP . 0.8 OUTLIER -51.16 95.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.799 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -90.69 27.32 1.79 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 30.2 m -74.0 -32.49 63.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.97 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 233' ' ' ILE . 13.9 m -103.12 -3.91 25.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.204 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.527 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -40.79 -27.84 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.095 0.474 . . . . 0.0 110.749 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.682 ' H ' HD13 ' A' ' 233' ' ' ILE . 0.0 OUTLIER -144.01 -177.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.585 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 236' ' ' THR . 12.3 m-20 -118.51 91.93 3.69 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 13.1 m -62.22 1.51 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.291 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 234' ' ' ASP . 44.6 p -90.24 -22.9 21.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.36 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -102.87 6.66 39.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.607 0.241 . . . . 0.0 111.049 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.82 138.26 32.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.947 0.403 . . . . 0.0 110.269 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 104' ' ' SER . 46.5 mttm -126.43 142.55 51.49 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.039 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.07 167.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 242' ' ' VAL . 40.7 t -132.39 -11.51 3.18 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.491 ' OXT' HG22 ' A' ' 242' ' ' VAL . 13.4 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.164 -1.398 . . . . 0.0 111.295 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.733 0.301 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.78 118.9 3.88 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.644 2.229 . . . . 0.0 111.868 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . 0.457 ' O ' ' SD ' ' B' ' 3' ' ' MET . 0.0 OUTLIER -56.65 142.49 39.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.472 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.52 161.12 52.69 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.162 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.417 ' O ' ' N ' ' B' ' 7' ' ' PRO . 16.3 t -70.17 169.95 12.56 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.513 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' B' ' 5' ' ' SER . 34.5 t70 -21.0 84.7 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 21.1 Cg_exo -65.85 -173.6 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.463 2.109 . . . . 0.0 111.751 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 74.5 Cg_exo -54.34 -132.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 123.322 2.681 . . . . 0.0 113.215 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.485 ' O ' ' N ' ' B' ' 11' ' ' CYS . 2.8 t 177.73 45.06 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.503 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.32 93.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.762 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.516 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 94.1 m -137.27 128.07 27.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.099 0.476 . . . . 0.0 111.34 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 t -39.71 135.82 1.14 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.638 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.516 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 12.4 m-85 -117.17 -25.85 6.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.317 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -151.94 150.77 30.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.423 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -107.81 157.59 18.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -78.79 135.8 37.19 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.08 24.82 2.0 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.69 0.281 . . . . 0.0 110.388 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.576 ' HE ' HG21 ' A' ' 95' ' ' THR . 0.0 OUTLIER -145.75 127.88 15.66 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 110.74 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -79.0 122.19 25.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.612 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 tp -90.54 111.0 45.09 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -42.79 148.45 0.48 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.857 1.705 . . . . 0.0 112.478 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 18.7 mtp-105 -47.27 -47.45 25.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.545 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -37.36 -34.73 0.1 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.539 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 2.4 m-85 -106.78 44.32 1.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.495 0.188 . . . . 0.0 110.926 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 t -149.22 95.87 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 m -83.78 -25.9 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -168.67 170.82 9.18 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.408 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -124.2 163.58 21.28 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.95 0.881 . . . . 0.0 112.369 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -154.99 134.87 12.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 113.942 -1.481 . . . . 0.0 108.514 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.406 ' O ' ' O ' ' B' ' 31' ' ' THR . 18.4 pt-20 -99.43 148.96 23.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.257 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 30' ' ' GLU . 46.9 p -55.03 -112.39 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 7.0 m -150.28 -141.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.701 0.286 . . . . 0.0 110.597 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 35' ' ' CYS . 26.1 t -143.04 -24.42 0.61 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.467 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -58.12 -6.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.438 ' H ' ' C ' ' B' ' 33' ' ' SER . 22.0 m -114.91 118.58 33.87 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.549 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -73.12 38.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.392 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -165.74 58.99 0.57 Allowed Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.81 -170.48 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.721 2.281 . . . . 0.0 113.25 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -178.24 176.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 49.4 t -109.49 129.81 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.59 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 t -109.6 128.84 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.064 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.425 ' C ' ' NE2' ' B' ' 43' ' ' GLN . 30.5 p90 -107.93 145.88 33.18 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.211 0.529 . . . . 0.0 111.225 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.594 ' NE2' ' N ' ' B' ' 43' ' ' GLN . 1.7 mp0 -93.34 170.17 9.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.403 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 9.8 p -140.1 -143.22 0.15 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.202 0.525 . . . . 0.0 111.233 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.403 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -125.79 -38.57 2.2 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.854 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.65 2.28 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.88 -0.145 . . . . 0.0 111.197 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 23.3 t -153.54 -82.24 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.458 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.05 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.418 0.449 . . . . 0.0 109.908 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -140.96 147.76 39.29 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.7 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 25.1 t -151.62 117.95 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 110.876 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.536 ' H ' ' CB ' ' A' ' 182' ' ' SER . 22.9 t -52.13 157.99 1.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.19 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.47 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.45 127.91 8.55 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -68.57 123.81 88.58 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.04 0.36 8.48 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.279 1.319 . . . . 0.0 111.271 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -66.57 -13.82 61.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.097 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -100.07 123.46 44.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.022 0.439 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 16.4 m -50.8 -38.35 47.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.965 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -56.72 -33.23 66.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.224 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.22 -35.31 57.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.111 0.482 . . . . 0.0 110.195 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -73.35 -39.9 64.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.845 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -69.5 -38.66 77.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.216 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -63.11 -39.95 96.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.954 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.01 -42.58 79.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.938 0.399 . . . . 0.0 110.117 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -63.74 -21.72 66.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.99 -36.38 36.08 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.96 -19.42 37.19 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.361 -0.536 . . . . 0.0 109.667 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.57 -35.47 77.42 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.01 -70.25 0.42 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.919 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.575 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' O ' ' A' ' 2' ' ' PRO . 40.4 mtt . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.793 0.33 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 1' ' ' MET . 76.0 Cg_exo -49.88 -172.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.474 0.356 0 C-N-CA 122.737 2.291 . . . . 0.0 112.221 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.5 -151.91 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.437 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.5 t -170.03 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.627 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 2.3 mm? -70.3 157.21 38.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.093 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -164.95 83.17 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.416 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -144.93 -160.6 1.15 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.4 t -167.39 -11.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.545 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.3 m -75.39 -34.48 61.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.583 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.4 p -50.21 125.71 13.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.519 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.2 m -55.66 -20.31 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.769 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.7 m -75.59 -27.6 58.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.565 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.7 t -82.62 -39.73 21.77 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 p -166.07 172.99 10.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 0.0 110.698 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.6 t -72.75 155.92 39.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.623 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.6 p -71.94 171.92 10.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.766 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -121.19 5.44 10.29 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.333 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 20' ' ' ASN . 43.2 mm-40 -80.88 91.88 6.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 2.9 pm0 -32.42 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.982 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 18' ' ' GLU . 23.0 p-10 -95.49 38.65 1.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.565 0.221 . . . . 0.0 111.308 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -154.1 139.31 17.49 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.533 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -135.54 158.97 43.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.213 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.459 ' CE1' ' CE ' ' A' ' 202' ' ' MET . 0.9 OUTLIER -96.53 76.88 2.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.453 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 24' ' ' MET . 3.8 mpp? -57.04 117.31 3.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.503 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -120.98 149.72 17.35 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.888 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -111.57 135.14 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.559 ' N ' HD13 ' A' ' 26' ' ' ILE . 63.2 t0 -140.46 137.82 34.2 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.495 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 11.5 t -138.66 142.78 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.046 0.451 . . . . 0.0 110.836 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.5 mm -133.01 132.61 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.248 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.43 135.31 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.178 0.513 . . . . 0.0 110.831 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -121.12 94.67 4.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.552 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.95 112.52 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.038 -178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 p -86.42 127.81 34.88 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.518 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' CB ' ' NZ ' ' A' ' 34' ' ' LYS . 5.0 mtpm? -80.37 151.76 29.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.138 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -70.73 164.21 25.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.71 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.01 -35.49 80.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.272 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.439 ' N ' ' CD ' ' A' ' 37' ' ' GLN . 4.4 mp0 -75.34 -35.17 61.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.023 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.6 m -44.14 106.9 0.55 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.245 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.422 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 92.6 Cg_exo -43.79 161.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 121.817 1.678 . . . . 0.0 112.021 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 64.3 p -70.06 148.7 48.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 5.4 p30 -173.49 102.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.412 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -103.1 -4.29 24.72 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.204 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.502 ' C ' HE22 ' A' ' 46' ' ' GLN . 11.0 ptpt -64.93 89.39 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.409 0.623 . . . . 0.0 110.242 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 45' ' ' CYS . 6.1 mm -96.3 164.1 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.807 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.499 ' N ' HG22 ' A' ' 44' ' ' ILE . 90.1 m 58.82 49.38 10.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.639 ' N ' HE21 ' A' ' 46' ' ' GLN . 0.0 OUTLIER -65.87 -44.36 85.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.861 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.3 t -167.7 176.8 6.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.201 0.524 . . . . 0.0 111.461 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.88 103.17 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.717 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.9 p -103.92 96.82 6.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.527 0.204 . . . . 0.0 111.178 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.27 142.27 32.23 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.427 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 79' ' ' THR . 7.2 mt -144.51 151.2 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.938 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.5 m -151.47 144.98 24.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' CD ' ' CE1' ' B' ' 24' ' ' PHE . 29.5 mt-10 -52.15 179.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.184 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -65.72 -34.75 78.92 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.24 90.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.729 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 p 175.14 -96.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.173 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.889 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 28.9 t70 -169.48 -4.65 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.889 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 97.5 Cg_endo -79.4 -98.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 CA-C-N 122.02 1.757 . . . . 0.0 111.906 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' H ' ' HD2' ' A' ' 60' ' ' PRO . 4.2 m-20 -155.13 -59.14 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.433 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HD2' ' H ' ' A' ' 59' ' ' ASP . 23.1 Cg_exo -19.86 112.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 123.711 2.941 . . . . 0.0 114.009 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' N ' ' CD ' ' A' ' 61' ' ' GLU . 30.0 mp0 -100.14 -145.03 0.34 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.531 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.74 HG22 ' N ' ' A' ' 63' ' ' GLU . 1.2 p -165.55 -98.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.74 ' N ' HG22 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -125.01 82.33 2.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.1 t 60.01 -172.04 0.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.635 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -147.3 84.05 1.57 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.954 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -156.3 46.42 0.45 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.541 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -59.12 -67.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.599 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.8 m 62.87 -149.8 0.35 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.598 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 t 33.63 65.87 0.26 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.903 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 71' ' ' VAL . 44.1 t -167.04 167.35 14.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.375 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 72' ' ' GLU . 21.9 m -157.21 -46.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.522 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 71' ' ' VAL . 49.6 tt0 -46.59 -95.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.217 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 165.24 84.25 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.13 103.96 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.132 0.491 . . . . 0.0 110.581 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -166.14 67.24 1.05 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.544 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -89.02 110.6 0.52 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.199 2.6 . . . . 0.0 111.95 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -87.58 163.36 7.96 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.164 1.909 . . . . 0.0 112.39 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 38.7 p -123.75 126.9 47.32 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.452 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 51' ' ' ILE . 6.9 m -102.87 126.23 49.93 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -126.46 119.6 27.61 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -112.54 121.17 44.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.62 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.4 t -90.58 78.43 6.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.296 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 83' ' ' ILE . 3.1 tp -71.72 114.41 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.068 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 pt -102.14 144.63 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.87 166.64 16.83 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.43 21.82 49.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.661 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.64 14.96 79.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.129 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.4 mt -133.18 157.24 45.85 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.102 0.477 . . . . 0.0 110.676 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -124.53 105.92 9.75 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.266 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -101.25 123.23 45.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.067 0.46 . . . . 0.0 111.06 -179.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -106.64 128.41 54.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 25.5 m-85 -100.11 -169.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.257 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.01 67.84 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.422 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.486 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.51 145.84 36.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.256 0.528 . . . . 0.0 110.182 -179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.9 m -132.2 102.6 5.85 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.529 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt 70.85 45.31 0.55 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.337 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.5 m -124.23 149.64 61.41 Favored Pre-proline 0 N--CA 1.47 0.534 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.53 142.72 0.26 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.878 1.719 . . . . 0.0 112.228 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -55.06 143.86 25.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.338 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 tp -98.01 135.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HZ2' ' H ' ' A' ' 126' ' ' ASP . 87.6 mttt -145.5 -7.66 0.59 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.921 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.1 p -111.02 111.1 21.97 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.2 tp -127.09 114.08 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.5 t -142.33 161.11 38.88 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.304 0.573 . . . . 0.0 112.067 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -155.42 173.22 16.98 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.72 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.8 t -170.65 165.24 8.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.039 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.42 136.61 46.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.928 0.394 . . . . 0.0 110.292 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -143.94 110.97 5.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.023 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.15 -91.0 0.36 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -142.86 21.33 1.97 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.5 m -114.69 138.42 50.72 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.787 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.33 120.58 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.841 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' HD11 ' A' ' 233' ' ' ILE . 23.7 m-20 -104.42 164.63 11.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.829 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -168.43 125.2 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.11 0.481 . . . . 0.0 111.073 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -113.82 114.36 26.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.633 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.424 HD12 ' CE2' ' A' ' 81' ' ' TYR . 2.5 mm? -110.41 118.79 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.2 t -161.55 173.12 15.24 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.507 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 94.0 p -89.4 170.5 10.48 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.824 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.84 133.16 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 121.003 0.43 . . . . 0.0 111.259 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.15 164.06 39.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.87 144.29 43.03 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.162 1.908 . . . . 0.0 111.406 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.03 9.13 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -126.4 -51.82 1.5 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.97 0.47 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.096 -0.574 . . . . 0.0 112.642 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -108.39 -178.54 3.63 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 2.2 m-20 -63.96 -179.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.895 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.0 m -171.29 59.76 0.3 Allowed Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.416 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.11 146.11 0.4 Allowed 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.465 2.11 . . . . 0.0 112.654 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.43 127.07 20.31 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 131' ' ' THR . 5.1 mm -132.8 167.55 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 110.109 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.502 ' H ' HG22 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -69.17 166.04 19.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.931 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -59.15 -33.96 71.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.556 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -51.51 -51.96 50.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.819 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 138' ' ' MET . 8.5 tp10 -66.52 -47.79 71.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.755 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.16 -57.77 8.61 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.412 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.9 mt -51.3 -42.29 61.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.08 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.71 -21.07 59.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.593 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.3 ttt -79.05 -64.19 1.24 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.94 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.953 HD13 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -54.55 -20.9 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.919 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.953 ' N ' HD13 ' A' ' 139' ' ' ILE . 56.0 tttp -74.3 -33.42 63.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.5 ' OD2' ' NE ' ' B' ' 18' ' ' ARG . 12.3 t70 -102.72 -21.33 14.11 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.5 t -51.64 119.83 4.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.65 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -138.65 125.55 21.12 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.24 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 t -120.23 125.89 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -101.75 164.67 11.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.102 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.37 146.92 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.896 0.379 . . . . 0.0 110.139 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -157.17 90.29 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.73 HD11 ' CG2' ' A' ' 190' ' ' VAL . 0.5 OUTLIER -89.7 146.33 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.341 0.591 . . . . 0.0 111.758 -178.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.472 ' N ' HD12 ' A' ' 148' ' ' ILE . 59.7 mtp85 -130.57 170.44 14.26 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.788 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.6 t -91.5 105.3 17.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.659 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.6 p -85.83 169.32 13.45 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.796 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -147.51 14.18 1.09 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.495 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.505 ' OE2' ' N ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -67.54 111.22 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.269 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -80.71 1.83 28.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -46.29 158.49 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.891 0.377 . . . . 0.0 111.226 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -75.75 170.65 15.78 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.587 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.8 m -87.23 135.52 33.28 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.046 0.451 . . . . 0.0 110.781 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -113.32 89.55 3.11 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.75 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 pt -119.85 171.22 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.85 -159.42 0.68 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.666 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.2 t -129.77 -4.32 4.65 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.707 0.289 . . . . 0.0 110.46 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -84.55 124.57 73.18 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -39.36 155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.884 1.723 . . . . 0.0 112.335 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.8 p -74.93 133.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.577 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.4 mp -79.05 134.23 36.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.324 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -102.31 179.71 27.07 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.668 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 169' ' ' ILE . 17.3 m -113.56 8.36 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.8 t30 62.73 -11.53 0.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.374 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 167' ' ' SER . 14.1 pt -93.33 139.89 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.225 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.406 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 40.4 t -100.94 150.52 22.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.264 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -79.05 47.24 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -71.1 169.57 14.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.757 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -83.8 119.24 24.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 175' ' ' SER . 13.8 p -151.49 163.34 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.089 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.55 ' N ' HG22 ' A' ' 174' ' ' VAL . 53.3 p -14.73 132.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.036 0.835 . . . . 0.0 113.197 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.422 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 45.1 p90 -90.6 134.38 34.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.423 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.54 134.57 20.33 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 0.9 OUTLIER -69.86 101.09 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.52 -179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 179' ' ' ILE . 41.1 mm -114.09 -14.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.65 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.8 mt -91.23 127.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.816 0.341 . . . . 0.0 111.031 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.66 -134.06 6.6 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 69.9 p -69.25 150.77 47.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 121.189 -0.205 . . . . 0.0 110.94 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.533 ' OG1' ' CE1' ' B' ' 13' ' ' PHE . 0.8 OUTLIER -142.43 95.06 2.73 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.239 -179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 18.4 mt -99.32 134.87 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.062 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 185' ' ' VAL . 27.9 m -149.32 114.05 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.11 106.96 3.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 14.0 m -48.08 -27.48 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -39.4 -37.66 0.48 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.622 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.7 m -137.95 37.45 2.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.732 0.301 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.73 ' CG2' HD11 ' A' ' 148' ' ' ILE . 45.4 t -150.74 103.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.547 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -85.39 -61.0 1.87 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.446 ' C ' ' ND2' ' A' ' 192' ' ' ASN . 0.4 OUTLIER -130.04 140.79 50.81 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.714 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.5 tt -139.91 114.73 9.5 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.888 0.375 . . . . 0.0 110.817 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -94.47 152.67 18.39 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -147.55 131.69 17.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.036 0.446 . . . . 0.0 111.149 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.2 m -144.26 138.08 27.73 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.434 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.533 HG22 ' N ' ' A' ' 198' ' ' ARG . 2.8 p -138.09 163.91 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 197' ' ' VAL . 55.1 ttt-85 -164.96 111.22 0.96 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.837 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.8 mm -94.1 126.7 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.18 173.25 46.14 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.402 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -72.24 131.85 43.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.691 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.459 ' CE ' ' CE1' ' A' ' 23' ' ' HIS . 28.8 mtm -86.49 4.59 39.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.724 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 85.5 m -97.74 -61.32 1.41 Allowed 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -152.64 122.83 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.484 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.84 148.52 0.37 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.589 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 4.7 t -133.91 13.41 3.98 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.793 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.1 m 58.81 -76.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.735 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 35.1 tt0 -49.59 -54.33 18.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.609 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -73.69 4.92 4.44 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.115 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 175' ' ' SER . 9.0 mm-40 -104.14 125.5 50.5 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.759 0.314 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.5 168.35 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 45.7 tttm -157.18 159.97 38.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.312 0.577 . . . . 0.0 111.224 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.436 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 9.7 t70 -153.59 170.35 21.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.034 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.14 166.22 25.85 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.758 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -148.89 169.73 19.88 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.402 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 7.7 mtpm? -131.84 103.42 6.32 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -100.02 116.4 31.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.61 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 218' ' ' VAL . 8.6 p -140.69 118.87 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 121.256 0.55 . . . . 0.0 110.752 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 50.54 43.26 27.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.516 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.87 -2.32 80.63 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.09 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -98.29 117.97 33.89 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 122.673 -0.31 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.86 158.85 15.51 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.0 t -169.97 123.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.528 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -78.39 139.02 38.79 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.53 108.2 0.27 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.481 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -72.06 104.89 3.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 2.0 t -132.16 152.98 50.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.139 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 95.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.406 ' OD2' HD23 ' A' ' 232' ' ' LEU . 3.4 m-20 -86.84 34.02 0.66 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.986 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.4 t -73.02 -35.0 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.912 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 233' ' ' ILE . 68.9 p -105.12 -0.36 26.69 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.978 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -42.01 -24.58 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.085 0.469 . . . . 0.0 110.526 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.558 HD11 ' ND2' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -165.11 137.79 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.0 108.18 7.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.055 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 66.2 m -76.23 6.36 5.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.61 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 -20.37 25.71 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -103.33 4.98 37.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.595 0.236 . . . . 0.0 111.339 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.66 147.81 29.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.042 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -132.9 142.83 49.12 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.4 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -69.46 134.82 49.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 242' ' ' VAL . 34.7 m -91.37 1.66 56.96 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.767 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 118.648 -0.692 . . . . 0.0 111.482 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.731 0.3 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.02 118.86 5.74 Favored 'Trans proline' 0 N--CA 1.474 0.331 0 C-N-CA 122.501 2.134 . . . . 0.0 111.575 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.27 159.0 30.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.528 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.67 164.69 25.85 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.266 -0.493 . . . . 0.0 111.999 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 p -76.54 -84.55 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.332 . . . . 0.0 110.671 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -123.36 82.35 52.68 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.421 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 52.0 Cg_exo -53.02 -168.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.538 2.159 . . . . 0.0 110.82 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.585 ' C ' HG22 ' B' ' 9' ' ' THR . 64.9 Cg_endo -88.17 -111.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.997 1.798 . . . . 0.0 111.67 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.585 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 158.01 72.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.34 71.62 1.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.138 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.467 ' SG ' ' OG1' ' B' ' 9' ' ' THR . 4.4 m -105.85 127.18 52.95 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 14.7 p -65.73 142.06 58.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.334 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.533 ' CE1' ' OG1' ' A' ' 183' ' ' THR . 11.1 p90 -116.19 -11.54 11.31 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 29.5 m -131.8 144.68 51.1 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.248 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -114.94 158.67 21.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.04 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 1.6 t -83.22 144.92 29.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.871 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.74 -47.59 11.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.903 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.5 ' NE ' ' OD2' ' A' ' 141' ' ' ASP . 5.3 tpt85 -70.9 126.2 28.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -83.74 118.95 24.24 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.494 ' N ' ' CD1' ' B' ' 20' ' ' LEU . 6.1 mp -75.48 145.53 79.42 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.693 -178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.7 152.07 37.15 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.382 2.055 . . . . 0.0 112.558 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' B' ' 24' ' ' PHE . 11.4 ptp180 -45.64 -43.84 12.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.38 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -68.09 24.82 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' B' ' 22' ' ' ARG . 12.2 t80 -150.88 32.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.371 0.605 . . . . 0.0 109.555 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -151.04 92.44 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.149 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 35.0 m -86.16 -25.28 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -156.42 -179.74 8.46 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.068 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.411 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 9.2 p90 -163.35 167.7 21.42 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.981 0.419 . . . . 0.0 111.256 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.411 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 57.4 m-85 -158.12 156.15 30.43 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' B' ' 31' ' ' THR . 69.7 mt-10 -98.53 145.58 26.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.812 0.339 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.425 ' O ' ' O ' ' B' ' 30' ' ' GLU . 63.2 p -52.35 -107.44 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.917 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 4.7 m -146.93 -128.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.453 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.477 ' C ' ' H ' ' B' ' 35' ' ' CYS . 18.2 t -158.95 -40.84 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.693 0.282 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.525 ' N ' HD22 ' B' ' 34' ' ' LEU . 2.2 mm? -59.08 -2.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.573 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.477 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.8 m -80.25 -34.48 37.1 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.224 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m 75.05 23.08 1.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.402 0.62 . . . . 0.0 110.087 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.523 ' N ' ' CD ' ' B' ' 38' ' ' PRO . 3.2 pt20 -173.56 49.61 0.09 OUTLIER Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.533 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 29.7 Cg_endo -58.63 -158.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.477 0.548 0 C-N-CA 123.191 2.594 . . . . 0.0 112.974 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 168.36 176.95 0.03 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.25 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.33 131.31 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 6.8 t -110.45 133.87 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.658 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.443 ' CD1' ' O ' ' B' ' 42' ' ' PHE . 29.9 p90 -113.16 146.02 39.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.071 0.462 . . . . 0.0 111.075 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.37 169.74 10.0 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 5.1 p -138.84 -142.73 0.16 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.187 0.517 . . . . 0.0 110.68 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.472 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.33 -36.33 1.71 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.177 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.97 46.43 2.34 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.287 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 23.6 m -153.72 -80.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.118 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.54 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 O-C-N 123.688 0.618 . . . . 0.0 109.475 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -161.34 143.71 12.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 t -148.9 136.19 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 0.0 109.781 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.65 162.22 13.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.631 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 124.79 7.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.318 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -62.33 122.58 74.05 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.59 1.28 7.07 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.225 1.284 . . . . 0.0 111.161 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -67.82 -18.22 64.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.108 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -95.31 125.88 40.24 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -51.56 -39.75 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.976 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -56.39 -34.92 67.18 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.078 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.92 -35.22 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.144 0.497 . . . . 0.0 109.93 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.03 -35.69 66.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.711 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -72.14 -35.89 69.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -65.09 -36.48 84.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.689 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -71.02 -44.47 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.04 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -62.11 -28.7 69.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -74.65 -40.87 61.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 110.959 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.12 -21.69 63.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.26 -29.37 62.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.17 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt -79.11 -84.5 0.08 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.374 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.562 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 2' ' ' PRO . 46.0 mtt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.765 0.317 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.408 ' O ' ' O ' ' A' ' 1' ' ' MET . 51.8 Cg_exo -54.4 -157.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 122.803 2.335 . . . . 0.0 112.257 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.76 -42.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.257 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.1 t 56.94 -157.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.1 mt 58.44 108.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.527 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -150.06 51.91 0.91 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.501 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 7' ' ' GLN . 1.5 mp0 -61.39 -166.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.414 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.4 m -164.62 -58.1 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.2 p -75.02 -22.15 58.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.117 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 t -48.22 133.13 15.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -60.07 -29.39 68.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.438 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 t -76.2 -27.42 56.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.8 t -72.04 -51.1 23.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.8 t -169.66 178.82 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.143 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 68.2 m -61.45 160.8 10.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.901 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.676 ' H ' ' CE1' ' A' ' 23' ' ' HIS . 2.9 p -81.58 166.67 20.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.192 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -117.41 4.37 12.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.436 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' O ' ' NZ ' ' A' ' 21' ' ' LYS . 56.5 mt-10 -62.52 -152.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.749 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.16 -72.15 0.7 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.562 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -83.09 59.33 4.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.277 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HD3' ' H ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -130.38 135.8 48.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.134 0.492 . . . . 0.0 111.242 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -132.93 123.35 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.438 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.676 ' CE1' ' H ' ' A' ' 16' ' ' THR . 67.5 m80 -75.27 76.18 2.39 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 tpt -46.54 170.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.358 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 158.19 132.94 1.48 Allowed Glycine 0 CA--C 1.512 -0.149 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 26' ' ' ILE . 16.4 tt -110.68 129.26 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.079 0.466 . . . . 0.0 110.921 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' OD2' ' O ' ' A' ' 198' ' ' ARG . 2.7 p30 -105.04 135.61 46.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.83 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.46 128.86 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.8 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.449 HG22 ' HE ' ' A' ' 115' ' ' ARG . 19.9 pt -124.42 162.86 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.8 tt -164.01 135.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.147 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -123.47 94.64 4.31 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.615 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.48 115.18 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.479 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -90.06 127.47 36.08 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -82.21 154.71 25.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.643 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -68.85 -170.55 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -88.8 -31.11 18.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.938 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -79.01 -39.72 33.33 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.237 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.3 p -40.7 106.48 0.42 Allowed Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.188 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -43.68 170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.963 1.776 . . . . 0.0 112.277 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p -75.49 134.88 40.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.923 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -158.1 95.31 1.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.106 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.77 -7.31 25.67 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -63.74 92.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.778 0.323 . . . . 0.0 110.407 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -90.55 154.75 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 34.9 t 53.7 65.46 1.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.122 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 153' ' ' GLU . 23.0 mt-30 -79.2 -24.62 43.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.4 m 178.09 164.82 0.71 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.417 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 p -150.65 132.14 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.404 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.4 p -134.17 104.4 6.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.177 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -83.29 136.79 34.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.282 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 52' ' ' THR . 8.1 mm -132.7 162.67 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.484 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 51' ' ' ILE . 93.0 m -154.18 151.25 28.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' B' ' 24' ' ' PHE . 91.4 mt-10 -52.71 175.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.6 p -62.91 -21.88 66.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.254 0.55 . . . . 0.0 109.818 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 56' ' ' SER . 65.7 mm-40 -44.95 164.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.748 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 2.0 m 159.76 -23.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.848 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.4 p30 -162.01 152.45 14.44 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.879 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -35.49 -27.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.451 2.101 . . . . 0.0 112.581 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' ASP . 73.6 m-20 -118.14 85.24 23.82 Favored Pre-proline 0 N--CA 1.469 0.486 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.184 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 59' ' ' ASP . 74.1 Cg_exo -50.27 -164.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.776 2.317 . . . . 0.0 112.898 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 64' ' ' SER . 39.5 tt0 -119.93 -115.96 0.32 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.033 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 p 41.19 91.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.903 0.859 . . . . 0.0 110.996 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 47.37 57.29 5.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.291 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 61' ' ' GLU . 20.1 m 55.95 -120.71 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.571 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' A' ' 67' ' ' ASP . 12.1 tt0 -161.14 -137.4 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 67.34 -3.93 0.96 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 110.368 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 69' ' ' THR . 3.4 p30 -156.6 154.29 29.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.323 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.6 t 73.18 -14.86 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.546 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 67' ' ' ASP . 10.1 t -70.33 -173.01 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.525 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.412 ' N ' ' OG1' ' A' ' 69' ' ' THR . 86.3 p -167.02 153.71 8.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.564 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.8 p -129.66 -30.77 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.175 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -49.62 -61.55 2.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.414 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -85.45 -175.56 5.73 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.319 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.2 -130.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.919 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -158.59 71.87 3.77 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.84 112.51 1.51 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.922 2.414 . . . . 0.0 112.335 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -87.19 151.21 8.1 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.441 2.094 . . . . 0.0 111.365 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.4 m -122.45 114.87 21.31 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.806 0.336 . . . . 0.0 110.964 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 p -96.35 129.96 43.57 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -130.56 141.7 50.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -136.31 134.44 37.95 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 122.428 1.109 . . . . 0.0 110.845 178.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' NE ' ' A' ' 89' ' ' ARG . 33.1 t -96.12 73.87 2.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.064 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.6 pt -71.13 98.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 tp -86.88 146.23 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.603 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.91 166.79 17.1 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.302 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.71 23.39 44.01 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.345 -0.455 . . . . 0.0 112.208 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.39 7.98 74.28 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.699 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.5 mt -127.99 153.82 46.31 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.439 ' NE ' ' OG ' ' A' ' 82' ' ' SER . 63.3 ttt180 -122.65 113.91 19.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -101.36 152.08 21.14 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.046 0.45 . . . . 0.0 110.147 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -149.06 126.95 11.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.413 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.548 ' CE2' ' CD1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -116.81 -169.99 1.74 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.947 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.05 81.53 0.16 Allowed Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.293 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.548 ' CD1' ' CE2' ' A' ' 92' ' ' PHE . 1.8 m-30 -73.35 115.01 12.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.6 m -124.69 111.79 16.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.686 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.1 tptp 64.84 31.3 11.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.399 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 66.2 m -116.02 150.32 44.88 Favored Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -38.64 160.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.956 1.771 . . . . 0.0 112.123 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -81.67 107.07 14.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.533 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.57 144.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.923 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -147.14 -21.92 0.4 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.8 p -98.18 122.02 40.82 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.361 . . . . 0.0 110.317 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 tp -139.89 133.53 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 239' ' ' LYS . 11.2 t -150.11 165.41 32.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.248 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -148.86 161.5 41.72 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.085 0.469 . . . . 0.0 110.789 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.5 t -162.14 156.64 22.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.228 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.5 137.95 44.3 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.219 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -151.06 108.04 3.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.337 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.35 -103.53 2.17 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.168 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 110' ' ' ASN . 17.5 p-10 -130.67 23.29 5.04 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.668 0.271 . . . . 0.0 110.552 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.1 155.63 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.645 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.7 t -127.31 129.73 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.064 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.609 ' ND2' ' H ' ' A' ' 114' ' ' ALA . 2.9 t-20 -107.54 154.99 20.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.525 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.609 ' H ' ' ND2' ' A' ' 113' ' ' ASN . . . -154.83 121.73 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.156 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.56 HH21 ' CD2' ' A' ' 238' ' ' LEU . 19.5 tpp85 -105.07 113.0 26.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.811 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.1 114.21 22.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.9 t -158.85 171.73 19.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.164 0.507 . . . . 0.0 112.029 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -87.83 163.83 16.22 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.559 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.1 141.15 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 111.141 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 p -83.22 152.6 65.12 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.616 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.52 152.35 33.81 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 121.921 1.747 . . . . 0.0 111.584 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.1 50.22 13.52 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.71 -53.96 0.88 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.59 0.233 . . . . 0.0 110.636 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 160.87 -11.35 0.14 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.232 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -129.94 151.12 50.84 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 117.278 0.539 . . . . 0.0 110.114 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.0 146.51 42.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.787 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.0 p -139.76 62.36 22.31 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.957 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.17 129.63 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.227 2.618 . . . . 0.0 113.427 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.48 165.08 13.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.2 pt -145.05 165.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.868 0.366 . . . . 0.0 111.045 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.0 m -82.67 154.84 24.67 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.738 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -51.35 -37.07 45.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -59.55 -51.82 68.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.943 0.402 . . . . 0.0 110.436 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.05 -43.66 91.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.133 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.49 -56.55 19.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.995 0.426 . . . . 0.0 110.319 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tp -51.65 -35.84 43.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.903 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.51 -33.09 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.5 mmt -71.3 -62.43 1.4 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 8.7 pt -46.9 -21.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.462 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -91.02 -28.72 17.8 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.622 0.248 . . . . 0.0 110.894 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.527 ' CG ' ' HE ' ' B' ' 18' ' ' ARG . 15.1 t0 -92.19 -44.12 8.95 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.4 t -43.43 120.51 1.94 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.937 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -141.5 132.93 26.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.699 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.41 132.08 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.033 0.444 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.7 p -103.14 171.02 7.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.362 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.9 mm -139.4 154.16 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -163.58 88.88 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.272 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.97 147.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.083 0.468 . . . . 0.0 111.292 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -137.04 171.68 14.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.804 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.2 m -100.31 116.21 31.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.197 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.1 m -104.85 -176.84 3.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.929 0.395 . . . . 0.0 110.256 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -149.47 0.69 0.5 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.888 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 153' ' ' GLU . 0.9 OUTLIER -55.37 99.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.56 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.64 9.72 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.952 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -45.43 156.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.806 0.336 . . . . 0.0 110.98 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.92 170.24 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.1 m -90.46 135.87 33.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.634 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.472 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 9.8 t70 -115.56 89.13 3.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.768 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -124.29 168.18 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -113.18 155.14 25.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.559 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 161' ' ' THR . 69.0 m -83.43 -3.92 58.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.903 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.546 ' NE2' ' CB ' ' A' ' 240' ' ' ALA . 0.5 OUTLIER -77.49 147.48 75.43 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.972 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.94 160.45 33.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.561 1.507 . . . . 0.0 110.988 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.63 134.92 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.205 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.6 mp -82.51 117.89 22.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.11 171.27 40.42 Favored Glycine 0 C--N 1.333 0.389 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.759 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 169' ' ' ILE . 2.0 p -101.12 7.29 43.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 60.97 -3.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.2 tt -98.24 139.2 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.323 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 67.5 p -98.34 145.62 26.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -75.59 40.88 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.011 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.499 ' NZ ' ' CB ' ' A' ' 172' ' ' LYS . 5.6 ttpm? -65.11 171.87 3.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 172' ' ' LYS . 36.7 pttt -87.27 128.24 35.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.307 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.734 HG22 ' H ' ' A' ' 175' ' ' SER . 14.9 p -157.13 177.15 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.773 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.734 ' H ' HG22 ' A' ' 174' ' ' VAL . 71.4 m -27.54 141.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 O-C-N 123.506 0.503 . . . . 0.0 112.018 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -100.24 134.09 43.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.07 138.85 33.88 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.006 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.75 86.78 2.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.772 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 37.8 mt -100.77 -36.89 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.303 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -71.58 124.54 28.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.231 0.538 . . . . 0.0 110.601 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -89.77 -125.41 2.81 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.555 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 12.0 m -79.76 153.05 29.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.164 0.507 . . . . 0.0 111.086 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 22.4 p -141.09 95.04 2.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.457 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.8 mp -98.44 117.09 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 185' ' ' VAL . 6.0 m -131.74 117.64 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.287 0.565 . . . . 0.0 111.602 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.552 ' O ' HG12 ' A' ' 190' ' ' VAL . 7.3 m-20 -78.66 111.89 15.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.823 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.6 m -46.34 -32.3 3.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.232 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.439 ' CD ' ' H ' ' A' ' 188' ' ' LYS . 12.0 mptt -34.97 -34.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.201 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 189' ' ' CYS . 32.1 p -152.1 56.93 0.84 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.305 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 190' ' ' VAL . 7.5 p -173.77 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.487 . . . . 0.0 110.009 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.78 -57.39 4.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.631 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.464 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 37.9 t-20 -127.16 137.92 53.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.464 ' N ' ' OD1' ' A' ' 192' ' ' ASN . 2.2 tt -134.13 128.14 33.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.926 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -113.57 135.81 53.5 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -137.01 134.59 36.76 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.019 0.437 . . . . 0.0 111.071 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.6 t -142.79 141.44 31.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.778 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 198' ' ' ARG . 44.4 t -134.69 159.16 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.069 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 197' ' ' VAL . 44.2 ttt180 -174.19 116.59 0.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.992 0.425 . . . . 0.0 110.903 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.4 tt -119.02 136.08 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -171.65 -150.13 6.97 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.568 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 43.3 t0 -88.49 119.15 28.66 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.622 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -78.38 3.57 15.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.08 -178.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 23.9 t -111.15 -51.3 2.87 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.742 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.479 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 67.6 mttm -146.94 109.93 4.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.145 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -44.52 147.58 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.372 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 208' ' ' GLU . 3.2 m -148.75 96.14 2.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 206' ' ' SER . 69.1 m -23.45 -41.81 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.339 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 206' ' ' SER . 36.3 mt-10 -58.65 -73.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.845 0.355 . . . . 0.0 111.629 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.3 9.6 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -96.5 126.1 41.45 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.834 0.349 . . . . 0.0 110.275 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.9 m -147.69 178.12 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.934 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.5 164.86 19.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.11 0.481 . . . . 0.0 111.105 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD2' HD12 ' A' ' 180' ' ' ILE . 16.4 t0 -158.92 168.63 26.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.178 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 165.34 171.03 31.07 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.8 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 12.7 m-85 -151.9 172.7 15.81 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -136.83 103.75 5.28 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.28 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -101.84 122.33 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.69 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 220' ' ' GLY . 7.3 p -140.48 115.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.298 0.571 . . . . 0.0 111.556 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.39 -8.87 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.768 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 137.99 -2.12 2.92 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 12.3 m -101.3 117.08 34.26 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.638 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.38 150.01 23.46 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.3 m -164.98 127.63 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.519 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -78.04 139.28 39.1 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -168.83 109.95 0.36 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.655 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.81 97.31 4.49 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 228' ' ' ASP . 59.3 m -126.75 157.23 39.69 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.936 0.398 . . . . 0.0 110.714 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' ' 227' ' ' THR . 9.6 m-20 -60.04 95.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.729 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -90.61 30.66 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.52 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 5.7 t -73.25 -30.12 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.285 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.0 t -111.4 1.34 16.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.5 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -44.31 -28.79 0.57 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.99 0.424 . . . . 0.0 110.478 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.42 143.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.179 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 236' ' ' THR . 6.1 p30 -75.75 97.04 3.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.042 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 49.0 m -59.29 -4.14 0.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 238' ' ' LEU . 41.1 p -78.96 -53.5 6.98 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.9 13.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.494 0.554 . . . . 0.0 112.494 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.56 ' CD2' HH21 ' A' ' 115' ' ' ARG . 8.3 mp -77.05 140.23 40.26 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 110.444 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.46 ' N ' ' OG ' ' A' ' 104' ' ' SER . 18.7 mtpp -131.64 131.59 43.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.616 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.546 ' CB ' ' NE2' ' A' ' 162' ' ' HIS . . . -54.87 155.73 4.19 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 46.9 t -123.98 -8.37 7.75 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.638 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 241' ' ' CYS . 2.0 p . . . . . 0 C--O 1.218 -0.564 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.379 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.7 0.286 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.88 115.78 4.47 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.538 2.159 . . . . 0.0 111.738 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 39.8 ttm -53.03 150.4 5.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.587 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.09 179.31 1.17 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.162 -0.542 . . . . 0.0 111.916 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 17.7 t -70.88 -88.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.843 0.354 . . . . 0.0 110.553 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -152.26 66.64 6.6 Favored Pre-proline 0 N--CA 1.464 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.343 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' B' ' 8' ' ' PRO . 98.5 Cg_endo -80.84 113.97 2.86 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.66 2.24 . . . . 0.0 111.846 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' B' ' 7' ' ' PRO . 82.8 Cg_exo -46.02 176.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.767 1.645 . . . . 0.0 111.181 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 25.3 p -150.5 -170.59 3.7 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.124 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.0 113.24 16.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.88 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.512 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 18.8 m -129.85 120.92 25.73 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 33.7 t -38.37 129.17 1.38 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.658 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 29.0 m-85 -109.63 -32.46 7.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.19 157.79 36.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.032 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.81 161.15 15.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.9 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -83.52 136.44 34.27 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.02 7.78 17.41 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.065 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.527 ' HE ' ' CG ' ' A' ' 141' ' ' ASP . 0.0 OUTLIER -134.0 127.48 32.41 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.812 0.339 . . . . 0.0 111.006 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -83.43 127.37 33.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.602 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.69 54.24 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -41.34 152.76 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.787 1.658 . . . . 0.0 111.942 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.686 HH21 HD21 ' B' ' 69' ' ' ASN . 8.5 tpt180 -45.14 -47.19 12.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.299 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -37.57 -33.59 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CE2' ' OE1' ' A' ' 53' ' ' GLU . 3.1 m-85 -109.5 43.19 1.34 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.795 0.331 . . . . 0.0 110.585 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -153.12 92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.707 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -90.28 -24.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -157.69 -179.03 7.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.168 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -157.78 170.69 21.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.223 0.535 . . . . 0.0 112.04 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 57.6 t80 -158.39 151.47 22.72 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.444 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 49.4 mt-10 -99.33 148.69 23.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.4 p -54.31 -109.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -152.58 -141.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.698 0.285 . . . . 0.0 110.526 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -146.53 -23.29 0.43 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.405 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' B' ' 34' ' ' LEU . 16.7 mt -57.63 -10.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.013 0.435 . . . . 0.0 109.935 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.403 ' C ' ' H ' ' B' ' 37' ' ' GLN . 83.1 m -112.8 122.04 46.49 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.575 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 30.8 t -72.75 37.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.84 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.2 pt20 -168.51 60.17 0.44 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.6 -164.75 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.713 2.275 . . . . 0.0 113.059 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 178.9 176.64 0.54 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.499 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -106.51 131.75 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.938 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -111.62 132.73 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.036 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -112.72 151.44 30.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.018 0.437 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -92.66 169.39 10.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.9 p -137.11 -145.09 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 110.703 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.476 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -129.99 -39.48 1.39 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.089 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.99 46.82 2.17 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.301 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 9.8 m -155.33 -83.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.375 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.35 -90.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -138.86 148.62 43.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.796 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 t -151.84 113.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.289 0.566 . . . . 0.0 110.446 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.555 ' N ' ' OG ' ' A' ' 182' ' ' SER . 54.0 t -50.53 161.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.842 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.439 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -153.58 139.97 18.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.187 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -74.64 115.36 43.12 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.29 -0.64 8.41 Favored 'Trans proline' 0 C--N 1.356 0.933 0 CA-C-N 120.145 1.087 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -74.72 -10.08 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.888 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.503 ' O ' ' NE2' ' B' ' 60' ' ' GLN . 37.4 mt-10 -98.97 125.55 44.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.21 0.529 . . . . 0.0 110.317 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.8 m -46.89 -50.58 18.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 63.9 p-90 -55.99 -25.29 43.55 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.077 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.99 -36.67 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.971 0.415 . . . . 0.0 110.139 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 56' ' ' GLU . 2.5 mp0 -68.3 -44.27 75.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.908 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.14 -35.31 80.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.294 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -63.1 -46.78 85.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 80.3 t -65.16 -47.64 86.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.725 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -57.5 -33.85 68.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.118 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -73.12 -34.49 66.16 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.982 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 16.9 mt -72.7 -21.65 61.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -73.07 -29.61 63.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.424 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -78.56 -77.27 0.17 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.686 HD21 HH21 ' B' ' 22' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.53 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.79 0.329 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.63 -49.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.688 2.259 . . . . 0.0 111.801 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.08 101.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.553 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.6 m -166.03 161.95 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.648 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.0 tp 55.74 45.85 23.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.383 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -87.68 177.73 6.95 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.524 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.594 ' CD ' ' H ' ' A' ' 7' ' ' GLN . 0.5 OUTLIER -84.41 -97.7 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.964 179.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.405 ' H ' ' H ' ' A' ' 9' ' ' SER . 95.5 p -154.28 -12.23 0.13 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.323 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.405 ' H ' ' H ' ' A' ' 8' ' ' SER . 56.0 p -79.68 -27.85 40.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.55 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.9 m -49.91 130.23 21.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.563 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.3 p -56.61 -25.89 54.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.681 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.9 p -73.67 -28.42 61.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.355 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -76.15 -55.6 5.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -158.91 162.79 36.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.589 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.5 t -60.75 149.62 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.4 p -73.27 171.26 13.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.777 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -115.4 15.93 16.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.215 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -90.21 90.87 8.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.046 0.45 . . . . 0.0 110.211 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -44.43 -23.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.164 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -80.99 18.92 0.93 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' C ' ' CG ' ' A' ' 22' ' ' HIS . 9.9 ptmm? -170.11 165.63 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.679 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.4 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 81.6 m-70 -152.94 -178.38 6.88 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.793 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.453 ' O ' ' SD ' ' A' ' 202' ' ' MET . 21.2 t60 -101.51 93.43 5.37 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.701 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.81 120.98 20.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.669 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SD ' ' A' ' 202' ' ' MET . . . -125.37 160.15 19.92 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.3 tp -110.55 134.02 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.481 ' CG ' ' HE2' ' A' ' 171' ' ' HIS . 58.6 t0 -124.68 124.29 41.86 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.041 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.463 ' H ' ' HG ' ' A' ' 117' ' ' SER . 11.9 t -137.61 142.07 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.6 pt -146.29 138.46 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.722 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -138.08 134.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 110.71 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -118.38 94.01 4.33 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 190' ' ' VAL . 7.7 p -90.13 135.7 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.483 0.658 . . . . 0.0 112.084 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -113.0 130.67 56.05 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.697 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -89.34 164.45 14.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.851 0.358 . . . . 0.0 110.741 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -77.81 151.31 34.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.712 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.06 -3.76 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.68 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -91.7 -41.45 10.7 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.004 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.6 p -48.26 146.08 4.84 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.832 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.21 162.36 28.57 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.023 1.816 . . . . 0.0 111.306 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.2 p -54.63 146.07 17.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.183 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.488 ' N ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -167.02 90.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.766 0.317 . . . . 0.0 110.836 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -98.31 -5.77 32.27 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.05 0.452 . . . . 0.0 110.036 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -61.05 83.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.658 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 tp -96.4 159.96 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.775 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.1 m 60.87 40.19 16.03 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 110.443 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 155' ' ' LYS . 3.7 tp60 -55.44 -55.05 36.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.921 0.391 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.1 t -178.87 150.97 0.51 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.684 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.6 p -115.31 142.72 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.232 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.5 m -127.7 102.11 6.67 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.27 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -82.92 129.01 34.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.678 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -138.94 149.54 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -153.37 145.94 24.16 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 54' ' ' SER . 1.5 mp0 -54.63 -176.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.506 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 6.2 t 102.22 -2.97 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 55' ' ' GLU . 2.6 mp0 65.06 167.98 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.454 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 m -102.19 -38.03 7.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.786 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.31 -51.19 65.73 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.369 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -86.53 55.31 3.36 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.391 2.061 . . . . 0.0 112.067 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.88 106.99 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 62' ' ' VAL . 90.2 Cg_exo -43.68 97.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.025 1.817 . . . . 0.0 112.952 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 33.24 29.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 60' ' ' PRO . 13.8 t -76.4 -78.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.043 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.06 170.87 7.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 66' ' ' ASP . 28.8 t -41.08 163.9 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.875 0.369 . . . . 0.0 111.34 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -60.84 -0.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.032 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 64' ' ' SER . 27.4 t0 51.99 100.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.414 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 29.0 p-10 -171.86 169.01 5.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.774 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.1 p -145.28 -59.48 0.34 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.461 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.78 HG23 ' H ' ' A' ' 70' ' ' SER . 4.8 t -58.48 -63.32 1.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.541 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.78 ' H ' HG23 ' A' ' 69' ' ' THR . 17.2 t 54.53 60.59 3.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.796 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.1 t -73.13 -76.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.447 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -172.14 28.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.697 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -110.07 -169.67 1.51 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.893 0.378 . . . . 0.0 110.961 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.7 m 37.42 73.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.157 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -48.28 150.48 2.21 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -35.72 156.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.628 2.218 . . . . 0.0 112.582 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.93 166.01 30.84 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.708 2.272 . . . . 0.0 112.211 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 p -123.63 137.53 54.71 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.56 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -93.1 126.72 38.34 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -122.59 101.6 7.57 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.949 0.404 . . . . 0.0 111.275 -178.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 80' ' ' TYR . 9.9 m -143.45 68.38 1.29 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.852 0.358 . . . . 0.0 110.409 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 83' ' ' ILE . 4.0 tp -73.65 107.09 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.225 0.536 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.2 mt -89.14 148.44 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.56 169.86 20.39 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.264 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.82 23.58 51.16 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.41 8.73 71.73 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.925 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -130.07 156.75 44.01 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.911 0.386 . . . . 0.0 110.403 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.7 ttm105 -115.95 117.84 31.29 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.472 ' SD ' HD12 ' A' ' 148' ' ' ILE . 68.4 mmm -102.22 108.35 19.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -100.98 120.44 40.19 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.122 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -100.9 -169.7 1.74 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.853 0.359 . . . . 0.0 110.89 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -178.92 70.65 0.07 OUTLIER Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.031 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -76.68 137.38 39.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.711 0.291 . . . . 0.0 110.776 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.9 m -138.83 118.46 13.04 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 60.09 32.34 20.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.133 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.1 m -119.81 149.72 49.09 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -38.61 145.55 0.17 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.851 . . . . 0.0 111.986 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -71.12 137.06 48.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.954 0.407 . . . . 0.0 110.889 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.89 145.65 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -143.04 -9.56 0.78 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.636 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -124.08 123.25 39.92 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.168 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.1 mp -134.16 106.99 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -140.16 145.83 38.01 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.807 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -142.35 -173.23 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.303 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.8 t -170.03 164.6 9.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.1 114.69 16.06 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.252 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -128.81 110.97 12.61 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.174 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.79 -127.48 22.54 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.857 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -100.98 21.42 13.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.66 0.267 . . . . 0.0 110.544 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.0 p -129.66 159.02 37.71 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.4 t -131.47 136.3 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.911 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -91.99 174.47 7.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.709 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -164.79 121.92 1.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.504 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.437 ' C ' HD22 ' A' ' 116' ' ' LEU . 8.4 tpt180 -121.97 102.43 8.16 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.755 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.437 HD22 ' C ' ' A' ' 115' ' ' ARG . 2.6 mm? -115.58 111.86 21.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.463 ' HG ' ' H ' ' A' ' 28' ' ' VAL . 12.1 m -166.34 168.01 15.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.168 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -90.2 176.09 6.89 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.451 HG22 ' N ' ' A' ' 120' ' ' SER . 7.9 p -116.9 155.13 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.094 0.473 . . . . 0.0 111.565 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 119' ' ' VAL . 8.4 t -91.22 146.31 33.26 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.748 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' HA ' HE22 ' A' ' 123' ' ' GLN . 33.9 Cg_exo -34.81 155.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 122.669 2.246 . . . . 0.0 112.778 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.586 ' N ' HE22 ' A' ' 123' ' ' GLN . . . 72.29 70.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.586 HE22 ' N ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -154.75 -40.67 0.09 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.662 0.268 . . . . 0.0 110.876 -179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.417 ' H ' ' CD ' ' A' ' 123' ' ' GLN . . . 124.89 7.16 6.17 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 123' ' ' GLN . 31.4 mmtp -125.33 170.34 11.43 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 23.0 p-10 -73.61 156.12 38.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.931 0.396 . . . . 0.0 110.83 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 p -155.7 66.18 4.5 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.894 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -48.24 134.31 25.0 Favored 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 122.893 2.395 . . . . 0.0 113.256 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.97 156.73 18.41 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.317 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.6 pt -150.46 166.54 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.178 0.513 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.5 p -72.69 164.66 26.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.347 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -60.74 -34.32 74.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.259 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 133' ' ' GLU . 4.3 mp0 -56.62 -57.17 13.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.142 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.467 ' O ' ' SD ' ' A' ' 138' ' ' MET . 39.6 mt-10 -57.3 -46.14 83.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.814 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.26 -55.4 18.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.968 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.05 -36.12 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.63 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.37 -30.23 64.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -76.35 -61.89 1.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.0 pp -47.21 -21.56 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.186 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -83.79 -55.05 4.47 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.565 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -76.67 -37.8 55.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 28.9 t -39.31 120.42 1.04 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 0.0 111.59 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.34 124.85 16.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.0 t -117.99 126.97 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.101 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.0 t -102.63 166.24 10.62 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.2 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.64 144.5 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.99 0.424 . . . . 0.0 110.719 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.38 88.67 1.23 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.848 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.472 HD12 ' SD ' ' A' ' 90' ' ' MET . 15.9 tt -77.47 151.27 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -145.25 -177.44 5.55 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.884 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.5 m -91.3 135.08 34.06 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.829 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.9 p -127.87 130.56 48.76 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -117.38 40.21 3.1 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.44 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.465 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 0.0 OUTLIER -81.5 100.9 9.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.159 0.504 . . . . 0.0 110.704 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -72.13 -2.59 19.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.525 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.487 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.8 mmtm -51.53 161.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.855 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -77.09 177.51 7.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.8 p -96.59 142.02 29.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -117.55 92.04 3.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.55 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.84 177.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -132.92 134.52 44.65 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.3 p -70.18 4.17 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.399 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -83.2 121.6 77.08 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -39.89 161.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.785 1.657 . . . . 0.0 112.076 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.47 134.26 27.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.36 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 165' ' ' LEU . 8.1 mp -84.38 121.29 27.33 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.49 168.3 25.23 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.482 -0.327 . . . . 0.0 112.675 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.5 p -95.83 6.92 47.72 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.8 t30 58.76 0.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.029 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 167' ' ' SER . 10.2 tp -100.84 138.67 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.494 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 97.0 p -99.09 142.31 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.567 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 27' ' ' ASP . 22.2 m80 -75.79 43.12 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.268 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -66.56 -174.52 0.3 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.4 ' HE3' ' H ' ' A' ' 228' ' ' ASP . 77.4 mttt -88.24 123.73 33.15 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.465 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.93 -175.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.779 0.323 . . . . 0.0 110.444 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 66.4 m -44.98 144.34 1.24 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.119 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD2' ' O ' ' A' ' 176' ' ' TYR . 48.4 p90 -96.29 126.9 41.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.817 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -141.49 130.99 23.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.42 97.13 1.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.071 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.2 mm -107.65 -38.32 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.23 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.88 124.01 22.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.55 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.53 -130.67 2.09 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.512 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 24.8 t -75.29 155.87 36.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 110.663 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.417 ' C ' HD12 ' A' ' 184' ' ' ILE . 26.4 m -142.94 93.8 2.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.91 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.747 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.8 mp -98.75 116.18 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 185' ' ' VAL . 3.0 m -124.59 132.59 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.012 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.76 94.69 6.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 189' ' ' CYS . 17.8 p -47.38 -26.68 1.37 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.878 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -43.49 -16.23 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.509 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 187' ' ' THR . 13.0 m -148.43 12.59 0.93 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 190' ' ' VAL . 0.4 OUTLIER -153.63 91.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.678 0.751 . . . . 0.0 110.563 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.95 -53.88 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.391 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -131.99 148.44 52.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.66 -0.245 . . . . 0.0 110.601 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.0 tt -148.13 110.56 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.044 0.449 . . . . 0.0 111.425 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -93.41 135.76 34.34 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -130.02 135.69 48.56 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.968 0.413 . . . . 0.0 111.106 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.2 t -144.31 141.06 29.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.488 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 198' ' ' ARG . 4.1 p -137.73 163.48 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.564 ' N ' HG22 ' A' ' 197' ' ' VAL . 60.4 ttt180 -171.7 115.94 0.38 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.361 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 tt -114.95 126.05 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.462 ' O ' ' SD ' ' A' ' 202' ' ' MET . . . -168.54 -149.24 6.07 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.228 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.51 140.31 33.4 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.913 0.387 . . . . 0.0 110.641 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -103.98 -2.58 25.86 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.914 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 70.7 m -107.33 -56.54 2.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.679 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -146.42 126.4 13.66 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.483 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.72 144.96 4.0 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 208' ' ' GLU . 20.7 m -127.06 9.09 6.77 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.25 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 12.4 m 58.29 -76.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.716 0.293 . . . . 0.0 111.476 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' SER . 71.6 mm-40 -49.35 -50.19 40.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.64 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.1 mt -75.1 -1.36 22.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.368 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.22 130.05 44.49 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.863 0.363 . . . . 0.0 110.865 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.8 m -142.68 -179.96 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.473 ' CG ' ' N ' ' A' ' 213' ' ' ASP . 48.6 tttm -171.04 161.94 7.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.369 0.604 . . . . 0.0 111.611 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 212' ' ' LYS . 15.4 t70 -158.95 169.52 24.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.711 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 167.64 138.35 2.43 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.935 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -118.39 168.65 10.44 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -132.63 103.06 5.94 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -97.63 113.38 25.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.109 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 218' ' ' VAL . 11.8 p -139.61 116.16 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.3 0.572 . . . . 0.0 110.726 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 219' ' ' ASP . 1.2 m-20 52.82 28.28 6.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.861 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.4 66.15 Favored Glycine 0 N--CA 1.463 0.462 0 C-N-CA 121.456 -0.402 . . . . 0.0 112.994 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.5 t -98.61 116.22 30.36 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.31 158.66 15.44 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.029 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.8 m -168.28 117.69 0.75 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.992 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -85.05 96.64 9.48 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.089 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -129.33 133.93 7.74 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.47 -0.332 . . . . 0.0 112.56 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.34 97.69 10.75 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 228' ' ' ASP . 86.0 m -123.96 156.21 36.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.291 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 227' ' ' THR . 5.6 p-10 -57.68 95.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -87.2 30.0 0.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 23.4 m -70.38 -49.28 50.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.631 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 27.2 t -90.01 2.21 55.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.8 tp -39.2 -33.14 0.12 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.875 0.369 . . . . 0.0 111.15 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.54 144.43 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.894 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 234' ' ' ASP . 1.5 p30 -74.97 102.47 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.044 0.45 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 92.6 p -68.94 -4.14 15.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.478 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 69.9 p -83.21 -15.68 49.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.348 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -102.01 11.41 38.51 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.585 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.58 153.89 34.94 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -142.33 121.16 12.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.14 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 123.24 16.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.728 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.436 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 15.0 m -88.15 4.72 44.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 242' ' ' VAL . 11.1 p . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 117.169 -1.396 . . . . 0.0 111.375 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.822 0.344 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.51 116.82 3.9 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.749 2.299 . . . . 0.0 111.859 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -65.01 148.49 51.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.38 169.79 2.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.07 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.0 m -78.32 -76.49 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.786 0.327 . . . . 0.0 110.695 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -119.71 84.18 30.33 Favored Pre-proline 0 N--CA 1.472 0.631 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.719 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.459 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 23.4 Cg_exo -61.36 -174.29 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.463 2.109 . . . . 0.0 112.727 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 34.7 Cg_exo -58.03 -138.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.288 2.658 . . . . 0.0 113.876 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.497 ' O ' ' N ' ' B' ' 11' ' ' CYS . 2.9 t -178.53 31.07 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.897 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -41.36 91.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.779 0.323 . . . . 0.0 110.959 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.51 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 63.5 m -138.39 128.35 25.44 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.026 0.441 . . . . 0.0 110.528 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 80.1 m -45.37 141.37 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.808 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.51 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 24.9 m-85 -114.1 -26.24 8.17 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.785 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.6 m -155.42 157.22 36.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.88 162.56 15.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.377 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -85.28 139.52 31.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.651 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.46 -26.19 32.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.338 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.75 125.9 41.53 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.08 0.467 . . . . 0.0 111.522 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -77.95 122.68 25.84 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mt -87.14 112.71 49.64 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.725 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -44.45 148.4 1.3 Allowed 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 121.909 1.74 . . . . 0.0 112.289 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -44.99 -41.83 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.353 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.56 -32.39 0.55 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 7.0 m-85 -108.53 41.67 1.53 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.66 0.267 . . . . 0.0 110.473 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -151.4 92.37 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.68 -25.82 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 35.1 t70 -155.11 -179.19 7.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.743 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.478 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 9.1 p90 -161.86 173.93 13.85 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.338 0.589 . . . . 0.0 111.848 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.493 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 45.2 t80 -156.64 179.75 8.97 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.265 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.493 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 13.1 pt-20 -128.76 152.23 48.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.721 0.296 . . . . 0.0 110.267 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.474 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 35.7 p -57.2 -113.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.758 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 13.7 m -151.66 -142.56 0.12 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.514 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.421 ' C ' ' H ' ' B' ' 35' ' ' CYS . 13.2 t -143.32 -16.78 0.65 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.336 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.91 -3.86 1.85 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.018 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.421 ' H ' ' C ' ' B' ' 33' ' ' SER . 2.9 p -123.3 122.9 39.51 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -74.49 44.14 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.566 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -173.31 57.85 0.22 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 91.5 Cg_endo -72.61 -162.51 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.964 2.443 . . . . 0.0 113.137 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 174.62 176.96 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.029 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 58.0 t -108.93 133.98 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.187 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 140.86 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.768 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -115.09 150.87 35.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -93.1 170.26 9.78 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.0 p -137.95 -145.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.18 0.514 . . . . 0.0 111.107 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.469 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -124.94 -38.32 2.36 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.37 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.17 46.07 2.43 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.065 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.613 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 32.3 t -154.05 -83.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.61 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 159.21 -87.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -144.65 148.19 33.98 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.835 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 38.5 t -150.79 121.72 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.069 0.461 . . . . 0.0 110.394 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.512 ' H ' ' CB ' ' A' ' 182' ' ' SER . 99.6 m -57.75 161.59 3.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.384 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.86 132.37 12.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.83 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -68.74 116.11 37.54 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.74 0.38 7.12 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 120.935 1.09 . . . . 0.0 111.112 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 13.0 m -71.59 -6.06 38.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.962 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -105.77 128.04 53.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.049 0.452 . . . . 0.0 110.344 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -48.38 -49.25 35.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -56.12 -30.43 62.1 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.736 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -70.04 -36.92 70.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.996 0.427 . . . . 0.0 110.092 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -73.1 -36.63 66.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.72 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.24 -35.53 78.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.338 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -64.54 -37.94 89.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.529 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.91 -45.76 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.25 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -59.64 -38.44 81.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -64.88 -48.5 74.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.0 110.771 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -64.94 -24.88 67.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.785 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -71.63 -30.89 66.26 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.258 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 23.9 mt -82.26 -81.78 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 110.272 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 38.2 t30 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.915 -1.04 . . . . 0.0 110.54 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.748 0.309 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.07 111.15 2.88 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.79 2.327 . . . . 0.0 111.824 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.42 147.31 51.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.513 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.3 t -71.13 117.39 12.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.562 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.502 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 2.3 mm? -70.67 165.37 23.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.165 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -148.51 158.62 44.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.34 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -61.56 -139.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.471 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.5 m -158.26 -44.11 0.06 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.458 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.1 p -74.81 -14.93 60.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.9 t -50.88 126.14 15.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.658 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.6 p -59.28 -10.61 3.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.378 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 79.1 p -92.51 -25.36 18.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.559 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.3 p -81.08 -45.58 16.27 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.1 m -167.8 173.06 8.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 0.0 110.649 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.38 146.57 50.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.943 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.401 ' H ' ' HE2' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -74.29 173.22 10.52 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -114.0 21.28 15.0 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.432 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -87.71 86.49 7.19 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 18' ' ' GLU . 49.3 mt-10 -17.71 -61.06 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.55 52.12 0.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HE2' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -153.8 149.15 27.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.599 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.408 ' HD1' ' N ' ' A' ' 22' ' ' HIS . 10.1 p-80 -168.1 120.9 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.242 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.496 ' CE1' ' OG ' ' A' ' 127' ' ' SER . 7.0 t-80 -67.79 78.73 0.2 Allowed 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.758 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.489 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -54.28 138.19 39.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.041 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' O ' HD12 ' A' ' 199' ' ' ILE . . . -142.56 162.68 27.31 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 pt -109.15 169.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.077 0.439 . . . . 0.0 110.959 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -154.12 105.62 2.73 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.295 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 t -99.08 128.45 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.751 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.587 HD11 ' NE2' ' A' ' 171' ' ' HIS . 2.6 mm -123.59 123.11 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.52 133.64 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.32 92.8 3.15 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.22 135.44 25.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.117 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 m -103.75 124.72 49.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.638 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' CG ' ' OG1' ' A' ' 38' ' ' THR . 18.9 ttpp -76.14 151.62 36.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.805 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.461 ' C ' ' H ' ' A' ' 37' ' ' GLN . 49.7 tt0 -74.24 148.28 41.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.168 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.5 p30 -74.12 36.51 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.85 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 35' ' ' GLN . 14.7 tt0 -136.56 -46.98 0.61 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.377 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.44 ' OG1' ' CG ' ' A' ' 34' ' ' LYS . 1.4 p -53.25 151.66 9.32 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -70.22 157.47 59.4 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.21 1.94 . . . . 0.0 111.875 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -65.06 141.67 58.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -158.82 97.41 1.42 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.468 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 13.5 t70 -91.56 -18.6 23.84 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -51.43 87.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 9.9 tp -96.19 150.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.376 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 17.1 t 58.81 67.05 0.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.87 -42.39 33.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.7 p -173.65 163.42 4.28 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.777 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.39 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -123.4 115.15 21.14 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 111.412 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -82.78 135.59 34.93 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.728 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.3 mt -132.59 150.21 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -152.75 121.86 6.63 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.18 114.24 22.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.92 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t 69.87 -48.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.396 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' O ' ' OG ' ' A' ' 56' ' ' SER . 34.4 tt0 -48.55 -85.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.762 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 55' ' ' GLU . 54.0 p 51.9 -91.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.197 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -163.89 -61.95 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.628 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -55.58 -93.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.809 1.673 . . . . 0.0 111.861 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -163.3 151.95 11.99 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -36.33 152.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.37 2.047 . . . . 0.0 112.498 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -168.46 56.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.497 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 63' ' ' GLU . 2.0 m -136.48 -106.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.818 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 62' ' ' VAL . 58.7 mm-40 -89.18 10.5 21.76 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 110.333 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 65' ' ' GLU . 96.9 p -50.99 179.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.651 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 64' ' ' SER . 6.8 pt-20 38.79 98.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.058 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -175.83 -22.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.13 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -81.3 -127.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.54 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.4 m -169.09 -104.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.453 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 m -80.56 -2.02 44.44 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.988 0.423 . . . . 0.0 110.19 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.9 m -108.67 109.04 20.13 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.298 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.11 7.52 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.736 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 43.94 80.34 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.743 0.306 . . . . 0.0 111.29 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -51.55 -16.38 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.532 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.6 p -132.14 124.6 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.15 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 38.5 t0 -173.06 50.45 0.11 Allowed Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.576 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 75' ' ' ASP . 19.0 Cg_endo -55.95 106.99 0.22 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.287 2.658 . . . . 0.0 112.194 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.67 -159.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.758 1.639 . . . . 0.0 112.358 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -140.37 138.24 34.67 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.345 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.504 ' OG1' ' CE2' ' A' ' 94' ' ' PHE . 10.8 p -101.35 138.22 38.65 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.643 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 10.4 m-85 -119.03 160.84 21.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.327 0.584 . . . . 0.0 110.976 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -142.43 118.93 10.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.444 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.9 t -97.66 65.55 1.88 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.748 0.309 . . . . 0.0 110.364 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -71.43 109.13 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.705 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -97.2 148.1 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.978 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.15 168.48 23.08 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.94 26.94 43.04 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.001 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.28 72.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.435 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.4 mt -132.75 158.71 41.7 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.889 0.376 . . . . 0.0 110.453 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.67 109.07 13.8 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.802 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 10.7 mtt -103.41 107.11 17.81 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -90.37 107.18 18.99 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.51 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 56.4 t80 -92.42 163.23 13.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.763 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.09 143.16 8.07 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.504 ' CE2' ' OG1' ' A' ' 79' ' ' THR . 4.6 p90 -147.28 157.86 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.948 0.404 . . . . 0.0 110.328 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 95' ' ' THR . 9.2 t -142.16 127.46 18.73 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.96 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' SD ' ' A' ' 138' ' ' MET . 30.1 mtpt 56.89 33.11 22.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.473 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.5 141.3 40.5 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -32.71 135.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.777 2.318 . . . . 0.0 113.195 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.578 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -70.06 147.73 49.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.563 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -91.77 137.31 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.957 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -124.68 3.74 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.123 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.7 t -137.7 135.04 36.07 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.128 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.95 98.52 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 121.302 0.572 . . . . 0.0 109.681 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.3 p -113.35 158.75 20.2 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.932 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -151.06 169.37 21.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 p -166.51 163.07 17.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.61 134.23 42.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -151.89 113.85 4.45 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.3 -122.41 8.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.812 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.71 22.91 15.12 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.664 0.269 . . . . 0.0 110.633 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -133.52 159.24 41.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.882 0.372 . . . . 0.0 110.518 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.62 136.04 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -104.25 167.43 9.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.15 0.5 . . . . 0.0 111.299 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -165.72 119.55 1.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.017 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -116.55 122.9 46.01 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.503 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.89 117.13 28.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.9 p -161.41 152.09 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.264 -0.574 . . . . 0.0 112.127 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.5 t -71.03 170.25 13.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.13 147.67 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 111.256 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 m -69.79 150.84 96.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.149 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.406 ' CD ' ' SD ' ' A' ' 202' ' ' MET . 35.5 Cg_endo -62.57 142.61 90.59 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.743 1.629 . . . . 0.0 111.252 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.67 53.64 2.38 Favored Glycine 0 C--N 1.331 0.28 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -143.67 -33.65 0.42 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.968 -0.137 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.18 20.38 0.51 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.142 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.813 ' HZ1' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -144.78 177.69 8.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.91 0.355 . . . . 0.0 110.72 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -90.36 135.79 33.46 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.217 0.532 . . . . 0.0 112.189 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.813 ' CB ' ' HZ1' ' A' ' 125' ' ' LYS . 1.1 m -133.58 67.24 75.27 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.548 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -42.09 129.88 4.44 Favored 'Trans proline' 0 N--CA 1.474 0.381 0 C-N-CA 123.066 2.511 . . . . 0.0 113.404 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.82 26.33 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.559 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 131' ' ' THR . 14.3 mm -141.5 153.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -84.44 166.99 16.85 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.074 0.464 . . . . 0.0 111.003 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -60.23 -35.68 76.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.201 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -66.55 -52.39 46.16 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.609 -0.437 . . . . 0.0 111.475 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -65.59 -41.94 92.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.968 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.06 -56.85 16.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.539 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 10.3 tp -49.72 -32.78 14.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.087 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.79 -37.2 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.975 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 96' ' ' LYS . 23.7 mmt -64.8 -49.47 70.53 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 19.8 mm -46.92 -22.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 0.0 111.071 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -87.52 -47.94 8.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.89 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.32 -34.27 55.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 1.7 m -40.27 110.27 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.007 0.432 . . . . 0.0 111.493 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 42.9 tp10 -141.16 114.14 8.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.997 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 144' ' ' VAL . 12.1 m -108.01 130.8 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.538 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.2 m -108.6 164.18 12.58 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.904 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.4 tp -154.76 149.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.945 0.402 . . . . 0.0 110.533 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -148.9 95.02 2.34 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.015 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.7 mm -80.5 136.87 22.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.64 175.71 9.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 2.8 t -91.96 130.16 37.77 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.871 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.9 p -120.26 148.36 43.79 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -131.3 34.66 3.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.499 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.72 101.4 10.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.616 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -71.96 -3.98 25.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.685 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -48.71 149.44 1.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.839 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.27 176.46 1.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.924 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 73.2 m -98.51 142.06 30.58 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.467 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 26.8 t70 -119.03 92.61 3.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.665 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.0 pt -121.48 161.59 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -108.31 139.26 43.28 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.133 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.6 p -73.53 4.51 4.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.765 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -80.5 127.27 76.38 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.316 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -39.06 162.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.921 1.747 . . . . 0.0 112.297 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.6 m -84.37 133.51 29.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.961 0.41 . . . . 0.0 110.521 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.86 123.69 33.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.352 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -109.99 173.16 16.39 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.593 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 169' ' ' ILE . 16.1 t -99.95 3.87 44.61 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 50.2 t30 67.07 -10.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.208 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 167' ' ' SER . 13.4 mt -73.43 143.77 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.166 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.41 ' C ' ' H ' ' A' ' 172' ' ' LYS . 95.5 p -102.44 141.54 35.1 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.587 ' NE2' HD11 ' A' ' 29' ' ' ILE . 7.8 m80 -77.22 33.72 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.079 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 170' ' ' SER . 76.9 tttt -62.05 172.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -88.13 132.76 34.2 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.713 0.292 . . . . 0.0 110.329 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.58 -162.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.319 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.4 m -47.59 149.89 1.1 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.678 0.275 . . . . 0.0 110.569 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' CD1' ' O ' ' A' ' 176' ' ' TYR . 53.5 p90 -107.48 135.4 49.02 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.952 0.406 . . . . 0.0 111.379 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.494 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 4.0 tm-20 -146.03 141.67 27.87 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.014 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.494 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 6.3 p-10 -76.68 96.86 4.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.618 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.4 tt -112.72 -29.84 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.192 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.401 HD12 ' OD1' ' A' ' 213' ' ' ASP . 13.6 mt -76.01 111.36 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.85 -117.68 0.47 Allowed Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.703 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.511 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 12.4 t -77.7 141.89 39.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 0.0 111.351 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.1 m -139.22 85.83 2.09 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 184' ' ' ILE . 9.9 tp -104.17 120.03 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.87 0.367 . . . . 0.0 110.131 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 185' ' ' VAL . 10.0 m -136.69 131.66 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.883 0.373 . . . . 0.0 111.379 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.34 108.3 18.38 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.955 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 187' ' ' THR . 2.7 p -48.55 -27.88 3.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.346 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -41.05 -26.28 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.002 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 68.3 m -142.49 27.99 1.67 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.796 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.403 ' O ' HG22 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -165.18 99.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.498 0.666 . . . . 0.0 109.855 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -72.29 -55.91 6.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.41 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -133.19 142.65 48.71 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.282 -178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.12 138.08 31.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 111.029 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 4.1 mp0 -105.19 156.81 17.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 133.57 18.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.207 0.527 . . . . 0.0 110.869 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.05 18.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.3 t -136.6 112.77 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.448 HH12 ' H ' ' A' ' 211' ' ' VAL . 12.9 ttt85 -108.43 163.27 13.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.189 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.424 HG23 HG13 ' A' ' 211' ' ' VAL . 0.9 OUTLIER -160.96 109.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -162.52 -150.85 6.14 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.754 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 201' ' ' ASP . 1.1 m-20 -89.37 140.63 29.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 110.692 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.535 ' SD ' ' SG ' ' A' ' 203' ' ' CYS . 0.0 OUTLIER -97.64 1.52 48.79 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.3 179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.535 ' SG ' ' SD ' ' A' ' 202' ' ' MET . 24.1 m -115.37 -58.11 2.17 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -134.39 108.91 8.43 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.145 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 9.4 mp0 -58.39 121.9 11.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.184 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 209' ' ' LEU . 25.3 m -116.43 110.26 18.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.572 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 63.1 p -33.55 -46.86 0.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.617 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -60.88 -40.93 94.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.57 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.614 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.3 mm? -88.05 0.59 55.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.542 ' C ' HG12 ' A' ' 211' ' ' VAL . 50.2 mt-10 -86.64 137.44 32.47 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.914 0.388 . . . . 0.0 110.21 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.542 HG12 ' C ' ' A' ' 210' ' ' GLU . 0.2 OUTLIER -170.09 152.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -161.68 153.75 19.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.313 0.578 . . . . 0.0 111.89 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 16.9 t70 -134.37 172.75 12.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.489 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 164.11 144.53 4.07 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.207 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -131.17 -178.26 4.76 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -149.67 105.82 3.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.201 0.524 . . . . 0.0 110.164 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.456 ' CE1' ' CE2' ' B' ' 13' ' ' PHE . 5.3 t80 -96.44 128.38 43.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.573 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 220' ' ' GLY . 18.4 m -139.27 107.82 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.317 0.579 . . . . 0.0 111.95 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 8.7 t70 64.58 -12.68 0.11 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.39 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 144.06 -0.36 1.14 Allowed Glycine 0 N--CA 1.461 0.366 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.687 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.4 m -105.2 121.39 43.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.003 0.43 . . . . 0.0 111.486 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.37 160.24 14.52 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 13.7 t -173.83 120.74 0.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.438 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -74.42 135.93 42.38 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.24 103.66 0.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.413 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -73.91 95.75 2.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 51.4 m -123.42 150.81 43.32 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -55.33 95.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.604 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -88.75 36.18 0.8 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.6 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 231' ' ' SER . 5.7 t -75.36 -41.7 55.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.792 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 230' ' ' THR . 92.1 p -96.05 1.47 52.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.844 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.5 tp -42.26 -34.44 0.78 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.912 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.0 mt -148.37 145.68 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.013 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -75.18 94.6 2.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.988 0.423 . . . . 0.0 109.936 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 15.1 m -56.43 -13.76 2.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.826 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.46 -7.81 58.71 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -103.9 9.12 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.563 0.221 . . . . 0.0 110.964 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 238' ' ' LEU . 7.3 mp -84.86 142.14 29.94 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 110.695 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -129.11 132.8 47.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.007 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.67 141.23 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 242' ' ' VAL . 48.5 t -108.08 -4.47 17.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.628 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 242' ' ' VAL . 10.4 p . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.129 -1.415 . . . . 0.0 111.503 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.764 0.316 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.63 109.94 3.0 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.553 2.168 . . . . 0.0 111.641 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . 0.404 ' O ' ' O ' ' B' ' 4' ' ' GLY . 15.5 ptt? -48.24 174.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.855 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' B' ' 3' ' ' MET . . . -60.17 -143.69 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.427 ' O ' ' CB ' ' B' ' 6' ' ' ASP . 36.0 p -169.14 25.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.122 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.565 ' H ' ' CD ' ' B' ' 7' ' ' PRO . 1.9 m-20 161.38 50.24 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.565 ' CD ' ' H ' ' B' ' 6' ' ' ASP . 12.3 Cg_endo -53.11 166.25 1.05 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 122.536 2.157 . . . . 0.0 112.035 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.43 -123.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.603 2.202 . . . . 0.0 110.833 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.451 ' O ' ' N ' ' B' ' 11' ' ' CYS . 2.1 t 175.53 47.33 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 118.321 0.509 . . . . 0.0 110.774 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.44 95.35 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.272 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 71.1 m -140.64 143.45 35.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.757 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 3.9 m -69.08 148.0 50.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.02 0.438 . . . . 0.0 111.667 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 3.3 m-85 -122.71 -19.01 6.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.499 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -145.01 149.5 35.23 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.142 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -114.23 149.08 36.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.8 t -71.78 133.05 45.3 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.385 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.556 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -78.17 -42.79 30.54 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.877 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 12.4 mmm-85 -81.79 127.91 33.45 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.081 0.467 . . . . 0.0 111.493 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -68.18 152.97 44.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.624 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 19.6 mt -108.5 94.62 14.16 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.13 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -40.65 152.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.758 1.639 . . . . 0.0 112.343 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' B' ' 22' ' ' ARG . 8.1 tpt85 -45.49 -51.26 11.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.935 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -40.51 -39.22 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -105.77 46.05 0.94 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -155.67 92.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.564 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.33 -19.25 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.2 t70 -157.99 -179.55 8.23 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.436 -0.505 . . . . 0.0 111.492 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.484 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.4 p90 -165.48 163.37 19.59 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 111.287 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -148.06 179.83 7.46 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.437 ' N ' ' CD2' ' B' ' 29' ' ' TYR . 49.9 mt-10 -123.7 149.06 45.96 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.041 0.448 . . . . 0.0 111.168 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 41.3 p -55.58 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.997 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -148.29 -156.15 0.69 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.675 0.274 . . . . 0.0 110.536 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 47.4 t -129.82 -25.69 2.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.508 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 28.7 mt -58.24 -11.28 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.013 0.435 . . . . 0.0 110.031 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.47 ' C ' ' H ' ' B' ' 37' ' ' GLN . 26.9 m -106.72 121.03 43.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.959 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 36.1 t -73.54 34.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.063 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.0 pt20 -168.67 63.08 0.54 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 73.3 Cg_endo -71.63 -161.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.629 2.22 . . . . 0.0 113.16 -178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.35 176.94 0.11 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.77 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 82.9 t -108.95 133.6 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.539 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.2 m -106.29 139.32 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.67 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -115.32 148.18 39.55 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.03 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.467 ' CG ' ' N ' ' B' ' 44' ' ' THR . 5.3 tt0 -100.18 168.05 10.05 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 1.7 p -143.84 -142.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.975 0.417 . . . . 0.0 110.227 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.529 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -119.55 -39.93 2.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.063 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.73 46.65 2.36 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 81.1 p -147.42 -84.58 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.581 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.01 -84.68 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.441 ' NE2' ' C ' ' B' ' 48' ' ' ALA . 21.8 mp0 -139.66 145.22 38.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.718 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.8 117.93 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.511 ' H ' ' CB ' ' A' ' 182' ' ' SER . 0.1 OUTLIER -73.48 148.82 42.81 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.377 0.608 . . . . 0.0 112.025 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.75 134.25 28.24 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.53 126.25 89.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.79 -0.73 9.8 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.332 1.354 . . . . 0.0 111.258 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 51.9 m -69.76 -17.39 63.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.99 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -91.0 125.74 35.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.093 0.473 . . . . 0.0 110.176 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -48.6 -49.04 38.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -56.26 -26.43 51.59 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.677 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -72.91 -35.67 49.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.002 0.429 . . . . 0.0 110.112 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -70.42 -35.51 73.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.693 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -72.14 -35.25 69.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -64.73 -35.37 80.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.661 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 68.4 t -72.12 -45.63 61.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.81 -30.5 71.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.26 -39.35 63.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.718 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.91 -23.31 59.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.304 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -34.14 65.87 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.03 -75.04 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.402 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.628 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtm . . . . . 0 CA--C 1.528 0.099 0 CA-C-O 120.748 0.309 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.09 164.22 31.71 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.52 2.147 . . . . 0.0 111.674 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.72 -17.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.552 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.5 t 52.44 43.92 30.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.576 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.5 mt 55.75 80.26 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.657 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -79.72 64.91 4.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.526 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 53.69 -142.27 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.612 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t -161.42 -13.2 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.41 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.5 -21.98 55.06 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.602 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 p -49.95 127.89 17.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.531 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 6.3 t -54.28 -23.96 17.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 98.8 p -76.17 -31.54 58.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.3 m -74.44 -47.46 33.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.977 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.3 p -167.21 165.79 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.764 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.1 146.72 54.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.432 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 174.69 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.909 0.385 . . . . 0.0 110.834 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -116.99 17.28 14.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.13 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.53 97.07 6.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.261 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.604 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 6.8 mp0 -32.99 -60.22 0.33 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.07 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -80.1 52.98 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.324 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 13.1 tttp -164.24 139.33 5.86 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.107 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 50.4 m80 -155.7 122.61 5.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.843 0.354 . . . . 0.0 111.252 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 23' ' ' HIS . 0.3 OUTLIER -57.76 115.53 2.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.752 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -88.94 124.42 34.22 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.056 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.22 141.02 12.21 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.78 150.83 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.797 0.332 . . . . 0.0 110.253 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 28' ' ' VAL . 21.2 t0 -139.46 142.82 37.37 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.215 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.484 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 27.6 t -137.62 107.52 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.844 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.598 ' CG1' ' HE ' ' A' ' 115' ' ' ARG . 4.1 mp -102.07 128.06 55.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 30' ' ' ILE . 8.5 tt -135.85 130.46 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.429 0.633 . . . . 0.0 111.75 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -116.34 125.11 51.65 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.44 131.53 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.088 0.47 . . . . 0.0 111.406 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.2 m -105.81 132.55 51.79 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HZ2' ' HB3' ' A' ' 110' ' ' ASN . 11.8 pttm -86.58 163.45 17.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.318 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.438 ' C ' ' H ' ' A' ' 37' ' ' GLN . 6.7 tt0 -75.81 137.48 40.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.675 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -50.52 -10.57 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.308 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 35' ' ' GLN . 1.2 mp0 -87.83 -41.73 13.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.963 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 p -46.36 148.29 1.67 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.796 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.57 167.26 25.86 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.06 1.84 . . . . 0.0 111.519 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.0 p -69.79 135.55 49.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.304 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -158.32 98.21 1.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.404 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 44' ' ' ILE . 7.0 m-20 -97.55 -13.61 21.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.164 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 35.1 mmtm -54.93 85.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.963 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.1 tp -89.46 153.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.281 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 21.2 t 57.93 64.79 1.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.234 0.54 . . . . 0.0 110.402 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.4 ' NE2' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -72.86 -33.5 66.14 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 t -173.09 -172.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.579 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 48' ' ' VAL . 3.5 p -167.7 91.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.38 0.61 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.3 m -82.54 155.24 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.723 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -152.22 124.34 8.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.33 0.586 . . . . 0.0 110.682 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.8 168.97 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.26 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 53' ' ' GLU . 10.1 t -153.36 154.29 34.22 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' OE1' ' N ' ' A' ' 53' ' ' GLU . 2.6 pm0 -38.74 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.667 0.27 . . . . 0.0 110.675 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 56' ' ' SER . 29.7 t -76.02 -14.07 60.22 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.58 39.0 0.12 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.031 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 54' ' ' SER . 27.7 t -64.02 -91.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.223 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.67 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 10.5 m-20 -118.09 -33.13 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.554 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.67 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 95.5 Cg_endo -85.82 -96.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.74 1.627 . . . . 0.0 112.038 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -150.7 150.75 29.03 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.395 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -71.43 179.23 4.76 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 121.947 1.764 . . . . 0.0 111.638 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -175.72 31.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.551 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.4 m -73.34 18.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 61' ' ' GLU . 45.8 tt0 -155.51 -55.52 0.09 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.778 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -168.58 -103.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.682 0.277 . . . . 0.0 110.661 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.74 137.08 24.92 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.874 0.368 . . . . 0.0 110.474 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -168.5 166.84 11.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.582 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.79 159.83 33.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.31 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 t -164.21 73.59 0.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.894 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.5 m -50.38 -44.5 54.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.373 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.9 p 61.98 105.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.855 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -163.51 -34.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.395 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -74.55 -51.2 15.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.208 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.23 81.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.218 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.6 t -73.51 -64.24 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.678 ' H ' ' HD3' ' A' ' 76' ' ' PRO . 2.5 p30 -175.6 31.81 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.949 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.678 ' HD3' ' H ' ' A' ' 75' ' ' ASP . 71.9 Cg_endo -69.24 -14.45 37.75 Favored 'Trans proline' 0 CA--C 1.558 1.677 0 N-CA-C 117.632 2.128 . . . . 0.0 117.632 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -93.51 116.74 0.3 Allowed 'Trans proline' 0 C--N 1.365 1.437 0 CA-C-N 123.086 2.138 . . . . 0.0 114.13 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.1 p -118.66 117.44 28.95 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.056 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -86.54 129.84 34.71 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' B' ' 47' ' ' SER . 49.2 t80 -113.52 143.3 44.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.695 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.42 ' OH ' HD11 ' A' ' 100' ' ' ILE . 70.0 m-85 -138.01 118.61 13.95 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.743 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 t -101.02 67.0 1.17 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.909 0.385 . . . . 0.0 110.61 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.2 mt -72.23 111.63 6.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.727 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.5 mm -98.84 145.89 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.867 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.45 161.44 11.77 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.68 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.88 26.85 48.96 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.323 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.41 ' O ' HD22 ' A' ' 88' ' ' LEU . . . 73.51 3.03 61.36 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.177 -0.535 . . . . 0.0 111.923 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.41 HD22 ' O ' ' A' ' 87' ' ' GLY . 2.8 mm? -115.94 149.4 38.81 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.04 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.622 ' CZ ' HD21 ' A' ' 91' ' ' ASN . 44.7 ttt-85 -111.91 115.05 28.35 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.9 mpt? -101.07 145.48 28.68 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.175 0.512 . . . . 0.0 110.847 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.622 HD21 ' CZ ' ' A' ' 89' ' ' ARG . 72.0 m-80 -138.4 129.76 27.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.051 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -112.05 -167.04 1.13 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.788 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.11 67.5 0.07 OUTLIER Glycine 0 C--N 1.332 0.341 0 C-N-CA 121.332 -0.461 . . . . 0.0 112.028 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.24 132.53 39.95 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.761 0.315 . . . . 0.0 111.101 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -135.89 115.58 12.92 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.336 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? 70.22 30.91 3.3 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.865 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.92 149.16 50.33 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.6 148.04 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.898 1.732 . . . . 0.0 111.97 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.16 138.69 54.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.384 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.636 ' C ' HD12 ' A' ' 100' ' ' ILE . 2.1 pp -92.74 159.43 2.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' H ' ' H ' ' A' ' 102' ' ' SER . 6.5 tmtm? -156.8 -22.86 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.303 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.403 ' H ' ' H ' ' A' ' 101' ' ' LYS . 53.1 p -101.1 121.73 42.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.08 130.49 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.9 p -152.52 160.62 43.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.252 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -148.19 170.54 17.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -165.29 161.89 19.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.41 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.61 124.91 30.93 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -138.63 107.72 6.04 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.138 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.78 -127.73 19.59 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.543 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 31.3 m-80 -97.98 19.52 13.78 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.581 0.229 . . . . 0.0 110.867 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.3 p -127.21 155.5 43.33 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.887 0.375 . . . . 0.0 110.754 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.27 133.19 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.437 ' CG ' ' N ' ' A' ' 114' ' ' ALA . 10.1 t30 -99.05 165.18 11.86 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.752 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' N ' ' CG ' ' A' ' 113' ' ' ASN . . . -164.41 118.72 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.498 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.598 ' HE ' ' CG1' ' A' ' 29' ' ' ILE . 12.2 mmt85 -112.13 130.58 55.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.809 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 tt -137.97 116.23 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.7 p -160.31 170.46 21.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.269 0.557 . . . . 0.0 111.603 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.4 p -84.61 163.73 19.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.906 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.3 149.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.795 0.331 . . . . 0.0 110.808 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 121' ' ' PRO . 37.3 p -98.14 149.78 36.07 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 120' ' ' SER . 72.7 Cg_exo -40.08 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 122.54 2.16 . . . . 0.0 113.046 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.65 3.06 61.98 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' CD ' ' H ' ' A' ' 125' ' ' LYS . 2.3 pt20 -81.84 -115.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 0.0 110.421 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 123' ' ' GLN . . . -161.16 20.84 0.21 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.555 ' H ' ' CD ' ' A' ' 123' ' ' GLN . 7.2 tptm -144.83 -179.26 6.48 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.99 152.0 26.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.372 0.606 . . . . 0.0 112.04 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.2 p -146.9 70.0 12.12 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.386 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.74 134.02 2.41 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.228 2.619 . . . . 0.0 114.135 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.462 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . . . -89.3 161.49 16.35 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.154 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 129' ' ' ALA . 1.0 OUTLIER -153.56 154.72 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.262 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.565 HG22 ' N ' ' A' ' 132' ' ' HIS . 62.2 m -82.54 162.31 22.03 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.427 0.632 . . . . 0.0 111.695 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.565 ' N ' HG22 ' A' ' 131' ' ' THR . 38.3 t60 -50.88 -40.67 57.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.168 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.07 -57.42 11.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.143 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.7 OUTLIER -56.48 -44.38 80.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.038 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.51 -56.58 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 109.896 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.402 HD11 ' CD2' ' A' ' 132' ' ' HIS . 23.1 mt -53.81 -35.08 61.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.781 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.11 -28.6 61.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.423 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 mmt -74.78 -61.82 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.036 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.964 HD13 ' N ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -53.61 -20.41 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.189 -178.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.964 ' N ' HD13 ' A' ' 139' ' ' ILE . 34.9 ttpt -77.64 -55.16 5.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.634 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.1 -31.76 56.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.6 t -43.89 118.75 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.996 0.426 . . . . 0.0 111.493 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 144' ' ' VAL . 1.6 tm-20 -141.23 126.44 18.51 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.127 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.46 ' N ' ' OE2' ' A' ' 143' ' ' GLU . 7.2 p -122.07 128.5 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.83 0.348 . . . . 0.0 110.59 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.2 p -101.39 167.67 10.02 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.55 146.74 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -166.99 94.95 0.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.452 ' H ' HG12 ' A' ' 185' ' ' VAL . 1.9 pt -92.68 127.31 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.29 0.567 . . . . 0.0 112.273 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -103.0 -179.33 3.92 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.946 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 8.0 m -93.35 129.29 39.52 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.451 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.8 p -103.45 -179.07 3.84 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.788 0.328 . . . . 0.0 110.29 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -155.49 -2.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 153' ' ' GLU . 6.1 mp0 -62.1 100.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.793 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -81.04 11.91 3.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.176 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -56.51 149.75 16.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.576 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 2.2 m-20 -55.74 172.8 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.713 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.3 t -98.8 145.65 26.74 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.637 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.5 p-10 -119.99 93.43 4.06 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.693 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.754 HD13 ' H ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -119.03 176.46 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -130.08 135.28 48.05 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 161' ' ' THR . 24.7 m -70.16 2.81 3.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -80.74 117.98 70.34 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -40.35 155.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.698 1.598 . . . . 0.0 112.05 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 19.6 m -81.64 138.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.868 0.366 . . . . 0.0 110.935 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 2.3 mm? -83.84 114.69 21.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.05 171.56 46.61 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.492 -0.385 . . . . 0.0 112.197 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 169' ' ' ILE . 9.3 t -101.95 7.32 41.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 109.891 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 33.8 t30 64.15 -8.36 0.19 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 167' ' ' SER . 2.1 pp -80.35 161.27 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.804 -0.359 . . . . 0.0 110.218 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.502 ' H ' ' NH1' ' A' ' 198' ' ' ARG . 13.0 t -123.57 137.46 54.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.491 ' CE1' HD11 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -74.19 38.57 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.106 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.417 ' NZ ' ' CB ' ' A' ' 170' ' ' SER . 58.8 mttp -67.62 -170.79 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.217 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -102.76 127.5 49.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.998 0.428 . . . . 0.0 110.509 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.486 ' H ' ' CD ' ' A' ' 212' ' ' LYS . 12.1 m -151.64 -168.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.896 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -43.97 144.08 0.98 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.344 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -111.78 141.97 44.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -162.29 151.6 15.69 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.534 177.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.98 104.5 2.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.161 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.3 mt -107.09 -42.76 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 195' ' ' PHE . 9.0 tt -72.59 138.08 22.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.087 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -101.13 -118.52 4.34 Favored Glycine 0 C--N 1.331 0.252 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.9 t -72.84 143.91 47.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 0.0 111.839 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.1 m -137.78 84.17 2.03 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 12.2 mt -109.93 103.95 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.187 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.452 HG12 ' H ' ' A' ' 148' ' ' ILE . 25.1 m -124.16 143.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.551 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.37 110.3 21.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.499 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 189' ' ' CYS . 7.0 m -50.75 -28.47 9.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.484 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -36.4 -28.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.077 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 187' ' ' THR . 30.2 p -149.34 24.23 0.91 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.455 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 24.9 t -143.25 81.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -69.19 -57.47 5.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.266 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 193' ' ' LEU . 14.0 t-20 -111.7 162.08 15.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.403 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 193' ' ' LEU . 6.9 tt -169.22 106.46 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 110.419 178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -100.89 130.87 46.96 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.481 ' CD1' HD12 ' A' ' 180' ' ' ILE . 5.2 t80 -125.24 133.44 52.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.809 0.338 . . . . 0.0 110.514 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.8 p -143.92 139.0 28.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.951 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 198' ' ' ARG . 18.7 t -135.03 160.34 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.502 ' NH1' ' H ' ' A' ' 170' ' ' SER . 57.0 ttt180 -170.67 111.54 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.124 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.3 tt -110.45 128.52 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.669 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.96 -155.24 8.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.878 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -91.39 119.98 31.85 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.789 0.328 . . . . 0.0 110.793 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.464 ' SD ' ' O ' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -82.01 2.37 31.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.215 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 92.2 m -100.77 -55.85 2.47 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 109.861 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.498 ' CB ' ' NZ ' ' A' ' 204' ' ' LYS . 0.2 OUTLIER -150.58 122.25 8.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.677 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -42.94 141.66 1.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.147 0.499 . . . . 0.0 111.754 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 208' ' ' GLU . 12.7 t -140.83 89.3 2.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.272 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 10.1 m -37.11 -27.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.25 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 206' ' ' SER . 85.0 mt-10 -73.06 -52.33 14.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.01 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.502 HD21 ' CE1' ' A' ' 132' ' ' HIS . 39.3 mt -91.5 7.81 39.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.305 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -97.21 119.03 34.96 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 19.2 m -145.29 168.21 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.486 ' CD ' ' H ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -154.22 167.71 28.98 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 112.557 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -151.12 163.96 37.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.295 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 171.29 160.21 19.28 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.837 -1.173 . . . . 0.0 113.156 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -148.02 172.64 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -139.6 104.74 5.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.928 0.394 . . . . 0.0 110.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -103.31 122.96 45.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.703 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 218' ' ' VAL . 5.7 m -143.59 120.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.252 0.548 . . . . 0.0 110.918 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.5 37.99 10.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.101 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.12 -4.86 83.14 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.726 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.2 t -100.08 116.18 31.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.23 0.515 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.28 154.6 19.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.356 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 42.2 t -169.7 127.51 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.329 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -77.53 140.55 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -169.25 111.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.452 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.24 100.91 8.56 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 69.7 p -131.63 166.26 21.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.631 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.14 96.88 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.781 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -87.92 18.2 4.34 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.589 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 77.0 p -62.7 -38.18 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 84.0 p -98.01 -2.28 40.72 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.297 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -41.68 -36.34 0.95 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.992 0.425 . . . . 0.0 110.541 -179.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 8.6 mt -148.26 142.81 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.078 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 236' ' ' THR . 0.9 OUTLIER -75.99 101.5 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.213 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.45 ' CB ' HH12 ' A' ' 115' ' ' ARG . 84.9 p -65.58 4.19 0.61 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 234' ' ' ASP . 46.9 p -91.19 -18.38 24.54 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.456 ' CB ' ' NZ ' ' A' ' 237' ' ' LYS . 9.1 mtmp? -104.64 8.44 35.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 238' ' ' LEU . 0.3 OUTLIER -78.94 161.8 26.43 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -145.21 134.6 23.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.69 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -57.39 134.04 55.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.151 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.418 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 41.0 t -100.92 -7.03 23.81 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.275 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.414 ' OXT' ' O ' ' A' ' 241' ' ' CYS . 1.6 p . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 117.641 -1.171 . . . . 0.0 111.751 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.755 0.312 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -51.34 112.79 0.89 Allowed 'Trans proline' 0 N--CA 1.475 0.399 0 C-N-CA 122.697 2.265 . . . . 0.0 112.138 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.42 158.49 5.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.49 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.7 171.24 30.66 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.874 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 58.3 m -73.63 -84.3 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 110.632 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -131.88 78.44 69.93 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.613 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.411 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 38.1 Cg_exo -57.19 -175.06 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.517 2.145 . . . . 0.0 112.31 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.42 ' HB3' ' H ' ' A' ' 187' ' ' THR . 58.1 Cg_exo -54.19 -132.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 123.23 2.62 . . . . 0.0 113.925 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t 175.81 50.83 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.391 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.83 97.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.534 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 98.0 m -142.53 142.24 32.19 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.22 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . 0.487 ' SG ' ' O ' ' B' ' 14' ' ' SER . 2.7 t -73.43 147.07 44.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.119 0.485 . . . . 0.0 110.685 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.534 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 15.1 m-85 -114.68 -20.86 10.49 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . 0.487 ' O ' ' SG ' ' B' ' 12' ' ' CYS . 7.9 m -146.23 148.82 32.89 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.049 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.493 ' CD2' ' OD2' ' B' ' 53' ' ' ASP . 9.5 m-85 -107.92 164.5 12.21 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.01 0.433 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.7 t -86.94 138.15 31.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.784 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.39 23.51 3.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.925 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.25 125.46 18.71 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 110.721 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -80.53 119.19 22.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.755 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' B' ' 20' ' ' LEU . 2.6 mm? -80.57 113.56 40.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.343 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -46.66 149.34 3.04 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.38 1.387 . . . . 0.0 111.786 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -43.87 -47.3 8.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.315 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -38.3 -32.25 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.0 44.33 1.23 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.775 0.322 . . . . 0.0 110.735 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -149.8 86.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.796 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -89.11 -28.23 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -153.26 -179.41 7.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.998 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -164.11 164.1 22.93 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.527 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.509 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 57.1 t80 -148.12 -179.98 7.32 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.509 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 44.3 mt-10 -123.0 149.62 44.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 110.789 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.409 ' O ' ' O ' ' B' ' 30' ' ' GLU . 40.8 p -55.67 -111.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.815 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.9 t -152.01 -153.84 0.5 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.781 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.417 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.4 m -132.98 -25.51 1.81 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.399 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 22.3 mt -59.36 -7.08 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 110.032 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.438 ' C ' ' H ' ' B' ' 37' ' ' GLN . 25.2 m -112.54 120.92 43.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.851 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 9.9 m -74.08 36.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.305 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.4 pt20 -169.91 61.68 0.41 Allowed Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 86.6 Cg_endo -73.14 -162.06 0.12 Allowed 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.793 2.329 . . . . 0.0 113.319 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.96 176.93 0.13 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.972 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -107.77 135.79 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.136 0.493 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.01 137.83 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.605 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.07 146.08 42.5 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.369 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -92.79 169.97 10.06 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.2 p -138.59 -143.34 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.18 0.514 . . . . 0.0 110.742 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.492 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -128.69 -38.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.278 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.27 41.66 3.46 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.76 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.615 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 11.6 t -147.06 -84.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.568 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.08 -90.35 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.321 0.388 . . . . 0.0 110.044 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -144.0 145.94 32.56 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.344 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 24.1 t -153.2 125.86 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.033 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.472 ' SG ' ' O ' ' B' ' 14' ' ' SER . 13.8 p -77.55 148.84 35.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.169 0.509 . . . . 0.0 111.395 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.89 142.37 42.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.753 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.493 ' OD2' ' CD2' ' B' ' 15' ' ' TYR . 9.2 m-20 -64.15 122.78 79.64 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.07 0.46 8.37 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 121.062 1.175 . . . . 0.0 110.863 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 44.5 t -77.27 -5.25 48.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.702 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' B' ' 57' ' ' SER . 1.1 tp10 -105.4 125.18 50.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.526 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 19.2 m -44.83 -43.86 9.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -56.4 -34.36 66.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.401 HG21 ' O ' ' B' ' 53' ' ' ASP . 40.2 t -69.94 -38.87 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.334 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.04 -52.49 59.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.796 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -59.85 -35.64 75.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.06 -35.91 81.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.19 -45.55 61.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.832 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -63.13 -32.31 73.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -71.48 -41.82 68.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.361 . . . . 0.0 110.933 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 19.1 mt -70.29 -19.45 63.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.265 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.51 -34.08 67.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.98 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.51 -77.62 0.15 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.813 0.339 . . . . 0.0 110.361 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 53.0 p30 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.537 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.815 0.34 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -43.27 -53.97 3.83 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.699 2.266 . . . . 0.0 112.152 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.93 127.03 22.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.444 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.8 m -164.16 83.57 0.43 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.565 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 pp -168.13 133.1 1.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.42 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -166.29 -33.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.532 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -168.0 143.5 3.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.487 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m -105.14 -21.37 13.27 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.819 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.6 m -65.37 -27.87 68.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.985 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.2 m -49.5 132.2 20.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.3 t -56.93 -25.36 57.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.581 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m -74.74 -29.45 61.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.609 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.6 m -74.35 -56.36 4.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.273 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.7 p -159.25 173.17 16.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 110.791 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.4 m -62.9 161.3 13.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.828 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.8 p -74.32 163.58 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.86 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 30.1 mp0 -112.15 7.47 19.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.529 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -67.32 -149.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.211 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -135.38 -68.87 0.51 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.461 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 41.8 t30 -79.02 52.07 1.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.424 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' O ' ' ND1' ' A' ' 22' ' ' HIS . 10.5 tptm -148.86 137.5 21.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.819 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.443 ' ND1' ' O ' ' A' ' 21' ' ' LYS . 22.9 m-70 -143.24 158.05 43.97 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.156 0.503 . . . . 0.0 111.184 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -99.47 76.76 2.05 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.415 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.523 ' CE ' ' HB1' ' A' ' 135' ' ' ALA . 46.6 tpp -65.71 128.33 35.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 0.0 111.441 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -135.67 149.04 19.89 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.3 tt -110.79 148.21 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' CB ' HD11 ' A' ' 169' ' ' ILE . 15.7 t0 -135.15 139.12 44.36 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.501 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.15 101.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.984 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.4 mt -98.0 131.9 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 mm -136.39 140.1 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.506 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.97 0.414 . . . . 0.0 110.056 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.48 135.06 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.746 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -102.15 120.1 39.89 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.636 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -74.58 152.87 39.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.853 0.358 . . . . 0.0 110.858 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 37' ' ' GLN . 33.7 mm-40 -70.63 158.82 35.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.284 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.33 28.62 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.737 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 35' ' ' GLN . 22.8 tt0 -141.05 -19.44 0.8 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.907 0.384 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.8 m -67.72 115.68 29.98 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.168 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 61.5 Cg_exo -40.0 157.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.823 1.682 . . . . 0.0 112.316 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.0 p -73.42 136.13 44.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.737 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 39' ' ' PRO . 20.0 m-80 -156.58 101.77 2.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.169 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -97.65 7.56 46.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.668 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -67.47 88.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.345 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 44' ' ' ILE . 20.1 pt -85.12 141.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.02 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 22.1 t 55.43 67.82 0.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 46' ' ' GLN . 10.2 tm0? -78.73 -25.99 44.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 t 177.48 159.34 0.42 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.589 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.25 125.86 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.0 m -119.76 123.34 43.5 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.643 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 19.1 mp0 -102.69 129.43 49.3 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 52' ' ' THR . 7.3 mm -134.71 159.61 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 51' ' ' ILE . 22.2 m -152.63 108.41 3.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.621 ' CG ' ' H ' ' A' ' 78' ' ' THR . 4.3 pt-20 -52.3 120.97 6.09 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.508 ' CB ' ' O ' ' A' ' 53' ' ' GLU . 22.6 t 112.14 -1.62 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 56' ' ' SER . 72.6 tt0 -28.97 -52.8 0.11 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 112.741 -2.027 . . . . 0.0 112.067 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 55' ' ' GLU . 5.5 m 29.48 -123.65 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.511 0.507 . . . . 0.0 112.138 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' H ' ' HD2' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -171.65 -54.47 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 57' ' ' ASP . 41.2 Cg_endo -85.75 -104.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.254 1.969 . . . . 0.0 111.64 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.05 132.42 95.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.16 125.45 6.48 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.842 1.695 . . . . 0.0 113.048 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.439 ' N ' ' OG ' ' A' ' 54' ' ' SER . 21.9 mt-10 70.74 52.96 0.29 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.12 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 64' ' ' SER . 2.1 t -148.78 15.07 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.838 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 64' ' ' SER . 6.3 tp10 -41.14 84.55 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.213 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 62' ' ' VAL . 48.2 m 48.64 108.16 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.84 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 64' ' ' SER . 19.7 tt0 90.54 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -75.88 54.61 0.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 59.75 171.66 0.08 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.304 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 t -148.2 133.14 18.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.517 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m 75.08 -47.79 0.62 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.723 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -44.0 155.55 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 111.107 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 m -108.93 39.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.224 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 53.19 84.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.124 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -137.25 19.32 2.96 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.374 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.4 m -146.05 145.89 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.977 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' O ' ' OE2' ' A' ' 61' ' ' GLU . 1.1 m-20 -178.64 -62.42 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.43 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -27.82 94.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.358 2.706 . . . . 0.0 113.588 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.24 176.32 8.21 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.392 2.061 . . . . 0.0 111.185 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.621 ' H ' ' CG ' ' A' ' 53' ' ' GLU . 16.1 p -130.3 139.59 50.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.858 0.361 . . . . 0.0 110.869 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 m -98.83 132.15 44.4 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -113.72 143.24 44.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.068 0.461 . . . . 0.0 110.429 -178.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 86.3 m-85 -129.57 124.87 34.9 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.652 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.2 p -103.91 62.66 0.76 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.662 0.267 . . . . 0.0 110.859 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 83' ' ' ILE . 13.1 tt -71.22 102.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.421 0.629 . . . . 0.0 110.12 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 tt -102.14 148.05 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.956 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.51 144.52 5.18 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.31 9.22 57.05 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.28 2.52 57.88 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.758 -0.258 . . . . 0.0 113.098 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.501 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -151.16 173.95 13.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.307 0.554 . . . . 0.0 111.367 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -129.09 117.18 20.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.738 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 1.5 mtt -101.99 122.0 43.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.297 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -109.93 122.57 47.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.493 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.8 178.03 4.68 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.617 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.01 74.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.037 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -76.9 143.26 39.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.045 0.423 . . . . 0.0 110.441 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.1 m -127.75 105.53 8.52 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.474 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.8 tttt 67.08 40.14 2.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.759 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 80.8 m -119.02 148.86 45.67 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.28 129.95 1.56 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.882 1.721 . . . . 0.0 111.937 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.706 ' NE2' ' H ' ' A' ' 99' ' ' GLN . 3.9 mp0 -50.39 144.99 6.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.9 mt -96.39 142.56 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -139.78 -11.54 1.15 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.016 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 m -113.17 116.48 29.88 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 pt -128.58 120.02 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.0 p -135.82 172.22 13.32 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.177 0.513 . . . . 0.0 111.928 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 64.0 tt0 -161.57 152.83 18.53 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 t -155.47 152.23 28.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.033 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.23 121.83 28.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.332 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -133.41 108.61 8.78 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.006 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.68 -119.06 6.35 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -112.58 26.35 10.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.806 0.336 . . . . 0.0 110.192 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.5 p -130.34 157.36 42.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.511 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.3 t -138.64 136.68 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.601 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -124.48 158.22 33.38 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.967 0.413 . . . . 0.0 110.728 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.49 135.82 13.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.461 HH21 HG21 ' A' ' 164' ' ' VAL . 53.9 ttp180 -114.0 123.66 50.26 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.041 0.448 . . . . 0.0 111.141 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.02 118.83 34.5 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.2 t -167.05 161.22 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.902 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.9 t -82.69 174.59 10.86 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.06 144.43 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.013 0.435 . . . . 0.0 110.982 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.4 p -79.73 151.02 73.58 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.047 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -39.77 163.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.921 1.747 . . . . 0.0 112.185 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 56.55 61.78 7.1 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.209 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -139.31 -52.27 0.54 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 156.07 -12.78 0.37 Allowed Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.696 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm -126.92 172.46 10.42 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.937 0.399 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -74.56 150.7 39.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.644 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.0 m -143.41 63.05 12.09 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.292 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -40.52 131.54 2.52 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.116 2.544 . . . . 0.0 113.339 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.8 152.46 23.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.38 176.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.699 0.285 . . . . 0.0 110.735 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.2 p -81.19 172.33 13.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.183 0.516 . . . . 0.0 111.692 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.461 ' CG ' ' OD1' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -61.26 -37.35 82.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -63.65 -57.07 11.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.568 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.105 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.523 ' HB1' ' CE ' ' A' ' 24' ' ' MET . . . -65.44 -57.24 8.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.039 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -53.54 -31.57 47.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.219 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.48 73.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.823 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 68.7 mtm -65.68 -52.34 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.6 mp -46.54 -22.84 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.453 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -87.28 -54.51 4.27 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -79.89 -36.02 37.16 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 t -44.26 116.03 0.95 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.721 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' B' ' 17' ' ' ALA . 49.9 mt-10 -145.02 156.61 44.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.12 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.9 136.05 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 120.965 0.412 . . . . 0.0 110.374 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.0 p -102.37 163.91 11.97 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.71 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.56 137.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.88 0.372 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -143.95 92.89 2.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.638 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.7 mm -79.23 139.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.648 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.452 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 58.3 ttt180 -134.17 165.36 25.27 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 7.1 t -90.67 118.09 29.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.318 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 152' ' ' GLU . 31.2 t -100.3 -176.05 3.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.706 0.289 . . . . 0.0 110.262 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.431 ' N ' ' OG ' ' A' ' 151' ' ' SER . 16.0 tp10 -162.45 17.74 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.993 0.425 . . . . 0.0 110.043 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -77.12 103.38 7.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.485 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -77.16 8.7 3.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -56.01 138.38 49.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.112 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.09 174.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.975 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 t -94.66 143.9 26.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.498 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.464 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 1.6 m-20 -117.6 91.44 3.57 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.955 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.5 pt -124.51 170.3 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.035 0.445 . . . . 0.0 110.689 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.492 ' CD ' ' HB3' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -104.95 -160.88 0.78 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.034 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.7 t -130.53 -3.48 4.26 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -83.45 130.6 55.65 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -39.29 158.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.876 1.717 . . . . 0.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.461 HG21 HH21 ' A' ' 115' ' ' ARG . 14.6 p -80.25 135.8 24.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.257 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 18.0 mt -82.07 125.04 30.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.591 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.89 163.96 17.29 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.163 -0.472 . . . . 0.0 112.562 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.8 t -94.72 5.61 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.801 0.334 . . . . 0.0 110.425 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.444 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 1.2 m-20 60.31 9.5 1.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.988 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.516 HD11 ' CB ' ' A' ' 27' ' ' ASP . 2.2 pp -98.01 154.65 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 172' ' ' LYS . 80.1 p -117.49 129.17 55.64 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -73.21 35.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.328 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.452 ' H ' ' C ' ' A' ' 170' ' ' SER . 19.3 tttp -59.21 -164.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -99.31 119.9 38.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 175' ' ' SER . 2.7 t -148.02 171.1 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.554 ' H ' HG12 ' A' ' 174' ' ' VAL . 6.3 p -31.48 149.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.495 0.497 . . . . 0.0 111.529 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -106.58 141.69 37.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.191 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.433 ' OE2' ' N ' ' A' ' 178' ' ' ASP . 3.8 tm-20 -150.85 137.42 18.79 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.619 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.433 ' N ' ' OE2' ' A' ' 177' ' ' GLU . 13.1 t70 -65.92 96.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.754 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.1 mt -107.26 -52.99 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.388 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 180' ' ' ILE . 5.5 tp -63.45 124.95 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.048 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.61 -117.38 2.44 Favored Glycine 0 C--N 1.331 0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.22 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.574 ' OG ' ' N ' ' B' ' 51' ' ' CYS . 41.5 m -74.18 139.25 44.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.793 -0.203 . . . . 0.0 111.16 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.7 p -138.3 91.58 2.57 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.21 0.529 . . . . 0.0 110.77 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 44.1 mm -99.13 115.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.051 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.27 138.48 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.155 0.502 . . . . 0.0 111.497 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -93.84 92.81 7.61 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 189' ' ' CYS . 1.3 p -47.27 -44.15 22.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.061 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -37.55 -27.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.038 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.452 ' N ' ' O ' ' A' ' 187' ' ' THR . 81.6 m -146.17 31.43 1.02 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.138 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.4 t -149.75 100.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.711 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -77.02 -60.64 2.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.843 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -117.91 177.94 4.59 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.567 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 195' ' ' PHE . 1.1 tt -174.07 108.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.474 ' OE1' HD21 ' A' ' 232' ' ' LEU . 48.3 mt-10 -93.44 137.65 32.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.553 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 193' ' ' LEU . 88.7 m-85 -117.37 130.77 56.72 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.713 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 4.0 m -144.3 119.73 10.3 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 198' ' ' ARG . 45.3 t -131.06 157.87 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.326 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.475 ' N ' HG12 ' A' ' 197' ' ' VAL . 45.5 ttt180 -158.31 156.13 30.05 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.981 0.42 . . . . 0.0 110.955 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.56 112.71 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.688 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.21 167.89 40.91 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.078 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -49.28 141.14 8.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 60.7 mtm -95.66 3.81 53.62 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.2 t -118.57 -47.92 2.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.719 0.295 . . . . 0.0 110.867 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -145.79 108.84 4.58 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 110.164 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -48.28 156.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 1.6 p -156.54 112.27 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.485 -0.779 . . . . 0.0 108.982 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 t -33.16 -59.3 0.36 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.582 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 208' ' ' GLU . 0.0 OUTLIER -52.19 -53.34 44.5 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 209' ' ' LEU . 0.8 OUTLIER -92.0 61.87 4.12 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -163.8 105.59 0.94 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.717 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.7 m -138.15 174.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.969 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -171.38 147.3 2.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.567 . . . . 0.0 111.584 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.3 t70 -121.73 171.2 9.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.39 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.483 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . -179.83 158.57 22.34 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.888 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.429 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 46.7 m-85 -150.31 165.45 32.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -134.03 104.92 6.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.995 0.426 . . . . 0.0 110.851 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -101.93 117.58 35.12 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.89 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.79 104.04 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.061 0.458 . . . . 0.0 110.703 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.6 t0 55.23 52.17 11.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.255 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.63 -9.52 50.24 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.908 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.8 p -89.6 109.11 20.09 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.63 -0.335 . . . . 0.0 110.944 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' A' ' 223' ' ' SER . . . -103.08 147.65 26.71 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 222' ' ' ALA . 73.1 m -166.79 129.53 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.285 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -82.2 141.14 33.27 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -171.07 108.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.272 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.1 97.28 2.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.242 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 76.6 p -126.06 154.18 43.39 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.91 95.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.55 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.2 35.6 0.81 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.353 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.6 m -74.65 -41.62 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.714 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -93.61 5.04 52.93 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.149 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -38.52 -37.22 0.3 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.135 0.493 . . . . 0.0 110.767 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 7.7 tp -159.66 148.88 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.728 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.65 100.57 4.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 110.274 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 27.3 t -68.23 -0.82 5.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.753 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 41.2 p -82.58 -21.15 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -105.2 10.06 33.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.241 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 1.7 mt -92.84 129.27 38.81 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -113.67 143.85 43.91 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.068 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' LYS . . . -55.75 171.32 0.23 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 241' ' ' CYS . 40.1 t -126.21 -6.13 6.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.71 179.695 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.785 0.326 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.21 118.04 5.23 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.536 2.157 . . . . 0.0 111.718 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -59.47 152.04 22.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.618 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.15 173.39 3.02 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.956 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.8 t -67.27 -88.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.727 0.298 . . . . 0.0 110.616 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' B' ' 6' ' ' ASP . 31.6 p-10 -151.1 59.17 3.2 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.359 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' B' ' 8' ' ' PRO . 73.2 Cg_endo -73.92 118.16 5.31 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.397 2.065 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' B' ' 7' ' ' PRO . 83.0 Cg_exo -42.72 172.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.852 1.701 . . . . 0.0 111.413 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.698 HG22 ' H ' ' B' ' 10' ' ' ALA . 6.5 m -134.34 173.21 11.87 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.425 0.631 . . . . 0.0 111.631 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.698 ' H ' HG22 ' B' ' 9' ' ' THR . . . -80.59 123.09 27.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.875 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 87.8 m -149.29 116.23 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . 0.402 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 0.1 OUTLIER -62.94 137.53 58.29 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.96 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -114.94 -20.62 10.46 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.985 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 73.4 m -122.43 143.58 49.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.062 177.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.483 ' CD2' ' OD1' ' B' ' 53' ' ' ASP . 16.4 m-85 -121.73 152.48 39.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.967 0.413 . . . . 0.0 111.808 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -80.29 141.27 35.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.913 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.572 ' H ' ' CD ' ' A' ' 143' ' ' GLU . . . -89.15 -28.02 20.31 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.349 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -87.54 126.03 34.68 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.724 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -85.85 114.61 22.91 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.553 ' N ' HD12 ' B' ' 20' ' ' LEU . 9.3 mp -75.33 115.08 41.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -41.93 151.04 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.134 1.889 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' B' ' 25' ' ' VAL . 39.7 ttm180 -45.87 -50.0 14.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.386 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -28.99 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.2 OUTLIER -109.6 50.26 0.8 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.941 0.4 . . . . 0.0 110.241 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' B' ' 22' ' ' ARG . 66.1 t -150.22 88.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -95.42 -21.14 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.35 179.21 8.52 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.499 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -166.98 163.38 15.99 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.287 0.565 . . . . 0.0 112.037 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -152.16 167.25 29.14 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.165 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' B' ' 31' ' ' THR . 50.9 mt-10 -114.08 152.18 31.44 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.422 ' O ' ' O ' ' B' ' 30' ' ' GLU . 73.0 p -55.92 -115.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.091 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -147.84 -149.29 0.29 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.874 0.368 . . . . 0.0 110.676 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.438 ' C ' ' H ' ' B' ' 35' ' ' CYS . 91.1 p -135.51 -24.38 1.37 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.276 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.24 -3.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.067 0.46 . . . . 0.0 109.788 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.446 ' C ' ' H ' ' B' ' 37' ' ' GLN . 58.0 m -114.99 117.31 30.23 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.503 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -73.65 37.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.964 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' B' ' 35' ' ' CYS . 10.2 pt20 -169.22 64.3 0.54 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 86.0 Cg_endo -75.95 -162.86 0.17 Allowed 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.921 2.414 . . . . 0.0 113.422 -177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' B' ' 51' ' ' CYS . . . 174.32 176.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.971 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.14 144.06 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 120.938 0.399 . . . . 0.0 110.224 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.44 130.47 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.505 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -112.14 144.21 41.9 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -111.51 115.19 28.79 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.066 0.46 . . . . 0.0 111.047 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 3.4 p -79.52 -140.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.48 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.85 -27.91 2.04 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.87 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -123.97 46.44 2.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.435 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 48.0 t -157.26 -84.95 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 121.108 -0.237 . . . . 0.0 110.944 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.76 -90.42 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.715 0.635 . . . . 0.0 109.777 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -131.17 140.68 49.96 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.726 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 43.0 t -150.19 112.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.505 0.669 . . . . 0.0 110.827 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.574 ' N ' ' OG ' ' A' ' 182' ' ' SER . 2.6 t -73.33 152.16 41.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.605 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.13 135.79 22.02 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.893 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.483 ' OD1' ' CD2' ' B' ' 15' ' ' TYR . 69.3 m-20 -61.74 125.9 85.81 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.99 2.64 5.24 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.433 1.422 . . . . 0.0 111.448 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 30.2 m -73.39 -3.49 27.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.292 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.404 ' O ' ' OE1' ' B' ' 60' ' ' GLN . 39.0 mt-10 -109.53 125.13 52.18 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.93 0.395 . . . . 0.0 110.363 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -50.12 -36.19 28.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.113 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -56.14 -36.18 67.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.936 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 t -70.72 -36.88 66.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.001 0.429 . . . . 0.0 110.271 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.404 ' OE1' ' O ' ' B' ' 56' ' ' GLU . 2.2 mp0 -70.07 -36.79 75.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.859 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.99 -37.56 69.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.225 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -65.31 -41.03 94.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.628 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -68.47 -44.21 83.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.919 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -60.13 -28.9 68.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.746 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -75.33 -43.7 49.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.946 0.403 . . . . 0.0 110.728 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -69.74 -22.75 63.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.457 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.57 -36.53 68.21 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.21 -75.34 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.279 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.581 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 mtt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.01 -4.82 16.04 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.019 1.812 . . . . 0.0 111.533 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.57 148.7 2.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.423 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 t -170.18 12.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.579 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.54 174.92 12.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.612 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -166.48 -72.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.509 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -70.65 122.09 19.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.546 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t -66.28 -17.12 64.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.579 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -72.37 -20.77 61.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.592 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.9 t -50.42 131.98 24.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.565 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.5 p -57.77 -29.59 64.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.638 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.3 p -76.83 -23.54 52.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.721 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 t -79.08 -48.05 15.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.2 m -165.35 171.27 13.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.093 0.473 . . . . 0.0 111.05 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.9 t -63.66 148.75 48.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.553 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.7 p -70.93 176.18 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.548 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -126.6 5.71 6.81 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.341 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 19' ' ' GLU . 43.1 mt-10 -83.03 92.9 7.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.411 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 18' ' ' GLU . 37.1 tt0 -23.54 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.171 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.408 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 5.0 p30 -76.22 50.09 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.358 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -158.49 135.71 9.99 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -145.53 166.43 25.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.82 0.343 . . . . 0.0 111.003 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -95.03 107.05 19.09 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.114 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.567 ' SD ' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -78.64 107.21 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.297 0.57 . . . . 0.0 110.581 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -113.86 148.32 18.71 Favored Glycine 0 C--N 1.332 0.333 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 tp -110.98 151.86 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' ' CD1' ' A' ' 29' ' ' ILE . 59.0 t0 -147.25 130.83 16.81 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 t -138.67 99.8 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.846 0.355 . . . . 0.0 111.558 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.7 mp -95.23 139.54 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 pt -148.71 135.13 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.471 0.653 . . . . 0.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' HD12 ' A' ' 193' ' ' LEU . 36.7 ttmt -115.98 123.19 47.39 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.589 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.63 110.18 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.784 0.326 . . . . 0.0 111.162 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 p -87.58 122.24 31.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.758 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' NZ ' ' C ' ' A' ' 110' ' ' ASN . 25.1 mtmm -80.55 154.31 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.758 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.653 ' NE2' ' H ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -74.06 154.06 39.38 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.496 ' H ' ' CD ' ' A' ' 35' ' ' GLN . 15.2 t70 -62.1 -19.47 63.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.4 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.653 ' H ' ' NE2' ' A' ' 35' ' ' GLN . 70.6 mt-30 -82.75 -36.71 25.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.193 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.8 p -48.04 147.21 3.71 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.742 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.09 168.47 24.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.113 1.876 . . . . 0.0 111.575 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.0 m -75.36 128.46 35.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.63 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.475 ' ND2' ' OE1' ' A' ' 154' ' ' GLU . 29.7 m120 -158.24 101.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.73 -0.27 21.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.643 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -72.69 71.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -71.06 170.36 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 110.383 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 32.6 t 50.35 57.86 6.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.48 0.657 . . . . 0.0 110.443 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.98 -21.2 47.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 t 173.14 154.12 0.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.905 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.16 135.06 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.249 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -114.29 153.93 28.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -136.22 109.73 7.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.531 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 79' ' ' THR . 6.0 mt -122.01 154.02 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 t -153.59 151.32 29.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.407 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 37.8 tt0 -52.96 171.57 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.2 p -83.28 -19.37 36.42 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -48.89 -67.03 0.3 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.435 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 t -33.59 115.3 0.22 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.572 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.627 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -92.17 -24.99 0.27 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 57' ' ' ASP . 93.0 Cg_exo -45.79 -5.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.221 1.948 . . . . 0.0 114.008 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -177.53 -50.68 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.809 178.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 38.2 Cg_exo -59.11 -143.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.597 0 C-N-CA 121.939 1.759 . . . . 0.0 111.88 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 62' ' ' VAL . 9.4 tm-20 91.47 160.23 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.478 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 1.9 m -143.5 -104.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.491 0.186 . . . . 0.0 110.692 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.465 ' H ' HG23 ' A' ' 62' ' ' VAL . 17.0 tp10 -160.45 156.7 26.41 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 0.9 OUTLIER 82.99 130.78 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.733 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -159.02 -175.73 5.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.829 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -161.82 153.56 18.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.359 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 68' ' ' SER . 1.8 p-10 -87.68 -94.84 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.516 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.427 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 51.6 p 52.62 56.96 6.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.661 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 78.4 p 50.43 80.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.616 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 p -46.49 140.84 4.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 71' ' ' VAL . 11.8 p -160.97 37.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.802 0.811 . . . . 0.0 109.55 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.44 41.64 1.11 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.429 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -132.11 15.09 4.68 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.521 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.48 -62.69 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.671 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.92 97.46 49.52 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.644 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -38.9 157.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.315 2.01 . . . . 0.0 112.071 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.97 -170.01 0.26 Allowed 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.875 2.383 . . . . 0.0 113.105 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -140.67 149.56 42.4 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.032 0.444 . . . . 0.0 111.498 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 51' ' ' ILE . 9.2 m -101.37 129.85 47.45 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 63.8 t80 -118.39 101.8 8.45 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -108.96 117.56 34.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.915 0.388 . . . . 0.0 110.277 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.8 t -95.95 85.32 4.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.327 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.59 118.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.069 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.0 tt -106.62 146.79 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.796 0.331 . . . . 0.0 110.109 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.56 157.57 7.77 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.31 7.95 82.02 Favored Glycine 0 C--N 1.331 0.293 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.99 9.99 60.29 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.829 -0.224 . . . . 0.0 112.582 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.56 174.47 15.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.978 0.418 . . . . 0.0 111.045 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -115.81 123.88 49.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.719 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.557 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.2 mpp? -102.71 97.94 8.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.91 0.386 . . . . 0.0 110.832 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' HG23 ' A' ' 146' ' ' ILE . 84.3 m-20 -86.88 133.89 33.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.377 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.456 ' CG ' ' CE2' ' A' ' 81' ' ' TYR . 78.6 m-85 -116.27 -164.91 1.0 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.76 71.94 0.03 OUTLIER Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.616 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 94' ' ' PHE . 0.1 OUTLIER -77.07 140.54 40.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.166 0.508 . . . . 0.0 110.641 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -131.97 108.27 9.25 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.253 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? 69.04 36.5 2.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.991 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 31.9 m -122.38 149.65 55.53 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -34.91 153.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.408 2.072 . . . . 0.0 112.573 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -76.21 106.43 7.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.228 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -62.48 146.05 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.963 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -147.21 -12.05 0.42 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.861 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.9 t -106.09 113.79 27.53 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.2 mt -124.03 108.2 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.0 m -139.48 153.92 47.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.77 0.319 . . . . 0.0 111.815 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' N ' ' OE1' ' A' ' 105' ' ' GLU . 17.0 mp0 -145.11 169.69 17.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.655 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 11.6 p -157.83 153.95 27.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.87 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.27 118.2 20.97 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.853 0.358 . . . . 0.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -132.4 107.63 8.64 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.99 -138.7 25.96 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.442 ' C ' ' NZ ' ' A' ' 34' ' ' LYS . 24.5 p30 -91.99 26.29 2.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.741 0.305 . . . . 0.0 110.494 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 112' ' ' VAL . 87.0 m -129.63 156.47 44.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.772 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.48 ' N ' HG22 ' A' ' 111' ' ' THR . 35.0 m -142.07 138.87 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.316 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.47 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -119.57 168.08 11.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.115 0.483 . . . . 0.0 111.194 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -152.25 127.33 9.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.105 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.477 ' NH1' ' OG ' ' A' ' 235' ' ' SER . 76.9 ttt180 -113.52 110.79 20.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.656 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.423 HD22 ' C ' ' A' ' 115' ' ' ARG . 3.2 mm? -115.19 124.9 52.62 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.3 p -168.07 161.75 12.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.938 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -77.93 171.0 15.66 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.623 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.83 145.56 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.043 0.449 . . . . 0.0 111.338 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.15 163.38 53.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.43 150.23 84.37 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 122.209 1.939 . . . . 0.0 111.664 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.37 9.67 85.59 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.329 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -82.96 -60.51 2.14 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.436 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 158.35 -16.73 0.29 Allowed Glycine 0 C--N 1.331 0.296 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -110.42 179.0 4.21 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -70.48 158.74 35.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.108 0.48 . . . . 0.0 111.242 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.4 p -155.04 61.03 2.86 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.908 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -40.36 135.55 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.936 2.424 . . . . 0.0 113.286 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -114.99 145.87 41.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.272 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.567 HG22 ' SD ' ' A' ' 24' ' ' MET . 5.8 tp -140.71 168.35 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.655 0.264 . . . . 0.0 110.54 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.5 p -73.14 178.58 4.32 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 111.475 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.437 ' H ' ' CD2' ' A' ' 132' ' ' HIS . 14.0 p80 -71.23 -34.3 70.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.735 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -56.54 -57.61 11.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.64 -31.89 73.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.993 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.89 82.18 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.505 ' O ' ' NZ ' ' A' ' 140' ' ' LYS . 35.3 tp -74.23 -32.82 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.595 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.18 -52.02 18.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.55 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -64.12 -54.53 32.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.587 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.585 ' N ' ' SD ' ' A' ' 138' ' ' MET . 20.7 tt -45.87 -22.01 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 136' ' ' LEU . 26.4 mtmm -92.96 -26.35 17.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.283 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.47 -30.84 14.83 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 38.0 t -47.3 117.02 1.59 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.942 0.401 . . . . 0.0 111.568 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' B' ' 17' ' ' ALA . 8.5 tm-20 -138.74 121.57 16.52 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.349 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.9 t -111.26 125.77 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.952 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -100.78 159.2 15.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.906 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 91' ' ' ASN . 3.2 mt -148.78 156.86 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.938 0.399 . . . . 0.0 110.536 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -166.1 85.76 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.59 144.79 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.495 . . . . 0.0 111.793 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -135.8 175.41 9.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.812 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 3.7 t -91.46 134.88 34.26 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.45 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.1 p -111.39 166.16 11.35 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.771 0.319 . . . . 0.0 110.169 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.89 6.99 2.24 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -74.93 99.45 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.096 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.475 ' OE1' ' ND2' ' A' ' 41' ' ' ASN . 9.8 mm-40 -83.23 18.88 1.6 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.854 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -63.71 148.84 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.891 0.377 . . . . 0.0 110.613 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 157' ' ' SER . 38.4 t70 -52.16 171.79 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.194 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.433 ' N ' ' CG ' ' A' ' 156' ' ' ASP . 35.2 p -100.02 149.82 23.07 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.086 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 4.2 m-20 -116.73 88.83 2.98 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.3 pt -103.25 177.13 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.388 0.613 . . . . 0.0 111.528 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.875 ' HZ3' ' H ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -108.36 -173.29 2.24 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.06 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 161' ' ' THR . 91.8 m -124.56 -9.26 7.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.413 ' H ' ' HG2' ' A' ' 160' ' ' LYS . 14.6 m-70 -100.14 127.56 33.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.787 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -39.42 159.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.03 1.82 . . . . 0.0 112.705 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.8 t -76.09 140.38 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 20.2 mt -85.2 125.29 32.73 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.366 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 159.85 20.32 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.291 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.469 ' O ' ' SD ' ' A' ' 202' ' ' MET . 1.3 m -93.8 12.0 27.31 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.159 0.504 . . . . 0.0 110.187 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.4 t30 58.08 9.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.719 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.22 148.58 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' A' ' 198' ' ' ARG . 20.5 m -112.6 140.06 47.68 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.495 ' NE2' HD13 ' A' ' 29' ' ' ILE . 22.0 m80 -74.95 43.95 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.535 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -71.53 162.68 29.06 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -77.39 128.02 33.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.049 0.452 . . . . 0.0 110.595 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.7 m -149.29 -166.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.0 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.1 p -48.08 145.06 3.3 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.423 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -112.47 144.38 42.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.906 0.384 . . . . 0.0 111.239 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -158.74 152.1 22.83 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.483 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -68.61 106.33 2.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.274 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.1 mm -116.93 -59.65 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.724 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.1 mt -61.26 122.05 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.14 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.4 -119.81 2.11 Favored Glycine 0 C--O 1.225 -0.412 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.955 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.552 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 52.2 p -72.07 141.86 49.23 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.47 ' OG1' ' CE2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -145.02 83.82 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.68 97.04 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.991 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 185' ' ' VAL . 18.1 m -112.18 131.65 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 120.953 0.406 . . . . 0.0 111.59 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -79.44 114.99 18.8 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.112 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.9 p -52.25 -28.04 17.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -39.21 -30.41 0.06 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.514 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 65.1 m -143.95 26.43 1.53 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.732 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 44.0 t -149.22 89.27 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.871 0.367 . . . . 0.0 110.483 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -67.71 -56.44 9.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.648 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -133.65 146.32 50.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.598 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 31' ' ' LYS . 23.0 tp -144.14 120.81 11.15 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.839 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 12.7 mp0 -105.92 130.78 53.8 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.512 ' N ' ' CD1' ' A' ' 195' ' ' PHE . 0.2 OUTLIER -107.23 138.63 43.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.912 0.387 . . . . 0.0 110.528 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.2 t -144.35 120.64 10.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.62 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 ' N ' ' A' ' 198' ' ' ARG . 6.7 p -131.93 159.64 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 197' ' ' VAL . 11.4 ttt85 -171.25 112.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.241 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 199' ' ' ILE . 8.5 tt -113.3 129.84 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.819 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -168.83 -148.97 5.97 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.862 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -95.95 119.83 35.15 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.469 ' SD ' ' O ' ' A' ' 167' ' ' SER . 21.8 mmt -82.85 3.86 27.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.601 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.29 -54.31 2.71 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.689 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -153.76 120.73 5.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.726 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -49.2 129.22 17.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.148 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.4 t -124.8 113.33 17.78 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.797 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 59.9 p -35.58 -39.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.859 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -79.21 -45.58 19.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.02 61.21 3.98 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.747 0.308 . . . . 0.0 111.07 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.34 128.17 7.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.185 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.489 HG23 HD11 ' A' ' 139' ' ' ILE . 3.8 t -142.9 164.35 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.03 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.477 ' N ' ' CG1' ' A' ' 211' ' ' VAL . 0.9 OUTLIER -161.13 127.34 3.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.081 0.467 . . . . 0.0 110.816 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.03 171.51 11.79 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.448 ' C ' ' CD1' ' A' ' 215' ' ' PHE . . . 155.76 160.49 10.01 Favored Glycine 0 CA--C 1.511 -0.166 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.188 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 215' ' ' PHE . 14.5 m-85 -141.57 -176.8 4.88 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -134.73 105.99 6.72 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.203 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.66 113.55 25.31 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 218' ' ' VAL . 31.8 m -135.98 120.14 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.038 0.447 . . . . 0.0 110.523 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 218' ' ' VAL . 4.5 p-10 46.09 51.32 11.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.979 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 75.24 2.96 68.53 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.668 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.7 t -104.41 119.89 39.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.066 0.433 . . . . 0.0 110.678 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.07 155.87 18.33 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.121 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 79.3 p -170.87 129.81 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.209 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -80.14 141.9 35.29 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -170.86 101.6 0.17 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.17 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.39 96.55 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.714 0.292 . . . . 0.0 110.387 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 77.2 p -126.04 160.43 30.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.559 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.64 99.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -91.66 21.96 4.4 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 87.5 m -63.24 -35.4 80.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.746 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.1 p -97.95 -4.75 35.7 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.1 tp -43.45 -31.8 0.76 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.852 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 6.3 tt -143.53 144.35 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.203 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 236' ' ' THR . 31.5 m-20 -83.15 91.4 7.23 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 115' ' ' ARG . 14.2 t -56.78 -0.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.202 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 234' ' ' ASP . 58.4 m -88.36 -20.24 25.59 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -101.6 11.42 38.96 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.747 0.308 . . . . 0.0 111.465 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 238' ' ' LEU . 2.5 mm? -84.78 133.23 34.35 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.694 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -127.09 132.3 50.67 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.361 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.875 ' H ' ' HZ3' ' A' ' 160' ' ' LYS . . . -55.67 165.48 0.85 Allowed 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.156 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 38.1 t -126.23 -2.9 6.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.971 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.765 0.317 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.93 111.68 0.72 Allowed 'Trans proline' 0 N--CA 1.475 0.438 0 C-N-CA 122.628 2.219 . . . . 0.0 112.15 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 154.5 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.539 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.53 170.15 10.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.761 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 p -72.61 -84.65 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.868 0.366 . . . . 0.0 110.618 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -136.23 75.9 51.93 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.636 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' B' ' 8' ' ' PRO . 27.4 Cg_exo -60.27 176.9 0.66 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.534 2.156 . . . . 0.0 112.355 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.415 ' O ' ' O ' ' B' ' 7' ' ' PRO . 86.7 Cg_exo -51.37 -124.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.484 0.946 0 C-N-CA 123.268 2.646 . . . . 0.0 113.547 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.993 HG23 ' H ' ' B' ' 10' ' ' ALA . 1.2 t -170.59 -74.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.599 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.993 ' H ' HG23 ' B' ' 9' ' ' THR . . . 74.0 64.9 0.09 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.324 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 33.3 m -116.29 135.49 53.84 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.603 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 31.2 t -41.31 138.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.779 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.47 ' CE2' ' OG1' ' A' ' 183' ' ' THR . 0.0 OUTLIER -125.17 -26.79 3.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.305 179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 23.6 m -138.66 143.02 39.03 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.506 ' N ' ' CD1' ' B' ' 15' ' ' TYR . 1.1 m-85 -107.18 149.12 28.04 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.2 t -74.94 133.72 41.69 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.463 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 143' ' ' GLU . . . -79.06 -45.44 20.13 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.589 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -79.33 126.13 30.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.87 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.61 150.22 48.24 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.118 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 20.8 mt -105.01 100.06 22.51 Favored Pre-proline 0 N--CA 1.469 0.505 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.513 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -42.23 146.44 0.68 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.69 1.594 . . . . 0.0 111.968 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -46.12 -48.21 17.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.643 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' B' ' 23' ' ' ASN . 11.5 m-80 -49.37 -22.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.718 0.294 . . . . 0.0 111.291 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.407 ' CE1' ' OE1' ' A' ' 53' ' ' GLU . 9.6 t80 -109.42 33.57 4.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.201 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 66.3 t -153.47 93.79 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.686 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 32.0 m -88.42 -23.72 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 21.5 t70 -156.76 -179.52 8.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.163 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.477 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 7.9 p90 -158.51 170.61 21.81 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.084 0.469 . . . . 0.0 111.36 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.45 ' CG ' ' N ' ' B' ' 30' ' ' GLU . 47.4 t80 -154.02 179.28 9.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.12 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.45 ' N ' ' CG ' ' B' ' 29' ' ' TYR . 85.9 mt-10 -124.14 147.37 48.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.873 0.368 . . . . 0.0 110.364 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -55.82 -109.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.5 m -153.86 -147.96 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.669 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.455 ' C ' ' H ' ' B' ' 35' ' ' CYS . 11.1 t -136.47 -32.43 0.84 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.308 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.54 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 4.3 mp -51.79 -10.99 0.13 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.38 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.455 ' H ' ' C ' ' B' ' 33' ' ' SER . 1.6 p -111.04 118.63 36.57 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 79.4 p -72.58 37.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.723 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' B' ' 35' ' ' CYS . 3.4 pt20 -171.27 61.83 0.35 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.66 -167.66 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.669 2.246 . . . . 0.0 113.386 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -175.45 176.02 2.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.639 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -106.25 131.85 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.683 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.08 132.94 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.597 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -103.74 147.7 26.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.167 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -94.05 169.57 10.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.468 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.2 p -142.0 -145.82 0.18 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.719 0.691 . . . . 0.0 111.499 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.468 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -127.62 -40.12 1.78 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.33 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.75 43.09 3.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.361 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 8.5 t -149.04 -83.78 0.1 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.435 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -87.56 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.004 0.43 . . . . 0.0 109.878 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -139.53 147.37 41.13 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.65 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -150.39 119.09 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 111.098 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.552 ' H ' ' CB ' ' A' ' 182' ' ' SER . 7.2 t -59.8 157.51 12.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.664 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.485 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.1 134.79 13.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.811 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -73.01 121.28 84.7 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -72.32 1.4 6.15 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.223 1.282 . . . . 0.0 111.863 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 27.7 t -76.05 -4.05 39.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.957 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' B' ' 57' ' ' SER . 0.8 OUTLIER -106.87 124.87 50.24 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.511 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 22.1 p -44.32 -47.34 9.55 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.4 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 85.9 m95 -55.11 -27.79 47.75 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.22 -43.98 56.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.5 0.667 . . . . 0.0 109.646 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -62.05 -41.67 98.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.97 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -70.66 -34.86 72.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.451 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -66.45 -37.57 85.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.792 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 73.3 t -71.11 -47.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -59.95 -31.72 70.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.047 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -72.56 -37.44 68.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 110.848 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.58 -22.09 61.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.558 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -73.17 -32.2 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.235 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.63 -78.07 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.217 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 41.8 t30 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.549 -180.0 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.98 -51.94 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.129 1.886 . . . . 0.0 111.682 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.16 127.46 1.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.563 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.2 t -68.26 -84.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.59 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 7' ' ' GLN . 11.1 tp -168.23 -75.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.442 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -62.92 79.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.43 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 5' ' ' LEU . 22.9 mt-30 -148.07 139.78 23.82 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.546 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 99.6 p -165.37 -33.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.162 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.7 m -79.14 -25.48 42.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.625 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.0 p -47.93 128.52 13.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.513 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 t -61.28 -19.94 62.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.719 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.1 p -77.4 -30.9 53.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.379 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.0 p -77.24 -46.68 22.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.6 m -163.15 158.88 22.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.912 0.387 . . . . 0.0 110.669 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.1 t -57.11 154.34 10.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.733 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.5 p -68.62 165.5 19.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.514 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' CD ' ' N ' ' A' ' 17' ' ' GLU . 34.9 mp0 -115.42 7.94 15.16 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.258 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.24 -163.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.532 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 15.3 mp0 -114.56 -73.01 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.023 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -87.61 60.26 5.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.145 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 21.7 tttm -157.78 141.46 15.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.258 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -149.42 179.13 8.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.387 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.508 ' CD2' ' OG ' ' A' ' 127' ' ' SER . 32.1 t60 -108.93 90.23 3.23 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.928 0.394 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.506 ' CE ' ' HB1' ' A' ' 135' ' ' ALA . 53.9 tpp -71.92 126.72 30.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.903 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 199' ' ' ILE . . . -136.07 167.13 24.48 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.5 pt -111.32 150.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.23 121.04 9.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.8 146.88 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.184 0.516 . . . . 0.0 111.254 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD12 ' NH2' ' A' ' 198' ' ' ARG . 21.1 mt -137.27 140.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 30' ' ' ILE . 7.9 tt -130.77 122.26 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.138 0.494 . . . . 0.0 111.429 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -107.69 111.28 23.41 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.7 t -112.32 122.1 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.952 0.406 . . . . 0.0 111.643 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.0 m -97.25 114.62 26.39 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -68.3 151.8 46.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -64.82 179.35 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -80.63 -28.43 36.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.737 0.303 . . . . 0.0 110.71 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -85.31 -34.75 21.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.2 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.3 m -40.3 104.1 0.32 Allowed Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -43.87 161.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.931 1.754 . . . . 0.0 112.039 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.8 p -67.99 140.14 56.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.639 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.419 HD22 ' C ' ' A' ' 41' ' ' ASN . 0.4 OUTLIER -165.3 96.21 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.42 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -99.32 10.62 41.07 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -65.35 82.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.125 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.6 pt -81.26 142.74 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.634 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.53 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 33.9 t 56.21 67.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.5 tp60 -78.47 -31.45 47.88 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.4 p -178.32 167.47 1.9 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.927 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.504 ' CG1' ' SG ' ' A' ' 241' ' ' CYS . 4.0 m -145.95 130.04 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.918 0.39 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 82' ' ' SER . 41.6 p -102.99 172.89 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.933 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -159.93 116.02 2.45 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.73 158.25 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -150.87 110.64 4.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.497 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 53' ' ' GLU . 7.4 pt-20 -57.17 84.85 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 123.566 1.65 . . . . 0.0 109.601 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' THR . 9.9 p -145.55 17.05 1.48 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.26 -1.791 . . . . 0.0 106.571 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.4 pm0 -135.24 14.02 3.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.405 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.6 p -164.78 30.9 0.07 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.422 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 59' ' ' ASP . 6.3 p-10 -172.89 150.38 2.01 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.653 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' O ' ' CG ' ' A' ' 59' ' ' ASP . 32.0 Cg_exo -35.15 86.36 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.598 2.198 . . . . 0.0 112.775 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.9 m-20 164.12 64.5 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.14 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -83.16 65.25 7.86 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.704 2.27 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -139.96 81.13 1.8 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.092 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -173.2 -27.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.297 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -172.59 30.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.7 p 177.73 -177.61 0.2 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.347 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.7 155.73 37.82 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.085 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -136.0 -127.31 0.15 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.328 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 18.9 p-10 -162.94 136.26 5.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.943 0.401 . . . . 0.0 110.832 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.0 t 52.22 65.67 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.76 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 p -79.7 -14.02 59.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.4 t -76.52 48.44 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.047 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 72' ' ' GLU . 27.5 m -51.75 -46.96 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.301 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' N ' HG23 ' A' ' 71' ' ' VAL . 44.2 mt-10 -147.91 -33.78 0.25 Allowed 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 69.76 47.96 0.6 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.792 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.51 46.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.064 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -158.35 66.8 3.38 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.76 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.72 158.34 2.97 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.495 2.13 . . . . 0.0 111.937 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.84 167.61 22.0 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.462 2.108 . . . . 0.0 111.707 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.501 ' N ' ' OE2' ' A' ' 53' ' ' GLU . 32.8 m -119.14 131.28 55.87 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.793 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.9 p -87.72 126.17 34.83 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.462 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 59.8 t80 -136.72 107.8 6.75 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CD2' ' CE1' ' A' ' 92' ' ' PHE . 4.8 p90 -106.8 -179.03 3.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.496 ' N ' ' OG1' ' A' ' 49' ' ' THR . 15.8 m -152.53 75.42 1.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.932 0.396 . . . . 0.0 109.992 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 pt -72.4 119.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.51 0.671 . . . . 0.0 110.753 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.1 mt -101.26 145.13 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.518 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.46 166.1 16.32 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.37 22.36 50.86 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.09 14.18 76.32 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.36 156.57 48.27 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.938 0.399 . . . . 0.0 110.502 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.7 ttp180 -122.57 114.87 21.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.314 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 36.5 mtt -101.3 123.06 44.8 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.78 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -115.48 119.97 37.95 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.256 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.655 ' CE1' ' CD2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -108.15 169.36 8.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.77 77.63 0.19 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.337 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.45 145.35 29.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.157 0.503 . . . . 0.0 110.642 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.1 m -141.63 122.21 14.2 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? 66.45 34.26 6.3 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.378 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -132.55 143.72 49.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -34.39 144.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.387 2.058 . . . . 0.0 112.74 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -68.59 154.87 41.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.338 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.9 tt -93.65 144.62 9.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.221 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -143.27 -15.96 0.66 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.717 0.294 . . . . 0.0 110.331 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -113.16 118.06 33.66 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.278 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 103' ' ' ILE . 5.9 tp -135.05 128.68 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 p -142.79 179.41 7.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.912 0.387 . . . . 0.0 110.865 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.53 ' CD ' ' H ' ' A' ' 45' ' ' CYS . 60.0 tt0 -164.22 154.58 14.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.575 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.2 t -157.63 153.03 26.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.414 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.24 123.65 30.65 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.29 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -135.3 107.9 7.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.966 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.31 -124.69 7.35 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -106.61 27.78 8.5 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.732 0.301 . . . . 0.0 110.511 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -133.72 159.83 39.37 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.985 0.421 . . . . 0.0 110.731 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.35 134.89 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.476 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CG ' HD12 ' A' ' 233' ' ' ILE . 4.9 m120 -114.86 155.08 27.47 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.06 128.44 8.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.848 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -108.24 122.99 48.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.033 0.444 . . . . 0.0 111.154 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.878 ' N ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -112.98 114.6 27.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.4 t -157.58 170.0 23.41 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.843 -0.743 . . . . 0.0 112.593 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.3 p -94.52 166.17 12.18 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.438 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.98 150.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.374 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 p -99.43 150.42 36.74 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.867 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -38.84 163.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.121 1.88 . . . . 0.0 112.543 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 50.23 73.54 0.36 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.215 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -152.89 -27.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 0.0 110.088 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.88 12.62 13.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.193 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -134.95 155.42 50.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -56.31 151.33 13.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.527 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.508 ' OG ' ' CD2' ' A' ' 23' ' ' HIS . 2.2 t -153.19 67.13 6.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.53 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.22 130.0 27.19 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.887 2.391 . . . . 0.0 113.331 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -96.2 158.07 15.61 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.694 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 25.8 pt -145.34 160.87 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.82 0.343 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.8 p -75.78 178.53 6.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.047 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.422 ' CE1' HD21 ' A' ' 209' ' ' LEU . 10.0 t60 -69.27 -35.95 76.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.503 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -64.31 -57.85 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.989 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -57.26 -30.61 64.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.995 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.506 ' HB1' ' CE ' ' A' ' 24' ' ' MET . . . -68.29 -56.96 6.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.769 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.0 tp -54.46 -32.61 58.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.127 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.51 -52.46 18.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.646 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mtt -57.16 -52.72 64.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.145 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 6.2 mm -45.98 -21.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.296 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -91.43 -41.55 10.8 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.79 -31.06 56.73 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 7.0 m -41.47 111.15 0.2 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.925 0.393 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -139.48 116.96 11.35 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.055 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 144' ' ' VAL . 12.1 p -117.57 127.35 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.055 0.455 . . . . 0.0 110.659 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 m -101.06 162.9 12.57 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.449 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 9.4 tp -145.47 136.92 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.992 0.425 . . . . 0.0 110.646 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -146.99 90.42 1.9 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.882 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.9 tt -83.73 140.33 16.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.72 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 150' ' ' CYS . 35.8 ttm180 -133.39 170.45 15.45 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.43 ' N ' ' CG ' ' A' ' 149' ' ' ARG . 5.8 t -90.48 126.64 35.98 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.187 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.7 p -120.38 133.45 55.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.865 0.364 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -100.57 21.23 13.64 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.622 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' A' ' 153' ' ' GLU . 0.0 OUTLIER -50.29 158.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -144.54 -0.74 0.94 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.197 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 26.8 mtmm -63.89 171.58 2.74 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.632 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -78.23 173.89 11.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.5 t -92.54 144.28 25.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.503 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.6 t70 -120.18 89.86 3.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.999 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.0 pt -120.53 172.25 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.428 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.59 ' NZ ' ' NE2' ' A' ' 162' ' ' HIS . 31.0 tttm -124.32 136.4 54.08 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.005 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 161' ' ' THR . 29.8 m -64.26 0.43 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.59 ' NE2' ' NZ ' ' A' ' 160' ' ' LYS . 1.8 m-70 -79.3 119.14 76.03 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -40.11 157.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 121.811 1.674 . . . . 0.0 112.281 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.45 134.7 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.686 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 13.8 mt -77.47 120.02 21.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.18 162.42 22.77 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 111.906 -0.477 . . . . 0.0 111.906 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 169' ' ' ILE . 10.3 p -98.08 5.37 48.73 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.091 0.472 . . . . 0.0 109.766 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 58.5 t30 60.31 -0.74 0.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.815 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 167' ' ' SER . 0.2 OUTLIER -88.98 133.62 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 21.7 t -79.12 -176.49 5.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.271 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.541 ' CD2' HH21 ' A' ' 198' ' ' ARG . 0.0 OUTLIER -124.52 22.23 8.41 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -59.63 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.884 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -93.5 123.97 37.17 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.852 HG22 ' H ' ' A' ' 175' ' ' SER . 14.4 p -146.97 -176.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.931 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.852 ' H ' HG22 ' A' ' 174' ' ' VAL . 58.6 m -38.65 143.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.744 0.307 . . . . 0.0 111.228 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -104.35 140.64 37.61 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.056 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -151.09 144.81 25.06 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.373 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.58 89.18 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.764 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.3 mm -102.1 -42.74 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.964 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 180' ' ' ILE . 6.8 tp -64.03 124.84 19.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -90.22 -128.73 3.79 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.448 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 10.1 t -73.26 148.54 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 69.0 m -129.58 133.85 47.41 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.8 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 7.6 mm -138.42 128.16 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 185' ' ' VAL . 2.3 m -144.56 124.49 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.959 0.409 . . . . 0.0 111.859 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.0 97.82 11.42 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 187' ' ' THR . 26.1 p -45.27 -27.84 0.71 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.386 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -44.56 -20.96 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.961 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 97.0 m -147.33 16.75 1.17 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 190' ' ' VAL . 35.7 m -148.27 108.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.485 0.66 . . . . 0.0 111.119 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -79.42 -56.19 4.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.586 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -109.69 170.1 8.29 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.545 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.672 HD12 ' CZ ' ' A' ' 195' ' ' PHE . 0.0 OUTLIER -169.74 105.84 0.35 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -108.36 130.81 55.2 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.672 ' CZ ' HD12 ' A' ' 193' ' ' LEU . 15.6 m-85 -114.81 140.48 48.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.594 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.46 ' O ' ' NH1' ' A' ' 198' ' ' ARG . 14.4 t -143.95 124.2 13.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.484 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.46 150.19 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.541 HH21 ' CD2' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -166.41 108.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.674 -179.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.473 HG23 ' O ' ' A' ' 25' ' ' GLY . 12.0 mt -104.51 148.64 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.233 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 173.73 -163.29 34.41 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.575 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -88.07 121.22 30.23 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.905 0.384 . . . . 0.0 110.303 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -79.48 1.15 26.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.731 -179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.62 -47.36 5.12 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.121 0.486 . . . . 0.0 109.9 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -168.09 127.21 1.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -43.65 148.05 0.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.848 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 208' ' ' GLU . 47.9 p -136.69 12.81 3.18 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.924 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.6 m 58.39 -75.63 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 206' ' ' SER . 40.4 mt-10 -46.24 -54.38 8.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.681 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.422 HD21 ' CE1' ' A' ' 132' ' ' HIS . 14.4 mt -76.99 -0.83 25.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.785 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -94.88 134.83 37.09 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.669 0.271 . . . . 0.0 110.491 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 35.2 m -154.62 -179.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.295 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.46 ' HZ3' ' CB ' ' A' ' 226' ' ' ALA . 13.9 pttp -170.67 167.5 7.79 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.431 0.634 . . . . 0.0 112.136 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 11.2 t70 -155.26 168.33 27.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.7 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 215' ' ' PHE . . . 172.1 168.13 33.14 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 214' ' ' GLY . 10.4 m-85 -153.4 167.3 29.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.449 ' CB ' ' NZ ' ' A' ' 216' ' ' LYS . 2.7 ttmp? -133.42 104.0 6.21 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.035 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -100.57 118.13 36.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.866 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.4 p -139.38 111.48 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.614 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.4 t70 53.12 47.47 24.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.692 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.28 -5.61 71.72 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.356 -0.45 . . . . 0.0 113.408 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 35.7 t -96.95 116.66 29.57 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 117.099 0.45 . . . . 0.0 110.716 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.63 153.51 21.14 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.079 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.4 m -167.83 129.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.276 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -83.01 142.62 31.21 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.66 116.74 0.61 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.587 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.46 ' CB ' ' HZ3' ' A' ' 212' ' ' LYS . . . -73.86 111.45 9.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 28.5 m -140.99 153.07 45.4 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.924 0.392 . . . . 0.0 110.581 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 95.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.617 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -87.27 30.03 0.81 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 231' ' ' SER . 9.3 t -71.34 -39.1 71.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.451 ' N ' HG23 ' A' ' 230' ' ' THR . 55.6 m -96.94 2.67 51.88 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.9 tp -44.38 -40.64 5.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.788 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.507 HD12 ' CG ' ' A' ' 113' ' ' ASN . 27.5 mm -141.18 146.33 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.777 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 236' ' ' THR . 34.4 m-20 -78.18 92.86 4.49 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 23.9 m -56.6 -6.5 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 234' ' ' ASP . 26.0 m -86.68 -17.05 34.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.411 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -99.04 7.43 45.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.503 0.192 . . . . 0.0 111.347 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.8 mt -78.67 144.77 35.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.956 0.407 . . . . 0.0 110.809 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -133.49 133.49 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.536 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.71 156.73 4.66 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.504 ' SG ' ' CG1' ' A' ' 48' ' ' VAL . 53.7 t -126.5 -10.28 6.27 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.457 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.857 -1.068 . . . . 0.0 110.434 -179.842 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.747 0.308 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -70.69 116.69 4.77 Favored 'Trans proline' 0 N--CA 1.473 0.303 0 C-N-CA 122.497 2.132 . . . . 0.0 111.639 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 14.8 ptt? -54.33 154.91 4.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.51 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.76 -150.51 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.93 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 74.4 m -151.49 119.63 6.3 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 110.437 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 40.89 70.4 1.59 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.355 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.502 ' O ' ' O ' ' B' ' 8' ' ' PRO . 58.1 Cg_endo -87.53 157.6 7.86 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.73 2.287 . . . . 0.0 110.924 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.572 ' C ' HG22 ' B' ' 9' ' ' THR . 17.4 Cg_exo -36.11 -116.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.628 2.886 . . . . 0.0 114.546 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.622 HG23 ' H ' ' B' ' 10' ' ' ALA . 0.1 OUTLIER 172.64 -73.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.071 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.622 ' H ' HG23 ' B' ' 9' ' ' THR . . . 80.0 63.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.488 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.499 ' O ' ' CE2' ' B' ' 13' ' ' PHE . 85.6 m -106.4 161.42 14.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.67 135.48 56.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.346 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.499 ' CE2' ' O ' ' B' ' 11' ' ' CYS . 6.8 m-85 -114.01 -26.91 7.9 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -149.66 153.76 37.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.261 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.4 OUTLIER -111.52 155.07 23.84 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.74 -179.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -77.49 137.17 38.5 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -27.17 41.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.62 0.248 . . . . 0.0 110.99 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -92.5 127.09 37.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 111.385 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -77.43 116.24 17.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.825 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 13.3 mt -64.01 139.87 97.75 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.505 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.49 147.67 32.46 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.859 1.706 . . . . 0.0 111.367 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' B' ' 24' ' ' PHE . 41.5 ttp180 -44.68 -49.53 10.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.73 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' B' ' 23' ' ' ASN . 46.0 t-20 -69.67 29.9 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 57.8 t80 -155.45 33.33 0.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 86.4 t -155.97 97.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.751 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.42 -7.19 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 25.3 t0 -166.67 -178.74 4.49 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.096 -0.641 . . . . 0.0 111.259 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.482 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 5.7 p90 -158.24 163.52 37.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.097 0.475 . . . . 0.0 111.303 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -155.39 141.6 18.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.893 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' B' ' 31' ' ' THR . 88.8 mt-10 -90.0 142.5 27.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.91 0.386 . . . . 0.0 111.287 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.42 ' O ' ' O ' ' B' ' 30' ' ' GLU . 67.4 p -51.45 -108.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 69.8 m -154.47 -167.37 2.6 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.818 0.342 . . . . 0.0 110.773 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.445 ' C ' ' N ' ' B' ' 35' ' ' CYS . 11.8 t -117.32 -30.4 5.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.502 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.536 ' N ' ' CD1' ' B' ' 34' ' ' LEU . 4.4 mp -49.59 -13.14 0.08 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.706 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.445 ' N ' ' C ' ' B' ' 33' ' ' SER . 27.8 m -111.06 127.12 55.45 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.049 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 53.5 p -76.44 35.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' B' ' 35' ' ' CYS . 2.7 pt20 -163.98 59.27 0.74 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -60.4 -164.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 122.59 2.194 . . . . 0.0 112.862 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.14 176.69 0.25 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.089 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.43 127.87 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.99 134.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.766 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -105.3 151.52 24.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.994 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.698 ' NE2' ' H ' ' B' ' 44' ' ' THR . 41.5 tp60 -93.67 164.56 13.1 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.698 ' H ' ' NE2' ' B' ' 43' ' ' GLN . 56.5 p -136.57 -168.42 2.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.289 0.566 . . . . 0.0 111.528 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.78 -41.82 4.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.713 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.91 47.11 2.02 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.374 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 3.0 m -158.47 -79.61 0.06 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.227 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.8 -90.54 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 123.397 0.436 . . . . 0.0 110.042 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -136.86 151.45 49.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -150.08 124.0 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.014 0.435 . . . . 0.0 110.061 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 10.2 t -64.18 159.5 20.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.298 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.496 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.0 130.59 10.68 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.238 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -67.76 116.88 42.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.33 0.57 5.87 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 120.938 1.092 . . . . 0.0 111.71 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 53.4 m -73.89 -16.07 61.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.983 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -91.61 127.25 36.99 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.168 0.509 . . . . 0.0 110.666 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 52.9 m -47.22 -49.8 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -56.15 -25.05 44.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.14 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 62.2 t -73.77 -37.38 48.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.181 0.515 . . . . 0.0 110.302 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.14 -37.56 78.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.504 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -72.07 -35.36 69.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.242 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.99 -36.1 82.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.477 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.06 -44.87 65.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.978 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -63.49 -27.59 69.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.018 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.41 -39.17 62.81 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.812 0.339 . . . . 0.0 110.934 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.43 -29.76 62.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.347 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.4 ' OE2' ' OH ' ' B' ' 28' ' ' TYR . 32.1 mm-40 -69.7 -32.94 71.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.85 -74.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.336 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.553 179.891 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.748 0.309 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.08 178.52 7.09 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.687 2.258 . . . . 0.0 111.898 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.18 138.71 3.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.526 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' LEU . 70.2 m -166.37 25.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.605 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.556 HD12 ' N ' ' A' ' 5' ' ' LEU . 7.9 mp 57.45 150.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.571 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.45 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 2.8 pm0 -169.62 149.47 3.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.646 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -72.75 142.86 48.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.505 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 p -74.08 -8.26 55.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.718 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 74.8 m -75.44 -24.59 57.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.748 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.3 t -50.57 134.47 24.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.642 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 m -57.62 -29.39 64.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.665 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.4 p -74.35 -25.94 59.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.656 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 t -74.23 -57.08 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.974 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.1 m -159.01 175.94 12.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.922 0.392 . . . . 0.0 110.907 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.8 m -61.92 159.92 13.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.887 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 m -75.2 165.89 24.5 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 17' ' ' GLU . 1.4 pm0 -114.75 3.16 14.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.777 0.323 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.64 -165.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.35 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -116.05 -75.92 0.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.901 0.382 . . . . 0.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.494 ' OD1' ' CG ' ' A' ' 132' ' ' HIS . 64.8 t30 -77.81 53.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.627 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -154.63 132.13 11.27 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.577 ' CE1' ' NE2' ' A' ' 132' ' ' HIS . 34.3 m170 -140.9 165.49 27.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.201 0.524 . . . . 0.0 111.257 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -97.75 76.19 2.46 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.965 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.2 ttm -68.88 133.69 48.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.4 167.29 25.03 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.0 tp -111.17 142.37 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -149.89 106.31 3.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.556 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 197' ' ' VAL . 12.2 m -122.29 134.53 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.68 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.5 pt -113.99 163.33 11.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.6 tt -163.92 132.63 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.437 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -120.68 133.08 55.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.538 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.4 116.71 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.872 0.368 . . . . 0.0 111.326 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.2 m -81.76 112.41 18.89 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.59 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -68.22 150.14 48.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.888 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -58.89 168.75 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.86 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -91.3 5.02 50.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.843 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -120.48 -33.38 3.86 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.846 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 38' ' ' THR . 4.4 t -54.17 119.28 19.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.894 -0.323 . . . . 0.0 110.463 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -39.25 157.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.976 1.784 . . . . 0.0 112.544 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.4 p -75.49 143.91 42.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.46 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -157.33 107.1 2.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.424 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' ILE . 2.7 p30 -101.16 -2.56 31.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.064 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 154' ' ' GLU . 4.8 mmmm -63.51 83.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 42' ' ' ASP . 3.3 tp -90.53 150.62 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.078 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.451 ' SG ' ' CG ' ' A' ' 105' ' ' GLU . 1.7 m 56.17 62.09 2.49 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.139 0.495 . . . . 0.0 110.566 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -78.19 -40.02 38.93 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 t -172.51 163.32 5.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.04 0.448 . . . . 0.0 111.181 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -138.06 140.36 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.489 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -129.54 105.29 7.98 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.847 0.356 . . . . 0.0 110.857 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.08 128.87 34.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.494 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 52' ' ' THR . 7.7 mm -132.36 154.7 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -152.62 142.57 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -51.11 176.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 26.6 m -55.08 -39.95 69.85 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 54' ' ' SER . 3.5 pt-20 113.62 -151.23 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 O-C-N 125.929 2.018 . . . . 0.0 111.112 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.468 ' N ' ' CG ' ' A' ' 55' ' ' GLU . 13.8 t -138.68 -66.53 0.48 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.416 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.683 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 3.5 p30 -124.95 -23.7 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.683 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 31.5 Cg_exo -38.16 -68.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.647 1.564 . . . . 0.0 113.621 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER 169.27 -64.62 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 59' ' ' ASP . 11.1 Cg_exo -24.05 -105.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.85 3.033 . . . . 0.0 114.219 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.441 ' N ' ' OE2' ' A' ' 55' ' ' GLU . 39.7 tt0 51.3 83.91 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.507 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 t -80.85 8.97 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.277 0.56 . . . . 0.0 109.499 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -77.67 169.33 18.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.211 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.6 m -162.18 34.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.435 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -171.37 66.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.412 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -171.27 56.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -69.24 93.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.616 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.7 p -63.25 -178.55 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.622 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 t -162.18 27.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.363 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.6 p -75.69 107.67 8.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.3 t -103.96 59.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.3 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -165.82 -27.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -157.48 148.42 21.41 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.532 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.7 -135.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.677 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -147.74 82.17 8.1 Favored Pre-proline 0 N--CA 1.465 0.317 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.85 106.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.557 2.171 . . . . 0.0 112.58 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.2 165.68 12.84 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.312 2.008 . . . . 0.0 111.363 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -123.76 141.46 52.01 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.883 0.373 . . . . 0.0 110.822 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.9 p -107.59 127.0 53.25 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.755 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -112.25 148.02 35.01 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.201 0.524 . . . . 0.0 110.285 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -139.89 116.85 11.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.9 p -103.45 69.38 0.99 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.821 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 103' ' ' ILE . 12.0 tt -74.37 102.3 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.185 0.517 . . . . 0.0 110.534 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 pt -88.08 147.84 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.181 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.5 170.06 19.91 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.87 19.7 37.8 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.77 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.09 86.47 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.618 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.1 mt -133.08 159.2 40.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.057 0.456 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -117.4 108.98 16.22 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.312 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 45.7 mtt -101.23 112.13 24.54 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.45 124.1 48.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.257 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.482 ' O ' ' CD2' ' A' ' 80' ' ' TYR . 84.7 m-85 -100.97 -176.03 3.05 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.1 71.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.249 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -75.92 138.54 41.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.91 0.385 . . . . 0.0 110.367 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.7 m -144.42 119.89 10.34 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.248 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? 66.87 26.74 9.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.214 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 m -120.72 149.83 51.33 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -40.06 154.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.815 1.677 . . . . 0.0 111.942 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -75.06 137.9 41.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.508 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.5 pt -95.54 138.5 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -137.4 -10.6 1.66 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.738 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.9 t -112.21 122.77 48.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.576 HD11 HD12 ' A' ' 83' ' ' ILE . 16.0 tt -141.57 129.6 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.844 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.1 p -158.01 171.39 20.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.603 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.451 ' CG ' ' SG ' ' A' ' 45' ' ' CYS . 7.7 pt-20 -168.07 -172.39 1.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.726 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.6 t -171.56 165.96 6.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.445 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -127.01 116.68 21.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.172 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -127.93 107.9 10.23 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.029 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 70.81 -127.78 16.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.667 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -102.6 23.73 11.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.737 0.304 . . . . 0.0 110.41 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 p -131.33 158.69 40.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.521 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.45 136.04 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.687 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -112.26 163.04 14.82 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.41 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -160.9 129.41 4.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.123 0.487 . . . . 0.0 110.661 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 116' ' ' LEU . 31.0 ttm180 -116.85 113.31 22.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.52 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 115' ' ' ARG . 2.5 mm? -110.29 123.62 50.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -164.06 175.02 10.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.157 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.3 m -95.28 171.77 8.52 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.145 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.4 149.03 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.891 0.377 . . . . 0.0 111.136 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 t -93.23 144.56 28.52 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -37.62 144.68 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.05 1.833 . . . . 0.0 112.516 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.62 57.11 6.16 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.123 -0.56 . . . . 0.0 112.187 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -138.75 -5.13 1.54 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.48 -8.35 64.19 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.81 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -115.56 168.82 9.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.98 147.06 39.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.288 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.5 m -148.73 65.56 8.42 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.689 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -44.27 148.03 1.32 Allowed 'Trans proline' 0 N--CA 1.474 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.903 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -117.87 146.68 43.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.311 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -132.42 171.11 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.844 0.354 . . . . 0.0 110.087 -179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -81.73 162.61 22.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.429 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.577 ' NE2' ' CE1' ' A' ' 22' ' ' HIS . 36.4 m170 -58.0 -36.45 72.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.267 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -54.38 -47.63 72.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.479 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -72.94 -33.21 65.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.643 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.34 -57.97 9.39 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.233 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -56.14 -32.86 64.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.17 63.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.777 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.5 tpp -71.18 -63.17 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.102 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.3 -21.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.455 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -79.39 -55.11 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 41.4 t0 -79.14 -30.26 43.55 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 35.9 t -45.74 117.78 1.59 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.003 0.43 . . . . 0.0 111.503 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.18 124.29 16.4 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.04 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 144' ' ' VAL . 13.8 p -116.67 131.24 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.87 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 58.4 m -103.09 157.59 16.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.201 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 7.0 mm -140.43 145.53 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' OD2' ' NE2' ' B' ' 49' ' ' GLN . 2.0 m-20 -152.88 92.86 1.69 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.877 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.4 mt -89.26 142.11 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.301 0.572 . . . . 0.0 111.075 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 mtp85 -138.53 177.25 8.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.639 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 7.3 m -91.58 132.23 36.46 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.739 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 p -103.79 -173.98 2.44 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.47 11.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.861 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -79.92 103.59 9.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.965 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.435 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 11.1 pt-20 -77.52 7.75 5.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -49.73 145.66 5.03 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.93 0.395 . . . . 0.0 110.365 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.21 173.11 0.38 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.99 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.1 t -94.97 142.1 27.88 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -120.04 91.6 3.58 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.589 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.4 pt -121.06 168.69 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.606 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -119.5 139.6 51.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.123 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.0 p -72.29 5.55 2.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.426 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -80.5 121.06 81.0 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.4 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -40.1 154.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.826 1.684 . . . . 0.0 112.064 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 33.2 t -80.05 133.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.422 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.71 123.35 30.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.489 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.25 162.4 19.03 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.363 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -91.15 9.42 31.15 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 109.94 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 57.6 5.25 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.825 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 9.9 tp -101.93 141.31 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 18.5 m -100.77 149.04 24.24 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.748 0.309 . . . . 0.0 110.35 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.448 ' NE2' ' N ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER -83.13 39.55 0.65 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.019 0.438 . . . . 0.0 110.547 -179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.681 ' N ' HH12 ' A' ' 198' ' ' ARG . 74.7 tttt -65.16 173.5 2.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.295 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.425 ' HZ3' ' CB ' ' A' ' 226' ' ' ALA . 61.8 tttp -84.18 123.81 30.5 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.533 HG13 ' N ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -149.11 -170.77 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.533 ' N ' HG13 ' A' ' 174' ' ' VAL . 25.3 p -44.71 146.87 0.69 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.571 0.224 . . . . 0.0 110.752 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -112.64 145.52 40.27 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.986 0.422 . . . . 0.0 111.437 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.447 ' CD ' ' N ' ' A' ' 178' ' ' ASP . 1.6 tm-20 -157.88 145.73 18.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.559 179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.447 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 9.9 t0 -70.34 100.64 1.77 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.403 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 22.4 mm -109.37 -50.81 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.891 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 tp -61.67 125.35 17.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.407 ' O ' ' OG ' ' B' ' 14' ' ' SER . . . -91.44 -123.11 2.87 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.066 -0.516 . . . . 0.0 112.191 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.2 t -73.3 140.58 46.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.628 0.251 . . . . 0.0 111.16 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.515 ' O ' ' CZ ' ' B' ' 13' ' ' PHE . 18.0 p -139.08 87.83 2.23 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 184' ' ' ILE . 15.0 tt -102.65 129.1 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.0 m -143.6 137.67 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.556 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.78 109.41 19.23 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.22 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 189' ' ' CYS . 12.7 p -51.55 -27.48 11.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.573 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -38.36 -28.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.291 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.428 ' N ' ' O ' ' A' ' 187' ' ' THR . 27.5 p -148.42 29.39 0.86 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.984 0.421 . . . . 0.0 110.323 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.1 88.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.092 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -68.16 -58.33 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.167 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -123.07 179.38 4.69 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.153 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 193' ' ' LEU . 5.7 tt -173.22 106.65 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.648 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 25.2 mp0 -97.24 128.83 44.46 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -128.08 134.69 49.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.093 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.0 m -143.42 144.08 31.89 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.626 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 28' ' ' VAL . 18.1 m -140.6 167.39 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.124 0.488 . . . . 0.0 111.34 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.681 HH12 ' N ' ' A' ' 172' ' ' LYS . 21.8 ttm180 -164.09 156.32 16.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.154 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.6 mt -148.5 120.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.54 174.37 46.6 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.277 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -56.26 129.34 39.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 0.0 110.923 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 57.0 mtm -86.23 8.14 22.39 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.6 t -112.88 -48.2 3.0 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.239 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -159.19 115.02 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.978 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 205' ' ' GLU . 7.9 mp0 -47.63 158.71 0.18 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.444 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 208' ' ' GLU . 69.9 m -143.38 23.02 1.84 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.01 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 t 57.68 -75.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.822 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 206' ' ' SER . 75.5 mm-40 -48.68 -48.39 40.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.729 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 209' ' ' LEU . 8.6 mp -77.54 -0.65 27.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.445 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.79 155.36 19.6 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.971 0.415 . . . . 0.0 110.602 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 212' ' ' LYS . 3.8 p -175.55 158.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.409 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 211' ' ' VAL . 1.2 pptp? -168.56 136.83 2.16 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.401 0.62 . . . . 0.0 111.767 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 9.3 t70 -124.95 172.6 9.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.292 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 172.4 164.58 28.13 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.946 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -148.97 170.22 18.83 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -135.69 104.34 5.74 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.315 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -101.44 119.83 39.37 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.85 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 218' ' ' VAL . 7.2 p -144.48 123.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.126 0.488 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.62 37.88 27.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.31 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.32 89.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.91 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.41 ' OG ' HG13 ' A' ' 218' ' ' VAL . 26.4 p -103.19 120.9 41.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.843 0.321 . . . . 0.0 110.576 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.74 165.15 12.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.019 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.6 t -174.97 120.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.564 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -78.44 136.71 37.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -167.95 116.22 0.66 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.702 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.425 ' CB ' ' HZ3' ' A' ' 173' ' ' LYS . . . -81.61 96.56 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 23.3 m -129.55 151.41 50.19 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.989 0.423 . . . . 0.0 110.767 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.32 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.553 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.443 ' OD1' HD23 ' A' ' 232' ' ' LEU . 74.6 m-20 -93.26 31.0 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.6 p -73.71 -34.81 64.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.768 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -99.89 -2.55 34.54 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.896 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 232' ' ' LEU . 0.1 OUTLIER -43.42 -29.27 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.935 0.398 . . . . 0.0 110.563 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.3 pp -149.21 143.38 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.628 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.76 101.13 4.95 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 19.4 m -63.9 -5.68 4.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.147 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -47.28 12.67 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -71.4 9.43 0.8 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 238' ' ' LEU . 7.5 mp -72.98 152.28 41.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.493 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -137.15 135.16 37.11 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.561 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.19 144.71 23.42 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.49 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . 0.537 ' SG ' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -104.34 -17.88 14.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.925 -179.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.48 HG13 ' C ' ' A' ' 241' ' ' CYS . 1.5 m . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.606 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.44 -107.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.088 1.859 . . . . 0.0 111.358 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 4.0 ptt? 163.25 20.79 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.15 -129.35 49.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.336 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 28.0 t -162.24 -97.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.842 0.353 . . . . 0.0 110.173 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -117.25 61.99 3.13 Favored Pre-proline 0 N--CA 1.468 0.448 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.778 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.496 ' O ' ' O ' ' B' ' 8' ' ' PRO . 21.0 Cg_endo -58.34 164.12 9.32 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.078 1.852 . . . . 0.0 112.276 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.562 ' C ' HG22 ' B' ' 9' ' ' THR . 35.7 Cg_exo -38.65 -124.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 124.287 3.325 . . . . 0.0 115.254 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.562 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 159.3 67.67 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.133 -179.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.73 103.03 0.09 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.146 0.498 . . . . 0.0 110.455 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -144.6 118.0 9.07 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.426 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 85.5 m -63.93 131.32 47.33 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.01 0.433 . . . . 0.0 110.873 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.515 ' CZ ' ' O ' ' A' ' 183' ' ' THR . 0.1 OUTLIER -93.44 -26.78 17.06 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.018 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 181' ' ' GLY . 28.0 p -122.9 155.05 37.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.375 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.86 158.94 25.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.392 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -82.92 139.22 33.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.184 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.06 19.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.612 0.244 . . . . 0.0 111.32 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -80.2 127.83 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 111.785 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -81.92 128.68 34.3 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.492 ' N ' HD12 ' B' ' 20' ' ' LEU . 9.4 mp -90.39 112.38 52.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.808 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -42.04 153.08 0.13 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 122.208 1.938 . . . . 0.0 112.878 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' B' ' 25' ' ' VAL . 13.3 tpt180 -46.07 -50.46 15.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.353 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -35.95 -35.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 3.3 m-85 -105.58 43.23 1.14 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.102 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 22' ' ' ARG . 49.9 t -151.61 92.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.937 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -97.72 -22.95 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.265 -0.272 . . . . 0.0 110.823 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.455 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 6.3 p90 -166.06 168.91 15.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.253 0.549 . . . . 0.0 111.871 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.455 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 89.0 m-85 -157.34 178.26 10.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.243 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' B' ' 31' ' ' THR . 11.3 pt-20 -127.64 149.62 50.11 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.804 0.335 . . . . 0.0 110.501 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.414 ' O ' ' O ' ' B' ' 30' ' ' GLU . 77.8 p -53.93 -111.4 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.102 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 10.6 t -154.98 -148.68 0.24 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.828 0.347 . . . . 0.0 110.586 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.412 ' C ' ' N ' ' B' ' 35' ' ' CYS . 10.5 m -135.82 -24.02 1.34 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.103 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.3 mm? -53.67 -13.56 0.7 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.794 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.423 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.3 p -115.94 122.16 44.45 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.58 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 12.3 m -73.31 38.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.402 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.423 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.5 pt20 -164.29 61.1 0.87 Allowed Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 97.4 Cg_endo -74.14 -161.82 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.438 0 C-N-CA 122.887 2.391 . . . . 0.0 113.294 -177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 170.76 176.53 0.06 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.217 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -111.59 136.74 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.477 HG12 ' SG ' ' B' ' 51' ' ' CYS . 0.8 OUTLIER -113.73 143.2 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.618 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -115.69 149.9 37.65 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.444 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 24.7 mm100 -92.97 169.26 10.57 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.501 ' OG1' ' N ' ' B' ' 45' ' ' ALA . 2.3 p -138.17 -144.85 0.19 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.196 0.522 . . . . 0.0 110.767 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.501 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -126.27 -39.0 2.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.234 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.81 46.48 2.32 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.143 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 52.1 m -152.83 -83.17 0.08 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.428 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.29 -86.78 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.586 0.554 . . . . 0.0 109.55 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' B' ' 49' ' ' GLN . 3.4 pp0? -145.31 147.87 32.8 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.12 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 6.1 t -150.26 115.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' B' ' 41' ' ' VAL . 71.7 m -68.05 144.72 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.785 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.69 139.3 41.85 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.998 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.69 126.33 92.49 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.54 -0.52 9.41 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.368 1.379 . . . . 0.0 111.554 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 72.2 m -65.18 -14.54 60.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.06 127.74 47.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.187 0.518 . . . . 0.0 110.513 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 42.2 t -50.42 -46.89 56.7 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.2 p-90 -55.99 -28.12 55.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.374 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.92 -36.16 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.112 0.482 . . . . 0.0 109.848 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.72 -39.23 64.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.569 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -67.89 -35.7 78.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.443 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.47 -42.55 87.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.619 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 72.3 t -67.74 -46.01 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.841 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.66 -31.49 66.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.32 -35.67 63.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.585 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.11 -19.17 64.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.336 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.52 -35.19 70.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.622 ' N ' HD12 ' B' ' 68' ' ' LEU . 7.3 mp -79.79 -83.57 0.1 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.225 0.536 . . . . 0.0 109.64 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.643 -179.918 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 mmt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.706 0.288 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -44.08 104.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.674 2.249 . . . . 0.0 111.997 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.95 85.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.614 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -68.93 77.05 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.409 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.561 ' CD2' ' H ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -57.48 -161.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.85 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.561 ' H ' ' CD2' ' A' ' 5' ' ' LEU . 25.9 mt-30 51.72 -165.44 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.574 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 58.16 159.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.625 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.5 p -163.06 -27.46 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.516 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.7 t -79.44 -18.15 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.776 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.5 t -50.5 134.36 23.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.652 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -58.25 -27.41 63.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.564 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 125' ' ' LYS . 95.8 p -73.76 -23.9 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.63 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.4 m -80.0 -53.43 6.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 p -168.07 169.38 11.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.866 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.1 m -55.3 155.8 4.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.537 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 t -76.46 173.19 11.8 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -112.84 5.59 17.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.252 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -62.44 -167.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.246 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.443 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 17.2 mp0 -119.21 -65.48 1.16 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.874 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.0 54.29 3.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.392 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' C ' ' ND1' ' A' ' 22' ' ' HIS . 3.6 tppt? -151.17 140.06 20.93 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.42 ' ND1' ' C ' ' A' ' 21' ' ' LYS . 53.5 m80 -145.67 158.59 43.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.059 0.457 . . . . 0.0 110.888 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -95.65 76.41 3.26 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 29.9 ttp -64.74 133.0 51.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.088 0.47 . . . . 0.0 111.181 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' H ' ' HE3' ' A' ' 202' ' ' MET . . . -139.74 160.89 26.21 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.258 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.6 tt -114.68 158.49 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.98 0.419 . . . . 0.0 110.586 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' HA ' ' HG ' ' A' ' 117' ' ' SER . 10.7 t70 -151.35 137.48 18.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.986 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.69 109.26 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.325 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.2 mt -97.5 134.2 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mp -139.29 134.41 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 121.174 0.511 . . . . 0.0 112.003 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -121.05 127.49 51.75 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.79 112.89 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.9 p -84.71 121.3 27.47 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -75.32 151.82 38.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.782 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -67.85 144.5 55.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.215 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 47.7 p30 -76.26 43.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.599 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -152.3 -28.33 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.377 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.8 m -71.16 125.45 91.94 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -38.47 156.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.026 1.817 . . . . 0.0 112.542 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -76.27 140.08 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.42 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -157.17 107.29 2.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.366 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.84 8.82 37.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.258 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 12.0 mptt -69.0 82.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt -77.5 -177.92 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.73 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 76.9 m 32.82 40.29 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -55.56 -34.44 64.75 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.289 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 t -178.12 168.99 1.95 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.991 0.424 . . . . 0.0 111.104 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.1 t -149.14 112.27 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.942 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.2 m -111.39 116.46 30.97 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.323 . . . . 0.0 110.87 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -95.38 135.42 37.01 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.184 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 79' ' ' THR . 4.2 mp -139.76 151.44 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -150.76 149.11 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 54' ' ' SER . 18.5 tp10 -51.7 171.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.082 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.51 ' H ' ' CD ' ' A' ' 53' ' ' GLU . 58.1 m -70.09 -21.91 63.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.981 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 56' ' ' SER . 35.6 tt0 -39.53 158.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 123.285 0.366 . . . . 0.0 110.415 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 57' ' ' ASP . 75.0 m -27.31 -103.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.698 0.624 . . . . 0.0 112.557 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.8 m-20 55.27 153.56 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.6 39.97 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.738 1.626 . . . . 0.0 110.916 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 57' ' ' ASP . 28.7 t70 -174.03 72.53 0.34 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.441 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.09 -178.5 4.68 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.422 2.081 . . . . 0.0 111.867 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -133.11 -9.77 2.98 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.082 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -164.86 -34.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.821 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' OE2' ' N ' ' A' ' 64' ' ' SER . 0.9 OUTLIER 71.88 124.85 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.356 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.479 ' N ' ' OE2' ' A' ' 63' ' ' GLU . 4.8 p 69.77 105.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.448 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -78.04 -64.03 1.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.741 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 67' ' ' ASP . 39.0 t70 -162.05 160.9 28.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.672 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' THR . 32.7 t70 -41.86 165.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.492 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.9 m -44.25 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.18 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' ASP . 19.1 m -43.82 -45.65 7.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.209 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.9 m -166.91 -119.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.806 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.1 m -102.74 37.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.494 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 47.88 96.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.644 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -157.71 43.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.285 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.12 177.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.462 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -112.71 137.05 21.61 Favored Pre-proline 0 N--CA 1.469 0.518 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -37.18 157.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.097 1.865 . . . . 0.0 112.371 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.02 171.38 15.34 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.504 2.136 . . . . 0.0 111.025 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.9 m -125.93 131.03 52.38 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 51' ' ' ILE . 16.3 m -107.16 123.95 49.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -121.64 112.98 19.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.947 0.403 . . . . 0.0 111.112 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -93.83 127.41 39.55 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.4 t -103.07 69.38 1.02 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.24 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 83' ' ' ILE . 17.5 tt -74.54 122.25 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 110.566 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.44 147.46 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.741 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.94 169.53 20.94 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.209 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 54.47 22.34 23.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.239 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.407 ' C ' HD22 ' A' ' 88' ' ' LEU . . . 74.8 4.06 69.91 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.187 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.407 HD22 ' C ' ' A' ' 87' ' ' GLY . 4.3 mm? -117.48 149.15 41.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' NH2' ' OG ' ' A' ' 151' ' ' SER . 45.6 ttm-85 -115.83 105.15 12.37 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 92' ' ' PHE . 18.8 ttt -101.71 135.63 42.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.116 0.484 . . . . 0.0 110.882 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -127.44 120.44 28.4 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.043 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 90' ' ' MET . 67.1 m-85 -90.42 -168.4 2.09 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.04 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.74 67.7 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.08 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -90.28 162.08 15.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.163 0.506 . . . . 0.0 111.448 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 t -150.91 131.82 14.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.942 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 62.95 33.65 14.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.529 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 98' ' ' PRO . 33.5 m -124.04 145.6 48.59 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 97' ' ' CYS . 78.2 Cg_exo -38.55 162.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.012 1.808 . . . . 0.0 112.423 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -71.33 142.54 50.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -97.1 118.09 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' N ' HD13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -124.33 -21.67 4.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -178.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 117' ' ' SER . 5.7 p -100.45 111.16 23.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.771 0.319 . . . . 0.0 110.862 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.23 121.83 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 105' ' ' GLU . 28.3 t -142.45 177.56 8.19 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.064 0.459 . . . . 0.0 111.171 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 104' ' ' SER . 34.9 tt0 -165.83 161.68 17.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.42 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.4 t -163.9 158.67 20.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.588 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.06 132.75 46.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.331 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -144.73 111.66 5.86 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.155 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.73 -110.87 3.31 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -122.21 23.88 9.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.86 0.362 . . . . 0.0 110.106 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 p -128.74 156.16 43.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.8 p -134.64 132.99 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.632 ' ND2' ' H ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -117.96 155.76 29.68 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.885 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -153.52 133.07 12.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -118.0 125.76 51.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 111.333 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.7 121.48 40.97 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.424 ' HG ' ' HA ' ' A' ' 27' ' ' ASP . 1.8 m -164.94 156.67 15.3 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.58 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 85.8 p -74.19 173.85 9.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.39 134.37 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 110.999 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 123' ' ' GLN . 0.6 OUTLIER -59.55 155.15 40.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.0 157.6 28.57 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.254 1.969 . . . . 0.0 111.486 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.419 ' N ' ' OE1' ' A' ' 123' ' ' GLN . . . 73.68 59.73 3.97 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.845 HE21 ' H ' ' A' ' 125' ' ' LYS . 4.3 pm0 -141.24 -37.35 0.43 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.739 0.304 . . . . 0.0 110.348 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 133.03 5.97 2.93 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.265 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.845 ' H ' HE21 ' A' ' 123' ' ' GLN . 51.7 mttp -129.45 -173.48 3.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.782 0.325 . . . . 0.0 110.463 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 156.17 21.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.128 0.49 . . . . 0.0 111.456 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.4 t -159.19 63.42 2.31 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.439 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -41.78 142.31 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.112 2.541 . . . . 0.0 113.447 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.26 28.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -142.46 162.56 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.813 0.339 . . . . 0.0 110.24 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.7 p -78.69 164.6 24.46 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.535 ' CD2' HD21 ' A' ' 209' ' ' LEU . 16.4 t-160 -60.51 -34.71 74.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.462 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -63.15 -55.1 28.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.31 -44.71 92.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.335 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.29 -56.58 20.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.123 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.1 tp -49.37 -35.63 19.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.096 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.46 -49.24 43.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.557 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 140' ' ' LYS . 44.2 mtt -60.09 -60.42 3.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.522 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 40.7 mt -44.64 -21.23 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.13 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' MET . 31.5 ttmt -87.5 -33.81 18.85 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.595 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -94.92 -23.33 17.47 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 42.2 t -51.98 122.9 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.889 0.376 . . . . 0.0 110.758 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -139.1 123.26 18.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.218 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 144' ' ' VAL . 10.8 m -114.31 128.21 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.06 0.457 . . . . 0.0 111.114 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.6 m -109.33 167.24 10.26 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.548 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.8 pt -151.2 149.17 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.097 0.475 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -147.9 88.47 1.68 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.544 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 tt -83.35 145.24 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.506 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.402 ' HG3' ' H ' ' A' ' 150' ' ' CYS . 5.0 tpt180 -145.59 -177.2 5.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 149' ' ' ARG . 7.1 m -90.61 134.44 34.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.698 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' NH2' ' A' ' 89' ' ' ARG . 5.6 t -117.3 119.58 35.58 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.075 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -93.62 14.81 17.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.161 0.505 . . . . 0.0 109.82 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 153' ' ' GLU . 0.2 OUTLIER -50.68 150.62 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.155 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -131.55 -10.08 3.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.466 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.78 158.06 11.08 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.906 0.384 . . . . 0.0 110.9 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -72.93 175.49 6.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.355 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -90.48 143.33 26.85 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.68 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -114.07 92.23 3.9 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.6 pt -119.03 165.79 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.147 0.499 . . . . 0.0 111.323 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -119.54 134.63 55.14 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 m -76.52 54.59 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.538 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -130.77 123.74 20.35 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -38.14 147.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.916 1.744 . . . . 0.0 112.344 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 164' ' ' VAL . 20.3 m -73.4 130.46 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.341 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 34.8 mt -79.32 115.46 18.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.315 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -94.97 159.55 22.85 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.117 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.426 ' OG ' ' SD ' ' A' ' 202' ' ' MET . 0.1 OUTLIER -95.2 11.14 33.41 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.797 0.332 . . . . 0.0 110.295 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 168' ' ' ASN . 10.9 t30 58.72 21.19 8.6 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.343 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.413 ' C ' HD12 ' A' ' 169' ' ' ILE . 1.1 pp -76.63 -176.78 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.66 ' H ' ' HE ' ' A' ' 198' ' ' ARG . 51.1 m -147.94 113.82 5.76 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.619 ' N ' ' ND1' ' A' ' 171' ' ' HIS . 0.0 OUTLIER -68.6 28.22 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.284 -178.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 170' ' ' SER . 16.9 mmmt -67.6 175.27 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.125 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.42 ' CB ' ' NZ ' ' A' ' 173' ' ' LYS . 0.2 OUTLIER -90.86 124.7 35.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.881 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 m -141.12 -165.67 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.041 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.4 p -50.55 145.77 6.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.807 0.337 . . . . 0.0 110.53 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -95.69 132.52 40.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -141.45 127.07 18.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.209 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -68.45 95.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.65 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 38.9 mt -107.35 -40.61 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.475 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 tp -66.84 114.42 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.468 . . . . 0.0 110.502 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -82.22 -122.91 0.7 Allowed Glycine 0 C--N 1.332 0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.4 m -77.21 150.8 35.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.768 0.318 . . . . 0.0 110.342 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.4 93.07 2.1 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.093 0.473 . . . . 0.0 110.263 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.3 tt -98.86 133.26 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.914 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 185' ' ' VAL . 14.2 m -146.76 131.29 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.99 0.424 . . . . 0.0 111.86 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 34.0 p-10 -85.93 103.34 14.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.754 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.7 m -46.99 -27.12 1.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.845 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -41.92 -26.38 0.09 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.966 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.404 ' O ' HD11 ' A' ' 88' ' ' LEU . 9.8 m -142.78 36.23 1.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 190' ' ' VAL . 7.4 p -169.43 105.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.4 0.619 . . . . 0.0 110.756 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -74.56 -54.43 7.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.729 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.31 173.83 6.59 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.137 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 193' ' ' LEU . 1.7 tt -173.56 106.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.228 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 194' ' ' GLU . 19.2 mp0 -93.24 149.74 21.0 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -140.83 134.32 29.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.872 0.368 . . . . 0.0 110.253 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -143.19 129.54 19.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.799 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.8 t -122.61 153.47 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.66 ' HE ' ' H ' ' A' ' 170' ' ' SER . 14.4 ttt85 -154.55 144.42 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.871 0.367 . . . . 0.0 110.155 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.94 119.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.652 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -169.57 -156.59 11.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.063 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 58.3 t0 -79.21 123.78 27.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.865 0.364 . . . . 0.0 110.434 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.426 ' SD ' ' OG ' ' A' ' 167' ' ' SER . 24.2 mmt -81.14 -3.24 51.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.417 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.4 -50.05 3.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.466 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.537 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 20.2 tptp -157.38 112.35 2.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE2' ' NH2' ' A' ' 198' ' ' ARG . 2.0 mm-40 -43.65 156.17 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.849 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 208' ' ' GLU . 2.5 p -156.86 67.08 0.54 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.1 p 30.84 -88.21 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 206' ' ' SER . 17.8 mm-40 -40.52 -50.93 2.95 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.453 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.642 ' N ' HD22 ' A' ' 209' ' ' LEU . 1.9 mm? -81.68 54.27 2.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.547 ' CG ' HH22 ' A' ' 198' ' ' ARG . 1.3 tp10 -156.22 120.25 4.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.965 0.412 . . . . 0.0 110.083 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.74 179.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.96 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -171.01 146.67 2.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.143 0.496 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 10.2 t70 -144.17 169.43 17.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.017 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 159.58 154.07 7.12 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.613 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -134.7 177.52 7.72 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -132.48 103.68 6.3 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -98.31 113.81 25.89 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.596 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.25 111.81 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.957 0.408 . . . . 0.0 110.691 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.13 43.39 30.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.98 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.61 -6.16 74.77 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 121.455 -0.402 . . . . 0.0 112.561 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 31.8 p -89.84 112.9 24.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.67 149.45 23.3 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.714 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.6 m -166.29 124.29 1.44 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.623 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -77.99 138.99 39.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.424 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -173.75 108.22 0.27 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.52 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -75.11 104.23 5.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 82.6 p -129.53 159.22 36.99 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.468 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.577 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 37.6 t70 -62.13 95.64 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.29 12.65 4.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.577 ' HG1' ' CG ' ' A' ' 228' ' ' ASP . 40.0 m -45.29 -51.45 10.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.706 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 233' ' ' ILE . 20.4 m -97.18 6.37 48.56 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.8 tp -42.64 -24.44 0.06 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.936 0.398 . . . . 0.0 110.84 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 231' ' ' SER . 0.4 OUTLIER -163.93 142.91 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -74.87 100.52 4.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.862 0.363 . . . . 0.0 110.181 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 12.8 t -64.28 -6.35 6.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.916 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 236' ' ' THR . 0.0 OUTLIER -88.04 -10.35 50.53 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.531 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -100.94 0.21 37.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.477 0.18 . . . . 0.0 111.145 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 238' ' ' LEU . 9.0 mp -80.02 142.06 35.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 111.152 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 104' ' ' SER . 63.8 mttp -130.44 136.83 49.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.837 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.84 138.03 57.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.733 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 74.6 m -100.17 -8.73 23.28 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.088 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.516 -179.324 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.745 0.307 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.08 120.29 5.67 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.573 2.182 . . . . 0.0 111.527 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' B' ' 4' ' ' GLY . 0.0 OUTLIER -51.66 175.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.47 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' B' ' 3' ' ' MET . . . -60.68 -131.73 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.641 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.456 ' O ' ' CB ' ' B' ' 6' ' ' ASP . 13.2 p -175.74 20.85 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.732 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' B' ' 5' ' ' SER . 4.8 m-20 148.31 70.73 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 124.314 1.009 . . . . 0.0 109.031 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -70.04 176.44 6.98 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.336 2.024 . . . . 0.0 110.348 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.59 ' C ' HG22 ' B' ' 9' ' ' THR . 93.9 Cg_endo -74.9 -110.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 121.711 1.607 . . . . 0.0 110.725 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.59 HG22 ' C ' ' B' ' 8' ' ' PRO . 0.0 OUTLIER 160.65 65.55 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.82 84.86 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.507 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.548 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 76.2 m -119.29 155.8 31.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.987 0.422 . . . . 0.0 110.619 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.21 134.51 52.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.677 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.548 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 23.5 m-85 -111.89 -27.52 8.42 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -152.05 155.07 37.22 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.991 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' B' ' 15' ' ' TYR . 0.5 OUTLIER -110.42 160.53 16.51 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.894 -179.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -84.0 139.08 32.77 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.48 5.53 38.56 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.453 -178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.73 126.56 47.76 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.822 0.344 . . . . 0.0 111.247 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -77.89 133.42 38.12 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.687 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' B' ' 24' ' ' PHE . 3.8 mm? -93.7 111.11 51.22 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.908 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.05 149.51 1.25 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 122.164 1.909 . . . . 0.0 112.599 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' B' ' 24' ' ' PHE . 7.5 ptp85 -45.46 -43.07 11.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.677 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -70.2 26.31 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.628 ' CD2' HD12 ' B' ' 20' ' ' LEU . 14.9 t80 -146.22 27.42 1.15 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 64.2 t -152.27 100.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.013 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.409 HG22 ' H ' ' B' ' 26' ' ' VAL . 20.4 m -84.15 -27.98 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.647 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -165.61 -178.34 4.83 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.755 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' B' ' 29' ' ' TYR . 8.6 p90 -154.08 173.48 15.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.273 0.558 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.48 ' CG ' ' O ' ' B' ' 28' ' ' TYR . 74.2 m-85 -160.91 141.12 11.14 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.802 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' B' ' 30' ' ' GLU . 2.1 mp0 -84.83 146.24 27.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.122 0.487 . . . . 0.0 111.636 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.416 ' O ' ' O ' ' B' ' 30' ' ' GLU . 32.0 p -52.51 -108.57 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.948 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.6 m -150.57 -149.45 0.3 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.83 0.348 . . . . 0.0 110.641 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.45 ' C ' ' H ' ' B' ' 35' ' ' CYS . 67.9 m -142.2 -24.6 0.67 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.279 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -54.77 -10.13 0.42 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.732 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' B' ' 37' ' ' GLN . 4.1 p -118.71 123.03 43.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.505 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 45.2 p -72.61 35.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.347 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' B' ' 35' ' ' CYS . 26.0 mt-30 -155.04 56.16 1.35 Allowed Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 46.5 Cg_endo -64.98 -167.86 0.1 Allowed 'Trans proline' 0 N--CA 1.476 0.473 0 C-N-CA 122.712 2.275 . . . . 0.0 112.827 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 173.21 176.57 0.11 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.787 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 57.1 t -107.82 131.85 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.95 129.81 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.657 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -110.82 146.16 36.91 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.972 0.415 . . . . 0.0 111.147 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -93.85 169.79 10.03 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 15.8 p -140.08 -143.1 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.224 0.535 . . . . 0.0 111.089 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.36 -36.95 2.06 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.297 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.03 46.86 2.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.557 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 18.4 m -156.09 -80.48 0.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.532 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 154.72 -90.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.679 0.612 . . . . 0.0 109.759 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -143.68 144.18 31.75 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.439 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 15.9 t -149.31 120.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.437 0.636 . . . . 0.0 110.73 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' B' ' 52' ' ' ALA . 6.9 t -54.61 159.06 2.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.776 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.463 ' N ' ' SG ' ' B' ' 51' ' ' CYS . . . -154.13 131.29 11.09 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.62 120.5 71.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.72 0.1 8.66 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.114 1.21 . . . . 0.0 111.242 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 90.0 p -67.99 -18.55 64.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.169 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -93.02 124.38 36.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.006 0.431 . . . . 0.0 110.29 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 73.4 m -50.87 -40.69 56.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.909 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.449 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 88.9 m95 -56.43 -33.48 65.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.047 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.89 -35.79 55.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.185 0.516 . . . . 0.0 109.706 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -68.7 -48.05 64.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.606 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -64.9 -35.79 82.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.449 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -62.02 -37.76 86.1 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.25 -44.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.85 -32.81 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.902 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -72.86 -38.29 67.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.787 0.327 . . . . 0.0 110.818 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.42 -22.22 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.8 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -73.23 -31.06 63.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.416 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.44 -84.51 0.09 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.572 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.596 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.817 0.341 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -44.3 149.37 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.677 2.252 . . . . 0.0 112.154 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.03 87.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.502 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.4 p -169.66 68.82 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.479 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.1 mt 52.3 179.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.449 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -146.84 -175.34 4.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.349 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -57.48 130.37 45.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.58 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -72.89 -2.95 22.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.597 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -75.7 -33.47 60.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.6 m -49.47 131.06 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.498 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 t -59.84 -20.52 57.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.662 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.7 m -75.86 -21.39 57.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.283 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -87.37 -41.39 13.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.112 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -167.94 179.71 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.881 0.372 . . . . 0.0 110.994 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.19 157.37 37.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.448 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -78.93 175.58 10.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.993 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -125.26 7.56 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.859 0.361 . . . . 0.0 110.302 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 19' ' ' GLU . 42.4 mm-40 -83.68 89.81 7.19 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.573 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' GLU . 42.2 mt-10 -23.51 -63.6 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.378 -0.828 . . . . 0.0 113.059 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.663 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -76.68 49.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.594 0.235 . . . . 0.0 111.014 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -155.85 125.56 6.41 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.579 ' CD2' ' NE2' ' A' ' 132' ' ' HIS . 27.5 m-70 -125.61 152.44 45.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.572 ' CE1' ' SD ' ' A' ' 202' ' ' MET . 11.6 t-160 -93.7 82.57 4.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.47 ' O ' ' SD ' ' A' ' 202' ' ' MET . 0.0 OUTLIER -47.05 174.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.617 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.99 133.79 1.61 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.3 tt -111.17 146.1 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.381 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -136.99 140.04 41.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.66 139.82 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.152 0.501 . . . . 0.0 111.837 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.0 mt -114.58 149.19 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.189 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.483 HD12 ' CZ ' ' A' ' 195' ' ' PHE . 0.9 OUTLIER -147.46 107.96 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 232' ' ' LEU . 32.3 ttmt -110.69 95.05 5.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.38 133.72 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.933 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.7 m -107.97 124.85 50.77 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.024 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -76.61 149.48 36.55 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -73.14 159.12 34.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.38 40.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.798 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -145.3 -28.51 0.45 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.425 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.2 m -68.32 115.72 32.29 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.414 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -40.29 158.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.79 1.66 . . . . 0.0 112.229 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.497 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 67.0 p -69.03 136.39 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.796 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 40' ' ' THR . 25.9 m120 -153.94 102.35 2.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.114 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -102.75 11.05 38.14 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.558 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 43' ' ' LYS . 1.8 mptp? -70.36 88.59 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.307 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 pt -90.96 157.73 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.347 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.5 m 57.18 39.44 28.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.307 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -55.51 -50.67 69.34 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.976 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.4 p -173.26 156.56 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 p -136.85 134.8 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.621 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.7 p -133.41 106.3 7.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.178 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -81.84 146.4 29.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.181 0.515 . . . . 0.0 110.862 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.457 HD12 ' CE2' ' A' ' 80' ' ' TYR . 5.4 mt -142.06 156.22 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.255 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -152.53 151.67 30.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 54' ' ' SER . 19.4 tp10 -56.27 174.72 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -72.81 -28.26 62.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.938 0.399 . . . . 0.0 110.215 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' H ' ' HG3' ' A' ' 53' ' ' GLU . 63.1 mm-40 -51.5 -62.7 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.303 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.1 t -60.06 -27.53 67.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.171 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -156.0 87.17 3.05 Favored Pre-proline 0 N--CA 1.464 0.251 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' N ' ' O ' ' A' ' 54' ' ' SER . 85.7 Cg_endo -79.85 69.44 7.94 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.933 1.755 . . . . 0.0 112.779 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.719 ' H ' ' CD ' ' A' ' 60' ' ' PRO . 2.3 t70 -121.78 -38.75 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.884 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.719 ' CD ' ' H ' ' A' ' 59' ' ' ASP . 27.9 Cg_exo -61.72 -49.97 6.14 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.055 1.837 . . . . 0.0 112.137 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -49.5 -96.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.746 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.81 HG13 ' H ' ' A' ' 63' ' ' GLU . 3.6 p 178.17 -65.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.81 ' H ' HG13 ' A' ' 62' ' ' VAL . 4.3 tm-20 -173.05 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.273 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.5 t -43.79 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.63 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 63' ' ' GLU . 33.0 tt0 -166.54 105.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -60.8 139.84 57.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.66 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.03 -115.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.547 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.0 p -168.29 167.31 12.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.057 0.455 . . . . 0.0 111.054 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -162.57 22.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.646 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 m 165.15 -177.68 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.821 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 73' ' ' ASP . 2.4 p 36.64 85.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.707 0.765 . . . . 0.0 111.433 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -54.98 -7.4 0.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.455 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 71' ' ' VAL . 20.5 t70 -100.01 63.49 1.18 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.252 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -65.33 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.364 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -159.63 93.31 1.75 Allowed Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -42.84 129.54 5.42 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.019 1.813 . . . . 0.0 112.09 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.85 150.45 21.07 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.225 1.95 . . . . 0.0 111.886 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.5 p -118.81 125.68 50.12 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.458 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.4 p -94.37 119.27 32.86 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.513 ' CE1' ' OD1' ' A' ' 91' ' ' ASN . 0.1 OUTLIER -126.72 113.66 16.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.733 0.301 . . . . 0.0 110.569 -178.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 92' ' ' PHE . 11.9 p90 -113.01 122.22 46.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.967 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -92.07 76.88 5.39 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.318 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -74.74 110.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.402 0.62 . . . . 0.0 109.725 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 83' ' ' ILE . 71.3 mt -93.21 145.84 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.437 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.28 159.11 10.28 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.211 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.65 27.54 68.37 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.046 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.23 18.25 72.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.94 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -134.61 159.02 42.52 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 110.544 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -122.3 110.24 15.43 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 38.1 mtt -100.17 99.59 10.3 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.124 0.487 . . . . 0.0 110.808 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.531 ' C ' HD22 ' A' ' 91' ' ' ASN . 0.3 OUTLIER -84.02 129.28 34.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.1 179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CD2' ' CE2' ' A' ' 81' ' ' TYR . 70.3 m-85 -112.94 -173.45 2.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.0 0.429 . . . . 0.0 110.736 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.64 72.49 0.05 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.643 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.62 147.25 35.69 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 95' ' ' THR . 11.7 t -146.57 128.45 15.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm 59.3 29.94 19.59 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.515 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.2 146.47 40.73 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.47 153.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.681 1.587 . . . . 0.0 111.933 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.553 ' CD ' ' HZ3' ' A' ' 101' ' ' LYS . 3.4 pt20 -67.81 140.28 56.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.642 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.67 122.51 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.553 ' HZ3' ' CD ' ' A' ' 99' ' ' GLN . 47.1 mttp -126.36 -1.39 6.94 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.125 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.2 t -123.42 126.14 46.24 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 0.0 110.271 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.2 pt -147.89 139.92 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.858 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.1 p -146.46 177.06 9.33 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 111.07 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -158.64 155.36 28.06 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.925 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.6 p -155.45 151.63 28.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.229 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.47 110.34 11.79 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.639 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -118.91 107.7 13.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.768 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.68 -126.8 18.73 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -100.79 24.06 9.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.82 0.343 . . . . 0.0 110.24 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.5 p -126.12 154.07 43.65 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.722 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.7 t -133.39 132.73 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -123.38 155.68 36.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.886 0.374 . . . . 0.0 110.768 -178.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.05 142.25 10.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.101 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -118.05 125.13 49.74 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.804 ' N ' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -112.59 119.34 37.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 178.038 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 t -164.47 168.62 18.2 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.083 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.0 m -83.77 172.93 11.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.607 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -105.39 132.87 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.583 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.473 ' CB ' ' ND2' ' A' ' 168' ' ' ASN . 0.0 OUTLIER -70.18 164.49 52.48 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.952 179.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.413 ' HD3' ' HD1' ' A' ' 23' ' ' HIS . 95.3 Cg_endo -75.25 139.21 23.4 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.455 2.104 . . . . 0.0 112.103 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 107.24 -11.63 40.13 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.562 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.499 ' OE1' ' N ' ' A' ' 123' ' ' GLN . 12.2 mp0 -76.29 -50.79 13.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 144.82 -2.17 1.18 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.404 -0.427 . . . . 0.0 112.419 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -103.97 -176.89 3.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.89 161.44 30.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.497 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 23' ' ' HIS . 1.9 t -156.48 68.33 4.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.809 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.16 115.24 2.23 Favored 'Trans proline' 0 N--CA 1.476 0.454 0 C-N-CA 122.68 2.253 . . . . 0.0 112.861 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.9 141.59 29.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.5 pt -137.88 175.34 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 111.128 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 132' ' ' HIS . 25.9 m -83.48 161.16 21.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.788 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.579 ' NE2' ' CD2' ' A' ' 22' ' ' HIS . 21.0 m170 -58.63 -34.2 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.416 ' CD ' ' N ' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -61.34 -53.06 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.214 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -60.73 -43.95 97.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.564 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 138' ' ' MET . . . -59.95 -57.17 14.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.124 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.5 tp -47.05 -39.07 12.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.988 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.82 62.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.344 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 135' ' ' ALA . 36.3 tpp -73.59 -29.67 62.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.83 -178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.35 -21.13 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.7 -37.37 18.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.438 ' OD2' ' CZ ' ' B' ' 18' ' ' ARG . 10.4 m-20 -85.43 -33.96 21.79 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.5 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.406 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 30.6 t -51.39 114.38 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.08 0.467 . . . . 0.0 111.419 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 141' ' ' ASP . 0.3 OUTLIER -127.25 164.26 22.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 145' ' ' SER . 96.1 t -141.4 162.78 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.571 ' N ' HG12 ' A' ' 144' ' ' VAL . 88.0 p -143.37 145.66 32.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.637 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 3.9 mp -140.2 144.32 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.025 0.44 . . . . 0.0 110.594 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -157.89 79.97 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.612 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 185' ' ' VAL . 9.4 mt -73.8 142.29 15.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.535 -178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -134.37 171.99 13.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.446 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.06 118.72 30.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.842 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.3 t -85.94 -173.51 4.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.924 0.393 . . . . 0.0 110.26 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.401 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 6.9 tp10 -165.52 7.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -81.57 105.76 12.99 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.769 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 154' ' ' GLU . 20.1 mp0 -78.35 12.97 1.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.682 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -49.45 155.93 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.771 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.54 167.6 14.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.667 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.0 p -89.51 143.31 26.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.868 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -117.07 88.49 2.91 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.678 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 14.7 pt -110.14 177.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.119 0.485 . . . . 0.0 111.424 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 162' ' ' HIS . 73.7 tttt -137.33 125.95 23.75 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.781 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 161' ' ' THR . 58.4 m -59.22 -0.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.526 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 160' ' ' LYS . 1.9 m80 -82.07 114.88 54.05 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 121.104 -0.239 . . . . 0.0 110.375 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -40.77 154.6 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.729 1.619 . . . . 0.0 112.184 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 49.2 t -77.28 136.56 24.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.577 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 15.8 mt -83.61 124.31 30.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.659 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 164.94 32.68 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.327 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 169' ' ' ILE . 1.4 t -99.12 9.12 44.12 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.473 ' ND2' ' CB ' ' A' ' 120' ' ' SER . 7.1 m-20 59.11 -0.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.523 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.601 ' C ' HD12 ' A' ' 169' ' ' ILE . 2.5 pp -82.03 173.56 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.989 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 172' ' ' LYS . 19.9 m -133.28 129.38 37.54 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -73.13 31.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.48 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 170' ' ' SER . 3.1 mmmm -64.61 -178.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -90.63 121.37 32.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.413 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.497 HG21 ' HE ' ' A' ' 198' ' ' ARG . 17.2 m -141.44 -167.3 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.727 0.299 . . . . 0.0 110.477 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.1 t -48.24 142.95 4.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.922 0.391 . . . . 0.0 110.88 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -95.72 129.09 43.04 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.848 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -141.43 141.07 33.73 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.033 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -79.1 91.6 4.93 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.581 -178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.08 -59.63 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 180' ' ' ILE . 16.3 tt -50.26 122.28 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.48 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -91.66 -122.26 2.8 Favored Glycine 0 C--O 1.228 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.82 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.471 ' OG ' ' SG ' ' B' ' 51' ' ' CYS . 7.6 t -76.61 143.73 40.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.108 0.48 . . . . 0.0 112.202 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 62.8 m -139.89 84.97 2.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.103 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.5 mt -103.89 103.83 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.942 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 148' ' ' ILE . 16.1 m -120.83 134.27 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.8 p-10 -78.89 116.5 19.25 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.716 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 20.6 m -52.09 -29.24 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -36.18 -36.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.679 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . . . . . . . . . 96.2 m -141.54 32.74 1.65 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.643 0.259 . . . . 0.0 110.486 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 92.4 t -149.71 95.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 110.35 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -61.92 1.81 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.106 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.498 ' ND2' ' OE1' ' A' ' 194' ' ' GLU . 22.3 t30 -122.55 137.41 54.9 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -145.27 122.51 11.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.498 ' OE1' ' ND2' ' A' ' 192' ' ' ASN . 2.7 mp0 -109.8 161.35 15.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.483 ' CZ ' HD12 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -153.89 139.25 17.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.142 0.496 . . . . 0.0 110.415 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.9 p -144.15 140.07 29.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.341 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.2 m -128.12 158.23 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.497 ' HE ' HG21 ' A' ' 174' ' ' VAL . 7.3 tpt180 -159.76 104.09 1.55 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.878 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 36.1 mt -106.99 118.83 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -165.67 -157.16 9.74 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.316 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 204' ' ' LYS . 53.6 t0 -86.2 123.34 31.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.86 0.362 . . . . 0.0 110.734 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 23' ' ' HIS . 55.2 mtp -78.12 0.26 25.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.326 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 5.7 t -112.4 -48.77 3.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.773 0.321 . . . . 0.0 110.628 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.481 ' H ' ' CG ' ' A' ' 201' ' ' ASP . 3.2 tppp? -158.29 113.4 2.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.165 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -46.1 145.61 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.541 ' H ' ' CD ' ' A' ' 210' ' ' GLU . 7.5 t -130.23 25.25 5.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.495 ' N ' ' OE1' ' A' ' 210' ' ' GLU . 84.1 p 52.93 -76.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.602 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 206' ' ' SER . 33.5 tt0 -51.58 -34.24 36.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.589 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.0 mm? -88.59 -4.18 58.63 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.787 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 206' ' ' SER . 14.5 mp0 -96.15 144.84 26.03 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.983 0.421 . . . . 0.0 110.793 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 10.0 m -153.98 175.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.592 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 227' ' ' THR . 25.1 tttt -170.23 147.01 3.05 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.478 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -140.86 168.54 19.55 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 174.68 145.08 5.17 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 119.624 -1.274 . . . . 0.0 113.052 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . 0.441 ' CZ ' ' OG ' ' B' ' 14' ' ' SER . 27.9 m-85 -129.37 164.9 22.6 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -137.45 103.27 5.02 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.427 ' O ' ' OD1' ' A' ' 192' ' ' ASN . 21.9 m-85 -97.44 116.5 29.76 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.817 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 44.7 t -128.76 101.89 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.311 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.6 t70 56.29 37.61 28.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.938 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.39 -8.35 75.02 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 112.639 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.9 t -89.23 112.47 23.52 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.699 -0.295 . . . . 0.0 110.452 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.25 167.5 11.16 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.5 t -174.49 116.77 0.2 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.906 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.82 95.03 9.94 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -136.96 129.27 4.71 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 116.416 -0.357 . . . . 0.0 112.448 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -90.67 102.07 14.82 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.712 0.292 . . . . 0.0 110.494 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.499 ' O ' ' NZ ' ' A' ' 212' ' ' LYS . 69.4 p -123.71 153.13 41.29 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.447 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.8 95.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.699 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -90.71 35.55 0.89 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 231' ' ' SER . 9.8 t -75.29 -39.62 59.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.309 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.466 ' N ' HG23 ' A' ' 230' ' ' THR . 99.3 p -102.56 3.78 37.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.339 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 232' ' ' LEU . 0.8 OUTLIER -48.41 -32.87 8.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.097 0.475 . . . . 0.0 110.133 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.6 tt -135.06 150.59 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.242 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -87.41 92.39 9.06 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.405 ' O ' HD11 ' A' ' 238' ' ' LEU . 45.8 m -60.66 -3.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.332 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 30.7 p -91.01 -21.56 21.21 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -101.55 8.45 41.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 238' ' ' LEU . 0.3 OUTLIER -78.65 153.09 31.32 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.281 0.562 . . . . 0.0 111.148 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -141.12 133.88 28.82 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.727 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.63 55.1 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.379 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 59.8 m -110.42 -1.93 16.85 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.528 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.817 0.342 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.56 115.84 2.0 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.762 2.308 . . . . 0.0 112.299 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -59.38 153.54 18.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.511 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.11 166.24 24.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.939 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 25.8 p -70.95 -86.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.369 . . . . 0.0 110.694 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -127.91 80.88 71.38 Favored Pre-proline 0 N--CA 1.47 0.536 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.738 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.431 ' CB ' ' CD ' ' B' ' 8' ' ' PRO . 27.2 Cg_exo -59.38 -174.91 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.502 2.135 . . . . 0.0 112.337 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' B' ' 7' ' ' PRO . 72.8 Cg_exo -53.79 -131.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.37 2.713 . . . . 0.0 113.818 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.493 ' O ' ' N ' ' B' ' 11' ' ' CYS . 1.8 t 177.21 41.93 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.731 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -44.53 93.26 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.538 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.539 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.6 m -134.76 146.33 49.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . 0.469 ' SG ' ' CG2' ' B' ' 31' ' ' THR . 55.7 m -67.47 140.54 57.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.215 0.531 . . . . 0.0 111.017 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.539 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 38.7 m-85 -117.33 -31.02 5.41 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.766 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 215' ' ' PHE . 2.7 m -140.88 145.29 35.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.04 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -109.28 152.22 25.51 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.3 t -78.43 139.56 38.73 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.599 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.1 -42.86 20.33 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.778 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.438 ' CZ ' ' OD2' ' A' ' 141' ' ' ASP . 0.9 OUTLIER -75.9 126.29 30.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.682 -179.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -77.12 137.85 39.16 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.601 HD22 ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -92.79 110.71 47.29 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -44.62 150.09 0.89 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.041 1.827 . . . . 0.0 112.68 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.519 ' C ' ' H ' ' B' ' 24' ' ' PHE . 50.1 mtt85 -46.02 -44.03 14.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.751 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' B' ' 23' ' ' ASN . 2.0 m-20 -68.45 27.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.519 ' H ' ' C ' ' B' ' 22' ' ' ARG . 22.2 t80 -151.98 27.3 0.62 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 93.3 t -155.97 104.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.353 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.14 -10.75 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.7 t0 -161.88 -178.61 6.59 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.897 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.471 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 12.6 p90 -163.2 175.74 10.67 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.217 0.532 . . . . 0.0 111.658 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' O ' ' B' ' 30' ' ' GLU . 59.9 t80 -167.18 140.81 3.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.837 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' B' ' 29' ' ' TYR . 11.3 pt-20 -89.44 147.33 24.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.781 0.324 . . . . 0.0 111.17 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.469 ' CG2' ' SG ' ' B' ' 12' ' ' CYS . 41.1 p -50.51 -107.29 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -151.7 -132.93 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.52 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.444 ' C ' ' H ' ' B' ' 35' ' ' CYS . 23.8 t -152.47 -25.28 0.17 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.684 0.278 . . . . 0.0 110.588 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 20.3 mt -57.7 -7.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.057 0.456 . . . . 0.0 109.921 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.456 ' C ' ' H ' ' B' ' 37' ' ' GLN . 37.8 m -113.42 118.59 34.95 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.524 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 87.4 p -72.33 35.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.533 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.456 ' H ' ' C ' ' B' ' 35' ' ' CYS . 12.9 pt20 -167.59 61.71 0.57 Allowed Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 95.2 Cg_endo -73.94 -161.29 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.803 2.335 . . . . 0.0 113.134 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 174.57 176.37 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.834 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 72.7 t -103.4 139.15 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.038 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.44 124.26 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.794 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -100.64 148.78 24.45 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.035 0.445 . . . . 0.0 110.542 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.465 ' CG ' ' N ' ' B' ' 44' ' ' THR . 26.9 tt0 -93.15 169.22 10.57 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.465 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 17.6 p -138.11 -145.99 0.21 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.337 0.589 . . . . 0.0 111.709 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.49 -40.24 1.96 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.736 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.17 47.05 2.14 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 116.794 -0.184 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 8.6 t -156.2 -79.23 0.08 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.504 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 155.59 -90.05 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -143.76 147.97 34.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.438 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 9.6 t -150.28 114.4 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.259 0.552 . . . . 0.0 111.021 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.471 ' SG ' ' OG ' ' A' ' 182' ' ' SER . 74.5 m -50.12 159.99 0.39 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.704 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.05 130.59 10.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.34 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' B' ' 53' ' ' ASP . 23.4 p-10 -66.17 125.45 90.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.33 -2.06 11.84 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.141 1.227 . . . . 0.0 111.011 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 36.2 t -69.2 -12.22 61.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.199 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -101.02 122.65 43.92 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.132 0.491 . . . . 0.0 110.307 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 45.2 t -48.17 -46.86 35.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.496 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 35.4 p-90 -56.27 -24.71 44.71 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.572 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -75.26 -38.08 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 109.771 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -66.6 -48.43 69.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.551 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -62.41 -34.98 77.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.327 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.1 m-85 -61.8 -40.81 96.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.301 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.36 -47.71 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.06 -31.43 65.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.748 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -73.7 -35.16 65.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.702 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.91 -20.01 59.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -73.27 -35.76 66.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.77 -77.46 0.14 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.839 0.352 . . . . 0.0 110.342 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 18.2 p30 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.524 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 10.9 tpt . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 1' ' ' MET . 60.6 Cg_endo -89.43 -49.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.225 1.95 . . . . 0.0 111.986 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 50.93 86.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.603 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 m -166.28 61.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.505 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.4 mt 50.7 -177.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.461 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -170.02 69.13 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.613 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.469 ' C ' ' H ' ' A' ' 9' ' ' SER . 78.6 mt-30 -70.49 -20.21 62.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.52 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 p 74.22 -26.86 0.19 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 7' ' ' GLN . 10.1 t -72.82 -25.5 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.796 0.331 . . . . 0.0 110.755 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 t -51.53 144.16 10.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.54 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -68.07 -28.57 67.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.0 t -76.88 -22.68 53.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.8 p -81.11 -49.0 11.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -162.24 169.98 19.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.024 0.44 . . . . 0.0 111.026 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.3 t -63.84 153.43 36.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.68 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.7 p -72.84 172.36 10.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.461 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.68 2.69 9.53 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.427 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 1.6 mp0 -77.78 98.17 5.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.439 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -31.17 -53.53 0.21 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.694 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -86.65 52.06 2.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.607 0.241 . . . . 0.0 110.682 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' NZ ' ' C ' ' A' ' 129' ' ' ALA . 16.7 tttm -160.26 133.46 6.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 110.246 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.44 ' CG ' ' C ' ' A' ' 21' ' ' LYS . 70.6 m-70 -154.35 124.31 6.76 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.991 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.523 ' CE1' ' CG ' ' A' ' 121' ' ' PRO . 11.1 p80 -76.68 97.2 4.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.53 149.13 40.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.091 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.61 158.38 26.56 Favored Glycine 0 CA--C 1.508 -0.388 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 tt -110.33 150.73 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -152.1 106.44 3.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.987 0.422 . . . . 0.0 110.008 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.86 126.7 74.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.991 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -107.97 166.47 4.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.274 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 30' ' ' ILE . 12.9 tt -161.2 110.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.796 -178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -98.3 132.9 43.4 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.03 120.67 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.995 0.426 . . . . 0.0 110.844 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.539 ' HG1' ' H ' ' A' ' 192' ' ' ASN . 68.4 p -88.33 121.26 30.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -75.81 150.76 37.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.027 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -75.75 136.44 40.3 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.82 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -46.77 -19.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 37' ' ' GLN . 1.3 mp0 -81.31 -43.89 18.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.547 0.213 . . . . 0.0 111.16 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -42.7 147.77 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.067 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.71 172.1 16.81 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.122 1.881 . . . . 0.0 111.446 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 34.7 p -74.02 135.23 43.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.474 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -167.09 99.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.47 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -103.64 -1.08 28.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.535 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -67.87 91.47 0.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -89.8 160.49 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.907 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 45' ' ' CYS . 36.9 t 55.26 62.87 2.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.507 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.557 ' NE2' ' N ' ' A' ' 155' ' ' LYS . 3.4 tp60 -77.44 -27.55 52.24 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.1 p -174.2 -176.19 1.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.888 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.3 p -170.36 101.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 109.956 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.8 p -103.38 126.7 50.68 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.732 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 1.5 pm0 -104.39 142.51 34.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.964 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 tp -147.99 157.9 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t -153.37 151.61 30.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.481 ' OE1' ' CE1' ' B' ' 24' ' ' PHE . 52.0 tt0 -48.0 168.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 p -70.07 -23.73 63.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.006 0.432 . . . . 0.0 110.06 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -42.77 -61.51 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.045 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 39.5 m -27.15 -96.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.393 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.717 ' H ' ' CD ' ' A' ' 58' ' ' PRO . 18.9 t70 -170.99 -33.15 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.717 ' CD ' ' H ' ' A' ' 57' ' ' ASP . 91.9 Cg_endo -90.62 -65.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.993 1.796 . . . . 0.0 113.437 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -40.73 103.11 0.28 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -90.9 60.42 1.3 Allowed 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 122.221 1.947 . . . . 0.0 112.02 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 63' ' ' GLU . 21.2 mt-10 -62.29 89.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 61' ' ' GLU . 17.1 m 10.32 55.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 124.255 0.972 . . . . 0.0 113.517 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 61' ' ' GLU . 6.6 tp10 -43.12 172.75 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.871 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 63' ' ' GLU . 3.5 p 145.53 50.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.942 0.776 . . . . 0.0 109.736 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -170.8 159.75 6.54 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.035 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 69.85 62.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.025 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -83.96 -122.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.904 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.6 t -74.68 85.47 2.13 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.4 p -151.67 158.71 43.8 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.734 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 93.2 p 50.7 -162.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.764 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 m -153.71 67.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.985 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 59.55 75.77 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.425 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 74' ' ' VAL . 25.0 t70 -76.86 -139.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.323 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.477 ' H ' ' CG ' ' A' ' 73' ' ' ASP . 60.7 t -91.84 -40.27 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.782 0.325 . . . . 0.0 110.596 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 43.1 75.84 0.59 Allowed Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.966 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -89.51 110.68 0.48 Allowed 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.203 2.602 . . . . 0.0 112.638 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -87.6 164.3 7.87 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.474 2.116 . . . . 0.0 111.039 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -124.27 121.95 36.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.751 0.31 . . . . 0.0 111.001 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 p -97.76 125.45 42.59 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.507 ' C ' ' CD1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -121.47 110.49 16.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.248 0.547 . . . . 0.0 111.019 -178.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -93.73 124.09 37.5 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.519 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' ' CZ ' ' A' ' 80' ' ' TYR . 4.9 m -94.53 72.9 3.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.051 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.3 mm -74.67 101.73 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.801 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.6 mm -94.25 145.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.021 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.55 169.71 18.17 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.502 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.1 20.48 54.1 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.22 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.28 10.84 84.41 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 23.7 mt -131.98 155.62 47.65 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.58 115.45 27.2 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 33.3 mtt -102.07 124.16 47.2 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.04 0.448 . . . . 0.0 110.939 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.542 ' C ' HD22 ' A' ' 91' ' ' ASN . 0.2 OUTLIER -114.18 133.1 55.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.729 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -120.38 -174.73 2.86 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.821 0.343 . . . . 0.0 110.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -171.52 74.13 0.1 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.077 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -76.98 135.35 38.69 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.703 0.287 . . . . 0.0 110.474 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.404 ' CB ' HH21 ' B' ' 18' ' ' ARG . 91.7 m -143.65 121.12 11.7 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.449 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.9 tmtp? 65.0 31.72 11.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.979 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 69.2 m -126.42 149.81 68.58 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -39.22 143.51 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.999 1.799 . . . . 0.0 111.978 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.434 ' CD ' ' N ' ' A' ' 99' ' ' GLN . 4.2 mp0 -73.21 110.03 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.849 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.4 pt -69.13 142.1 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.051 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -135.34 -6.89 2.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.349 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.2 m -107.36 119.54 39.68 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.81 0.338 . . . . 0.0 110.207 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 34.8 mt -132.04 120.02 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.425 ' OG ' HD12 ' A' ' 238' ' ' LEU . 35.1 p -146.58 162.87 37.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 111.015 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -148.39 164.83 32.92 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -155.12 151.86 28.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.911 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.08 124.9 33.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.424 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -145.22 111.43 5.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.002 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.47 -127.14 8.96 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -108.29 24.67 12.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.753 0.311 . . . . 0.0 110.32 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 p -129.16 159.17 36.88 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.637 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t -139.09 137.17 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 106' ' ' SER . 50.9 p30 -120.93 153.21 37.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.078 0.465 . . . . 0.0 111.006 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.21 130.66 19.9 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.605 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -116.52 116.49 27.72 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.02 0.438 . . . . 0.0 110.899 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.3 mt -116.25 126.72 53.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.1 p -166.68 167.42 15.27 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.508 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 167' ' ' SER . 74.0 m -84.28 172.82 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.686 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 119' ' ' VAL . 10.7 m -96.18 147.92 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.958 0.408 . . . . 0.0 111.024 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.466 ' OG ' ' ND2' ' A' ' 168' ' ' ASN . 1.6 t -92.71 152.2 41.63 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.523 ' CG ' ' CE1' ' A' ' 23' ' ' HIS . 74.0 Cg_exo -37.89 158.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.178 1.919 . . . . 0.0 112.188 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 51.21 64.45 3.81 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.175 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -140.99 -1.12 1.41 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.33 11.15 82.59 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.439 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -136.47 150.14 48.56 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -50.53 154.72 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.982 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -158.44 60.72 1.84 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.384 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -35.53 143.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.333 2.689 . . . . 0.0 113.715 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.45 ' C ' ' NZ ' ' A' ' 21' ' ' LYS . . . -109.96 146.56 35.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.568 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.01 165.81 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 110.186 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.479 ' OG1' ' N ' ' A' ' 132' ' ' HIS . 0.2 OUTLIER -87.44 174.48 8.49 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' N ' ' OG1' ' A' ' 131' ' ' THR . 2.0 t60 -63.92 -39.33 93.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.67 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.34 -57.52 12.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.28 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.428 ' H ' HG23 ' A' ' 131' ' ' THR . 8.0 tp10 -63.18 -42.26 99.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.538 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.16 -57.01 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.177 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.86 -36.68 59.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.056 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.48 -37.66 71.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 21.1 mtt -62.34 -58.43 7.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.345 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.2 -24.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.859 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -78.29 -55.27 5.38 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.376 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.41 ' O ' ' OE2' ' A' ' 143' ' ' GLU . 33.9 m-20 -77.82 -23.65 48.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 19.0 t -58.07 113.59 1.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.526 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.54 ' CD ' ' HE ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -143.51 148.3 35.79 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.269 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.95 131.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.931 0.396 . . . . 0.0 110.309 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.6 p -103.19 173.12 6.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.63 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 15.1 pt -150.78 148.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.01 0.433 . . . . 0.0 110.776 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -152.19 83.37 1.26 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.879 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.4 tt -76.58 154.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.885 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 150' ' ' CYS . 34.1 ttt85 -145.36 172.17 13.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.022 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 149' ' ' ARG . 6.2 t -91.02 116.16 28.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.774 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 11.8 p -92.94 -176.85 4.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.208 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -158.9 6.06 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.295 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.469 ' O ' ' NE2' ' A' ' 46' ' ' GLN . 63.8 tt0 -70.24 107.01 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.309 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -87.95 16.25 6.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.225 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.557 ' N ' ' NE2' ' A' ' 46' ' ' GLN . 3.9 mmmm -60.73 172.72 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.674 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -76.55 169.65 17.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.636 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 71.6 m -96.6 147.65 23.66 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.747 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.47 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 16.3 t70 -113.18 90.94 3.48 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 160' ' ' LYS . 63.6 mt -115.11 159.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.17 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.521 ' N ' HG22 ' A' ' 159' ' ' ILE . 6.7 mmtp -121.9 128.93 52.13 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.9 p -62.55 1.97 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 160' ' ' LYS . 80.1 t60 -78.72 116.91 63.36 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.273 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -40.39 150.12 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.654 1.569 . . . . 0.0 111.939 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -79.85 137.14 22.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.968 0.413 . . . . 0.0 110.898 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.6 mt -78.01 147.43 34.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.753 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -119.46 156.96 15.61 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.091 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 169' ' ' ILE . 3.5 m -89.57 10.31 23.43 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.466 ' ND2' ' OG ' ' A' ' 120' ' ' SER . 10.6 m-20 56.5 1.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.502 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.494 ' H ' ' C ' ' A' ' 167' ' ' SER . 8.4 tp -94.33 144.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 26.6 p -105.65 149.91 25.92 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -83.83 46.34 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.373 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -73.0 -177.16 2.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.398 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -93.55 117.56 30.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.538 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.502 ' O ' ' CE1' ' A' ' 176' ' ' TYR . 13.3 m -139.83 -171.24 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.145 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.1 t -43.31 138.15 2.41 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.77 0.319 . . . . 0.0 110.898 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.502 ' CE1' ' O ' ' A' ' 174' ' ' VAL . 2.3 m-85 -98.95 136.79 38.43 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.252 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 178' ' ' ASP . 5.1 tm-20 -151.84 158.11 42.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.512 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 4.5 p-10 -92.94 93.36 8.33 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 179' ' ' ILE . 0.2 OUTLIER -115.42 17.31 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.126 0.488 . . . . 0.0 110.016 178.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 180' ' ' ILE . 2.3 pp -113.14 119.11 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.292 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -79.59 -142.67 2.64 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.876 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' B' ' 51' ' ' CYS . 37.5 t -69.33 158.96 34.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.434 ' O ' ' CD1' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -144.6 95.06 2.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.114 0.483 . . . . 0.0 110.151 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.8 132.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.655 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.578 HG21 ' CE2' ' A' ' 217' ' ' TYR . 3.3 m -142.74 123.02 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.691 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 186' ' ' ASP . 30.6 p-10 -85.08 98.06 10.21 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 189' ' ' CYS . 31.3 m -47.58 -26.88 1.6 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.592 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -39.82 -26.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.21 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 187' ' ' THR . 94.0 m -146.31 24.94 1.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.185 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 23.3 t -148.5 95.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.83 0.348 . . . . 0.0 110.574 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.74 -54.9 13.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.283 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.539 ' H ' ' HG1' ' A' ' 33' ' ' THR . 7.2 m-20 -125.35 -176.57 3.62 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.753 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.509 HD23 ' C ' ' A' ' 193' ' ' LEU . 4.7 tt -172.88 109.16 0.19 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -96.12 121.3 37.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -120.73 129.88 53.82 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.038 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 2.9 p -144.58 134.22 23.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 198' ' ' ARG . 59.1 t -122.88 154.91 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.449 ' N ' HG12 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -145.53 144.77 30.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.237 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 10.8 mt -148.99 117.34 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.568 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.44 172.53 45.55 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.416 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.43 119.92 10.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 0.0 111.326 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' MET . . . . . . . . . . . . . 49.7 mtm -77.17 4.18 10.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.64 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 6.7 t -97.23 -61.74 1.36 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.437 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -147.49 115.02 6.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.323 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -43.64 123.23 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.633 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 11.0 t -117.16 105.05 11.83 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.652 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.3 m -38.21 -36.97 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.156 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -68.83 -48.98 62.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.522 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.677 ' N ' HD22 ' A' ' 209' ' ' LEU . 2.5 mm? -90.42 13.88 14.44 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.829 -0.169 . . . . 0.0 111.245 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 128.16 42.65 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 212' ' ' LYS . 74.6 t -153.31 161.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.374 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 211' ' ' VAL . 0.0 OUTLIER -167.38 160.34 13.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.473 0.654 . . . . 0.0 112.444 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 214' ' ' GLY . 13.6 t70 -146.5 171.39 15.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.352 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 213' ' ' ASP . . . 162.89 145.4 4.34 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.902 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -136.23 -171.4 2.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -152.93 108.14 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.439 0.638 . . . . 0.0 111.439 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.578 ' CE2' HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -96.85 123.66 40.61 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 220' ' ' GLY . 6.2 p -141.06 118.31 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.4 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 30.0 t70 59.92 -13.92 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.308 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 218' ' ' VAL . . . 140.08 0.44 1.93 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 112.115 -0.394 . . . . 0.0 112.115 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.5 t -104.11 117.5 34.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.58 156.24 17.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.906 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 36.3 t -166.17 123.26 1.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 11.8 pttm -81.28 99.09 8.44 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -120.55 134.51 10.36 Favored Glycine 0 C--N 1.337 0.584 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.934 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.46 ' HA ' ' HZ2' ' A' ' 212' ' ' LYS . . . -98.39 98.09 9.36 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 70.0 p -134.73 163.34 30.0 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.919 0.39 . . . . 0.0 110.943 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.403 ' CG ' ' HG1' ' A' ' 230' ' ' THR . 22.4 t70 -66.16 95.8 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.486 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -85.69 28.96 0.73 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.712 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.403 ' HG1' ' CG ' ' A' ' 228' ' ' ASP . 27.6 m -64.21 -57.09 10.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.165 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 m -84.57 1.25 46.79 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.544 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.3 tp -41.35 -29.5 0.15 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.75 0.31 . . . . 0.0 111.413 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 2.4 pp -152.29 145.03 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.304 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.79 93.08 3.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.121 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . 0.428 ' O ' ' CD2' ' A' ' 238' ' ' LEU . 31.4 t -64.42 -2.54 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.188 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . . . . . . . . . 74.3 m -93.73 -19.41 21.1 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.424 ' N ' ' CD ' ' A' ' 237' ' ' LYS . 3.3 mptp? -98.76 -2.38 38.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.514 ' CD2' ' H ' ' A' ' 238' ' ' LEU . 1.1 pt? -91.04 158.2 16.82 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.363 0.983 . . . . 0.0 111.223 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -131.92 151.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.617 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -55.57 161.62 1.96 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.723 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' CYS . . . . . . . . . . . . . 54.0 t -124.19 -13.78 7.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.017 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.588 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.731 0.3 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -45.65 121.45 4.07 Favored 'Trans proline' 0 N--CA 1.473 0.317 0 C-N-CA 122.732 2.288 . . . . 0.0 112.265 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -56.71 144.29 33.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.482 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.1 152.17 48.16 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.141 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.4 t -60.11 173.88 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 121.153 -0.219 . . . . 0.0 110.43 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -31.27 96.96 0.1 OUTLIER Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' B' ' 8' ' ' PRO . 63.9 Cg_endo -87.62 161.39 7.9 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.351 2.034 . . . . 0.0 110.903 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' B' ' 7' ' ' PRO . 25.1 Cg_exo -34.61 -118.81 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.838 3.026 . . . . 0.0 114.296 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.957 HG23 ' H ' ' B' ' 10' ' ' ALA . 0.9 OUTLIER 177.42 -75.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 -179.019 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.957 ' H ' HG23 ' B' ' 9' ' ' THR . . . 80.72 57.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.446 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.528 ' O ' ' CE1' ' B' ' 13' ' ' PHE . 67.0 m -104.57 151.8 23.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.849 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' CYS . . . . . . . . . . . . . 95.6 m -55.48 139.94 41.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.133 0.492 . . . . 0.0 112.008 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' B' ' 11' ' ' CYS . 8.8 m-85 -112.17 -27.26 8.43 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.7 t -158.42 158.8 34.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.489 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.39 -178.2 3.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.18 0.514 . . . . 0.0 111.778 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -99.05 135.83 39.9 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.78 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.4 12.12 4.82 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.639 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.54 ' HE ' ' CD ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -148.92 136.64 20.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.023 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -79.54 130.31 35.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.543 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.607 HD22 ' N ' ' B' ' 20' ' ' LEU . 3.3 mm? -84.12 114.46 54.59 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.546 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -42.34 141.87 1.97 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.783 1.655 . . . . 0.0 112.168 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.503 ' C ' ' H ' ' B' ' 24' ' ' PHE . 46.0 mtt85 -44.18 -42.62 6.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.597 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -69.77 28.24 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' B' ' 22' ' ' ARG . 23.2 t80 -153.12 29.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 97.3 t -155.03 99.12 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.902 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -97.48 -9.35 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' B' ' 28' ' ' TYR . 30.6 t70 -163.85 -178.97 6.0 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.883 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . 0.472 ' H ' ' CG ' ' B' ' 27' ' ' ASP . 8.2 p90 -165.09 172.44 12.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.285 0.564 . . . . 0.0 111.652 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.441 ' CZ ' ' OD2' ' B' ' 27' ' ' ASP . 76.7 m-85 -153.87 179.63 8.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.064 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -125.5 147.38 49.26 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.843 0.354 . . . . 0.0 110.081 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 36.9 p -53.92 -106.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.814 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.5 t -157.7 -142.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.595 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.468 ' C ' ' H ' ' B' ' 35' ' ' CYS . 70.3 m -145.65 -22.28 0.47 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.296 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' B' ' 34' ' ' LEU . 2.2 mm? -56.83 -7.46 0.45 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' B' ' 33' ' ' SER . 3.6 p -121.29 122.51 40.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.517 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 86.1 p -74.55 42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.195 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -167.69 57.0 0.36 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' B' ' 39' ' ' ALA . 64.3 Cg_endo -68.94 -164.2 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.909 2.406 . . . . 0.0 113.116 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' B' ' 38' ' ' PRO . . . 175.59 176.82 0.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.972 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.47 135.05 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.021 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.71 134.28 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.217 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -108.34 151.74 25.58 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.707 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.479 ' CG ' ' N ' ' B' ' 44' ' ' THR . 28.0 tt0 -93.13 168.84 10.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . 0.479 ' N ' ' CG ' ' B' ' 43' ' ' GLN . 7.5 p -135.6 -144.96 0.21 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.343 0.592 . . . . 0.0 111.132 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ALA . . . . . 0.412 ' N ' ' OG1' ' B' ' 44' ' ' THR . . . -130.46 -38.82 1.33 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.988 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.47 46.24 2.34 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.728 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.613 ' O ' ' HB2' ' B' ' 48' ' ' ALA . 15.5 t -156.58 -81.02 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.532 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . 156.16 -87.79 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.93 148.02 32.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.98 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 48.0 t -152.32 123.21 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.153 0.502 . . . . 0.0 109.844 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.479 ' H ' ' CB ' ' A' ' 182' ' ' SER . 5.4 t -58.36 164.44 2.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.979 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.9 134.62 13.68 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.717 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -68.21 120.13 72.43 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.05 -0.02 8.49 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.065 1.177 . . . . 0.0 111.318 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' SER . . . . . . . . . . . . . 59.5 p -74.11 -9.1 58.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.28 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -102.28 125.65 49.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.219 0.533 . . . . 0.0 110.422 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.6 m -47.47 -50.07 24.04 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.463 ' O ' ' CD1' ' B' ' 62' ' ' TYR . 64.4 p-90 -56.13 -27.56 54.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.758 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 41.7 t -71.48 -38.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -67.12 -51.6 52.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.357 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.81 -35.46 70.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' B' ' 58' ' ' TRP . 3.0 m-85 -62.88 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 75.2 t -71.01 -46.38 67.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.92 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.17 -28.85 69.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.537 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.27 -41.07 61.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.699 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' LEU . . . . . . . . . . . . . 17.5 mt -70.34 -22.5 62.79 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -69.93 -33.56 72.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.2 -102.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 4.9 t30 . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.6 179.916 . . . . . . . . 0 0 . 1 stop_ save_